CAS No. | Saflık | Ürün Adı | BOSTON KODU |
---|---|---|---|
Cas.: 2225173-89-5 | Purity: 95% | 1-(3,5-Difluorophenyl)-1H-pyrazole-4-boronic acid | ESD-908138-25MG |
Cas.: 2225173-93-1 | Purity: 95% | 4-Bromo-2-(1H-pyrazol-1-yl)phenylboronic acid | ESD-908139-5MG |
Cas.: 2225173-93-1 | Purity: 95% | 4-Bromo-2-(1H-pyrazol-1-yl)phenylboronic acid | ESD-908139-25MG |
Cas.: 2225174-01-4 | Purity: 95% | 2-(iso-Propyl-d7)-pyridine-5-boronic acid | ESD-908140-5MG |
Cas.: 2225174-01-4 | Purity: 95% | 2-(iso-Propyl-d7)-pyridine-5-boronic acid | ESD-908140-25MG |
Cas.: 2225174-08-1 | Purity: 95% | 5-Chloro-6-(iso-butyl)pyridine-3-boronic acid | ESD-908141-5MG |
Cas.: 2225174-08-1 | Purity: 95% | 5-Chloro-6-(iso-butyl)pyridine-3-boronic acid | ESD-908141-25MG |
Cas.: 2225174-09-2 | Purity: 95% | 4-Chloro-2-(iso-propyl)pyrimidine-5-boronic acid | ESD-908142-5MG |
Cas.: 2225174-09-2 | Purity: 95% | 4-Chloro-2-(iso-propyl)pyrimidine-5-boronic acid | ESD-908142-25MG |
Cas.: 2225174-15-0 | Purity: 95% | 1-(2-Methyl-4-pyridyl)-1H-pyrazole-4-boronic acid | ESD-908143-5MG |
Cas.: 2225174-15-0 | Purity: 95% | 1-(2-Methyl-4-pyridyl)-1H-pyrazole-4-boronic acid | ESD-908143-25MG |
Cas.: 2225174-18-3 | Purity: 95% | 2-(Morpholino-d8)-4-chloropyrimidine-5-boronic acid | ESD-908144-5MG |
Cas.: 2225174-18-3 | Purity: 95% | 2-(Morpholino-d8)-4-chloropyrimidine-5-boronic acid | ESD-908144-25MG |
Cas.: 2225174-27-4 | Purity: 95% | 3-Methyl-1-(pyridin-4-yl)pyrazole-4-boronic acid | ESD-908145-5MG |
Cas.: 2225174-27-4 | Purity: 95% | 3-Methyl-1-(pyridin-4-yl)pyrazole-4-boronic acid | ESD-908145-25MG |
Cas.: 2225174-28-5 | Purity: 95% | 4-Chloro-2-(4-fluorophenyl)pyrimidine-5-boronic acid | ESD-908146-5MG |
Cas.: 2225174-28-5 | Purity: 95% | 4-Chloro-2-(4-fluorophenyl)pyrimidine-5-boronic acid | ESD-908146-25MG |
Cas.: 2225174-35-4 | Purity: 95% | 4-Chloro-2-methylpyrimidine-5-boronic acid | ESD-908147-5MG |
Cas.: 2225174-35-4 | Purity: 95% | 4-Chloro-2-methylpyrimidine-5-boronic acid | ESD-908147-25MG |
Cas.: 2225174-47-8 | Purity: 95% | 2-(Ethoxy-d5)-4-chloropyrimidine-5-boronic acid | ESD-908148-5MG |
Cas.: 2225174-47-8 | Purity: 95% | 2-(Ethoxy-d5)-4-chloropyrimidine-5-boronic acid | ESD-908148-25MG |
Cas.: 2225174-55-8 | Purity: 95% | 4-Chloro-2-(2-fluorophenyl)pyrimidine-5-boronic acid | ESD-908149-5MG |
Cas.: 2225174-55-8 | Purity: 95% | 4-Chloro-2-(2-fluorophenyl)pyrimidine-5-boronic acid | ESD-908149-25MG |
Cas.: 2225174-67-2 | Purity: 95% | 2-Chloro-4-(Methyl-d3)-pyrimidine-5-boronic acid | ESD-908150-5MG |
Cas.: 2225174-67-2 | Purity: 95% | 2-Chloro-4-(Methyl-d3)-pyrimidine-5-boronic acid | ESD-908150-25MG |
Cas.: 2225174-85-4 | Purity: 95% | 3-(Piperidin-4-yl)-5-(iso-butyl)phenylboronic acid | ESD-908151-5MG |
Cas.: 2225174-85-4 | Purity: 95% | 3-(Piperidin-4-yl)-5-(iso-butyl)phenylboronic acid | ESD-908151-25MG |
Cas.: 2225174-91-2 | Purity: 95% | 3-Cyclopropyl-5-(piperidino)phenylboronic acid | ESD-908152-5MG |
Cas.: 2225174-91-2 | Purity: 95% | 3-Cyclopropyl-5-(piperidino)phenylboronic acid | ESD-908152-25MG |
Cas.: 2225174-97-8 | Purity: 95% | 2-Fluoro-4-(iso-propyl)phenylboronic acid | ESD-908153-5MG |
Cas.: 2225174-97-8 | Purity: 95% | 2-Fluoro-4-(iso-propyl)phenylboronic acid | ESD-908153-25MG |
Cas.: 2225175-07-3 | Purity: 95% | 2-Fluoro-5-(cyclohexyl)phenylboronic acid | ESD-908154-5MG |
Cas.: 2225175-07-3 | Purity: 95% | 2-Fluoro-5-(cyclohexyl)phenylboronic acid | ESD-908154-25MG |
Cas.: 2225175-14-2 | Purity: 95% | 2-Cyclopropyl-5-(2-methylimidazol-1-yl)phenylboronic acid | ESD-908155-5MG |
Cas.: 2225175-14-2 | Purity: 95% | 2-Cyclopropyl-5-(2-methylimidazol-1-yl)phenylboronic acid | ESD-908155-25MG |
Cas.: 2225175-25-5 | Purity: 95% | 4-Cyclopropyl-3-(1H-imidazol-1-yl)phenylboronic acid | ESD-908156-5MG |
Cas.: 2225175-25-5 | Purity: 95% | 4-Cyclopropyl-3-(1H-imidazol-1-yl)phenylboronic acid | ESD-908156-25MG |
Cas.: 2225175-34-6 | Purity: 95% | 5-Chloro-2-(1H-pyrazol-1-yl)phenylboronic acid | ESD-908157-5MG |
Cas.: 2225175-34-6 | Purity: 95% | 5-Chloro-2-(1H-pyrazol-1-yl)phenylboronic acid | ESD-908157-25MG |
Cas.: 2225175-42-6 | Purity: 95% | (6-(furan-3-yl)pyridin-3-yl)boronic acid | ESD-908158-25MG |
Cas.: 2225175-42-6 | Purity: 95% | (6-(furan-3-yl)pyridin-3-yl)boronic acid | ESD-908158-100MG |
Cas.: 2225175-53-9 | Purity: 95% | 5-Chloro-6-(5-pyrimidyl)pyridine-3-boronic acid | ESD-908159-5MG |
Cas.: 2225175-53-9 | Purity: 95% | 5-Chloro-6-(5-pyrimidyl)pyridine-3-boronic acid | ESD-908159-25MG |
Cas.: 2225175-69-7 | Purity: 95% | 1-(4-Methoxyphenyl)-1H-pyrazole-4-boronic acid | ESD-908160-5MG |
Cas.: 2225175-69-7 | Purity: 95% | 1-(4-Methoxyphenyl)-1H-pyrazole-4-boronic acid | ESD-908160-25MG |
Cas.: 2225175-83-5 | Purity: 95% | 1-Cyclopropyl-1H-1,2,3-triazole-4-boronic acid | ESD-908161-5MG |
Cas.: 2225175-83-5 | Purity: 95% | 1-Cyclopropyl-1H-1,2,3-triazole-4-boronic acid | ESD-908161-25MG |
Cas.: 2225175-88-0 | Purity: 95% | 4-Chloro-2-(cyclohexyl)pyrimidine-5-boronic acid | ESD-908162-5MG |
Cas.: 2225175-88-0 | Purity: 95% | 4-Chloro-2-(cyclohexyl)pyrimidine-5-boronic acid | ESD-908162-25MG |
Cas.: 2225175-97-1 | Purity: 95% | 4-Chloro-2-(4-trifluoromethylphenyl)pyrimidine-5-boronic acid | ESD-908163-5MG |
Cas.: 2225175-97-1 | Purity: 95% | 4-Chloro-2-(4-trifluoromethylphenyl)pyrimidine-5-boronic acid | ESD-908163-25MG |
Cas.: 2225176-64-5 | Purity: 95% | 3-(tert-Butyl)-5-(2-thienyl)phenylboronic acid | ESD-908164-5MG |
Cas.: 2225176-64-5 | Purity: 95% | 3-(tert-Butyl)-5-(2-thienyl)phenylboronic acid | ESD-908164-25MG |
Cas.: 2225176-75-8 | Purity: 95% | 4-(4-Tolyl)thiophene-2-boronic acid | ESD-908165-50MG |
Cas.: 2225176-75-8 | Purity: 95% | 4-(4-Tolyl)thiophene-2-boronic acid | ESD-908165-250MG |
Cas.: 2225176-81-6 | Purity: 95% | 4-Cyclopropyl-3-(methoxymethyl)phenylboronic acid | ESD-908166-5MG |
Cas.: 2225176-81-6 | Purity: 95% | 4-Cyclopropyl-3-(methoxymethyl)phenylboronic acid | ESD-908166-25MG |
Cas.: 2225176-86-1 | Purity: 95% | 4-(4-Methoxyphenyl)thiophene-2-boronic acid | ESD-908167-50MG |
Cas.: 2225176-86-1 | Purity: 95% | 4-(4-Methoxyphenyl)thiophene-2-boronic acid | ESD-908167-250MG |
Cas.: 2225176-95-2 | Purity: 95% | 4-Cyclopropyl-2-(1H-pyrazol-1-yl)phenylboronic acid | ESD-908168-5MG |
Cas.: 2225176-95-2 | Purity: 95% | 4-Cyclopropyl-2-(1H-pyrazol-1-yl)phenylboronic acid | ESD-908168-25MG |
Cas.: 2225177-00-2 | Purity: 95% | 3-Chloro-4-(1H-imidazol-1-yl)phenylboronic acid | ESD-908169-5MG |
Cas.: 2225177-00-2 | Purity: 95% | 3-Chloro-4-(1H-imidazol-1-yl)phenylboronic acid | ESD-908169-25MG |
Cas.: 2225177-05-7 | Purity: 95% | 2-(4-tert-Butylphenyl)pyridine-4-boronic acid | ESD-908170-5MG |
Cas.: 2225177-05-7 | Purity: 95% | 2-(4-tert-Butylphenyl)pyridine-4-boronic acid | ESD-908170-25MG |
Cas.: 2225177-10-4 | Purity: 95% | 5-(Cyclobutyl)furan-2-boronic acid | ESD-908171-5MG |
Cas.: 2225177-10-4 | Purity: 95% | 5-(Cyclobutyl)furan-2-boronic acid | ESD-908171-25MG |
Cas.: 2225177-24-0 | Purity: 95% | (2-(3-cyanophenyl)pyrimidin-5-yl)boronic acid | ESD-908172-25MG |
Cas.: 2225177-24-0 | Purity: 95% | (2-(3-cyanophenyl)pyrimidin-5-yl)boronic acid | ESD-908172-100MG |
Cas.: 2225177-30-8 | Purity: 95% | 3-(tert-Butyl)-5-(pyridin-2-yl)phenylboronic acid | ESD-908173-5MG |
Cas.: 2225177-30-8 | Purity: 95% | 3-(tert-Butyl)-5-(pyridin-2-yl)phenylboronic acid | ESD-908173-25MG |
Cas.: 2225177-32-0 | Purity: 95% | 1-(2-Thienyl)-1H-pyrazole-4-boronic acid | ESD-908174-5MG |
Cas.: 2225177-32-0 | Purity: 95% | 1-(2-Thienyl)-1H-pyrazole-4-boronic acid | ESD-908174-25MG |
Cas.: 2225177-37-5 | Purity: 95% | 1-(3-Methoxyphenyl)-1H-pyrazole-4-boronic acid | ESD-908175-5MG |
Cas.: 2225177-37-5 | Purity: 95% | 1-(3-Methoxyphenyl)-1H-pyrazole-4-boronic acid | ESD-908175-25MG |
Cas.: 2225177-40-0 | Purity: 95% | 3-Bromo-4-(methoxymethyl)phenylboronic acid | ESD-908176-5MG |
Cas.: 2225177-40-0 | Purity: 95% | 3-Bromo-4-(methoxymethyl)phenylboronic acid | ESD-908176-25MG |
Cas.: 2225177-44-4 | Purity: 95% | 3-Methyl-1-(thiazol-5-yl)pyrazole-4-boronic acid | ESD-908177-5MG |
Cas.: 2225177-44-4 | Purity: 95% | 3-Methyl-1-(thiazol-5-yl)pyrazole-4-boronic acid | ESD-908177-25MG |
Cas.: 2225177-52-4 | Purity: 95% | 2-Cyclopropyl-5-(1H-pyrazol-1-yl)phenylboronic acid | ESD-908178-5MG |
Cas.: 2225177-52-4 | Purity: 95% | 2-Cyclopropyl-5-(1H-pyrazol-1-yl)phenylboronic acid | ESD-908178-25MG |
Cas.: 2225177-54-6 | Purity: 95% | 3-Methyl-1-(2-fluorophenyl)pyrazole-4-boronic acid | ESD-908179-25MG |
Cas.: 2225177-54-6 | Purity: 95% | 3-Methyl-1-(2-fluorophenyl)pyrazole-4-boronic acid | ESD-908179-100MG |
Cas.: 2225177-64-8 | Purity: 95% | 3,5-Bis(piperidino)phenylboronic acid | ESD-908180-5MG |
Cas.: 2225177-64-8 | Purity: 95% | 3,5-Bis(piperidino)phenylboronic acid | ESD-908180-25MG |
Cas.: 2225177-67-1 | Purity: 95% | 4-Chloro-2-(cyclopropyl)pyrimidine-5-boronic acid | ESD-908181-5MG |
Cas.: 2225177-67-1 | Purity: 95% | 4-Chloro-2-(cyclopropyl)pyrimidine-5-boronic acid | ESD-908181-25MG |
Cas.: 2225177-71-7 | Purity: 95% | 4-Cyclopropyl-3-(1H-pyrazol-1-yl)phenylboronic acid | ESD-908182-5MG |
Cas.: 2225177-71-7 | Purity: 95% | 4-Cyclopropyl-3-(1H-pyrazol-1-yl)phenylboronic acid | ESD-908182-25MG |
Cas.: 2225177-75-1 | Purity: 95% | 4-Chloro-2-(2-thienyl)pyrimidine-5-boronic acid | ESD-908183-5MG |
Cas.: 2225177-75-1 | Purity: 95% | 4-Chloro-2-(2-thienyl)pyrimidine-5-boronic acid | ESD-908183-25MG |
Cas.: 2225177-78-4 | Purity: 95% | 3-Bromo-4-(1H-pyrazol-1-yl)phenylboronic acid | ESD-908184-5MG |
Cas.: 2225177-78-4 | Purity: 95% | 3-Bromo-4-(1H-pyrazol-1-yl)phenylboronic acid | ESD-908184-25MG |
Cas.: 2225177-81-9 | Purity: 95% | 4-Chloro-2-(2-methoxyphenyl)pyrimidine-5-boronic acid | ESD-908185-5MG |
Cas.: 2225177-81-9 | Purity: 95% | 4-Chloro-2-(2-methoxyphenyl)pyrimidine-5-boronic acid | ESD-908185-25MG |
Cas.: 2225177-92-2 | Purity: 95% | (6-(furan-2-yl)pyridin-3-yl)boronic acid | ESD-908186-25MG |
Cas.: 2225177-92-2 | Purity: 95% | (6-(furan-2-yl)pyridin-3-yl)boronic acid | ESD-908186-100MG |
Cas.: 2225177-99-9 | Purity: 95% | (2-(2-cyanophenyl)pyrimidin-5-yl)boronic acid | ESD-908187-25MG |
Cas.: 2225177-99-9 | Purity: 95% | (2-(2-cyanophenyl)pyrimidin-5-yl)boronic acid | ESD-908187-100MG |
Cas.: 2225178-68-5 | Purity: 95% | (2-(pyrazin-2-yl)pyrimidin-5-yl)boronic acid | ESD-908188-25MG |
Cas.: 2225178-68-5 | Purity: 95% | (2-(pyrazin-2-yl)pyrimidin-5-yl)boronic acid | ESD-908188-100MG |
Cas.: 2225178-71-0 | Purity: 95% | (1-(3-(Trifluoromethyl)phenyl)-1H-pyrazol-4-yl)boronic acid | ESD-908189-5MG |
Cas.: 2225178-71-0 | Purity: 95% | (1-(3-(Trifluoromethyl)phenyl)-1H-pyrazol-4-yl)boronic acid | ESD-908189-25MG |
Cas.: 2225178-72-1 | Purity: 95% | 3-(tert-Butyl)-5-(3-thienyl)phenylboronic acid | ESD-908190-5MG |
Cas.: 2225178-72-1 | Purity: 95% | 3-(tert-Butyl)-5-(3-thienyl)phenylboronic acid | ESD-908190-25MG |
Cas.: 2225178-75-4 | Purity: 95% | 3-Trifluoromethyl-5-(iso-propyl)phenylboronic acid | ESD-908191-5MG |
Cas.: 2225178-75-4 | Purity: 95% | 3-Trifluoromethyl-5-(iso-propyl)phenylboronic acid | ESD-908191-25MG |
Cas.: 2225178-76-5 | Purity: 95% | 1-(3,4-Difluorophenyl)-1H-pyrazole-4-boronic acid | ESD-908192-5MG |
Cas.: 2225178-76-5 | Purity: 95% | 1-(3,4-Difluorophenyl)-1H-pyrazole-4-boronic acid | ESD-908192-25MG |
Cas.: 2225178-77-6 | Purity: 95% | 2-Fluoro-4-(cyclopentyl)phenylboronic acid | ESD-908193-5MG |
Cas.: 2225178-77-6 | Purity: 95% | 2-Fluoro-4-(cyclopentyl)phenylboronic acid | ESD-908193-25MG |
Cas.: 2225178-80-1 | Purity: 95% | 2-Cyclopropyl-5-(3-methyl-1H-pyrazol-1-yl)phenylboronic acid | ESD-908194-5MG |
Cas.: 2225178-80-1 | Purity: 95% | 2-Cyclopropyl-5-(3-methyl-1H-pyrazol-1-yl)phenylboronic acid | ESD-908194-25MG |
Cas.: 2225178-82-3 | Purity: 95% | 3-Methyl-1-(2-fluoropyridin-4-yl)pyrazole-4-boronic acid | ESD-908195-5MG |
Cas.: 2225178-82-3 | Purity: 95% | 3-Methyl-1-(2-fluoropyridin-4-yl)pyrazole-4-boronic acid | ESD-908195-25MG |
Cas.: 2225178-85-6 | Purity: 95% | 2-Cyclopropyl-4-(1H-pyrazol-1-yl)phenylboronic acid | ESD-908196-5MG |
Cas.: 2225178-85-6 | Purity: 95% | 2-Cyclopropyl-4-(1H-pyrazol-1-yl)phenylboronic acid | ESD-908196-25MG |
Cas.: 2225178-86-7 | Purity: 95% | 3-Methyl-1-(3-furyl)pyrazole-4-boronic acid | ESD-908197-5MG |
Cas.: 2225178-86-7 | Purity: 95% | 3-Methyl-1-(3-furyl)pyrazole-4-boronic acid | ESD-908197-25MG |
Cas.: 2225178-88-9 | Purity: 95% | 4-(Thiazol-2-yl)pyridine-2-boronic acid | ESD-908198-5MG |
Cas.: 2225178-88-9 | Purity: 95% | 4-(Thiazol-2-yl)pyridine-2-boronic acid | ESD-908198-25MG |
Cas.: 2225178-91-4 | Purity: 95% | 2-(Ethyl-d5)-4-chloropyrimidine-5-boronic acid | ESD-908199-5MG |
Cas.: 2225178-91-4 | Purity: 95% | 2-(Ethyl-d5)-4-chloropyrimidine-5-boronic acid | ESD-908199-25MG |
Cas.: 2225178-93-6 | Purity: 95% | 5-(Cyclobutyl)thiophene-2-boronic acid | ESD-908200-5MG |
Cas.: 2225178-93-6 | Purity: 95% | 5-(Cyclobutyl)thiophene-2-boronic acid | ESD-908200-25MG |
Cas.: 2225178-95-8 | Purity: 95% | 1-(2-Fluorophenyl)-1H-pyrazole-4-boronic acid | ESD-908201-5MG |
Cas.: 2225178-95-8 | Purity: 95% | 1-(2-Fluorophenyl)-1H-pyrazole-4-boronic acid | ESD-908201-25MG |
Cas.: 2225178-97-0 | Purity: 95% | 1-(2-Fluopro-4-pyridyl)-1H-pyrazole-4-boronic acid | ESD-908202-5MG |
Cas.: 2225178-97-0 | Purity: 95% | 1-(2-Fluopro-4-pyridyl)-1H-pyrazole-4-boronic acid | ESD-908202-25MG |
Cas.: 2225178-99-2 | Purity: 95% | 2-(Piperidino-d10)-4-chloropyrimidine-5-boronic acid | ESD-908203-5MG |
Cas.: 2225178-99-2 | Purity: 95% | 2-(Piperidino-d10)-4-chloropyrimidine-5-boronic acid | ESD-908203-25MG |
Cas.: 2225179-05-3 | Purity: 95% | 4-Chloro-2-(3-fluorophenyl)pyrimidine-5-boronic acid | ESD-908204-5MG |
Cas.: 2225179-05-3 | Purity: 95% | 4-Chloro-2-(3-fluorophenyl)pyrimidine-5-boronic acid | ESD-908204-25MG |
Cas.: 2225179-09-7 | Purity: 95% | (2-(pipidin-4-yl)pyrimidin-5-yl)boronic acid | ESD-908205-25MG |
Cas.: 2225179-09-7 | Purity: 95% | (2-(pipidin-4-yl)pyrimidin-5-yl)boronic acid | ESD-908205-100MG |
Cas.: 2225179-90-6 | Purity: 95% | 3-(tert-Butyl)-5-(2-furyl)phenylboronic acid | ESD-908206-5MG |
Cas.: 2225179-90-6 | Purity: 95% | 3-(tert-Butyl)-5-(2-furyl)phenylboronic acid | ESD-908206-25MG |
Cas.: 2225179-96-2 | Purity: 95% | 3-Trifluoromethyl-5-ethylphenylboronic acid | ESD-908207-5MG |
Cas.: 2225179-96-2 | Purity: 95% | 3-Trifluoromethyl-5-ethylphenylboronic acid | ESD-908207-25MG |
Cas.: 2225179-99-5 | Purity: 95% | 2-Fluoro-4-(cyclohexyl)phenylboronic acid | ESD-908208-5MG |
Cas.: 2225179-99-5 | Purity: 95% | 2-Fluoro-4-(cyclohexyl)phenylboronic acid | ESD-908208-25MG |
Cas.: 2225180-01-6 | Purity: 95% | 3,5-Bis(imidazol-1-yl)phenylboronic acid | ESD-908209-5MG |
Cas.: 2225180-01-6 | Purity: 95% | 3,5-Bis(imidazol-1-yl)phenylboronic acid | ESD-908209-25MG |
Cas.: 2225180-03-8 | Purity: 95% | 4-Cyclopropyl-2-(1H-imidazol-1-yl)phenylboronic acid | ESD-908210-5MG |
Cas.: 2225180-03-8 | Purity: 95% | 4-Cyclopropyl-2-(1H-imidazol-1-yl)phenylboronic acid | ESD-908210-25MG |
Cas.: 2225180-05-0 | Purity: 95% | 5-(Oxan-4-yl)thiophene-2-boronic acid | ESD-908211-5MG |
Cas.: 2225180-05-0 | Purity: 95% | 5-(Oxan-4-yl)thiophene-2-boronic acid | ESD-908211-25MG |
Cas.: 2225180-07-2 | Purity: 95% | 1-(2-Methoxy-4-pyridyl)-1H-pyrazole-4-boronic acid | ESD-908212-5MG |
Cas.: 2225180-07-2 | Purity: 95% | 1-(2-Methoxy-4-pyridyl)-1H-pyrazole-4-boronic acid | ESD-908212-25MG |
Cas.: 2225180-09-4 | Purity: 95% | 3-Methyl-1-(2-thienyl)pyrazole-4-boronic acid | ESD-908213-5MG |
Cas.: 2225180-09-4 | Purity: 95% | 3-Methyl-1-(2-thienyl)pyrazole-4-boronic acid | ESD-908213-25MG |
Cas.: 2225180-10-7 | Purity: 95% | 2-(Methyl-d3)-4-chloropyrimidine-5-boronic acid | ESD-908214-5MG |
Cas.: 2225180-10-7 | Purity: 95% | 2-(Methyl-d3)-4-chloropyrimidine-5-boronic acid | ESD-908214-25MG |
Cas.: 2225180-13-0 | Purity: 95% | 2-(Methylethylamino-d8)-4-chloropyrimidine-5-boronic acid | ESD-908215-5MG |
Cas.: 2225180-13-0 | Purity: 95% | 2-(Methylethylamino-d8)-4-chloropyrimidine-5-boronic acid | ESD-908215-25MG |
Cas.: 2225180-15-2 | Purity: 95% | 4-Chloro-2-(3-trifluoromethylphenyl)pyrimidine-5-boronic acid | ESD-908216-5MG |
Cas.: 2225180-15-2 | Purity: 95% | 4-Chloro-2-(3-trifluoromethylphenyl)pyrimidine-5-boronic acid | ESD-908216-25MG |
Cas.: 2225181-06-4 | Purity: 95% | 4-(Cyclohexyl)thiophene-2-boronic acid | ESD-908217-5MG |
Cas.: 2225181-06-4 | Purity: 95% | 4-(Cyclohexyl)thiophene-2-boronic acid | ESD-908217-25MG |
Cas.: 2225181-07-5 | Purity: 95% | 2-Fluoro-4-(cyclobutyl)phenylboronic acid | ESD-908218-5MG |
Cas.: 2225181-07-5 | Purity: 95% | 2-Fluoro-4-(cyclobutyl)phenylboronic acid | ESD-908218-25MG |
Cas.: 2225181-08-6 | Purity: 95% | 3-Cyclopropyl-5-(N-methylpiperazin-1-yl)phenylboronic acid | ESD-908219-5MG |
Cas.: 2225181-08-6 | Purity: 95% | 3-Cyclopropyl-5-(N-methylpiperazin-1-yl)phenylboronic acid | ESD-908219-25MG |
Cas.: 2225181-09-7 | Purity: 95% | 3,5-Bis(morpholino)phenylboronic acid | ESD-908220-5MG |
Cas.: 2225181-09-7 | Purity: 95% | 3,5-Bis(morpholino)phenylboronic acid | ESD-908220-25MG |
Cas.: 2225181-10-0 | Purity: 95% | 3-Bromo-4-(1H-imidazol-1-yl)phenylboronic acid | ESD-908221-5MG |
Cas.: 2225181-10-0 | Purity: 95% | 3-Bromo-4-(1H-imidazol-1-yl)phenylboronic acid | ESD-908221-25MG |
Cas.: 2225181-11-1 | Purity: 95% | 2-(Cyclobutoxy)pyridine-5-boronic acid | ESD-908222-5MG |
Cas.: 2225181-11-1 | Purity: 95% | 2-(Cyclobutoxy)pyridine-5-boronic acid | ESD-908222-25MG |
Cas.: 2225181-12-2 | Purity: 95% | 4-(Cyclobutyl)furan-2-boronic acid | ESD-908223-5MG |
Cas.: 2225181-12-2 | Purity: 95% | 4-(Cyclobutyl)furan-2-boronic acid | ESD-908223-25MG |
Cas.: 2225181-13-3 | Purity: 95% | 1-(2-Trifluoromethylphenyl)-1H-pyrazole-4-boronic acid | ESD-908224-5MG |
Cas.: 2225181-13-3 | Purity: 95% | 1-(2-Trifluoromethylphenyl)-1H-pyrazole-4-boronic acid | ESD-908224-25MG |
Cas.: 2225181-14-4 | Purity: 95% | 1-(2-Chloro-4-pyridyl)-1H-pyrazole-4-boronic acid | ESD-908225-5MG |
Cas.: 2225181-14-4 | Purity: 95% | 1-(2-Chloro-4-pyridyl)-1H-pyrazole-4-boronic acid | ESD-908225-25MG |
Cas.: 2225181-15-5 | Purity: 95% | 3-Methyl-1-(2-furyl)pyrazole-4-boronic acid | ESD-908226-5MG |
Cas.: 2225181-15-5 | Purity: 95% | 3-Methyl-1-(2-furyl)pyrazole-4-boronic acid | ESD-908226-25MG |
Cas.: 2225181-16-6 | Purity: 95% | 4-Chloro-2-(3-tolyl)pyrimidine-5-boronic acid | ESD-908227-5MG |
Cas.: 2225181-16-6 | Purity: 95% | 4-Chloro-2-(3-tolyl)pyrimidine-5-boronic acid | ESD-908227-25MG |
Cas.: 2241864-95-7 | Purity: 95% | Tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-imidazole-1-carboxylate-2,5-d2 | ESD-908228-25MG |
Cas.: 2241864-95-7 | Purity: 95% | Tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-imidazole-1-carboxylate-2,5-d2 | ESD-908228-100MG |
Cas.: 2241864-96-8 | Purity: 95% | Tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-pyrrole-1-carboxylate-2,2,3,3 ,5-d5 | ESD-908229-25MG |
Cas.: 2241864-96-8 | Purity: 95% | Tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-pyrrole-1-carboxylate-2,2,3,3 ,5-d5 | ESD-908229-100MG |
Cas.: 2241864-98-0 | Purity: 95% | 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-pyrrol-1-yl)ethyl acetate | ESD-908230-25MG |
Cas.: 2241864-98-0 | Purity: 95% | 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-pyrrol-1-yl)ethyl acetate | ESD-908230-100MG |
Cas.: 2241864-99-1 | Purity: 95% | 1-Methyl-4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-3-yl)piperazine | ESD-908231-25MG |
Cas.: 2241864-99-1 | Purity: 95% | 1-Methyl-4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-3-yl)piperazine | ESD-908231-100MG |
Cas.: 2241865-00-7 | Purity: 95% | 1-methyl-4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)furan-3-yl)piperazine | ESD-908232-25MG |
Cas.: 2241865-00-7 | Purity: 95% | 1-methyl-4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)furan-3-yl)piperazine | ESD-908232-100MG |
Cas.: 2241867-63-8 | Purity: 95% | 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-6-d | ESD-908233-25MG |
Cas.: 2241867-63-8 | Purity: 95% | 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-6-d | ESD-908233-100MG |
Cas.: 2241869-79-2 | Purity: 95% | 2-(2,5-bis(methyl-d3)furan-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908234-5MG |
Cas.: 2241869-79-2 | Purity: 95% | 2-(2,5-bis(methyl-d3)furan-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908234-25MG |
Cas.: 2241869-84-9 | Purity: 95% | 2-(methyl-d3)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-imidazole | ESD-908235-5MG |
Cas.: 2241869-84-9 | Purity: 95% | 2-(methyl-d3)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-imidazole | ESD-908235-25MG |
Cas.: 2241875-59-0 | Purity: 95% | (6-(methyl-d3)pyridin-3-yl)boronic acid | ESD-908236-5MG |
Cas.: 2241875-59-0 | Purity: 95% | (6-(methyl-d3)pyridin-3-yl)boronic acid | ESD-908236-25MG |
Cas.: 2241875-60-3 | Purity: 95% | (6-(ethyl-d5)pyridin-3-yl)boronic acid | ESD-908237-5MG |
Cas.: 2241875-60-3 | Purity: 95% | (6-(ethyl-d5)pyridin-3-yl)boronic acid | ESD-908237-25MG |
Cas.: 2241875-61-4 | Purity: 95% | (6-(propyl-d7)pyridin-3-yl)boronic acid | ESD-908238-5MG |
Cas.: 2241875-61-4 | Purity: 95% | (6-(propyl-d7)pyridin-3-yl)boronic acid | ESD-908238-25MG |
Cas.: 2241875-62-5 | Purity: 95% | (6-(2-(methyl-d3)propan-2-yl-1,1,1,3,3,3-d6)pyridin-3-yl)boronic acid | ESD-908239-5MG |
Cas.: 2241875-62-5 | Purity: 95% | (6-(2-(methyl-d3)propan-2-yl-1,1,1,3,3,3-d6)pyridin-3-yl)boronic acid | ESD-908239-25MG |
Cas.: 2223033-32-5 | Purity: 95% | 5-(1-Hydroxy-1-methylethyl-d6)-furan-2-boronic acid pinacol ester | ESD-908240-5MG |
Cas.: 2223033-32-5 | Purity: 95% | 5-(1-Hydroxy-1-methylethyl-d6)-furan-2-boronic acid pinacol ester | ESD-908240-25MG |
Cas.: 2241876-16-2 | Purity: 95% | 2-(propoxy-d7)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole | ESD-908241-5MG |
Cas.: 2241876-16-2 | Purity: 95% | 2-(propoxy-d7)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole | ESD-908241-25MG |
Cas.: 2241876-99-1 | Purity: 95% | (2-(2-(methyl-d3)propan-2-yl-1,1,1,3,3,3-d6)pyrimidin-5-yl)boronic acid | ESD-908242-5MG |
Cas.: 2241876-99-1 | Purity: 95% | (2-(2-(methyl-d3)propan-2-yl-1,1,1,3,3,3-d6)pyrimidin-5-yl)boronic acid | ESD-908242-25MG |
Cas.: 2241877-18-7 | Purity: 95% | 2-(2,5-bis(methyl-d3)thiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908243-5MG |
Cas.: 2241877-18-7 | Purity: 95% | 2-(2,5-bis(methyl-d3)thiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908243-25MG |
Cas.: 2256708-81-1 | Purity: 95% | (3-(azetidin-3-yl)phenyl)boronic acid | ESD-908244-50MG |
Cas.: 2256708-81-1 | Purity: 95% | (3-(azetidin-3-yl)phenyl)boronic acid | ESD-908244-250MG |
Cas.: 2256708-82-2 | Purity: 95% | (3-fluoro-4-(oxetan-3-yl)phenyl)boronic acid | ESD-908245-25MG |
Cas.: 2256708-82-2 | Purity: 95% | (3-fluoro-4-(oxetan-3-yl)phenyl)boronic acid | ESD-908245-100MG |
Cas.: 2256708-83-3 | Purity: 95% | (3-cyano-4-(oxetan-3-yl)phenyl)boronic acid | ESD-908246-25MG |
Cas.: 2256708-83-3 | Purity: 95% | (3-cyano-4-(oxetan-3-yl)phenyl)boronic acid | ESD-908246-100MG |
Cas.: 2256708-84-4 | Purity: 95% | (4-(oxetan-3-yl)-3-(trifluoromethyl)phenyl)boronic acid | ESD-908247-25MG |
Cas.: 2256708-84-4 | Purity: 95% | (4-(oxetan-3-yl)-3-(trifluoromethyl)phenyl)boronic acid | ESD-908247-100MG |
Cas.: 2256708-85-5 | Purity: 95% | (4-(azetidin-3-yl)-3-(trifluoromethyl)phenyl)boronic acid | ESD-908248-25MG |
Cas.: 2256708-85-5 | Purity: 95% | (4-(azetidin-3-yl)-3-(trifluoromethyl)phenyl)boronic acid | ESD-908248-100MG |
Cas.: 2256708-86-6 | Purity: 95% | (4-(pyrrolidin-3-yl)-3-(trifluoromethyl)phenyl)boronic acid | ESD-908249-25MG |
Cas.: 2256708-86-6 | Purity: 95% | (4-(pyrrolidin-3-yl)-3-(trifluoromethyl)phenyl)boronic acid | ESD-908249-100MG |
Cas.: 2256708-87-7 | Purity: 95% | (6-fluoro-4-hydroxypyridin-3-yl)boronic acid | ESD-908250-25MG |
Cas.: 2256708-87-7 | Purity: 95% | (6-fluoro-4-hydroxypyridin-3-yl)boronic acid | ESD-908250-100MG |
Cas.: 2256708-88-8 | Purity: 95% | (2-(methoxycarbonyl)thiazol-5-yl)boronic acid | ESD-908251-25MG |
Cas.: 2256708-88-8 | Purity: 95% | (2-(methoxycarbonyl)thiazol-5-yl)boronic acid | ESD-908251-100MG |
Cas.: 463336-26-7 | Purity: 95% | 2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-3-carbonitrile | ESD-908252-5MG |
Cas.: 463336-26-7 | Purity: 95% | 2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-3-carbonitrile | ESD-908252-25MG |
Cas.: 676501-85-2 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carbonitrile | ESD-908253-50MG |
Cas.: 676501-85-2 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carbonitrile | ESD-908253-250MG |
Cas.: 676501-89-6 | Purity: 95% | Methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-2-carboxylate | ESD-908254-50MG |
Cas.: 676501-89-6 | Purity: 95% | Methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-2-carboxylate | ESD-908254-250MG |
Cas.: 680600-46-8 | Purity: 95% | (2-(tert-butyl)cyclopropyl)boronic acid | ESD-908255-25MG |
Cas.: 680600-46-8 | Purity: 95% | (2-(tert-butyl)cyclopropyl)boronic acid | ESD-908255-100MG |
Cas.: 775351-40-1 | Purity: 95% | 5-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2H-tetrazole | ESD-908256-25MG |
Cas.: 775351-40-1 | Purity: 95% | 5-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2H-tetrazole | ESD-908256-100MG |
Cas.: 791819-04-0 | Purity: 95% | 5-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-908257-25MG |
Cas.: 791819-04-0 | Purity: 95% | 5-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-908257-100MG |
Cas.: 802836-52-8 | Purity: 95% | (2-Amino-3-Methylphenyl)Boronic Acid | ESD-908258-50MG |
Cas.: 802836-52-8 | Purity: 95% | (2-Amino-3-Methylphenyl)Boronic Acid | ESD-908258-250MG |
Cas.: 874959-74-7 | Purity: 95% | 4,4,5,5-Tetramethyl-2-(5-methylthiophen-3-yl)-1,3,2-dioxaborolane | ESD-908259-5MG |
Cas.: 874959-74-7 | Purity: 95% | 4,4,5,5-Tetramethyl-2-(5-methylthiophen-3-yl)-1,3,2-dioxaborolane | ESD-908259-25MG |
Cas.: 889672-72-4 | Purity: 95% | 2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole | ESD-908260-50MG |
Cas.: 889672-72-4 | Purity: 95% | 2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole | ESD-908260-250MG |
Cas.: 914672-66-5 | Purity: 95% | 1-TERT-BUTYLOXYCARBONYLPYRAZOLE-3-BORONIC ACID PINACOL ESTER | ESD-908261-25MG |
Cas.: 914672-66-5 | Purity: 95% | 1-TERT-BUTYLOXYCARBONYLPYRAZOLE-3-BORONIC ACID PINACOL ESTER | ESD-908261-100MG |
Cas.: 916454-59-6 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-3-carbonitrile | ESD-908262-50MG |
Cas.: 916454-59-6 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-3-carbonitrile | ESD-908262-250MG |
Cas.: 942070-06-6 | Purity: 95% | 4-Bromothiophene-2-boronic acid pinacol ester | ESD-908263-50MG |
Cas.: 942070-06-6 | Purity: 95% | 4-Bromothiophene-2-boronic acid pinacol ester | ESD-908263-250MG |
Cas.: 942070-20-4 | Purity: 95% | 2-(2,5-Dimethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908264-5MG |
Cas.: 942070-20-4 | Purity: 95% | 2-(2,5-Dimethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908264-25MG |
Cas.: 124481-62-5 | Purity: 99% | 3,7,11,18,22,26-Hexaazatricyclo[26.2.2.213,16]tetratriaconta-13,15,28,30,31,33-hexaene | ESD-908266-100MG |
Cas.: 124481-62-5 | Purity: 99% | 3,7,11,18,22,26-Hexaazatricyclo[26.2.2.213,16]tetratriaconta-13,15,28,30,31,33-hexaene | ESD-908266-500MG |
Cas.: 29471-17-8 | Purity: 95% | 4′,4′′(5′′)-Di-tert-butyldibenzo-18-crown-6 | ESD-908267-250MG |
Cas.: 29471-17-8 | Purity: 95% | 4′,4′′(5′′)-Di-tert-butyldibenzo-18-crown-6 | ESD-908267-1G |
Cas.: 126531-26-8 | Purity: 98% | 4′-Aminodibenzo-18-crown-6 | ESD-908268-100MG |
Cas.: 126531-26-8 | Purity: 98% | 4′-Aminodibenzo-18-crown-6 | ESD-908268-500MG |
Cas.: 83585-61-9 | Purity: 95% | 2-Aminomethyl-18-crown-6 | ESD-908269-50MG |
Cas.: 83585-61-9 | Purity: 95% | 2-Aminomethyl-18-crown-6 | ESD-908269-250MG |
Cas.: 112247-07-1 | Purity: 95% | C-Undecylcalix[4]resorcinarene monohydrate | ESD-908271-250MG |
Cas.: 151657-13-5 | Purity: 95% | 4-Sulfocalix[4]arene sodium salt | ESD-908272-100MG |
Cas.: 151657-13-5 | Purity: 95% | 4-Sulfocalix[4]arene sodium salt | ESD-908272-500MG |
Cas.: 168476-58-2 | Purity: 95% | 2-(Chloromethyl)phenethyl benzoate | ESD-908274-250MG |
Cas.: 168476-58-2 | Purity: 95% | 2-(Chloromethyl)phenethyl benzoate | ESD-908274-1G |
Cas.: 1686102-84-0 | Purity: 98% | 4-[4-(Trifluoromethoxy)phenoxy]benzenemethanol | ESD-908275-250MG |
Cas.: 1686102-84-0 | Purity: 98% | 4-[4-(Trifluoromethoxy)phenoxy]benzenemethanol | ESD-908275-1G |
Cas.: 1686126-88-4 | Purity: 99% | 4,5-Dimethyl-2-(4-methylphenyl)pyridine | ESD-908276-250MG |
Cas.: 1686126-88-4 | Purity: 99% | 4,5-Dimethyl-2-(4-methylphenyl)pyridine | ESD-908276-1G |
Cas.: 1688701-62-3 | Purity: 95% | 2-methyl-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanamide | ESD-908277-250MG |
Cas.: 1688701-62-3 | Purity: 95% | 2-methyl-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanamide | ESD-908277-1G |
Cas.: 1689511-55-4 | Purity: 95% | 2-fluoro-N-isopropyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | ESD-908278-250MG |
Cas.: 1689511-55-4 | Purity: 95% | 2-fluoro-N-isopropyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | ESD-908278-1G |
Cas.: 1694615-69-4 | Purity: 95% | 4-(trifluoromethyl)imidazolidin-2-one | ESD-908279-100MG |
Cas.: 1694615-69-4 | Purity: 95% | 4-(trifluoromethyl)imidazolidin-2-one | ESD-908279-250MG |
Cas.: 1700611-18-2 | Purity: 95% | (3R,4S)-tert-Butyl 3-amino-4-fluoropiperidine-1-carboxylate | ESD-908280-100MG |
Cas.: 1700611-18-2 | Purity: 95% | (3R,4S)-tert-Butyl 3-amino-4-fluoropiperidine-1-carboxylate | ESD-908280-250MG |
Cas.: 170235-19-5 | Purity: 95% | Methyl 6-bromo-5-hydroxypicolinate | ESD-908281-100MG |
Cas.: 170235-19-5 | Purity: 95% | Methyl 6-bromo-5-hydroxypicolinate | ESD-908281-250MG |
Cas.: 1703-51-1 | Purity: 95% | 2,5-HEPTANEDIONE | ESD-908282-100MG |
Cas.: 1704069-03-3 | Purity: 95% | 4-Bromo-N-cyclopropyl-2,6-dimethylbenzenesulfonamide | ESD-908283-100MG |
Cas.: 1704069-03-3 | Purity: 95% | 4-Bromo-N-cyclopropyl-2,6-dimethylbenzenesulfonamide | ESD-908283-250MG |
Cas.: 17043-02-6 | Purity: 95% | 1,6,11,16-Tetraoxacycloeicosane | ESD-908284-10MG |
Cas.: 17043-02-6 | Purity: 95% | 1,6,11,16-Tetraoxacycloeicosane | ESD-908284-25MG |
Cas.: 1705578-40-0 | Purity: 95% | Potassium ((cyclopentylamino)methyl)trifluoroborate | ESD-908285-250MG |
Cas.: 1705578-40-0 | Purity: 95% | Potassium ((cyclopentylamino)methyl)trifluoroborate | ESD-908285-1G |
Cas.: 17066-08-9 | Purity: 95% | N-(2-carboxyethyl)-N-dodecyl-β-alanine | ESD-908286-1G |
Cas.: 17066-08-9 | Purity: 95% | N-(2-carboxyethyl)-N-dodecyl-β-alanine | ESD-908286-5G |
Cas.: 17070-97-2 | Purity: 98% | 2-Bromo-4-ethyl-1-methylbenzene | ESD-908287-100MG |
Cas.: 17070-97-2 | Purity: 98% | 2-Bromo-4-ethyl-1-methylbenzene | ESD-908287-250MG |
Cas.: 17140-68-0 | Purity: 95% | 7-(2-(DIETHYLAMINO)ETHYL)THEOPHYLLINE HYDROCHLORIDE | ESD-908288-5MG |
Cas.: 17140-68-0 | Purity: 95% | 7-(2-(DIETHYLAMINO)ETHYL)THEOPHYLLINE HYDROCHLORIDE | ESD-908288-25MG |
Cas.: 171738-68-4 | Purity: 95% | (5-(Methylthio)furan-2-yl)methanol | ESD-908289-10MG |
Cas.: 171738-68-4 | Purity: 95% | (5-(Methylthio)furan-2-yl)methanol | ESD-908289-50MG |
Cas.: 17281-74-2 | Purity: 95% | 1-phenyloctadecane-1,3-dione | ESD-908291-100MG |
Cas.: 17281-74-2 | Purity: 95% | 1-phenyloctadecane-1,3-dione | ESD-908291-250MG |
Cas.: 1733-55-7 | Purity: 95% | Ethyldiphenylphosphinate | ESD-908292-100MG |
Cas.: 1733-55-7 | Purity: 95% | Ethyldiphenylphosphinate | ESD-908292-250MG |
Cas.: 17351-34-7 | Purity: 95% | 14-Pentadecenoicacid | ESD-908294-100MG |
Cas.: 17351-34-7 | Purity: 95% | 14-Pentadecenoicacid | ESD-908294-250MG |
Cas.: 17404-44-3 | Purity: 95% | 2-(Octan-3-Yl)Phenol | ESD-908295-25MG |
Cas.: 17404-44-3 | Purity: 95% | 2-(Octan-3-Yl)Phenol | ESD-908295-100MG |
Cas.: 174498-06-7 | Purity: 95% | Propane-1,3-diylbis(3-oxobutanoate | ESD-908296-100MG |
Cas.: 174498-06-7 | Purity: 95% | Propane-1,3-diylbis(3-oxobutanoate | ESD-908296-250MG |
Cas.: 17471-10-2 | Purity: 95% | 2-(DIPHENYLMETHOXY)-N-METHYLETHYLAMINE | ESD-908297-25MG |
Cas.: 17471-10-2 | Purity: 95% | 2-(DIPHENYLMETHOXY)-N-METHYLETHYLAMINE | ESD-908297-100MG |
Cas.: 1749-71-9 | Purity: 95% | 5-Methoxy-4-methylpyrimidin-2-amine | ESD-908298-100MG |
Cas.: 1749-71-9 | Purity: 95% | 5-Methoxy-4-methylpyrimidin-2-amine | ESD-908298-250MG |
Cas.: 17515-75-2 | Purity: 98% | 2-Methyl-5-(trifluoromethyl)furan | ESD-908299-250MG |
Cas.: 17515-75-2 | Purity: 98% | 2-Methyl-5-(trifluoromethyl)furan | ESD-908299-1G |
Cas.: 1759-68-8 | Purity: 95% | N-cyclohexylbenzamide | ESD-908300-250MG |
Cas.: 1759-68-8 | Purity: 95% | N-cyclohexylbenzamide | ESD-908300-1G |
Cas.: 176214-14-5 | Purity: 95% | 2-Methoxy-5-trifluoromethyl-pyrimidine | ESD-908301-250MG |
Cas.: 176214-14-5 | Purity: 95% | 2-Methoxy-5-trifluoromethyl-pyrimidine | ESD-908301-1G |
Cas.: 17671-27-1 | Purity: 95% | Docosyl docosanoate | ESD-908302-100MG |
Cas.: 17671-27-1 | Purity: 95% | Docosyl docosanoate | ESD-908302-250MG |
Cas.: 177785-14-7 | Purity: 95% | Methyl 2-(chloromethyl)nicotinate | ESD-908303-250MG |
Cas.: 177785-14-7 | Purity: 95% | Methyl 2-(chloromethyl)nicotinate | ESD-908303-1G |
Cas.: 177985-31-8 | Purity: 95% | 2-(2-Amino-4-chlorophenyl)acetic acid | ESD-908304-250MG |
Cas.: 177985-31-8 | Purity: 95% | 2-(2-Amino-4-chlorophenyl)acetic acid | ESD-908304-1G |
Cas.: 1779899-46-5 | Purity: 95% | 1,3-Pyrrolidinedicarboxylic acid, 4-ethyl-, 1-(1,1-dimethylethyl) ester | ESD-908305-250MG |
Cas.: 1779899-46-5 | Purity: 95% | 1,3-Pyrrolidinedicarboxylic acid, 4-ethyl-, 1-(1,1-dimethylethyl) ester | ESD-908305-1G |
Cas.: 1780091-22-6 | Purity: 95% | 3-Chloro-6-Methoxy-5-Methylpyridine-2-Carbonitrile | ESD-908306-100MG |
Cas.: 1780091-22-6 | Purity: 95% | 3-Chloro-6-Methoxy-5-Methylpyridine-2-Carbonitrile | ESD-908306-250MG |
Cas.: 178403-35-5 | Purity: 95% | N-(4,6-Dimethoxy-2-pyrimidinyl)-N-[3-(trifluoromethyl)-2-pyridinyl]urea | ESD-908307-100MG |
Cas.: 178403-35-5 | Purity: 95% | N-(4,6-Dimethoxy-2-pyrimidinyl)-N-[3-(trifluoromethyl)-2-pyridinyl]urea | ESD-908307-250MG |
Cas.: 178408-16-7 | Purity: 95% | (3Z)-1-methyl-3-[2-(4-methylphenyl)-2-oxo-ethylidene]piperazin-2-one | ESD-908308-100MG |
Cas.: 178408-16-7 | Purity: 95% | (3Z)-1-methyl-3-[2-(4-methylphenyl)-2-oxo-ethylidene]piperazin-2-one | ESD-908308-250MG |
Cas.: 17879-23-1 | Purity: 97% | trans-4-(Aminomethyl)cyclohexylmethanol | ESD-908309-250MG |
Cas.: 17879-23-1 | Purity: 97% | trans-4-(Aminomethyl)cyclohexylmethanol | ESD-908309-1G |
Cas.: 1803565-55-0 | Purity: 95% | 4-Cyclopropyl-1H-pyrazole hydrochloride | ESD-908310-25MG |
Cas.: 1803565-55-0 | Purity: 95% | 4-Cyclopropyl-1H-pyrazole hydrochloride | ESD-908310-100MG |
Cas.: 1803608-00-5 | Purity: 95% | Ethyl 2-{3-azaspiro[5.5]undecan-9-yl}acetate hydrochloride | ESD-908311-100MG |
Cas.: 1803608-00-5 | Purity: 95% | Ethyl 2-{3-azaspiro[5.5]undecan-9-yl}acetate hydrochloride | ESD-908311-250MG |
Cas.: 180465-02-5 | Purity: 95% | (S)-3-(Amino(carboxy)methyl)bicyclo[1.1.1]pentane-1-carboxylicacid | ESD-908312-10MG |
Cas.: 180465-02-5 | Purity: 95% | (S)-3-(Amino(carboxy)methyl)bicyclo[1.1.1]pentane-1-carboxylicacid | ESD-908312-50MG |
Cas.: 1805518-71-1 | Purity: 95% | 6-Bromo-2-chloro-3-fluorophenol | ESD-908313-100MG |
Cas.: 1805518-71-1 | Purity: 95% | 6-Bromo-2-chloro-3-fluorophenol | ESD-908313-250MG |
Cas.: 1805568-90-4 | Purity: 96% | 2-Bromo-3-methoxy-4-trifluoromethoxy-phenylamine | ESD-908314-100MG |
Cas.: 1805568-90-4 | Purity: 96% | 2-Bromo-3-methoxy-4-trifluoromethoxy-phenylamine | ESD-908314-250MG |
Cas.: 1805931-15-0 | Purity: 95% | 4-Fluoro-6-methoxypyridin-3-amine | ESD-908315-100MG |
Cas.: 1805931-15-0 | Purity: 95% | 4-Fluoro-6-methoxypyridin-3-amine | ESD-908315-250MG |
Cas.: 1809063-96-4 | Purity: 95% | (2-((hexylamino)methyl)phenyl)boronic acid | ESD-908316-250MG |
Cas.: 1809063-96-4 | Purity: 95% | (2-((hexylamino)methyl)phenyl)boronic acid | ESD-908316-1G |
Cas.: 1809866-68-9 | Purity: 95% | (4-(((4-methylphenyl)sulfonamido)methyl)phenyl)boronic acid | ESD-908317-250MG |
Cas.: 1809866-68-9 | Purity: 95% | (4-(((4-methylphenyl)sulfonamido)methyl)phenyl)boronic acid | ESD-908317-1G |
Cas.: 1809866-76-9 | Purity: 95% | (4-(((4-chlorophenyl)sulfonamido)methyl)phenyl)boronic acid | ESD-908318-250MG |
Cas.: 1809866-76-9 | Purity: 95% | (4-(((4-chlorophenyl)sulfonamido)methyl)phenyl)boronic acid | ESD-908318-1G |
Cas.: 2246860-49-9 | Purity: 95% | N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzenesulfonamide | ESD-908319-250MG |
Cas.: 2246860-49-9 | Purity: 95% | N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzenesulfonamide | ESD-908319-1G |
Cas.: 2246862-47-3 | Purity: 95% | 3-methyl-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide | ESD-908320-250MG |
Cas.: 2246862-47-3 | Purity: 95% | 3-methyl-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide | ESD-908320-1G |
Cas.: 2246865-32-5 | Purity: 95% | (3-(3-bromobenzamido)phenyl)boronic acid | ESD-908321-250MG |
Cas.: 2246865-32-5 | Purity: 95% | (3-(3-bromobenzamido)phenyl)boronic acid | ESD-908321-1G |
Cas.: 2246871-89-4 | Purity: 95% | 2-methoxy-N-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide | ESD-908322-250MG |
Cas.: 2246871-89-4 | Purity: 95% | 2-methoxy-N-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide | ESD-908322-1G |
Cas.: 2246874-27-9 | Purity: 95% | (4-(propylsulfonamidomethyl)phenyl)boronic acid | ESD-908323-250MG |
Cas.: 2246874-27-9 | Purity: 95% | (4-(propylsulfonamidomethyl)phenyl)boronic acid | ESD-908323-1G |
Cas.: 2246874-83-7 | Purity: 95% | 2-(4-((3-bromophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908324-250MG |
Cas.: 2246874-83-7 | Purity: 95% | 2-(4-((3-bromophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908324-1G |
Cas.: 2246875-71-6 | Purity: 95% | N-(3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)isobutyramide | ESD-908325-250MG |
Cas.: 2246875-71-6 | Purity: 95% | N-(3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)isobutyramide | ESD-908325-1G |
Cas.: 2246877-79-0 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine-1-carboxamide | ESD-908326-250MG |
Cas.: 2246877-79-0 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine-1-carboxamide | ESD-908326-1G |
Cas.: 2246878-24-8 | Purity: 95% | 1-(tert-butyl)-3-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | ESD-908327-250MG |
Cas.: 2246878-24-8 | Purity: 95% | 1-(tert-butyl)-3-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | ESD-908327-1G |
Cas.: 2246885-97-0 | Purity: 95% | 3-tert-butyl-1-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea | ESD-908328-50MG |
Cas.: 2246885-97-0 | Purity: 95% | 3-tert-butyl-1-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea | ESD-908328-250MG |
Cas.: 2246886-35-9 | Purity: 95% | N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pentanamide | ESD-908329-250MG |
Cas.: 2246886-35-9 | Purity: 95% | N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pentanamide | ESD-908329-1G |
Cas.: 2246887-09-0 | Purity: 95% | (4-(3,3-dimethylbutanamido)phenyl)boronic acid | ESD-908330-250MG |
Cas.: 2246887-09-0 | Purity: 95% | (4-(3,3-dimethylbutanamido)phenyl)boronic acid | ESD-908330-1G |
Cas.: 2246887-57-8 | Purity: 95% | 2-{4-[(3-chlorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908331-250MG |
Cas.: 2246887-57-8 | Purity: 95% | 2-{4-[(3-chlorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908331-1G |
Cas.: 2246887-71-6 | Purity: 95% | 2-(3-((3-bromophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908332-250MG |
Cas.: 2246887-71-6 | Purity: 95% | 2-(3-((3-bromophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908332-1G |
Cas.: 2246888-14-0 | Purity: 97% | 4-fluoro-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide | ESD-908333-100MG |
Cas.: 2246888-14-0 | Purity: 97% | 4-fluoro-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide | ESD-908333-250MG |
Cas.: 2246890-53-7 | Purity: 95% | 4-methyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]Benzamide | ESD-908334-250MG |
Cas.: 2246890-53-7 | Purity: 95% | 4-methyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]Benzamide | ESD-908334-1G |
Cas.: 2246894-51-7 | Purity: 95% | 1-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-propylurea | ESD-908335-250MG |
Cas.: 2246894-51-7 | Purity: 95% | 1-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-propylurea | ESD-908335-1G |
Cas.: 2246894-62-0 | Purity: 95% | (4-(((N,N-dimethylsulfamoyl)amino)methyl)phenyl)boronic acid | ESD-908336-250MG |
Cas.: 2246894-62-0 | Purity: 95% | (4-(((N,N-dimethylsulfamoyl)amino)methyl)phenyl)boronic acid | ESD-908336-1G |
Cas.: 2246895-78-1 | Purity: 95% | N-(4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2-methoxyacetamide | ESD-908337-250MG |
Cas.: 2246895-78-1 | Purity: 95% | N-(4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2-methoxyacetamide | ESD-908337-1G |
Cas.: 2246895-97-4 | Purity: 95% | N-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pivalamide | ESD-908338-250MG |
Cas.: 2246895-97-4 | Purity: 95% | N-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pivalamide | ESD-908338-1G |
Cas.: 1823969-59-0 | Purity: 95% | Methyl 5-bromo-4-methylpyrimidine-2-carboxylate | ESD-908339-10MG |
Cas.: 1823969-59-0 | Purity: 95% | Methyl 5-bromo-4-methylpyrimidine-2-carboxylate | ESD-908339-50MG |
Cas.: 1823969-59-0 | Purity: 95% | Methyl 5-bromo-4-methylpyrimidine-2-carboxylate | ESD-908339-250MG |
Cas.: 1831152-32-9 | Purity: 95% | 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-pyrrole | ESD-908340-10MG |
Cas.: 1831152-32-9 | Purity: 95% | 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-pyrrole | ESD-908340-50MG |
Cas.: 1831152-32-9 | Purity: 95% | 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-pyrrole | ESD-908340-250MG |
Cas.: 189172-28-9 | Purity: 95% | 2-Propenoic acid, 2-methyl-, 2,3-dihydro-1H-inden-1-yl ester | ESD-908341-10MG |
Cas.: 189172-28-9 | Purity: 95% | 2-Propenoic acid, 2-methyl-, 2,3-dihydro-1H-inden-1-yl ester | ESD-908341-50MG |
Cas.: 189172-28-9 | Purity: 95% | 2-Propenoic acid, 2-methyl-, 2,3-dihydro-1H-inden-1-yl ester | ESD-908341-250MG |
Cas.: 19006-59-8 | Purity: 95% | 1,1,3-Triethylurea | ESD-908342-10MG |
Cas.: 19006-59-8 | Purity: 95% | 1,1,3-Triethylurea | ESD-908342-50MG |
Cas.: 19006-59-8 | Purity: 95% | 1,1,3-Triethylurea | ESD-908342-250MG |
Cas.: 19812-60-3 | Purity: 95% | 2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl acrylate | ESD-908343-10MG |
Cas.: 19812-60-3 | Purity: 95% | 2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl acrylate | ESD-908343-50MG |
Cas.: 19812-60-3 | Purity: 95% | 2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl acrylate | ESD-908343-250MG |
Cas.: 20545-92-0 | Purity: 95% | N-(2-hydroxyethyl)undec-10-enamide | ESD-908344-10MG |
Cas.: 20545-92-0 | Purity: 95% | N-(2-hydroxyethyl)undec-10-enamide | ESD-908344-50MG |
Cas.: 20545-92-0 | Purity: 95% | N-(2-hydroxyethyl)undec-10-enamide | ESD-908344-250MG |
Cas.: 20587-61-5 | Purity: 95% | 2-(2-hydroxyethoxy)ethyl benzoate | ESD-908345-10MG |
Cas.: 20587-61-5 | Purity: 95% | 2-(2-hydroxyethoxy)ethyl benzoate | ESD-908345-50MG |
Cas.: 20587-61-5 | Purity: 95% | 2-(2-hydroxyethoxy)ethyl benzoate | ESD-908345-250MG |
Cas.: 20602-94-2 | Purity: 95% | 2-(azepan-1-yl)ethyl 2-methylprop-2-enoate | ESD-908346-10MG |
Cas.: 20602-94-2 | Purity: 95% | 2-(azepan-1-yl)ethyl 2-methylprop-2-enoate | ESD-908346-50MG |
Cas.: 20602-94-2 | Purity: 95% | 2-(azepan-1-yl)ethyl 2-methylprop-2-enoate | ESD-908346-250MG |
Cas.: 2073-32-7 | Purity: 95% | 3-Methylazepan-2-one | ESD-908347-10MG |
Cas.: 2073-32-7 | Purity: 95% | 3-Methylazepan-2-one | ESD-908347-50MG |
Cas.: 2073-32-7 | Purity: 95% | 3-Methylazepan-2-one | ESD-908347-250MG |
Cas.: 2082-77-1 | Purity: 95% | undecanoic anhydride | ESD-908348-10MG |
Cas.: 2082-77-1 | Purity: 95% | undecanoic anhydride | ESD-908348-50MG |
Cas.: 2082-77-1 | Purity: 95% | undecanoic anhydride | ESD-908348-250MG |
Cas.: 20901-69-3 | Purity: 95% | 3-fluoro-4-(methylsulfanyl)aniline | ESD-908349-10MG |
Cas.: 20901-69-3 | Purity: 95% | 3-fluoro-4-(methylsulfanyl)aniline | ESD-908349-50MG |
Cas.: 20901-69-3 | Purity: 95% | 3-fluoro-4-(methylsulfanyl)aniline | ESD-908349-250MG |
Cas.: 21081-74-3 | Purity: 95% | 1-chloro-2-methanesulfonyl-4-nitrobenzene | ESD-908350-10MG |
Cas.: 21081-74-3 | Purity: 95% | 1-chloro-2-methanesulfonyl-4-nitrobenzene | ESD-908350-50MG |
Cas.: 21081-74-3 | Purity: 95% | 1-chloro-2-methanesulfonyl-4-nitrobenzene | ESD-908350-250MG |
Cas.: 2142519-15-9 | Purity: 95% | 2-(methyl(2-(methyl(pyridin-2-yl)amino)ethyl)amino)ethan-1-ol | ESD-908351-10MG |
Cas.: 2142519-15-9 | Purity: 95% | 2-(methyl(2-(methyl(pyridin-2-yl)amino)ethyl)amino)ethan-1-ol | ESD-908351-50MG |
Cas.: 2142519-15-9 | Purity: 95% | 2-(methyl(2-(methyl(pyridin-2-yl)amino)ethyl)amino)ethan-1-ol | ESD-908351-250MG |
Cas.: 2170734-03-7 | Purity: 95% | 2-Chloro-N-[2,6-di(propan-2-yl)phenyl]quinolin-8-amine | ESD-908352-10MG |
Cas.: 2170734-03-7 | Purity: 95% | 2-Chloro-N-[2,6-di(propan-2-yl)phenyl]quinolin-8-amine | ESD-908352-50MG |
Cas.: 2170734-03-7 | Purity: 95% | 2-Chloro-N-[2,6-di(propan-2-yl)phenyl]quinolin-8-amine | ESD-908352-250MG |
Cas.: 2246765-62-6 | Purity: 95% | [4-[(Cyclohexanecarbonylamino)methyl]phenyl]boronic acid | ESD-908353-10MG |
Cas.: 2246765-62-6 | Purity: 95% | [4-[(Cyclohexanecarbonylamino)methyl]phenyl]boronic acid | ESD-908353-50MG |
Cas.: 2246765-62-6 | Purity: 95% | [4-[(Cyclohexanecarbonylamino)methyl]phenyl]boronic acid | ESD-908353-250MG |
Cas.: 25401-89-2 | Purity: 95% | 4-tetradecylphenol | ESD-908354-10MG |
Cas.: 25401-89-2 | Purity: 95% | 4-tetradecylphenol | ESD-908354-50MG |
Cas.: 25401-89-2 | Purity: 95% | 4-tetradecylphenol | ESD-908354-250MG |
Cas.: 260804-70-4 | Purity: 95% | (R)-5-((1H-Imidazol-5-yl)methyl)-3-phenyl-2-thioxoimidazolidin-4-one | ESD-908355-10MG |
Cas.: 260804-70-4 | Purity: 95% | (R)-5-((1H-Imidazol-5-yl)methyl)-3-phenyl-2-thioxoimidazolidin-4-one | ESD-908355-50MG |
Cas.: 260804-70-4 | Purity: 95% | (R)-5-((1H-Imidazol-5-yl)methyl)-3-phenyl-2-thioxoimidazolidin-4-one | ESD-908355-250MG |
Cas.: 26818-06-4 | Purity: 95% | 1-bromooctan-2-ol | ESD-908356-10MG |
Cas.: 26818-06-4 | Purity: 95% | 1-bromooctan-2-ol | ESD-908356-50MG |
Cas.: 26818-06-4 | Purity: 95% | 1-bromooctan-2-ol | ESD-908356-250MG |
Cas.: 3129-54-2 | Purity: 95% | N-2-4-dnp-sarcosine | ESD-908357-10MG |
Cas.: 3129-54-2 | Purity: 95% | N-2-4-dnp-sarcosine | ESD-908357-50MG |
Cas.: 3129-54-2 | Purity: 95% | N-2-4-dnp-sarcosine | ESD-908357-250MG |
Cas.: 313231-56-0 | Purity: 98% | 4,6-Dimethyl-2-((2-(pyrrolidin-1-yl)ethyl)thio)pyrimidine | ESD-908358-10MG |
Cas.: 313231-56-0 | Purity: 98% | 4,6-Dimethyl-2-((2-(pyrrolidin-1-yl)ethyl)thio)pyrimidine | ESD-908358-50MG |
Cas.: 313231-56-0 | Purity: 98% | 4,6-Dimethyl-2-((2-(pyrrolidin-1-yl)ethyl)thio)pyrimidine | ESD-908358-250MG |
Cas.: 341008-38-6 | Purity: 95% | 2,6-dichloro-N-[(4-chlorophenyl)methyl]aniline | ESD-908359-10MG |
Cas.: 341008-38-6 | Purity: 95% | 2,6-dichloro-N-[(4-chlorophenyl)methyl]aniline | ESD-908359-50MG |
Cas.: 341008-38-6 | Purity: 95% | 2,6-dichloro-N-[(4-chlorophenyl)methyl]aniline | ESD-908359-250MG |
Cas.: 3547-33-9 | Purity: 95% | 2-(octylthio)ethanol | ESD-908360-10MG |
Cas.: 3547-33-9 | Purity: 95% | 2-(octylthio)ethanol | ESD-908360-50MG |
Cas.: 3547-33-9 | Purity: 95% | 2-(octylthio)ethanol | ESD-908360-250MG |
Cas.: 221526-80-3 | Purity: 95% | 4-butyl-4′-[2-(4-butyl-2,6-difluorophenyl)ethynyl]-1,1′-biphenyl | ESD-908361-5MG |
Cas.: 221526-80-3 | Purity: 95% | 4-butyl-4′-[2-(4-butyl-2,6-difluorophenyl)ethynyl]-1,1′-biphenyl | ESD-908361-25MG |
Cas.: 221526-80-3 | Purity: 95% | 4-butyl-4′-[2-(4-butyl-2,6-difluorophenyl)ethynyl]-1,1′-biphenyl | ESD-908361-100MG |
Cas.: 2246564-39-4 | Purity: 95% | 1-(tert-butyl)-3-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | ESD-908362-5MG |
Cas.: 2246564-39-4 | Purity: 95% | 1-(tert-butyl)-3-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | ESD-908362-25MG |
Cas.: 2246564-39-4 | Purity: 95% | 1-(tert-butyl)-3-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | ESD-908362-100MG |
Cas.: 25800-31-1 | Purity: 97% | Propyl 2,4-dichlorobenzoate | ESD-908363-5MG |
Cas.: 25800-31-1 | Purity: 97% | Propyl 2,4-dichlorobenzoate | ESD-908363-25MG |
Cas.: 25800-31-1 | Purity: 97% | Propyl 2,4-dichlorobenzoate | ESD-908363-100MG |
Cas.: 26496-94-6 | Purity: 98% | 4-Bromobenzoic acid ethyl ester | ESD-908364-5G |
Cas.: 26496-94-6 | Purity: 98% | 4-Bromobenzoic acid ethyl ester | ESD-908364-25G |
Cas.: 26496-94-6 | Purity: 98% | 4-Bromobenzoic acid ethyl ester | ESD-908364-100G |
Cas.: 18650-13-0 | Purity: 95% | 2,15-hexadecanedione | ESD-908365-1G |
Cas.: 18650-13-0 | Purity: 95% | 2,15-hexadecanedione | ESD-908365-5G |
Cas.: 18650-13-0 | Purity: 95% | 2,15-hexadecanedione | ESD-908365-25G |
Cas.: 20816-79-9 | Purity: 98% | 1-Bromo-8-chloronaphthalene | ESD-908366-1G |
Cas.: 20816-79-9 | Purity: 98% | 1-Bromo-8-chloronaphthalene | ESD-908366-5G |
Cas.: 20816-79-9 | Purity: 98% | 1-Bromo-8-chloronaphthalene | ESD-908366-25G |
Cas.: 208516-15-8 | Purity: 95% | [4-(tert-butylsulfamoyl)phenyl]boronic acid | ESD-908367-1G |
Cas.: 208516-15-8 | Purity: 95% | [4-(tert-butylsulfamoyl)phenyl]boronic acid | ESD-908367-5G |
Cas.: 208516-15-8 | Purity: 95% | [4-(tert-butylsulfamoyl)phenyl]boronic acid | ESD-908367-25G |
Cas.: 20900-19-0 | Purity: 98% | 1-butoxynaphthalene | ESD-908368-1G |
Cas.: 20900-19-0 | Purity: 98% | 1-butoxynaphthalene | ESD-908368-5G |
Cas.: 20900-19-0 | Purity: 98% | 1-butoxynaphthalene | ESD-908368-25G |
Cas.: 21364-46-5 | Purity: 98% | isoquinolinium chloride | ESD-908369-1G |
Cas.: 21364-46-5 | Purity: 98% | isoquinolinium chloride | ESD-908369-5G |
Cas.: 21364-46-5 | Purity: 98% | isoquinolinium chloride | ESD-908369-25G |
Cas.: 2177-77-7 | Purity: 98% | Methyl 2-methylvalerate | ESD-908370-1G |
Cas.: 2177-77-7 | Purity: 98% | Methyl 2-methylvalerate | ESD-908370-5G |
Cas.: 2177-77-7 | Purity: 98% | Methyl 2-methylvalerate | ESD-908370-25G |
Cas.: 224789-21-3 | Purity: ≥95% | 2-(2-ethoxyphenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one | ESD-908371-1G |
Cas.: 224789-21-3 | Purity: ≥95% | 2-(2-ethoxyphenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one | ESD-908371-5G |
Cas.: 224789-21-3 | Purity: ≥95% | 2-(2-ethoxyphenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one | ESD-908371-25G |
Cas.: 29710-34-7 | Purity: 95% | hexadecyl decanoate | ESD-908372-1G |
Cas.: 29710-34-7 | Purity: 95% | hexadecyl decanoate | ESD-908372-5G |
Cas.: 29710-34-7 | Purity: 95% | hexadecyl decanoate | ESD-908372-25G |
Cas.: 3109-99-7 | Purity: 95% | 2-Fluoro-2-methyl-1-propanol | ESD-908373-1G |
Cas.: 3109-99-7 | Purity: 95% | 2-Fluoro-2-methyl-1-propanol | ESD-908373-5G |
Cas.: 3109-99-7 | Purity: 95% | 2-Fluoro-2-methyl-1-propanol | ESD-908373-25G |
Cas.: 18719-58-9 | Purity: 95% | TRIS(2-CHLOROETHYL)- ORTHOFORMATE | ESD-908374-250MG |
Cas.: 18719-58-9 | Purity: 95% | TRIS(2-CHLOROETHYL)- ORTHOFORMATE | ESD-908374-1G |
Cas.: 20687-53-0 | Purity: 95% | 1-(tert-butyl)pyrrolidin-2-one | ESD-908375-250MG |
Cas.: 20687-53-0 | Purity: 95% | 1-(tert-butyl)pyrrolidin-2-one | ESD-908375-1G |
Cas.: 20687-53-0 | Purity: 95% | 1-(tert-butyl)pyrrolidin-2-one | ESD-908375-5G |
Cas.: 282116-97-6 | Purity: 98% | [4-(2-ethoxy-2-oxoethoxy)phenyl]boronic acid | ESD-908376-250MG |
Cas.: 282116-97-6 | Purity: 98% | [4-(2-ethoxy-2-oxoethoxy)phenyl]boronic acid | ESD-908376-1G |
Cas.: 282116-97-6 | Purity: 98% | [4-(2-ethoxy-2-oxoethoxy)phenyl]boronic acid | ESD-908376-5G |
Cas.: 29512-46-7 | Purity: 95% | 3′-(diethylamino)-7′-(phenylamino)-3H-spiro[2-benzofuran-1,9′-xanthen]-3-one | ESD-908377-250MG |
Cas.: 29512-46-7 | Purity: 95% | 3′-(diethylamino)-7′-(phenylamino)-3H-spiro[2-benzofuran-1,9′-xanthen]-3-one | ESD-908377-1G |
Cas.: 29512-46-7 | Purity: 95% | 3′-(diethylamino)-7′-(phenylamino)-3H-spiro[2-benzofuran-1,9′-xanthen]-3-one | ESD-908377-5G |
Cas.: 2955-62-6 | Purity: 95% | Methyl 4-Oxohexanoate | ESD-908378-250MG |
Cas.: 2955-62-6 | Purity: 95% | Methyl 4-Oxohexanoate | ESD-908378-1G |
Cas.: 2955-62-6 | Purity: 95% | Methyl 4-Oxohexanoate | ESD-908378-5G |
Cas.: 33720-71-7 | Purity: 95% | 5-Acetyl-2-aminobenzonitrile | ESD-908379-250MG |
Cas.: 33720-71-7 | Purity: 95% | 5-Acetyl-2-aminobenzonitrile | ESD-908379-1G |
Cas.: 33720-71-7 | Purity: 95% | 5-Acetyl-2-aminobenzonitrile | ESD-908379-5G |
Cas.: 33974-27-5 | Purity: 95% | phenyl(4-pyridyl)methanol | ESD-908380-250MG |
Cas.: 33974-27-5 | Purity: 95% | phenyl(4-pyridyl)methanol | ESD-908380-1MG |
Cas.: 33974-27-5 | Purity: 95% | phenyl(4-pyridyl)methanol | ESD-908380-5G |
Cas.: 18312-57-7 | Purity: 95% | 2,2′-(Tridecylazanediyl)diethanol | ESD-908381-50MG |
Cas.: 18312-57-7 | Purity: 95% | 2,2′-(Tridecylazanediyl)diethanol | ESD-908381-250MG |
Cas.: 18312-57-7 | Purity: 95% | 2,2′-(Tridecylazanediyl)diethanol | ESD-908381-1G |
Cas.: 1895467-61-4 | Purity: 98% | 1-(Piperidin-4-yl)cyclobutan-1-ol | ESD-908382-50MG |
Cas.: 1895467-61-4 | Purity: 98% | 1-(Piperidin-4-yl)cyclobutan-1-ol | ESD-908382-250MG |
Cas.: 1895467-61-4 | Purity: 98% | 1-(Piperidin-4-yl)cyclobutan-1-ol | ESD-908382-1G |
Cas.: 194805-04-4 | Purity: 97% | ethyl 7-bromo-1-cyclopropyl-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate | ESD-908383-50MG |
Cas.: 194805-04-4 | Purity: 97% | ethyl 7-bromo-1-cyclopropyl-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate | ESD-908383-250MG |
Cas.: 194805-04-4 | Purity: 97% | ethyl 7-bromo-1-cyclopropyl-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate | ESD-908383-1G |
Cas.: 1998216-01-5 | Purity: 95% | [1,1′-Biphenyl]-3-methanol, 2′-methyl-,3-acetate | ESD-908384-50MG |
Cas.: 1998216-01-5 | Purity: 95% | [1,1′-Biphenyl]-3-methanol, 2′-methyl-,3-acetate | ESD-908384-250MG |
Cas.: 1998216-01-5 | Purity: 95% | [1,1′-Biphenyl]-3-methanol, 2′-methyl-,3-acetate | ESD-908384-1G |
Cas.: 2007908-60-1 | Purity: 95% | Ethyl 3-amino-4,6-dichloropicolinate | ESD-908385-50MG |
Cas.: 2007908-60-1 | Purity: 95% | Ethyl 3-amino-4,6-dichloropicolinate | ESD-908385-250MG |
Cas.: 2007908-60-1 | Purity: 95% | Ethyl 3-amino-4,6-dichloropicolinate | ESD-908385-1G |
Cas.: 2044702-44-3 | Purity: 95% | {2′-methyl-[1,1′-biphenyl]-4-yl}methyl acetate | ESD-908386-50MG |
Cas.: 2044702-44-3 | Purity: 95% | {2′-methyl-[1,1′-biphenyl]-4-yl}methyl acetate | ESD-908386-250MG |
Cas.: 2044702-44-3 | Purity: 95% | {2′-methyl-[1,1′-biphenyl]-4-yl}methyl acetate | ESD-908386-1G |
Cas.: 2057448-75-4 | Purity: 95% | N-phenyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetamide | ESD-908387-50MG |
Cas.: 2057448-75-4 | Purity: 95% | N-phenyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetamide | ESD-908387-250MG |
Cas.: 2057448-75-4 | Purity: 95% | N-phenyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetamide | ESD-908387-1G |
Cas.: 2071707-87-2 | Purity: 95% | N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propane-1-sulfonamide | ESD-908388-50MG |
Cas.: 2071707-87-2 | Purity: 95% | N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propane-1-sulfonamide | ESD-908388-250MG |
Cas.: 2071707-87-2 | Purity: 95% | N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propane-1-sulfonamide | ESD-908388-1G |
Cas.: 2093041-45-1 | Purity: 95% | 2-methyl-N,N-bis(propan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | ESD-908389-50MG |
Cas.: 2093041-45-1 | Purity: 95% | 2-methyl-N,N-bis(propan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | ESD-908389-250MG |
Cas.: 2093041-45-1 | Purity: 95% | 2-methyl-N,N-bis(propan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | ESD-908389-1G |
Cas.: 2213440-04-9 | Purity: 95% | N-(3-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzenesulfonamide | ESD-908390-50MG |
Cas.: 2213440-04-9 | Purity: 95% | N-(3-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzenesulfonamide | ESD-908390-250MG |
Cas.: 2213440-04-9 | Purity: 95% | N-(3-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzenesulfonamide | ESD-908390-1G |
Cas.: 2222544-79-6 | Purity: 95% | 2-fluoro-6-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine | ESD-908391-50MG |
Cas.: 2222544-79-6 | Purity: 95% | 2-fluoro-6-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine | ESD-908391-250MG |
Cas.: 2222544-79-6 | Purity: 95% | 2-fluoro-6-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine | ESD-908391-1G |
Cas.: 2246397-38-4 | Purity: 95% | 3-methyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperidine-1-carboxamide | ESD-908392-50MG |
Cas.: 2246397-38-4 | Purity: 95% | 3-methyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperidine-1-carboxamide | ESD-908392-250MG |
Cas.: 2246397-38-4 | Purity: 95% | 3-methyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperidine-1-carboxamide | ESD-908392-1G |
Cas.: 2246551-83-5 | Purity: 95% | 3,3-diethyl-1-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea | ESD-908393-50MG |
Cas.: 2246551-83-5 | Purity: 95% | 3,3-diethyl-1-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea | ESD-908393-250MG |
Cas.: 2246551-83-5 | Purity: 95% | 3,3-diethyl-1-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea | ESD-908393-1G |
Cas.: 2246646-52-4 | Purity: 95% | N-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]butanamide | ESD-908394-50MG |
Cas.: 2246646-52-4 | Purity: 95% | N-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]butanamide | ESD-908394-250MG |
Cas.: 2246646-52-4 | Purity: 95% | N-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]butanamide | ESD-908394-1G |
Cas.: 2246682-09-5 | Purity: 95% | 1-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-propylurea | ESD-908395-50MG |
Cas.: 2246682-09-5 | Purity: 95% | 1-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-propylurea | ESD-908395-250MG |
Cas.: 2246682-09-5 | Purity: 95% | 1-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-propylurea | ESD-908395-1G |
Cas.: 2246698-15-5 | Purity: 95% | N-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanamide | ESD-908396-50MG |
Cas.: 2246698-15-5 | Purity: 95% | N-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanamide | ESD-908396-250MG |
Cas.: 2246698-15-5 | Purity: 95% | N-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanamide | ESD-908396-1G |
Cas.: 2246765-26-2 | Purity: 95% | (4-(butyramidomethyl)phenyl)boronic acid | ESD-908397-50MG |
Cas.: 2246765-26-2 | Purity: 95% | (4-(butyramidomethyl)phenyl)boronic acid | ESD-908397-250MG |
Cas.: 2246765-26-2 | Purity: 95% | (4-(butyramidomethyl)phenyl)boronic acid | ESD-908397-1G |
Cas.: 2246772-82-5 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethane-1-sulfonamide | ESD-908398-50MG |
Cas.: 2246772-82-5 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethane-1-sulfonamide | ESD-908398-250MG |
Cas.: 2246772-82-5 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethane-1-sulfonamide | ESD-908398-1G |
Cas.: 2246778-85-6 | Purity: 95% | 1-benzyl-3-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | ESD-908399-50MG |
Cas.: 2246778-85-6 | Purity: 95% | 1-benzyl-3-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | ESD-908399-250MG |
Cas.: 2246778-85-6 | Purity: 95% | 1-benzyl-3-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | ESD-908399-1G |
Cas.: 2246799-61-9 | Purity: 95% | 1-[2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(propan-2-yl)urea | ESD-908400-50MG |
Cas.: 2246799-61-9 | Purity: 95% | 1-[2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(propan-2-yl)urea | ESD-908400-250MG |
Cas.: 2246799-61-9 | Purity: 95% | 1-[2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(propan-2-yl)urea | ESD-908400-1G |
Cas.: 2246802-84-4 | Purity: 95% | N-(1-methylethyl)-N’-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-Urea | ESD-908401-50MG |
Cas.: 2246802-84-4 | Purity: 95% | N-(1-methylethyl)-N’-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-Urea | ESD-908401-250MG |
Cas.: 2246802-84-4 | Purity: 95% | N-(1-methylethyl)-N’-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-Urea | ESD-908401-1G |
Cas.: 2246828-84-0 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutanecarboxamide | ESD-908402-50MG |
Cas.: 2246828-84-0 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutanecarboxamide | ESD-908402-250MG |
Cas.: 2246828-84-0 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutanecarboxamide | ESD-908402-1G |
Cas.: 2246834-15-9 | Purity: 95% | N-(2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)isobutyramide | ESD-908403-50MG |
Cas.: 2246834-15-9 | Purity: 95% | N-(2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)isobutyramide | ESD-908403-250MG |
Cas.: 2246834-15-9 | Purity: 95% | N-(2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)isobutyramide | ESD-908403-1G |
Cas.: 22687-02-1 | Purity: 95% | tert-butyl[2-(dimethylamino)ethyl]amine | ESD-908404-50MG |
Cas.: 22687-02-1 | Purity: 95% | tert-butyl[2-(dimethylamino)ethyl]amine | ESD-908404-250MG |
Cas.: 22687-02-1 | Purity: 95% | tert-butyl[2-(dimethylamino)ethyl]amine | ESD-908404-1G |
Cas.: 24003-66-5 | Purity: 95% | 2-pentanamidoacetic acid | ESD-908405-50MG |
Cas.: 24003-66-5 | Purity: 95% | 2-pentanamidoacetic acid | ESD-908405-250MG |
Cas.: 24003-66-5 | Purity: 95% | 2-pentanamidoacetic acid | ESD-908405-1G |
Cas.: 24006-92-6 | Purity: 95% | (4,5-dichlorobenzene-1,2-diyl)dimethanol | ESD-908406-50MG |
Cas.: 24006-92-6 | Purity: 95% | (4,5-dichlorobenzene-1,2-diyl)dimethanol | ESD-908406-250MG |
Cas.: 24006-92-6 | Purity: 95% | (4,5-dichlorobenzene-1,2-diyl)dimethanol | ESD-908406-1G |
Cas.: 2451-86-7 | Purity: 95% | propane-1,3-diyl dibenzoate | ESD-908407-50MG |
Cas.: 2451-86-7 | Purity: 95% | propane-1,3-diyl dibenzoate | ESD-908407-250MG |
Cas.: 2451-86-7 | Purity: 95% | propane-1,3-diyl dibenzoate | ESD-908407-1G |
Cas.: 25187-01-3 | Purity: 95% | bis(2-bromophenyl)methanone | ESD-908408-50MG |
Cas.: 25187-01-3 | Purity: 95% | bis(2-bromophenyl)methanone | ESD-908408-250MG |
Cas.: 25187-01-3 | Purity: 95% | bis(2-bromophenyl)methanone | ESD-908408-1G |
Cas.: 26399-02-0 | Purity: 95% | 2-Ethylhexyl oleate | ESD-908409-50MG |
Cas.: 26399-02-0 | Purity: 95% | 2-Ethylhexyl oleate | ESD-908409-250MG |
Cas.: 26399-02-0 | Purity: 95% | 2-Ethylhexyl oleate | ESD-908409-1G |
Cas.: 264263-98-1 | Purity: 95% | 3,7-dibromo-10-(2-ethylhexyl)-10H-phenothiazine | ESD-908410-50MG |
Cas.: 264263-98-1 | Purity: 95% | 3,7-dibromo-10-(2-ethylhexyl)-10H-phenothiazine | ESD-908410-250MG |
Cas.: 264263-98-1 | Purity: 95% | 3,7-dibromo-10-(2-ethylhexyl)-10H-phenothiazine | ESD-908410-1G |
Cas.: 269398-86-9 | Purity: 99% | Fmoc-(R)-3-amino-4-(4-methyl-phenyl)-butyric acid | ESD-908411-50MG |
Cas.: 269398-86-9 | Purity: 99% | Fmoc-(R)-3-amino-4-(4-methyl-phenyl)-butyric acid | ESD-908411-250MG |
Cas.: 269398-86-9 | Purity: 99% | Fmoc-(R)-3-amino-4-(4-methyl-phenyl)-butyric acid | ESD-908411-1G |
Cas.: 33021-02-2 | Purity: 95% | 1-(1,1-dimethylethoxy)-2-methylpropane | ESD-908412-50MG |
Cas.: 33021-02-2 | Purity: 95% | 1-(1,1-dimethylethoxy)-2-methylpropane | ESD-908412-250MG |
Cas.: 33021-02-2 | Purity: 95% | 1-(1,1-dimethylethoxy)-2-methylpropane | ESD-908412-1G |
Cas.: 3322-70-1 | Purity: 95% | 2,2,5,5-Tetrakis(hydroxymethyl) cyclopentanone | ESD-908413-50MG |
Cas.: 3322-70-1 | Purity: 95% | 2,2,5,5-Tetrakis(hydroxymethyl) cyclopentanone | ESD-908413-250MG |
Cas.: 3322-70-1 | Purity: 95% | 2,2,5,5-Tetrakis(hydroxymethyl) cyclopentanone | ESD-908413-1G |
Cas.: 345306-43-6 | Purity: 95% | 6H-Cyclopenta[b]thiophene, 2,5-dimethyl-3-phenyl- | ESD-908414-50MG |
Cas.: 345306-43-6 | Purity: 95% | 6H-Cyclopenta[b]thiophene, 2,5-dimethyl-3-phenyl- | ESD-908414-250MG |
Cas.: 345306-43-6 | Purity: 95% | 6H-Cyclopenta[b]thiophene, 2,5-dimethyl-3-phenyl- | ESD-908414-1G |
Cas.: 345975-15-7 | Purity: 95% | (2R)-2-[(2-nitrophenoxy)methyl]oxirane | ESD-908415-50MG |
Cas.: 345975-15-7 | Purity: 95% | (2R)-2-[(2-nitrophenoxy)methyl]oxirane | ESD-908415-250MG |
Cas.: 345975-15-7 | Purity: 95% | (2R)-2-[(2-nitrophenoxy)methyl]oxirane | ESD-908415-1G |
Cas.: 363598-42-9 | Purity: 97% | 1,3-dibromo-2-(trimethylsilyl)benzene | ESD-908416-50MG |
Cas.: 363598-42-9 | Purity: 97% | 1,3-dibromo-2-(trimethylsilyl)benzene | ESD-908416-250MG |
Cas.: 363598-42-9 | Purity: 97% | 1,3-dibromo-2-(trimethylsilyl)benzene | ESD-908416-1G |
Cas.: 1809876-45-6 | Purity: 95% | 1-(3-methoxyphenyl)-3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | ESD-908417-50MG |
Cas.: 1809876-45-6 | Purity: 95% | 1-(3-methoxyphenyl)-3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | ESD-908417-250MG |
Cas.: 1810074-65-7 | Purity: ≥95% | (2S)-2-AMINO-3-(4-VINYLPHENYL)PROPANOIC ACID-HCL | ESD-908418-25MG |
Cas.: 1810074-65-7 | Purity: ≥95% | (2S)-2-AMINO-3-(4-VINYLPHENYL)PROPANOIC ACID-HCL | ESD-908418-100MG |
Cas.: 181052-63-1 | Purity: 97% | methyl 2-(7-hydroxybenzofuran-3-yl)acetate | ESD-908419-250MG |
Cas.: 181052-63-1 | Purity: 97% | methyl 2-(7-hydroxybenzofuran-3-yl)acetate | ESD-908419-1G |
Cas.: 181282-80-4 | Purity: 95% | Methyl 4-chloro-3-cyanobenzoate | ESD-908420-250MG |
Cas.: 181282-80-4 | Purity: 95% | Methyl 4-chloro-3-cyanobenzoate | ESD-908420-1G |
Cas.: 1813552-97-4 | Purity: 95% | Methyl 4-((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)methyl)benzoate | ESD-908421-250MG |
Cas.: 1813552-97-4 | Purity: 95% | Methyl 4-((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)methyl)benzoate | ESD-908421-1G |
Cas.: 1813554-40-3 | Purity: 95% | 4,4,5,5-Tetramethyl-2-[4-[[4-(trifluoromethyl)phenyl]methoxy]phenyl]-1,3,2-dioxaborolane | ESD-908422-250MG |
Cas.: 1813554-40-3 | Purity: 95% | 4,4,5,5-Tetramethyl-2-[4-[[4-(trifluoromethyl)phenyl]methoxy]phenyl]-1,3,2-dioxaborolane | ESD-908422-1G |
Cas.: 1813554-41-4 | Purity: 95% | 4,4,5,5-Tetramethyl-2-[4-[[3-(trifluoromethyl)phenyl]methoxy]phenyl]-1,3,2-dioxaborolane | ESD-908423-50MG |
Cas.: 1813554-41-4 | Purity: 95% | 4,4,5,5-Tetramethyl-2-[4-[[3-(trifluoromethyl)phenyl]methoxy]phenyl]-1,3,2-dioxaborolane | ESD-908423-250MG |
Cas.: 181518-87-6 | Purity: 95% | (S)-2-((tert-Butoxycarbonyl)amino)-4-(dimethylamino)butanoic acid | ESD-908424-50MG |
Cas.: 181518-87-6 | Purity: 95% | (S)-2-((tert-Butoxycarbonyl)amino)-4-(dimethylamino)butanoic acid | ESD-908424-250MG |
Cas.: 18197-25-6 | Purity: 95% | N-formyl-N-methylformamide | ESD-908425-250MG |
Cas.: 18197-25-6 | Purity: 95% | N-formyl-N-methylformamide | ESD-908425-1G |
Cas.: 1821640-79-2 | Purity: 95% | [3-(pyridine-4-amido)phenyl]boronic acid | ESD-908426-250MG |
Cas.: 1821640-79-2 | Purity: 95% | [3-(pyridine-4-amido)phenyl]boronic acid | ESD-908426-1G |
Cas.: 1823244-05-8 | Purity: 95% | 4-(2-Formylfuran-3-yl)benzoic acid | ESD-908427-250MG |
Cas.: 1823244-05-8 | Purity: 95% | 4-(2-Formylfuran-3-yl)benzoic acid | ESD-908427-1G |
Cas.: 1823552-72-2 | Purity: 95% | Ethyl 6-chloroisoquinoline-3-carboxylate | ESD-908428-25MG |
Cas.: 1823552-72-2 | Purity: 95% | Ethyl 6-chloroisoquinoline-3-carboxylate | ESD-908428-100MG |
Cas.: 1823888-27-2 | Purity: 95% | Methyl 5-bromo-6-methylpyrazine-2-carboxylate | ESD-908429-250MG |
Cas.: 1823888-27-2 | Purity: 95% | Methyl 5-bromo-6-methylpyrazine-2-carboxylate | ESD-908429-1G |
Cas.: 1823921-17-0 | Purity: 95% | methyl 5-amino-6-bromo-3-methylpyrazine-2-carboxylate | ESD-908430-5MG |
Cas.: 1823921-17-0 | Purity: 95% | methyl 5-amino-6-bromo-3-methylpyrazine-2-carboxylate | ESD-908430-25MG |
Cas.: 1823985-74-5 | Purity: 95% | 3-(2-Formylfuran-3-yl)benzoic acid | ESD-908431-250MG |
Cas.: 1823985-74-5 | Purity: 95% | 3-(2-Formylfuran-3-yl)benzoic acid | ESD-908431-1G |
Cas.: 1824080-82-1 | Purity: 95% | 3-(Chloromethyl)pyrazolo[1,5-a]pyrimidine | ESD-908432-250MG |
Cas.: 1824080-82-1 | Purity: 95% | 3-(Chloromethyl)pyrazolo[1,5-a]pyrimidine | ESD-908432-1G |
Cas.: 1824265-83-9 | Purity: 97% | 2-(2-(Benzyloxy)-4-fluorophenyl)acetonitrile | ESD-908433-250MG |
Cas.: 1824265-83-9 | Purity: 97% | 2-(2-(Benzyloxy)-4-fluorophenyl)acetonitrile | ESD-908433-1G |
Cas.: 18312-31-7 | Purity: 95% | octadecyl octanoate | ESD-908434-1G |
Cas.: 18312-31-7 | Purity: 95% | octadecyl octanoate | ESD-908434-5G |
Cas.: 1832-64-0 | Purity: 95% | 4-nitrophenyl methylphosphonate | ESD-908435-25MG |
Cas.: 1832-64-0 | Purity: 95% | 4-nitrophenyl methylphosphonate | ESD-908435-100MG |
Cas.: 1842-70-2 | Purity: 95% | methyl 10-oxooctadecanoate | ESD-908436-5MG |
Cas.: 1842-70-2 | Purity: 95% | methyl 10-oxooctadecanoate | ESD-908436-25MG |
Cas.: 1847480-32-3 | Purity: 95% | 2-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetonitrile | ESD-908437-25MG |
Cas.: 1847480-32-3 | Purity: 95% | 2-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetonitrile | ESD-908437-100MG |
Cas.: 18479-49-7 | Purity: 95% | 3,7-dimethyloct-1-en-3-ol | ESD-908438-1G |
Cas.: 18479-49-7 | Purity: 95% | 3,7-dimethyloct-1-en-3-ol | ESD-908438-5G |
Cas.: 184962-88-7 | Purity: 96% | FMOC-3,4-DIMETHOXY-L-PHENYLALANINE | ESD-908439-250MG |
Cas.: 184962-88-7 | Purity: 96% | FMOC-3,4-DIMETHOXY-L-PHENYLALANINE | ESD-908439-1G |
Cas.: 185040-35-1 | Purity: 95% | 4-(Ethylamino)-2-(methylthio)pyrimidine-5-carbaldehyde | ESD-908440-250MG |
Cas.: 185040-35-1 | Purity: 95% | 4-(Ethylamino)-2-(methylthio)pyrimidine-5-carbaldehyde | ESD-908440-1G |
Cas.: 1852-18-2 | Purity: 95% | 5-hydroxy-1,3-diazinan-2-one | ESD-908441-1G |
Cas.: 1852-18-2 | Purity: 95% | 5-hydroxy-1,3-diazinan-2-one | ESD-908441-5G |
Cas.: 1853185-35-9 | Purity: 95% | 2-methoxy-N-[3-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide | ESD-908442-25MG |
Cas.: 1853185-35-9 | Purity: 95% | 2-methoxy-N-[3-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide | ESD-908442-100MG |
Cas.: 185329-96-8 | Purity: 95% | (2-methyl-4-propylphenyl)boronic acid | ESD-908443-25MG |
Cas.: 185329-96-8 | Purity: 95% | (2-methyl-4-propylphenyl)boronic acid | ESD-908443-100MG |
Cas.: 18600-41-4 | Purity: 95% | 1-Propanamine, 3-methoxy-, hydrochloride | ESD-908444-5G |
Cas.: 18600-41-4 | Purity: 95% | 1-Propanamine, 3-methoxy-, hydrochloride | ESD-908444-25G |
Cas.: 1862885-26-4 | Purity: 95% | 2-(5,6-dimethylpyridin-3-yl)propan-2-ol | ESD-908445-250MG |
Cas.: 1862885-26-4 | Purity: 95% | 2-(5,6-dimethylpyridin-3-yl)propan-2-ol | ESD-908445-1G |
Cas.: 186293-54-9 | Purity: 95% | (2R)-2-(Chloromethyl)-4-(phenylmethyl)morpholine | ESD-908446-250MG |
Cas.: 186293-54-9 | Purity: 95% | (2R)-2-(Chloromethyl)-4-(phenylmethyl)morpholine | ESD-908446-1G |
Cas.: 186413-76-3 | Purity: 95% | 3-Bromo-6-methoxy-2-methyl-5-nitropyridine | ESD-908447-250MG |
Cas.: 186413-76-3 | Purity: 95% | 3-Bromo-6-methoxy-2-methyl-5-nitropyridine | ESD-908447-1G |
Cas.: 18649-16-6 | Purity: 95% | Methanesulfinamide | ESD-908448-5MG |
Cas.: 18649-16-6 | Purity: 95% | Methanesulfinamide | ESD-908448-25MG |
Cas.: 186590-30-7 | Purity: 95% | 4,5-Difluoro-2-iodophenol | ESD-908449-250MG |
Cas.: 186590-30-7 | Purity: 95% | 4,5-Difluoro-2-iodophenol | ESD-908449-1G |
Cas.: 186661-19-8 | Purity: 95% | N-dansyl-N’-ethylthiourea | ESD-908450-10MG |
Cas.: 186661-19-8 | Purity: 95% | N-dansyl-N’-ethylthiourea | ESD-908450-50MG |
Cas.: 1872387-85-3 | Purity: 95% | 1-(4-Tert-butylphenyl)-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea | ESD-908451-25MG |
Cas.: 1872387-85-3 | Purity: 95% | 1-(4-Tert-butylphenyl)-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea | ESD-908451-100MG |
Cas.: 1872388-26-5 | Purity: 95% | 4-tert-butyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzamide | ESD-908452-50MG |
Cas.: 1872388-26-5 | Purity: 95% | 4-tert-butyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzamide | ESD-908452-250MG |
Cas.: 18749-84-3 | Purity: 98% | didodecylbenzene-1,4-dicarboxylate | ESD-908453-250MG |
Cas.: 18749-84-3 | Purity: 98% | didodecylbenzene-1,4-dicarboxylate | ESD-908453-1G |
Cas.: 1883598-68-2 | Purity: 95% | tert-butyl 5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate | ESD-908454-25MG |
Cas.: 1883598-68-2 | Purity: 95% | tert-butyl 5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate | ESD-908454-100MG |
Cas.: 1884710-54-6 | Purity: 95% | (4-(Pyrazin-2-ylcarbamoyl)phenyl)boronic acid | ESD-908455-250MG |
Cas.: 1884710-54-6 | Purity: 95% | (4-(Pyrazin-2-ylcarbamoyl)phenyl)boronic acid | ESD-908455-1G |
Cas.: 1884715-43-8 | Purity: 95% | B-[4-[[(5-chloro-2-pyridinyl)amino]carbonyl]phenyl]Boronic acid | ESD-908456-50MG |
Cas.: 1884715-43-8 | Purity: 95% | B-[4-[[(5-chloro-2-pyridinyl)amino]carbonyl]phenyl]Boronic acid | ESD-908456-250MG |
Cas.: 188480-50-4 | Purity: 95% | 4-(hydroxyamino)-N-[2-(naphthalen-2-yloxy)ethyl]benzene-1-sulfonamide | ESD-908457-50MG |
Cas.: 188480-50-4 | Purity: 95% | 4-(hydroxyamino)-N-[2-(naphthalen-2-yloxy)ethyl]benzene-1-sulfonamide | ESD-908457-250MG |
Cas.: 18867-43-1 | Purity: 95% | (R)2-Hydroxy-2-phenylethanaminium chloride-(-)-2-AMINO-1-PHENYLETHANOL HCL | ESD-908458-250MG |
Cas.: 18867-43-1 | Purity: 95% | (R)2-Hydroxy-2-phenylethanaminium chloride-(-)-2-AMINO-1-PHENYLETHANOL HCL | ESD-908458-1G |
Cas.: 18895-00-6 | Purity: 95% | 2-iodothiophene-3-carboxylic acid | ESD-908459-50MG |
Cas.: 18895-00-6 | Purity: 95% | 2-iodothiophene-3-carboxylic acid | ESD-908459-250MG |
Cas.: 1889970-48-2 | Purity: 98% | 2-amino-3-(2,4-dichlorophenyl)propanenitrile | ESD-908460-25MG |
Cas.: 1889970-48-2 | Purity: 98% | 2-amino-3-(2,4-dichlorophenyl)propanenitrile | ESD-908460-100MG |
Cas.: 189102-97-4 | Purity: 95% | 5,6-dichloro-3H-iMidazo[4,5-b]pyridine | ESD-908461-50MG |
Cas.: 189102-97-4 | Purity: 95% | 5,6-dichloro-3H-iMidazo[4,5-b]pyridine | ESD-908461-250MG |
Cas.: 18924-67-9 | Purity: 95% | 2,2′-(hexadecylimino)bisethanol | ESD-908462-50MG |
Cas.: 1897-50-3 | Purity: 95% | 5-Chloro-2,4,6-trifluoroisophthalonitrile | ESD-908463-25MG |
Cas.: 1897-50-3 | Purity: 95% | 5-Chloro-2,4,6-trifluoroisophthalonitrile | ESD-908463-100MG |
Cas.: 1900755-49-8 | Purity: 95% | (1-Tritylimidazol-4-yl)boronic acid | ESD-908464-50MG |
Cas.: 1900755-49-8 | Purity: 95% | (1-Tritylimidazol-4-yl)boronic acid | ESD-908464-250MG |
Cas.: 19019-43-3 | Purity: 95% | Glycine, N-(carboxymethyl)-N-2-(carboxymethyl)aminoethyl-, trisodium salt | ESD-908465-25MG |
Cas.: 19078-97-8 | Purity: 95% | 2,2-DIMETHYL-3-HEPTANONE | ESD-908466-25MG |
Cas.: 19078-97-8 | Purity: 95% | 2,2-DIMETHYL-3-HEPTANONE | ESD-908466-100MG |
Cas.: 191089-06-2 | Purity: 97% | 4-Borono-2-methylbenzoic acid | ESD-908467-250MG |
Cas.: 191089-06-2 | Purity: 97% | 4-Borono-2-methylbenzoic acid | ESD-908467-1G |
Cas.: 191228-04-3 | Purity: 95% | 7-((4′-Cyano-[1,1′-biphenyl]-4-yl)oxy)-N-hydroxyheptanamide | ESD-908468-5MG |
Cas.: 191228-04-3 | Purity: 95% | 7-((4′-Cyano-[1,1′-biphenyl]-4-yl)oxy)-N-hydroxyheptanamide | ESD-908468-25MG |
Cas.: 1912-30-7 | Purity: 95% | Ethyl ethanesulfonate | ESD-908469-250MG |
Cas.: 1912-30-7 | Purity: 95% | Ethyl ethanesulfonate | ESD-908469-1G |
Cas.: 19123-21-8 | Purity: 95% | Trans-siduron | ESD-908470-25MG |
Cas.: 19123-21-8 | Purity: 95% | Trans-siduron | ESD-908470-100MG |
Cas.: 1912427-64-5 | Purity: 95% | Succinic acid Monohydrazide Hcl | ESD-908471-50MG |
Cas.: 1912427-64-5 | Purity: 95% | Succinic acid Monohydrazide Hcl | ESD-908471-250MG |
Cas.: 1912447-03-0 | Purity: 95% | N-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethenesulfonamide | ESD-908472-50MG |
Cas.: 1912447-03-0 | Purity: 95% | N-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethenesulfonamide | ESD-908472-250MG |
Cas.: 1914078-87-7 | Purity: 95% | phenyl (2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate | ESD-908473-25MG |
Cas.: 1914078-87-7 | Purity: 95% | phenyl (2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate | ESD-908473-100MG |
Cas.: 1914-20-1 | Purity: 95% | N-Methoxyphthalimide | ESD-908474-50MG |
Cas.: 1914-20-1 | Purity: 95% | N-Methoxyphthalimide | ESD-908474-250MG |
Cas.: 19162-00-6 | Purity: 95% | 1,5-dimethylhex-4-enyl acetate | ESD-908475-250MG |
Cas.: 19162-00-6 | Purity: 95% | 1,5-dimethylhex-4-enyl acetate | ESD-908475-1G |
Cas.: 1927-68-0 | Purity: 95% | 2-butoxyoxane | ESD-908476-50MG |
Cas.: 1927-68-0 | Purity: 95% | 2-butoxyoxane | ESD-908476-250MG |
Cas.: 193022-99-0 | Purity: 95% | 4-(Hydroxymethyl)tetrahydro-2H-pyran-4-carboxylic acid | ESD-908477-250MG |
Cas.: 193022-99-0 | Purity: 95% | 4-(Hydroxymethyl)tetrahydro-2H-pyran-4-carboxylic acid | ESD-908477-1G |
Cas.: 1934-92-5 | Purity: 95% | N-methylbenzanilide | ESD-908478-1G |
Cas.: 1934-92-5 | Purity: 95% | N-methylbenzanilide | ESD-908478-5G |
Cas.: 1935294-81-7 | Purity: 95% | 2-Chloro-5-isopropoxy-3-nitropyridine | ESD-908479-250MG |
Cas.: 1935294-81-7 | Purity: 95% | 2-Chloro-5-isopropoxy-3-nitropyridine | ESD-908479-1G |
Cas.: 193542-65-3 | Purity: 95% | BX 513 hydrochloride | ESD-908480-10MG |
Cas.: 193542-65-3 | Purity: 95% | BX 513 hydrochloride | ESD-908480-50MG |
Cas.: 194032-35-4 | Purity: 95% | TETRT-BUTYL3-METHYL-1,4-DIAZEPANE-1-CARBOXYLATE | ESD-908481-50MG |
Cas.: 194032-35-4 | Purity: 95% | TETRT-BUTYL3-METHYL-1,4-DIAZEPANE-1-CARBOXYLATE | ESD-908481-250MG |
Cas.: 1942-31-0 | Purity: 95% | 1-[4-(2-phenyleth-1-ynyl)phenyl]ethan-1-one | ESD-908482-1G |
Cas.: 1942-31-0 | Purity: 95% | 1-[4-(2-phenyleth-1-ynyl)phenyl]ethan-1-one | ESD-908482-5G |
Cas.: 194421-56-2 | Purity: 97% | 6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione | ESD-908483-1G |
Cas.: 194421-56-2 | Purity: 97% | 6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione | ESD-908483-5G |
Cas.: 19532-98-0 | Purity: 98% | 1,2-Benzenedicarboxamide, N,N’-dimethyl- | ESD-908484-250MG |
Cas.: 19532-98-0 | Purity: 98% | 1,2-Benzenedicarboxamide, N,N’-dimethyl- | ESD-908484-1G |
Cas.: 195517-88-5 | Purity: 95% | TERT-BUTYL 5-CHLORO-2-HYDROXYBENZYLCARBAMATE | ESD-908485-50MG |
Cas.: 195517-88-5 | Purity: 95% | TERT-BUTYL 5-CHLORO-2-HYDROXYBENZYLCARBAMATE | ESD-908485-250MG |
Cas.: 19611-45-1 | Purity: 95% | 2H-PYRAN-2-CARBOXALDEHYDE, TETRAHYDRO- | ESD-908486-50MG |
Cas.: 1962-75-0 | Purity: 95% | Dibutyl Terephthalate | ESD-908487-250MG |
Cas.: 1962-75-0 | Purity: 95% | Dibutyl Terephthalate | ESD-908487-1G |
Cas.: 1965304-61-3 | Purity: 95% | tert-Butyl [2-(4-amino-1H-pyrazol-1-yl)ethyl]carbamate oxalate | ESD-908488-50MG |
Cas.: 1965304-61-3 | Purity: 95% | tert-Butyl [2-(4-amino-1H-pyrazol-1-yl)ethyl]carbamate oxalate | ESD-908488-250MG |
Cas.: 196809-85-5 | Purity: 95% | [4-[(propylamino)sulfonyl]phenyl]Boronic acid | ESD-908489-250MG |
Cas.: 196809-85-5 | Purity: 95% | [4-[(propylamino)sulfonyl]phenyl]Boronic acid | ESD-908489-1G |
Cas.: 197304-94-2 | Purity: 95% | 1,2-Diethyl-3,5-pyrazolidinedione | ESD-908490-5MG |
Cas.: 197304-94-2 | Purity: 95% | 1,2-Diethyl-3,5-pyrazolidinedione | ESD-908490-25MG |
Cas.: 197389-70-1 | Purity: 95% | 5-[13-(3-Carboxy-4-hydroxyphenyl)-5,7,12,14-tetraoxo-6,13-diazatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),2,4( 16),8,10-pentaen-6-yl]-2-hydroxybenzoic acid | ESD-908491-5MG |
Cas.: 197389-70-1 | Purity: 95% | 5-[13-(3-Carboxy-4-hydroxyphenyl)-5,7,12,14-tetraoxo-6,13-diazatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),2,4( 16),8,10-pentaen-6-yl]-2-hydroxybenzoic acid | ESD-908491-25MG |
Cas.: 19786-36-8 | Purity: 95% | H-Pro-Tyr-OH | ESD-908492-250MG |
Cas.: 19786-36-8 | Purity: 95% | H-Pro-Tyr-OH | ESD-908492-1G |
Cas.: 19846-21-0 | Purity: 98% | 2,4-dichlorobenzene-1,3-dicarbonitrile | ESD-908493-50MG |
Cas.: 19846-21-0 | Purity: 98% | 2,4-dichlorobenzene-1,3-dicarbonitrile | ESD-908493-250MG |
Cas.: 19853-09-9 | Purity: 97% | 2-phenylbenzyl bromide | ESD-908494-5G |
Cas.: 19853-09-9 | Purity: 97% | 2-phenylbenzyl bromide | ESD-908494-25G |
Cas.: 19854-92-3 | Purity: 95% | phenyl(1H-pyrazol-5-yl)methanone | ESD-908495-50MG |
Cas.: 19854-92-3 | Purity: 95% | phenyl(1H-pyrazol-5-yl)methanone | ESD-908495-250MG |
Cas.: 1990151-16-0 | Purity: 95% | 2-Benzyl-2,6-diazaspiro[3.5]nonane hydrochloride | ESD-908496-25MG |
Cas.: 1990151-16-0 | Purity: 95% | 2-Benzyl-2,6-diazaspiro[3.5]nonane hydrochloride | ESD-908496-100MG |
Cas.: 199327-59-8 | Purity: 95% | 4-(3-((4-Chloro-7-methoxyquinazolin-6-yl)oxy)propyl)morpholine | ESD-908497-25MG |
Cas.: 199327-59-8 | Purity: 95% | 4-(3-((4-Chloro-7-methoxyquinazolin-6-yl)oxy)propyl)morpholine | ESD-908497-100MG |
Cas.: 199655-36-2 | Purity: 95% | 3-(2-chlorophenyl)-2-(2-{6-[(diethylamino)methyl]pyridin-2-yl}ehenyl)-6-fluoro-3,4-dihydroquinazolin-4-one | ESD-908498-5MG |
Cas.: 199655-36-2 | Purity: 95% | 3-(2-chlorophenyl)-2-(2-{6-[(diethylamino)methyl]pyridin-2-yl}ehenyl)-6-fluoro-3,4-dihydroquinazolin-4-one | ESD-908498-25MG |
Cas.: 199942-74-0 | Purity: 95% | (S)-1-N-BOC-PIPERIDINE-2-ETHANOL | ESD-908499-250MG |
Cas.: 199942-74-0 | Purity: 95% | (S)-1-N-BOC-PIPERIDINE-2-ETHANOL | ESD-908499-1G |
Cas.: 201282-04-4 | Purity: 95% | ert-Butyl (6-(2-chloroacetamido)hexyl)carbamate | ESD-908500-50MG |
Cas.: 201282-04-4 | Purity: 95% | ert-Butyl (6-(2-chloroacetamido)hexyl)carbamate | ESD-908500-250MG |
Cas.: 202415-95-0 | Purity: 95% | (3β,5α,6α,7β)-3,6,7-Trihydroxyandrostan-17-one | ESD-908502-25MG |
Cas.: 202415-95-0 | Purity: 95% | (3β,5α,6α,7β)-3,6,7-Trihydroxyandrostan-17-one | ESD-908502-100MG |
Cas.: 202925-05-1 | Purity: ≥95% | 4-Chloro-3,5-dibromotoluene | ESD-908503-100G |
Cas.: 20294-50-2 | Purity: 95% | 4-bromo-2-methyl-6-nitrophenol | ESD-908504-1G |
Cas.: 20294-50-2 | Purity: 95% | 4-bromo-2-methyl-6-nitrophenol | ESD-908504-5G |
Cas.: 20315-68-8 | Purity: 95% | 6-Methoxy-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole | ESD-908505-250MG |
Cas.: 20315-68-8 | Purity: 95% | 6-Methoxy-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole | ESD-908505-500MG |
Cas.: 203854-58-4 | Purity: 98% | (2S)-3-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-2-methylpropanoic acid | ESD-908506-250MG |
Cas.: 203854-58-4 | Purity: 98% | (2S)-3-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-2-methylpropanoic acid | ESD-908506-1G |
Cas.: 2040-86-0 | Purity: 95% | 2-Bromo-6-iodophenol | ESD-908507-250MG |
Cas.: 2040-86-0 | Purity: 95% | 2-Bromo-6-iodophenol | ESD-908507-1G |
Cas.: 204315-81-1 | Purity: 95% | 4,4′-Diiodo-[1,1′-biphenyl]-2,2′-diol | ESD908508-50MG |
Cas.: 204315-81-1 | Purity: 95% | 4,4′-Diiodo-[1,1′-biphenyl]-2,2′-diol | ESD908508-250MG |
Cas.: 2045409-68-3 | Purity: 95% | N-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2-phenylacetamide | ESD-908509-25MG |
Cas.: 2045409-68-3 | Purity: 95% | N-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2-phenylacetamide | ESD-908509-100MG |
Cas.: 20503-78-0 | Purity: 95% | 2-[(4,5-diphenyl-1,3-oxazol-2-yl)(methyl)amino]ethanol | ESD-908510-5MG |
Cas.: 20503-78-0 | Purity: 95% | 2-[(4,5-diphenyl-1,3-oxazol-2-yl)(methyl)amino]ethanol | ESD-908510-25MG |
Cas.: 20503-79-1 | Purity: 95% | 4,5-Diphenyl-2-(N-ethyl-N-(2-hydroxyethyl)amino)oxazole | ESD-908511-5MG |
Cas.: 20503-79-1 | Purity: 95% | 4,5-Diphenyl-2-(N-ethyl-N-(2-hydroxyethyl)amino)oxazole | ESD-908511-25MG |
Cas.: 2050-54-6 | Purity: 95% | DIBUTYLCYANAMIDE | ESD-908512-50MG |
Cas.: 2050-54-6 | Purity: 95% | DIBUTYLCYANAMIDE | ESD-908512-250MG |
Cas.: 2056919-34-5 | Purity: 95% | N-cyclopentyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetamide | ESD-908513-25MG |
Cas.: 2056919-34-5 | Purity: 95% | N-cyclopentyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetamide | ESD-908513-100MG |
Cas.: 2056919-38-9 | Purity: 95% | N-(2-methylpropyl)-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetamide | ESD-908514-50MG |
Cas.: 2056919-38-9 | Purity: 95% | N-(2-methylpropyl)-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetamide | ESD-908514-250MG |
Cas.: 2056919-55-0 | Purity: 95% | N-tert-butyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetamide | ESD-908515-250MG |
Cas.: 2056919-55-0 | Purity: 95% | N-tert-butyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetamide | ESD-908515-1G |
Cas.: 2056919-60-7 | Purity: 95% | N-(pentan-3-yl)-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetamide | ESD-908516-25MG |
Cas.: 2056919-60-7 | Purity: 95% | N-(pentan-3-yl)-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetamide | ESD-908516-100MG |
Cas.: 2057448-28-7 | Purity: 95% | 1-(morpholin-4-yl)-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethan-1-one | ESD-908517-25MG |
Cas.: 2057448-28-7 | Purity: 95% | 1-(morpholin-4-yl)-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethan-1-one | ESD-908517-100MG |
Cas.: 2057448-33-4 | Purity: 95% | N-propyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetamide | ESD-908518-25MG |
Cas.: 2057448-33-4 | Purity: 95% | N-propyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetamide | ESD-908518-100MG |
Cas.: 2057448-57-2 | Purity: 95% | N,N-diethyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetamide | ESD-908519-25MG |
Cas.: 2057448-57-2 | Purity: 95% | N,N-diethyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetamide | ESD-908519-100MG |
Cas.: 2057448-81-2 | Purity: 95% | N-cyclohexyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetamide | ESD-908520-25MG |
Cas.: 2057448-81-2 | Purity: 95% | N-cyclohexyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetamide | ESD-908520-100MG |
Cas.: 2057449-99-5 | Purity: 95% | 2-chloro-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide | ESD-908521-25MG |
Cas.: 2057449-99-5 | Purity: 95% | 2-chloro-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide | ESD-908521-100MG |
Cas.: 2057450-00-5 | Purity: 95% | 2-(4-Methylpiperazin-1-yl)-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide | ESD-908522-25MG |
Cas.: 2057450-00-5 | Purity: 95% | 2-(4-Methylpiperazin-1-yl)-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide | ESD-908522-100MG |
Cas.: 20599-01-3 | Purity: 98% | 2,2-bis(bromomethyl)-1,3-dioxolane | ESD-908523-1G |
Cas.: 20599-01-3 | Purity: 98% | 2,2-bis(bromomethyl)-1,3-dioxolane | ESD-908523-5G |
Cas.: 20636-48-0 | Purity: 95% | 14-(4-nonylphenoxy)-3,6,9,12-tetraoxatetradecan-1-ol | ESD-908524-25MG |
Cas.: 20636-48-0 | Purity: 95% | 14-(4-nonylphenoxy)-3,6,9,12-tetraoxatetradecan-1-ol | ESD-908524-100MG |
Cas.: 20662-83-3 | Purity: 95% | 4,5-dimethyl-1,3-oxazole | ESD-908525-250MG |
Cas.: 20662-83-3 | Purity: 95% | 4,5-dimethyl-1,3-oxazole | ESD-908525-1G |
Cas.: 20677-52-5 | Purity: 95% | 3-chlorobenzene-1-sulfonic acid | ESD-908526-25MG |
Cas.: 20677-52-5 | Purity: 95% | 3-chlorobenzene-1-sulfonic acid | ESD-908526-100MG |
Cas.: 2068759-01-1 | Purity: 95% | 4-chloro-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzene-1-sulfonamide | ESD-908527-25MG |
Cas.: 2068759-01-1 | Purity: 95% | 4-chloro-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzene-1-sulfonamide | ESD-908527-100MG |
Cas.: 2071741-37-0 | Purity: 95% | N,N-diethyl-3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | ESD-908528-25MG |
Cas.: 2071741-37-0 | Purity: 95% | N,N-diethyl-3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | ESD-908528-100MG |
Cas.: 207307-51-5 | Purity: 95% | [1-(triphenylmethyl)-1H-pyrazol-4-yl]boronic acid | ESD-908529-250MG |
Cas.: 207307-51-5 | Purity: 95% | [1-(triphenylmethyl)-1H-pyrazol-4-yl]boronic acid | ESD-908529-1G |
Cas.: 208252-67-9 | Purity: 95% | (4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea | ESD-908530-50MG |
Cas.: 208252-67-9 | Purity: 95% | (4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea | ESD-908530-250MG |
Cas.: 208338-50-5 | Purity: 95% | 4-[difluoro(3,4,5-trifluorophenoxy)methyl]-4′-propyl-1,1′-bi(cyclohexyl) | ESD-908531-250MG |
Cas.: 208338-50-5 | Purity: 95% | 4-[difluoro(3,4,5-trifluorophenoxy)methyl]-4′-propyl-1,1′-bi(cyclohexyl) | ESD-908531-1G |
Cas.: 20836-11-7 | Purity: 98% | 2,2-dimethyl-2,3-dihydro-1H-indene | ESD-908532-250MG |
Cas.: 20836-11-7 | Purity: 98% | 2,2-dimethyl-2,3-dihydro-1H-indene | ESD-908532-1G |
Cas.: 20850-43-5 | Purity: ≥95% | 5-(chloromethyl)-1,3-benzodioxole | ESD-908533-1G |
Cas.: 20850-43-5 | Purity: ≥95% | 5-(chloromethyl)-1,3-benzodioxole | ESD-908533-5G |
Cas.: 20877-84-3 | Purity: 95% | 2-(aminomethyl)-N-phenylaniline | ESD-908534-5MG |
Cas.: 20877-84-3 | Purity: 95% | 2-(aminomethyl)-N-phenylaniline | ESD-908534-25MG |
Cas.: 2090832-20-3 | Purity: 95% | 1-(4-Methylphenyl)-D-proline | ESD-908535-250MG |
Cas.: 2090832-20-3 | Purity: 95% | 1-(4-Methylphenyl)-D-proline | ESD-908535-1G |
Cas.: 2093041-44-0 | Purity: 95% | N,N-diethyl-2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | ESD-908536-25MG |
Cas.: 2093041-44-0 | Purity: 95% | N,N-diethyl-2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | ESD-908536-100MG |
Cas.: 2093041-46-2 | Purity: 95% | N,N-DIethyl-2-methoxy-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | ESD-908537-50MG |
Cas.: 2093041-46-2 | Purity: 95% | N,N-DIethyl-2-methoxy-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | ESD-908537-250MG |
Cas.: 209396-01-0 | Purity: 95% | (2-{[benzyl(methyl)amino]methyl}phenyl)boronic acid | ESD-908538-250MG |
Cas.: 209396-01-0 | Purity: 95% | (2-{[benzyl(methyl)amino]methyl}phenyl)boronic acid | ESD-908538-1G |
Cas.: 2095464-28-9 | Purity: 95% | TERT-BUTYL 5-FLUORO-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDOLE-1-CARBOXYLATE | ESD-908539-50MG |
Cas.: 2095464-28-9 | Purity: 95% | TERT-BUTYL 5-FLUORO-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDOLE-1-CARBOXYLATE | ESD-908539-250MG |
Cas.: 2096331-74-5 | Purity: 95% | 3-(2-Bromoacetamido)phenylboronic acid, pinacol ester | ESD-908540-250MG |
Cas.: 2096331-74-5 | Purity: 95% | 3-(2-Bromoacetamido)phenylboronic acid, pinacol ester | ESD-908540-1G |
Cas.: 2096332-25-9 | Purity: 95% | {4-fluoro-3-[(2-methylpropyl)carbamoyl]phenyl}boronic acid | ESD-908541-25MG |
Cas.: 2096332-25-9 | Purity: 95% | {4-fluoro-3-[(2-methylpropyl)carbamoyl]phenyl}boronic acid | ESD-908541-100MG |
Cas.: 2096338-40-6 | Purity: 97% | (3-(N-(p-tolyl)sulfamoyl)phenyl)boronic acid | ESD-908542-5MG |
Cas.: 2096338-40-6 | Purity: 97% | (3-(N-(p-tolyl)sulfamoyl)phenyl)boronic acid | ESD-908542-25MG |
Cas.: 2096338-77-9 | Purity: 95% | {4-[(piperazin-1-yl)methyl]phenyl}boronic acid hydrochloride | ESD-908543-50MG |
Cas.: 2096338-77-9 | Purity: 95% | {4-[(piperazin-1-yl)methyl]phenyl}boronic acid hydrochloride | ESD-908543-250MG |
Cas.: 2096338-93-9 | Purity: 95% | {3-fluoro-5-[(2-methylpropyl)carbamoyl]phenyl}boronic acid | ESD-908544-25MG |
Cas.: 2096338-93-9 | Purity: 95% | {3-fluoro-5-[(2-methylpropyl)carbamoyl]phenyl}boronic acid | ESD-908544-100MG |
Cas.: 2096339-62-5 | Purity: 97% | (4-(Ethoxycarbonyl)-2-methylphenyl)boronic acid | ESD-908545-250MG |
Cas.: 2096339-62-5 | Purity: 97% | (4-(Ethoxycarbonyl)-2-methylphenyl)boronic acid | ESD-908545-1G |
Cas.: 2096339-76-1 | Purity: 95% | (6-chloro-2-(trifluoromethyl)pyridin-3-yl)boronic acid | ESD-908546-25MG |
Cas.: 2096339-76-1 | Purity: 95% | (6-chloro-2-(trifluoromethyl)pyridin-3-yl)boronic acid | ESD-908546-100MG |
Cas.: 20968-04-1 | Purity: 95% | 2,2-Bis(4-chlorophenyl)acetonitrile | ESD-908547-250MG |
Cas.: 20968-04-1 | Purity: 95% | 2,2-Bis(4-chlorophenyl)acetonitrile | ESD-908547-1G |
Cas.: 2096994-84-0 | Purity: 95% | 3-(2,4-dimethylphenyl)-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea | ESD-908548-50MG |
Cas.: 2096994-84-0 | Purity: 95% | 3-(2,4-dimethylphenyl)-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea | ESD-908548-250MG |
Cas.: 2097168-79-9 | Purity: 95% | 2-{4-[(4-fluorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908549-250MG |
Cas.: 2097168-79-9 | Purity: 95% | 2-{4-[(4-fluorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908549-1G |
Cas.: 20984-63-8 | Purity: 95% | 3-[methyl(phenyl)amino]pyrrolidine-1-carboxamide | ESD-908550-10MG |
Cas.: 20984-63-8 | Purity: 95% | 3-[methyl(phenyl)amino]pyrrolidine-1-carboxamide | ESD-908550-50MG |
Cas.: 2098632-64-3 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-4-fluorobenzenesulfonamide | ESD-908551-25MG |
Cas.: 2098632-64-3 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-4-fluorobenzenesulfonamide | ESD-908551-100MG |
Cas.: 2102202-96-8 | Purity: 95% | B-[4-[[(2-methylpropyl)amino]sulfonyl]phenyl]Boronic acid | ESD-908552-25MG |
Cas.: 2102202-96-8 | Purity: 95% | B-[4-[[(2-methylpropyl)amino]sulfonyl]phenyl]Boronic acid | ESD-908552-100MG |
Cas.: 21022-17-3 | Purity: 95% | N,N’-di(biphenyl-2-yl)ethanediamide | ESD-908553-50MG |
Cas.: 21022-17-3 | Purity: 95% | N,N’-di(biphenyl-2-yl)ethanediamide | ESD-908553-250MG |
Cas.: 210300-09-7 | Purity: 95% | 3-Hydroxy-4-methoxypicolinic acid | ESD-908554-250MG |
Cas.: 210300-09-7 | Purity: 95% | 3-Hydroxy-4-methoxypicolinic acid | ESD-908554-1G |
Cas.: 2103386-32-7 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-phenylacetamide | ESD-908555-250MG |
Cas.: 2103386-32-7 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-phenylacetamide | ESD-908555-1G |
Cas.: 210827-34-2 | Purity: 95% | 4-(2-hydroxypropan-2-yl)furan-2-sulfonamide | ESD-908556-25MG |
Cas.: 210827-34-2 | Purity: 95% | 4-(2-hydroxypropan-2-yl)furan-2-sulfonamide | ESD-908556-100MG |
Cas.: 2114-36-5 | Purity: 95% | (1-Bromopropyl)benzene | ESD-908557-250MG |
Cas.: 2114-36-5 | Purity: 95% | (1-Bromopropyl)benzene | ESD-908557-1G |
Cas.: 211495-85-1 | Purity: 95% | dicyclopentylsilanediol | ESD-908558-250MG |
Cas.: 211495-85-1 | Purity: 95% | dicyclopentylsilanediol | ESD-908558-1G |
Cas.: 211682-15-4 | Purity: 98% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | ESD-908559-50MG |
Cas.: 211682-15-4 | Purity: 98% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | ESD-908559-250MG |
Cas.: 212554-91-1 | Purity: 95% | [4-(dibenzylcarbamoyl)phenyl]boronic acid | ESD-908560-50MG |
Cas.: 212554-91-1 | Purity: 95% | [4-(dibenzylcarbamoyl)phenyl]boronic acid | ESD-908560-250MG |
Cas.: 212780-23-9 | Purity: 95% | (3-butanamidophenyl)boronic acid | ESD-908561-250MG |
Cas.: 212780-23-9 | Purity: 95% | (3-butanamidophenyl)boronic acid | ESD-908561-1G |
Cas.: 2132382-87-5 | Purity: 95% | [2-fluoro-6-(pyrrolidin-1-yl)pyridin-3-yl]boronic acid | ESD-908562-25MG |
Cas.: 2132382-87-5 | Purity: 95% | [2-fluoro-6-(pyrrolidin-1-yl)pyridin-3-yl]boronic acid | ESD-908562-100MG |
Cas.: 21344-28-5 | Purity: 98% | thieno[2,3-b]pyridin-5-amine | ESD-908563-25MG |
Cas.: 21344-28-5 | Purity: 98% | thieno[2,3-b]pyridin-5-amine | ESD-908563-100MG |
Cas.: 2136-70-1 | Purity: 95% | 2-(tetradecyloxy)ethanol | ESD-908564-50MG |
Cas.: 2136-70-1 | Purity: 95% | 2-(tetradecyloxy)ethanol | ESD-908564-250MG |
Cas.: 2138482-09-2 | Purity: 97% | N-Fmoc-N-methyl-3-(2-naphthyl)-L-alanine | ESD-908565-250MG |
Cas.: 2138482-09-2 | Purity: 97% | N-Fmoc-N-methyl-3-(2-naphthyl)-L-alanine | ESD-908565-1G |
Cas.: 2142-64-5 | Purity: 95% | 1-(2-ethylphenyl)ethanone | ESD-908566-250MG |
Cas.: 2142-64-5 | Purity: 95% | 1-(2-ethylphenyl)ethanone | ESD-908566-1G |
Cas.: 214360-81-3 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-indan-1-one | ESD-908567-250MG |
Cas.: 214360-81-3 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-indan-1-one | ESD-908567-1G |
Cas.: 214852-56-9 | Purity: 98% | Fmoc-β-(2-quinolyl)-Ala-OH | ESD-908568-50MG |
Cas.: 214852-56-9 | Purity: 98% | Fmoc-β-(2-quinolyl)-Ala-OH | ESD-908568-250MG |
Cas.: 215394-03-9 | Purity: 95% | N,N-bis(2-ethylhexyl)-2,2-dimethylpropanamide | ESD-908569-1G |
Cas.: 215394-03-9 | Purity: 95% | N,N-bis(2-ethylhexyl)-2,2-dimethylpropanamide | ESD-908569-5G |
Cas.: 2155834-10-7 | Purity: 95% | N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propane-2-sulfonamide | ESD-908570-250MG |
Cas.: 2155834-10-7 | Purity: 95% | N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propane-2-sulfonamide | ESD-908570-1G |
Cas.: 21565-82-2 | Purity: 97% | 4-Pentynoic Acid Methyl Ester | ESD-908571-50MG |
Cas.: 21565-82-2 | Purity: 97% | 4-Pentynoic Acid Methyl Ester | ESD-908571-250MG |
Cas.: 2156-96-9 | Purity: 95% | Decyl acrylate | ESD-908572-50MG |
Cas.: 2156-96-9 | Purity: 95% | Decyl acrylate | ESD-908572-250MG |
Cas.: 216144-91-1 | Purity: 95% | 3-[-(E)-2-Carboxyvinyl]benzeneboronic acid | ESD-908573-250MG |
Cas.: 216144-91-1 | Purity: 95% | 3-[-(E)-2-Carboxyvinyl]benzeneboronic acid | ESD-908573-1G |
Cas.: 2166118-09-6 | Purity: 95% | methyl (2R)-3-(4-bromophenyl)-2-hydroxypropanoate | ESD-908574-25MG |
Cas.: 2166118-09-6 | Purity: 95% | methyl (2R)-3-(4-bromophenyl)-2-hydroxypropanoate | ESD-908574-100MG |
Cas.: 2168294-35-5 | Purity: 95% | 2-Bromo-7H-pyrazino[2,3-b]pyrazin-6-one | ESD-908575-5MG |
Cas.: 2168294-35-5 | Purity: 95% | 2-Bromo-7H-pyrazino[2,3-b]pyrazin-6-one | ESD-908575-25MG |
Cas.: 2171363-38-3 | Purity: 95% | N-[4-(propan-2-yl)phenyl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | ESD-908576-25MG |
Cas.: 2171363-38-3 | Purity: 95% | N-[4-(propan-2-yl)phenyl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | ESD-908576-100MG |
Cas.: 21835-00-7 | Purity: 95% | 2-hydroxy-3,4-dimethylcyclopent-2-en-1-one | ESD-908577-25MG |
Cas.: 219311-44-1 | Purity: 98% | Dabuzalgron | ESD-908578-5MG |
Cas.: 219311-44-1 | Purity: 98% | Dabuzalgron | ESD-908578-25MG |
Cas.: 21956-56-9 | Purity: 95% | 3,5-dimethoxystilbene | ESD-908579-250MG |
Cas.: 21956-56-9 | Purity: 95% | 3,5-dimethoxystilbene | ESD-908579-1G |
Cas.: 21962-84-5 | Purity: 95% | 1,4-dioxocane-5,8-dione | ESD-908580-5MG |
Cas.: 21962-84-5 | Purity: 95% | 1,4-dioxocane-5,8-dione | ESD-908580-25MG |
Cas.: 220180-55-2 | Purity: 95% | methyl 4-fluoro-1-benzothiophene-2-carboxylate | ESD-908581-250MG |
Cas.: 220180-55-2 | Purity: 95% | methyl 4-fluoro-1-benzothiophene-2-carboxylate | ESD-908581-1G |
Cas.: 220352-36-3 | Purity: ≥95% | (1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarboxylic acid | ESD-908582-50MG |
Cas.: 220352-36-3 | Purity: ≥95% | (1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarboxylic acid | ESD-908582-250MG |
Cas.: 220389-34-4 | Purity: 95% | Ethyl 4-Bromo-2-Methylbenzoate | ESD-908583-1G |
Cas.: 220389-34-4 | Purity: 95% | Ethyl 4-Bromo-2-Methylbenzoate | ESD-908583-5G |
Cas.: 220444-99-5 | Purity: 95% | 7-chloro-1-(4-nitrophenyl)-3,4-dihydro-1H-2-benzopyran | ESD-908584-25MG |
Cas.: 220444-99-5 | Purity: 95% | 7-chloro-1-(4-nitrophenyl)-3,4-dihydro-1H-2-benzopyran | ESD-908584-100MG |
Cas.: 220640-14-2 | Purity: 95% | N-methylthian-4-amine | ESD-908585-250MG |
Cas.: 220640-14-2 | Purity: 95% | N-methylthian-4-amine | ESD-908585-1G |
Cas.: 220728-62-1 | Purity: 95% | 5-Iodo-2-methylanisole | ESD-908586-250MG |
Cas.: 220728-62-1 | Purity: 95% | 5-Iodo-2-methylanisole | ESD-908586-1G |
Cas.: 220844-73-5 | Purity: 95% | 6-fluoroquinoline-4-carboxylic acid | ESD-908587-250MG |
Cas.: 220844-73-5 | Purity: 95% | 6-fluoroquinoline-4-carboxylic acid | ESD-908587-1G |
Cas.: 22106-39-4 | Purity: 98% | 1-(3-methoxy-4-nitrophenyl)ethanone | ESD-908588-250MG |
Cas.: 22106-39-4 | Purity: 98% | 1-(3-methoxy-4-nitrophenyl)ethanone | ESD-908588-1G |
Cas.: 22122-18-5 | Purity: 95% | 2-hydroxyethyl myristate | ESD-908589-250MG |
Cas.: 22122-18-5 | Purity: 95% | 2-hydroxyethyl myristate | ESD-908589-1G |
Cas.: 22163-52-6 | Purity: 95% | 1,4-Benzenedicarboxylic acid, ethyl methyl ester | ESD-908590-1G |
Cas.: 22163-52-6 | Purity: 95% | 1,4-Benzenedicarboxylic acid, ethyl methyl ester | ESD-908590-5G |
Cas.: 221655-54-5 | Purity: 95% | bis(2-methoxyethyl) sulfate | ESD-908591-250MG |
Cas.: 221655-54-5 | Purity: 95% | bis(2-methoxyethyl) sulfate | ESD-908591-1G |
Cas.: 2223043-31-8 | Purity: 95% | 2-fluoro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-908592-25MG |
Cas.: 2223043-31-8 | Purity: 95% | 2-fluoro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-908592-100MG |
Cas.: 2223049-72-5 | Purity: 95% | 3-bromo-2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-908593-50MG |
Cas.: 2223049-72-5 | Purity: 95% | 3-bromo-2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-908593-250MG |
Cas.: 22233-52-9 | Purity: 95% | 3-CHLORO-2-NITROBENZALDEHYDE | ESD-908594-250MG |
Cas.: 22233-52-9 | Purity: 95% | 3-CHLORO-2-NITROBENZALDEHYDE | ESD-908594-1G |
Cas.: 22317-34-6 | Purity: 95% | 3-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-2-(2-methoxyphenoxy)propan-1-one | ESD-908595-25MG |
Cas.: 22317-34-6 | Purity: 95% | 3-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-2-(2-methoxyphenoxy)propan-1-one | ESD-908595-100MG |
Cas.: 223404-63-5 | Purity: 97% | 4-(2-methyl-4-nitrophenyl)morpholine | ESD-908596-1G |
Cas.: 223404-63-5 | Purity: 97% | 4-(2-methyl-4-nitrophenyl)morpholine | ESD-908596-5G |
Cas.: 2235408-81-6 | Purity: 95% | 4-tert-butyl-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzamide | ESD-908597-25MG |
Cas.: 2235408-81-6 | Purity: 95% | 4-tert-butyl-N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzamide | ESD-908597-100MG |
Cas.: 223671-71-4 | Purity: 95% | 1-chloroisoquinoline-5-carboxylic acid | ESD-908598-50MG |
Cas.: 223671-71-4 | Purity: 95% | 1-chloroisoquinoline-5-carboxylic acid | ESD-908598-250MG |
Cas.: 2240-81-5 | Purity: 97% | cis-Tetrahydrofuran-2,5-dicarboxylic acid | ESD-908599-1G |
Cas.: 2240-81-5 | Purity: 97% | cis-Tetrahydrofuran-2,5-dicarboxylic acid | ESD-908599-5G |
Cas.: 22421-62-1 | Purity: 95% | N-(4-benzoylphenyl)prop-2-enamide | ESD-908600-50MG |
Cas.: 22421-62-1 | Purity: 95% | N-(4-benzoylphenyl)prop-2-enamide | ESD-908600-250MG |
Cas.: 224431-84-9 | Purity: 95% | 1-(2-Hydroxyethyl)piperidin-4-ol | ESD-908601-250MG |
Cas.: 224431-84-9 | Purity: 95% | 1-(2-Hydroxyethyl)piperidin-4-ol | ESD-908601-1G |
Cas.: 2245053-33-0 | Purity: 95% | 2-(4-((2-Fluorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908602-25MG |
Cas.: 2245053-33-0 | Purity: 95% | 2-(4-((2-Fluorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908602-100MG |
Cas.: 2245819-88-7 | Purity: 95% | N-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propane-1-sulfonamide | ESD-908603-50MG |
Cas.: 2245819-88-7 | Purity: 95% | N-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propane-1-sulfonamide | ESD-908603-250MG |
Cas.: 2246389-11-5 | Purity: 95% | 3-methyl-1-(2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)piperidine | ESD-908604-25MG |
Cas.: 2246389-11-5 | Purity: 95% | 3-methyl-1-(2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)piperidine | ESD-908604-100MG |
Cas.: 2246419-29-2 | Purity: 95% | 2-methyl-1-{2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl}piperidine | ESD-908605-25MG |
Cas.: 2246419-29-2 | Purity: 95% | 2-methyl-1-{2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl}piperidine | ESD-908605-100MG |
Cas.: 2246447-62-9 | Purity: 95% | 3-methyl-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperidine-1-carboxamide | ESD-908606-25MG |
Cas.: 2246447-62-9 | Purity: 95% | 3-methyl-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperidine-1-carboxamide | ESD-908606-100MG |
Cas.: 2246544-61-4 | Purity: 95% | {4-[(2,6-difluorophenyl)methoxy]phenyl}boronic acid | ESD-908607-250MG |
Cas.: 2246544-61-4 | Purity: 95% | {4-[(2,6-difluorophenyl)methoxy]phenyl}boronic acid | ESD-908607-1G |
Cas.: 2246545-24-2 | Purity: 95% | (4-((3,3-diethylureido)methyl)phenyl)boronic acid | ESD-908608-25MG |
Cas.: 2246545-24-2 | Purity: 95% | (4-((3,3-diethylureido)methyl)phenyl)boronic acid | ESD-908608-100MG |
Cas.: 2246545-69-5 | Purity: 95% | 2-{4-[(4-bromophenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908609-25MG |
Cas.: 2246545-69-5 | Purity: 95% | 2-{4-[(4-bromophenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908609-100MG |
Cas.: 2246547-20-4 | Purity: 95% | 3-chloro-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzamide | ESD-908610-250MG |
Cas.: 2246547-20-4 | Purity: 95% | 3-chloro-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzamide | ESD-908610-1G |
Cas.: 2246548-35-4 | Purity: 95% | 4-(nicotinamido)phenylboronic acid | ESD-908611-25MG |
Cas.: 2246548-35-4 | Purity: 95% | 4-(nicotinamido)phenylboronic acid | ESD-908611-100MG |
Cas.: 2246556-15-8 | Purity: 95% | 2-{3-[(2-ethylphenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908612-25MG |
Cas.: 2246556-15-8 | Purity: 95% | 2-{3-[(2-ethylphenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908612-100MG |
Cas.: 2246563-75-5 | Purity: 95% | 3-methyl-N-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]butanamide | ESD-908613-25MG |
Cas.: 2246563-75-5 | Purity: 95% | 3-methyl-N-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]butanamide | ESD-908613-100MG |
Cas.: 2246573-09-9 | Purity: 95% | 2-(2-((4-bromo-2-fluorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908614-25MG |
Cas.: 2246573-09-9 | Purity: 95% | 2-(2-((4-bromo-2-fluorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908614-100MG |
Cas.: 2246577-10-4 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine-4-carboxamide | ESD-908615-25MG |
Cas.: 2246577-10-4 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine-4-carboxamide | ESD-908615-100MG |
Cas.: 2246581-88-2 | Purity: 95% | (4-((3-methylbutanamido)methyl)phenyl)boronic acid | ESD-908616-50MG |
Cas.: 2246581-88-2 | Purity: 95% | (4-((3-methylbutanamido)methyl)phenyl)boronic acid | ESD-908616-250MG |
Cas.: 2246583-62-8 | Purity: 95% | 1-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-methylurea | ESD-908617-25MG |
Cas.: 2246583-62-8 | Purity: 95% | 1-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-methylurea | ESD-908617-100MG |
Cas.: 2246585-68-0 | Purity: 95% | N-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanamide | ESD-908618-25MG |
Cas.: 2246585-68-0 | Purity: 95% | N-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanamide | ESD-908618-100MG |
Cas.: 2246585-78-2 | Purity: 95% | N-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)butyramide | ESD-908619-25MG |
Cas.: 2246585-78-2 | Purity: 95% | N-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)butyramide | ESD-908619-100MG |
Cas.: 2246586-62-7 | Purity: 95% | 4-Chloro-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzamide | ESD-908620-250MG |
Cas.: 2246586-62-7 | Purity: 95% | 4-Chloro-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzamide | ESD-908620-1G |
Cas.: 2246588-01-0 | Purity: 95% | 4-(3-cyclopropylureido)-3-methylphenylboronic acid | ESD-908621-50MG |
Cas.: 2246588-01-0 | Purity: 95% | 4-(3-cyclopropylureido)-3-methylphenylboronic acid | ESD-908621-250MG |
Cas.: 2246589-58-0 | Purity: 95% | 2-(2-((5-bromo-2-methylphenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908622-25MG |
Cas.: 2246589-58-0 | Purity: 95% | 2-(2-((5-bromo-2-methylphenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908622-100MG |
Cas.: 2246597-84-0 | Purity: 95% | 2-(1H-imidazol-1-yl)-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide | ESD-908623-25MG |
Cas.: 2246597-84-0 | Purity: 95% | 2-(1H-imidazol-1-yl)-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide | ESD-908623-100MG |
Cas.: 2246605-51-4 | Purity: 95% | 1-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-isopropylurea | ESD-908624-50MG |
Cas.: 2246605-51-4 | Purity: 95% | 1-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-isopropylurea | ESD-908624-250MG |
Cas.: 2246614-75-3 | Purity: 95% | 2-{2-[(4-methoxyphenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908625-250MG |
Cas.: 2246614-75-3 | Purity: 95% | 2-{2-[(4-methoxyphenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908625-1G |
Cas.: 2246615-20-1 | Purity: 95% | 4-methyl-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide | ESD-908626-250MG |
Cas.: 2246615-20-1 | Purity: 95% | 4-methyl-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide | ESD-908626-1G |
Cas.: 2246616-92-0 | Purity: 95% | 3-methyl-4-(3-methylureido)phenylboronic acid | ESD-908627-25MG |
Cas.: 2246616-92-0 | Purity: 95% | 3-methyl-4-(3-methylureido)phenylboronic acid | ESD-908627-100MG |
Cas.: 2246619-90-7 | Purity: 95% | N-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propionamide | ESD-908628-25MG |
Cas.: 2246619-90-7 | Purity: 95% | N-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propionamide | ESD-908628-100MG |
Cas.: 2246631-55-8 | Purity: 97% | N-(4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pivalamide | ESD-908629-25MG |
Cas.: 2246631-55-8 | Purity: 97% | N-(4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pivalamide | ESD-908629-100MG |
Cas.: 2246632-59-5 | Purity: 95% | 4,4,5,5-tetramethyl-2-{3-[(2-methylphenoxy)methyl]phenyl}-1,3,2-dioxaborolane | ESD-908630-250MG |
Cas.: 2246632-59-5 | Purity: 95% | 4,4,5,5-tetramethyl-2-{3-[(2-methylphenoxy)methyl]phenyl}-1,3,2-dioxaborolane | ESD-908630-1G |
Cas.: 2246633-90-7 | Purity: 95% | N-[2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentanamide | ESD-908631-25MG |
Cas.: 2246633-90-7 | Purity: 95% | N-[2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pentanamide | ESD-908631-100MG |
Cas.: 2246637-22-7 | Purity: 95% | 2-{3-[(3,5-difluorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908632-250MG |
Cas.: 2246637-22-7 | Purity: 95% | 2-{3-[(3,5-difluorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908632-1G |
Cas.: 2246638-38-8 | Purity: 95% | 2-{2-[(4-fluorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908633-250MG |
Cas.: 2246638-38-8 | Purity: 95% | 2-{2-[(4-fluorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908633-1G |
Cas.: 2246642-41-9 | Purity: 95% | 2-{4-[(2-fluorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908634-25MG |
Cas.: 2246642-41-9 | Purity: 95% | 2-{4-[(2-fluorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908634-100MG |
Cas.: 2246642-92-0 | Purity: 95% | 2-{2-[(4-fluorophenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908635-25MG |
Cas.: 2246642-92-0 | Purity: 95% | 2-{2-[(4-fluorophenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908635-100MG |
Cas.: 2246643-10-5 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-methylbutanamide | ESD-908636-25MG |
Cas.: 2246643-10-5 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-methylbutanamide | ESD-908636-100MG |
Cas.: 2246646-61-5 | Purity: 95% | 2-{3-[(4-bromo-2-chlorophenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908637-25MG |
Cas.: 2246646-61-5 | Purity: 95% | 2-{3-[(4-bromo-2-chlorophenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908637-100MG |
Cas.: 2246652-82-2 | Purity: 95% | N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-Thiophenecarboxamide | ESD-908638-50MG |
Cas.: 2246652-82-2 | Purity: 95% | N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-Thiophenecarboxamide | ESD-908638-250MG |
Cas.: 2246654-50-0 | Purity: 95% | 3-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,1-dimethylurea | ESD-908639-50MG |
Cas.: 2246654-50-0 | Purity: 95% | 3-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,1-dimethylurea | ESD-908639-250MG |
Cas.: 2246655-25-2 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclohexanecarboxamide | ESD-908640-25MG |
Cas.: 2246655-25-2 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclohexanecarboxamide | ESD-908640-100MG |
Cas.: 2246657-11-2 | Purity: 95% | N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutanecarboxamide | ESD-908641-50MG |
Cas.: 2246657-11-2 | Purity: 95% | N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutanecarboxamide | ESD-908641-250MG |
Cas.: 2246657-45-2 | Purity: 95% | N-[3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclohexanecarboxamide | ESD-908642-250MG |
Cas.: 2246657-45-2 | Purity: 95% | N-[3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclohexanecarboxamide | ESD-908642-1G |
Cas.: 2246664-51-5 | Purity: 97% | 2-Methoxy-N-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide | ESD-908643-25MG |
Cas.: 2246664-51-5 | Purity: 97% | 2-Methoxy-N-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide | ESD-908643-100MG |
Cas.: 2246666-70-4 | Purity: 95% | 3-cyclopropyl-1-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea | ESD-908644-25MG |
Cas.: 2246666-70-4 | Purity: 95% | 3-cyclopropyl-1-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea | ESD-908644-100MG |
Cas.: 2246667-45-6 | Purity: 95% | 2-fluoro-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzamide | ESD-908645-25MG |
Cas.: 2246667-45-6 | Purity: 95% | 2-fluoro-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzamide | ESD-908645-100MG |
Cas.: 2246668-24-4 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-methoxyacetamide | ESD-908646-25MG |
Cas.: 2246668-24-4 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-methoxyacetamide | ESD-908646-100MG |
Cas.: 2246671-04-3 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-methylbutanamide | ESD-908647-50MG |
Cas.: 2246671-04-3 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-methylbutanamide | ESD-908647-250MG |
Cas.: 2246671-57-6 | Purity: 95% | 2,2-Dimethyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]butanamide | ESD-908648-50MG |
Cas.: 2246671-57-6 | Purity: 95% | 2,2-Dimethyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]butanamide | ESD-908648-250MG |
Cas.: 2246673-66-3 | Purity: 95% | 1,1-diethyl-3-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | ESD-908649-25MG |
Cas.: 2246673-66-3 | Purity: 95% | 1,1-diethyl-3-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | ESD-908649-100MG |
Cas.: 2246676-49-1 | Purity: 95% | 2-methyl-N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanamide | ESD-908650-250MG |
Cas.: 2246676-49-1 | Purity: 95% | 2-methyl-N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanamide | ESD-908650-1G |
Cas.: 2246676-56-0 | Purity: 95% | N-[3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzamide | ESD-908651-25MG |
Cas.: 2246676-56-0 | Purity: 95% | N-[3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzamide | ESD-908651-100MG |
Cas.: 2246676-65-1 | Purity: 95% | 2-(4-((2-Bromophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908652-25MG |
Cas.: 2246676-65-1 | Purity: 95% | 2-(4-((2-Bromophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908652-100MG |
Cas.: 2246677-40-5 | Purity: 95% | 2-{2-[(2-ethylphenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908653-25MG |
Cas.: 2246677-40-5 | Purity: 95% | 2-{2-[(2-ethylphenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908653-100MG |
Cas.: 2246677-65-4 | Purity: 95% | (4-(pivalamidomethyl)phenyl)boronic acid | ESD-908654-250MG |
Cas.: 2246677-65-4 | Purity: 95% | (4-(pivalamidomethyl)phenyl)boronic acid | ESD-908654-1G |
Cas.: 2246679-53-6 | Purity: 95% | 1-[2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3,3-dimethylurea | ESD-908655-50MG |
Cas.: 2246679-53-6 | Purity: 95% | 1-[2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3,3-dimethylurea | ESD-908655-250MG |
Cas.: 2246681-91-2 | Purity: 95% | 3-methyl-N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]butanamide | ESD-908656-25MG |
Cas.: 2246681-91-2 | Purity: 95% | 3-methyl-N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]butanamide | ESD-908656-100MG |
Cas.: 2246685-26-5 | Purity: 97% | 3,3-dimethyl-N-(4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)butanamide | ESD-908657-25MG |
Cas.: 2246685-26-5 | Purity: 97% | 3,3-dimethyl-N-(4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)butanamide | ESD-908657-100MG |
Cas.: 2246691-45-0 | Purity: 95% | 1-Methyl-4-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)piperazine | ESD-908658-50MG |
Cas.: 2246691-45-0 | Purity: 95% | 1-Methyl-4-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)piperazine | ESD-908658-250MG |
Cas.: 2246691-80-3 | Purity: 95% | 2-methoxy-N-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide | ESD-908659-25MG |
Cas.: 2246691-80-3 | Purity: 95% | 2-methoxy-N-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide | ESD-908659-100MG |
Cas.: 2246693-75-2 | Purity: 95% | N-[2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutanecarboxamide | ESD-908660-50MG |
Cas.: 2246693-75-2 | Purity: 95% | N-[2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutanecarboxamide | ESD-908660-250MG |
Cas.: 2246693-81-0 | Purity: 95% | 2-{4-[(3,5-difluorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908661-25MG |
Cas.: 2246693-81-0 | Purity: 95% | 2-{4-[(3,5-difluorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908661-100MG |
Cas.: 2246696-13-7 | Purity: 95% | 2-phenyl-N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide | ESD-908662-250MG |
Cas.: 2246696-13-7 | Purity: 95% | 2-phenyl-N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide | ESD-908662-1G |
Cas.: 2246696-15-9 | Purity: 95% | N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine-4-sulfonamide | ESD-908663-25MG |
Cas.: 2246696-15-9 | Purity: 95% | N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine-4-sulfonamide | ESD-908663-100MG |
Cas.: 2246698-24-6 | Purity: 95% | {2-[(2,6-difluorophenyl)methoxy]phenyl}boronic acid | ESD-908664-250MG |
Cas.: 2246698-24-6 | Purity: 95% | {2-[(2,6-difluorophenyl)methoxy]phenyl}boronic acid | ESD-908664-1G |
Cas.: 2246720-26-1 | Purity: 95% | N,3-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | ESD-908665-250MG |
Cas.: 2246720-26-1 | Purity: 95% | N,3-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | ESD-908665-1G |
Cas.: 2246728-07-2 | Purity: 95% | 2-{3-[(2,4-dichlorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908666-250MG |
Cas.: 2246728-07-2 | Purity: 95% | 2-{3-[(2,4-dichlorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908666-1G |
Cas.: 2246736-67-2 | Purity: 95% | 2-{3-[(4-bromo-2-fluorophenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908667-250MG |
Cas.: 2246736-67-2 | Purity: 95% | 2-{3-[(4-bromo-2-fluorophenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908667-1G |
Cas.: 2246740-41-8 | Purity: 95% | 2-{4-[(3,4-dichlorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908668-250MG |
Cas.: 2246740-41-8 | Purity: 95% | 2-{4-[(3,4-dichlorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908668-1G |
Cas.: 2246741-86-4 | Purity: 97% | N-(2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pivalamide | ESD-908669-25MG |
Cas.: 2246741-86-4 | Purity: 97% | N-(2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pivalamide | ESD-908669-100MG |
Cas.: 2246743-13-3 | Purity: 95% | N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropanecarboxamide | ESD-908670-25MG |
Cas.: 2246743-13-3 | Purity: 95% | N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropanecarboxamide | ESD-908670-100MG |
Cas.: 2246744-18-1 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzamide | ESD-908671-25MG |
Cas.: 2246744-18-1 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzamide | ESD-908671-100MG |
Cas.: 2246746-25-6 | Purity: 95% | N-[4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutanecarboxamide | ESD-908672-250MG |
Cas.: 2246746-25-6 | Purity: 95% | N-[4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutanecarboxamide | ESD-908672-1G |
Cas.: 2246746-56-3 | Purity: 95% | 1-[2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-propylurea | ESD-908673-25MG |
Cas.: 2246746-56-3 | Purity: 95% | 1-[2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-propylurea | ESD-908673-100MG |
Cas.: 2246751-27-7 | Purity: 95% | [3-[(Thiophene-2-carbonylamino)methyl]phenyl]boronic acid | ESD-908674-250MG |
Cas.: 2246751-27-7 | Purity: 95% | [3-[(Thiophene-2-carbonylamino)methyl]phenyl]boronic acid | ESD-908674-1G |
Cas.: 2246751-85-7 | Purity: 95% | N-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropanesulfonamide | ESD-908675-50MG |
Cas.: 2246751-85-7 | Purity: 95% | N-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropanesulfonamide | ESD-908675-250MG |
Cas.: 2246751-94-8 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2-methoxyacetamide | ESD-908676-25MG |
Cas.: 2246751-94-8 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2-methoxyacetamide | ESD-908676-100MG |
Cas.: 2246754-80-1 | Purity: 95% | N-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperidine-1-carboxamide | ESD-908677-25MG |
Cas.: 2246754-80-1 | Purity: 95% | N-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperidine-1-carboxamide | ESD-908677-100MG |
Cas.: 2246755-99-5 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2-(thiophen-2-yl)acetamide | ESD-908678-25MG |
Cas.: 2246755-99-5 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2-(thiophen-2-yl)acetamide | ESD-908678-100MG |
Cas.: 2246758-17-6 | Purity: 95% | 2-{2-[(4-bromophenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908679-250MG |
Cas.: 2246758-17-6 | Purity: 95% | 2-{2-[(4-bromophenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908679-1G |
Cas.: 2246759-61-3 | Purity: 95% | 1-benzyl-3-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea | ESD-908680-50MG |
Cas.: 2246759-61-3 | Purity: 95% | 1-benzyl-3-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea | ESD-908680-250MG |
Cas.: 2246760-60-9 | Purity: 95% | N-(4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide | ESD-908681-25MG |
Cas.: 2246760-60-9 | Purity: 95% | N-(4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide | ESD-908681-100MG |
Cas.: 2246761-65-7 | Purity: 95% | N-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethane-1-sulfonamide | ESD-908682-25MG |
Cas.: 2246761-65-7 | Purity: 95% | N-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethane-1-sulfonamide | ESD-908682-100MG |
Cas.: 2246769-29-7 | Purity: 95% | 1-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(propan-2-yl)urea | ESD-908683-25MG |
Cas.: 2246769-29-7 | Purity: 95% | 1-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(propan-2-yl)urea | ESD-908683-100MG |
Cas.: 2246771-83-3 | Purity: 95% | N-[4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3,3-dimethylbutanamide | ESD-908684-25MG |
Cas.: 2246771-83-3 | Purity: 95% | N-[4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3,3-dimethylbutanamide | ESD-908684-100MG |
Cas.: 2246772-09-6 | Purity: 95% | 2-{[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]methyl}benzonitrile | ESD-908685-25MG |
Cas.: 2246772-09-6 | Purity: 95% | 2-{[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]methyl}benzonitrile | ESD-908685-100MG |
Cas.: 2246774-05-8 | Purity: 95% | N-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine-4-carboxamide | ESD-908686-25MG |
Cas.: 2246774-05-8 | Purity: 95% | N-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine-4-carboxamide | ESD-908686-100MG |
Cas.: 2246776-78-1 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)isobutyramide | ESD-908687-50MG |
Cas.: 2246776-78-1 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)isobutyramide | ESD-908687-250MG |
Cas.: 2246777-76-2 | Purity: 95% | 4,4,5,5-tetramethyl-2-{2-[(4-methylphenoxy)methyl]phenyl}-1,3,2-dioxaborolane | ESD-908688-25MG |
Cas.: 2246777-76-2 | Purity: 95% | 4,4,5,5-tetramethyl-2-{2-[(4-methylphenoxy)methyl]phenyl}-1,3,2-dioxaborolane | ESD-908688-100MG |
Cas.: 2246779-56-4 | Purity: 95% | 2-{3-[(3,4-dichlorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908689-250MG |
Cas.: 2246779-56-4 | Purity: 95% | 2-{3-[(3,4-dichlorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908689-1G |
Cas.: 2246780-16-3 | Purity: 95% | 2-{2-[(3-fluorophenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908690-250MG |
Cas.: 2246780-16-3 | Purity: 95% | 2-{2-[(3-fluorophenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908690-1G |
Cas.: 2246782-64-7 | Purity: 95% | N-[4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropanecarboxamide | ESD-908691-25MG |
Cas.: 2246782-64-7 | Purity: 95% | N-[4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropanecarboxamide | ESD-908691-100MG |
Cas.: 2246785-58-8 | Purity: 95% | 1-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-cyclopropylurea | ESD-908692-50MG |
Cas.: 2246785-58-8 | Purity: 95% | 1-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-cyclopropylurea | ESD-908692-250MG |
Cas.: 2246786-07-0 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxamide | ESD-908693-25MG |
Cas.: 2246786-07-0 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxamide | ESD-908693-100MG |
Cas.: 2246801-72-7 | Purity: 95% | N-[3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutanecarboxamide | ESD-908694-25MG |
Cas.: 2246801-72-7 | Purity: 95% | N-[3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutanecarboxamide | ESD-908694-100MG |
Cas.: 2246802-64-0 | Purity: 95% | 2-{3-[(4-chlorophenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908695-250MG |
Cas.: 2246802-64-0 | Purity: 95% | 2-{3-[(4-chlorophenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908695-1G |
Cas.: 2246811-02-7 | Purity: 95% | 2-{3-[(2-fluorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908696-25MG |
Cas.: 2246811-02-7 | Purity: 95% | 2-{3-[(2-fluorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908696-100MG |
Cas.: 2246811-63-0 | Purity: 95% | 2-{3-[(4-chlorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908697-25MG |
Cas.: 2246811-63-0 | Purity: 95% | 2-{3-[(4-chlorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908697-100MG |
Cas.: 2246811-65-2 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperidine-1-carboxamide | ESD-908698-25MG |
Cas.: 2246811-65-2 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperidine-1-carboxamide | ESD-908698-100MG |
Cas.: 2246814-38-8 | Purity: 95% | N-(4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)butyramide | ESD-908699-50MG |
Cas.: 2246814-38-8 | Purity: 95% | N-(4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)butyramide | ESD-908699-250MG |
Cas.: 2246814-89-9 | Purity: 95% | 3,3-dimethyl-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]butanamide | ESD-908700-250MG |
Cas.: 2246814-89-9 | Purity: 95% | 3,3-dimethyl-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]butanamide | ESD-908700-1G |
Cas.: 2246815-87-0 | Purity: 95% | (4-((3,3-dimethylureido)methyl)phenyl)boronic acid | ESD-908701-50MG |
Cas.: 2246815-87-0 | Purity: 95% | (4-((3,3-dimethylureido)methyl)phenyl)boronic acid | ESD-908701-250MG |
Cas.: 2246818-94-8 | Purity: 95% | N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclohexanecarboxamide | ESD-908702-250MG |
Cas.: 2246818-94-8 | Purity: 95% | N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclohexanecarboxamide | ESD-908702-1G |
Cas.: 2246823-64-1 | Purity: 95% | 1-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-methylurea | ESD-908703-25MG |
Cas.: 2246823-64-1 | Purity: 95% | 1-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-methylurea | ESD-908703-100MG |
Cas.: 2246826-36-6 | Purity: 95% | 2-[2-[(3,4-Dichlorophenyl)methoxy]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908704-25MG |
Cas.: 2246826-36-6 | Purity: 95% | 2-[2-[(3,4-Dichlorophenyl)methoxy]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908704-100MG |
Cas.: 2246827-16-5 | Purity: 95% | 2-[3-[(2,6-Difluorophenyl)methoxy]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908705-50MG |
Cas.: 2246827-16-5 | Purity: 95% | 2-[3-[(2,6-Difluorophenyl)methoxy]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908705-250MG |
Cas.: 2246827-33-6 | Purity: 95% | N-[2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]furan-2-carboxamide | ESD-908706-25MG |
Cas.: 2246827-33-6 | Purity: 95% | N-[2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]furan-2-carboxamide | ESD-908706-100MG |
Cas.: 2246829-52-5 | Purity: 95% | N-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanesulfonamide | ESD-908707-50MG |
Cas.: 2246829-52-5 | Purity: 95% | N-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanesulfonamide | ESD-908707-250MG |
Cas.: 2246831-80-9 | Purity: 95% | 3-(4-methylpentanamido)phenylboronic acid | ESD-908708-250MG |
Cas.: 2246831-80-9 | Purity: 95% | 3-(4-methylpentanamido)phenylboronic acid | ESD-908708-1G |
Cas.: 2246833-34-9 | Purity: 95% | 2-(2-((4-Chlorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908709-250MG |
Cas.: 2246833-34-9 | Purity: 95% | 2-(2-((4-Chlorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908709-1G |
Cas.: 2246834-90-0 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine-1-carboxamide | ESD-908710-50MG |
Cas.: 2246834-90-0 | Purity: 95% | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine-1-carboxamide | ESD-908710-250MG |
Cas.: 2246836-43-9 | Purity: 95% | N-[2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanesulfonamide | ESD-908711-5MG |
Cas.: 2246836-43-9 | Purity: 95% | N-[2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanesulfonamide | ESD-908711-25MG |
Cas.: 2246838-42-4 | Purity: 95% | 2-{3-[(3-chlorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908712-250MG |
Cas.: 2246838-42-4 | Purity: 95% | 2-{3-[(3-chlorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908712-1G |
Cas.: 2246845-30-5 | Purity: 95% | (4-(butylsulfonamidomethyl)phenyl)boronic acid | ESD-908713-50MG |
Cas.: 2246845-30-5 | Purity: 95% | (4-(butylsulfonamidomethyl)phenyl)boronic acid | ESD-908713-250MG |
Cas.: 2246849-82-9 | Purity: 95% | 1-butyl-3-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | ESD-908714-50MG |
Cas.: 2246849-82-9 | Purity: 95% | 1-butyl-3-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | ESD-908714-250MG |
Cas.: 2246852-44-6 | Purity: 95% | 3-methyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)butanamide | ESD-908715-50MG |
Cas.: 2246852-44-6 | Purity: 95% | 3-methyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)butanamide | ESD-908715-250MG |
Cas.: 2246852-97-9 | Purity: 95% | 1-benzyl-3-[2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea | ESD-908716-25MG |
Cas.: 2246852-97-9 | Purity: 95% | 1-benzyl-3-[2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea | ESD-908716-100MG |
Cas.: 2246858-67-1 | Purity: 95% | 2-{3-[(2-bromophenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908717-250MG |
Cas.: 2246858-67-1 | Purity: 95% | 2-{3-[(2-bromophenoxy)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908717-1G |
Cas.: 2246900-42-3 | Purity: 97% | N-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanesulfonamide | ESD-908718-25MG |
Cas.: 2246900-42-3 | Purity: 97% | N-(2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanesulfonamide | ESD-908718-100MG |
Cas.: 2246901-18-6 | Purity: 95% | 1-[(2,4-dichlorophenyl)methyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-908719-25MG |
Cas.: 2246901-18-6 | Purity: 95% | 1-[(2,4-dichlorophenyl)methyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-908719-100MG |
Cas.: 2246937-34-6 | Purity: 95% | 2-{4-[(4-chlorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908720-25MG |
Cas.: 2246937-34-6 | Purity: 95% | 2-{4-[(4-chlorophenyl)methoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908720-100MG |
Cas.: 2248763-87-1 | Purity: 95% | N,N-diisopropyl-2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | ESD-908721-50MG |
Cas.: 2248763-87-1 | Purity: 95% | N,N-diisopropyl-2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | ESD-908721-250MG |
Cas.: 2258-21-1 | Purity: 98% | 2-Methyl-1H-imidazole-1-propanamine | ESD-908722-5G |
Cas.: 2258-21-1 | Purity: 98% | 2-Methyl-1H-imidazole-1-propanamine | ESD-908722-25G |
Cas.: 226396-31-2 | Purity: 95% | [4-(methylsulfamoyl)phenyl]boronic acid | ESD-908723-50MG |
Cas.: 226396-31-2 | Purity: 95% | [4-(methylsulfamoyl)phenyl]boronic acid | ESD-908723-250MG |
Cas.: 2267377-24-0 | Purity: 95% | N-cyclopentyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-908724-250MG |
Cas.: 2267377-24-0 | Purity: 95% | N-cyclopentyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-908724-1G |
Cas.: 227088-94-0 | Purity: 95% | 3-[1-[[(3′-NItro[1,1′-biphenyl]-4-yl)oxy]methyl]-3-(4-pyridinyl)propyl]-2,4-thiazolidinedione | ESD-908725-5MG |
Cas.: 227088-94-0 | Purity: 95% | 3-[1-[[(3′-NItro[1,1′-biphenyl]-4-yl)oxy]methyl]-3-(4-pyridinyl)propyl]-2,4-thiazolidinedione | ESD-908725-25MG |
Cas.: 2271-93-4 | Purity: 96% | N,N’-hexane-1,6-diylbis(aziridine-1-carboxamide) | ESD-908726-5G |
Cas.: 2271-93-4 | Purity: 96% | N,N’-hexane-1,6-diylbis(aziridine-1-carboxamide) | ESD-908726-25G |
Cas.: 22760-18-5 | Purity: 95% | proquazone | ESD-908727-1MG |
Cas.: 22760-18-5 | Purity: 95% | proquazone | ESD-908727-5MG |
Cas.: 22795-97-7 | Purity: 95% | (R)-2-(Aminomethyl)-1-ethylpyrrolidine | ESD-908728-250MG |
Cas.: 22795-97-7 | Purity: 95% | (R)-2-(Aminomethyl)-1-ethylpyrrolidine | ESD-908728-1G |
Cas.: 2282-84-0 | Purity: 95% | Methyl 2,4,6-trimethylbenzoate | ESD-908729-250MG |
Cas.: 2282-84-0 | Purity: 95% | Methyl 2,4,6-trimethylbenzoate | ESD-908729-1G |
Cas.: 22930-55-8 | Purity: 97% | (5-methoxy-1H-indol-2-yl)(pipidin-1-yl)methanone | ESD-908730-5MG |
Cas.: 22930-55-8 | Purity: 97% | (5-methoxy-1H-indol-2-yl)(pipidin-1-yl)methanone | ESD-908730-25MG |
Cas.: 2293965-52-1 | Purity: 97% | 4-nitro-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide | ESD-908731-5MG |
Cas.: 2293965-52-1 | Purity: 97% | 4-nitro-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide | ESD-908731-250MG |
Cas.: 22965-12-4 | Purity: 95% | Methyl 10,11-dihydro-5H-dibenzo[b,f]azepine-4-carboxylate | ESD-908732-250MG |
Cas.: 22965-12-4 | Purity: 95% | Methyl 10,11-dihydro-5H-dibenzo[b,f]azepine-4-carboxylate | ESD-908732-1G |
Cas.: 23010-10-8 | Purity: 95% | 2-tert-Butoxyphenol | ESD-908733-50MG |
Cas.: 23010-10-8 | Purity: 95% | 2-tert-Butoxyphenol | ESD-908733-250MG |
Cas.: 230618-41-4 | Purity: 98% | 2-Bromo-6-pyrrolidin-1-ylpyridine | ESD-908734-5G |
Cas.: 230618-41-4 | Purity: 98% | 2-Bromo-6-pyrrolidin-1-ylpyridine | ESD-908734-25G |
Cas.: 23062-06-8 | Purity: 95% | 4,16-ANDROSTADIEN-3-BETA-OL | ESD-908735-5MG |
Cas.: 23062-06-8 | Purity: 95% | 4,16-ANDROSTADIEN-3-BETA-OL | ESD-908735-25MG |
Cas.: 23205-23-4 | Purity: 95% | 4-amino-2-(benzyloxy)-5-chloro-N-[2-(morpholin-4-yl)ethyl]benzamide | ESD-908736-5MG |
Cas.: 23205-23-4 | Purity: 95% | 4-amino-2-(benzyloxy)-5-chloro-N-[2-(morpholin-4-yl)ethyl]benzamide | ESD-908736-25MG |
Cas.: 233775-53-6 | Purity: 95% | 6-amino-1,3-dimethyl-1,2,3,4-tetrahydroquinazolin-2-one | ESD-908737-250MG |
Cas.: 233775-53-6 | Purity: 95% | 6-amino-1,3-dimethyl-1,2,3,4-tetrahydroquinazolin-2-one | ESD-908737-1G |
Cas.: 23433-05-8 | Purity: 95% | octane-1,3-diol | ESD-908738-250MG |
Cas.: 23433-05-8 | Purity: 95% | octane-1,3-diol | ESD-908738-1G |
Cas.: 23442-22-0 | Purity: 95% | 4-amino-3-butoxybenzoic acid | ESD-908739-50MG |
Cas.: 2351-43-1 | Purity: 95% | Diethylene glycol mono-methacrylate | ESD-908740-50MG |
Cas.: 2351-43-1 | Purity: 95% | Diethylene glycol mono-methacrylate | ESD-908740-250MG |
Cas.: 2355-31-9 | Purity: 95% | N-Methylperfluoro-1-octanesulfonamidoacetic Acid | ESD-908741-250MG |
Cas.: 2355-31-9 | Purity: 95% | N-Methylperfluoro-1-octanesulfonamidoacetic Acid | ESD-908741-1G |
Cas.: 23662-75-1 | Purity: 95% | 2-amino-8-methyl-3,7-dihydro-6H-purin-6-one | ESD-908742-50MG |
Cas.: 23662-75-1 | Purity: 95% | 2-amino-8-methyl-3,7-dihydro-6H-purin-6-one | ESD-908742-250MG |
Cas.: 236739-03-0 | Purity: 95% | 1,4-Difluoro-2-(methylsulphonyl)benzene | ESD-908743-250MG |
Cas.: 236739-03-0 | Purity: 95% | 1,4-Difluoro-2-(methylsulphonyl)benzene | ESD-908743-1G |
Cas.: 2370-13-0 | Purity: 95% | 2,2-dimethylhexan-1-ol | ESD-908744-50MG |
Cas.: 2370-13-0 | Purity: 95% | 2,2-dimethylhexan-1-ol | ESD-908744-250MG |
Cas.: 23893-84-7 | Purity: 95% | 5,6-dibromo-octahydro-2-benzofuran-1,3-dione | ESD-908746-250MG |
Cas.: 23893-84-7 | Purity: 95% | 5,6-dibromo-octahydro-2-benzofuran-1,3-dione | ESD-908746-1G |
Cas.: 2391-56-2 | Purity: 95% | 1,5-Bis(4-aminophenoxy)pentane | ESD-908747-1G |
Cas.: 2391-56-2 | Purity: 95% | 1,5-Bis(4-aminophenoxy)pentane | ESD-908747-5G |
Cas.: 23949-50-0 | Purity: 95% | 4-propylmorpholine | ESD-908748-50MG |
Cas.: 23949-50-0 | Purity: 95% | 4-propylmorpholine | ESD-908748-250MG |
Cas.: 239-69-0 | Purity: 95% | Dinaphtho[1,2-b:2′,1′-d]furan | ESD-908749-5MG |
Cas.: 239-69-0 | Purity: 95% | Dinaphtho[1,2-b:2′,1′-d]furan | ESD-908749-25MG |
Cas.: 24223-07-2 | Purity: ≥95% | 9H-Pyrido[3,4-b]indole, 2-oxide | ESD-908750-5MG |
Cas.: 24223-07-2 | Purity: ≥95% | 9H-Pyrido[3,4-b]indole, 2-oxide | ESD-908750-25MG |
Cas.: 242-51-3 | Purity: 95% | dinaphtho[2,3-b:2′,3′-d]furan | ESD-908751-5MG |
Cas.: 242-51-3 | Purity: 95% | dinaphtho[2,3-b:2′,3′-d]furan | ESD-908751-25MG |
Cas.: 24271-12-3 | Purity: 95% | stearyl behenate | ESD-908752-5MG |
Cas.: 24271-12-3 | Purity: 95% | stearyl behenate | ESD-908752-250MG |
Cas.: 2432-74-8 | Purity: 95% | 6-Aminocapronitrile | ESD-908753-250MG |
Cas.: 2432-74-8 | Purity: 95% | 6-Aminocapronitrile | ESD-908753-1G |
Cas.: 243-69-6 | Purity: 95% | Benzo[4,5]thieno[2,3-b]quinoxaline | ESD-908754-250MG |
Cas.: 243-69-6 | Purity: 95% | Benzo[4,5]thieno[2,3-b]quinoxaline | ESD-908754-1G |
Cas.: 243991-62-0 | Purity: 95% | Pentaerythritol tetrakis(2-bromoisobutyrate) | ESD-908755-250MG |
Cas.: 243991-62-0 | Purity: 95% | Pentaerythritol tetrakis(2-bromoisobutyrate) | ESD-908755-1G |
Cas.: 245116-90-9 | Purity: 95% | 2-{3-[(4,5,7-trifluoro-1,3-benzothiazol-2-yl)methyl]-1H-indol-1-yl}acetic acid | ESD-908756-25MG |
Cas.: 245116-90-9 | Purity: 95% | 2-{3-[(4,5,7-trifluoro-1,3-benzothiazol-2-yl)methyl]-1H-indol-1-yl}acetic acid | ESD-908756-100MG |
Cas.: 24567-27-9 | Purity: 95% | 2-hydroxyethyl propanoate | ESD-908757-250MG |
Cas.: 24567-27-9 | Purity: 95% | 2-hydroxyethyl propanoate | ESD-908757-1G |
Cas.: 245762-27-0 | Purity: 95% | 3-(5-fluoro-1H-indol-3-yl)propan-1-amine | ESD-908758-50MG |
Cas.: 245762-27-0 | Purity: 95% | 3-(5-fluoro-1H-indol-3-yl)propan-1-amine | ESD-908758-250MG |
Cas.: 24598-73-0 | Purity: 98% | Potassium orotate | ESD-908759-25G |
Cas.: 24598-73-0 | Purity: 98% | Potassium orotate | ESD-908759-100G |
Cas.: 2461-46-3 | Purity: 95% | 4,4′-bis(2,3-epoxypropoxy)biphenyl | ESD-908760-50MG |
Cas.: 2461-46-3 | Purity: 95% | 4,4′-bis(2,3-epoxypropoxy)biphenyl | ESD-908760-250MG |
Cas.: 24683-21-4 | Purity: 95% | ethyl 4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide | ESD-908761-10MG |
Cas.: 24683-21-4 | Purity: 95% | ethyl 4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide | ESD-908761-50MG |
Cas.: 246852-12-0 | Purity: 98% | Amlodipine mesylate | ESD-908762-250MG |
Cas.: 246852-12-0 | Purity: 98% | Amlodipine mesylate | ESD-908762-1G |
Cas.: 247035-47-8 | Purity: 95% | tert-Butyl (4-isothiocyanatobutyl)carbamate | ESD-908763-50MG |
Cas.: 247035-47-8 | Purity: 95% | tert-Butyl (4-isothiocyanatobutyl)carbamate | ESD-908763-250MG |
Cas.: 24764-40-7 | Purity: 95% | 1-tert-Butylpyrrole | ESD-908764-250MG |
Cas.: 24802-07-1 | Purity: 95% | alpha,alpha-Dimethyl-3-isopropenylbenzenemethanol | ESD-908765-5MG |
Cas.: 24802-07-1 | Purity: 95% | alpha,alpha-Dimethyl-3-isopropenylbenzenemethanol | ESD-908765-25MG |
Cas.: 24910-32-5 | Purity: 95% | 2-[(2-hydroxyethyl)(pentadecyl)amino]ethan-1-ol | ESD-908766-25MG |
Cas.: 24910-32-5 | Purity: 95% | 2-[(2-hydroxyethyl)(pentadecyl)amino]ethan-1-ol | ESD-908766-100MG |
Cas.: 249285-50-5 | Purity: 95% | 2-Hydroxyethyl benzenesulfonate | ESD-908767-50MG |
Cas.: 249285-50-5 | Purity: 95% | 2-Hydroxyethyl benzenesulfonate | ESD-908767-250MG |
Cas.: 2494-89-5 | Purity: 96% | 2-((4-Aminophenyl)sulfonyl)ethyl hydrogen sulfate | ESD-908768-100G |
Cas.: 2494-89-5 | Purity: 96% | 2-((4-Aminophenyl)sulfonyl)ethyl hydrogen sulfate | ESD-908768-500G |
Cas.: 249737-01-7 | Purity: 95% | 3-amino-6,7-dimethoxy-4-(trifluoromethyl)-1,2-dihydroquinolin-2-one | ESD-908769-50MG |
Cas.: 249737-01-7 | Purity: 95% | 3-amino-6,7-dimethoxy-4-(trifluoromethyl)-1,2-dihydroquinolin-2-one | ESD-908769-250MG |
Cas.: 2500-59-6 | Purity: 95% | methyl 9,10-epoxystearate | ESD-908770-50MG |
Cas.: 2500-59-6 | Purity: 95% | methyl 9,10-epoxystearate | ESD-908770-250MG |
Cas.: 25023-01-2 | Purity: 95% | 9,9-dichloro-9H-fluorene | ESD-908771-25MG |
Cas.: 25023-01-2 | Purity: 95% | 9,9-dichloro-9H-fluorene | ESD-908771-100MG |
Cas.: 2504-18-9 | Purity: 95% | N,2-dimethyl-N-nitrosopropan-2-amine | ESD-908772-250MG |
Cas.: 2504-18-9 | Purity: 95% | N,2-dimethyl-N-nitrosopropan-2-amine | ESD-908772-1G |
Cas.: 251316-98-0 | Purity: 98% | Fmoc-L-allo-isoleucine | ESD-908774-50MG |
Cas.: 251316-98-0 | Purity: 98% | Fmoc-L-allo-isoleucine | ESD-908774-250MG |
Cas.: 25176-75-4 | Purity: 95% | ethylenebis(oxyethylene) dihexanoate | ESD-908775-50MG |
Cas.: 25176-75-4 | Purity: 95% | ethylenebis(oxyethylene) dihexanoate | ESD-908775-250MG |
Cas.: 25216-74-4 | Purity: 97% | tert-butyl (3-bromophenyl)carbamate | ESD-908776-25G |
Cas.: 25216-74-4 | Purity: 97% | tert-butyl (3-bromophenyl)carbamate | ESD-908776-100G |
Cas.: 252362-02-0 | Purity: 95% | 4-Chloro-1H-indol-5-amine | ESD-908777-10MG |
Cas.: 252362-02-0 | Purity: 95% | 4-Chloro-1H-indol-5-amine | ESD-908777-50MG |
Cas.: 25245-33-4 | Purity: 95% | 1-Iodo-2,3-Dimethoxybenzene | ESD-908778-1G |
Cas.: 25245-33-4 | Purity: 95% | 1-Iodo-2,3-Dimethoxybenzene | ESD-908778-5G |
Cas.: 252663-48-2 | Purity: 95% | 4-(Butylaminocarbonyl)phenylboronic acid | ESD-908779-1G |
Cas.: 252663-48-2 | Purity: 95% | 4-(Butylaminocarbonyl)phenylboronic acid | ESD-908779-5G |
Cas.: 2527-66-4 | Purity: 95% | 2-Methyl-1,2-benzothiazol-3(2H)-one | ESD-908780-5G |
Cas.: 2527-66-4 | Purity: 95% | 2-Methyl-1,2-benzothiazol-3(2H)-one | ESD-908780-25G |
Cas.: 252771-08-7 | Purity: 95% | 5-ethynyl-2-hydroxybenzaldehyde | ESD-908781-50MG |
Cas.: 252771-08-7 | Purity: 95% | 5-ethynyl-2-hydroxybenzaldehyde | ESD-908781-250MG |
Cas.: 2528-39-4 | Purity: 95% | Trihexyl phosphate | ESD-908782-1G |
Cas.: 2528-39-4 | Purity: 95% | Trihexyl phosphate | ESD-908782-5G |
Cas.: 252930-37-3 | Purity: 95% | (S)-2-Amino-3-(5-(tert-butyl)-3-(phosphonomethoxy)isoxazol-4-yl)propanoic acid | ESD-908783-5MG |
Cas.: 252930-37-3 | Purity: 95% | (S)-2-Amino-3-(5-(tert-butyl)-3-(phosphonomethoxy)isoxazol-4-yl)propanoic acid | ESD-908783-25MG |
Cas.: 25306-75-6 | Purity: 95% | Sodium Isobutyl Xanthate | ESD-908784-25G |
Cas.: 25306-75-6 | Purity: 95% | Sodium Isobutyl Xanthate | ESD-908784-100G |
Cas.: 25415-62-7 | Purity: 95% | pentyl isovalerate | ESD-908785-25MG |
Cas.: 25415-62-7 | Purity: 95% | pentyl isovalerate | ESD-908785-100MG |
Cas.: 25475-76-7 | Purity: 95% | thiophen-3-amine hydrochloride | ESD-908786-5G |
Cas.: 25475-76-7 | Purity: 95% | thiophen-3-amine hydrochloride | ESD-908786-25G |
Cas.: 2552-91-2 | Purity: 95% | (1S)-(+)-Neomenthyl acetate | ESD-908787-50MG |
Cas.: 2552-91-2 | Purity: 95% | (1S)-(+)-Neomenthyl acetate | ESD-908787-250MG |
Cas.: 25539-27-9 | Purity: 95% | 4-Cbz-piperazine-1-carbonyl Chloride | ESD-908788-250MG |
Cas.: 25539-27-9 | Purity: 95% | 4-Cbz-piperazine-1-carbonyl Chloride | ESD-908788-1G |
Cas.: 255727-66-3 | Purity: 95% | 10-Undecenyl 2-bromoisobutyrate | ESD-908789-250MG |
Cas.: 255727-66-3 | Purity: 95% | 10-Undecenyl 2-bromoisobutyrate | ESD-908789-1G |
Cas.: 25601-41-6 | Purity: 95% | 9-Decenoic acid, methyl ester | ESD-908790-250MG |
Cas.: 25601-41-6 | Purity: 95% | 9-Decenoic acid, methyl ester | ESD-908790-1G |
Cas.: 256656-73-2 | Purity: 95% | 2-(4-Boronobenzamido)acetic acid | ESD-908791-25MG |
Cas.: 256656-73-2 | Purity: 95% | 2-(4-Boronobenzamido)acetic acid | ESD-908791-100MG |
Cas.: 2567-59-1 | Purity: 95% | N,N-dibutyl-2-chloroacetamide | ESD-908792-250MG |
Cas.: 2567-59-1 | Purity: 95% | N,N-dibutyl-2-chloroacetamide | ESD-908792-1G |
Cas.: 2568-89-0 | Purity: 95% | 2-[(propan-2-yloxy)methoxy]propane | ESD-908793-250MG |
Cas.: 2568-89-0 | Purity: 95% | 2-[(propan-2-yloxy)methoxy]propane | ESD-908793-1G |
Cas.: 25727-91-7 | Purity: 95% | 4-hexadecylmorpholine | ESD-908794-50MG |
Cas.: 25727-91-7 | Purity: 95% | 4-hexadecylmorpholine | ESD-908794-250MG |
Cas.: 2576-29-6 | Purity: 95% | 2-[(2-chloroethyl)amino]ethanol | ESD-908795-250MG |
Cas.: 2576-29-6 | Purity: 95% | 2-[(2-chloroethyl)amino]ethanol | ESD-908795-1G |
Cas.: 257946-66-0 | Purity: 95% | (4-Benzoylpiperidin-1-yl)(3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl)methanone | ESD-908796-25MG |
Cas.: 257946-66-0 | Purity: 95% | (4-Benzoylpiperidin-1-yl)(3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl)methanone | ESD-908796-100MG |
Cas.: 25844-13-7 | Purity: 95% | Heptadecanamide | ESD-908797-50MG |
Cas.: 25844-13-7 | Purity: 95% | Heptadecanamide | ESD-908797-250MG |
Cas.: 25878-60-8 | Purity: 95% | 1,2,3,4,6-penta-o-acetyl-d-galactopyranose | ESD-908798-25G |
Cas.: 25878-60-8 | Purity: 95% | 1,2,3,4,6-penta-o-acetyl-d-galactopyranose | ESD-908798-100G |
Cas.: 2589-78-8 | Purity: 95% | 4-Hexadecylphenol | ESD-908799-50MG |
Cas.: 2589-78-8 | Purity: 95% | 4-Hexadecylphenol | ESD-908799-250MG |
Cas.: 2589-79-9 | Purity: 95% | 4-n-Octadecylphenol | ESD-908800-50MG |
Cas.: 2589-79-9 | Purity: 95% | 4-n-Octadecylphenol | ESD-908800-250MG |
Cas.: 2611-01-0 | Purity: 95% | hexahydrobenzofuran-2(3H)-one | ESD-908801-5MG |
Cas.: 2611-01-0 | Purity: 95% | hexahydrobenzofuran-2(3H)-one | ESD-908801-25MG |
Cas.: 26159-35-3 | Purity: 95% | (S)-Naproxen Methyl Ester | ESD-908802-250MG |
Cas.: 26159-35-3 | Purity: 95% | (S)-Naproxen Methyl Ester | ESD-908802-1G |
Cas.: 261777-31-5 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-4-phenylpiperidine-2-carboxylic acid | ESD-908803-250MG |
Cas.: 261777-31-5 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-4-phenylpiperidine-2-carboxylic acid | ESD-908803-1G |
Cas.: 261956-22-3 | Purity: 95% | 5-(4-Biphenylyl)-5-[4-(4-nitrophenyl)piperazin-1-yl]barbituric acid | ESD-908804-5MG |
Cas.: 261956-22-3 | Purity: 95% | 5-(4-Biphenylyl)-5-[4-(4-nitrophenyl)piperazin-1-yl]barbituric acid | ESD-908804-25MG |
Cas.: 262352-25-0 | Purity: 95% | (2-((m-Tolylamino)methyl)phenyl)boronic acid | ESD-908805-250MG |
Cas.: 262352-25-0 | Purity: 95% | (2-((m-Tolylamino)methyl)phenyl)boronic acid | ESD-908805-1G |
Cas.: 26289-39-4 | Purity: 95% | S-(2,4-Dinitrophenyl)-Glutathione | ESD-908806-50MG |
Cas.: 26289-39-4 | Purity: 95% | S-(2,4-Dinitrophenyl)-Glutathione | ESD-908806-250MG |
Cas.: 26347-98-8 | Purity: 95% | 3-hydroxy-2,2-bis(hydroxymethyl)propyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoate | ESD-908807-5MG |
Cas.: 26347-98-8 | Purity: 95% | 3-hydroxy-2,2-bis(hydroxymethyl)propyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoate | ESD-908807-25MG |
Cas.: 26378-73-4 | Purity: 95% | 2,4,6-trichlororesorcinol | ESD-908808-50MG |
Cas.: 26378-73-4 | Purity: 95% | 2,4,6-trichlororesorcinol | ESD-908808-250MG |
Cas.: 26407-07-8 | Purity: 95% | 4-(2-bromoethyl)aniline hydrochloride | ESD-908809-250MG |
Cas.: 26407-07-8 | Purity: 95% | 4-(2-bromoethyl)aniline hydrochloride | ESD-908809-1G |
Cas.: 26543-97-5 | Purity: 95% | p-isononylphenol | ESD-908810-5MG |
Cas.: 26543-97-5 | Purity: 95% | p-isononylphenol | ESD-908810-25MG |
Cas.: 2657-44-5 | Purity: 95% | 4-(naphthalen-2-yl)butan-1-ol | ESD-908811-50MG |
Cas.: 2657-44-5 | Purity: 95% | 4-(naphthalen-2-yl)butan-1-ol | ESD-908811-250MG |
Cas.: 26591-72-0 | Purity: 97% | 3-methyl-1-vinyl-1H-imidazolium methyl sulphate | ESD-908812-1G |
Cas.: 26591-72-0 | Purity: 97% | 3-methyl-1-vinyl-1H-imidazolium methyl sulphate | ESD-908812-5G |
Cas.: 266999-35-3 | Purity: 95% | 2-[(t-butoxycarbonyl) amino]-3-[4-(dihydroxyboranyl) phenyl] propionic acid | ESD-908813-250MG |
Cas.: 266999-35-3 | Purity: 95% | 2-[(t-butoxycarbonyl) amino]-3-[4-(dihydroxyboranyl) phenyl] propionic acid | ESD-908813-1G |
Cas.: 26869-12-5 | Purity: 95% | 2-Chloro-9H-pyrido[2,3-b]indole | ESD-908814-50MG |
Cas.: 26869-12-5 | Purity: 95% | 2-Chloro-9H-pyrido[2,3-b]indole | ESD-908814-250MG |
Cas.: 26896-18-4 | Purity: 95% | Isononanoicacid | ESD-908815-250MG |
Cas.: 26896-18-4 | Purity: 95% | Isononanoicacid | ESD-908815-1G |
Cas.: 269398-80-3 | Purity: 95% | Boc-(R)-3-amino-4-(2-methyl-phenyl)-butyric acid | ESD-908816-50MG |
Cas.: 269398-80-3 | Purity: 95% | Boc-(R)-3-amino-4-(2-methyl-phenyl)-butyric acid | ESD-908816-250MG |
Cas.: 269410-27-7 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide | ESD-908817-250MG |
Cas.: 269410-27-7 | Purity: 95% | N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide | ESD-908817-1G |
Cas.: 269726-83-2 | Purity: 95% | Boc-(R)-3-amino-4-(3-cyano-phenyl)-butyric acid | ESD-908818-250MG |
Cas.: 269726-83-2 | Purity: 95% | Boc-(R)-3-amino-4-(3-cyano-phenyl)-butyric acid | ESD-908818-1G |
Cas.: 269726-86-5 | Purity: 98% | (R)-Boc-4-cyano-β-Homophe-OH | ESD-908819-250MG |
Cas.: 269726-86-5 | Purity: 98% | (R)-Boc-4-cyano-β-Homophe-OH | ESD-908819-1G |
Cas.: 270062-93-6 | Purity: 98% | Boc-(S)-3-amino-4-(3-methyl-phenyl)-butyric acid | ESD-908820-250MG |
Cas.: 270062-93-6 | Purity: 98% | Boc-(S)-3-amino-4-(3-methyl-phenyl)-butyric acid | ESD-908820-1G |
Cas.: 270062-96-9 | Purity: 98% | Boc-(S)-3-amino-4-(4-methyl-phenyl)-butyric acid | ESD-908821-250MG |
Cas.: 270062-96-9 | Purity: 98% | Boc-(S)-3-amino-4-(4-methyl-phenyl)-butyric acid | ESD-908821-1G |
Cas.: 27090-63-7 | Purity: 97% | N,N’-Di-n-butyl-1,6-hexanediamine | ESD-908822-1G |
Cas.: 27090-63-7 | Purity: 97% | N,N’-Di-n-butyl-1,6-hexanediamine | ESD-908822-5G |
Cas.: 27129-87-9 | Purity: 98% | 3,5-dimethylbenzyl alcohol | ESD-908823-1G |
Cas.: 27129-87-9 | Purity: 98% | 3,5-dimethylbenzyl alcohol | ESD-908823-5G |
Cas.: 2715-68-6 | Purity: 97% | 9-ethyladenine | ESD-908824-250MG |
Cas.: 2715-68-6 | Purity: 97% | 9-ethyladenine | ESD-908824-1G |
Cas.: 2719-62-2 | Purity: 95% | 6-phenyldodecane | ESD-908825-250MG |
Cas.: 2719-62-2 | Purity: 95% | 6-phenyldodecane | ESD-908825-1G |
Cas.: 27337-63-9 | Purity: 98% | 2,9-Dimethyl-1,10-phenanthroline-4,7-diol | ESD-908826-50MG |
Cas.: 27337-63-9 | Purity: 98% | 2,9-Dimethyl-1,10-phenanthroline-4,7-diol | ESD-908826-250MG |
Cas.: 27561-50-8 | Purity: 95% | 1-bromo-2-(bromomethyl)-4-methylbenzene | ESD-908827-250MG |
Cas.: 27561-50-8 | Purity: 95% | 1-bromo-2-(bromomethyl)-4-methylbenzene | ESD-908827-1G |
Cas.: 27646-78-2 | Purity: 95% | 2-(methylamino)propan-1-ol | ESD-908828-250MG |
Cas.: 27646-78-2 | Purity: 95% | 2-(methylamino)propan-1-ol | ESD-908828-1G |
Cas.: 276669-71-7 | Purity: 95% | [3-[[4-(Trifluoromethyl)benzoyl]amino]phenyl]boronic acid | ESD-908829-50MG |
Cas.: 276669-71-7 | Purity: 95% | [3-[[4-(Trifluoromethyl)benzoyl]amino]phenyl]boronic acid | ESD-908829-250MG |
Cas.: 27701-01-5 | Purity: 95% | methyl N-tert-butylcarbamate | ESD-908830-50MG |
Cas.: 27701-01-5 | Purity: 95% | methyl N-tert-butylcarbamate | ESD-908830-250MG |
Cas.: 27704-96-7 | Purity: 95% | Methyl 2-bromo-3-methoxypropanoate | ESD-908831-1G |
Cas.: 27704-96-7 | Purity: 95% | Methyl 2-bromo-3-methoxypropanoate | ESD-908831-5G |
Cas.: 27886-58-4 | Purity: 95% | 2-Chlorobenzenesulfonic Acid hydrate | ESD-908832-100MG |
Cas.: 27886-58-4 | Purity: 95% | 2-Chlorobenzenesulfonic Acid hydrate | ESD-908832-500MG |
Cas.: 280753-14-2 | Purity: 95% | 2-amino-3-[(tert-butyldiphenylsilyl)oxy]-2-methylpropan-1-ol | ESD-908834-250MG |
Cas.: 280753-14-2 | Purity: 95% | 2-amino-3-[(tert-butyldiphenylsilyl)oxy]-2-methylpropan-1-ol | ESD-908834-1G |
Cas.: 281192-95-8 | Purity: 95% | 1-ethyl-1H,2H,3H-pyrrolo[2,3-b]pyridine-2,3-dione | ESD-908835-250MG |
Cas.: 281192-95-8 | Purity: 95% | 1-ethyl-1H,2H,3H-pyrrolo[2,3-b]pyridine-2,3-dione | ESD-908835-1G |
Cas.: 28129-15-9 | Purity: 95% | 2-hydroxyethyl 4-methylbenzoate | ESD-908836-250MG |
Cas.: 28129-15-9 | Purity: 95% | 2-hydroxyethyl 4-methylbenzoate | ESD-908836-1G |
Cas.: 281666-44-2 | Purity: 95% | (2S,4S)-1-Cbz-4-(Boc-amino)pyrrolidine-2-carboxylic Acid | ESD-908837-50MG |
Cas.: 281666-44-2 | Purity: 95% | (2S,4S)-1-Cbz-4-(Boc-amino)pyrrolidine-2-carboxylic Acid | ESD-908837-250MG |
Cas.: 28340-72-9 | Purity: 95% | 2-amino-4-(morpholin-4-yl)benzonitrile | ESD-908838-50MG |
Cas.: 28340-72-9 | Purity: 95% | 2-amino-4-(morpholin-4-yl)benzonitrile | ESD-908838-250MG |
Cas.: 2837-61-8 | Purity: 97% | 2,2-dichloro-N-[3-(trifluoromethyl)phenyl]acetamide | ESD-908839-250MG |
Cas.: 2837-61-8 | Purity: 97% | 2,2-dichloro-N-[3-(trifluoromethyl)phenyl]acetamide | ESD-908839-1G |
Cas.: 284030-58-6 | Purity: 97% | Methyl 4-amino-2,3-difluoro-5-nitrobenzoate | ESD-908840-1G |
Cas.: 284030-58-6 | Purity: 97% | Methyl 4-amino-2,3-difluoro-5-nitrobenzoate | ESD-908840-5G |
Cas.: 2845-83-2 | Purity: 95% | 4-methoxypent-3-en-2-one | ESD-908841-5MG |
Cas.: 2845-83-2 | Purity: 95% | 4-methoxypent-3-en-2-one | ESD-908841-25MG |
Cas.: 28495-88-7 | Purity: 95% | 1-methyl-5-nitropyrimidine-2,4(1H,3H)-dione | ESD-908842-250MG |
Cas.: 28495-88-7 | Purity: 95% | 1-methyl-5-nitropyrimidine-2,4(1H,3H)-dione | ESD-908842-1G |
Cas.: 28563-19-1 | Purity: 95% | 7-chloro-2-hydroxy-3-phenylquinolin-4(1H)-one | ESD-908843-250MG |
Cas.: 28563-19-1 | Purity: 95% | 7-chloro-2-hydroxy-3-phenylquinolin-4(1H)-one | ESD-908843-1G |
Cas.: 28588-73-0 | Purity: 95% | 3,3′-dithiobis[2,5-dimethylfuran] | ESD-908844-1G |
Cas.: 28588-73-0 | Purity: 95% | 3,3′-dithiobis[2,5-dimethylfuran] | ESD-908844-5G |
Cas.: 28593-14-8 | Purity: 95% | 4-Fluoropentylbenzene | ESD-908845-250MG |
Cas.: 28593-14-8 | Purity: 95% | 4-Fluoropentylbenzene | ESD-908845-1G |
Cas.: 286411-09-4 | Purity: 95% | 7-chloro-2-phenyl-1,8-naphthyridin-4-ol | ESD-908846-5MG |
Cas.: 286411-09-4 | Purity: 95% | 7-chloro-2-phenyl-1,8-naphthyridin-4-ol | ESD-908846-25MG |
Cas.: 287175-08-0 | Purity: 95% | 2,6-dichloro-3,5-dimethoxybenzaldehyde | ESD-908847-5MG |
Cas.: 287175-08-0 | Purity: 95% | 2,6-dichloro-3,5-dimethoxybenzaldehyde | ESD-908847-25MG |
Cas.: 28726-30-9 | Purity: 95% | N1,N4-bis(2,3-dimethylphenyl)benzene-1,4-diamine | ESD-908848-250MG |
Cas.: 28726-30-9 | Purity: 95% | N1,N4-bis(2,3-dimethylphenyl)benzene-1,4-diamine | ESD-908848-1G |
Cas.: 28746-99-8 | Purity: 95% | 1′-hydroxy-1,1′-bi(cyclohexyl)-2-one | ESD-908849-250MG |
Cas.: 28746-99-8 | Purity: 95% | 1′-hydroxy-1,1′-bi(cyclohexyl)-2-one | ESD-908849-1G |
Cas.: 288259-39-2 | Purity: 95% | N-(5-AMinopentyl)biotinamide trifluoroacetate salt | ESD-908850-50MG |
Cas.: 288259-39-2 | Purity: 95% | N-(5-AMinopentyl)biotinamide trifluoroacetate salt | ESD-908850-250MG |
Cas.: 28832-58-8 | Purity: 95% | 1-[2-(5-chloropyridin-2-yl)diazen-1-yl]naphthalen-2-ol | ESD-908851-50MG |
Cas.: 28832-58-8 | Purity: 95% | 1-[2-(5-chloropyridin-2-yl)diazen-1-yl]naphthalen-2-ol | ESD-908851-250MG |
Cas.: 28896-49-3 | Purity: 95% | 4-Iododiphenyl ether | ESD-908852-250MG |
Cas.: 28896-49-3 | Purity: 95% | 4-Iododiphenyl ether | ESD-908852-1G |
Cas.: 28947-77-5 | Purity: 95% | Trihexadecylamine | ESD-908853-50MG |
Cas.: 28947-77-5 | Purity: 95% | Trihexadecylamine | ESD-908853-250MG |
Cas.: 290326-23-7 | Purity: 95% | 4-(5-chloro-2-thienyl)benzoic acid | ESD-908854-250MG |
Cas.: 290326-23-7 | Purity: 95% | 4-(5-chloro-2-thienyl)benzoic acid | ESD-908854-1G |
Cas.: 2909-79-7 | Purity: 97% | 4-tert-butyl-N,N-dimethylaniline | ESD-908855-5G |
Cas.: 2909-79-7 | Purity: 97% | 4-tert-butyl-N,N-dimethylaniline | ESD-908855-25G |
Cas.: 2915-57-3 | Purity: 95% | 1,4-bis(2-ethylhexyl) butanedioate | ESD-908856-50MG |
Cas.: 2915-57-3 | Purity: 95% | 1,4-bis(2-ethylhexyl) butanedioate | ESD-908856-250MG |
Cas.: 2915-72-2 | Purity: 95% | dodecyl benzoate | ESD-908857-250MG |
Cas.: 2915-72-2 | Purity: 95% | dodecyl benzoate | ESD-908857-1G |
Cas.: 29203-58-5 | Purity: 97% | 4-BROMO-N-HYDROXYBENZIMIDOYL CHLORIDE | ESD-908858-1G |
Cas.: 29203-58-5 | Purity: 97% | 4-BROMO-N-HYDROXYBENZIMIDOYL CHLORIDE | ESD-908858-5G |
Cas.: 29214-57-1 | Purity: 95% | 3-acetylheptane-2,6-dione | ESD-908859-50MG |
Cas.: 29214-57-1 | Purity: 95% | 3-acetylheptane-2,6-dione | ESD-908859-250MG |
Cas.: 2936-62-1 | Purity: 95% | 1-(2-methylphenyl)-1-phenylmethanamine | ESD-908860-50MG |
Cas.: 2936-62-1 | Purity: 95% | 1-(2-methylphenyl)-1-phenylmethanamine | ESD-908860-250MG |
Cas.: 29376-83-8 | Purity: 95% | Tridecyl benzoate | ESD-908861-50MG |
Cas.: 29376-83-8 | Purity: 95% | Tridecyl benzoate | ESD-908861-250MG |
Cas.: 294181-97-8 | Purity: 95% | ethyl 2,2-difluoro-2-(quinolin-2-yl)acetate | ESD-908862-50MG |
Cas.: 294181-97-8 | Purity: 95% | ethyl 2,2-difluoro-2-(quinolin-2-yl)acetate | ESD-908862-250MG |
Cas.: 29450-12-2 | Purity: 95% | N-(2-methoxyethyl)pyridin-2-amine | ESD-908863-50MG |
Cas.: 29450-12-2 | Purity: 95% | N-(2-methoxyethyl)pyridin-2-amine | ESD-908863-250MG |
Cas.: 294653-58-0 | Purity: 95% | ethyl 4-(3-hydroxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate | ESD-908864-5MG |
Cas.: 294653-58-0 | Purity: 95% | ethyl 4-(3-hydroxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate | ESD-908864-25MG |
Cas.: 295803-26-8 | Purity: 95% | 4-Bromo-1-(dibromomethyl)-2-fluorobenzene | ESD-908865-250MG |
Cas.: 295803-26-8 | Purity: 95% | 4-Bromo-1-(dibromomethyl)-2-fluorobenzene | ESD-908865-1G |
Cas.: 2959-74-2 | Purity: 95% | benzyl(diphenyl)phosphane oxide | ESD-908866-50MG |
Cas.: 2959-74-2 | Purity: 95% | benzyl(diphenyl)phosphane oxide | ESD-908866-250MG |
Cas.: 29635-98-1 | Purity: 95% | (5S)-5-(1H-imidazol-5-ylmethyl)-3-phenyl-2-thioxoimidazolidin-4-one | ESD-908867-50MG |
Cas.: 29635-98-1 | Purity: 95% | (5S)-5-(1H-imidazol-5-ylmethyl)-3-phenyl-2-thioxoimidazolidin-4-one | ESD-908867-250MG |
Cas.: 29806-75-5 | Purity: 95% | 2-ethylhexyl myristate | ESD-908868-250MG |
Cas.: 29806-75-5 | Purity: 95% | 2-ethylhexyl myristate | ESD-908868-1G |
Cas.: 29808-81-9 | Purity: 95% | 2-nitroacridine | ESD-908869-5MG |
Cas.: 29808-81-9 | Purity: 95% | 2-nitroacridine | ESD-908869-25MG |
Cas.: 2985-57-1 | Purity: 95% | 4-decylphenol | ESD-908870-50MG |
Cas.: 2985-57-1 | Purity: 95% | 4-decylphenol | ESD-908870-250MG |
Cas.: 2991-50-6 | Purity: 95% | N-ethyl-N-[(heptadecafluorooctyl)sulphonyl]glycine | ESD-908871-50MG |
Cas.: 2991-50-6 | Purity: 95% | N-ethyl-N-[(heptadecafluorooctyl)sulphonyl]glycine | ESD-908871-250MG |
Cas.: 30081-63-1 | Purity: 95% | BENZO[F]ISOQUINOLIN-4(3H)-ONE | ESD-908872-50MG |
Cas.: 30081-63-1 | Purity: 95% | BENZO[F]ISOQUINOLIN-4(3H)-ONE | ESD-908872-250MG |
Cas.: 3012-69-9 | Purity: 95% | 9,10-12,13-Diepoxyoctadecanoic Acid | ESD-908873-10MG |
Cas.: 3012-69-9 | Purity: 95% | 9,10-12,13-Diepoxyoctadecanoic Acid | ESD-908873-50MG |
Cas.: 3013-38-5 | Purity: 95% | 2,4-Dinitrobenzylbromide | ESD-908874-250MG |
Cas.: 3013-38-5 | Purity: 95% | 2,4-Dinitrobenzylbromide | ESD-908874-1G |
Cas.: 303-14-0 | Purity: 95% | dimethyl(2-phenothiazin-10-ylpropyl)amine | ESD-908875-5MG |
Cas.: 303-14-0 | Purity: 95% | dimethyl(2-phenothiazin-10-ylpropyl)amine | ESD-908875-25MG |
Cas.: 303752-38-7 | Purity: 97% | 3-([(Tert-Butoxy)Carbonyl]Amino)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid | ESD-908876-250MG |
Cas.: 303752-38-7 | Purity: 97% | 3-([(Tert-Butoxy)Carbonyl]Amino)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid | ESD-908876-1G |
Cas.: 30388-70-6 | Purity: 95% | 1,1′-sulfinylbis(2-nitrobenzene) | ESD-908877-50MG |
Cas.: 30388-70-6 | Purity: 95% | 1,1′-sulfinylbis(2-nitrobenzene) | ESD-908877-250MG |
Cas.: 3041-40-5 | Purity: 95% | Homophthalonitrile | ESD-908878-250MG |
Cas.: 3041-40-5 | Purity: 95% | Homophthalonitrile | ESD-908878-1G |
Cas.: 3042-57-7 | Purity: 95% | 2-(pentan-3-yl)naphthalene | ESD-908879-50MG |
Cas.: 3042-57-7 | Purity: 95% | 2-(pentan-3-yl)naphthalene | ESD-908879-250MG |
Cas.: 304457-86-1 | Purity: 95% | 1-(1H-Imidazol-4-yl)propan-1-one | ESD-908880-50MG |
Cas.: 304457-86-1 | Purity: 95% | 1-(1H-Imidazol-4-yl)propan-1-one | ESD-908880-250MG |
Cas.: 306934-70-3 | Purity: 95% | 1-[5-(Trifluoromethyl)pyrid-2-yl]-1,4-diazepane | ESD-908881-1G |
Cas.: 306934-70-3 | Purity: 95% | 1-[5-(Trifluoromethyl)pyrid-2-yl]-1,4-diazepane | ESD-908881-5G |
Cas.: 306936-50-5 | Purity: 95% | methyl 2-(aminomethyl)-3-furoate | ESD-908882-250MG |
Cas.: 306936-50-5 | Purity: 95% | methyl 2-(aminomethyl)-3-furoate | ESD-908882-1G |
Cas.: 310881-48-2 | Purity: 95% | 3-(pipidin-4-yloxy)pyridine | ESD-908883-250MG |
Cas.: 310881-48-2 | Purity: 95% | 3-(pipidin-4-yloxy)pyridine | ESD-908883-1G |
Cas.: 31098-40-5 | Purity: 95% | 6-Aminohexane-1-thiol hydrochloride | ESD-908884-50MG |
Cas.: 31098-40-5 | Purity: 95% | 6-Aminohexane-1-thiol hydrochloride | ESD-908884-250MG |
Cas.: 31161-71-4 | Purity: 95% | benzyl myristate | ESD-908885-250MG |
Cas.: 31161-71-4 | Purity: 95% | benzyl myristate | ESD-908885-1G |
Cas.: 31255-10-4 | Purity: 95% | 1,2-Bis(2-bromoethoxy)ethane | ESD-908886-250MG |
Cas.: 31255-10-4 | Purity: 95% | 1,2-Bis(2-bromoethoxy)ethane | ESD-908886-1G |
Cas.: 3126-90-7 | Purity: 95% | Dibutyl isophthalate | ESD-908887-1G |
Cas.: 3126-90-7 | Purity: 95% | Dibutyl isophthalate | ESD-908887-5G |
Cas.: 3128-29-8 | Purity: 95% | N-methyl-4-oxo-1,4-dihydropyridine-3-carboxamide | ESD-908888-50MG |
Cas.: 3128-29-8 | Purity: 95% | N-methyl-4-oxo-1,4-dihydropyridine-3-carboxamide | ESD-908888-250MG |
Cas.: 31327-97-6 | Purity: 95% | 4-Acridinecarboxylic acid | ESD-908889-250MG |
Cas.: 31327-97-6 | Purity: 95% | 4-Acridinecarboxylic acid | ESD-908889-1G |
Cas.: 313535-27-2 | Purity: 97% | 1-(Naphthalen-1-yl)-1H-tetrazole | ESD-908890-50MG |
Cas.: 313535-27-2 | Purity: 97% | 1-(Naphthalen-1-yl)-1H-tetrazole | ESD-908890-250MG |
Cas.: 31470-16-3 | Purity: 95% | 2H-Pyran-2,4(3H)-dione | ESD-908891-25MG |
Cas.: 31470-16-3 | Purity: 95% | 2H-Pyran-2,4(3H)-dione | ESD-908891-100MG |
Cas.: 31582-37-3 | Purity: 95% | N-(2,2,6,6-tetramethylpiperidin-4-yl)prop-2-enamide | ESD-908892-250MG |
Cas.: 31582-37-3 | Purity: 95% | N-(2,2,6,6-tetramethylpiperidin-4-yl)prop-2-enamide | ESD-908892-1G |
Cas.: 3158-73-4 | Purity: 95% | 2-cyclopropylaniline | ESD-908893-250MG |
Cas.: 3158-73-4 | Purity: 95% | 2-cyclopropylaniline | ESD-908893-1G |
Cas.: 31683-47-3 | Purity: 95% | trimethyl(3-phenylprop-1-yn-1-yl)silane | ESD-908894-25MG |
Cas.: 31683-47-3 | Purity: 95% | trimethyl(3-phenylprop-1-yn-1-yl)silane | ESD-908894-100MG |
Cas.: 31737-09-4 | Purity: 95% | 6-Chloro-1-methyluracil | ESD-908895-250MG |
Cas.: 31737-09-4 | Purity: 95% | 6-Chloro-1-methyluracil | ESD-908895-1G |
Cas.: 319442-16-5 | Purity: 97% | 4-chloro-2-methylthieno[3,2-d]pyrimidine | ESD-908896-250MG |
Cas.: 319442-16-5 | Purity: 97% | 4-chloro-2-methylthieno[3,2-d]pyrimidine | ESD-908896-1G |
Cas.: 3195-37-7 | Purity: 95% | Hexanedioic acid,1,6-diphenyl ester | ESD-908897-250MG |
Cas.: 3195-37-7 | Purity: 95% | Hexanedioic acid,1,6-diphenyl ester | ESD-908897-1G |
Cas.: 32017-77-9 | Purity: 95% | 2-(3-Methoxyphenyl)oxirane | ESD-908898-250MG |
Cas.: 32017-77-9 | Purity: 95% | 2-(3-Methoxyphenyl)oxirane | ESD-908898-1G |
Cas.: 321-54-0 | Purity: 95% | Coumaphos-oxon | ESD-908899-10MG |
Cas.: 321-54-0 | Purity: 95% | Coumaphos-oxon | ESD-908899-50MG |
Cas.: 3228-71-5 | Purity: 95% | 2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol | ESD-908900-50MG |
Cas.: 3228-71-5 | Purity: 95% | 2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol | ESD-908900-250MG |
Cas.: 32292-78-7 | Purity: 95% | 2-Benzoyloxy-4,6-dihydroxybenzaldehyde | ESD-908901-50MG |
Cas.: 32292-78-7 | Purity: 95% | 2-Benzoyloxy-4,6-dihydroxybenzaldehyde | ESD-908901-250MG |
Cas.: 3234-31-9 | Purity: 97% | 3-(2-cyanoethanesulfonyl)propanenitrile | ESD-908902-50MG |
Cas.: 3234-31-9 | Purity: 97% | 3-(2-cyanoethanesulfonyl)propanenitrile | ESD-908902-250MG |
Cas.: 32509-42-5 | Purity: 95% | N-methyldecylamine hydrochloride | ESD-908903-250MG |
Cas.: 32509-42-5 | Purity: 95% | N-methyldecylamine hydrochloride | ESD-908903-1G |
Cas.: 325956-47-6 | Purity: 95% | 3-bromo-1-chloronaphthalene | ESD-908904-25MG |
Cas.: 325956-47-6 | Purity: 95% | 3-bromo-1-chloronaphthalene | ESD-908904-100MG |
Cas.: 32648-01-4 | Purity: 95% | Dibutyrin | ESD-908905-50MG |
Cas.: 32648-01-4 | Purity: 95% | Dibutyrin | ESD-908905-250MG |
Cas.: 326816-37-9 | Purity: 95% | 2-(3-Chloro-5-(trifluoromethyl)-pyridin-2-yl)ethanamine hydrochloride | ESD-908906-50MG |
Cas.: 326816-37-9 | Purity: 95% | 2-(3-Chloro-5-(trifluoromethyl)-pyridin-2-yl)ethanamine hydrochloride | ESD-908906-250MG |
Cas.: 326829-08-7 | Purity: 95% | 3-chloro-5,5-dimethyl-4,5-dihydro-1,2-oxazole | ESD-908907-25MG |
Cas.: 326829-08-7 | Purity: 95% | 3-chloro-5,5-dimethyl-4,5-dihydro-1,2-oxazole | ESD-908907-100MG |
Cas.: 3271-56-5 | Purity: 95% | 2-heptyl-4-methyl-1,3-dioxane | ESD-908908-50MG |
Cas.: 3271-56-5 | Purity: 95% | 2-heptyl-4-methyl-1,3-dioxane | ESD-908908-250MG |
Cas.: 3278-14-6 | Purity: 95% | N-(2-phenylethyl)benzamide | ESD-908909-250MG |
Cas.: 3278-14-6 | Purity: 95% | N-(2-phenylethyl)benzamide | ESD-908909-100G |
Cas.: 32852-15-6 | Purity: 95% | [3-(1H-indazol-3-yloxy)propyl]dimethylamine | ESD-908910-50MG |
Cas.: 32852-15-6 | Purity: 95% | [3-(1H-indazol-3-yloxy)propyl]dimethylamine | ESD-908910-250MG |
Cas.: 32852-95-2 | Purity: 95% | 2-(3-Phenoxyphenyl)propiononitrile; | ESD-908911-5MG |
Cas.: 32852-95-2 | Purity: 95% | 2-(3-Phenoxyphenyl)propiononitrile; | ESD-908911-25MG |
Cas.: 328546-66-3 | Purity: 95% | 9-amino-1,2,3,4-tetrahydro-5H-1,4-benzodiazepin-5-one | ESD-908912-25MG |
Cas.: 328546-66-3 | Purity: 95% | 9-amino-1,2,3,4-tetrahydro-5H-1,4-benzodiazepin-5-one | ESD-908912-100MG |
Cas.: 328917-29-9 | Purity: 95% | 2-[3-(Diphenylphosphoroso)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908913-250MG |
Cas.: 328917-29-9 | Purity: 95% | 2-[3-(Diphenylphosphoroso)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-908913-1G |
Cas.: 329187-59-9 | Purity: 95% | 4-[(4,6-dichloropyrimidin-2-yl)amino]benzonitrile | ESD-908914-250MG |
Cas.: 329187-59-9 | Purity: 95% | 4-[(4,6-dichloropyrimidin-2-yl)amino]benzonitrile | ESD-908914-1G |
Cas.: 329216-67-3 | Purity: 97% | 2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethanol | ESD-908915-250MG |
Cas.: 329216-67-3 | Purity: 97% | 2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethanol | ESD-908915-1G |
Cas.: 32969-26-9 | Purity: 95% | 3-bromo-5-chloro-1-benzothiophene | ESD-908916-50MG |
Cas.: 32969-26-9 | Purity: 95% | 3-bromo-5-chloro-1-benzothiophene | ESD-908916-250MG |
Cas.: 32999-37-4 | Purity: 95% | 1,2,3,4-Tetrahydroisoquinolin-8-ol | ESD-908917-250MG |
Cas.: 32999-37-4 | Purity: 95% | 1,2,3,4-Tetrahydroisoquinolin-8-ol | ESD-908917-1G |
Cas.: 3307-00-4 | Purity: 95% | 4-(octan-3-yl)phenol | ESD-908918-50MG |
Cas.: 3307-00-4 | Purity: 95% | 4-(octan-3-yl)phenol | ESD-908918-250MG |
Cas.: 330793-45-8 | Purity: 95% | [4-(phenylcarbamoyl)phenyl]boronic acid | ESD-908919-250MG |
Cas.: 330793-45-8 | Purity: 95% | [4-(phenylcarbamoyl)phenyl]boronic acid | ESD-908919-1G |
Cas.: 330793-46-9 | Purity: 95% | 4-(Phenethylcarbamoyl)phenylboronic acid | ESD-908920-1G |
Cas.: 330793-46-9 | Purity: 95% | 4-(Phenethylcarbamoyl)phenylboronic acid | ESD-908920-5G |
Cas.: 331273-58-6 | Purity: 97% | 2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol | ESD-908921-250MG |
Cas.: 331273-58-6 | Purity: 97% | 2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol | ESD-908921-1G |
Cas.: 331282-37-2 | Purity: 95% | Potassium cyclopentylmethyltrifluoroborate | ESD-908922-250MG |
Cas.: 331282-37-2 | Purity: 95% | Potassium cyclopentylmethyltrifluoroborate | ESD-908922-1G |
Cas.: 33250-32-7 | Purity: 95% | 1-(dimethoxymethyl)naphthalene | ESD-908923-250MG |
Cas.: 33250-32-7 | Purity: 95% | 1-(dimethoxymethyl)naphthalene | ESD-908923-1G |
Cas.: 33328-29-9 | Purity: 95% | 2-(prop-2-en-1-yl)quinoline | ESD-908924-250MG |
Cas.: 33328-29-9 | Purity: 95% | 2-(prop-2-en-1-yl)quinoline | ESD-908924-1G |
Cas.: 33422-34-3 | Purity: 95% | methyl 2-methyl-5-oxo-2-(propan-2-yl)hexanoate | ESD-908925-25MG |
Cas.: 33422-34-3 | Purity: 95% | methyl 2-methyl-5-oxo-2-(propan-2-yl)hexanoate | ESD-908925-100MG |
Cas.: 3358-28-9 | Purity: 95% | 2,2,4,4-tetramethyltetrahydrofuran | ESD-908926-5MG |
Cas.: 3358-28-9 | Purity: 95% | 2,2,4,4-tetramethyltetrahydrofuran | ESD-908926-25MG |
Cas.: 33587-20-1 | Purity: 95% | 1-methylethane-1,2-diyldipalmitate | ESD-908927-250MG |
Cas.: 33587-20-1 | Purity: 95% | 1-methylethane-1,2-diyldipalmitate | ESD-908927-1G |
Cas.: 33622-50-3 | Purity: 95% | methyl 3-(3-methoxy-3-oxopropanesulfinyl)propanoate | ESD-908928-250MG |
Cas.: 33622-50-3 | Purity: 95% | methyl 3-(3-methoxy-3-oxopropanesulfinyl)propanoate | ESD-908928-1G |
Cas.: 3368-13-6 | Purity: 95% | 5-(Phenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide | ESD-908929-25MG |
Cas.: 3368-13-6 | Purity: 95% | 5-(Phenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide | ESD-908929-100MG |
Cas.: 33786-47-9 | Purity: 95% | 2-Propyl-2(E)-pentenoic acid | ESD-908930-25MG |
Cas.: 33786-47-9 | Purity: 95% | 2-Propyl-2(E)-pentenoic acid | ESD-908930-100MG |
Cas.: 33786-93-5 | Purity: 95% | 3,5-diaminobenzonitrile | ESD-908931-250MG |
Cas.: 33786-93-5 | Purity: 95% | 3,5-diaminobenzonitrile | ESD-908931-1G |
Cas.: 339048-81-6 | Purity: 95% | methyl 3-(4-bromophenyl)-2-hydroxypropanoate | ESD-908932-50MG |
Cas.: 339048-81-6 | Purity: 95% | methyl 3-(4-bromophenyl)-2-hydroxypropanoate | ESD-908932-250MG |
Cas.: 339161-04-5 | Purity: 95% | (2R,3S)-3-amino-2-hydroxybutanoic acid hydrochloride | ESD-908933-5MG |
Cas.: 339161-04-5 | Purity: 95% | (2R,3S)-3-amino-2-hydroxybutanoic acid hydrochloride | ESD-908933-25MG |
Cas.: 33948-22-0 | Purity: 99% | Iminostilbene carbonyl chloride | ESD-908934-5G |
Cas.: 33948-22-0 | Purity: 99% | Iminostilbene carbonyl chloride | ESD-908934-25G |
Cas.: 34066-75-6 | Purity: 95% | N,N’-bis(4-aminophenyl)benzene-1,4-dicarboxamide | ESD-908935-50MG |
Cas.: 34066-75-6 | Purity: 95% | N,N’-bis(4-aminophenyl)benzene-1,4-dicarboxamide | ESD-908935-250MG |
Cas.: 342594-80-3 | Purity: 95% | 4-[Bis(2-methyl-1H-indol-3-yl)methyl]-2-methoxyphenol | ESD-908936-5MG |
Cas.: 342594-80-3 | Purity: 95% | 4-[Bis(2-methyl-1H-indol-3-yl)methyl]-2-methoxyphenol | ESD-908936-25MG |
Cas.: 342600-96-8 | Purity: 95% | 2-(5-bromo-3-pyridyl)oxazole | ESD-908937-50MG |
Cas.: 342600-96-8 | Purity: 95% | 2-(5-bromo-3-pyridyl)oxazole | ESD-908937-250MG |
Cas.: 342899-37-0 | Purity: 95% | 3-amino-2-chloroisonicotinonitrile | ESD-908938-250MG |
Cas.: 342899-37-0 | Purity: 95% | 3-amino-2-chloroisonicotinonitrile | ESD-908938-1G |
Cas.: 343-04-4 | Purity: 95% | 2-Bromo-1-(5-fluoro-2-methoxyphenyl)ethanone | ESD-908939-5G |
Cas.: 343-04-4 | Purity: 95% | 2-Bromo-1-(5-fluoro-2-methoxyphenyl)ethanone | ESD-908939-25G |
Cas.: 34316-64-8 | Purity: 95% | hexyl laurate | ESD-908940-1G |
Cas.: 34316-64-8 | Purity: 95% | hexyl laurate | ESD-908940-5G |
Cas.: 343569-02-8 | Purity: 95% | 4-iodo-1,2-dimethyl-1H-imidazole | ESD-908941-250MG |
Cas.: 343569-02-8 | Purity: 95% | 4-iodo-1,2-dimethyl-1H-imidazole | ESD-908941-1G |
Cas.: 3440-32-2 | Purity: 95% | 3-(ethylamino)propanamide | ESD-908942-1G |
Cas.: 3440-32-2 | Purity: 95% | 3-(ethylamino)propanamide | ESD-908942-5G |
Cas.: 34419-76-6 | Purity: 95% | N,2-dimethyl-N-nitrosopropan-1-amine | ESD-908943-25MG |
Cas.: 34419-76-6 | Purity: 95% | N,2-dimethyl-N-nitrosopropan-1-amine | ESD-908943-100MG |
Cas.: 345304-65-6 | Purity: 95% | N-[(adamantan-1-yl)methyl]-2-chloro-5-{3-[(3-hydroxypropyl)amino]propyl}benzamide | ESD-908944-25MG |
Cas.: 345304-65-6 | Purity: 95% | N-[(adamantan-1-yl)methyl]-2-chloro-5-{3-[(3-hydroxypropyl)amino]propyl}benzamide | ESD-908944-100MG |
Cas.: 34680-81-4 | Purity: 95% | 2-Bromo-N-methylacetamide | ESD-908945-250MG |
Cas.: 34680-81-4 | Purity: 95% | 2-Bromo-N-methylacetamide | ESD-908945-1G |
Cas.: 34790-80-2 | Purity: 95% | 1-benzyl-1,3-diazinan-2-one | ESD-908946-250MG |
Cas.: 34790-80-2 | Purity: 95% | 1-benzyl-1,3-diazinan-2-one | ESD-908946-1G |
Cas.: 34917-91-4 | Purity: 95% | 4′-hydroxy-2-methylpropiophenone | ESD-908947-250MG |
Cas.: 34917-91-4 | Purity: 95% | 4′-hydroxy-2-methylpropiophenone | ESD-908947-1G |
Cas.: 35065-12-4 | Purity: 95% | 3-(4-hydroxyphenoxy)benzoic acid | ESD-908948-50MG |
Cas.: 35065-12-4 | Purity: 95% | 3-(4-hydroxyphenoxy)benzoic acid | ESD-908948-250MG |
Cas.: 35149-23-6 | Purity: 95% | 2-iodo-4,5-dimethylbenzoic acid | ESD-908949-250MG |
Cas.: 35149-23-6 | Purity: 95% | 2-iodo-4,5-dimethylbenzoic acid | ESD-908949-1G |
Cas.: 35193-44-3 | Purity: 95% | 3-ethyl-2-nitrobenzoic acid | ESD-908950-25MG |
Cas.: 35193-44-3 | Purity: 95% | 3-ethyl-2-nitrobenzoic acid | ESD-908950-100MG |
Cas.: 35205-70-0 | Purity: 95% | 3-methylhex-2-enoic acid | ESD-908951-50MG |
Cas.: 35205-70-0 | Purity: 95% | 3-methylhex-2-enoic acid | ESD-908951-250MG |
Cas.: 35251-84-4 | Purity: 95% | 1,4-Dihydropyrido[3,4-b]pyrazine-2,3-dione | ESD-908952-250MG |
Cas.: 35251-84-4 | Purity: 95% | 1,4-Dihydropyrido[3,4-b]pyrazine-2,3-dione | ESD-908952-1G |
Cas.: 35363-42-9 | Purity: 95% | EThyl Isobutyl Carbonate | ESD-908953-50MG |
Cas.: 35363-42-9 | Purity: 95% | EThyl Isobutyl Carbonate | ESD-908953-250MG |
Cas.: 3540-95-2 | Purity: 95% | fenpiprane | ESD-908954-5MG |
Cas.: 3540-95-2 | Purity: 95% | fenpiprane | ESD-908954-25MG |
Cas.: 35441-11-3 | Purity: 95% | 2,6-dihydroxynicotinamide | ESD-908955-50MG |
Cas.: 35441-11-3 | Purity: 95% | 2,6-dihydroxynicotinamide | ESD-908955-250MG |
Cas.: 35480-23-0 | Purity: 95% | naphthalen-2-ylmethyl acetate | ESD-908956-250MG |
Cas.: 35480-23-0 | Purity: 95% | naphthalen-2-ylmethyl acetate | ESD-908956-1G |
Cas.: 3552-01-0 | Purity: 95% | 1-(propan-2-yl)cyclohexan-1-ol | ESD-908957-250MG |
Cas.: 3552-01-0 | Purity: 95% | 1-(propan-2-yl)cyclohexan-1-ol | ESD-908957-1G |
Cas.: 3556-81-8 | Purity: 95% | 3′-Methoxy-4′-methylacetophenone | ESD-908958-250MG |
Cas.: 3556-81-8 | Purity: 95% | 3′-Methoxy-4′-methylacetophenone | ESD-908958-1G |
Cas.: 3566-61-8 | Purity: 98% | 3,3,4,4-tetramethylpyrrolidine-2,5-dione | ESD-908959-50MG |
Cas.: 3566-61-8 | Purity: 98% | 3,3,4,4-tetramethylpyrrolidine-2,5-dione | ESD-908959-250MG |
Cas.: 3567-62-2 | Purity: 95% | 1-(3,4-dichlorophenyl)-3-methylurea | ESD-908960-250MG |
Cas.: 3567-62-2 | Purity: 95% | 1-(3,4-dichlorophenyl)-3-methylurea | ESD-908960-1G |
Cas.: 3572-52-9 | Purity: 95% | 2-(diethylamino)ethyl 2-hydroxy-[1,1′-biphenyl]-3-carboxylate | ESD-908961-25MG |
Cas.: 3572-52-9 | Purity: 95% | 2-(diethylamino)ethyl 2-hydroxy-[1,1′-biphenyl]-3-carboxylate | ESD-908961-100MG |
Cas.: 35852-75-6 | Purity: 95% | 3-chloro-4-nitro-1H-pyrazole 3-chloro-4-nitro-1H-pyrazole | ESD-908962-250MG |
Cas.: 35852-75-6 | Purity: 95% | 3-chloro-4-nitro-1H-pyrazole 3-chloro-4-nitro-1H-pyrazole | ESD-908962-1G |
Cas.: 35979-69-2 | Purity: 95% | 4-Bromo-2-methyl-2-butanol | ESD-908964-1G |
Cas.: 35979-69-2 | Purity: 95% | 4-Bromo-2-methyl-2-butanol | ESD-908964-5G |
Cas.: 360779-31-3 | Purity: 95% | methyl 2-amino-2-(4-nitrophenyl)acetate | ESD-908965-250MG |
Cas.: 360779-31-3 | Purity: 95% | methyl 2-amino-2-(4-nitrophenyl)acetate | ESD-908965-1G |
Cas.: 36078-10-1 | Purity: 95% | dodecyl oleate | ESD-908966-50MG |
Cas.: 36078-10-1 | Purity: 95% | dodecyl oleate | ESD-908966-250MG |
Cas.: 361548-95-0 | Purity: 98% | tert-Butyl (3-amino-4-fluorophenyl)carbamate | ESD-908967-250MG |
Cas.: 361548-95-0 | Purity: 98% | tert-Butyl (3-amino-4-fluorophenyl)carbamate | ESD-908967-1G |
Cas.: 361-63-7 | Purity: 95% | 2,2-BIS(4-FLUOROPHENYL)ACETIC ACID | ESD-908968-50MG |
Cas.: 361-63-7 | Purity: 95% | 2,2-BIS(4-FLUOROPHENYL)ACETIC ACID | ESD-908968-250MG |
Cas.: 36173-52-1 | Purity: 95% | rac-(3S,4R)-3-methyl-4-piperidinol hydrochloride | ESD-908969-5MG |
Cas.: 36173-52-1 | Purity: 95% | rac-(3S,4R)-3-methyl-4-piperidinol hydrochloride | ESD-908969-25MG |
Cas.: 363166-11-4 | Purity: 95% | Benzaldehyde, 4-bromo-3,5-diethoxy- | ESD-908970-250MG |
Cas.: 363166-11-4 | Purity: 95% | Benzaldehyde, 4-bromo-3,5-diethoxy- | ESD-908970-1G |
Cas.: 364070-34-8 | Purity: 95% | 4-(2,6-Dimethylphenyl)benzoic acid | ESD-908971-250MG |
Cas.: 364070-34-8 | Purity: 95% | 4-(2,6-Dimethylphenyl)benzoic acid | ESD-908971-1G |
Cas.: 3641-23-4 | Purity: 95% | 5-(Chloromethyl)-2-methoxybenzoic acid | ESD-908972-250MG |
Cas.: 3641-23-4 | Purity: 95% | 5-(Chloromethyl)-2-methoxybenzoic acid | ESD-908972-1G |
Cas.: 36526-32-6 | Purity: 95% | ethyl 3-aminopyrazine-2-carboxylate | ESD-908973-250MG |
Cas.: 36526-32-6 | Purity: 95% | ethyl 3-aminopyrazine-2-carboxylate | ESD-908973-1G |
Cas.: 365526-34-7 | Purity: 95% | methyl 4-chloro-3-iodobenzoate | ESD-908974-1MG |
Cas.: 365526-34-7 | Purity: 95% | methyl 4-chloro-3-iodobenzoate | ESD-908974-5G |
Cas.: 36556-44-2 | Purity: 95% | 5-chloro-1,2,3-trifluorobenzene | ESD-908975-250MG |
Cas.: 36556-44-2 | Purity: 95% | 5-chloro-1,2,3-trifluorobenzene | ESD-908975-1G |
Cas.: 3658-44-4 | Purity: 95% | undecyl dodecanoate | ESD-908976-250MG |
Cas.: 3658-44-4 | Purity: 95% | undecyl dodecanoate | ESD-908976-1G |
Cas.: 25088-96-4 | Purity: 99% | Disodium stannous citrate | ESD-908977-25G |
Cas.: 25088-96-4 | Purity: 99% | Disodium stannous citrate | ESD-908977-100G |
Cas.: 25088-96-4 | Purity: 99% | Disodium stannous citrate | ESD-908977-500G |
Cas.: 25395-66-8 | Purity: 98% | Ascorbyl stearate | ESD-908978-25G |
Cas.: 25395-66-8 | Purity: 98% | Ascorbyl stearate | ESD-908978-100G |
Cas.: 20109-57-3 | Purity: 96% | Dodecafluoroheptyl thacrylate | ESD-908979-25G |
Cas.: 20109-57-3 | Purity: 96% | Dodecafluoroheptyl thacrylate | ESD-908979-100G |
Cas.: 20109-57-3 | Purity: 96% | Dodecafluoroheptyl thacrylate | ESD-908979-500G |
Cas.: 102286-67-9 | Purity: ≥97% | Fluorescein mono-β-D-galactopyranoside | ESD-908980-25MG |
Cas.: 102286-67-9 | Purity: ≥97% | Fluorescein mono-β-D-galactopyranoside | ESD-908980-100MG |
Cas.: 102286-67-9 | Purity: ≥97% | Fluorescein mono-β-D-galactopyranoside | ESD-908980-500MG |
Cas.: 13927-71-4 | Purity: ≥95% | Copper(II) Dibutyldithiocarbamate | ESD-908981-25G |
Cas.: 13927-71-4 | Purity: ≥95% | Copper(II) Dibutyldithiocarbamate | ESD-908981-100G |
Cas.: 13927-71-4 | Purity: ≥95% | Copper(II) Dibutyldithiocarbamate | ESD-908981-500G |
Cas.: 10238-28-5 | Purity: ≥97% | p-Nitrophenyl α-D-Xylopyranoside | ESD-908982-10MG |
Cas.: 10238-28-5 | Purity: ≥97% | p-Nitrophenyl α-D-Xylopyranoside | ESD-908982-50MG |
Cas.: 246256-50-8 | Purity: 95% | 5(6)-Carboxytetramethylrhodamine N-succinimidyl ester | ESD-908983-10MG |
Cas.: 246256-50-8 | Purity: 95% | 5(6)-Carboxytetramethylrhodamine N-succinimidyl ester | ESD-908983-50MG |
Cas.: 246256-50-8 | Purity: 95% | 5(6)-Carboxytetramethylrhodamine N-succinimidyl ester | ESD-908983-100MG |
Cas.: 91809-66-4 | Purity: 98% | 5-Carboxytetramethylrhodamine | ESD-908984-5MG |
Cas.: 91809-66-4 | Purity: 98% | 5-Carboxytetramethylrhodamine | ESD-908984-25MG |
Cas.: 91809-66-4 | Purity: 98% | 5-Carboxytetramethylrhodamine | ESD-908984-100MG |
Cas.: 13001-38-2 | Purity: 97% | 1-(2-Cyanostyryl)-4-(4-cyanostyryl)benzene | ESD-908985-5G |
Cas.: 13001-38-2 | Purity: 97% | 1-(2-Cyanostyryl)-4-(4-cyanostyryl)benzene | ESD-908985-25G |
Cas.: 13001-38-2 | Purity: 97% | 1-(2-Cyanostyryl)-4-(4-cyanostyryl)benzene | ESD-908985-100G |
Cas.: 12222-69-4 | Purity: 98% | Disperse black 9 | ESD-908986-5G |
Cas.: 12222-69-4 | Purity: 98% | Disperse black 9 | ESD-908986-25G |
Cas.: 12222-69-4 | Purity: 98% | Disperse black 9 | ESD-908986-100G |
Cas.: 1000805-93-5 | Purity: 97% | [(4-fluorophenyl)methyl]hydrazine dihydrochloride | ESD-908987-1G |
Cas.: 1000805-93-5 | Purity: 97% | [(4-fluorophenyl)methyl]hydrazine dihydrochloride | ESD-908987-5G |
Cas.: 1000805-93-5 | Purity: 97% | [(4-fluorophenyl)methyl]hydrazine dihydrochloride | ESD-908987-25G |
Cas.: 4773-33-5 | Purity: 97% | Ethyl α-chlorophenylacetate | ESD-908988-1G |
Cas.: 4773-33-5 | Purity: 97% | Ethyl α-chlorophenylacetate | ESD-908988-5G |
Cas.: 4773-33-5 | Purity: 97% | Ethyl α-chlorophenylacetate | ESD-908988-25G |
Cas.: 7570-47-0 | Purity: 97% | 2-Methyl-5-nitro-1H-indole | ESD-908989-1G |
Cas.: 7570-47-0 | Purity: 97% | 2-Methyl-5-nitro-1H-indole | ESD-908989-5G |
Cas.: 7570-47-0 | Purity: 97% | 2-Methyl-5-nitro-1H-indole | ESD-908989-25G |
Cas.: 1026355-57-6 | Purity: 97% | Methyl 2-bromo-5-(trifluoromethyl)benzoate | ESD-908990-250MG |
Cas.: 1026355-57-6 | Purity: 97% | Methyl 2-bromo-5-(trifluoromethyl)benzoate | ESD-908990-1G |
Cas.: 1026355-57-6 | Purity: 97% | Methyl 2-bromo-5-(trifluoromethyl)benzoate | ESD-908990-5G |
Cas.: 118430-73-2 | Purity: 97% | 3-(tert-Butyl)-1-methyl-1H-pyrazol-5-amine | ESD-908991-250MG |
Cas.: 118430-73-2 | Purity: 97% | 3-(tert-Butyl)-1-methyl-1H-pyrazol-5-amine | ESD-908991-1G |
Cas.: 118430-73-2 | Purity: 97% | 3-(tert-Butyl)-1-methyl-1H-pyrazol-5-amine | ESD-908991-5G |
Cas.: 16689-34-2 | Purity: 97% | tert-Butyl 2-(propan-2-ylidene)hydrazinecarboxylate | ESD-908992-250MG |
Cas.: 16689-34-2 | Purity: 97% | tert-Butyl 2-(propan-2-ylidene)hydrazinecarboxylate | ESD-908992-1G |
Cas.: 16689-34-2 | Purity: 97% | tert-Butyl 2-(propan-2-ylidene)hydrazinecarboxylate | ESD-908992-5G |
Cas.: 20248-64-0 | Purity: 97% | 1,5-Diamino-2,4-dichlorobenzene | ESD-908993-250MG |
Cas.: 20248-64-0 | Purity: 97% | 1,5-Diamino-2,4-dichlorobenzene | ESD-908993-1G |
Cas.: 20248-64-0 | Purity: 97% | 1,5-Diamino-2,4-dichlorobenzene | ESD-908993-5G |
Cas.: 3524-33-2 | Purity: 97% | 1-Ethyl-3-methyl-1H-pyrazol-5-amine | ESD-908994-250MG |
Cas.: 3524-33-2 | Purity: 97% | 1-Ethyl-3-methyl-1H-pyrazol-5-amine | ESD-908994-1G |
Cas.: 3524-33-2 | Purity: 97% | 1-Ethyl-3-methyl-1H-pyrazol-5-amine | ESD-908994-5G |
Cas.: 42251-84-3 | Purity: 97% | 2-(3-Chloropropyl)-1H-isoindole-1,3(2H)-dione | ESD-908995-250MG |
Cas.: 42251-84-3 | Purity: 97% | 2-(3-Chloropropyl)-1H-isoindole-1,3(2H)-dione | ESD-908995-1G |
Cas.: 42251-84-3 | Purity: 97% | 2-(3-Chloropropyl)-1H-isoindole-1,3(2H)-dione | ESD-908995-5G |
Cas.: 4987-96-6 | Purity: 97% | 4,6-Dinitro-1,3-benzenediamine | ESD-908996-250MG |
Cas.: 4987-96-6 | Purity: 97% | 4,6-Dinitro-1,3-benzenediamine | ESD-908996-1G |
Cas.: 4987-96-6 | Purity: 97% | 4,6-Dinitro-1,3-benzenediamine | ESD-908996-5G |
Cas.: 54070-74-5 | Purity: 97% | Cyclopropanecarboximidamide | ESD-908997-250MG |
Cas.: 54070-74-5 | Purity: 97% | Cyclopropanecarboximidamide | ESD-908997-1G |
Cas.: 54070-74-5 | Purity: 97% | Cyclopropanecarboximidamide | ESD-908997-5G |
Cas.: 6270-06-0 | Purity: 97% | N-(2-chloroethyl)phthalimide | ESD-908998-250MG |
Cas.: 6270-06-0 | Purity: 97% | N-(2-chloroethyl)phthalimide | ESD-908998-1G |
Cas.: 6270-06-0 | Purity: 97% | N-(2-chloroethyl)phthalimide | ESD-908998-5G |
Cas.: 6978-97-8 | Purity: 97% | 3-(Hydrazinylmethyl)pyridine Dihydrochloride | ESD-908999-250MG |
Cas.: 6978-97-8 | Purity: 97% | 3-(Hydrazinylmethyl)pyridine Dihydrochloride | ESD-908999-1G |
Cas.: 6978-97-8 | Purity: 97% | 3-(Hydrazinylmethyl)pyridine Dihydrochloride | ESD-908999-5G |
Cas.: 154237-70-4 | Purity: 95% | 4-Bromopyridine-3-carbonitrile | ESD-909000-250MG |
Cas.: 154237-70-4 | Purity: 95% | 4-Bromopyridine-3-carbonitrile | ESD-909000-1G |
Cas.: 154237-70-4 | Purity: 95% | 4-Bromopyridine-3-carbonitrile | ESD-909000-5G |
Cas.: 1431374-74-1 | Purity: 98% | 2-(2,3,4-Trifluorophenyl)pyridine | ESD-909001-200MG |
Cas.: 1431374-74-1 | Purity: 98% | 2-(2,3,4-Trifluorophenyl)pyridine | ESD-909001-1G |
Cas.: 1431374-74-1 | Purity: 98% | 2-(2,3,4-Trifluorophenyl)pyridine | ESD-909001-5G |
Cas.: 157402-44-3 | Purity: 97% | 6-Phenylpicolinaldehyde | ESD-909002-250MG |
Cas.: 157402-44-3 | Purity: 97% | 6-Phenylpicolinaldehyde | ESD-909002-1G |
Cas.: 157402-44-3 | Purity: 97% | 6-Phenylpicolinaldehyde | ESD-909002-5G |
Cas.: 2214-53-1 | Purity: 97% | 2-Methylpyridine-4-carbonitrile | ESD-909003-250MG |
Cas.: 2214-53-1 | Purity: 97% | 2-Methylpyridine-4-carbonitrile | ESD-909003-1G |
Cas.: 2214-53-1 | Purity: 97% | 2-Methylpyridine-4-carbonitrile | ESD-909003-5G |
Cas.: 30162-37-9 | Purity: 98% | 3-Pyridylthiourea | ESD-909004-250MG |
Cas.: 30162-37-9 | Purity: 98% | 3-Pyridylthiourea | ESD-909004-1G |
Cas.: 30162-37-9 | Purity: 98% | 3-Pyridylthiourea | ESD-909004-5G |
Cas.: 72093-14-2 | Purity: 97% | 2-Chloro-3,6-dimethylpyridine | ESD-909005-250MG |
Cas.: 72093-14-2 | Purity: 97% | 2-Chloro-3,6-dimethylpyridine | ESD-909005-1G |
Cas.: 72093-14-2 | Purity: 97% | 2-Chloro-3,6-dimethylpyridine | ESD-909005-5G |
Cas.: 101349-12-6 | Purity: 98% | 2-(5-Fluoro-1H-indol-3-yl)ethanol | ESD-909006-250MG |
Cas.: 101349-12-6 | Purity: 98% | 2-(5-Fluoro-1H-indol-3-yl)ethanol | ESD-909006-1G |
Cas.: 101349-12-6 | Purity: 98% | 2-(5-Fluoro-1H-indol-3-yl)ethanol | ESD-909006-5G |
Cas.: 128092-72-8 | Purity: 97% | (2-Fluorophenyl)(4-fluorophenyl)(phenyl)methanol | ESD-909007-250MG |
Cas.: 128092-72-8 | Purity: 97% | (2-Fluorophenyl)(4-fluorophenyl)(phenyl)methanol | ESD-909007-1G |
Cas.: 128092-72-8 | Purity: 97% | (2-Fluorophenyl)(4-fluorophenyl)(phenyl)methanol | ESD-909007-5G |
Cas.: 1630193-77-9 | Purity: 97% | 2,5-Dimethoxypyridine-4-boronic Acid | ESD-909008-250MG |
Cas.: 1630193-77-9 | Purity: 97% | 2,5-Dimethoxypyridine-4-boronic Acid | ESD-909008-1G |
Cas.: 1630193-77-9 | Purity: 97% | 2,5-Dimethoxypyridine-4-boronic Acid | ESD-909008-5G |
Cas.: 3322-93-8 | Purity: 97% | 1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane | ESD-909009-250MG |
Cas.: 3322-93-8 | Purity: 97% | 1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane | ESD-909009-1G |
Cas.: 3322-93-8 | Purity: 97% | 1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane | ESD-909009-5G |
Cas.: 23920-15-2 | Purity: 98%, brown crystalline powder | 4-[Di(2-hydroxyethyl)amino]-1-[(2-methoxyethyl)amino]-2-nitrobenzene | ESD-909010-250MG |
Cas.: 23920-15-2 | Purity: 98%, brown crystalline powder | 4-[Di(2-hydroxyethyl)amino]-1-[(2-methoxyethyl)amino]-2-nitrobenzene | ESD-909010-1G |
Cas.: 23920-15-2 | Purity: 98%, brown crystalline powder | 4-[Di(2-hydroxyethyl)amino]-1-[(2-methoxyethyl)amino]-2-nitrobenzene | ESD-909010-5G |
Cas.: 150809-89-5 | Purity: 98% | 1,4-Phenylene bis(4-((6-(acryloyloxy)-3-methylhexyl)oxy)benzoate) | ESD-909011-250MG |
Cas.: 150809-89-5 | Purity: 98% | 1,4-Phenylene bis(4-((6-(acryloyloxy)-3-methylhexyl)oxy)benzoate) | ESD-909011-1G |
Cas.: 150809-89-5 | Purity: 98% | 1,4-Phenylene bis(4-((6-(acryloyloxy)-3-methylhexyl)oxy)benzoate) | ESD-909011-5G |
Cas.: 12768-92-2 | Purity: 97% | Fluorescent Brightener 113 | ESD-909012-100G |
Cas.: 12768-92-2 | Purity: 97% | Fluorescent Brightener 113 | ESD-909012-500G |
Cas.: 12768-92-2 | Purity: 97% | Fluorescent Brightener 113 | ESD-909012-2.5KG |
Cas.: 5743-27-1 | Purity: 99% | Calcium diascorbate | ESD-909013-100G |
Cas.: 5743-27-1 | Purity: 99% | Calcium diascorbate | ESD-909013-500G |
Cas.: 5743-27-1 | Purity: 99% | Calcium diascorbate | ESD-909013-2.5KG |
Cas.: 7378-23-6 | Purity: 99% | Sodium erythorbate | ESD-909014-100G |
Cas.: 7378-23-6 | Purity: 99% | Sodium erythorbate | ESD-909014-500G |
Cas.: 7378-23-6 | Purity: 99% | Sodium erythorbate | ESD-909014-2.5KG |
Cas.: 25155-23-1 | Purity: 98% | TRixyl phosphate | ESD-909015-100G |
Cas.: 25155-23-1 | Purity: 98% | TRixyl phosphate | ESD-909015-500G |
Cas.: 25155-23-1 | Purity: 98% | TRixyl phosphate | ESD-909015-2.5KG |
Cas.: 56803-37-3 | Purity: 98% | tert-Butylphenyl Diphenyl Phosphate | ESD-909016-100G |
Cas.: 56803-37-3 | Purity: 98% | tert-Butylphenyl Diphenyl Phosphate | ESD-909016-500G |
Cas.: 56803-37-3 | Purity: 98% | tert-Butylphenyl Diphenyl Phosphate | ESD-909016-2.5KG |
Cas.: 38640-62-9 | Purity: 98%, mixture of isomers | Diisopropylnaphthalene | ESD-909018-100G |
Cas.: 38640-62-9 | Purity: 98%, mixture of isomers | Diisopropylnaphthalene | ESD-909018-500G |
Cas.: 38640-62-9 | Purity: 98%, mixture of isomers | Diisopropylnaphthalene | ESD-909018-2.5KG |
Cas.: 4128-31-8 | Purity: 99% | 2-Octanol | ESD-909019-100G |
Cas.: 4128-31-8 | Purity: 99% | 2-Octanol | ESD-909019-500G |
Cas.: 4128-31-8 | Purity: 99% | 2-Octanol | ESD-909019-2.5KG |
Cas.: 144246-02-6 | Purity: 98% | Solvent yellow 135 | ESD-909020-100G |
Cas.: 144246-02-6 | Purity: 98% | Solvent yellow 135 | ESD-909020-500G |
Cas.: 144246-02-6 | Purity: 98% | Solvent yellow 135 | ESD-909020-2.5KG |
Cas.: 3771-13-9 | Purity: 97% | 2-(Bromomethyl)-1-chloro-4-methoxybenzene | ESD-909022-100MG |
Cas.: 3771-13-9 | Purity: 97% | 2-(Bromomethyl)-1-chloro-4-methoxybenzene | ESD-909022-250MG |
Cas.: 3771-13-9 | Purity: 97% | 2-(Bromomethyl)-1-chloro-4-methoxybenzene | ESD-909022-1G |
Cas.: 10071-38-2 | Purity: 97% | 6-Chloro-2-methylpyridazin-3(2H)-one | ESD-909023-100MG |
Cas.: 10071-38-2 | Purity: 97% | 6-Chloro-2-methylpyridazin-3(2H)-one | ESD-909023-250MG |
Cas.: 10071-38-2 | Purity: 97% | 6-Chloro-2-methylpyridazin-3(2H)-one | ESD-909023-1G |
Cas.: 84611-43-8 | Purity: 98% | 2-Chloro-5-benzyloxypyridine | ESD-909024-100MG |
Cas.: 84611-43-8 | Purity: 98% | 2-Chloro-5-benzyloxypyridine | ESD-909024-250MG |
Cas.: 84611-43-8 | Purity: 98% | 2-Chloro-5-benzyloxypyridine | ESD-909024-1G |
Cas.: 1233501-57-9 | Purity: 96% | 4-Ethynyl-3-fluoroaniline | ESD-909025-100MG |
Cas.: 1233501-57-9 | Purity: 96% | 4-Ethynyl-3-fluoroaniline | ESD-909025-250MG |
Cas.: 1233501-57-9 | Purity: 96% | 4-Ethynyl-3-fluoroaniline | ESD-909025-1G |
Cas.: 1799612-08-0 | Purity: 97% | 4-Bromo-2-chloro-3-methylphenol | ESD-909026-100MG |
Cas.: 1799612-08-0 | Purity: 97% | 4-Bromo-2-chloro-3-methylphenol | ESD-909026-250MG |
Cas.: 1799612-08-0 | Purity: 97% | 4-Bromo-2-chloro-3-methylphenol | ESD-909026-1G |
Cas.: 331647-04-2 | Purity: 97% | 8-Bromo-2-chloroquinazolin-4(3H)-one | ESD-909027-100MG |
Cas.: 331647-04-2 | Purity: 97% | 8-Bromo-2-chloroquinazolin-4(3H)-one | ESD-909027-250MG |
Cas.: 331647-04-2 | Purity: 97% | 8-Bromo-2-chloroquinazolin-4(3H)-one | ESD-909027-1G |
Cas.: 7675-32-3 | Purity: 97% | 2-Methyl-1,5-naphthyridine | ESD-909028-100MG |
Cas.: 7675-32-3 | Purity: 97% | 2-Methyl-1,5-naphthyridine | ESD-909028-250MG |
Cas.: 7675-32-3 | Purity: 97% | 2-Methyl-1,5-naphthyridine | ESD-909028-1G |
Cas.: 1022919-86-3 | Purity: ≥97% | 2-Ethyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | ESD-909029-50MG |
Cas.: 1022919-86-3 | Purity: ≥97% | 2-Ethyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | ESD-909029-250MG |
Cas.: 1022919-86-3 | Purity: ≥97% | 2-Ethyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | ESD-909029-1G |
Cas.: 109105-51-3 | Purity: ≥97% | 1-Benzylazepan-4-amine | ESD-909030-50MG |
Cas.: 109105-51-3 | Purity: ≥97% | 1-Benzylazepan-4-amine | ESD-909030-250MG |
Cas.: 109105-51-3 | Purity: ≥97% | 1-Benzylazepan-4-amine | ESD-909030-1G |
Cas.: 2428-14-0 | Purity: ≥97% | 2-(2-Chloro-6-methylphenoxy)aceticacid | ESD-909031-50MG |
Cas.: 2428-14-0 | Purity: ≥97% | 2-(2-Chloro-6-methylphenoxy)aceticacid | ESD-909031-250MG |
Cas.: 2428-14-0 | Purity: ≥97% | 2-(2-Chloro-6-methylphenoxy)aceticacid | ESD-909031-1G |
Cas.: 63014-04-0 | Purity: ≥97% | 4-Propylbenzenesulphonyl chloride | ESD-909032-50MG |
Cas.: 63014-04-0 | Purity: ≥97% | 4-Propylbenzenesulphonyl chloride | ESD-909032-250MG |
Cas.: 63014-04-0 | Purity: ≥97% | 4-Propylbenzenesulphonyl chloride | ESD-909032-1G |
Cas.: 461-56-3 | Purity: 95% | 3-Fluoropropanoic acid | ESD-909033-100MG |
Cas.: 461-56-3 | Purity: 95% | 3-Fluoropropanoic acid | ESD-909033-250MG |
Cas.: 461-56-3 | Purity: 95% | 3-Fluoropropanoic acid | ESD-909033-1G |
Cas.: 9028-53-9 | Purity: ≥800U/mg | Glucose Dehydrogenase | ESD-909034-1KU |
Cas.: 9028-53-9 | Purity: ≥800U/mg | Glucose Dehydrogenase | ESD-909034-5KU |
Cas.: 9028-53-9 | Purity: ≥600U/mg | Glucose Dehydrogenase | ESD-909035-1KU |
Cas.: 9028-53-9 | Purity: ≥600U/mg | Glucose Dehydrogenase | ESD-909035-5KU |
Cas.: 84603-93-0 | Purity: Linoleic acid: 45% | rose hip oil | ESD-909036-100G |
Cas.: 84603-93-0 | Purity: Linoleic acid: 45% | rose hip oil | ESD-909036-500G |
Cas.: 12626-81-2 | Purity: 99.99%, Particle size: 1μm | Lead zirconate titanate wafer | ESD-909037-1G |
Cas.: 12626-81-2 | Purity: 99.99%, Particle size: 1μm | Lead zirconate titanate wafer | ESD-909037-5G |
Cas.: 12626-81-2 | Purity: 99.9%, Particle size: 1-3μm | Lead zirconate titanate wafer | ESD-909038-1G |
Cas.: 12626-81-2 | Purity: 99.9%, Particle size: 1-3μm | Lead zirconate titanate wafer | ESD-909038-5G |
Cas.: 1950-68-1 | Purity: 97% | 4-Methoxybenzenesulfonyl hydrazide | ESD-909039-1G |
Cas.: 1950-68-1 | Purity: 97% | 4-Methoxybenzenesulfonyl hydrazide | ESD-909039-5G |
Cas.: 24239-82-5 | Purity: 97% | 1,5-Dibromo-2,4-dinitrobenzene | ESD-909040-250MG |
Cas.: 24239-82-5 | Purity: 97% | 1,5-Dibromo-2,4-dinitrobenzene | ESD-909040-1G |
Cas.: 31465-25-5 | Purity: 97% | Sodium 4-hydroxybutane-1-sulphonate | ESD-909041-250MG |
Cas.: 31465-25-5 | Purity: 97% | Sodium 4-hydroxybutane-1-sulphonate | ESD-909041-1G |
Cas.: 5906-99-0 | Purity: 97% | 2-Nitrobenzenesulfonohydrazide | ESD-909042-250MG |
Cas.: 5906-99-0 | Purity: 97% | 2-Nitrobenzenesulfonohydrazide | ESD-909042-1G |
Cas.: 57597-64-5 | Purity: ≥95% | 7-(DiethylaMino)-2-oxo-2H-chroMene-3-carbaldehyde | ESD-909044-250MG |
Cas.: 57597-64-5 | Purity: ≥95% | 7-(DiethylaMino)-2-oxo-2H-chroMene-3-carbaldehyde | ESD-909044-1G |
Cas.: 1060810-36-7 | Purity: ≥95% | 5-Chloro-2-methoxyisonicotinaldehyde | ESD-909045-250MG |
Cas.: 1060810-36-7 | Purity: ≥95% | 5-Chloro-2-methoxyisonicotinaldehyde | ESD-909045-1G |
Cas.: 1130759-48-6 | Purity: ≥95% | 1-(5-Bromopyridin-3-yl)-4-methylpiperazine | ESD-909046-250MG |
Cas.: 1130759-48-6 | Purity: ≥95% | 1-(5-Bromopyridin-3-yl)-4-methylpiperazine | ESD-909046-1G |
Cas.: 1187386-01-1 | Purity: 98% | 2-(4-BOC-piperazin-1-yl)-3-bromopyridine | ESD-909047-1G |
Cas.: 1187386-01-1 | Purity: 98% | 2-(4-BOC-piperazin-1-yl)-3-bromopyridine | ESD-909047-5G |
Cas.: 131231-24-8 | Purity: 95% | 3-(Pyridin-3-yl)benzaldehyde | ESD-909048-1G |
Cas.: 131231-24-8 | Purity: 95% | 3-(Pyridin-3-yl)benzaldehyde | ESD-909048-5G |
Cas.: 133362-99-9 | Purity: ≥95% | 2-Pyridin-4-ylbenzoic acid | ESD-909049-250MG |
Cas.: 133362-99-9 | Purity: ≥95% | 2-Pyridin-4-ylbenzoic acid | ESD-909049-1G |
Cas.: 197516-48-6 | Purity: ≥95% | 5-Hydrazinyl-2-methylpyridine | ESD-909050-250MG |
Cas.: 197516-48-6 | Purity: ≥95% | 5-Hydrazinyl-2-methylpyridine | ESD-909050-1G |
Cas.: 203321-83-9 | Purity: 96% | (6-Hydroxymethyl-pyridin-2-yl)-carbamic acid tert-butyl ester | ESD-909051-250MG |
Cas.: 203321-83-9 | Purity: 96% | (6-Hydroxymethyl-pyridin-2-yl)-carbamic acid tert-butyl ester | ESD-909051-1G |
Cas.: 217189-04-3 | Purity: 97% | (4-(Pyridin-3-yl)phenyl)methanol | ESD-909052-250MG |
Cas.: 217189-04-3 | Purity: 97% | (4-(Pyridin-3-yl)phenyl)methanol | ESD-909052-1G |
Cas.: 217192-22-8 | Purity: 95% | (4-(Pyridin-4-yl)phenyl)methanol | ESD-909053-250MG |
Cas.: 217192-22-8 | Purity: 95% | (4-(Pyridin-4-yl)phenyl)methanol | ESD-909053-1G |
Cas.: 330682-30-9 | Purity: 95% | 4-(6-Chloropyridin-2-yl)morpholine | ESD-909054-250MG |
Cas.: 330682-30-9 | Purity: 95% | 4-(6-Chloropyridin-2-yl)morpholine | ESD-909054-1G |
Cas.: 3718-67-0 | Purity: 97% | 3,5-Dimethylpyridin-2(1H)-one | ESD-909055-250MG |
Cas.: 3718-67-0 | Purity: 97% | 3,5-Dimethylpyridin-2(1H)-one | ESD-909055-1G |
Cas.: 38749-92-7 | Purity: 99% | 2-Bromo-3,6-dimethylpyridine | ESD-909056-25MG |
Cas.: 38749-92-7 | Purity: 99% | 2-Bromo-3,6-dimethylpyridine | ESD-909056-100MG |
Cas.: 4423-09-0 | Purity: 98% | 3-(4-Methylphenyl)pyridine | ESD-909057-250MG |
Cas.: 4423-09-0 | Purity: 98% | 3-(4-Methylphenyl)pyridine | ESD-909057-1G |
Cas.: 51061-67-7 | Purity: 96% | 2-(4-(Pyridin-2-yl)phenyl)acetic acid | ESD-909058-50MG |
Cas.: 51061-67-7 | Purity: 96% | 2-(4-(Pyridin-2-yl)phenyl)acetic acid | ESD-909058-250MG |
Cas.: 52311-42-9 | Purity: 98% | 4,4′-Bipyridin-2-amine | ESD-909059-250MG |
Cas.: 52311-42-9 | Purity: 98% | 4,4′-Bipyridin-2-amine | ESD-909059-1G |
Cas.: 53428-02-7 | Purity: 99% | 3,6-Dimethylpyridin-2(1H)-one | ESD-909060-250MG |
Cas.: 53428-02-7 | Purity: 99% | 3,6-Dimethylpyridin-2(1H)-one | ESD-909060-1G |
Cas.: 54231-38-8 | Purity: 97% | 4-(3-Bromopyridin-2-yl)morpholine | ESD-909061-1G |
Cas.: 54231-38-8 | Purity: 97% | 4-(3-Bromopyridin-2-yl)morpholine | ESD-909061-5G |
Cas.: 55397-08-5 | Purity: 98% | 2-(4-(Pyridin-4-yl)phenyl)acetic acid | ESD-909062-250MG |
Cas.: 55397-08-5 | Purity: 98% | 2-(4-(Pyridin-4-yl)phenyl)acetic acid | ESD-909062-1G |
Cas.: 68223-13-2 | Purity: ≥95% | 4-(Pyridin-3-yl)phenol | ESD-909063-250MG |
Cas.: 68223-13-2 | Purity: ≥95% | 4-(Pyridin-3-yl)phenol | ESD-909063-1G |
Cas.: 80635-91-2 | Purity: 98% | 4-Methyl-2-(m-tolyl)pyridine | ESD-909064-1G |
Cas.: 80635-91-2 | Purity: 98% | 4-Methyl-2-(m-tolyl)pyridine | ESD-909064-5G |
Cas.: 834884-77-4 | Purity: 95% | 6-(4-Fluorophenyl)-2-pyridinecarboxaldehyde | ESD-909065-250MG |
Cas.: 834884-77-4 | Purity: 95% | 6-(4-Fluorophenyl)-2-pyridinecarboxaldehyde | ESD-909065-1G |
Cas.: 87394-56-7 | Purity: 98% | 1-(3-Bromopyridin-2-yl)piperazine | ESD-909066-1G |
Cas.: 87394-56-7 | Purity: 98% | 1-(3-Bromopyridin-2-yl)piperazine | ESD-909066-5G |
Cas.: 87394-59-0 | Purity: 97% | 1-(3-Bromopyridin-2-yl)-4-methylpiperazine | ESD-909067-1G |
Cas.: 87394-59-0 | Purity: 97% | 1-(3-Bromopyridin-2-yl)-4-methylpiperazine | ESD-909067-5G |
Cas.: 887344-42-5 | Purity: 95% | 2-(Pyridin-3-yloxy)benzaldehyde | ESD-909068-250MG |
Cas.: 887344-42-5 | Purity: 95% | 2-(Pyridin-3-yloxy)benzaldehyde | ESD-909068-1G |
Cas.: 90151-10-3 | Purity: 98% | 4-Methoxypicolinamide | ESD-909069-1G |
Cas.: 90151-10-3 | Purity: 98% | 4-Methoxypicolinamide | ESD-909069-5G |
Cas.: 98061-39-3 | Purity: ≥95% | 2-(4-Hydroxymethylphenyl)pyridine | ESD-909070-250MG |
Cas.: 98061-39-3 | Purity: ≥95% | 2-(4-Hydroxymethylphenyl)pyridine | ESD-909070-1G |
Cas.: 1364663-38-6 | Purity: 96% | tert-Butyl 5-cyano-1H-pyrrolo[3,2-b]pyridine-1-carboxylate | ESD-909071-50MG |
Cas.: 1364663-38-6 | Purity: 96% | tert-Butyl 5-cyano-1H-pyrrolo[3,2-b]pyridine-1-carboxylate | ESD-909071-250MG |
Cas.: 27992-31-0 | Purity: 96% | 5,6-Dimethylpyridin-2(1H)-one | ESD-909072-50MG |
Cas.: 27992-31-0 | Purity: 96% | 5,6-Dimethylpyridin-2(1H)-one | ESD-909072-250MG |
Cas.: 351410-38-3 | Purity: 97% | 2-(2-Methoxypyridin-3-yl)acetic acid | ESD-909073-50MG |
Cas.: 351410-38-3 | Purity: 97% | 2-(2-Methoxypyridin-3-yl)acetic acid | ESD-909073-250MG |
Cas.: 61102-76-9 | Purity: 96% | 4-(2,6-Diphenylpyridin-4-yl)aniline | ESD-909074-250MG |
Cas.: 61102-76-9 | Purity: 96% | 4-(2,6-Diphenylpyridin-4-yl)aniline | ESD-909074-1G |
Cas.: 754129-80-1 | Purity: 96% | 5-(Aminomethyl)pyridin-3-amine | ESD-909075-50MG |
Cas.: 754129-80-1 | Purity: 96% | 5-(Aminomethyl)pyridin-3-amine | ESD-909075-250MG |
Cas.: 757174-04-2 | Purity: 96% | 3-Fluoropicolinimidamide | ESD-909076-50MG |
Cas.: 757174-04-2 | Purity: 96% | 3-Fluoropicolinimidamide | ESD-909076-250MG |
Cas.: 134272-63-2 | Purity: 97% | N-BOC-2-MaleMidoethylaMine | ESD-909077-250MG |
Cas.: 134272-63-2 | Purity: 97% | N-BOC-2-MaleMidoethylaMine | ESD-909077-1G |
Cas.: 13654-62-1 | Purity: 95% | 2-(Ethanesulfonyl)acetonitrile | ESD-909078-250MG |
Cas.: 13654-62-1 | Purity: 95% | 2-(Ethanesulfonyl)acetonitrile | ESD-909078-1G |
Cas.: 2089311-47-5 | Purity: 97% | 3-Bromo-4-chloro-5-methoxy-N-methylbenzamide | ESD-909079-250MG |
Cas.: 2089311-47-5 | Purity: 97% | 3-Bromo-4-chloro-5-methoxy-N-methylbenzamide | ESD-909079-1G |
Cas.: 273735-64-1 | Purity: 98% | 2,6-Dichloro-4-(perfluoropropan-2-yl)aniline | ESD-909080-50MG |
Cas.: 273735-64-1 | Purity: 98% | 2,6-Dichloro-4-(perfluoropropan-2-yl)aniline | ESD-909080-250MG |
Cas.: 3771-14-0 | Purity: 95% | 4-Hydroxynaphthalene-2-sulfonic acid | ESD-909081-1G |
Cas.: 3771-14-0 | Purity: 95% | 4-Hydroxynaphthalene-2-sulfonic acid | ESD-909081-5G |
Cas.: 42590-00-1 | Purity: 97% | Methyl 4-hydroxy-3-methoxy-5-nitrobenzoate | ESD-909082-1G |
Cas.: 42590-00-1 | Purity: 97% | Methyl 4-hydroxy-3-methoxy-5-nitrobenzoate | ESD-909082-5G |
Cas.: 516-09-6 | Purity: 97% | 4-Hydroxy-3-methylfuran-2(5H)-one | ESD-909083-1G |
Cas.: 516-09-6 | Purity: 97% | 4-Hydroxy-3-methylfuran-2(5H)-one | ESD-909083-5G |
Cas.: 1000545-64-1 | Purity: ≥97% | 2-(Isoquinolin-6-yl)acetic acid | ESD-909084-50MG |
Cas.: 1000545-64-1 | Purity: ≥97% | 2-(Isoquinolin-6-yl)acetic acid | ESD-909084-250MG |
Cas.: 100511-78-2 | Purity: ≥97% | Methyl 3-[4-(Aminomethyl)phenyl]propanoate | ESD-909085-50MG |
Cas.: 100511-78-2 | Purity: ≥97% | Methyl 3-[4-(Aminomethyl)phenyl]propanoate | ESD-909085-250MG |
Cas.: 1005631-56-0 | Purity: ≥97% | 1-(2,2-Diethoxyethyl)-4-methyl-1H-pyrazole | ESD-909086-250MG |
Cas.: 1005631-56-0 | Purity: ≥97% | 1-(2,2-Diethoxyethyl)-4-methyl-1H-pyrazole | ESD-909086-1G |
Cas.: 1009075-40-4 | Purity: ≥97% | (R)-tert-Butyl 2-((ethylamino)methyl)pyrrolidine-1-carboxylate | ESD-909087-250MG |
Cas.: 1009075-40-4 | Purity: ≥97% | (R)-tert-Butyl 2-((ethylamino)methyl)pyrrolidine-1-carboxylate | ESD-909087-1G |
Cas.: 10132-01-1 | Purity: ≥97% | 1-Chloro-4-phenylphthalazine | ESD-909088-250MG |
Cas.: 10132-01-1 | Purity: ≥97% | 1-Chloro-4-phenylphthalazine | ESD-909088-1G |
Cas.: 1211595-04-8 | Purity: ≥97% | Ethyl 2-(2-(methylthio)pyrimidin-4-yl)-2-oxoacetate | ESD-909089-50MG |
Cas.: 1211595-04-8 | Purity: ≥97% | Ethyl 2-(2-(methylthio)pyrimidin-4-yl)-2-oxoacetate | ESD-909089-250MG |
Cas.: 1369509-72-7 | Purity: ≥97% | 5-Bromo-3-iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-c]pyridine | ESD-909090-50MG |
Cas.: 1369509-72-7 | Purity: ≥97% | 5-Bromo-3-iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-c]pyridine | ESD-909090-250MG |
Cas.: 138872-44-3 | Purity: ≥97% | 5-(Benzamidomethyl)thiophene-2-sulfonyl chloride | ESD-909091-250MG |
Cas.: 138872-44-3 | Purity: ≥97% | 5-(Benzamidomethyl)thiophene-2-sulfonyl chloride | ESD-909091-1G |
Cas.: 189321-67-3 | Purity: ≥97% | 3H-Spiro[isobenzofuran-1,3′-piperidin]-3-one | ESD-909092-50MG |
Cas.: 189321-67-3 | Purity: ≥97% | 3H-Spiro[isobenzofuran-1,3′-piperidin]-3-one | ESD-909092-250MG |
Cas.: 41536-44-1 | Purity: ≥97% | 2-(4-Morpholino)phenol | ESD-909093-250MG |
Cas.: 41536-44-1 | Purity: ≥97% | 2-(4-Morpholino)phenol | ESD-909093-1G |
Cas.: 62538-21-0 | Purity: ≥97% | 2-(4-Chlorophenyl)-2-cyanoacetaldehyde | ESD-909094-250MG |
Cas.: 62538-21-0 | Purity: ≥97% | 2-(4-Chlorophenyl)-2-cyanoacetaldehyde | ESD-909094-1G |
Cas.: 675590-10-0 | Purity: ≥97% | 3-Bromo-5-(3-methoxyphenyl)pyridine | ESD-909095-250MG |
Cas.: 675590-10-0 | Purity: ≥97% | 3-Bromo-5-(3-methoxyphenyl)pyridine | ESD-909095-1G |
Cas.: 675590-26-8 | Purity: ≥97% | 3-Bromo-5-(3-chlorophenyl)pyridine | ESD-909096-250MG |
Cas.: 675590-26-8 | Purity: ≥97% | 3-Bromo-5-(3-chlorophenyl)pyridine | ESD-909096-1G |
Cas.: 71932-18-8 | Purity: ≥97% | 3,4,5-Triacetoxybenzaldehyde | ESD-909097-50MG |
Cas.: 71932-18-8 | Purity: ≥97% | 3,4,5-Triacetoxybenzaldehyde | ESD-909097-250MG |
Cas.: 80278-25-7 | Purity: ≥97% | 2-(Isoquinolin-5-yloxy)acetic acid | ESD-909098-250MG |
Cas.: 80278-25-7 | Purity: ≥97% | 2-(Isoquinolin-5-yloxy)acetic acid | ESD-909098-1G |
Cas.: 87394-64-7 | Purity: ≥97% | 2-(1-Piperazinyl)nicotinamide | ESD-909099-50MG |
Cas.: 87394-64-7 | Purity: ≥97% | 2-(1-Piperazinyl)nicotinamide | ESD-909099-250MG |
Cas.: 889943-79-7 | Purity: ≥97% | N-Hydroxy-5-methoxy-1H-indole-3-carboximidamide | ESD-909100-50MG |
Cas.: 889943-79-7 | Purity: ≥97% | N-Hydroxy-5-methoxy-1H-indole-3-carboximidamide | ESD-909100-250MG |
Cas.: 890652-02-5 | Purity: ≥97% | 5-Methyl-1-propyl-1H-pyrazole-4-carbaldehyde | ESD-909101-50MG |
Cas.: 890652-02-5 | Purity: ≥97% | 5-Methyl-1-propyl-1H-pyrazole-4-carbaldehyde | ESD-909101-250MG |
Cas.: 892492-27-2 | Purity: ≥97% | tert-Butyl 1-(5-aminopyridin-2-yl)piperidine-4-carboxylate | ESD-909102-250MG |
Cas.: 892492-27-2 | Purity: ≥97% | tert-Butyl 1-(5-aminopyridin-2-yl)piperidine-4-carboxylate | ESD-909102-1G |
Cas.: 128639-02-1 | Purity: 99% | Carfentrazone-ethyl | ESD-909103-10MG |
Cas.: 128639-02-1 | Purity: 99% | Carfentrazone-ethyl | ESD-909103-50MG |
Cas.: 206986-79-0 | Purity: 98% | Chlorhexidine diacetate salt hydrate | ESD-909105-5G |
Cas.: 206986-79-0 | Purity: 98% | Chlorhexidine diacetate salt hydrate | ESD-909105-25G |
Cas.: 228321-87-7 | Purity: 99% | Miconazole nitrate | ESD-909106-100G |
Cas.: 228321-87-7 | Purity: 99% | Miconazole nitrate | ESD-909106-500G |
Cas.: 1219813-78-1 | Purity: 95% | tert-Butyl 3-(2-bromoacetyl)piperidine-1-carboxylate | ESD-909107-1G |
Cas.: 1219813-78-1 | Purity: 95% | tert-Butyl 3-(2-bromoacetyl)piperidine-1-carboxylate | ESD-909107-5G |
Cas.: 83732-72-3 | Purity: 98%, dark blue-purple crystal powder | 6-Methoxy-N2-methylpyridine-2,3-diamine Dihydrochloride | ESD-909108-1G |
Cas.: 83732-72-3 | Purity: 98%, dark blue-purple crystal powder | 6-Methoxy-N2-methylpyridine-2,3-diamine Dihydrochloride | ESD-909108-5G |
Cas.: 2479-62-1 | Purity: 98% | N-(2-Amino-2-oxoethyl)acrylamide | ESD-909109-1G |
Cas.: 2479-62-1 | Purity: 98% | N-(2-Amino-2-oxoethyl)acrylamide | ESD-909109-5G |
Cas.: 1137-99-1 | Purity: 98% | 4-((2-Hydroxyethoxy)carbonyl)benzoic acid | ESD-909110-100MG |
Cas.: 1137-99-1 | Purity: 98% | 4-((2-Hydroxyethoxy)carbonyl)benzoic acid | ESD-909110-250MG |
Cas.: 899430-07-0 | Purity: Analysis control, ≥98% | Gymnoside VII | ESD-909111-1MG |
Cas.: 1156-51-0 | Purity: 95% | 2,2-Bis-(4-cyanatophenyl)propane | ESD-831390-500G |
Cas.: 808758-81-8 | Purity: 96% | 4-(Bis(4-iodophenyl)amino)benzaldehyde | ESD-843836-1G |
Cas.: 26468-86-0 | Purity: PEH-6 | Polyethyleneglycol2-ethylhexylether | ESD-888317-2.5KG |
Cas.: 24937-79-9 | Purity: average Mw ~400, 000, pellets | Poly(vinylidene fluoride) | ESD-875314-2.5KG |
Cas.: 185137-29-5 | Purity: ≥95%, ≥99%ee | (S)-4-Phenylthiazolidine-2-thione | ESD-853935-250MG |
Cas.: 538-42-1 | Purity: 99% | Sodium cinnamate | ESD-890197-2.5KG |
Cas.: 9013-95-0 | Purity: from Erwinia herbicola | Levan | ESD-909112-250MG |
Cas.: 9013-95-0 | Purity: from Erwinia herbicola | Levan | ESD-909112-100MG |
Cas.: 91944-64-8 | Purity: 95% | N,N-Dimethylpyridin-4-amine 4-methylbenzenesulfonate | ESD-847230-5G |
Cas.: 91944-64-8 | Purity: 95% | N,N-Dimethylpyridin-4-amine 4-methylbenzenesulfonate | ESD-847230-25G |
Cas.: 9012-76-4 | Mw: 800-1000 | Chitosan oligosaccharide | ESD-909113-100G |
Cas.: 9012-76-4 | Mw: 800-1000 | Chitosan oligosaccharide | ESD-909113-500G |
Cas.: 9012-76-4 | Mw: 800-1000 | Chitosan oligosaccharide | ESD-909113-50G |
Cas.: 9012-76-4 | Mw: 800-1000 | Chitosan oligosaccharide | ESD-909113-10G |
Cas.: 1360614-48-7 | Purity: 99% | Necrosulfonamide | ESD-872613-25MG |
Cas.: 12217-48-0 | Purity: AR | Astrazon Brilliant Red 4G | ESD-871542-25G |
Cas.: 12217-48-0 | Purity: AR | Astrazon Brilliant Red 4G | ESD-871542-100G |
Cas.: 68648-82-8 | Purity: Injection grade | Chlorinated polyvinyl chloride (CPVC) | ESD-909114-100G |
Cas.: 68648-82-8 | Purity: Injection grade | Chlorinated polyvinyl chloride (CPVC) | ESD-909114-500G |
Cas.: 7778-80-5 | Purity: AR, 99% | Potassium sulfate | ESD-816432-10KG |
Cas.: 2453-03-4 | Purity: ≥98% | 1,3-Dioxan-2-One | ESD-859393-5G |
Cas.: 475-80-9 | Purity: Analysis control, >98% | Aristolochic acid B | ESD-889701-10MG |
Cas.: 1186-10-3 | Purity: ≥95.0%(GC) | Diethyl (3-Bromopropyl)phosphonate | ESD-854734-5G |
Cas.: 1186-10-3 | Purity: ≥95.0%(GC) | Diethyl (3-Bromopropyl)phosphonate | ESD-854734-25G |
Cas.: 5285-60-9 | Purity: 96% | 4,4′-methylenebis[N-sec-butylaniline] | ESD-909116-100ML |
Cas.: 5285-60-9 | Purity: 96% | 4,4′-methylenebis[N-sec-butylaniline] | ESD-909116-500ML |
Cas.: NONE7929 | Purity: 95% | 2-(6,6-difluorobicyclo[3.1.0]hexan-1-yl)acetonitrile | ESD-909117-250MG |
Cas.: NONE7929 | Purity: 95% | 2-(6,6-difluorobicyclo[3.1.0]hexan-1-yl)acetonitrile | ESD-909117-1G |
Cas.: NONE7930 | Purity: 95% | ethyl 7,7-difluoro-6-methylbicyclo[4.1.0]heptane-3-carboxylate | ESD-909118-100MG |
Cas.: NONE7930 | Purity: 95% | ethyl 7,7-difluoro-6-methylbicyclo[4.1.0]heptane-3-carboxylate | ESD-909118-250MG |
Cas.: 13897-55-7 | Purity: 99% | Methylcyclohexanediamine | ESD-909119-500ML |
Cas.: 13897-55-7 | Purity: 99% | Methylcyclohexanediamine | ESD-909119-100ML |
Cas.: NONE7931 | Purity: 95% | 7,7-difluoro-6-methylbicyclo[4.1.0]heptane-3-carboxylic acid | ESD-909120-250MG |
Cas.: XBPY | Purity: 1M, pH8.5 | HEPES Buffer | ESD-885803-1L |
Cas.: 725255-70-9 | Purity: 95% | tert-butyl (4-methylenecyclohexyl)carbamate | ESD-909121-1G |
Cas.: 725255-70-9 | Purity: 95% | tert-butyl (4-methylenecyclohexyl)carbamate | ESD-909121-250MG |
Cas.: NONE6798 | Purity: 1X | TE-LiAc Solution | ESD-885350-25ML |
Cas.: 19900-65-3 | Purity: 95% | 4,4′-Methylenebis(2-ethylbenzenamine) | ESD-909123-500ML |
Cas.: 19900-65-3 | Purity: 95% | 4,4′-Methylenebis(2-ethylbenzenamine) | ESD-909123-100ML |
Cas.: NONE7932 | Purity: 95% | tert-butyl (7,7-difluoro-6-methylbicyclo[4.1.0]heptan-3-yl)carbamate | ESD-909122-250MG |
Cas.: 350820-01-8 | Purity: AR | 4-AMinobenzoic-d4 Acid | ESD-874538-1G |
Cas.: NONE7933 | Purity: 90% | tert-butyl (2,2-difluoro-1-(p-tolyl)cyclopropyl)carbamate | ESD-909125-25MG |
Cas.: NONE7934 | Purity: 95% | tert-butyl 1,1-difluoro-5-azaspiro[2.3]hexane-5-carboxylate | ESD-909126-250MG |
Cas.: 42523-29-5 | Purity: 98% | 2,7-Dihydroxy-9-fluorenone | ESD-836515-100G |
Cas.: 938-94-3 | Purity: 99% | 2-(p-Tolyl)propionic acid | ESD-909127-1G |
Cas.: NONE7935 | Purity: 95% | ethyl 2-(2,6-dimethoxyphenyl)propanoate | ESD-909128-100MG |
Cas.: NONE7935 | Purity: 95% | ethyl 2-(2,6-dimethoxyphenyl)propanoate | ESD-909128-250MG |
Cas.: NONE7936 | Purity: 95% | ethyl 2,2-difluoro-1-(o-tolyl)cyclopropane-1-carboxylate | ESD-909129-100MG |
Cas.: 73225-15-7 | Purity: 98% | 2-Methyl-1-(4-nitrophenyl)-1H-imidazole | ESD-842950-5G |
Cas.: 62835-95-4 | Purity: 95% | 2-(2-methylphenyl)propanoic acid | ESD-909130-1G |
Cas.: 62835-95-4 | Purity: 95% | 2-(2-methylphenyl)propanoic acid | ESD-909130-100MG |
Cas.: 61925-77-7 | Purity: ≥98% | Boc-S-(4-Methylbenzyl)-L-Cysteine | ESD-858009-5G |
Cas.: 7148-07-4 | Purity: ≥97% | 1-Pyrrolidino-1-cyclopentene | ESD-865144-25G |
Cas.: 1598806-79-1 | Purity: 95% | 2-(2,6-dimethoxyphenyl)propanoic acid | ESD-909131-100MG |
Cas.: 1598806-79-1 | Purity: 95% | 2-(2,6-dimethoxyphenyl)propanoic acid | ESD-909131-250MG |
Cas.: 1707737-35-6 | Purity: 95% | 2,2-difluoro-1-(4-methylphenyl)cyclopropane-1-carboxylic acid | ESD-909132-1G |
Cas.: 1707737-35-6 | Purity: 95% | 2,2-difluoro-1-(4-methylphenyl)cyclopropane-1-carboxylic acid | ESD-909132-100MG |
Cas.: NONE7937 | Purity: 95% | ethyl 2-(3-isopropoxyphenyl)acrylate | ESD-909133-1G |
Cas.: NONE7937 | Purity: 95% | ethyl 2-(3-isopropoxyphenyl)acrylate | ESD-909133-10G |
Cas.: NONE7938 | Purity: 95% | ethyl 2-(3-isopropoxyphenyl)propanoate | ESD-909134-100MG |
Cas.: 1774902-99-6 | Purity: 95% | 2,2-difluoro-1-(o-tolyl)cyclopropane-1-carboxylic acid | ESD-909135-1G |
Cas.: 1774902-99-6 | Purity: 95% | 2,2-difluoro-1-(o-tolyl)cyclopropane-1-carboxylic acid | ESD-909135-100MG |
Cas.: NONE7939 | Purity: 90% | (2,2-difluoro-1-(o-tolyl)cyclopropyl)methanol | ESD-909136-1G |
Cas.: NONE7939 | Purity: 90% | (2,2-difluoro-1-(o-tolyl)cyclopropyl)methanol | ESD-909136-100MG |
Cas.: NONE7940 | Purity: 95% | 2-(3-isopropoxyphenyl)propanoic acid | ESD-909137-250MG |
Cas.: NONE7940 | Purity: 95% | 2-(3-isopropoxyphenyl)propanoic acid | ESD-909137-100MG |
Cas.: 1087723-47-4 | Purity: 90% | 2-(2-bromophenyl)propan-2-amine hydrochloride | ESD-909138-100MG |
Cas.: 1087723-47-4 | Purity: 90% | 2-(2-bromophenyl)propan-2-amine hydrochloride | ESD-909138-1G |
Cas.: 1087723-47-4 | Purity: 90% | 2-(2-bromophenyl)propan-2-amine hydrochloride | ESD-909138-250MG |
Cas.: 1305-78-8 | Purity: CP, powder | Calcium oxide | ESD-804126-10KG |
Cas.: NONE7941 | Purity: 95% | 2-(2-fluoro-5-methoxyphenyl)propan-2-amine hydrochloride | ESD-909139-1G |
Cas.: NONE7941 | Purity: 95% | 2-(2-fluoro-5-methoxyphenyl)propan-2-amine hydrochloride | ESD-909139-250MG |
Cas.: 915192-32-4 | Purity: 95% | ethyl 2-(2,6-dimethoxyphenyl)acrylate | ESD-909140-1G |
Cas.: 915192-32-4 | Purity: 95% | ethyl 2-(2,6-dimethoxyphenyl)acrylate | ESD-909140-5G |
Cas.: 1314666-26-6 | Purity: 95% | 2-(2-chloro-5-(trifluoromethyl)phenyl)propan-2-amine hydrochloride | ESD-909141-1G |
Cas.: 1314666-26-6 | Purity: 95% | 2-(2-chloro-5-(trifluoromethyl)phenyl)propan-2-amine hydrochloride | ESD-909141-250MG |
Cas.: 1314-98-3 | Purity: AR | Zinc sulfide | ESD-886312-2.5KG |
Cas.: 2386-57-4 | Purity: 99% | Sodium methanesulfonate | ESD-823837-2.5KG |
Cas.: 69816-37-1 | Purity: ≥98% | 2-Aminoacetamidine Dihydrobromide | ESD-859094-5G |
Cas.: 1314735-95-9 | Purity: 95% | 2-(4-chloro-2-methylphenyl)propan-2-amine hydrochloride | ESD-909142-1G |
Cas.: 1314735-95-9 | Purity: 95% | 2-(4-chloro-2-methylphenyl)propan-2-amine hydrochloride | ESD-909142-250MG |
Cas.: 1704075-90-0 | Purity: 95% | 2-(4-bromo-3-(trifluoromethyl)phenyl)propan-2-amine hydrochloride | ESD-909143-50MG |
Cas.: 1704075-90-0 | Purity: 95% | 2-(4-bromo-3-(trifluoromethyl)phenyl)propan-2-amine hydrochloride | ESD-909143-250MG |
Cas.: 1178479-16-7 | Purity: 95% | 2-(3-methoxy-4-methylphenyl)propan-2-amine hydrochloride | ESD-909144-250MG |
Cas.: 1178479-16-7 | Purity: 95% | 2-(3-methoxy-4-methylphenyl)propan-2-amine hydrochloride | ESD-909144-100MG |
Cas.: 1314785-60-8 | Purity: 95% | 2-(4-chloro-3-(trifluoromethyl)phenyl)propan-2-amine hydrochloride | ESD-909145-250MG |
Cas.: 1314785-60-8 | Purity: 95% | 2-(4-chloro-3-(trifluoromethyl)phenyl)propan-2-amine hydrochloride | ESD-909145-1G |
Cas.: NONE7942 | Purity: 90% | ethyl 2-(4-(trifluoromethoxy)phenyl)propanoate | ESD-909146-1G |
Cas.: NONE7942 | Purity: 90% | ethyl 2-(4-(trifluoromethoxy)phenyl)propanoate | ESD-909146-250MG |
Cas.: NONE7942 | Purity: 90% | ethyl 2-(4-(trifluoromethoxy)phenyl)propanoate | ESD-909146-100MG |
Cas.: 902837-63-2 | Purity: 95% | 2-(4-(trifluoromethoxy)phenyl)propanoic acid | ESD-909147-1G |
Cas.: 902837-63-2 | Purity: 95% | 2-(4-(trifluoromethoxy)phenyl)propanoic acid | ESD-909147-250MG |
Cas.: 902837-63-2 | Purity: 95% | 2-(4-(trifluoromethoxy)phenyl)propanoic acid | ESD-909147-10G |
Cas.: 2106-10-7 | Purity: ≥98% | α-D-Glucopyranosyl Fluoride | ESD-886518-5G |
Cas.: NONE7943 | Purity: 90% | ethyl 2,2-difluoro-1-(4-(trifluoromethoxy)phenyl)cyclopropane-1-carboxylate | ESD-909148-1G |
Cas.: NONE7943 | Purity: 90% | ethyl 2,2-difluoro-1-(4-(trifluoromethoxy)phenyl)cyclopropane-1-carboxylate | ESD-909148-250MG |
Cas.: NONE7944 | Purity: 95% | tert-butyl (1,1-difluorospiro[2.5]octan-6-yl)carbamate | ESD-909149-250MG |
Cas.: NONE7944 | Purity: 95% | tert-butyl (1,1-difluorospiro[2.5]octan-6-yl)carbamate | ESD-909149-1G |
Cas.: NONE6705 | Purity: BR | Beef extract desicxant | ESD-874856-2.5KG |
Cas.: NONE7945 | Purity: 95% | tert-butyl 1,1-difluoro-5-azaspiro[2.4]heptane-5-carboxylate | ESD-909150-1G |
Cas.: NONE7945 | Purity: 95% | tert-butyl 1,1-difluoro-5-azaspiro[2.4]heptane-5-carboxylate | ESD-909150-250MG |
Cas.: 1630906-91-0 | Purity: 95% | 1,1-difluoro-5-azaspiro[2.3]hexane hydrochloride | ESD-909151-1G |
Cas.: 1630906-91-0 | Purity: 95% | 1,1-difluoro-5-azaspiro[2.3]hexane hydrochloride | ESD-909151-100MG |
Cas.: 1215071-12-7 | Purity: 95% | 1,1-difluoro-5-azaspiro[2.4]heptane hydrochloride | ESD-909152-1G |
Cas.: 1215071-12-7 | Purity: 95% | 1,1-difluoro-5-azaspiro[2.4]heptane hydrochloride | ESD-909152-250MG |
Cas.: 1093751-02-0 | Purity: 95% | 6,6-difluorobicyclo[3.1.0]hexane-3-carboxylic acid | ESD-909153-1G |
Cas.: 1093751-02-0 | Purity: 95% | 6,6-difluorobicyclo[3.1.0]hexane-3-carboxylic acid | ESD-909153-100MG |
Cas.: 1093751-02-0 | Purity: 95% | 6,6-difluorobicyclo[3.1.0]hexane-3-carboxylic acid | ESD-909153-250MG |
Cas.: NONE7946 | Purity: 95% | 2-(7,7-difluorobicyclo[4.1.0]heptan-1-yl)acetonitrile | ESD-909154-1G |
Cas.: NONE7946 | Purity: 95% | 2-(7,7-difluorobicyclo[4.1.0]heptan-1-yl)acetonitrile | ESD-909154-250MG |
Cas.: NONE7946 | Purity: 95% | 2-(7,7-difluorobicyclo[4.1.0]heptan-1-yl)acetonitrile | ESD-909154-100MG |
Cas.: NONE7947 | Purity: 95% | tert-butyl (6,6-difluorobicyclo[3.1.0]hexan-3-yl)carbamate | ESD-909155-1G |
Cas.: NONE7947 | Purity: 95% | tert-butyl (6,6-difluorobicyclo[3.1.0]hexan-3-yl)carbamate | ESD-909155-250MG |
Cas.: 107761-42-2 | Purity: Homo Aβ42 95% | Amyloid β Protein Fragment 1-42 | ESD-834110-100MG |
Cas.: 588-30-7 | Purity: ≥98% | 3-(3-Hydroxyphenyl)acrylic Acid | ESD-873577-25MG |
Cas.: NONE6137 | Schiff | ESD-829847-1L | |
Cas.: 15383-49-0 | Purity: 98% | 1,2,4,5-Cyclohexanetetracarboxylic Acid | ESD-870800-25G |
Cas.: 15383-49-0 | Purity: 98% | 1,2,4,5-Cyclohexanetetracarboxylic Acid | ESD-870800-100G |
Cas.: 3695-73-6 | Purity: ≥99% | Glycyl-L-alanine | ESD-835060-5G |
Cas.: 208-96-8 | Purity: 99% | Acenaphthylene | ESD-823021-100G |
Cas.: 69980-24-1 | Purity: BR | nicotine-methyl-D3 | ESD-874754-25MG |
Cas.: 9041-11-6 | Purity: 2000 U/mL | Levan hydrolase | ESD-885069-5ML |
Cas.: 12060-08-1 | Purity: 99.9% metals basis | Scandium(Ⅲ)oxide | ESD-818448-100G |
Cas.: 174500-20-0 | Purity: 98% | 2,6-Bis[|4S|-4-phenyl-2-oxazolinyl]pyridine | ESD-803100-5G |
Cas.: 76-49-3 | Purity: ≥97% | Bornyl acetate | ESD-824186-1G |
Cas.: 76-49-3 | Purity: ≥97% | Bornyl acetate | ESD-824186-5G |
Cas.: 76-49-3 | Purity: 99,5% | Bornyl acetate | ESD-909157-1G |
Cas.: 76-49-3 | Purity: 99,5% | Bornyl acetate | ESD-909157-250MG |
Cas.: 76-49-3 | Purity: 99,5% | Bornyl acetate | ESD-909157-5G |
Cas.: 952-06-7 | Purity: ≥98% | 1,2-Diphenyl-1-ethanone oxime | ESD-909158-250MG |
Cas.: 952-06-7 | Purity: ≥98% | 1,2-Diphenyl-1-ethanone oxime | ESD-909158-1G |
Cas.: 952-06-7 | Purity: ≥98% | 1,2-Diphenyl-1-ethanone oxime | ESD-909158-5G |
Cas.: 952-06-7 | Purity: ≥98% | 1,2-Diphenyl-1-ethanone oxime | ESD-909158-25G |
Cas.: 7440-21-3 | Purity: 99.9% metals basis, 1μm | Silicon Standard | ESD-909159-100G |
Cas.: 7440-21-3 | Purity: 99.9% metals basis, 1μm | Silicon Standard | ESD-909159-25G |
Cas.: 346-06-5 | Purity: 98% | 2-(TRIFLUOROMETHYL)BENZYL ALCOHOL | ESD-834285-500G |
Cas.: 401915-53-5 | Purity: >95% | Nalpha-Fmoc-Nomega-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzo[b]furan-5-ylsulfonyl)-L-beta-homoarginine | ESD-849739-250MG |
Cas.: 401915-53-5 | Purity: >95% | Nalpha-Fmoc-Nomega-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzo[b]furan-5-ylsulfonyl)-L-beta-homoarginine | ESD-849739-1G |
Cas.: 6858-44-2 | Purity: ≥99% | Sodium citrate tribasic hydrate | ESD-886024-10KG |
Cas.: 98-94-2 | Purity: 98% | |N|,|N|-Dimethylcyclohexylamine | ESD-806705-10L |
Cas.: 52089-65-3 | Purity: ≥98 atom % D | ADIPIC-DB ACID | ESD-874524-50MG |
Cas.: 36953-41-0 | Purity: 98% | 3-Bromo-4-hydroxypyridine | ESD-909160-1G |
Cas.: 36953-41-0 | Purity: 98% | 3-Bromo-4-hydroxypyridine | ESD-909160-5G |
Cas.: 36953-41-0 | Purity: 98% | 3-Bromo-4-hydroxypyridine | ESD-909160-10G |
Cas.: 10028-24-7 | Purity: AR | Sodium hydrogenphosphate dihydrate | ESD-821246-25KG |
Cas.: 22904-40-1 | Purity: 98% | Ethylenediaminetetraacetic Acid Lead(II) Disodium Salt Hydrate | ESD-870214-25G |
Cas.: 22904-40-1 | Purity: 98% | Ethylenediaminetetraacetic Acid Lead(II) Disodium Salt Hydrate | ESD-870214-100G |
Cas.: 13818-75-2 | Purity: No water, powder, 99.99% metals basis | Gadolinium(III) bromide | ESD-810660-5G |
Cas.: 303180-11-2 | Purity: 95% | 1H-Pyrazole-3,5-dicarboxylic acid hydrate | ESD-843907-100G |
Cas.: 2496-15-3 | Purity: ≥98%(HPLC)(T) | 4-Hydroxy-4′-dimethylaminoazobenzene | ESD-862135-5G |
Cas.: 87121-89-9 | Purity: 97% | Ethyl 3-oxocyclobutanecarboxylate | ESD-839227-5G |
Cas.: 87121-89-9 | Purity: 97% | Ethyl 3-oxocyclobutanecarboxylate | ESD-839227-25G |
Cas.: 87121-89-9 | Purity: 97% | Ethyl 3-oxocyclobutanecarboxylate | ESD-839227-100G |
Cas.: 1310-43-6 | Purity: 99% | IRON PHOSPHIDE | ESD-888940-100G |
Cas.: 108-05-4 | Purity: CP, 98% | Vinyl acetate | ESD-820406-2.5L |
Cas.: 546-56-5 | Purity: 98% | Octaphenylcyclotetrasiloxane | ESD-815343-500G |
Cas.: 16673-34-0 | Purity: 95% | 5-Chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide | ESD-863822-1G |
Cas.: 100486-97-3 | Purity: ≥95% | 2,2′,4-Tris(2-chlorophenyl)-5-(3,4-dimethoxyphenyl)-4′,5′-diphenyl-1,1′-biimidazole | ESD-909161-5G |
Cas.: 100486-97-3 | Purity: ≥95% | 2,2′,4-Tris(2-chlorophenyl)-5-(3,4-dimethoxyphenyl)-4′,5′-diphenyl-1,1′-biimidazole | ESD-909161-25G |
Cas.: 57774-35-3 | Purity: 98% | 4′-Bromo-4-cyanobiphenyl | ESD-887097-5G |
Cas.: 57774-35-3 | Purity: 98% | 4′-Bromo-4-cyanobiphenyl | ESD-887097-25G |
Cas.: 117-77-1 | Purity: ≥98% | 2-Amino-3-hydroxyanthraquinone | ESD-864849-100G |
Cas.: 180268-82-0 | Purity: 99% | L-Phenylalanine-13C6 | ESD-874340-2.5MG |
Cas.: 69214-33-1 | Purity: ≥95% | 8-chloroimidazo[1,2-a]pyrazine | ESD-825603-5G |
Cas.: 69214-33-1 | Purity: ≥95% | 8-chloroimidazo[1,2-a]pyrazine | ESD-825603-25G |
Cas.: 6795-87-5 | Purity: Analysis control | sec-Butyl Methyl Ether | ESD-909162-100MG |
Cas.: 90322-84-2 | Purity: 95% | 3-Cyano-7-methyl-1H-indazole | ESD-909163-1G |
Cas.: 90322-84-2 | Purity: 95% | 3-Cyano-7-methyl-1H-indazole | ESD-909163-250MG |
Cas.: 90322-84-2 | Purity: 95% | 3-Cyano-7-methyl-1H-indazole | ESD-909163-50MG |
Cas.: 2051-31-2 | Purity: 98% | 4-Decanol | ESD-869878-5ML |
Cas.: 2051-31-2 | Purity: 98% | 4-Decanol | ESD-869878-25ML |
Cas.: 1066-33-7 | Purity: AR | Ammonium bicarbonate | ESD-800860-10KG |
Cas.: 53801-63-1 | Purity: copper contains amount1-3% | Zinc-Copper couple | ESD-830921-100G |
Cas.: 53801-63-1 | Purity: copper contains amount1-3% | Zinc-Copper couple | ESD-830921-250G |
Cas.: 62006-39-7 | Purity: 98% | Senkyunolide A | ESD-873725-25MG |
Cas.: 2239-88-5 | Purity: Analysis control, ≥98% | 3,3′-Di-O-methylellagic acid | ESD-861384-5MG |
Cas.: 89889-51-0 | Purity: 98% | LC-LC-(+)-Biotin | ESD-855447-250MG |
Cas.: 11099-06-2 | Purity: Silica: 38.0%~42.0% | Ethyl silicate | ESD-887930-10KG |
Cas.: 886362-90-9 | Purity: 95% | 3-(2-(3-Ethoxy-3-oxopropoxy)ethoxy)propanoic acid | ESD-909164-250MG |
Cas.: 886362-90-9 | Purity: 95% | 3-(2-(3-Ethoxy-3-oxopropoxy)ethoxy)propanoic acid | ESD-909164-1G |
Cas.: 42823-72-3 | Purity: 97% | 4-Carbamimidoylbenzoic acid hydrochloride | ESD-845639-5G |
Cas.: 42823-72-3 | Purity: 97% | 4-Carbamimidoylbenzoic acid hydrochloride | ESD-845639-25G |
Cas.: 877-24-7 | Purity: AR, 99.8% | Potassium biphthalate | ESD-816390-10KG |
Cas.: 16423-68-0 | Purity: 95% | Erythrosin B | ESD-808958-100G |
Cas.: 16423-68-0 | Purity: 95% | Erythrosin B | ESD-808958-500G |
Cas.: 12018-10-9 | Copper chromite | ESD-909165-25G | |
Cas.: 53801-63-1 | Purity: copper contains amount1-3% | Zinc-Copper couple | ESD-830921-25G |
Cas.: 12018-10-9 | Copper chromite | ESD-909165-100G | |
Cas.: 12018-10-9 | Copper chromite | ESD-909165-500G | |
Cas.: 1004-00-8 | Purity: 96% | 2-Amino-4-chlorobenzenethiol | ESD-800185-100G |
Cas.: 7774-34-7 | Purity: ≥97% | Calcium chloride hexahydrate | ESD-886092-10KG |
Cas.: 74420-15-8 | Purity: 97% | 3-Bromo-7-azaindole | ESD-803857-100G |
Cas.: 74420-15-8 | Purity: 97% | 3-Bromo-7-azaindole | ESD-803857-500G |
Cas.: 2792-42-9 | Purity: ≥98% | (1R)-Camphor Oxime | ESD-866025-5G |
Cas.: 117029-34-2 | Purity: ≥98% | 1-Methylpyridinium Hexafluorophosphate | ESD-865264-25G |
Cas.: 6515-58-8 | Purity: 95% | 3-(BROMOMETHYL)BENZOIC ACID | ESD-822175-25G |
Cas.: 1192765-24-4 | Purity: 98% | ethyl 4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzoate | ESD-886368-25G |
Cas.: 144245-85-2 | Purity: 90% | Alkylketene dimer | ESD-909167-25G |
Cas.: 144245-85-2 | Purity: 90% | Alkylketene dimer | ESD-909167-100G |
Cas.: 144245-85-2 | Purity: 90% | Alkylketene dimer | ESD-909167-500G |
Cas.: 13752-51-7 | 4-[(4-Morpholinylthio)thioxomethyl]-morpholine | ESD-909166-25G | |
Cas.: 13752-51-7 | 4-[(4-Morpholinylthio)thioxomethyl]-morpholine | ESD-909166-100G | |
Cas.: 13752-51-7 | 4-[(4-Morpholinylthio)thioxomethyl]-morpholine | ESD-909166-500G | |
Cas.: 57294-38-9 | Purity: 98% | N-Boc-γ-Aminobutyric acid | ESD-824033-500G |
Cas.: 86329-79-5 | Purity: 90% | Cefodizime sodium | ESD-873423-1G |
Cas.: 1223405-08-0 | Purity: 99% | larotrectinib sulfate | ESD-909168-1G |
Cas.: 1223405-08-0 | Purity: 99% | larotrectinib sulfate | ESD-909168-100MG |
Cas.: 14643-87-9 | Purity: 98% | Zinc acrylate | ESD-909169-25G |
Cas.: 14643-87-9 | Purity: 98% | Zinc acrylate | ESD-909169-100G |
Cas.: 14643-87-9 | Purity: 98% | Zinc acrylate | ESD-909169-500G |
Cas.: 143606-53-5 | Purity: blow molding grade | Poly(1,4-butylene succinate) | ESD-909170-100G |
Cas.: 143606-53-5 | Purity: blow molding grade | Poly(1,4-butylene succinate) | ESD-909170-500G |
Cas.: 143606-53-5 | Purity: Extrusion grade | Poly(1,4-butylene succinate) | ESD-909171-100G |
Cas.: 143606-53-5 | Purity: Extrusion grade | Poly(1,4-butylene succinate) | ESD-909171-500G |
Cas.: 143606-53-5 | Purity: Injection grade | Poly(1,4-butylene succinate) | ESD-909172-100G |
Cas.: 143606-53-5 | Purity: Injection grade | Poly(1,4-butylene succinate) | ESD-909172-500G |
Cas.: 15521-65-0 | Nickel bis(dimethyldithiocarbamate) | ESD-909174-1G | |
Cas.: 15521-65-0 | Nickel bis(dimethyldithiocarbamate) | ESD-909174-5G | |
Cas.: 960404-48-2 | Purity: 99%, single impurity <0.1% | Dapagliflozin propanediol hydrate | ESD-855646-50MG |
Cas.: 960404-48-2 | Purity: 99%, single impurity <0.1% | Dapagliflozin propanediol hydrate | ESD-855646-250MG |
Cas.: 58652-20-3 | Purity: 98% | Nomegestrol acetate | ESD-829820-1G |
Cas.: 15521-65-0 | Nickel bis(dimethyldithiocarbamate) | ESD-909174-25G | |
Cas.: 2222755-14-6 | Purity: 99% | LOXO-292 | ESD-909175-100MG |
Cas.: 2222755-14-6 | Purity: 99% | LOXO-292 | ESD-909175-250MG |
Cas.: 13490-32-9 | Purity: 97% | 4-Amino-N’-hydroxy-1,2,5-oxadiazole-3-carboximidamide | ESD-847197-25G |
Cas.: 104389-32-4 | Purity: 99% | 1, 4 – trans polyisoprene rubber | ESD-909176-100G |
Cas.: 104389-32-4 | Purity: 99% | 1, 4 – trans polyisoprene rubber | ESD-909176-500G |
Cas.: 2051-76-5 | Purity: 97% | Acrylic anhydride | ESD-822885-100G |
Cas.: 102782-97-8 | Purity: ≥98% | Epoxypropoxypropyl Terminated Poly Dimethysiloxanes | ESD-909177-100G |
Cas.: 128794-94-5 | Purity: 98% | Mycophenolate mofetil | ESD-909178-250MG |
Cas.: 128794-94-5 | Purity: 98% | Mycophenolate mofetil | ESD-909178-1G |
Cas.: 128794-94-5 | Purity: 98% | Mycophenolate mofetil | ESD-909178-5G |
Cas.: 128794-94-5 | Purity: 98% | Mycophenolate mofetil | ESD-909178-25G |
Cas.: 128794-94-5 | Purity: 98% | Mycophenolate mofetil | ESD-909178-100G |
Cas.: 1620202-27-8 | Purity: 90% | Acrylo POSS Cage Mixture | ESD-909179-25G |
Cas.: 1620202-27-8 | Purity: 90% | Acrylo POSS Cage Mixture | ESD-909179-5G |
Cas.: 1208-88-4 | Purity: 98% | 4-(Phenylthio)benzaldehyde | ESD-909180-1G |
Cas.: 1208-88-4 | Purity: 98% | 4-(Phenylthio)benzaldehyde | ESD-909180-5G |
Cas.: 1208-88-4 | Purity: 98% | 4-(Phenylthio)benzaldehyde | ESD-909180-25G |
Cas.: 100-93-6 | Purity: ≥98% | 4′-anilinotoluene-4-sulphonanilide | ESD-909181-100G |
Cas.: 100-93-6 | Purity: ≥98% | 4′-anilinotoluene-4-sulphonanilide | ESD-909181-500G |
Cas.: 221326-46-1 | Purity: AR | Octaisobutyl POSS | ESD-909184-100G |
Cas.: 221326-46-1 | Purity: AR | Octaisobutyl POSS | ESD-909184-25G |
Cas.: 221326-46-1 | Purity: AR | Octaisobutyl POSS | ESD-909184-5G |
Cas.: 174195-95-0 | Purity: 98% | tert-butyl 3-oxocyclopentane-1-carboxylate | ESD-909186-5G |
Cas.: 174195-95-0 | Purity: 98% | tert-butyl 3-oxocyclopentane-1-carboxylate | ESD-909186-1G |
Cas.: 174195-95-0 | Purity: 98% | tert-butyl 3-oxocyclopentane-1-carboxylate | ESD-909186-25G |
Cas.: 17902-95-3 | Purity: 95% | 1,1,3,5,5-pentamethyl-3-phenyl-1,5-divinyltrisiloxane | ESD-909189-1G |
Cas.: 918321-24-1 | Purity: 99% | methyl 2,3,4-trifluoro-5-nitrobenzoate | ESD-909188-1G |
Cas.: 918321-24-1 | Purity: 99% | methyl 2,3,4-trifluoro-5-nitrobenzoate | ESD-909188-5G |
Cas.: 918321-24-1 | Purity: 99% | methyl 2,3,4-trifluoro-5-nitrobenzoate | ESD-909188-25G |
Cas.: 25038-32-8 | Purity: styrene 22 wt. % | Polystyrene-block-polyisoprene-block-polystyrene | ESD-909190-100G |
Cas.: 25038-32-8 | Purity: styrene 17 wt. % | Polystyrene-block-polyisoprene-block-polystyrene | ESD-909191-100G |
Cas.: 25038-32-8 | Purity: styrene 14 wt. % | Polystyrene-block-polyisoprene-block-polystyrene | ESD-909192-500G |
Cas.: 25038-32-8 | Purity: styrene 14 wt. % | Polystyrene-block-polyisoprene-block-polystyrene | ESD-909192-100G |
Cas.: 2138-24-1 | Purity: ≥97% | Tetra-N-Hexylammonium Iodide | ESD-859224-5G |
Cas.: 25085-50-1 | Purity: AR | Alkylphenol disulfide | ESD-909196-2.5KG |
Cas.: 25085-50-1 | Purity: AR | Alkylphenol disulfide | ESD-909196-500G |
Cas.: 25085-50-1 | Purity: AR | Alkylphenol disulfide | ESD-909196-100G |
Cas.: 918321-27-4 | Purity: 95% | Methyl 2,4,5-triamino-3-fluorobenzoate | ESD-909198-1G |
Cas.: 918321-27-4 | Purity: 95% | Methyl 2,4,5-triamino-3-fluorobenzoate | ESD-909198-5G |
Cas.: 1415559-93-1 | Purity: 95% | Methyl 5-((4-broMo-2-fluorophenyl)aMino)-4-fluoro-1-Methyl-1H-benzo[d]iMidazole-6-carboxylate | ESD-909200-1G |
Cas.: 1415559-93-1 | Purity: 95% | Methyl 5-((4-broMo-2-fluorophenyl)aMino)-4-fluoro-1-Methyl-1H-benzo[d]iMidazole-6-carboxylate | ESD-909200-250MG |
Cas.: 531-95-3 | Purity: ≥98%, ≥99% ee | (S)-Equol; (3S)-3,4-Dihydro-3-(4-hydroxyphenyl)-2H-1-benzopyran-7-ol | ESD-854011-5G |
Cas.: 1415559-93-1 | Purity: 95% | Methyl 5-((4-broMo-2-fluorophenyl)aMino)-4-fluoro-1-Methyl-1H-benzo[d]iMidazole-6-carboxylate | ESD-909200-5G |
Cas.: 9028-76-6 | Purity: BR, 10-20u/mg | CHOLESTEROL OXIDASE | ESD-832436-5KU |
Cas.: 1908-87-8 | Purity: 95% | 3-Methylthiazolidine-2-thione | ESD-909202-1G |
Cas.: 1908-87-8 | Purity: 95% | 3-Methylthiazolidine-2-thione | ESD-909202-5G |
Cas.: 1415564-99-6 | Purity: 97% | 5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylic acid | ESD-909203-1G |
Cas.: 1415564-99-6 | Purity: 97% | 5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylic acid | ESD-909203-250MG |
Cas.: 845835-03-2 | Purity: 99% | 1-Butyl-3-Methylpyridinium Hexafluorophosphate | ESD-889449-100G |
Cas.: 606143-48-0 | Purity: 97% | 6-(4-bromo-2-fluoro-phenylamino)-7-fluoro-3H-benzoimidazole-5-carboxylic acid methyl ester | ESD-909204-1G |
Cas.: 606143-48-0 | Purity: 97% | 6-(4-bromo-2-fluoro-phenylamino)-7-fluoro-3H-benzoimidazole-5-carboxylic acid methyl ester | ESD-909204-250MG |
Cas.: 918321-29-6 | Purity: 98% | methyl 6-amino-7-fluoro-3H-benzimidazole-5-carboxylate | ESD-909206-1G |
Cas.: 918321-29-6 | Purity: 98% | methyl 6-amino-7-fluoro-3H-benzimidazole-5-carboxylate | ESD-909206-250MG |
Cas.: 68698-59-9 | Purity: ≥90%(GC) | trans-2-Hexenyl Isovalerate | ESD-863153-100ML |
Cas.: 68698-59-9 | Purity: ≥90%(GC) | trans-2-Hexenyl Isovalerate | ESD-863153-25ML |
Cas.: 26009-03-0 | Purity: Mn~150,000 | Polyglycolic acid | ESD-909207-1G |
Cas.: 25212-74-2 | Purity: average Mn ~10, 000, powder | Poly(1,4-phenylene sulfide) | ESD-909208-25G |
Cas.: 25085-53-4 | Purity: average Mw ~250, 000 by GPC | Polypropylene, isotactic | ESD-909211-100G |
Cas.: 27249-90-7 | Purity: 95% | Benzyl Benzodithioate | ESD-909213-5G |
Cas.: 27249-90-7 | Purity: 95% | Benzyl Benzodithioate | ESD-909213-1G |
Cas.: 1122-12-9 | Purity: 97% | 3,4-Dibromofuran-2,5-dione | ESD-839862-5G |
Cas.: 2622-60-8 | Purity: 98% | 1-Phenyl-1H-benzo[d]imidazole | ESD-842935-500MG |
Cas.: 2781-11-5 | Purity: 98% | Diethyl bis(2-hydroxyethyl)aminomethylphosphonate | ESD-909214-250MG |
Cas.: 8004-92-0 | Purity: 95% | Quinoline yellow | ESD-817115-1G |
Cas.: 8004-92-0 | Purity: 95% | Quinoline yellow | ESD-817115-100G |
Cas.: 1823998-53-3 | Purity: 92% | 2-(4-bromo-3-fluorophenyl)-2,2-difluoroacetic acid | ESD-909215-100MG |
Cas.: 1823998-53-3 | Purity: 92% | 2-(4-bromo-3-fluorophenyl)-2,2-difluoroacetic acid | ESD-909215-250MG |
Cas.: 28182-81-2 | Purity: viscosity 1, 300-2, 200 cP (25 °C)(lit.) | Poly(hexamethylene diisocyanate) | ESD-909216-25ML |
Cas.: 127-40-2 | Purity: 50% | Xanthophyll | ESD-909218-5MG |
Cas.: 127-40-2 | Purity: 50% | Xanthophyll | ESD-909218-1G |
Cas.: 127-40-2 | Purity: 50% | Xanthophyll | ESD-909218-5G |
Cas.: 127-40-2 | Purity: 50% | Xanthophyll | ESD-909218-25G |
Cas.: 243665-18-1 | Purity: 97% | trans-2-(3-(trifluoromethyl)phenyl)cyclopropane-1-carboxylic acid | ESD-909217-100MG |
Cas.: 243665-18-1 | Purity: 97% | trans-2-(3-(trifluoromethyl)phenyl)cyclopropane-1-carboxylic acid | ESD-909217-250MG |
Cas.: 31533-76-3 | Purity: 98% | Polyphenyl ether | ESD-909221-100G |
Cas.: 31533-76-3 | Purity: 98% | Polyphenyl ether | ESD-909221-500G |
Cas.: 1391636-49-9 | Purity: 95% | (trans-2-(o-tolyl)cyclopropyl)methanol | ESD-909223-100MG |
Cas.: 1391636-49-9 | Purity: 95% | (trans-2-(o-tolyl)cyclopropyl)methanol | ESD-909223-250MG |
Cas.: NONE7881 | Purity: 96% | 2-(1,1-difluoro-2-hydroxyethyl)-6-fluorobenzonitrile | ESD-909224-100MG |
Cas.: NONE7881 | Purity: 96% | 2-(1,1-difluoro-2-hydroxyethyl)-6-fluorobenzonitrile | ESD-909224-250MG |
Cas.: 13265-84-4 | Purity: 96% | D-Glucal | ESD-810464-25G |
Cas.: 1314-87-0 | Purity: 99.995% metals basis | Lead(II) sulfide | ESD-812451-100G |
Cas.: NONE7949 | Purity: 98% | 2-(3,5-bis(trifluoromethyl)phenyl)-2,2-difluoroacetic acid | ESD-909225-250MG |
Cas.: NONE7949 | Purity: 98% | 2-(3,5-bis(trifluoromethyl)phenyl)-2,2-difluoroacetic acid | ESD-909225-100MG |
Cas.: NONE7950 | Purity: 97% | ethyl 1-([1,1′-biphenyl]-3-yl)-2,2-dimethylcyclopropane-1-carboxylate | ESD-909227-1G |
Cas.: NONE7950 | Purity: 97% | ethyl 1-([1,1′-biphenyl]-3-yl)-2,2-dimethylcyclopropane-1-carboxylate | ESD-909227-250MG |
Cas.: 19817-92-6 | Purity: 98% biotech grade | Uridine 5′-triphosphate trisodium salt hydrate | ESD-6096-5G |
Cas.: NONE7951 | Purity: 98% | (1-([1,1′-biphenyl]-3-yl)-2,2-dimethylcyclopropyl)methanol | ESD-909228-1G |
Cas.: 36051-68-0 | Purity: 98% biotech grade | Cytidine-5-triphosphate, disodium salt | ESD-6047-5G |
Cas.: 4382-63-2 | Purity: 98% | PFK-015 | ESD-873374-5MG |
Cas.: 31694-55-0 | Purity: average Mn ~1,000 | Glycerol ethoxylate | ESD-909229-100ML |
Cas.: NONE7951 | Purity: 98% | (1-([1,1′-biphenyl]-3-yl)-2,2-dimethylcyclopropyl)methanol | ESD-909228-250MG |
Cas.: 31694-55-0 | Purity: average Mn ~1,000 | Glycerol ethoxylate | ESD-909229-500ML |
Cas.: NONE7951 | Purity: 98% | (1-([1,1′-biphenyl]-3-yl)-2,2-dimethylcyclopropyl)methanol | ESD-909228-100MG |
Cas.: 513-77-9 | Purity: 99.95% metals basis | Barium carbonate | ESD-802883-2.5KG |
Cas.: 4382-63-2 | Purity: 98% | PFK-015 | ESD-873374-25MG |
Cas.: 31694-55-0 | MW: 900 | Glycerol ethoxylate | ESD-909231-100G |
Cas.: 31694-55-0 | MW: 900 | Glycerol ethoxylate | ESD-909231-500G |
Cas.: 31694-55-0 | MW: 1200 | Glycerol ethoxylate | ESD-909232-100G |
Cas.: 31694-55-0 | MW: 1200 | Glycerol ethoxylate | ESD-909232-500G |
Cas.: 55231-08-8 | Purity: Mn~120,000 | Poly(butylene adipate-co-terephthalate); PBAT | ESD-909230-100G |
Cas.: 4382-63-2 | Purity: 98% | PFK-015 | ESD-873374-100MG |
Cas.: 55231-08-8 | Purity: Mn~120,000 | Poly(butylene adipate-co-terephthalate); PBAT | ESD-909230-500G |
Cas.: 55231-08-8 | Purity: Mn~120,000 | Poly(butylene adipate-co-terephthalate); PBAT | ESD-909230-2.5KG |
Cas.: 36051-68-0 | Purity: 98% biotech grade | Cytidine-5-triphosphate, disodium salt | ESD-6047-1G |
Cas.: 89485-61-0 | Purity: PEG average Mn 2,000 | Methoxypolyethylene glycol azide | ESD-850212-250MG |
Cas.: NONE7952 | Purity: 98% | ethyl 2,2-dimethyl-1-(p-tolyl)cyclopropane-1-carboxylate | ESD-909233-250MG |
Cas.: NONE7952 | Purity: 98% | ethyl 2,2-dimethyl-1-(p-tolyl)cyclopropane-1-carboxylate | ESD-909233-100MG |
Cas.: NONE7953 | Purity: 98% | ethyl 2,2-dimethyl-1-(o-tolyl)cyclopropane-1-carboxylate | ESD-909234-250MG |
Cas.: NONE7953 | Purity: 98% | ethyl 2,2-dimethyl-1-(o-tolyl)cyclopropane-1-carboxylate | ESD-909234-100MG |
Cas.: 6390-69-8 | Purity: ≥98% | 3,3′,5,5′-Tetra-tert-butyl-2,2′-dihydroxybiphenyl | ESD-866344-5G |
Cas.: 6390-69-8 | Purity: ≥98% | 3,3′,5,5′-Tetra-tert-butyl-2,2′-dihydroxybiphenyl | ESD-866344-25G |
Cas.: 35061-50-7 | Purity: ≥97%(HPLC) | Chitopentaose Hydrochloride | ESD-861200-5MG |
Cas.: 32171-39-4 | MW10000 | Poly(ethylene glycol) methyl ether acrylate | ESD-909236-1G |
Cas.: 32171-39-4 | MW10000 | Poly(ethylene glycol) methyl ether acrylate | ESD-909236-5G |
Cas.: 32171-39-4 | MW20000 | Poly(ethylene glycol) methyl ether acrylate | ESD-909237-1G |
Cas.: 32171-39-4 | MW20000 | Poly(ethylene glycol) methyl ether acrylate | ESD-909237-5G |
Cas.: 32171-39-4 | MW20000 | Poly(ethylene glycol) methyl ether acrylate | ESD-909237-250MG |
Cas.: 32171-39-4 | MW10000 | Poly(ethylene glycol) methyl ether acrylate | ESD-909236-250MG |
Cas.: 884091-45-6 | Purity: 98% | (2,2-dimethyl-1-(p-tolyl)cyclopropyl)methanol | ESD-909235-250MG |
Cas.: 884091-45-6 | Purity: 98% | (2,2-dimethyl-1-(p-tolyl)cyclopropyl)methanol | ESD-909235-100MG |
Cas.: NONE7954 | Purity: 98% | ethyl 2,2-dimethyl-1-(4-(trifluoromethoxy)phenyl)cyclopropane-1-carboxylate | ESD-909238-250MG |
Cas.: 9028-67-5 | Purity: BR, 8-20u/mg | CHOLINE OXIDASE | ESD-832329-500U |
Cas.: 4370-02-9 | Purity: 98% | 1,2-Dihydroxyindan | ESD-870949-1G |
Cas.: 2228876-15-9 | Purity: 98% | (2,2-dimethyl-1-(4-(trifluoromethoxy)phenyl)cyclopropyl)methanol | ESD-909239-250MG |
Cas.: NONE7955 | Purity: 98% | ethyl 1-(4-isopropylphenyl)-2,2-dimethylcyclopropane-1-carboxylate | ESD-909240-1G |
Cas.: NONE7955 | Purity: 98% | ethyl 1-(4-isopropylphenyl)-2,2-dimethylcyclopropane-1-carboxylate | ESD-909240-250MG |
Cas.: 1892645-09-8 | Purity: 98% | (1-(4-isopropylphenyl)-2,2-dimethylcyclopropyl)methanol | ESD-909241-250MG |
Cas.: 32-70-2 | Purity: ≥95% | Ninhydrine | ESD-886177-1G |
Cas.: NONE7956 | Purity: 98% | ethyl 1-(2,6-dimethoxyphenyl)-2,2-dimethylcyclopropane-1-carboxylate | ESD-909243-100MG |
Cas.: NONE7956 | Purity: 98% | ethyl 1-(2,6-dimethoxyphenyl)-2,2-dimethylcyclopropane-1-carboxylate | ESD-909243-250MG |
Cas.: 25017-13-4 | Purity: >97.0%(GC) | 2-(3-Fluorophenyl)ethyl Bromide | ESD-855393-25G |
Cas.: 392-41-6 | Purity: 97% | Methyl trifluoroacrylate | ESD-909245-1G |
Cas.: 392-41-6 | Purity: 97% | Methyl trifluoroacrylate | ESD-909245-5G |
Cas.: 2229466-66-2 | Purity: 98% | (1-(2,6-dimethoxyphenyl)-2,2-dimethylcyclopropyl)methanol | ESD-909244-250MG |
Cas.: 2372-82-9 | Purity: 99% | N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine | ESD-902417-2.5KG |
Cas.: 119586-44-6 | Purity: 99% | 4,4′-Bis[4-(di-p-tolylamino)styryl]biphenyl | ESD-857335-250MG |
Cas.: NONE7957 | Purity: 97% | ethyl 1-(4-butylphenyl)-2,2-dimethylcyclopropane-1-carboxylate | ESD-909246-250MG |
Cas.: 10294-70-9 | Purity: 99.99% metals basis | Tin(II) iodide | ESD-888779-25G |
Cas.: 1781189-72-7 | Purity: 96% | 2,2-difluoro-2-(4-(trifluoromethyl)phenyl)ethan-1-ol | ESD-909247-250MG |
Cas.: 140-89-6 | Purity: 90% | Potassium ethyl xanthogenate | ESD-875736-25G |
Cas.: 1781189-72-7 | Purity: 96% | 2,2-difluoro-2-(4-(trifluoromethyl)phenyl)ethan-1-ol | ESD-909247-1G |
Cas.: 444619-08-3 | PSS-Trisilanol-isooctyl substituted | ESD-909248-1G | |
Cas.: 5926-51-2 | Purity: 97% | 3-Bromofuran-2,5-dione | ESD-839330-5G |
Cas.: 705250-93-7 | Purity: 98% | trans-2-(3-cyanophenyl)cyclopropane-1-carboxylic acid | ESD-909249-250MG |
Cas.: 705250-93-7 | Purity: 98% | trans-2-(3-cyanophenyl)cyclopropane-1-carboxylic acid | ESD-909249-1G |
Cas.: 497931-76-7 | Purity: 98% | 3-[[(Benzylthio)carbonothioyl]thio]propionic Acid | ESD-909252-1G |
Cas.: NONE7863 | Purity: 98% | ethyl 2-(2,4-dichlorophenyl)-2,2-difluoroacetate | ESD-909251-1G |
Cas.: 497931-76-7 | Purity: 98% | 3-[[(Benzylthio)carbonothioyl]thio]propionic Acid | ESD-909252-250MG |
Cas.: NONE7863 | Purity: 98% | ethyl 2-(2,4-dichlorophenyl)-2,2-difluoroacetate | ESD-909251-250MG |
Cas.: 497931-76-7 | Purity: 98% | 3-[[(Benzylthio)carbonothioyl]thio]propionic Acid | ESD-909252-5G |
Cas.: 1260761-81-6 | Purity: 98% | 1-(3-chloro-5-fluorophenyl)cyclopropan-1-amine hydrochloride | ESD-909253-250MG |
Cas.: 1936-15-8 | Purity: BS | Orange G | ESD-815107-100G |
Cas.: 1260761-81-6 | Purity: 98% | 1-(3-chloro-5-fluorophenyl)cyclopropan-1-amine hydrochloride | ESD-909253-1G |
Cas.: 1936-15-8 | Purity: BS | Orange G | ESD-815107-500G |
Cas.: 1260841-36-8 | Purity: 98% | 1-(3-bromo-5-fluorophenyl)cyclopropan-1-amine hydrochloride | ESD-909254-1G |
Cas.: 1260841-36-8 | Purity: 98% | 1-(3-bromo-5-fluorophenyl)cyclopropan-1-amine hydrochloride | ESD-909254-250MG |
Cas.: 1260887-57-7 | Purity: 98% | 1-(4-bromo-3-fluorophenyl)cyclopropan-1-amine hydrochloride | ESD-909255-250MG |
Cas.: 1260887-57-7 | Purity: 98% | 1-(4-bromo-3-fluorophenyl)cyclopropan-1-amine hydrochloride | ESD-909255-100MG |
Cas.: 1266148-30-4 | Purity: 98% | 1-(3-bromo-4-chlorophenyl)cyclopropan-1-amine Hydrochloride | ESD-909256-100MG |
Cas.: 1266148-30-4 | Purity: 98% | 1-(3-bromo-4-chlorophenyl)cyclopropan-1-amine Hydrochloride | ESD-909256-1G |
Cas.: 920501-75-3 | Purity: 98% | 1-(2-chloro-4-fluorophenyl)cyclopropan-1-amine hydrochloride | ESD-909259-250MG |
Cas.: 920501-75-3 | Purity: 98% | 1-(2-chloro-4-fluorophenyl)cyclopropan-1-amine hydrochloride | ESD-909259-1G |
Cas.: 25103-87-1 | Purity: average Mw ~12,000 | Poly(1,4-butylene adipate) | ESD-909258-10G |
Cas.: 51777-38-9 | Octakis(trimethylsiloxy)silsesquioxane | ESD-909260-5G | |
Cas.: 51777-38-9 | Octakis(trimethylsiloxy)silsesquioxane | ESD-909260-1G | |
Cas.: 1248300-11-9 | Purity: 98% | 1-(3,4,5-trifluorophenyl)cyclopropan-1-amine hydrochloride | ESD-909261-250MG |
Cas.: 58670-89-6 | Purity: 97% | 2-Decyl-1-tetradecanol | ESD-856629-500ML |
Cas.: 1228880-06-5 | Purity: 98% | 1-(4-(trifluoromethyl)phenyl)cyclopropan-1-amine hydrochloride | ESD-909262-1G |
Cas.: 1228880-06-5 | Purity: 98% | 1-(4-(trifluoromethyl)phenyl)cyclopropan-1-amine hydrochloride | ESD-909262-250MG |
Cas.: 52022-77-2 | Purity: 95% | 3-Nitrophenethyl alcohol | ESD-909263-25G |
Cas.: 52022-77-2 | Purity: 95% | 3-Nitrophenethyl alcohol | ESD-909263-5G |
Cas.: 52022-77-2 | Purity: 95% | 3-Nitrophenethyl alcohol | ESD-909263-1G |
Cas.: 442-52-4 | Purity: ≥98% | Clemizole | ESD-864546-100MG |
Cas.: NONE7958 | Purity: 98% | 1-(4-fluoro-3-methoxyphenyl)cyclopropan-1-amine hydrochloride | ESD-909264-100MG |
Cas.: 1260778-44-6 | Purity: 98% | 1-(4-chloro-3-(trifluoromethyl)phenyl)cyclopropane-1-amine hydrochloride | ESD-909265-1G |
Cas.: 1260778-44-6 | Purity: 98% | 1-(4-chloro-3-(trifluoromethyl)phenyl)cyclopropane-1-amine hydrochloride | ESD-909265-250MG |
Cas.: 553-72-0 | Purity: AR | Zinc dibenzoate | ESD-909266-500G |
Cas.: 553-72-0 | Purity: AR | Zinc dibenzoate | ESD-909266-100G |
Cas.: 5137-70-2 | Purity: 98% | Dodecylphosphonic Acid | ESD-849494-5G |
Cas.: 5137-70-2 | Purity: 98% | Dodecylphosphonic Acid | ESD-849494-25G |
Cas.: NONE7959 | Purity: 91% | 1-(2-fluoro-5-methylphenyl)cyclopropan-1-amine hydrochloride | ESD-909268-250MG |
Cas.: NONE7959 | Purity: 91% | 1-(2-fluoro-5-methylphenyl)cyclopropan-1-amine hydrochloride | ESD-909268-1G |
Cas.: 1266126-30-0 | Purity: 98% | 1-(3,4-dimethylphenyl)cyclopropan-1-amine hydrochloride | ESD-909269-1G |
Cas.: 1266126-30-0 | Purity: 98% | 1-(3,4-dimethylphenyl)cyclopropan-1-amine hydrochloride | ESD-909269-250MG |
Cas.: 857641-46-4 | Purity: 95% | 2-(4-Bromo-1H-pyrazol-1-yl)pyrimidine | ESD-845954-1G |
Cas.: 63231-66-3 | Purity: 99% | Chlorinated Polyethylene | ESD-909271-25G |
Cas.: 63231-66-3 | Purity: 99% | Chlorinated Polyethylene | ESD-909271-100G |
Cas.: 63231-66-3 | Purity: 99% | Chlorinated Polyethylene | ESD-909271-500G |
Cas.: 459-47-2 | Purity: ≥98% | 1-Ethyl-4-Fluorobenzene | ESD-858613-5G |
Cas.: 459-47-2 | Purity: ≥98% | 1-Ethyl-4-Fluorobenzene | ESD-858613-25G |
Cas.: 26062-94-2 | Purity: Medium viscosity injection grade, MI: 18-22 g/10min(225°C) | Poly(butylene terephthalate) | ESD-909270-10KG |
Cas.: 26062-94-2 | Purity: Medium viscosity injection grade, MI: 18-22 g/10min(225°C) | Poly(butylene terephthalate) | ESD-909270-2.5KG |
Cas.: 26062-94-2 | Purity: Medium viscosity injection grade, MI: 18-22 g/10min(225°C) | Poly(butylene terephthalate) | ESD-909270-500G |
Cas.: NONE7960 | Purity: 94% | methyl 1-fluoro-2-(4-fluorophenyl)-2-methylcyclopropane-1-carboxylate | ESD-909272-250MG |
Cas.: NONE7960 | Purity: 94% | methyl 1-fluoro-2-(4-fluorophenyl)-2-methylcyclopropane-1-carboxylate | ESD-909272-100MG |
Cas.: 62479-72-5 | Formaldoxime trimer hydrochloride | ESD-909273-1G | |
Cas.: 27814-48-8 | Purity: BR | Peptidoglycan | ESD-909274-100MG |
Cas.: 27814-48-8 | Purity: BR | Peptidoglycan | ESD-909274-25MG |
Cas.: 27814-48-8 | Purity: BR | Peptidoglycan | ESD-909274-10MG |
Cas.: 51014-29-0 | Purity: Analysis control | Isocorynoxeine | ESD-860696-20MG |
Cas.: 630-94-4 | Purity: Analysis control, ≥98%(HPLC) | Corynoxeine | ESD-860665-20MG |
Cas.: 29435-48-1 | Poly[(R)-3-hydroxybutyric acid] natural origin | ESD-909275-25G | |
Cas.: 29435-48-1 | Poly[(R)-3-hydroxybutyric acid] natural origin | ESD-909275-10G | |
Cas.: 544-13-8 | Purity: ≥98% | Glutaronitrile | ESD-834930-1G |
Cas.: 4904-61-4 | Purity: 99% | 1,5,9-cyclododecatriene | ESD-909277-100ML |
Cas.: 4904-61-4 | Purity: 99% | 1,5,9-cyclododecatriene | ESD-909277-500ML |
Cas.: 637-50-3 | Purity: 95% | β-Methylstyrene (cis- and trans- mixture) (stabilized with TBC) | ESD-858204-250MG |
Cas.: 58-61-7 | Purity: Ultrapure grade, 99.5% | Adenosine | ESD-800689-2.5KG |
Cas.: 85-31-4 | Purity: 96% | 6-Thioguanosine | ESD-888612-1G |
Cas.: 14649-03-7 | Purity: 98% | (S)-(-)-1-Phenylethyl isocyanate | ESD-836183-25G |
Cas.: 68891-79-2 | MW: 4000-5000 | CTPB | ESD-909280-5ML |
Cas.: 68891-79-2 | MW: 4000-5000 | CTPB | ESD-909280-25ML |
Cas.: 68891-79-2 | MW: 4000-5000 | CTPB | ESD-909280-100ML |
Cas.: 68891-79-2 | MW: 3500-4500 | CTPB | ESD-909281-5ML |
Cas.: 68891-79-2 | MW: 3500-4500 | CTPB | ESD-909281-25ML |
Cas.: 68921-45-9 | Purity: AR | Alkylated Diphneylamines | ESD-909282-25G |
Cas.: 68921-45-9 | Purity: AR | Alkylated Diphneylamines | ESD-909282-100G |
Cas.: 68921-45-9 | Purity: AR | Alkylated Diphneylamines | ESD-909282-500G |
Cas.: 442912-55-2 | Sulfo-Cy5.5, SE | ESD-903591-5MG | |
Cas.: 471-34-1 | Purity: AR, 99% | Calcium carbonate | ESD-805318-10KG |
Cas.: 135-57-9 | Purity: 98% | Bis(2-benzamidophenyl) Disulfide | ESD-859332-100G |
Cas.: 135-57-9 | Purity: 98% | Bis(2-benzamidophenyl) Disulfide | ESD-859332-500G |
Cas.: 69013-23-6 | Hydride terminated methyhydrosiloxane dimethylsiloxane copolymer | ESD-909283-5G | |
Cas.: 69013-23-6 | Hydride terminated methyhydrosiloxane dimethylsiloxane copolymer | ESD-909283-25G | |
Cas.: 28523-86-6 | Purity: 98% | Fluoromethyl 1,1,1,3,3,3-hexafluoroisopropyl ether | ESD-809476-25G |
Cas.: 24980-41-4 | Purity: average Mn 45,000 | Polycaprolactone | ESD-871874-2.5KG |
Cas.: 7522-27-2 | Purity: 95% | 3-Chloro-N,N-Bis(Trimethylsilyl)Aniline | ESD-909284-1G |
Cas.: 7522-27-2 | Purity: 95% | 3-Chloro-N,N-Bis(Trimethylsilyl)Aniline | ESD-909284-5G |
Cas.: 2498-66-0 | Purity: 95% | 1,2-Benzanthraquinone | ESD-869012-5G |
Cas.: 796045-97-1 | Purity: 97% | Cyanomethyl dodecyl carbonotrithioate | ESD-909287-100MG |
Cas.: 796045-97-1 | Purity: 97% | Cyanomethyl dodecyl carbonotrithioate | ESD-909287-250MG |
Cas.: 796045-97-1 | Purity: 97% | Cyanomethyl dodecyl carbonotrithioate | ESD-909287-1G |
Cas.: 796045-97-1 | Purity: 97% | Cyanomethyl dodecyl carbonotrithioate | ESD-909287-5G |
Cas.: 724424-92-4 | Spirulina Powder | ESD-909286-100G | |
Cas.: 724424-92-4 | Spirulina Powder | ESD-909286-500G | |
Cas.: 148471-91-4 | Purity: ≥95% | Hematoporphyrin monomethyl Ether | ESD-909289-100MG |
Cas.: 80693-00-1 | Purity: AR | Bis(2,6-di-ter-butyl-4-methylphenyl)pentaerythritol-diphosphite | ESD-909290-5G |
Cas.: 80693-00-1 | Purity: AR | Bis(2,6-di-ter-butyl-4-methylphenyl)pentaerythritol-diphosphite | ESD-909290-25G |
Cas.: 80693-00-1 | Purity: AR | Bis(2,6-di-ter-butyl-4-methylphenyl)pentaerythritol-diphosphite | ESD-909290-100G |
Cas.: 882073-43-0 | Nonitol,1,2,3-trideoxy-4,6:5,7-bis-O-[(4-propylphenyl)methylene] | ESD-909291-250MG | |
Cas.: 887268-09-9 | Purity: 97% | 2-Fluoro-1,3-bis-trifluoromethyl-benzene | ESD-909292-1G |
Cas.: 887268-09-9 | Purity: 97% | 2-Fluoro-1,3-bis-trifluoromethyl-benzene | ESD-909292-5G |
Cas.: 5238-56-2 | Purity: 98% | N-(2-Hydroxyethyl)methacrylamide | ESD-909293-5G |
Cas.: 5238-56-2 | Purity: 98% | N-(2-Hydroxyethyl)methacrylamide | ESD-909293-25G |
Cas.: 1882-72-0 | Purity: 97% | Methyl 2-amino-5-hydroxybenzoate | ESD-842257-5G |
Cas.: 1882-72-0 | Purity: 97% | Methyl 2-amino-5-hydroxybenzoate | ESD-842257-25G |
Cas.: 160970-54-7 | Purity: ≥99% | Silodosin | ESD-833170-1G |
Cas.: 51-49-0 | Purity: 95% | (R)-2-Amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic acid | ESD-843863-500MG |
Cas.: 8023-88-9 | Purity: 99% | Costus root oil | ESD-905685-500ML |
Cas.: 5873-93-8 | Purity: ≥95% (HPLC) | Bis(thiobenzoyl) disulfide | ESD-909296-1G |
Cas.: 9003-54-7 | Purity: average Mw ~165, 000 by GPC, acrylonitrile 25 wt. %, pellets | Poly(styrene-co-acrylonitrile) | ESD-909298-25G |
Cas.: 9003-54-7 | Purity: average Mw ~185, 000 by GPC, acrylonitrile 30 wt. %, powder | Poly(styrene-co-acrylonitrile) | ESD-909299-25G |
Cas.: 64724-29-4 | Purity: 95% | cis-Tributyl(2-ethoxyethenyl)stannane | ESD-909300-1G |
Cas.: 9010-79-1 | Ethylene/propylene copolymer | ESD-909301-100G | |
Cas.: 9010-79-1 | Ethylene/propylene copolymer | ESD-909301-500G | |
Cas.: 1223404-90-7 | Purity: 98% | (R)-5-(2-(2,5-Difluorophenyl)pyrrolidin-1-yl)-3-nitropyrazolo[1,5-a]pyrimidine | ESD-909303-1G |
Cas.: 1223404-90-7 | Purity: 98% | (R)-5-(2-(2,5-Difluorophenyl)pyrrolidin-1-yl)-3-nitropyrazolo[1,5-a]pyrimidine | ESD-909303-5G |
Cas.: 1223404-90-7 | Purity: 98% | (R)-5-(2-(2,5-Difluorophenyl)pyrrolidin-1-yl)-3-nitropyrazolo[1,5-a]pyrimidine | ESD-909303-10G |
Cas.: 28556-81-2 | Purity: 97% | 2,6-Dimethylphenyl Isocyanate | ESD-858367-25G |
Cas.: 28556-81-2 | Purity: 97% | 2,6-Dimethylphenyl Isocyanate | ESD-858367-1G |
Cas.: 68554-70-1 | Poly(methylsilsesquioxane) | ESD-909306-100G | |
Cas.: 1234616-50-2 | Purity: 98% | 5-Chloropyrazolo[1,5-a]pyrimidin-3-amine | ESD-909307-1G |
Cas.: 1234616-50-2 | Purity: 98% | 5-Chloropyrazolo[1,5-a]pyrimidin-3-amine | ESD-909307-250MG |
Cas.: 1234616-50-2 | Purity: 98% | 5-Chloropyrazolo[1,5-a]pyrimidin-3-amine | ESD-909307-5G |
Cas.: 71060-57-6 | Purity: 99% | Alcohols, C8-10, Ethoxylated | ESD-909308-100G |
Cas.: 71060-57-6 | Purity: 99% | Alcohols, C8-10, Ethoxylated | ESD-909308-500G |
Cas.: 76358-47-9 | Purity: 97% | t-ButylDiphenylMethoxysilane | ESD-909309-5G |
Cas.: 76358-47-9 | Purity: 97% | t-ButylDiphenylMethoxysilane | ESD-909309-25G |
Cas.: 82961-52-2 | Purity: 97% | 3-chloro-2-methylphenyl methyl sulfide | ESD-909310-1G |
Cas.: 82961-52-2 | Purity: 97% | 3-chloro-2-methylphenyl methyl sulfide | ESD-909310-5G |
Cas.: 82961-52-2 | Purity: 97% | 3-chloro-2-methylphenyl methyl sulfide | ESD-909310-25G |
Cas.: 136738-23-3 | Purity: 99% | 4-Acetylamino-6-methyl-3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine | ESD-909311-100G |
Cas.: 136738-23-3 | Purity: 99% | 4-Acetylamino-6-methyl-3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine | ESD-909311-25G |
Cas.: 8006-90-4 | Purity: 60% | Peppermint oil | ESD-905724-500ML |
Cas.: 141942-85-0 | Purity: 97% | Ethyl (|R|)-(-)-4-cyano-3-hydroxybutyrate | ESD-809311-100G |
Cas.: 141942-85-0 | Purity: 97% | Ethyl (|R|)-(-)-4-cyano-3-hydroxybutyrate | ESD-809311-500G |
Cas.: 72830-09-2 | Purity: 97% | 2-(Chloromethyl)-3,4-dimethoxypyridine hydrochloride | ESD-806045-500G |
Cas.: 29658-26-2 | Mv~35, 000, coarse meal | PEEK | ESD-909312-500G |
Cas.: 29658-26-2 | Mv~35, 000, coarse meal | PEEK | ESD-909312-100G |
Cas.: 29658-26-2 | Mv~35, 000, pellets | PEEK | ESD-909313-500G |
Cas.: 29658-26-2 | Mv~35, 000, pellets | PEEK | ESD-909313-100G |
Cas.: 1223404-88-3 | Purity: 98% | (R)-5-(2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine | ESD-909314-1G |
Cas.: 1223404-88-3 | Purity: 98% | (R)-5-(2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine | ESD-909314-5G |
Cas.: 1919868-75-9 | Purity: 98% | 3-nitropyrazolo[1,5-a]pyrimidin-5(4H)-one | ESD-909315-1G |
Cas.: 1919868-75-9 | Purity: 98% | 3-nitropyrazolo[1,5-a]pyrimidin-5(4H)-one | ESD-909315-5G |
Cas.: 1919868-75-9 | Purity: 98% | 3-nitropyrazolo[1,5-a]pyrimidin-5(4H)-one | ESD-909315-250MG |
Cas.: 27129-87-9 | Purity: 98% | 3,5-dimethylbenzyl alcohol | ESD-908823-25G |
Cas.: NONE7961 | MW 1000 | MAL-PEG-MAL | ESD-909317-5G |
Cas.: NONE7961 | MW 1000 | MAL-PEG-MAL | ESD-909317-1G |
Cas.: NONE7961 | MW 1000 | MAL-PEG-MAL | ESD-909317-250MG |
Cas.: NONE7961 | MW 2000 | MAL-PEG-MAL | ESD-909318-5G |
Cas.: NONE7961 | MW 2000 | MAL-PEG-MAL | ESD-909318-1G |
Cas.: NONE7961 | MW 2000 | MAL-PEG-MAL | ESD-909318-250MG |
Cas.: NONE7961 | MW 5000 | MAL-PEG-MAL | ESD-909319-5G |
Cas.: NONE7961 | MW 5000 | MAL-PEG-MAL | ESD-909319-1G |
Cas.: NONE7961 | MW 5000 | MAL-PEG-MAL | ESD-909319-250MG |
Cas.: NONE7961 | MW 10000 | MAL-PEG-MAL | ESD-909320-5G |
Cas.: NONE7961 | MW 10000 | MAL-PEG-MAL | ESD-909320-1G |
Cas.: NONE7961 | MW 10000 | MAL-PEG-MAL | ESD-909320-250MG |
Cas.: 51094-17-8 | Purity: 95% | 5,10,15,20-Tetrakis(4-hydroxyphenyl)-21H,23H-porphine | ESD-821816-250MG |
Cas.: 832115-62-5 | Purity: 99% | Isoxazole 9 (ISX-9) | ESD-873003-25MG |
Cas.: 3133-16-2 | Purity: ≥99% | 4-Octyl Itaconate | ESD-879645-250MG |
Cas.: 1698293-93-4 | Purity: 90% | 2-Isopropyl-4-methylpyridin-3-amine | ESD-909316-1G |
Cas.: 1698293-93-4 | Purity: 90% | 2-Isopropyl-4-methylpyridin-3-amine | ESD-909316-5G |
Cas.: 1698293-93-4 | Purity: 90% | 2-Isopropyl-4-methylpyridin-3-amine | ESD-909316-25G |
Cas.: 1948-31-8 | Purity: 99% | Ala-Ala | ESD-801181-5G |
Cas.: 6055-52-3 | Purity: 97% | Hexane-1,6-diamine dihydrochloride | ESD-848915-100G |
Cas.: 7164-43-4 | Purity: 98% | 5-Aminoorotic acid | ESD-800436-5G |
Cas.: 13933-33-0 | Purity: 99,9% | Tetraammineplatinum(II) chloride monohydrate | ESD-909321-1G |
Cas.: 13933-33-0 | Purity: 99,9% | Tetraammineplatinum(II) chloride monohydrate | ESD-909321-5G |
Cas.: 6298-37-9 | Purity: 95% | 6-Aminoquinoxaline | ESD-800215-100G |
Cas.: 9004-95-9 | Purity: average Mn ~683 | Brij <<>>C10 | ESD-822695-2.5KG |
Cas.: 1126-58-5 | Purity: ≥97% | Girard’s Reagent P | ESD-857402-100G |
Cas.: 13820-46-7 | Purity: 99,9% | Tetraammineplatinum tetrachloroplatinate | ESD-909322-1G |
Cas.: 13820-46-7 | Purity: 99,9% | Tetraammineplatinum tetrachloroplatinate | ESD-909322-5G |
Cas.: NONE7241 | Purity: 96% | (trans-2-(4-(trifluoromethoxy)phenyl)cyclopropyl)methanol | ESD-902648-100MG |
Cas.: 62758-13-8 | Purity: 90% | Resazurin | ESD-817240-100G |
Cas.: 17780-75-5 | Purity: 98% | Clorgiline hydrochloride | ESD-849229-250MG |
Cas.: 127733-97-5 | Purity: 99,9% | (SP-4-1)-Tetraammineplatinum diacetate | ESD-909323-1G |
Cas.: 127733-97-5 | Purity: 99,9% | (SP-4-1)-Tetraammineplatinum diacetate | ESD-909323-5G |
Cas.: 123439-82-7 | Purity: 99,9% | Tetraammineplatinum(II) hydrogen carbonate | ESD-836076-1G |
Cas.: 123439-82-7 | Purity: 99,9% | Tetraammineplatinum(II) hydrogen carbonate | ESD-836076-5G |
Cas.: 4876-10-2 | Purity: 97% | 4-Bromomethyl-2(1H)-quinolinone | ESD-802032-100G |
Cas.: 22532-62-3 | Purity: >98.0%(GC) | 4-Bromo-2-hydroxybenzaldehyde | ESD-804053-100G |
Cas.: 14205-46-0 | Purity: 95% | Isopropyl 3-aminobut-2-enoate | ESD-844033-250G |
Cas.: 144494-65-5 | Purity: 95% | Tirofiban | ESD-855554-5MG |
Cas.: NONE7964 | Purity: BR, 98% | Galacto-Oligosaccharides | ESD-909326-500G |
Cas.: 127733-98-6 | Purity: 99,9% | azane,hydrogen phosphate,platinum(2+) | ESD-909327-1ML |
Cas.: NONE7964 | Purity: BR, 98% | Galacto-Oligosaccharides | ESD-909326-100G |
Cas.: 127733-98-6 | Purity: 99,9% | azane,hydrogen phosphate,platinum(2+) | ESD-909327-5ML |
Cas.: NONE7964 | Purity: BR, 98% | Galacto-Oligosaccharides | ESD-909326-2.5KG |
Cas.: 32811-75-9 | Purity: 98% | Methyl 3-oxocyclopentanecarboxylate | ESD-825485-5G |
Cas.: 81335-77-5 | Purity: 98% | Imazethapyr | ESD-873346-25G |
Cas.: 81335-77-5 | Purity: 98% | Imazethapyr | ESD-873346-100G |
Cas.: 10039-56-2 | Purity: AR | Sodium hypophosphite monohydrate | ESD-822521-25KG |
Cas.: 9002-97-5 | Purity: 30 wt. % in H2O | Poly(vinylsulfonic acid, sodium salt) solution | ESD-909335-100ML |
Cas.: 9002-97-5 | Purity: 30 wt. % in H2O | Poly(vinylsulfonic acid, sodium salt) solution | ESD-909335-500ML |
Cas.: NONE7969 | MW: 2000 | Polypropylene carbonate diol | ESD-909336-500G |
Cas.: NONE7969 | MW: 2000 | Polypropylene carbonate diol | ESD-909336-100G |
Cas.: 148411-57-8 | MW≤2000 | Chitosan oligosaccharides | ESD-875645-500G |
Cas.: NONE7969 | MW: 3000 | Polypropylene carbonate diol | ESD-909337-500G |
Cas.: NONE7969 | MW: 3000 | Polypropylene carbonate diol | ESD-909337-100G |
Cas.: 81093-37-0 | Purity: BR | Pravastatin | ESD-872875-25MG |
Cas.: 9006-04-6 | natural rubber | ESD-909339-500G | |
Cas.: 9006-04-6 | natural rubber | ESD-909339-100G | |
Cas.: 101084-96-2 | Purity: 98% | 2-METHOXY-4-NITROBENZONITRILE | ESD-833547-1G |
Cas.: 9003-17-2 | Purity: approx. 90% 1, 2-vinyl | Polybutadiene, predominantly 1,2-addition | ESD-817074-100ML |
Cas.: 9003-17-2 | Purity: approx. 90% 1, 2-vinyl | Polybutadiene, predominantly 1,2-addition | ESD-817074-25ML |
Cas.: 4876-10-2 | Purity: 97% | 4-Bromomethyl-2(1H)-quinolinone | ESD-802032-500G |
Cas.: 8001-75-0 | Purity: Melting point: 82-87C | CERESIN WAX | ESD-875533-10KG |
Cas.: 54193-36-1 | Purity: average Mw 4, 000-6, 000, 40 wt. % in H2O | Sodium polymethacrylate | ESD-902411-500ML |
Cas.: 54193-36-1 | Purity: average Mw 4, 000-6, 000, 40 wt. % in H2O | Sodium polymethacrylate | ESD-902411-100ML |
Cas.: 32099-65-3 | 1-(4-(Phenylamino)phenyl)-1H-pyrrole-2,5-dione | ESD-909345-250G | |
Cas.: 32099-65-3 | 1-(4-(Phenylamino)phenyl)-1H-pyrrole-2,5-dione | ESD-909345-50G | |
Cas.: 3934-20-1 | Purity: 98% | 2,4-Dichloropyrimidine | ESD-806643-1KG |
Cas.: 133-49-3 | Purity: 98,5% | Pentachlorothiophenol | ESD-815494-500G |
Cas.: 104504-45-2 | Purity: 98% | H-Bpa-OH H-Phe(4-Bz)-OH | ESD-843572-5G |
Cas.: 16056-11-4 | Purity: 98% | Trimethylphenylammonium bromide | ESD-818561-500G |
Cas.: 10038-98-9 | Purity: 99.9999% trace metals basis | Germanium(IV) chloride | ESD-835940-100G |
Cas.: NONE6730 | Purity: Battery grade, 0.5M LiCF3SO3, 0.5M LiNO3 in DME:DOL=1:1 Vol% | Lithium sulfide electrolyte | ESD-875341-100G |
Cas.: 944251-24-5 | Azido-PEG4-NHS Ester | ESD-862593-100MG | |
Cas.: 172827-25-7 | Purity: 10,000 × in DMSO | Green II RNA gel stain | ESD-909353-100ΜL |
Cas.: 172827-25-7 | Purity: 10,000 × in DMSO | Green II RNA gel stain | ESD-909353-50ΜL |
Cas.: 987-24-6 | Purity: 98% | Betamethasone 21-Acetate | ESD-829921-5G |
Cas.: 43076-61-5 | Purity: 98% | 4′-|tert|-Butyl-4-chlorobutyrophenone | ESD-818666-5G |
Cas.: 38862-24-7 | Purity: 98% | Acrylic acid N-hydroxysuccinimide ester | ESD-835791-100G |
Cas.: NONE7980 | EB Eraser | ESD-909354-100T/EA | |
Cas.: NONE7980 | EB Eraser | ESD-909354-50T/EA | |
Cas.: 77182-82-2 | Purity: 97% | Glufosinate-ammonium | ESD-890362-500G |
Cas.: NONE7982 | Sulfo-Cy3 cadaverine | ESD-909355-1MG | |
Cas.: NONE7982 | Sulfo-Cy3 cadaverine | ESD-909355-5MG | |
Cas.: 6084-76-0 | Purity: epoxy value~4 | (±)-trans-9,10-Epoxystearic Acid Methyl Ester | ESD-823550-25G |
Cas.: 6084-76-0 | Purity: epoxy value~4 | (±)-trans-9,10-Epoxystearic Acid Methyl Ester | ESD-823550-100G |
Cas.: NONE7981 | Purity: ≥98%, (Sum of α- and β-) | Disodium glycerophosphate hydrate | ESD-909356-100G |
Cas.: NONE7981 | Purity: ≥98%, (Sum of α- and β-) | Disodium glycerophosphate hydrate | ESD-909356-500G |
Cas.: NONE7983 | Sulfo-Cy5 ethylenediamine | ESD-909357-1MG | |
Cas.: NONE7983 | Sulfo-Cy5 ethylenediamine | ESD-909357-5MG | |
Cas.: 7681-53-0 | Purity: 98-101% | Sodium hypophosphite | ESD-909358-100G |
Cas.: 7681-53-0 | Purity: 98-101% | Sodium hypophosphite | ESD-909358-250G |
Cas.: 6084-76-0 | Purity: epoxy value~4 | (±)-trans-9,10-Epoxystearic Acid Methyl Ester | ESD-823550-500G |
Cas.: NONE7984 | Sulfo-Cy5 cadaverine | ESD-909359-1MG | |
Cas.: NONE7984 | Sulfo-Cy5 cadaverine | ESD-909359-5MG | |
Cas.: 1135-32-6 | Purity: 98% | 1,2-Di(4-pyridyl)ethylene | ESD-909360-25G |
Cas.: 1135-32-6 | Purity: 98% | 1,2-Di(4-pyridyl)ethylene | ESD-909360-5G |
Cas.: 1135-32-6 | Purity: 98% | 1,2-Di(4-pyridyl)ethylene | ESD-909360-1G |
Cas.: NONE7985 | Sulfo-Cy5.5 ethylenediamine | ESD-909361-1MG | |
Cas.: NONE7986 | Sulfo-Cy5.5 cadaverine | ESD-909362-1MG | |
Cas.: NONE7987 | Sulfo-Cy7 ethylenediamine | ESD-909363-1MG | |
Cas.: NONE7987 | Sulfo-Cy7 ethylenediamine | ESD-909363-5MG | |
Cas.: NONE7988 | Sulfo-Cy7 cadaverine | ESD-909364-5MG | |
Cas.: NONE7988 | Sulfo-Cy7 cadaverine | ESD-909364-1MG | |
Cas.: NONE7989 | Sulfo-Cy7 diacid, SE | ESD-909365-1MG | |
Cas.: NONE7989 | Sulfo-Cy7 diacid, SE | ESD-909365-5MG | |
Cas.: NONE7990 | Super Fluor 488 | ESD-909366-5MG | |
Cas.: NONE7992 | Super Fluor 488, SE | ESD-909367-1MG | |
Cas.: NONE7993 | Purity: AR, 99% | alumium polysulfate | ESD-909372-500G |
Cas.: NONE7993 | Purity: AR, 99% | alumium polysulfate | ESD-909372-100G |
Cas.: NONE7994 | Super Fluor 555 | ESD-909373-5MG | |
Cas.: 36913-91-4 | Purity: 97% | Nonafluorobutanesulfonic anhydride | ESD-815036-25G |
Cas.: NONE7995 | Super Fluor 555, SE | ESD-909374-1MG | |
Cas.: NONE7996 | Super Fluor 647 | ESD-909375-5MG | |
Cas.: NONE7997 | Super Fluor 647, SE | ESD-909377-1MG | |
Cas.: 521-24-4 | Purity: for spectrophotometric det. of isonicotic hydrazide, amines and amino acids, ≥98%(T) | 1,2-Naphthoquinone-4-sulfonic acid sodium salt | ESD-909376-5G |
Cas.: 20295-82-3 | Purity: 95% | 2-(Aminooxy)acetic acid hydrochloride | ESD-909378-250MG |
Cas.: 20295-82-3 | Purity: 95% | 2-(Aminooxy)acetic acid hydrochloride | ESD-909378-1G |
Cas.: 51258-15-2 | Purity: average Mn ~2, 600 | Glycerol ethoxylate-co-propoxylate triol | ESD-909379-100ML |
Cas.: 186204-37-5 | Purity: 98% | 4-(1,2-Benzothiazol-3-yl)-1-[(3aR,7aR)-octahydro-2H-isoindol-2-yl ]piperazin-1-ium-1-sulfonate | ESD-909381-5G |
Cas.: 186204-37-5 | Purity: 98% | 4-(1,2-Benzothiazol-3-yl)-1-[(3aR,7aR)-octahydro-2H-isoindol-2-yl ]piperazin-1-ium-1-sulfonate | ESD-909381-1G |
Cas.: 186204-37-5 | Purity: 98% | 4-(1,2-Benzothiazol-3-yl)-1-[(3aR,7aR)-octahydro-2H-isoindol-2-yl ]piperazin-1-ium-1-sulfonate | ESD-909381-25G |
Cas.: NONE7998 | Super Fluor 680 | ESD-909382-5MG | |
Cas.: NONE7999 | Super Fluor 680, SE | ESD-909383-1MG | |
Cas.: NONE8001 | Super Fluor 750 | ESD-909384-5MG | |
Cas.: NONE8000 | Purity: Diameter: 75 microns | Expandable Graphite | ESD-909385-100G |
Cas.: 308068-56-6 | Purity: >90%, ID:0.8-1.6nm, OD:1-2nm, Length:1-3μm, -COOH:~2.7wt% | Short Carboxyl single-walled CrabonNanotubes | ESD-835675-5G |
Cas.: NONE8001 | Super Fluor 750 | ESD-909384-1MG | |
Cas.: NONE8002 | Super Fluor 750, SE | ESD-909386-1MG | |
Cas.: 146397-20-8 | Cyanine3 | ESD-909388-5MG | |
Cas.: 146397-20-8 | Cyanine3 | ESD-909388-1MG | |
Cas.: 54802-79-8 | Poly(2,2,2-trifluoroethyl methacrylate) | ESD-909387-250MG | |
Cas.: NONE8003 | Cy3, SE | ESD-909389-1MG | |
Cas.: NONE8003 | Cy3, SE | ESD-909389-5MG | |
Cas.: NONE8004 | Nucleating agent WBG-Ⅱ | ESD-909390-25G | |
Cas.: NONE8004 | Nucleating agent WBG-Ⅱ | ESD-909390-100G | |
Cas.: NONE8005 | Cy3diacid | ESD-909391-5MG | |
Cas.: NONE8005 | Cy3diacid | ESD-909391-25MG | |
Cas.: NONE8006 | Cy3diacid, SE | ESD-909392-1MG | |
Cas.: NONE8006 | Cy3diacid, SE | ESD-909392-5MG | |
Cas.: NONE8004 | Nucleating agent WBG-Ⅱ | ESD-909390-500G | |
Cas.: NONE8004 | Nucleating agent WBG-Ⅱ | ESD-909390-2.5KG | |
Cas.: NONE8007 | Cy3.5 diacid | ESD-909394-5MG | |
Cas.: NONE8007 | Cy3.5 diacid | ESD-909394-25MG | |
Cas.: NONE8008 | Cy3.5 diacid , SE | ESD-909395-1MG | |
Cas.: NONE8008 | Cy3.5 diacid , SE | ESD-909395-5MG | |
Cas.: NONE8009 | Cy3 ethylenediamine | ESD-909396-1MG | |
Cas.: NONE8009 | Cy3 ethylenediamine | ESD-909396-5MG | |
Cas.: 67-72-1 | Purity: ≥99.0% (GC) | Hexachloroethane | ESD-811181-10KG |
Cas.: NONE8010 | Cy3 cadaverine | ESD-909397-1MG | |
Cas.: NONE8010 | Cy3 cadaverine | ESD-909397-5MG | |
Cas.: 17028-61-4 | Purity: ≥99%(GC)(T) | 2-Hydroxy-5-nitro-m-anisaldehyde | ESD-862015-25G |
Cas.: 118-58-1 | Purity: 98% | Benzyl salicylate | ESD-824177-500G |
Cas.: 118-58-1 | Purity: 98% | Benzyl salicylate | ESD-824177-2.5KG |
Cas.: 5382-49-0 | Purity: 95% | 1,2,3,4-Tetrahydroquinoline-6-carboxylic acid | ESD-842733-1G |
Cas.: 76931-93-6 | Purity: >94.0%(GC) | S-Acetylthioglycolic acid N-hydroxysuccinimide ester | ESD-861728-500MG |
Cas.: 596-27-0 | Purity: biotech grade | o-cresolphthalein | ESD-6228-500G |
Cas.: 345-89-1 | Purity: 98% | 4-Fluoro-4′-methoxybenzophenone | ESD-831231-500G |
Cas.: 9001-81-4 | Purity: 143 units/mg protein | Phosphoglucomutase | ESD-861441-1KU |
Cas.: 1118-71-4 | Purity: 98% | 2,2,6,6-Tetramethyl-3,5-heptanedione | ESD-819581-500G |
Cas.: 289-95-2 | Purity: 99% | Pyrimidine | ESD-815894-100G |
Cas.: 589-18-4 | Purity: 98% | 4-Methylbenzyl alcohol | ESD-813751-2.5KG |
Cas.: 22208-73-7 | Purity: 98% | CALCIUM BROMIDE DIHYDRATE | ESD-890209-2.5KG |
Cas.: 86718-08-3 | Purity: 98% | (4-Imidazol-1-yl-phenyl)methanol | ESD-842394-5G |
Cas.: 2873-29-2 | Purity: 97% | Tri-|O|-acetyl-D-glucal | ESD-819214-500G |
Cas.: 70639-77-9 | Purity: 97% | 2-Oxo-1,2,3,4-tetrahydroquinoline-6-carboxylic acid | ESD-845483-5G |
Cas.: 6065-27-6 | Purity: 98% | N,N-DIETHYL-P-PHENYLENEDIAMINE SULFATE | ESD-861754-500G |
Cas.: 819-83-0 | Purity: 95% | β-sodium glycerophosphate | ESD-909398-5G |
Cas.: 30811-80-4 | Purity: Assay≥85.0% | poly(cytidylic acid) | ESD-909399-1G |
Cas.: 30811-80-4 | Purity: Assay≥85.0% | poly(cytidylic acid) | ESD-909399-5G |
Cas.: 54016-70-5 | Purity: 98% | 3-Ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide | ESD-809321-500G |
Cas.: 73016-08-7 | Purity: 95% | 9,10-Anthracenedicarboxylic acid | ESD-886302-1G |
Cas.: 26171-23-3 | Purity: 95% | 1-Methyl-5-p-toluoylpyrrole-2-acetic acid | ESD-843642-5G |
Cas.: 26171-23-3 | Purity: 95% | 1-Methyl-5-p-toluoylpyrrole-2-acetic acid | ESD-843642-25G |
Cas.: 26171-23-3 | Purity: 95% | 1-Methyl-5-p-toluoylpyrrole-2-acetic acid | ESD-843642-100G |
Cas.: 1795-01-3 | Purity: 98% | 3-Ethylthiophene | ESD-824312-100G |
Cas.: 42424-50-0 | Purity: Assay: 45.0~55.0% | Polyinosinic Polycytidylic acid sodium salt | ESD-909400-1G |
Cas.: 3647-69-6 | Purity: 99% | 4-(2-chloroethyl)morpholine hydrochloride | ESD-888352-2.5KG |
Cas.: 595-91-5 | Purity: 97% | 2,2,2-Triphenylacetic acid | ESD-843014-25G |
Cas.: 184351-56-2 | Purity: 97% | Potassium 2,3,3-trimethyl-3H-indole-5-sulfonate | ESD-846784-500MG |
Cas.: 32171-39-4 | MW1000 | POLY(ETHYLENE GLYCOL) METHYL ETHER ACRYL ATE | ESD-902352-25G |
Cas.: NONE8011 | Cy5 | ESD-909401-5MG | |
Cas.: NONE8011 | Cy5 | ESD-909401-25MG | |
Cas.: 158923-11-6 | Purity: 97% | (R)-(-)-1-[(S)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-t-butylphosphine | ESD-835623-1G |
Cas.: 101084-96-2 | Purity: 98% | 2-METHOXY-4-NITROBENZONITRILE | ESD-833547-25G |
Cas.: 2068-78-2 | Purity: 98% | Vincristine sulfate salt | ESD-820430-500MG |
Cas.: 7440-21-3 | Purity: 99.9% metals basis, 1μm | Silicon Standard | ESD-909159-500G |
Cas.: 6587-31-1 | Purity: Analysis control | 4′-Galactosyllactose | ESD-909393-1MG |
Cas.: 58-85-5 | Purity: >98% biotech grade | D-Biotin | ESD-6221-100G |
Cas.: NONE8014 | Cy5, SE | ESD-909405-1MG | |
Cas.: NONE8014 | Cy5, SE | ESD-909405-5MG | |
Cas.: NONE8013 | Purity: L: ~200nm, OD: ~10nm | Cellulose nanocrystal | ESD-909406-5G |
Cas.: NONE8013 | Purity: L: ~200nm, OD: ~10nm | Cellulose nanocrystal | ESD-909406-25G |
Cas.: 75902-86-2 | Purity: for spectrophotometric det. of anionic surfactants | 4-(4-Diethylaminophenylazo)-1-(4-nitrobenzyl)pyridinium bromide | ESD-909407-25MG |
Cas.: NONE8015 | Cy5diacid | ESD-909408-5MG | |
Cas.: NONE8015 | Cy5diacid | ESD-909408-25MG | |
Cas.: 628-39-7 | Purity: ≥98% | Diethyldiselenide | ESD-858011-5G |
Cas.: NONE8016 | Cy5diacid, SE | ESD-909409-1MG | |
Cas.: NONE8016 | Cy5diacid, SE | ESD-909409-5MG | |
Cas.: NONE8012 | Purity: 200-400 Mesh | Styrogel | ESD-909403-25G |
Cas.: NONE8017 | Cy5 ethylenediamine | ESD-909411-1MG | |
Cas.: NONE8017 | Cy5 ethylenediamine | ESD-909411-5MG | |
Cas.: NONE8018 | Cy5 cadaverine | ESD-909412-5MG | |
Cas.: NONE8018 | Cy5 cadaverine | ESD-909412-25MG | |
Cas.: NONE8019 | Cy5.5 | ESD-909413-5MG | |
Cas.: NONE8019 | Cy5.5 | ESD-909413-25MG | |
Cas.: NONE8018 | Cy5 cadaverine | ESD-909412-1MG | |
Cas.: NONE80120 | Cy5.5, SE | ESD-909414-1MG | |
Cas.: NONE80120 | Cy5.5, SE | ESD-909414-5MG | |
Cas.: 124898-13-1 | Purity: ≥98% | Trimethyl(pentafluoroethyl)silane | ESD-866817-5G |
Cas.: 39831-55-5 | Purity: 95+% | Amikacin Sulfate | ESD-837352-100G |
Cas.: NONE8020 | Cy5.5 diacid | ESD-909415-5MG | |
Cas.: NONE8020 | Cy5.5 diacid | ESD-909415-25MG | |
Cas.: NONE8021 | Cy5.5 diacid, SE | ESD-909417-5MG | |
Cas.: NONE8021 | Cy5.5 diacid, SE | ESD-909417-1MG | |
Cas.: 25194-01-8 | Purity: 97% | 2,6-DICHLORO-4-NITROPYRIDINE | ESD-821864-25G |
Cas.: NONE8022 | Cy5.5 ethylenediamine | ESD-909418-1MG | |
Cas.: NONE8022 | Cy5.5 ethylenediamine | ESD-909418-5MG | |
Cas.: 15574-96-6 | Purity: ≥98% | Pizotifen | ESD-868076-250MG |
Cas.: 15574-96-6 | Purity: ≥98% | Pizotifen | ESD-868076-1G |
Cas.: NONE8023 | Cy5.5 cadaverine | ESD-909419-1MG | |
Cas.: NONE8023 | Cy5.5 cadaverine | ESD-909419-5MG | |
Cas.: 1123-49-5 | Purity: ≥98% | 3,5-Dimethyl-4-nitroisoxazole | ESD-865036-25G |
Cas.: 1123-49-5 | Purity: ≥98% | 3,5-Dimethyl-4-nitroisoxazole | ESD-865036-100G |
Cas.: 73513-43-6 | Purity: AR | Isooctyl Nitrate | ESD-909416-500G |
Cas.: 73513-43-6 | Purity: AR | Isooctyl Nitrate | ESD-909416-100G |
Cas.: 73513-43-6 | Purity: AR | Isooctyl Nitrate | ESD-909416-25G |
Cas.: NONE8024 | Purity: Octene contains amount25-27wt%, Mw:~382000 | Polyolefin elastomer (POE) | ESD-909420-500G |
Cas.: NONE8024 | Purity: Octene contains amount25-27wt%, Mw:~382000 | Polyolefin elastomer (POE) | ESD-909420-2.5KG |
Cas.: NONE8025 | Cy7 | ESD-909422-5MG | |
Cas.: NONE8025 | Cy7 | ESD-909422-25MG | |
Cas.: NONE8026 | Cy7, SE | ESD-909423-1MG | |
Cas.: NONE8026 | Cy7, SE | ESD-909423-5MG | |
Cas.: NONE8027 | Cy7 ethylenediamine | ESD-909425-1MG | |
Cas.: 119-91-5 | Purity: for spectrophotometric det. of Cu, ≥99% | 2,2′-Biquinoline | ESD-909424-1G |
Cas.: NONE8027 | Cy7 ethylenediamine | ESD-909425-5MG | |
Cas.: 7398-42-7 | Purity: 98% | Methyl 2-(4-(bromomethyl)phenyl)acetate | ESD-848094-5G |
Cas.: NONE8028 | Cy7 cadaverine | ESD-909426-1MG | |
Cas.: NONE8024 | Purity: Octene contains amount25-27wt%, Mw:~382000 | Polyolefin elastomer (POE) | ESD-909420-1G |
Cas.: NONE8028 | Cy7 cadaverine | ESD-909426-5MG | |
Cas.: 362043-46-7 | Purity: 98% | 1-Decyl-3-Methylimidazolium Hexafluorophosphate | ESD-857001-1G |
Cas.: 362043-46-7 | Purity: 98% | 1-Decyl-3-Methylimidazolium Hexafluorophosphate | ESD-857001-5G |
Cas.: 362043-46-7 | Purity: 98% | 1-Decyl-3-Methylimidazolium Hexafluorophosphate | ESD-857001-100G |
Cas.: NONE8029 | Fluo-4, pentasodium salt | ESD-909427-1MG | |
Cas.: 1148-79-4 | Purity: for spectrophotometric det. of Ag, Fe, Ru, ≥98.5% | 2,2′:6′,2”-Terpyridine | ESD-909428-250MG |
Cas.: NONE8030 | Fluo-4, pentapotassium salt | ESD-909429-1MG | |
Cas.: NONE8031 | Fluo-4, pentaammonium salt | ESD-909430-1MG | |
Cas.: 13598-36-2 | Purity: AR, 99% | Phosphorous acid | ESD-815557-10KG |
Cas.: NONE8032 | Fluo-3, pentasodium salt | ESD-909431-1MG | |
Cas.: NONE8033 | Fluo-3, pentapotassium salt | ESD-909432-1MG | |
Cas.: 80854-14-4 | Purity: 95% | 2-(4-Chlorophenyl)-2-methylpropanol | ESD-834737-500MG |
Cas.: 1186663-16-0 | Purity: 99% | 1-(3,4-difluorophenyl)cyclopropan-1-amine hydrochloride | ESD-902724-100MG |
Cas.: 19932-26-4 | Purity: ≥97% | Glycidyl 2,2,3,3-Tetrafluoropropyl Ether | ESD-857608-25G |
Cas.: 2228993-53-9 | Purity: 95% | 3-(1,1-difluoro-2-hydroxyethyl)benzonitrile | ESD-902972-200MG |
Cas.: 652-67-5 | Purity: 97% | Isosorbide | ESD-830614-2.5KG |
Cas.: 189763-86-8 | Purity: 97% | tert-Butyl 4-(4-acetylphenyl)-piperazine-1-carboxylate | ESD-909433-1G |
Cas.: 189763-86-8 | Purity: 97% | tert-Butyl 4-(4-acetylphenyl)-piperazine-1-carboxylate | ESD-909433-5G |
Cas.: 189763-86-8 | Purity: 97% | tert-Butyl 4-(4-acetylphenyl)-piperazine-1-carboxylate | ESD-909433-25G |
Cas.: 1630-79-1 | Purity: 97% | Tetrakis(dimethylamino)diboron | ESD-855369-5G |
Cas.: 1630-79-1 | Purity: 97% | Tetrakis(dimethylamino)diboron | ESD-855369-25G |
Cas.: 3401-74-9 | Purity: >98% | Didodecyl dimethyl ammonium chloride | ESD-886258-500G |
Cas.: 877399-52-5 | Purity: 98% | 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-Pyridinamine | ESD-823900-1G |
Cas.: 97-95-0 | Purity: 98% | 2-Ethyl-1-butanol | ESD-808976-2.5L |
Cas.: 13820-40-1 | Purity: Pd ≥36.5% | Ammonium tetrachloropalladate(II) | ESD-800828-250MG |
Cas.: 326-91-0 | Purity: for spectrophotometric det. of metal ions, ≥99% | 2-Thenoyltrifluoroacetone | ESD-909434-5G |
Cas.: 5970-45-6 | Purity: 99.995% metals basis | Zinc acetate dihydrate | ESD-820729-2.5KG |
Cas.: 491-67-8 | Purity: 98% | Baicalein | ESD-802464-100G |
Cas.: 108612-45-9 | Purity: ≥98% | Mizolastine | ESD-866586-5G |
Cas.: 6863-73-6 | Purity: 97% | 2-Amino-3-chloropyrazine | ESD-801638-25G |
Cas.: 6863-73-6 | Purity: 97% | 2-Amino-3-chloropyrazine | ESD-801638-100G |
Cas.: 7790-86-5 | Purity: 99.99% metals basis | Cerous chloride | ESD-875724-500G |
Cas.: 4021-12-9 | Purity: 97% | 3-Methylisonicotinic acid | ESD-846856-5G |
Cas.: 10034-88-5 | Purity: AR, 99.0% | Sodium bisulfate monohydrate | ESD-817841-10KG |
Cas.: 56660-19-6 | Purity: 97% | Bis(tetrabutylammonium) Dichromate | ESD-869343-5G |
Cas.: 56660-19-6 | Purity: 97% | Bis(tetrabutylammonium) Dichromate | ESD-869343-25G |
Cas.: 17272-45-6 | Purity: 99,9% | Lanthanum chloride, hexahydrate | ESD-871634-2.5KG |
Cas.: 22427-39-0 | Purity: ≥98% | Ginsenoside Rg1 | ESD-909437-25MG |
Cas.: 22427-39-0 | Purity: ≥98% | Ginsenoside Rg1 | ESD-909437-100MG |
Cas.: 7789-77-7 | Purity: AR, 99.0% | Calcium hydrogenphosphate dihydrate | ESD-804982-10KG |
Cas.: NONE8034 | Fluo-3, pentaammonium salt | ESD-909438-1MG | |
Cas.: 1345980-40-6 | Fluo-8, AM | ESD-909439-1MG | |
Cas.: 78763-58-3 | Purity: Analysis control, ≥98%(HPLC) | Deapioplatycodin D | ESD-909440-10MG |
Cas.: 86-30-6 | Purity: 98% | N-Nitrosodiphenylamine | ESD-814830-500G |
Cas.: NONE6730 | Purity: Battery grade, 1.0M LiTFSI, 0.2M LiNO3 in DME:DOL=1:1 Vol% | Lithium sulfide electrolyte | ESD-875343-100G |
Cas.: 30069-65-9 | Purity: 98% | 3-phenylnaphthalen-1-ol | ESD-909444-1G |
Cas.: 30069-65-9 | Purity: 98% | 3-phenylnaphthalen-1-ol | ESD-909444-5G |
Cas.: 30069-65-9 | Purity: 98% | 3-phenylnaphthalen-1-ol | ESD-909444-250MG |
Cas.: NONE8036 | TPAE | ESD-909443-100G | |
Cas.: NONE8036 | TPAE | ESD-909443-500G | |
Cas.: NONE8036 | TPAE | ESD-909443-2.5KG | |
Cas.: NONE8037 | Bis-(1,3-diethylthiobarbituric acid)pentamethine oxonol | ESD-909446-25MG | |
Cas.: 870196-83-1 | Purity: 97% | 2-Cyanopropan-2-yl dodecyl carbonotrithioate | ESD-909445-250MG |
Cas.: 870196-83-1 | Purity: 97% | 2-Cyanopropan-2-yl dodecyl carbonotrithioate | ESD-909445-1G |
Cas.: 7783-18-8 | Purity: 98% | Ammonium thiosulfate | ESD-800325-2.5KG |
Cas.: NONE8038 | JC-10 | ESD-909448-5MG | |
Cas.: NONE8038 | JC-10 | ESD-909448-1MG | |
Cas.: 109589-98-2 | Purity: 98% | 5-bromoindolo[3,2,1-jk]carbazole | ESD-909447-1G |
Cas.: 109589-98-2 | Purity: 98% | 5-bromoindolo[3,2,1-jk]carbazole | ESD-909447-250MG |
Cas.: 28523-86-6 | Purity: 98% | Fluoromethyl 1,1,1,3,3,3-hexafluoroisopropyl ether | ESD-809476-100G |
Cas.: NONE8039 | 6-Carboxy-2′,4,4′,5′,7,7′-hexachlorofluorescein, succinimidyl ester | ESD-909449-5MG | |
Cas.: 464-72-2 | Purity: 95% | 1,1,2,2-Tetraphenyl-1,2-ethanediol | ESD-909450-5G |
Cas.: 464-72-2 | Purity: 95% | 1,1,2,2-Tetraphenyl-1,2-ethanediol | ESD-909450-25G |
Cas.: 464-72-2 | Purity: 95% | 1,1,2,2-Tetraphenyl-1,2-ethanediol | ESD-909450-100G |
Cas.: NONE8040 | 6-Carboxy-2′,4,7,7′-tetrachlorofluorescein, succinimidyl ester | ESD-909451-5MG | |
Cas.: NONE8041 | 5-(and 6)-Carboxyrhodamine 110, mixed isomers | ESD-909452-25MG | |
Cas.: NONE8042 | 5-Carboxyrhodamine 110 | ESD-909453-5MG | |
Cas.: 5905-36-2 | Purity: 98% | N,N’-diphenyl-m-phenylenediamine | ESD-909454-1G |
Cas.: 5905-36-2 | Purity: 98% | N,N’-diphenyl-m-phenylenediamine | ESD-909454-5G |
Cas.: 5905-36-2 | Purity: 98% | N,N’-diphenyl-m-phenylenediamine | ESD-909454-25G |
Cas.: NONE8043 | 6-Carboxyrhodamine 110 | ESD-909455-5MG | |
Cas.: 112163-33-4 | Purity: ≥95%(SDS-PAGE) | Lactoferrin | ESD-902428-1G |
Cas.: NONE8044 | 5-Carboxyrhodamine 110, succinimidyl ester, single isomer | ESD-909457-5MG | |
Cas.: NONE8045 | 6-Carboxyrhodamine 110, succinimidyl ester, single isomer | ESD-909458-5MG | |
Cas.: 91-58-7 | Purity: for spectrophotometric det. of proline and thiophene, ≥99% | 2-Chloronaphthalene | ESD-909459-250MG |
Cas.: NONE8046 | 5(6)-CarboxyrhodaMine 6G | ESD-909460-25MG | |
Cas.: NONE8047 | 5-carboxyrhodamine-6G | ESD-909461-5MG | |
Cas.: 9010-41-7 | Purity: BR, 28% | Triton X-200 | ESD-909462-500ML |
Cas.: 9010-41-7 | Purity: BR, 28% | Triton X-200 | ESD-909462-100ML |
Cas.: 69898-45-9 | Purity: for spectrophotometric det. of Fe, ≥97% | PDT disulfonate | ESD-909464-1G |
Cas.: 101-94-0 | Purity: 99% | p-Tolyl Phenylacetate | ESD-871310-25G |
Cas.: 3100-04-7 | Purity: Content(1-MCP): ≥4.0%, Carrier cyclodextrin | 1-Methylcyclopropene | ESD-875518-25G |
Cas.: 9003-53-6 | MW 13,000, Mw/Mn 1.06 | Polystyrene standard | ESD-903575-500MG |
Cas.: 67460-86-0 | Purity: 98% | 3.5dibromo-1H-pyrazole | ESD-909466-1G |
Cas.: 67460-86-0 | Purity: 98% | 3.5dibromo-1H-pyrazole | ESD-909466-5G |
Cas.: 67460-86-0 | Purity: 98% | 3.5dibromo-1H-pyrazole | ESD-909466-25G |
Cas.: 10043-11-5 | Purity: 99.9% metals basis, 500nm | Boron nitride | ESD-909467-25G |
Cas.: 10043-11-5 | Purity: 99.9% metals basis, 500nm | Boron nitride | ESD-909467-100G |
Cas.: 10043-11-5 | Purity: 99.9% metals basis, 500nm | Boron nitride | ESD-909467-500G |
Cas.: NONE8048 | 6-Carboxyrhodamine 6G | ESD-909468-5MG | |
Cas.: NONE8049 | 5(6)-Carboxyrhodamine 6G succinimidyl ester | ESD-909469-10MG | |
Cas.: 49754-15-6 | Purity: ≥98% | Diethyl malonyldicarbamate | ESD-857911-5G |
Cas.: 49754-15-6 | Purity: ≥98% | Diethyl malonyldicarbamate | ESD-857911-25G |
Cas.: NONE8050 | 5-Carboxyrhodamine 6G, succinimidyl ester | ESD-909470-5MG | |
Cas.: 35218-75-8 | Purity: for spectrophotometric det. of transition metals, ≥95% | Tetraphenylporphyrin Tetrasulfonic Acid Hydrate | ESD-909472-100MG |
Cas.: 161558-45-8 | Purity: 99% | 2-((4-Chlorophenyl)(pipidin-4-yloxy)methyl)pyridine 4-nitrobenzoate | ESD-855661-5G |
Cas.: 161558-45-8 | Purity: 99% | 2-((4-Chlorophenyl)(pipidin-4-yloxy)methyl)pyridine 4-nitrobenzoate | ESD-855661-25G |
Cas.: 198978-94-8 | 5(6)-ROX | ESD-909473-25MG | |
Cas.: 198978-94-8 | 5(6)-ROX | ESD-909473-5MG | |
Cas.: 24979-70-2 | Purity: average Mw ~25,000 | Poly(4-vinylphenol) | ESD-909474-5G |
Cas.: 1134-35-6 | Purity: for spectrophotometric det., ≥99% | 4,4′-Dimethyl-2,2′-dipyridyl | ESD-909475-5G |
Cas.: 24979-70-2 | Mw ~11,000 | Poly(4-vinylphenol) | ESD-909476-5G |
Cas.: 25068-26-2 | Purity: low MW | Poly(4-methyl-1-pentene) | ESD-909478-25G |
Cas.: 25068-26-2 | Purity: medium MW | Poly(4-methyl-1-pentene) | ESD-909479-100G |
Cas.: 539-48-0 | Purity: 99% | |p|-Xylylenediamine | ESD-820591-100G |
Cas.: 110726-28-8 | Purity: ≥98% | 4,4′-(1-(4-(2-(4-Hydroxyphenyl)propan-2-yl)phenyl)ethane-1,1-diyl)diphenol | ESD-857889-500G |
Cas.: 1083-48-3 | Purity: for TLC derivatization, for spectrophotometric det. of phosphorus-containing pesticides, ≥98% | 4-(4-Nitrobenzyl)pyridine | ESD-909480-5G |
Cas.: 116-63-2 | Purity: for spectrophotometric det. of Si, ≥95% | 1-Amino-2-naphthol-4-sulfonic Acid | ESD-909481-25G |
Cas.: NONE8052 | 5(6)-Carboxy-X-rhodamine-N-hydroxysuccinimide ester | ESD-909482-25MG | |
Cas.: 82138-69-0 | Purity: 97% | 4-Methyl-5-(sulfomethylamino)-2-(2-thiazolylazo)benzoic acid | ESD-813948-100MG |
Cas.: 82138-69-0 | Purity: for spectrophotometric det. of Co(II), Cu(II), ≥90% | 4-Methyl-5-(sulfomethylamino)-2-(2-thiazolylazo)benzoic acid | ESD-909483-100MG |
Cas.: NONE8053 | Texas red-X, SE | ESD-909484-10MG | |
Cas.: 555-16-8 | Purity: for spectrophotometric det. of amino sugars, ≥99% | p-Nitrobenzaldehyde | ESD-909485-25G |
Cas.: NONE8054 | Super Texas Red, SE | ESD-909486-10MG | |
Cas.: 84-85-5 | Purity: 98% | 4-Methoxy-1-naphthol | ESD-838768-25G |
Cas.: 84-85-5 | Purity: 98% | 4-Methoxy-1-naphthol | ESD-838768-1G |
Cas.: 190788-60-4 | Purity: 97+% | 2-(2-Methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-837386-100G |
Cas.: 1032350-13-2 | Purity: ≥98% | MK-2206 2HCl | ESD-833034-100MG |
Cas.: 1032350-13-2 | Purity: ≥98% | MK-2206 2HCl | ESD-833034-250MG |
Cas.: 56962-00-6 | Purity: 98% | 2-Amino-3-chlorophenol | ESD-845321-1G |
Cas.: 63-64-9 | Purity: ≥97% | N-Methyl-3,4-dimethoxybenzylamine | ESD-853050-25G |
Cas.: 23271-47-8 | Purity: ≥98% | 1-Propylpyridinium Chloride | ESD-867891-5G |
Cas.: 1934-92-5 | Purity: 95% | N-methylbenzanilide | ESD-908478-25G |
Cas.: 23271-47-8 | Purity: ≥98% | 1-Propylpyridinium Chloride | ESD-867891-25G |
Cas.: 23271-47-8 | Purity: ≥98% | 1-Propylpyridinium Chloride | ESD-867891-100G |
Cas.: 28954-12-3 | Purity: 99% | L-|allo|-Threonine | ESD-819789-25G |
Cas.: 433337-11-2 | Purity: ≥99% | 1-Benzyl-3-methylimidazolium hexafluorophosphate | ESD-856862-100G |
Cas.: 433337-11-2 | Purity: ≥99% | 1-Benzyl-3-methylimidazolium hexafluorophosphate | ESD-856862-5G |
Cas.: 37286-64-9 | Purity: Hydroxyl Value (mg KOH/g): 133~148 | Polypropylene glycol monomethyl ether | ESD-888330-2.5KG |
Cas.: 62006-39-7 | Purity: 98% | Senkyunolide A | ESD-873725-100MG |
Cas.: 60-00-4 | Purity: 0.5M, pH7.4 | EDTA Solution | ESD-885216-1L |
Cas.: 38092-89-6 | Purity: 95% | 8-Chloroazatadine | ESD-843600-5G |
Cas.: 38092-89-6 | Purity: 95% | 8-Chloroazatadine | ESD-843600-25G |
Cas.: 58081-05-3 | Purity: technical, 90%, ee 99+% | (R)-(+)-β-Hydroxy-γ-butyrolactone | ESD-836610-250MG |
Cas.: 28705-46-6 | Purity: ≥98% | Ethyl 7-(Diethylamino)coumarin-3-carboxylate | ESD-867005-5G |
Cas.: 145783-14-8 | Purity: 97% | 4,6-DICHLORO-5-NITRO-2-PROPYLTHIOPYRIMIDINE | ESD-822272-100G |
Cas.: 102-24-9 | Purity: 95% | Trimethoxyboroxine | ESD-835950-5G |
Cas.: 850331-04-3 | Purity: 98% | 1-Ethyl-3-methylimidazolium tetrachloroferrate | ESD-809304-25G |
Cas.: 136790-76-6 | Purity: ≥98.0% | Lubiprostone | ESD-833131-50MG |
Cas.: 2499-95-8 | Purity: >96.0%(GC), stabilized with HQ | N-Hexyl Acrylate | ESD-909487-100ML |
Cas.: 2499-95-8 | Purity: >96.0%(GC), stabilized with HQ | N-Hexyl Acrylate | ESD-909487-25ML |
Cas.: 2499-95-8 | Purity: >96.0%(GC), stabilized with HQ | N-Hexyl Acrylate | ESD-909487-5ML |
Cas.: 74665-17-1 | Purity: 80wt.% in isopropanol | Titanium(IV) (triethanolaminato)isopropoxide solution | ESD-885891-20ML |
Cas.: 74665-17-1 | Purity: 80wt.% in isopropanol | Titanium(IV) (triethanolaminato)isopropoxide solution | ESD-885891-500ML |
Cas.: 117029-34-2 | Purity: ≥98% | 1-Methylpyridinium Hexafluorophosphate | ESD-865264-100G |
Cas.: 1820683-35-9 | Purity: ≥95% | 2-((tert-Butoxycarbonyl)amino)-4,5,6,7-tetrahydrobenzo[d]thiazole-6-carboxylic acid | ESD-909488-1G |
Cas.: 1820683-35-9 | Purity: ≥95% | 2-((tert-Butoxycarbonyl)amino)-4,5,6,7-tetrahydrobenzo[d]thiazole-6-carboxylic acid | ESD-909488-250MG |
Cas.: 100587-92-6 | Purity: 99.9% (REO) | Terbium(III) acetate hexahydrate | ESD-830882-100G |
Cas.: 111-51-3 | Purity: 98% | N,N,N’,N’-Tetramethyl-1,4-diaminobutane | ESD-823751-5ML |
Cas.: 212009-06-8 | Purity: ≥95% | 2-((S)-1-tert-Butoxycarbonyl-pyrrolidin-2-yl)-thiazole-4-carboxylic acid ethyl ester | ESD-909489-1G |
Cas.: 212009-06-8 | Purity: ≥95% | 2-((S)-1-tert-Butoxycarbonyl-pyrrolidin-2-yl)-thiazole-4-carboxylic acid ethyl ester | ESD-909489-250MG |
Cas.: 212009-06-8 | Purity: ≥95% | 2-((S)-1-tert-Butoxycarbonyl-pyrrolidin-2-yl)-thiazole-4-carboxylic acid ethyl ester | ESD-909489-100MG |
Cas.: 9014-00-0 | Luciferase from |Vibrio fischeri| (Photobacterium f) | ESD-812670-5MG | |
Cas.: 1256788-26-7 | Purity: ≥95% | 3-cyclopropylpyridine-2-carbaldehyde | ESD-909490-1G |
Cas.: 1256788-26-7 | Purity: ≥95% | 3-cyclopropylpyridine-2-carbaldehyde | ESD-909490-250MG |
Cas.: 29113-34-6 | Purity: ≥97% | 4-Quinazolone-2-carboxylic Acid | ESD-851735-50MG |
Cas.: 356-12-7 | Purity: 98% | Fluocinonide | ESD-829986-1G |
Cas.: 14855-76-6 | Purity: 90% | Methyl Green | ESD-887411-25G |
Cas.: 1346533-28-5 | Purity: ≥95% | 3-Cyclopropyl-2-methylpyridine | ESD-909491-1G |
Cas.: 1346533-28-5 | Purity: ≥95% | 3-Cyclopropyl-2-methylpyridine | ESD-909491-250MG |
Cas.: 37704-45-3 | Purity: ≥95% | Methyl 7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine-8-carboxylate | ESD-909492-100MG |
Cas.: 37704-45-3 | Purity: ≥95% | Methyl 7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine-8-carboxylate | ESD-909492-250MG |
Cas.: 16919-27-0 | Purity: AR, 99.5% | Potassium hexafluorotitanate(IV) | ESD-816422-10KG |
Cas.: 1360552-57-3 | Purity: ≥95% | 5-Bromo-4-fluoropyrimidin-2-amine | ESD-909493-100MG |
Cas.: 1360552-57-3 | Purity: ≥95% | 5-Bromo-4-fluoropyrimidin-2-amine | ESD-909493-250MG |
Cas.: 1240568-16-4 | Purity: ≥95% | 1-Cyclopropyl-4-nitro-1H-pyrazole | ESD-909494-1G |
Cas.: 1240568-16-4 | Purity: ≥95% | 1-Cyclopropyl-4-nitro-1H-pyrazole | ESD-909494-250MG |
Cas.: 862731-66-6 | Purity: ≥99% | 1-octyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide | ESD-857254-5G |
Cas.: 862731-66-6 | Purity: ≥99% | 1-octyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide | ESD-857254-1G |
Cas.: 33879-32-2 | Purity: 97% | (S)-2-Amino-3-(3-methoxyphenyl)propanoic acid | ESD-842119-5G |
Cas.: 13600-33-4 | Purity: 98% | 2-(1H-Tetrazol-5-yl)pyrimidine | ESD-887206-250MG |
Cas.: XBPY | Purity: 5X | RNase-Free Phosphate Buffered Saline | ESD-909495-250ML |
Cas.: XBPY | Purity: 5X | RNase-Free Phosphate Buffered Saline | ESD-909495-100ML |
Cas.: 39450-01-6 | Purity: >30U/mg, 20mg/ml in H2O | Proteinase K Solution | ESD-909496-1ML |
Cas.: 39450-01-6 | Purity: >30U/mg, 20mg/ml in H2O | Proteinase K Solution | ESD-909496-5ML |
Cas.: 39450-01-6 | Purity: >30U/mg, 20mg/ml in H2O | Proteinase K Solution | ESD-909496-0.5ML |
Cas.: 553-86-6 | Purity: 98% | 2-Coumaranone | ESD-804467-500G |
Cas.: 1679-53-4 | Purity: 96% | 10-Hydroxydecanoic acid | ESD-811330-100G |
Cas.: 56001-37-7 | Purity: ≥90% | Guanosine-5′-triphosphate disodium salt | ESD-810729-25G |
Cas.: 10039-54-0 | Purity: AR, 99.0% | Hydroxylamine sulfate | ESD-810903-10KG |
Cas.: 94-63-3 | Purity: BR | Pralidoxime Iodide | ESD-873668-25MG |
Cas.: 94-63-3 | Purity: BR | Pralidoxime Iodide | ESD-873668-100MG |
Cas.: 94-63-3 | Purity: BR | Pralidoxime Iodide | ESD-873668-500MG |
Cas.: 79-40-3 | Purity: 98% | Dithiooxamide | ESD-807255-25G |
Cas.: 94-63-3 | Purity: 99% | Pralidoxime Iodide | ESD-909497-5G |
Cas.: 94-63-3 | Purity: 99% | Pralidoxime Iodide | ESD-909497-25G |
Cas.: 94-63-3 | Purity: 99% | Pralidoxime Iodide | ESD-909497-100G |
Cas.: 35825-57-1 | Purity: 98% | Cryptotanshinone | ESD-804308-1G |
Cas.: 7721-01-9 | Purity: 99.99% trace metals basis | Tantalum(V) chloride | ESD-822484-100G |
Cas.: 2702-72-9 | Purity: 98% | 2,4-Dichlorophenoxyacetic acid | ESD-806831-25G |
Cas.: 34576-94-8 | Purity: ≥95% | 3,6-Dichloro-1-benzothiophene-2-carboxylic acid | ESD-909498-1G |
Cas.: 34576-94-8 | Purity: ≥95% | 3,6-Dichloro-1-benzothiophene-2-carboxylic acid | ESD-909498-250MG |
Cas.: 57-50-1 | Purity: ≥99.9%; RNase, DNase Free | Sucrose | ESD-818046-2.5KG |
Cas.: 32171-39-4 | MW1000 | POLY(ETHYLENE GLYCOL) METHYL ETHER ACRYL ATE | ESD-902352-100G |
Cas.: 113269-07-1 | Purity: ≥95% | 4-Bromo-5-nitrobenzene-1,2-diamine | ESD-901039-25MG |
Cas.: 112163-33-4 | Purity: ≥95%(SDS-PAGE) | Lactoferrin | ESD-902428-5G |
Cas.: 84268-36-0 | Purity: ≥97% | 3-(3-(2H-Benzo[d][1,2,3]triazol-2-yl)-5-(tert-butyl)-4-hydroxyphenyl)propanoic acid | ESD-860291-5G |
Cas.: 25322-68-3 | Purity: average Mv ~600, 000, powder | Poly(ethylene glycol) | ESD-815462-1KG |
Cas.: 65360-27-2 | Purity: 95% | Boc-D-Lys(Boc)-OH | ESD-845352-1G |
Cas.: 65360-27-2 | Purity: 95% | Boc-D-Lys(Boc)-OH | ESD-845352-5G |
Cas.: 14915-37-8 | Purity: ≥97% | Bis[1-Hydroxypyridine-2(1H)-Thionato-S,O]Copper(II) | ESD-857937-25G |
Cas.: 133115-55-6 | Purity: 97% | (3-(Trifluoromethoxy)phenyl)hydrazine hydrochloride | ESD-844369-5G |
Cas.: 133115-55-6 | Purity: 97% | (3-(Trifluoromethoxy)phenyl)hydrazine hydrochloride | ESD-844369-25G |
Cas.: 6851-99-6 | Purity: 97% | 2-Bromo-2′-nitroacetophenone | ESD-803799-100G |
Cas.: 19817-92-6 | Purity: 98% biotech grade | Uridine 5′-triphosphate trisodium salt hydrate | ESD-6096-25G |
Cas.: 52432-72-1 | Purity: 98% | OxeladinCitrate | ESD-872163-100MG |
Cas.: 49842-07-1 | Purity: GR | Tobramycin sulfate | ESD-873610-25MG |
Cas.: 10075-52-2 | Purity: ≥98% | 5-Bromo-1-Methylindole | ESD-859416-5G |
Cas.: 21211-18-7 | Purity: ≥95% | Methyl 3,6-dichlorobenzo[b]thiophene-2-carboxylate | ESD-909499-1G |
Cas.: 8006-28-8 | Purity: medical grade, white | Soda lime | ESD-861574-10KG |
Cas.: 151772-24-6 | Purity: ≥95% | 2,4-dichloro-6-methoxyquinoline-3-carbaldehyde | ESD-909500-1G |
Cas.: 151772-24-6 | Purity: ≥95% | 2,4-dichloro-6-methoxyquinoline-3-carbaldehyde | ESD-909500-250MG |
Cas.: 74630-73-2 | Purity: ≥95% | 6-Phenylimidazo[2,1-b]thiazole-5-carbaldehyde | ESD-909501-1G |
Cas.: 74630-73-2 | Purity: ≥95% | 6-Phenylimidazo[2,1-b]thiazole-5-carbaldehyde | ESD-909501-5G |
Cas.: 2650-50-2 | Purity: ≥98% | Trimethylpropylammonium Bromide | ESD-867558-25G |
Cas.: 885126-34-1 | Purity: ≥95% | 2-[(3-iodo-2H-indazol-6-yl)sulfanyl]-N-methylbenzamide | ESD-909502-1G |
Cas.: 885126-34-1 | Purity: ≥95% | 2-[(3-iodo-2H-indazol-6-yl)sulfanyl]-N-methylbenzamide | ESD-909502-5G |
Cas.: NONE8055 | MW~10000 | PS4-AZ | ESD-909503-1G |
Cas.: NONE8055 | MW~10000 | PS4-AZ | ESD-909503-5G |
Cas.: NONE8055 | MW~5000 | PS4-AZ | ESD-909504-1G |
Cas.: NONE8055 | MW~5000 | PS4-AZ | ESD-909504-5G |
Cas.: NONE8055 | MW~2000 | PS4-AZ | ESD-909505-1G |
Cas.: NONE8055 | MW~2000 | PS4-AZ | ESD-909505-5G |
Cas.: 16788-57-1 | Purity: 99.99% metals basis | Potassium phosphate dibasic trihydrate | ESD-816399-2.5KG |
Cas.: 83048-65-1 | Purity: 97% | 1H,1H,2H,2H-Perfluorodecyltrimethoxysilane | ESD-820163-500G |
Cas.: 2420-16-8 | Purity: 98% | 3-Chloro-4-hydroxybenzaldehyde | ESD-831331-500G |
Cas.: 1282516-66-8 | Purity: 95% | 5-broMo-2-(1H-iMidazol-2-yl)phenol | ESD-909506-5G |
Cas.: 1282516-66-8 | Purity: 95% | 5-broMo-2-(1H-iMidazol-2-yl)phenol | ESD-909506-1G |
Cas.: 1282516-66-8 | Purity: 95% | 5-broMo-2-(1H-iMidazol-2-yl)phenol | ESD-909506-250MG |
Cas.: 14813-85-5 | Purity: 98% | 1-Phenyl-1H-benzo[d]imidazol-2(3H)-one | ESD-831663-250MG |
Cas.: 14813-85-5 | Purity: 98% | 1-Phenyl-1H-benzo[d]imidazol-2(3H)-one | ESD-831663-1G |
Cas.: 14813-85-5 | Purity: 98% | 1-Phenyl-1H-benzo[d]imidazol-2(3H)-one | ESD-831663-5G |
Cas.: 50995-74-9 | Purity: 98% | 7-(Diethylamino)coumarin-3-carboxylic Acid | ESD-838680-500MG |
Cas.: 136068-42-3 | Purity: 99% | 2-(4-cinnamoylphenoxy)acetic acid | ESD-903561-250MG |
Cas.: NONE8056 | Purity: industry grade | Dispersing agent 155 | ESD-909507-100G |
Cas.: NONE8056 | Purity: industry grade | Dispersing agent 155 | ESD-909507-500G |
Cas.: NONE8056 | Purity: industry grade | Dispersing agent 155 | ESD-909507-2.5KG |
Cas.: 20368-79-0 | Purity: ≥95% | Sodium 4-hydroxyphenyl phosphate | ESD-900912-25MG |
Cas.: 2161380-87-4 | Purity: ≥95% | 5-bromo-4-(4-chlorothiophen-2-yl)thiazol-2-amine | ESD-909508-1G |
Cas.: 2161380-87-4 | Purity: ≥95% | 5-bromo-4-(4-chlorothiophen-2-yl)thiazol-2-amine | ESD-909508-5G |
Cas.: 58-82-2 | Purity: >98% | Bradykinin | ESD-860430-50MG |
Cas.: 58-82-2 | Purity: >98% | Bradykinin | ESD-860430-250MG |
Cas.: 148819-94-7 | Purity: 98% | Carboxy-PTIO potassium salt | ESD-885955-10MG |
Cas.: 547-91-1 | Purity: for spectrophotometric det. of Fe(III), ≥98.5% | Ferron | ESD-909509-25G |
Cas.: 16564-43-5 | Purity: 98% | Glycochenodeoxycholic acid sodium | ESD-835600-250MG |
Cas.: 151213-42-2 | Purity: 99% | (S,S)-2,8-Diazabicyclo[4,3,0]nonane | ESD-834102-1G |
Cas.: 409-21-2 | Purity: 99.9%, 1-2um | Silicon carbide | ESD-888680-500G |
Cas.: 570403-14-4 | Purity: ≥95% | (3-Chloro-5-([4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]carbamoyl)-2-pyridine Yl) piperidine-4- carboxylic acid ethyl ester | ESD-909510-5G |
Cas.: 570403-14-4 | Purity: ≥95% | (3-Chloro-5-([4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]carbamoyl)-2-pyridine Yl) piperidine-4- carboxylic acid ethyl ester | ESD-909510-1G |
Cas.: 6283-63-2 | Purity: for spectrophotometric det. of S2-, Cl2, ≥99% | 4-Amino-N,N-diethylaniline sulfate salt | ESD-909511-25G |
Cas.: 5672-89-9 | Purity: ≥95% | N-Succinimidyl Trifluoroacetate | ESD-867802-1G |
Cas.: 143314-16-3 | Purity: 98% | 1-Ethyl-3-methylimidazolium tetrafluoroborate | ESD-809293-500G |
Cas.: 7144-08-3 | Purity: 98% | Cholesteryl chloroformate | ESD-804851-5G |
Cas.: 1044764-21-7 | Ethanone,2-amino-1-[4-hydroxy-3-(hydroxymethyl)phenyl]-hydrochloride(1:1) | ESD-909512-1G | |
Cas.: 64-86-8 | Purity: 98% | Colchicine | ESD-804813-25G |
Cas.: 1044764-21-7 | Ethanone,2-amino-1-[4-hydroxy-3-(hydroxymethyl)phenyl]-hydrochloride(1:1) | ESD-909512-5G | |
Cas.: 503068-36-8 | Purity: ≥95% | (R)-3-(6-(2-((2,6-dichlorobenzyl)oxy)ethoxy)hexyl)-5-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6 -yl)oxazolidin-2-one | ESD-909513-100MG |
Cas.: 7790-99-0 | Purity: AR | Iodine monochloride | ESD-811646-2.5KG |
Cas.: 155742-64-6 | Purity: 98% | Methyl 2-(2-chloro-1-iminoethyl)-hydrazinecarboxylate | ESD-835871-100G |
Cas.: 503068-37-9 | Purity: ≥95% | (1R)-2-({6-[(2-{[(2,6-dichlorophenyl)methyl]oxy}ethyl)oxy]-hexyl}amino)-1-(2,2-dimethyl-4H-1, 3-benzodioxin-6-yl)ethanol | ESD-909515-50MG |
Cas.: 1914-99-4 | Purity: for spectrophotometric det. of alkaline earth metals | Chlorophosphonazo III | ESD-909514-25MG |
Cas.: 503068-37-9 | Purity: ≥95% | (1R)-2-({6-[(2-{[(2,6-dichlorophenyl)methyl]oxy}ethyl)oxy]-hexyl}amino)-1-(2,2-dimethyl-4H-1, 3-benzodioxin-6-yl)ethanol | ESD-909515-10MG |
Cas.: 99445-21-3 | Purity: ≥95% | N-METHYL-3-PYRROLIDINOL | ESD909516-20MG |
Cas.: 20083-34-5 | Purity: >95.0%(GC) | Triethoxy(pentafluorophenyl)silane | ESD-863786-5G |
Cas.: 7790-62-7 | Purity: 98% | Potassium pyrosulfate | ESD-816382-2.5KG |
Cas.: 474922-20-8 | Purity: >99% | 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[carboxy(polyethylene glycol)-2000] (ammonium salt) | ESD-864426-100MG |
Cas.: 663921-15-1 | Purity: 95% | α-Amine-ω-propionic acid tetraethylene glycol hydrochloride | ESD-855481-500MG |
Cas.: 106877-33-2 | Purity: 98% | 5-AMINO-2-(TRIFLUOROMETHYL)PYRIDINE | ESD-833540-5G |
Cas.: 18412-57-2 | Purity: ≥95% | Triethoxy(p-tolyl)silane | ESD-866323-5G |
Cas.: 30318-99-1 | Purity: 95% | 3-Bromo-4-methylthiophene | ESD-804011-1G |
Cas.: 5118-13-8 | Purity: 95% | 4-Bromobenzo[b]thiophene | ESD-832616-5G |
Cas.: 17306-46-6 | Purity: 99% | Rhoifolin | ESD-817354-25MG |
Cas.: 23145-07-5 | Purity: 97% | 5-Bromobenzofuran | ESD-830473-1G |
Cas.: 23145-07-5 | Purity: 97% | 5-Bromobenzofuran | ESD-830473-5G |
Cas.: 10030-73-6 | Purity: 98% | Palmitelaidic Acid | ESD-860714-100MG |
Cas.: 57675-44-2 | Purity: 98% | Trimethylolpropane trioleate | ESD-844072-5G |
Cas.: 4404-45-9 | Purity: ≥98% | Hexyl Isothiocyanate | ESD-859976-25G |
Cas.: 339539-94-5 | Purity: 90% | 1,1,2-trimethylhydrazine,dihydrochloride | ESD-829943-250MG |
Cas.: 289042-12-2 | Purity: 98% | tert-Butyl 6-[(1E)-2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]ehenyl]-2,2- dimethyl-1,3-dioxane-4-acetate | ESD-888448-100G |
Cas.: 106820-63-7 | Purity: 98% | Methyl 3-[(methoxycarbonylmethyl)sulfamoyl]thiophene-2-carboxylate | ESD-909517-100G |
Cas.: 106820-63-7 | Purity: 98% | Methyl 3-[(methoxycarbonylmethyl)sulfamoyl]thiophene-2-carboxylate | ESD-909517-25G |
Cas.: 98827-44-2 | Purity: 95% | Methyl 4-hydroxy-2H-thieno[2,3-e][1,2]thiazine-3-carboxylate 1,1-dioxide | ESD-909518-1G |
Cas.: 98827-44-2 | Purity: 95% | Methyl 4-hydroxy-2H-thieno[2,3-e][1,2]thiazine-3-carboxylate 1,1-dioxide | ESD-909518-5G |
Cas.: 7789-00-6 | Purity: 99.5% metals basis | Potassium chromate | ESD-816731-10KG |
Cas.: 59804-25-0 | Purity: 95% | Methyl 4-hydroxy-2-methyl-2H-thieno[2,3-e][1,2]thiazine-3-carboxylate 1,1-dioxide | ESD-909519-5G |
Cas.: 59804-25-0 | Purity: 95% | Methyl 4-hydroxy-2-methyl-2H-thieno[2,3-e][1,2]thiazine-3-carboxylate 1,1-dioxide | ESD-909519-25G |
Cas.: 58584-92-2 | Purity: ≥97% | 2-Amino-6-chloronicotinic acid | ESD-858694-5G |
Cas.: 58584-92-2 | Purity: ≥97% | 2-Amino-6-chloronicotinic acid | ESD-858694-25G |
Cas.: 3260-85-3 | Purity: 97% | 5-Chloro-2-methoxytoluene | ESD-869461-5G |
Cas.: 60-10-6 | Purity: ACS reagent, for spectrophotometric det. of Cd, Cu, Hg, Pb, Zn, ≥98%(TLC) | Dithizone | ESD-909520-5G |
Cas.: 158439-31-7 | Purity: 95% | Dimethyl3-(chlorosulfonyl)thiophene-2,5-dicarboxylate | ESD-909521-1G |
Cas.: 158439-31-7 | Purity: 95% | Dimethyl3-(chlorosulfonyl)thiophene-2,5-dicarboxylate | ESD-909521-5G |
Cas.: 906522-87-0 | Purity: 95% | Methyl 5-chloro-3-(N-(2-methoxy-2-oxoethyl)sulfamoyl)thiophene-2-carboxylate | ESD-909522-1G |
Cas.: 34246-96-3 | Purity: >96.0%(GC) | 1-Methoxypyrene | ESD-857447-500MG |
Cas.: 906522-87-0 | Purity: 95% | Methyl 5-chloro-3-(N-(2-methoxy-2-oxoethyl)sulfamoyl)thiophene-2-carboxylate | ESD-909522-5G |
Cas.: 4221-98-1 | Purity: ≥65%(GC) | (-)-α-Phellandrene | ESD-862198-25ML |
Cas.: 148440-81-7 | Purity: 95% | Thioperamide maleate | ESD-905506-25MG |
Cas.: 819-83-0 | Purity: 95% | β-sodium glycerophosphate | ESD-909398-500G |
Cas.: 4105-21-9 | Purity: ≥98% | 2-Phenylimidazo[1,2-a]pyridine | ESD-866753-5G |
Cas.: 819-83-0 | Purity: 95% | β-sodium glycerophosphate | ESD-909398-100G |
Cas.: 819-83-0 | Purity: 95% | β-sodium glycerophosphate | ESD-909398-25G |
Cas.: 50668-21-8 | Purity: 98% | 3-Iodo-9-ethylcarbazole | ESD-888085-1G |
Cas.: 70374-51-5 | Purity: 95% | Methyl 6-chloro-4-hydroxy-2H-thieno[2,3-e][1,2]thiazine-3-carboxylate 1,1-dioxide | ESD-909523-5G |
Cas.: 377085-58-0 | Purity: Analysis control | 4-Carbamoyl-1-hexadecylpyridinium Chloride | ESD-909524-25MG |
Cas.: 70415-50-8 | Purity: 95% | 6-Chloro-4-hydroxy-2-methyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxylic acid methyl ester 1,1-dioxide | ESD-909525-1G |
Cas.: 70415-50-8 | Purity: 95% | 6-Chloro-4-hydroxy-2-methyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxylic acid methyl ester 1,1-dioxide | ESD-909525-5G |
Cas.: 70415-50-8 | Purity: 95% | 6-Chloro-4-hydroxy-2-methyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxylic acid methyl ester 1,1-dioxide | ESD-909525-25G |
Cas.: 7558-80-7 | Purity: AR, 99.0% | Sodium dihydngen phoshate anhydrous | ESD-817781-10KG |
Cas.: 33528-09-5 | Purity: ≥95% | Methyl 2-hydroxy-6-methylbenzoate | ESD-895558-1G |
Cas.: 4670-56-8 | Purity: >97% | Methyl 2-hydroxy-4-methylbenzoate | ESD-837349-25G |
Cas.: 4670-56-8 | Purity: >97% | Methyl 2-hydroxy-4-methylbenzoate | ESD-837349-100G |
Cas.: 81335-77-5 | Purity: 98% | Imazethapyr | ESD-873346-500G |
Cas.: 13943-58-3 | Purity: 99% | Potassium hexacyanoferrate | ESD-871954-2.5KG |
Cas.: 106989-11-1 | Purity: Carboxyl terminal, MW~150000 | Poly(D-lactide)(PDLA) | ESD-909526-100MG |
Cas.: 106989-11-1 | Purity: Carboxyl terminal, MW~150000 | Poly(D-lactide)(PDLA) | ESD-909526-500MG |
Cas.: 106989-11-1 | Purity: Carboxyl terminal, MW~150000 | Poly(D-lactide)(PDLA) | ESD-909526-1G |
Cas.: 31108-57-3 | Purity: 98% | 1H-Pyrazole-4-carbonitrile | ESD-841407-25G |
Cas.: 27138-31-4 | Purity: 80% | Di(propylene glycol) dibenzoate | ESD-807471-250ML |
Cas.: 6780-13-8 | Purity: 98% | Ethylenediamine monohydrate | ESD-809067-25ML |
Cas.: NONE7968 | Purity: Epoxy Degree: 50% | Epoxy natural rubber | ESD-909333-10KG |
Cas.: NONE7968 | Purity: Epoxy Degree: 50% | Epoxy natural rubber | ESD-909333-2.5KG |
Cas.: 25086-89-9 | Purity: 50% Ethanol solution (Copolymer, 7:3) | Poly(1-vinylpyrrolidone-co-vinyl acetate) | ESD-816061-2.5KG |
Cas.: NONE7968 | Purity: Epoxy Degree: 50% | Epoxy natural rubber | ESD-909333-500G |
Cas.: 1447761-46-7 | Purity: ≥95% | 2-bromo-5-(tributylstannyl)thiazole | ESD-826616-1G |
Cas.: 105445-58-7 | Purity: ≥95% | 2-(tributylstannyl)benzo[d]thiazole | ESD-825803-5G |
Cas.: 243972-26-1 | Purity: ≥95% | Tert-butyl 5-(tributylstannyl)thiazol-2-ylcarbamate | ESD-826199-5G |
Cas.: 64099-82-7 | Purity: ≥95% | Tributyl(prop-1-ynyl)stannane | ESD-826836-5G |
Cas.: 1002-57-9 | Purity: 99% | 8-Aminooctanoic acid | ESD-833402-5G |
Cas.: 1002-57-9 | Purity: 99% | 8-Aminooctanoic acid | ESD-833402-25G |
Cas.: 259793-96-9 | Purity: 98% | Favipiravir | ESD-873754-500MG |
Cas.: 7803-68-1 | Purity: 98% | Telluric acid | ESD-819497-500G |
Cas.: 394-50-3 | Purity: 97% | 3-Fluorosalicylaldehyde | ESD-810313-25G |
Cas.: 50995-74-9 | Purity: 98% | 7-(Diethylamino)coumarin-3-carboxylic Acid | ESD-838680-1G |
Cas.: 66680-86-2 | Purity: 95% | tributyl(2-methylprop-1-enyl)stannane | ESD-909528-250MG |
Cas.: 932-72-9 | Purity: 95% | (Dichloroiodo)-Benzene | ESD-856661-1G |
Cas.: 7369-50-8 | Purity: 99% | 1-Ethyl-3-nitrobenzene | ESD-909529-250MG |
Cas.: 7369-50-8 | Purity: 99% | 1-Ethyl-3-nitrobenzene | ESD-909529-1G |
Cas.: 7369-50-8 | Purity: ≥95% | 1-Ethyl-3-nitrobenzene | ESD-901378-1G |
Cas.: 122-19-0 | Purity: 98% | Benzyldimethylstearylammonium Chloride | ESD-854769-500G |
Cas.: 56100-22-2 | Purity: 97% | 6-Methyl-2,2′-Bipyridine | ESD-837157-250MG |
Cas.: 369-26-6 | Purity: ≥95% | Methyl 3-amino-4-fluorobenzoate | ESD-826681-5G |
Cas.: 369-26-6 | Purity: ≥95% | Methyl 3-amino-4-fluorobenzoate | ESD-826681-100G |
Cas.: 10534-59-5 | Purity: 98% | Tetrabutylammonium acetate | ESD-819400-2.5KG |
Cas.: 4496-49-5 | Purity: ≥97% | 4-tert-Butyl-N-phenylaniline | ESD-853425-250MG |
Cas.: 1214377-42-0 | Purity: ≥95% | 5-bromo-3-(trifluoromethyl)-2-methoxypyridine | ESD-826572-1G |
Cas.: 1214377-42-0 | Purity: ≥95% | 5-bromo-3-(trifluoromethyl)-2-methoxypyridine | ESD-826572-25G |
Cas.: 191606-78-7 | Purity: 95% | 1-Methyl-5-(tributylstannyl)-3-(trifluoromethyl)-1H-pyrazole | ESD-909530-1G |
Cas.: 191606-78-7 | Purity: 95% | 1-Methyl-5-(tributylstannyl)-3-(trifluoromethyl)-1H-pyrazole | ESD-909530-5G |
Cas.: 191606-78-7 | Purity: 95% | 1-Methyl-5-(tributylstannyl)-3-(trifluoromethyl)-1H-pyrazole | ESD-909530-250MG |
Cas.: 176433-43-5 | Purity: 98% | 6-CHLORO-5-METHYLPYRIDINE-3-CARBALDEHYDE | ESD-909531-1G |
Cas.: 19430-93-4 | Purity: 99% | 1H,1H,2H-Perfluoro-1-hexene | ESD-888367-500G |
Cas.: 19430-93-4 | Purity: 99% | 1H,1H,2H-Perfluoro-1-hexene | ESD-888367-100G |
Cas.: 19430-93-4 | Purity: 99% | 1H,1H,2H-Perfluoro-1-hexene | ESD-888367-25G |
Cas.: 19430-93-4 | Purity: 99% | 1H,1H,2H-Perfluoro-1-hexene | ESD-888367-5G |
Cas.: 223556-07-8 | Purity: 95% | 2-Morpholino-5-(tributylstannyl)pyridine | ESD-909532-1G |
Cas.: 223556-07-8 | Purity: 95% | 2-Morpholino-5-(tributylstannyl)pyridine | ESD-909532-250MG |
Cas.: 11121-48-5 | Purity: 95% | FOOD RED NO 105 | ESD-885962-25G |
Cas.: 11121-48-5 | Purity: 95% | FOOD RED NO 105 | ESD-885962-100G |
Cas.: 63-42-3 | Purity: AR, 98% | Lactosum , anhydrous | ESD-812316-10KG |
Cas.: 21324-40-3 | Purity: 98% | Lithium hexafluorophosphate | ESD-822760-500G |
Cas.: 166526-03-0 | Purity: ≥95% | 4,6-dichloropyridine-3-carbonitrile | ESD-824962-1G |
Cas.: 1741-41-9 | Purity: ≥96%(GC) | Isobutyraldehyde Diethyl Acetal | ESD-862915-25ML |
Cas.: 166526-03-0 | Purity: ≥95% | 4,6-dichloropyridine-3-carbonitrile | ESD-824962-25G |
Cas.: 592-90-5 | Purity: ≥98%(GC) | Hexamethylene Oxide | ESD-863053-1ML |
Cas.: 2921-14-4 | Purity: 98% | O-(Carboxymethyl)hydroxylamine hemihydrochloride | ESD-805088-100G |
Cas.: 189195-41-3 | Purity: 95% | 5-Methyl-2-(tributylstannyl)pyridine | ESD-909533-1G |
Cas.: 189195-41-3 | Purity: 95% | 5-Methyl-2-(tributylstannyl)pyridine | ESD-909533-250MG |
Cas.: 528-48-3 | Purity: 98% | Fisetin | ESD-809598-1G |
Cas.: 63525-48-4 | Purity: 98% | 2,5-Dibromoterephthalaldehyde | ESD-856482-1G |
Cas.: 9039-53-6 | Purity: ≥85%, potency 50,000-60,000 IU/mg, specific activity 120,000 IU/mg | Urokinase from human urine | ESD-820333-1MG |
Cas.: 110-25-8 | Purity: 95% | 2-(N-Methyloleamido)acetic acid | ESD-843710-1KG |
Cas.: 194865-89-9 | Purity: 95% | 4-(Tributylstannyl)pyridazine | ESD-909534-100MG |
Cas.: 194865-89-9 | Purity: 95% | 4-(Tributylstannyl)pyridazine | ESD-909534-250MG |
Cas.: 16091-18-2 | Purity: 98% | 2,2-dioctyl-1,3,2-dioxastannepine-4,7-dione | ESD-909535-100G |
Cas.: 16091-18-2 | Purity: 98% | 2,2-dioctyl-1,3,2-dioxastannepine-4,7-dione | ESD-909535-25G |
Cas.: 653564-10-4 | Purity: 95% | tributyl-(2-methyl-1,3-thiazol-4-yl)stannane | ESD-909536-100MG |
Cas.: 653564-10-4 | Purity: 95% | tributyl-(2-methyl-1,3-thiazol-4-yl)stannane | ESD-909536-250MG |
Cas.: 136725-53-6 | Purity: 97% | (S)-3-Fluoropyrrolidine hydrochloride | ESD-844871-5G |
Cas.: 1341-38-4 | Purity: ≥98% | 6-Methylheptyl palmitate | ESD-859293-2.5KG |
Cas.: 1405-41-0 | Purity: USP, biotech grade | Gentamycin Sulfate | ESD-6065-100G |
Cas.: 1405-41-0 | Purity: USP, biotech grade | Gentamycin Sulfate | ESD-6065-500G |
Cas.: 769-21-1 | Purity: 95% | 5-Chloro-2,3-dihydrobenzofuran-3-amine | ESD-909537-1G |
Cas.: 769-21-1 | Purity: 95% | 5-Chloro-2,3-dihydrobenzofuran-3-amine | ESD-909537-250MG |
Cas.: 2133-40-6 | Purity: 98% | L-Proline methyl ester hydrochloride | ESD-816051-500G |
Cas.: 1338934-59-0 | Purity: 95% | 7-Hydroxy-6-methoxy-4-methyl-3-(2-morpholino-2-oxoethyl)-2-oxo-2H-chromene-8-carbaldehyde | ESD-909538-100MG |
Cas.: 1338934-59-0 | Purity: 95% | 7-Hydroxy-6-methoxy-4-methyl-3-(2-morpholino-2-oxoethyl)-2-oxo-2H-chromene-8-carbaldehyde | ESD-909538-250MG |
Cas.: 9001-32-5 | Purity: from bovine plasma | Fibrinogen | ESD-823834-5G |
Cas.: 1338934-59-0 | Purity: 95% | 7-Hydroxy-6-methoxy-4-methyl-3-(2-morpholino-2-oxoethyl)-2-oxo-2H-chromene-8-carbaldehyde | ESD-909538-50MG |
Cas.: 23783-42-8 | Purity: 98% | TETRAETHYLENEGLYCOL MONOMETHYL ETHER | ESD-831152-1G |
Cas.: 23783-42-8 | Purity: 98% | TETRAETHYLENEGLYCOL MONOMETHYL ETHER | ESD-831152-100G |
Cas.: 371-27-7 | Purity: ≥98% | 2,2,2-Trifluoroethyl Butyrate | ESD-865145-25G |
Cas.: 1403257-80-6 | Purity: 95% | 5-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-2 -methylbenzamide | ESD-909539-100MG |
Cas.: 1403257-80-6 | Purity: 95% | 5-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-2 -methylbenzamide | ESD-909539-250MG |
Cas.: 103-16-2 | Purity: 99,5% | 4-(Benzyloxy)phenol | ESD-909541-100G |
Cas.: 103-16-2 | Purity: 99,5% | 4-(Benzyloxy)phenol | ESD-909541-25G |
Cas.: 52262-58-5 | Tin(II) fluorophosphate | ESD-909540-1G | |
Cas.: 103-16-2 | Purity: 99,5% | 4-(Benzyloxy)phenol | ESD-909541-5G |
Cas.: 13651-14-4 | Purity: 95% | (2,3-Dimethylphenyl)methanol | ESD-839465-25G |
Cas.: 171364-78-6 | Purity: 98% | |N|,|N|-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-808065-25G |
Cas.: 110-36-1 | Purity: ≥97%(GC) | Butyl Myristate | ESD-862608-100ML |
Cas.: 63428-84-2 | Purity: Amine value: 380~420mgKOH/g, Viscosity (40℃): 2000~7000mpa.s | Polyamide curing agent (651) | ESD-875293-5KG |
Cas.: 1204580-81-3 | Purity: 95% | 4-Methyl-3-(tributylstannyl)pyridine | ESD-909542-100MG |
Cas.: 1204580-81-3 | Purity: 95% | 4-Methyl-3-(tributylstannyl)pyridine | ESD-909542-250MG |
Cas.: NONE6720 | Purity: Boronamine, amine value: 80~120mgKOH/g | Amine Curing agent | ESD-875180-1KG |
Cas.: 5579-84-0 | Purity: 99% | Betahistine dihydrochloride | ESD-802106-100G |
Cas.: 2438-80-4 | Purity: 99% | L-(-)-Fucose | ESD-809667-100G |
Cas.: 530-56-3 | Purity: ≥97% | 4-Hydroxy-3,5-dimethoxybenzyl alcohol | ESD-873639-250MG |
Cas.: 81098-60-4 | Purity: 99% | Cisapride | ESD-858067-1G |
Cas.: 530-56-3 | Purity: ≥97% | 4-Hydroxy-3,5-dimethoxybenzyl alcohol | ESD-873639-1G |
Cas.: 530-56-3 | Purity: ≥97% | 4-Hydroxy-3,5-dimethoxybenzyl alcohol | ESD-873639-50MG |
Cas.: 148961-81-3 | Purity: 95% | Benzofuran-2-yltributylstannane | ESD-909544-1G |
Cas.: 148961-81-3 | Purity: 95% | Benzofuran-2-yltributylstannane | ESD-909544-250MG |
Cas.: 2373-76-4 | Purity: ≥98% | 2-Methylcinnamic Acid | ESD-854636-100G |
Cas.: 130878-68-1 | Purity: 97% | Fmoc-Val-OSu | ESD-809423-100G |
Cas.: 8008-74-0 | Purity: 98% | Sesame oil | ESD-905725-50ML |
Cas.: 531-18-0 | Purity: 95% | ((1,3,5-Triazine-2,4,6-triyl)tris(azanetriyl))hexamethanol | ESD-843956-5G |
Cas.: 531-18-0 | Purity: 95% | ((1,3,5-Triazine-2,4,6-triyl)tris(azanetriyl))hexamethanol | ESD-843956-25G |
Cas.: 531-18-0 | Purity: 95% | ((1,3,5-Triazine-2,4,6-triyl)tris(azanetriyl))hexamethanol | ESD-843956-100G |
Cas.: 531-18-0 | Purity: 95% | ((1,3,5-Triazine-2,4,6-triyl)tris(azanetriyl))hexamethanol | ESD-843956-500G |
Cas.: 1204580-74-4 | Purity: 95% | 5-Methoxy-3-(tributylstannyl)pyridine | ESD-909545-1G |
Cas.: 1204580-74-4 | Purity: 95% | 5-Methoxy-3-(tributylstannyl)pyridine | ESD-909545-250MG |
Cas.: 167556-64-1 | Purity: 95% | 2-Methyl-5-(tributylstannyl)pyridine | ESD-909546-250MG |
Cas.: 8024-22-4 | Purity: 99% | Grape seed oil | ESD-905678-2.5L |
Cas.: 1210-83-9 | Purity: 98% | N-Acetyl-5-hydroxytryptamine | ESD-870484-50MG |
Cas.: NONE8057 | Tetramethylrhodamine-5-(and-6)-maleimide | ESD-909548-25MG | |
Cas.: 821-38-5 | Purity: 98% | Tetradecanedioic acid | ESD-819645-500G |
Cas.: 15658-35-2 | Purity: 97% | 6,6′-Dithiodinicotinic Acid | ESD-838679-1G |
Cas.: 10035-01-5 | Purity: 99.9% metals basis | Ytterbium(III) chloride hexahydrate | ESD-820642-500G |
Cas.: 23180-57-6 | Purity: ≥98%(HPLC) | Paeoniflorin | ESD-815486-1G |
Cas.: 189083-81-6 | Purity: 95% | (6-bromopyridin-2-yl)-tributylstannane | ESD-909549-1G |
Cas.: 189083-81-6 | Purity: 95% | (6-bromopyridin-2-yl)-tributylstannane | ESD-909549-250MG |
Cas.: 1304-82-1 | Purity: 99.9% metals basis | Bismuth telluride | ESD-886009-500G |
Cas.: 458-37-7 | Purity: 98% | Curcumin | ESD-805206-500G |
Cas.: 198481-32-2 | Purity: 98% | Bazedoxifene | ESD-880792-50MG |
Cas.: 161337-67-3 | Purity: ≥90.0% | Hafnium trifluoromethanesulfonate | ESD-832804-200MG |
Cas.: NONE8058 | 5(6)-FAM cadaverine | ESD-909550-1G | |
Cas.: 259793-96-9 | Purity: 98% | Favipiravir | ESD-873754-5G |
Cas.: 1094072-15-7 | Purity: 97% | tributyl-(3-methoxypyridin-2-yl)stannane | ESD-909551-1G |
Cas.: 1094072-15-7 | Purity: 97% | tributyl-(3-methoxypyridin-2-yl)stannane | ESD-909551-250MG |
Cas.: 1204580-72-2 | Purity: 95% | 2-Methoxy-4-(tributylstannyl)pyridine | ESD-909552-1G |
Cas.: 1204580-72-2 | Purity: 95% | 2-Methoxy-4-(tributylstannyl)pyridine | ESD-909552-250MG |
Cas.: 1006585-56-3 | Purity: 95% | 5-FAM cadaverine | ESD-909553-100MG |
Cas.: 446286-25-5 | Purity: 95% | 2-Chloro-4-(tributylstannyl)pyrimidine | ESD-909554-250MG |
Cas.: 446286-25-5 | Purity: 95% | 2-Chloro-4-(tributylstannyl)pyrimidine | ESD-909554-100MG |
Cas.: NONE8060 | 5-((5-Aminopentyl)thioureidyl)fluorescein | ESD-909555-5MG | |
Cas.: 2716-23-6 | Purity: 95% | Bicyclo[2.2.2]octan-2-one | ESD-839185-1G |
Cas.: 2716-23-6 | Purity: 95% | Bicyclo[2.2.2]octan-2-one | ESD-839185-500MG |
Cas.: 27490-32-0 | Purity: 95% | Tributyl(methoxymethyl)stannane | ESD-909556-1G |
Cas.: 8000-78-0 | Purity: 99% | Garlic Oil | ESD-823667-2.5KG |
Cas.: 8000-78-0 | Purity: 99% | Garlic Oil | ESD-823667-100G |
Cas.: 76375-60-5 | Purity: 98% | (3R,4R,5R,6R)-3-Acetamido-6-(acetoxymethyl)tetrahydro-2H-pyran-2,4,5-triyl triacetate | ESD-843789-5G |
Cas.: 76375-60-5 | Purity: 98% | (3R,4R,5R,6R)-3-Acetamido-6-(acetoxymethyl)tetrahydro-2H-pyran-2,4,5-triyl triacetate | ESD-843789-25G |
Cas.: 2646-30-2 | Purity: 97% | 1-(4-Bromophenyl)-2-thiourea | ESD-834375-100G |
Cas.: 57583-34-3 | Purity: 98% | 2-ethylhexyl 2-[bis[[2-(2-ethylhexoxy)-2-oxoethyl]sulfanyl]-methylstannyl]sulfanylacetate | ESD-909558-1KG |
Cas.: 57583-34-3 | Purity: 98% | 2-ethylhexyl 2-[bis[[2-(2-ethylhexoxy)-2-oxoethyl]sulfanyl]-methylstannyl]sulfanylacetate | ESD-909558-500G |
Cas.: 57583-34-3 | Purity: 98% | 2-ethylhexyl 2-[bis[[2-(2-ethylhexoxy)-2-oxoethyl]sulfanyl]-methylstannyl]sulfanylacetate | ESD-909558-5KG |
Cas.: 223437-11-4 | Purity: 98% | N-Butyl, methylpyrrolidinium bis(trifluoromethylsulfonyl)imide | ESD-801929-100G |
Cas.: 8049-11-4 | Purity: 300 Mesh | Devarda’s alloys | ESD-909559-500G |
Cas.: 8049-11-4 | Purity: 300 Mesh | Devarda’s alloys | ESD-909559-100G |
Cas.: 15894-70-9 | Purity: 98% | N,N”’-1,6-Hexanediylbis(N’-cyanoguanidine) | ESD-843376-100G |
Cas.: 8049-11-4 | Purity: 300 Mesh | Devarda’s alloys | ESD-909559-2.5KG |
Cas.: 51336-94-8 | Purity: 98% | 2-Chloro-2′,4′-difluoroacetophenone | ESD-806036-100G |
Cas.: 17375-41-6 | Purity: 90% | Ferrous Sulphate Monohydrate | ESD-904377-5KG |
Cas.: 183545-05-3 | Purity: 96% | tributyl-(6-chloropyridin-3-yl)stannane | ESD-909560-250MG |
Cas.: 1785-61-1 | Purity: ≥97% | 1,3-Diethynylbenzene | ESD-864545-250MG |
Cas.: 26410-42-4 | Purity: 98% | Butylmercaptooxo-stannane | ESD-909561-1KG |
Cas.: 26410-42-4 | Purity: 98% | Butylmercaptooxo-stannane | ESD-909561-5KG |
Cas.: 823-22-3 | Purity: 98% | 5-Methyl-Delta-Valerolactone | ESD-832037-500G |
Cas.: 626-08-4 | Purity: 98% | 6-AZA-2-THIOURACIL | ESD-888649-250MG |
Cas.: NONE8061 | 5(6)-TAMRA cadaverine | ESD-909562-10MG | |
Cas.: 626-08-4 | Purity: 98% | 6-AZA-2-THIOURACIL | ESD-888649-1G |
Cas.: 626-08-4 | Purity: 98% | 6-AZA-2-THIOURACIL | ESD-888649-5G |
Cas.: NONE8062 | 5-TAMRA cadaverine | ESD-909563-5MG | |
Cas.: 477773-67-4 | Purity: 30% in H2O | PotassiuM Azeloycinate Diglycinate | ESD-856939-100G |
Cas.: 477773-67-4 | Purity: 30% in H2O | PotassiuM Azeloycinate Diglycinate | ESD-856939-25G |
Cas.: NONE8063 | 6-TAMRA cadaverine | ESD-909564-5MG | |
Cas.: 99740-64-4 | Purity: 98% | γ-divinyltriaMine propyMethyldiMethoxyl silane | ESD-904773-25G |
Cas.: 10342-97-9 | Purity: ≥98.0% (GC) | N,N-Diisopropylmethylamine | ESD-822445-1ML |
Cas.: 1101120-33-5 | Purity: ≥95% | Ethyl 5-((tert-Butoxycarbonyl)amino)pyrazolo[1,5-a]pyridine-3-carboxylate | ESD-890248-50MG |
Cas.: 4774-10-1 | Purity: ≥95% | 3-methoxypyrazin-2-amine | ESD-826238-250MG |
Cas.: 1101120-33-5 | Purity: ≥95% | Ethyl 5-((tert-Butoxycarbonyl)amino)pyrazolo[1,5-a]pyridine-3-carboxylate | ESD-890248-1G |
Cas.: 4774-10-1 | Purity: ≥95% | 3-methoxypyrazin-2-amine | ESD-826238-5G |
Cas.: 80775-39-9 | Purity: 95% | 3-Acetyl-2,5-dibromothiophene | ESD-856255-250MG |
Cas.: 80775-39-9 | Purity: 95% | 3-Acetyl-2,5-dibromothiophene | ESD-856255-5G |
Cas.: NONE8064 | Sulfodaminer 101 sulfonyl hydrazide | ESD-909565-5MG | |
Cas.: NONE8065 | Sulforhodamine 101 cadaverine sulfonamide | ESD-909566-5MG | |
Cas.: 7648-30-8 | Purity: 97% | Ethyl Iododifluoroacetate | ESD-856230-25G |
Cas.: 76115-06-5 | Purity: 98% | 4-(1,2,2-triphenylethenyl)phenol | ESD-856439-5G |
Cas.: NONE8066 | N-FMOC-ethylenediamine | ESD-909567-5G | |
Cas.: 13613-65-5 | Purity: 99% | (|R|)-(-)-3-Hydroxybutyric acid sodium salt | ESD-811520-5G |
Cas.: 4419-39-0 | Purity: 98% | Beclomethasone | ESD-829968-100MG |
Cas.: 63884-78-6 | Purity: 97% | 4′-Aminooctanophenone | ESD-869542-1G |
Cas.: 535-15-9 | Purity: 98% | Ethyl dichloroacetate | ESD-830701-5G |
Cas.: 118486-97-8 | Purity: 98% | 1-Methyl-2-(tri-n-butylstannyl)pyrrole | ESD-909568-250MG |
Cas.: 121-90-4 | Purity: 98% | 3-Nitrobenzoyl Chloride | ESD-823391-500G |
Cas.: 183322-18-1 | Purity: ≥98%(HPLC) | CP-335963 | ESD-833198-1G |
Cas.: 183322-18-1 | Purity: ≥98%(HPLC) | CP-335963 | ESD-833198-5G |
Cas.: 183322-18-1 | Purity: ≥98%(HPLC) | CP-335963 | ESD-833198-25G |
Cas.: NONE8067 | N-FMOC-cadaverine | ESD-909569-5G | |
Cas.: NONE8068 | Rhodamine B, hexyl ester, perchlorate | ESD-909570-10MG | |
Cas.: 100073-15-2 | Purity: ≥95% | Tributyl(prop-1-en-2-yl)stannane | ESD-826201-5G |
Cas.: 106-49-0 | Purity: for spectrophotometric det. of Au, Tl(III), W, ≥99% | р-Touidine | ESD-909572-100G |
Cas.: 27490-33-1 | Purity: ≥95% | (Tributylstannyl)methanol | ESD-826676-5G |
Cas.: 910-31-6 | Purity: >95.0%(HPLC) | Cholesteryl chloride | ESD-863560-5G |
Cas.: NONE8069 | DiD triflate | ESD-909574-10MG | |
Cas.: 563-45-1 | Purity: 12.5% in tetrahydrofuran, 1.5mol/L | 3-Methyl-1-butenethis | ESD-875104-1ML |
Cas.: 563-45-1 | Purity: 12.5% in tetrahydrofuran, 1.5mol/L | 3-Methyl-1-butenethis | ESD-875104-5ML |
Cas.: 765916-82-3 | Purity: 95% | tributyl-(3,5-difluoropyridin-4-yl)stannane | ESD-909575-5G |
Cas.: 765916-82-3 | Purity: 95% | tributyl-(3,5-difluoropyridin-4-yl)stannane | ESD-909575-1G |
Cas.: 68-11-1 | Purity: ~80% in H2O, for spectrophotometric det. of palladium, iron, uranium(VI), molybdates and nitrites | Thioglycolic acid solution | ESD-909576-250ML |
Cas.: 14212-87-4 | Purity: 97% | 1,1-Bis(morpholino)ethylene | ESD-869628-250MG |
Cas.: 528543-96-6 | Purity: 97% | 1,3,5-tri(1H-Imidazol-1-yl)benzene | ESD-856195-5G |
Cas.: 10031-43-3 | Purity: AR, 99% | Copper nitrate trihydrate | ESD-805305-10KG |
Cas.: 34302-69-7 | Purity: for spectrophotometric det. of Cu, ≥99% | Neocuproine | ESD-909577-1G |
Cas.: NONE8070 | DiIC12(3) triflate | ESD-909578-25MG | |
Cas.: 34302-69-7 | Purity: for spectrophotometric det. of Cu, ≥99% | Neocuproine | ESD-909577-5G |
Cas.: 405556-98-1 | Purity: 95% | 2-Fluoro-3-methyl-5-(tributylstannyl)pyridine | ESD-909579-250MG |
Cas.: 34580-14-8 | Purity: 98% | KETOTIFEN FUMARATE | ESD-838242-500MG |
Cas.: 7081-53-0 | Purity: 98% | Doxapram hydrochloride monohydrate | ESD-860200-5G |
Cas.: 1073353-59-9 | Purity: 98% | [4-(Furfurylamino-1-carbonyl)phenyl]boronic acid pinacol ester | ESD-886663-250MG |
Cas.: NONE8071 | Purity: Solid contains amount: 60% | Waterborne polyurethane | ESD-909580-5KG |
Cas.: NONE8071 | Purity: Solid contains amount: 60% | Waterborne polyurethane | ESD-909580-1KG |
Cas.: NONE8071 | Purity: Solid contains amount: 60% | Waterborne polyurethane | ESD-909580-200G |
Cas.: NONE8071 | Purity: Solid contains amount: 45% | Waterborne polyurethane | ESD-909581-5KG |
Cas.: NONE8071 | Purity: Solid contains amount: 45% | Waterborne polyurethane | ESD-909581-1KG |
Cas.: NONE8071 | Purity: Solid contains amount: 45% | Waterborne polyurethane | ESD-909581-200G |
Cas.: 206357-78-0 | Purity: 95% | tributyl-(3-chloropyridin-2-yl)stannane | ESD-909582-250MG |
Cas.: 153898-63-6 | Purity: 97% | 2-Iodo-5-methoxyaniline | ESD-847368-5G |
Cas.: 153898-63-6 | Purity: 97% | 2-Iodo-5-methoxyaniline | ESD-847368-25G |
Cas.: 5847-59-6 | Purity: 98% | 2-Bromo-4-nitrophenol | ESD-834892-25G |
Cas.: 10361-46-3 | Purity: for spectrophotometric det., Bi, 71-74% Bi basis (KT) | Bismuth subnitrate | ESD-909583-100G |
Cas.: 1204580-73-3 | Purity: 95% | 2-Chloro-4-(tributylstannyl)pyridine | ESD-909584-250MG |
Cas.: 120279-85-8 | Purity: 95% | 5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one | ESD-909586-250MG |
Cas.: 120279-85-8 | Purity: 95% | 5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one | ESD-909586-1G |
Cas.: 120279-85-8 | Purity: 95% | 5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one | ESD-909586-5G |
Cas.: 103476-89-7 | Purity: biotech grade | Leupeptin (Acety1-Leu-Leu-Arginal) | ESD-6015-100MG |
Cas.: 1303-96-4 | Purity: GR, 99.9% | Sodium tetraborate decahydrate | ESD-818107-10KG |
Cas.: 1252597-70-8 | Purity: 98% | 2-Amino-3-chloro-5-iodopyrazine | ESD-831629-1G |
Cas.: 1252597-70-8 | Purity: 98% | 2-Amino-3-chloro-5-iodopyrazine | ESD-831629-250MG |
Cas.: 43181-78-8 | Purity: 95% | 1-Benzyl-2-chloro-1H-benzoiMidazole | ESD-909587-250MG |
Cas.: 43181-78-8 | Purity: 95% | 1-Benzyl-2-chloro-1H-benzoiMidazole | ESD-909587-1G |
Cas.: 43181-78-8 | Purity: 95% | 1-Benzyl-2-chloro-1H-benzoiMidazole | ESD-909587-5G |
Cas.: 68441-17-8 | Purity: average Mv ~3000, 000, powder | Polyethylene oxide | ESD-888665-2.5KG |
Cas.: 2297-64-5 | Purity: 97% | 4-Bromobenzenesulfonohydrazide | ESD-909588-250MG |
Cas.: 2297-64-5 | Purity: 97% | 4-Bromobenzenesulfonohydrazide | ESD-909588-1G |
Cas.: 2297-64-5 | Purity: 97% | 4-Bromobenzenesulfonohydrazide | ESD-909588-5G |
Cas.: 4178-93-2 | Purity: ≥98% | L-Leucine-|p|-nitroanilide | ESD-812578-25G |
Cas.: 119-56-2 | Purity: 98% | 4-Chlorobenzhydrol | ESD-830853-500G |
Cas.: 942282-40-8 | Purity: 98% | 4-Bromo-3-fluorophenylacetic acid | ESD-828970-1G |
Cas.: 942282-40-8 | Purity: 98% | 4-Bromo-3-fluorophenylacetic acid | ESD-828970-5G |
Cas.: 496-74-2 | Purity: for spectrophotometric det. of Mo, Sn, W, and also Ag and Re, ≥97% | Toluene-3,4-dithiol | ESD-909589-1G |
Cas.: 41731-33-3 | Purity: 95% | 2-bromothiazol-4-amine | ESD-909590-250MG |
Cas.: 41731-33-3 | Purity: 95% | 2-bromothiazol-4-amine | ESD-909590-1G |
Cas.: 1315459-30-3 | Purity: 98% | Tis108 | ESD-909591-5MG |
Cas.: 1315459-30-3 | Purity: 98% | Tis108 | ESD-909591-1MG |
Cas.: 2218-94-2 | Purity: for spectrophotometric det. of nitrate and perchlorate, ≥97% | Nitron | ESD-909592-5G |
Cas.: 26351-19-9 | Purity: for spectrophotometric det. of Co, ≥97% | Violuric acid monohydrate | ESD-909593-5G |
Cas.: 158407-04-6 | Purity: ≥98% | 1-Boc-4-bromomethylpiperidine | ESD-803678-1G |
Cas.: 158407-04-6 | Purity: ≥98% | 1-Boc-4-bromomethylpiperidine | ESD-803678-5G |
Cas.: 158407-04-6 | Purity: ≥98% | 1-Boc-4-bromomethylpiperidine | ESD-803678-25G |
Cas.: 796073-69-3 | Purity: ≥98% | DM4 | ESD-877338-25MG |
Cas.: 9012-76-4 | Purity: Deacetylation degree≥90%, density≥0.6g/ml | High density chitosan | ESD-875636-2.5KG |
Cas.: NONE8072 | Chu’s N6 vitamine Solution (1000×) | ESD-909594-100ML | |
Cas.: NONE8072 | Chu’s N6 vitamine Solution (1000×) | ESD-909594-250ML | |
Cas.: 59335-84-1 | Purity: 98% | (|S|)-(+)-2-Methylpyrrolidine | ESD-814252-5G |
Cas.: 910-31-6 | Purity: >95.0%(HPLC) | Cholesteryl chloride | ESD-863560-1G |
Cas.: NONE8073 | DKW Vitamine Solution(1000×) | ESD-909595-100ML | |
Cas.: NONE8073 | DKW Vitamine Solution(1000×) | ESD-909595-250ML | |
Cas.: NONE6846 | Purity: 2X, pH 9.5 | Alkaline Phosphatase Buffer-2 | ESD-909597-100ML |
Cas.: NONE6846 | Purity: 2X, pH 9.5 | Alkaline Phosphatase Buffer-2 | ESD-909597-250ML |
Cas.: NONE6846 | Purity: 1X, pH 7.5 | Alkaline Phosphatase Buffer-2 | ESD-909596-100ML |
Cas.: NONE6846 | Purity: 1X, pH 7.5 | Alkaline Phosphatase Buffer-2 | ESD-909596-250ML |
Cas.: NONE6846 | Purity: 1X, pH 9.5 | Alkaline Phosphatase Buffer-2 | ESD-909598-100ML |
Cas.: NONE6846 | Purity: 1X, pH 9.5 | Alkaline Phosphatase Buffer-2 | ESD-909598-250ML |
Cas.: NONE8074 | Eriksson Vitamine Solution (1000×) | ESD-909599-100ML | |
Cas.: NONE8074 | Eriksson Vitamine Solution (1000×) | ESD-909599-250ML | |
Cas.: NONE8075 | B5 Vitamin Solution (1000×) | ESD-909600-100ML | |
Cas.: NONE8075 | B5 Vitamin Solution (1000×) | ESD-909600-250ML | |
Cas.: 97108-50-4 | Purity: 97% | 2,5-Difluorophenylhydrazine | ESD-808342-250MG |
Cas.: 20548-54-3 | Purity: 99% | Calcium sulfide | ESD-805265-1G |
Cas.: 1127-01-1 | Purity: ≥96% | Ethyl 1-Hydroxycyclohexane-Carboxylate | ESD-859463-1G |
Cas.: 377085-58-0 | Purity: 96% | 4-Carbamoyl-1-hexadecylpyridinium Chloride | ESD-869223-5G |
Cas.: 24937-79-9 | Purity: average Mw ~180, 000, beads or pellets | Poly(vinylidene fluoride) | ESD-875316-100G |
Cas.: 24937-79-9 | Purity: average Mw ~180, 000, beads or pellets | Poly(vinylidene fluoride) | ESD-875316-500G |
Cas.: NONE8076 | Gresshof & Doy Vitamin Solution (1000×) | ESD-909601-100ML | |
Cas.: 22504-50-3 | Purity: ≥98%(T) | Ethylene Bis(3-mercaptopropionate) (Purified) | ESD-862767-100G |
Cas.: NONE8076 | Gresshof & Doy Vitamin Solution (1000×) | ESD-909601-250ML | |
Cas.: 22504-50-3 | Purity: ≥98%(T) | Ethylene Bis(3-mercaptopropionate) (Purified) | ESD-862767-500G |
Cas.: 3709-43-1 | Purity: 98% | Disodium 4,4′-Dinitrostilbene-2,2′-disulfonate | ESD-831278-25G |
Cas.: 3709-43-1 | Purity: 98% | Disodium 4,4′-Dinitrostilbene-2,2′-disulfonate | ESD-831278-5G |
Cas.: NONE8077 | Linsmaier & Skoog Vitamin Solution (1000×) | ESD-909602-100ML | |
Cas.: NONE8077 | Linsmaier & Skoog Vitamin Solution (1000×) | ESD-909602-250ML | |
Cas.: 48208-26-0 | Purity: >98% | RG108 | ESD-860942-50MG |
Cas.: 48208-26-0 | Purity: >98% | RG108 | ESD-860942-250MG |
Cas.: 82560-12-1 | Purity: 97% | 3-Amino-5-tert-butylpyrazole | ESD-844043-25G |
Cas.: 82560-12-1 | Purity: 97% | 3-Amino-5-tert-butylpyrazole | ESD-844043-100G |
Cas.: NONE8078 | Litvay Vitamin Solution (1000×) | ESD-909603-100ML | |
Cas.: NONE8078 | Litvay Vitamin Solution (1000×) | ESD-909603-250ML | |
Cas.: 30377-07-2 | Purity: 98% | N-Decanoylsarcosine Sodium Salt | ESD-870441-250MG |
Cas.: 108433-95-0 | Purity: ≥97% (HPLC) | Magainin II | ESD-814009-5MG |
Cas.: 1681007-44-2 | Purity: >99.0%(HPLC) | 4,4′-(2λ4σ2-Benzo[1,2-c:4,5-c’]bis[1,2,5]thiadiazole-4,8-diyldi-5,2-thiophenediyl)bis[2-dodecylbenzonitrile ] | ESD-909604-50MG |
Cas.: NONE8079 | MS Vitamin Solution (1000×) | ESD-909605-100ML | |
Cas.: NONE8079 | MS Vitamin Solution (1000×) | ESD-909605-250ML | |
Cas.: NONE8080 | WPM Vitamin Solution (1000×) | ESD-909606-100ML | |
Cas.: NONE8080 | WPM Vitamin Solution (1000×) | ESD-909606-250ML | |
Cas.: 63243-76-5 | Purity: 98% | Ethyl 2-amino-5-bromobenzoate | ESD-846799-5G |
Cas.: 63243-76-5 | Purity: 98% | Ethyl 2-amino-5-bromobenzoate | ESD-846799-25G |
Cas.: 7101-31-7 | Purity: >97% | Dimethyl Diselenide | ESD-837346-5G |
Cas.: NONE8081 | DiIC18(3)-DS | ESD-909607-50MG | |
Cas.: NONE8082 | Nitsch Vitamin Solution (1000×) | ESD-909608-100ML | |
Cas.: NONE8082 | Nitsch Vitamin Solution (1000×) | ESD-909608-250ML | |
Cas.: NONE8083 | DiIC18(5)-DS | ESD-909609-50MG | |
Cas.: NONE8084 | SH Vitamin Solution (100×) | ESD-909610-250ML | |
Cas.: NONE8084 | SH Vitamin Solution (100×) | ESD-909610-100ML | |
Cas.: 85-48-3 | Purity: 98% | Quinoline-8-sulfonic acid | ESD-860303-5G |
Cas.: 12645-53-3 | Purity: ≥95%(T) | Phosphoric acid, isooctyl ester | ESD-888319-2.5KG |
Cas.: 85-48-3 | Purity: 98% | Quinoline-8-sulfonic acid | ESD-860303-25G |
Cas.: 85-48-3 | Purity: 98% | Quinoline-8-sulfonic acid | ESD-860303-100G |
Cas.: NONE8085 | 9-DiI methanesulfonate | ESD-909611-25MG | |
Cas.: 6485-97-8 | Purity: ≥98% | 2-Phenylanthraquinone | ESD-866351-5G |
Cas.: NONE8086 | 1,1′-Dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine iodide | ESD-909612-100MG | |
Cas.: 288-05-1 | Purity: 97% | Selenophene | ESD-838410-5G |
Cas.: NONE8087 | DiI triflate | ESD-909613-100MG | |
Cas.: NONE8088 | DiOC16(3) perchlorate | ESD-909614-25MG | |
Cas.: 123938-86-3 | Purity: 60% | Glycol chitosan | ESD-810701-250MG |
Cas.: NONE8089 | DiOC6(3) iodide | ESD-909615-100MG | |
Cas.: NONE8090 | 1,1′-Dioctadecyl-5,5′-diphenyl-3,3,3′,3′-tetramethylindocarbocyanine chloride | ESD-909616-5MG | |
Cas.: NONE8091 | Purity: 95% | DiR iodide | ESD-909617-10MG |
Cas.: 2731-73-9 | Purity: 95% | 3-Chloro-L-alanine | ESD-830428-1G |
Cas.: 2731-73-9 | Purity: 95% | 3-Chloro-L-alanine | ESD-830428-5G |
Cas.: 679809-58-6 | Purity: BR | Enoxaparin sodium | ESD-872995-25MG |
Cas.: 679809-58-6 | Purity: BR | Enoxaparin sodium | ESD-872995-100MG |
Cas.: 1892-57-5 | Purity: 95% | N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide | ESD-807579-500G |
Cas.: NONE8093 | Super ECL Plus Detection Reagent | ESD-909619-100ML | |
Cas.: 56253-90-8 | Purity: D. 98% | L-Phenylalanine-d5 | ESD-874705-25MG |
Cas.: NONE8093 | Super ECL Plus Detection Reagent | ESD-909619-500ML | |
Cas.: 56253-90-8 | Purity: D. 98% | L-Phenylalanine-d5 | ESD-874705-5MG |
Cas.: 14438-32-5 | Purity: ≥98% | 2-Amino-3,5-dimethylbenzoic acid | ESD-821883-5G |
Cas.: NONE8094 | Purity: Linear type, Viscosity: 90 mPa s | Vinyl silicone oil | ESD-909620-100G |
Cas.: 5398-77-6 | Purity: 98% | 4-Methylsulphonyl benzaldehyde | ESD-823836-2.5KG |
Cas.: NONE8094 | Purity: Linear type, Viscosity: 90 mPa s | Vinyl silicone oil | ESD-909620-500G |
Cas.: NONE8094 | Purity: Linear type, Viscosity: 90 mPa s | Vinyl silicone oil | ESD-909620-2.5KG |
Cas.: NONE8094 | Purity: Linear type, Viscosity: 500 mPa s | Vinyl silicone oil | ESD-909621-100G |
Cas.: NONE8094 | Purity: Linear type, Viscosity: 500 mPa s | Vinyl silicone oil | ESD-909621-500G |
Cas.: NONE8094 | Purity: Linear type, Viscosity: 500 mPa s | Vinyl silicone oil | ESD-909621-2.5KG |
Cas.: 33821-94-2 | Purity: 95% (contains Potassium carbonate stabilizer) | 2-(3-Bromopropoxy)tetrahydro-2H-pyran | ESD-803115-25G |
Cas.: NONE8094 | Purity: Branched type, Viscosity: 1000 mPa s | Vinyl silicone oil | ESD-909623-100G |
Cas.: NONE8094 | Purity: Branched type, Viscosity: 1000 mPa s | Vinyl silicone oil | ESD-909623-500G |
Cas.: NONE8094 | Purity: Branched type, Viscosity: 1000 mPa s | Vinyl silicone oil | ESD-909623-2.5KG |
Cas.: 9012-54-8 | Purity: powder, 10,000 U/g | cellulase | ESD-805043-2.5KG |
Cas.: NONE8094 | Purity: Straight, branched, viscosity: 500 mPa s | Vinyl silicone oil | ESD-909625-100G |
Cas.: NONE8094 | Purity: Straight, branched, viscosity: 500 mPa s | Vinyl silicone oil | ESD-909625-500G |
Cas.: NONE8094 | Purity: Straight, branched, viscosity: 500 mPa s | Vinyl silicone oil | ESD-909625-2.5KG |
Cas.: 59-00-7 | Purity: 96% | Xanthurenic acid | ESD-820594-250MG |
Cas.: 84-78-6 | Purity: ≥95% | BUTYL OCTYL PHTHALATE | ESD-889391-1G |
Cas.: 4474-91-3 | Purity: 90% | Angiotensin II, human | ESD-800621-100MG |
Cas.: 102852-92-6 | Purity: 98% | 1,3,5-Tris(4-aminophenoxy)benzene | ESD-856274-250MG |
Cas.: 80-42-2 | Purity: 97% | Propyl benzenesulfonate | ESD-894207-250MG |
Cas.: 70539-42-3 | Purity: ≥97% | Ethylene glycol-bis(succinic acid N-hydroxysuccinimide ester) | ESD-909626-1G |
Cas.: 70539-42-3 | Purity: ≥97% | Ethylene glycol-bis(succinic acid N-hydroxysuccinimide ester) | ESD-909626-250MG |
Cas.: 243991-62-0 | Purity: 95% | Pentaerythritol tetrakis(2-bromoisobutyrate) | ESD-908755-5G |
Cas.: 74866-28-7 | Purity: ≥96% | 2,2′-Dibromo-1,1′-binaphthyl | ESD-866559-5G |
Cas.: 74866-28-7 | Purity: ≥96% | 2,2′-Dibromo-1,1′-binaphthyl | ESD-866559-25G |
Cas.: 11078-30-1 | Purity: 95% | D-Galacto-D-mannan from Ceratonia siliqua | ESD-832822-1G |
Cas.: 81069-02-5 | Purity: 90% | 3,3′-Dithiobis(sulfosuccinimidylpropionate) | ESD-909627-25MG |
Cas.: 81069-02-5 | Purity: 90% | 3,3′-Dithiobis(sulfosuccinimidylpropionate) | ESD-909627-5MG |
Cas.: 979-32-8 | Purity: 98% | beta-Estradiol 17-Valerate | ESD-829825-5G |
Cas.: 4045-29-8 | Purity: ≥98% | 3-Methoxypiperidine | ESD-859949-5G |
Cas.: 13709-94-9 | Purity: 98% | Potassium metaborate trihydrate | ESD-886074-2.5KG |
Cas.: 23708-56-7 | Purity: ≥98% | 6-Undecanol | ESD-868319-5G |
Cas.: 23708-56-7 | Purity: ≥98% | 6-Undecanol | ESD-868319-25G |
Cas.: 8001-31-8 | Purity: AR | White Coconut Oil | ESD-909629-100G |
Cas.: 8001-31-8 | Purity: AR | White Coconut Oil | ESD-909629-500G |
Cas.: 8001-31-8 | Purity: AR | White Coconut Oil | ESD-909629-2.5KG |
Cas.: 499-80-9 | Purity: No water, ≥98% | 2,4-Pyridinedicarboxylic acid | ESD-909628-100G |
Cas.: 499-80-9 | Purity: No water, ≥98% | 2,4-Pyridinedicarboxylic acid | ESD-909628-25G |
Cas.: 499-80-9 | Purity: No water, ≥98% | 2,4-Pyridinedicarboxylic acid | ESD-909628-5G |
Cas.: 499-80-9 | Purity: No water, ≥98% | 2,4-Pyridinedicarboxylic acid | ESD-909628-1G |
Cas.: NONE6826 | Purity: 10%(w/v) | Triton X-100 Solution | ESD-885426-1L |
Cas.: 833-66-9 | Purity: ≥98% | Potassium 6-Hydroxy-2-naphthalenesulfonate | ESD-867392-25G |
Cas.: 833-66-9 | Purity: ≥98% | Potassium 6-Hydroxy-2-naphthalenesulfonate | ESD-867392-100G |
Cas.: 833-66-9 | Purity: ≥98% | Potassium 6-Hydroxy-2-naphthalenesulfonate | ESD-867392-500G |
Cas.: 2495-37-6 | Purity: 98% | Benzyl methacrylate | ESD-802049-5KG |
Cas.: 5466-22-8 | Purity: 97% | Aminoacetonitrile Sulfate | ESD-854653-25G |
Cas.: 5466-22-8 | Purity: 97% | Aminoacetonitrile Sulfate | ESD-854653-500G |
Cas.: 13676-47-6 | Purity: ≥98% | 2-(4-Aminophenyl)benzoxazol-5-amine | ESD-865485-250MG |
Cas.: 49619-58-1 | Purity: 99% | 3-Formyl-6-isopropylchromone | ESD-834973-5G |
Cas.: 6160-80-1 | Purity: 98% | 4-Methylumbelliferyl–D-glucuronide | ESD-824525-1G |
Cas.: 7789-06-2 | Purity: 98% | Strontium chromate | ESD-888287-50G |
Cas.: 1009033-83-3 | Purity: ≥98% | 4-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyridine | ESD-868394-5G |
Cas.: 5867-45-8 | Purity: 98% | 3-Acetamidopyridine | ESD-870705-250MG |
Cas.: 932-87-6 | Purity: 95% | (Bromoethynyl)benzene | ESD-909630-1G |
Cas.: 932-87-6 | Purity: 95% | (Bromoethynyl)benzene | ESD-909630-5G |
Cas.: 7300-34-7 | Purity: ≥98% | 1,4-Butanediol Bis(3-aminopropyl) Ether | ESD-865848-5ML |
Cas.: 10101-97-0 | Purity: 99.9% metals basis | Nickel(II) sulfate hexahydrate | ESD-814474-10KG |
Cas.: 81-11-8 | Purity: 95% | 4,4′-Diamino-2,2′-stilbenedisulfonic acid | ESD-830781-2.5KG |
Cas.: 84650-60-2 | Purity: 99% | Tea polyphenol | ESD-821917-500G |
Cas.: 30389-33-4 | Purity: 97% | 5-Hydroxy-3,4-dihydroquinolin-2(1H)-one | ESD-842704-1G |
Cas.: 76738-62-0 | Purity: 95% | Paclobutrazol | ESD-909631-5G |
Cas.: 76738-62-0 | Purity: 95% | Paclobutrazol | ESD-909631-25G |
Cas.: 76738-62-0 | Purity: 95% | Paclobutrazol | ESD-909631-100G |
Cas.: 9005-38-3 | Purity: Low calcium type, calcium contains amount:≤0.1% | Sodium alginate | ESD-875039-2.5KG |
Cas.: 9005-38-3 | Purity: Low calcium type, calcium contains amount:≤0.1% | Sodium alginate | ESD-875039-100G |
Cas.: 67969-82-8 | Purity: 50-55% w/w HBF4 | Tetrafluoroboric acid diethyl ether complex | ESD-822369-100ML |
Cas.: 65381-09-1 | Purity: ≥98% | 2-hydroxy-3-(octanoyloxy)propyl decanoate | ESD-860154-2.5KG |
Cas.: 8008-56-8 | Purity: 99% | Lemon oil | ESD-905674-2.5L |
Cas.: 9063-38-1 | Purity: AR | Carboxy methyl starch sodium (CMS) | ESD-804712-10KG |
Cas.: 4045-24-3 | Purity: 97% | 4-Methoxypiperidine | ESD-829941-5G |
Cas.: 4045-24-3 | Purity: 97% | 4-Methoxypiperidine | ESD-829941-25G |
Cas.: 1198-77-2 | Uric acid sodium salt | ESD-886061-25G | |
Cas.: 12042-91-0 | Purity: Al2O3: 46% | ALUMINUM CHLOROHYDRATE | ESD-832294-500G |
Cas.: 12042-91-0 | Purity: Al2O3: 46% | ALUMINUM CHLOROHYDRATE | ESD-832294-2.5KG |
Cas.: 12042-91-0 | Purity: Al2O3: 46% | ALUMINUM CHLOROHYDRATE | ESD-832294-25G |
Cas.: 145934-92-5 | Purity: 95% | 5-fluoro-2-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-909632-1G |
Cas.: 145934-92-5 | Purity: 95% | 5-fluoro-2-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-909632-250MG |
Cas.: 1121-30-8 | Purity: 95% | pyrithione | ESD-909634-1G |
Cas.: 1121-30-8 | Purity: 95% | pyrithione | ESD-909634-250MG |
Cas.: NONE8095 | SE 340B | ESD-909633-5G | |
Cas.: 7545-50-8 | Purity: 95% | 3,3′-Diamino-4,4′-dihydroxydiphenyl sulfone | ESD-843889-25G |
Cas.: NONE8095 | SE 340B | ESD-909633-25G | |
Cas.: 7545-50-8 | Purity: 95% | 3,3′-Diamino-4,4′-dihydroxydiphenyl sulfone | ESD-843889-100G |
Cas.: NONE8095 | SE 340B | ESD-909633-100G | |
Cas.: NONE8095 | SE 340B | ESD-909633-500G | |
Cas.: 38821-49-7 | Purity: 98% | Carbidopa Monohydrate | ESD-835040-500MG |
Cas.: 411233-14-2 | Purity: 95% | resveratrol 3,5-di-O-acetate | ESD-909635-1G |
Cas.: 411233-14-2 | Purity: 95% | resveratrol 3,5-di-O-acetate | ESD-909635-250MG |
Cas.: 619-57-8 | Purity: 98% | 4-Hydroxybenzamide | ESD-834506-1G |
Cas.: 7789-46-0 | Purity: Ultra Dry, 99.995% metals basis | Iron(II) bromide | ESD-837008-1G |
Cas.: 3618-63-1 | Purity: dye content 85% | Eriochrome Red B | ESD-808607-100G |
Cas.: 3618-63-1 | Purity: dye content 85% | Eriochrome Red B | ESD-808607-500G |
Cas.: 1225283-27-1 | Purity: 95% | 6,7-Difluoro-1H-benzo[d]imidazole-2-carboxylic acid | ESD-909636-1G |
Cas.: 1225283-27-1 | Purity: 95% | 6,7-Difluoro-1H-benzo[d]imidazole-2-carboxylic acid | ESD-909636-5G |
Cas.: 105-40-8 | Purity: ≥98%(GC) | Ethyl N-Methylcarbamate | ESD-863250-100G |
Cas.: 705260-08-8 | Purity: ≥98% | Vorapaxar Sulfate | ESD-873167-25MG |
Cas.: 1694-57-1 | Purity: 95% | (2-Chlorophenyl)(pyridin-2-yl)methanone | ESD-909637-1G |
Cas.: 1694-57-1 | Purity: 95% | (2-Chlorophenyl)(pyridin-2-yl)methanone | ESD-909637-250MG |
Cas.: 1694-57-1 | Purity: 95% | (2-Chlorophenyl)(pyridin-2-yl)methanone | ESD-909637-100MG |
Cas.: 873-66-5 | Purity: ≥97%(GC) | trans-β-Methylstyrene (stabilized with TBC) | ESD-862176-5ML |
Cas.: 65096-46-0 | Purity: >99% | GPN; Glycylproline p-nitroanilide tosylate | ESD-860526-50MG |
Cas.: 65096-46-0 | Purity: >99% | GPN; Glycylproline p-nitroanilide tosylate | ESD-860526-250MG |
Cas.: 81-54-9 | Purity: for spectrophotometric det. (of B, Pb) | Purpurin | ESD-909638-5G |
Cas.: 6138-23-4 | Purity: biotech grade (from corn meal) | Trehalose Dihydrate | ESD-6235-2.5KG |
Cas.: 1662-01-7 | Purity: for spectrophotometric det. of Fe in serum, ≥99% | 4,7-Diphenyl-1,10-phenanthroline | ESD-909639-1G |
Cas.: 9003-35-4 | Purity: BR | Phenol-formaldehyde resin | ESD-832683-10KG |
Cas.: 925232-64-0 | Purity: 98% | 2-(Dodecylthiocarbonothioylthio)-2-methylpropionic acid N-hydroxysuccinimide ester | ESD-909640-250MG |
Cas.: 13638-82-9 | Purity: >98%(HPLC) | 1,3,6,8-Tetraphenylpyrene | ESD-861644-25MG |
Cas.: 13638-82-9 | Purity: >98%(HPLC) | 1,3,6,8-Tetraphenylpyrene | ESD-861644-50MG |
Cas.: 13638-82-9 | Purity: >98%(HPLC) | 1,3,6,8-Tetraphenylpyrene | ESD-861644-200MG |
Cas.: 25038-32-8 | Purity: styrene 22 wt. % | Polystyrene-block-polyisoprene-block-polystyrene | ESD-909190-25G |
Cas.: 52746-49-3 | Purity: 98% | Bathophenanthrolinedisulfonic acid disodium salt hydrate | ESD-828386-250MG |
Cas.: 81502-74-1 | Purity: 98% | 2-Hydroxy-1,3,5-benzenetricarbaldehyde | ESD-870517-5G |
Cas.: 16475-90-4 | Purity: 98% | Methyl 5-Acetylsalicylate | ESD-858442-25G |
Cas.: 16475-90-4 | Purity: 98% | Methyl 5-Acetylsalicylate | ESD-858442-100G |
Cas.: 73232-07-2 | Purity: 95% | Ethyl 2-[(Ethoxycarbonothioyl)thio]propionate | ESD-909641-250MG |
Cas.: 864066-74-0 | 4-Cyano-4-(phenylcarbonothioylthio)pentanoic acid N-succinimidyl ester | ESD-909642-250MG | |
Cas.: 607-66-9 | Purity: 97% | 4-Methylcarbostyril | ESD-858234-25G |
Cas.: 10022-68-1 | Purity: 99.999% metals basis | Cadmium nitrate tetrahydrate | ESD-805714-500G |
Cas.: 1158958-94-1 | N,N’-Dimethyl N,N’-di(4-pyridinyl)thiuram disulfide | ESD-909643-1G | |
Cas.: 40918-51-2 | Purity: 98% | L-Norvaline Ethyl Ester Hydrochloride | ESD-835016-100G |
Cas.: 119-90-4 | Purity: for spectrophotometric det. of Au, NO2-, Ce(IV), for the detection of Au, Co, Cu, SCN-, V, ≥97% | 3,3′-Dimethoxybenzidine | ESD-909644-10G |
Cas.: 1088555-95-6 | Purity: 97% | Methyl 2-(dodecylthiocarbonothioylthio)-2-methylpropionate | ESD-909645-250MG |
Cas.: 139115-90-5 | Purity: 95% | Azido-PEG2-alcohol | ESD-855497-500MG |
Cas.: 870532-86-8 | Purity: ≥95% | Bis(dodecylsulfanylthiocarbonyl) disulfide | ESD-909646-1G |
Cas.: 851729-48-1 | Purity: 98% | 2-Cyano-2-propyl 4-cyanobenzodithioate | ESD-909647-250MG |
Cas.: 1158958-96-3 | Purity: 97% | 2-Cyanopropan-2-yl N-methyl-N-(pyridin-4-yl)carbamodithioate | ESD-909648-250MG |
Cas.: 1158958-92-9 | Purity: 97% | Methyl 2-[methyl(4-pyridinyl)carbamothioylthio]propionate | ESD-909649-250MG |
Cas.: 459-03-0 | Purity: 99% | (4-Fluorophenyl)acetone | ESD-810274-100G |
Cas.: 5925-55-3 | Purity: 95% | 2-Methyl-2-propylbenzodithiolate | ESD-909650-1G |
Cas.: 62625-22-3 | Purity: for spectrophotometric det. of Cu, Zn | Zincon | ESD-909651-1G |
Cas.: 137780-73-5 | Purity: 97% | Benzyl 9H-carbazole-9-carbodithioate | ESD-909652-1G |
Cas.: 137780-73-5 | Purity: 97% | Benzyl 9H-carbazole-9-carbodithioate | ESD-909652-250MG |
Cas.: NONE8096 | Purity: Universal grade weather resistance ASA, MFR: 14 g/10 min | Acrylonitrile Styrene acrylate terpolymer (ASA) | ESD-909653-100G |
Cas.: NONE8096 | Purity: Universal grade weather resistance ASA, MFR: 14 g/10 min | Acrylonitrile Styrene acrylate terpolymer (ASA) | ESD-909653-500G |
Cas.: NONE8096 | Purity: Universal grade weather resistance ASA, MFR: 14 g/10 min | Acrylonitrile Styrene acrylate terpolymer (ASA) | ESD-909653-2.5KG |
Cas.: 838-57-3 | Purity: 98% | Ethyl (4-Nitrobenzoyl)acetate | ESD-858495-1G |
Cas.: 838-57-3 | Purity: 98% | Ethyl (4-Nitrobenzoyl)acetate | ESD-858495-25G |
Cas.: 85333-43-3 | Purity: ≥95% | 8-chloro-2-methylimidazo[1,2-a]pyrazine | ESD-826511-5G |
Cas.: 5144-89-8 | Purity: for the spectrophotometric determination of Fe, Pd, V, ≥99% | 1,10-Phenanthroline monohydrate | ESD-909655-5G |
Cas.: 1858249-76-9 | 2-Cyano-2-hexylbenzodithiolate | ESD-909656-100MG | |
Cas.: 585-74-0 | Purity: 98% | 3′-Methylacetophenone | ESD-814309-1G |
Cas.: 220182-83-2 | 2-Cyano-2-butylbenzodithiolate | ESD-909657-100MG | |
Cas.: 1823273-83-1 | 2-Cyano-2-pentylbenzodithiolate | ESD-909658-100MG | |
Cas.: 37912-25-7 | 2-Phenylethylbenzodithiolate | ESD-909660-100MG | |
Cas.: 1823268-46-7 | 2-Cyano-3-methyl-2-butylbenzodithiolate | ESD-909661-100MG | |
Cas.: NONE8097 | Purity: 50% Antioxidant 1010 + 50% Antioxidant 168 | Irganox B225 | ESD-909659-25G |
Cas.: NONE8097 | Purity: 50% Antioxidant 1010 + 50% Antioxidant 168 | Irganox B225 | ESD-909659-100G |
Cas.: NONE8097 | Purity: 50% Antioxidant 1010 + 50% Antioxidant 168 | Irganox B225 | ESD-909659-500G |
Cas.: NONE8097 | Purity: 50% Antioxidant 1010 + 50% Antioxidant 168 | Irganox B225 | ESD-909659-2.5KG |
Cas.: 10297-05-9 | Purity: 98%, stabilized with Copper chip | 1-CHLORO-4-IODOBUTANE | ESD-831358-100G |
Cas.: 626-97-1 | Purity: ≥98% | Pentanamide | ESD-859236-25G |
Cas.: 626-97-1 | Purity: ≥98% | Pentanamide | ESD-859236-100G |
Cas.: 135822-72-9 | Purity: 97% | 2,2′-Bipyridil-5,5′-dialdehyde | ESD-855429-5G |
Cas.: 82692-93-1 | Purity: for enzymic, spectrophotometric determination of H2O2, ≥98% | 3-(N-Ethyl-3-methylanilino)-2-hydroxypropanesulfonic acid sodium salt | ESD-909663-1G |
Cas.: 26504-29-0 | Purity: 97% | S,S-Dibenzyl trithiocarbonate | ESD-909664-1G |
Cas.: 26504-29-0 | Purity: 97% | S,S-Dibenzyl trithiocarbonate | ESD-909664-250MG |
Cas.: 26510-95-2 | Purity: 98% | Ethyl 3-(4-bromophenyl)-3-oxopropanoate | ESD-838354-25G |
Cas.: 1223397-11-2 | Purity: 99% | WZB117 | ESD-872569-25MG |
Cas.: 1223397-11-2 | Purity: 99% | WZB117 | ESD-872569-100MG |
Cas.: 78751-36-7 | 2-(Thiobenzoylthio)propionic acid | ESD-909662-100MG | |
Cas.: 101-98-4 | Purity: 95% | N-Benzyl-N-methylethanolamine | ESD-828118-2.5KG |
Cas.: 26402-26-6 | Purity: ≥98% | Monocaprylin | ESD-863511-5G |
Cas.: 26402-26-6 | Purity: ≥98% | Monocaprylin | ESD-863511-25G |
Cas.: 4425-10-9 | Purity: 95% | 1H-Azepino[1,2-a]azepine,decahydro- | ESD-909665-20MG |
Cas.: 70560-51-9 | Purity: ≥98% | Kanamycin Sulfate | ESD-859183-25G |
Cas.: 70560-51-9 | Purity: ≥98% | Kanamycin Sulfate | ESD-859183-100G |
Cas.: 27943-07-3 | Purity: ≥95% | 5-Cyclopropyl-2H-tetrazole | ESD-909666-250MG |
Cas.: 27943-07-3 | Purity: ≥95% | 5-Cyclopropyl-2H-tetrazole | ESD-909666-1G |
Cas.: 71060-57-6 | Purity: 99% | Alcohols, C8-10, Ethoxylated | ESD-909308-2.5KG |
Cas.: 75999-66-5 | Purity: ≥98% | 2,2,2-Trifluoro-N-(4-methoxyphenyl)acetimidoyl Chloride | ESD-868202-250MG |
Cas.: 6439-57-2 | Purity: >95.0%(GC) | Monobutyl Itaconate | ESD-863911-5G |
Cas.: 26761-45-5 | Purity: 99% | Glycidyl neodecanoate, mixture of branched isomers | ESD-906407-100G |
Cas.: 26761-45-5 | Purity: 99% | Glycidyl neodecanoate, mixture of branched isomers | ESD-906407-25G |
Cas.: 1282516-67-9 | Purity: 97% | 9-Bromo-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine | ESD-909667-1G |
Cas.: 1282516-67-9 | Purity: 97% | 9-Bromo-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine | ESD-909667-250MG |
Cas.: 1282516-67-9 | Purity: 97% | 9-Bromo-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine | ESD-909667-100MG |
Cas.: 3240-94-6 | Purity: 98% | 4-(2-Chloroethyl)morpholine | ESD-902433-1G |
Cas.: 84057-81-8 | Purity: 20% solution | RNase-free PVP K30 Solution | ESD-885163-1L |
Cas.: 925-93-9 | Purity: (D, 99.5%) (<5% D2O) | Ethanol-OD | ESD-858139-25G |
Cas.: 3718-65-8 | Purity: ≥98% | 3,5-Dimethylpyridine N-Oxide | ESD-865422-25G |
Cas.: 773-82-0 | Purity: 99% | 2,3,4,5,6-Pentafluorobenzonitrile | ESD-816934-500G |
Cas.: 7783-35-9 | Purity: GR, 99.5% | Mercuric sulfate | ESD-813160-5KG |
Cas.: 13685-30-8 | Purity: 98% | Bis(4-methoxyphenyl)chlorophosphine | ESD-849326-250MG |
Cas.: 1780-40-1 | Purity: 98% | 2,4,5,6-Tetrachloropyrimidine | ESD-839944-25G |
Cas.: 27834-99-7 | Purity: ≥98%(GC)(T | Ethyl 3-(3-Methoxyphenyl)-3-oxopropionate | ESD-862366-5G |
Cas.: 102-81-8 | Purity: 99% | 2-(Dibutylamino)ethanol | ESD-830970-25ML |
Cas.: 102-81-8 | Purity: 99% | 2-(Dibutylamino)ethanol | ESD-830970-100ML |
Cas.: 102-81-8 | Purity: 99% | 2-(Dibutylamino)ethanol | ESD-830970-500ML |
Cas.: 102-81-8 | Purity: 99% | 2-(Dibutylamino)ethanol | ESD-830970-2.5L |
Cas.: 102-81-8 | Purity: 99% | 2-(Dibutylamino)ethanol | ESD-830970-10L |
Cas.: 592-20-1 | Purity: 97%, contains stabilizerwater talc | Acetoxy-2-propanone | ESD-871448-25ML |
Cas.: 335-36-4 | Purity: ≥95% | Perfluoro(2-butyltetrahydrofuran) (so called) | ESD-867340-25G |
Cas.: 202869-92-9 | Purity: 98% | Cetylpyridinium bromide monohydrate | ESD-885854-25G |
Cas.: 6485-97-8 | Purity: ≥98% | 2-Phenylanthraquinone | ESD-866351-25G |
Cas.: 123622-48-0 | Purity: 98% | 5-(Fmoc-amino)pentanoic acid | ESD-858480-25G |
Cas.: 13685-24-0 | Purity: 97% | Bis(4-trifluoromethylphenyl)chlorophosphine | ESD-909668-1G |
Cas.: 15929-43-8 | Purity: 98% | oxo-bis[4-(trifluoromethyl)phenyl]phosphanium | ESD-831708-100MG |
Cas.: 15929-43-8 | Purity: 98% | oxo-bis[4-(trifluoromethyl)phenyl]phosphanium | ESD-831708-250MG |
Cas.: 15929-43-8 | Purity: 98% | oxo-bis[4-(trifluoromethyl)phenyl]phosphanium | ESD-831708-1G |
Cas.: 55-48-1 | Purity: 98% | Atropine sulfate | ESD-822894-1G |
Cas.: 55-48-1 | Purity: 98% | Atropine sulfate | ESD-822894-25G |
Cas.: 1313-13-9 | Purity: 99.95% metals basis | Manganese dioxide | ESD-812766-500G |
Cas.: 114457-94-2 | Purity: 98% | (S)-3-Phenyl-2-(pyrazine-2-carboxamido)propanoic acid | ESD-843858-5G |
Cas.: 114457-94-2 | Purity: 98% | (S)-3-Phenyl-2-(pyrazine-2-carboxamido)propanoic acid | ESD-843858-25G |
Cas.: 114457-94-2 | Purity: 98% | (S)-3-Phenyl-2-(pyrazine-2-carboxamido)propanoic acid | ESD-843858-100G |
Cas.: 6000-44-8 | Purity: 98% | Glycine sodium | ESD-810376-2.5KG |
Cas.: 161462-33-5 | Purity: 97% | 1-cyano-2-methylthio-4-trifluoromethylbenzene | ESD-909669-250MG |
Cas.: 161462-33-5 | Purity: 97% | 1-cyano-2-methylthio-4-trifluoromethylbenzene | ESD-909669-1G |
Cas.: 161462-33-5 | Purity: 97% | 1-cyano-2-methylthio-4-trifluoromethylbenzene | ESD-909669-5G |
Cas.: 8047-67-4 | Purity: ≥98% | Iron saccharate | ESD-859288-25G |
Cas.: 8047-67-4 | Purity: ≥98% | Iron saccharate | ESD-859288-100G |
Cas.: 1370264-16-6 | Purity: Analysis control, HPLC≥98% | Pseudoginsenoside Rh2 | ESD-909670-5MG |
Cas.: 9008-97-3 | Purity: 50-100ug/ml | PHA (Phytohemagglutinins) | ESD-812318-1G |
Cas.: 41203-22-9 | Purity: 98% | 1,4,8,11-Tetramethyl-1,4,8,11-tetraazacyclotetradecane | ESD-819671-200MG |
Cas.: 137-51-9 | Purity: 97% | 4-Aminobenzene-1,3-disulfonic acid | ESD-844748-25G |
Cas.: 137-51-9 | Purity: 97% | 4-Aminobenzene-1,3-disulfonic acid | ESD-844748-100G |
Cas.: 3963-95-9 | Purity: 98% | Methacycline Hydrochloride | ESD-837914-25G |
Cas.: 36886-76-7 | Purity: 98% | 3′,6′-Dimethoxyfluoran | ESD-870941-25G |
Cas.: 36886-76-7 | Purity: 98% | 3′,6′-Dimethoxyfluoran | ESD-870941-1G |
Cas.: 4393-09-3 | Purity: 99% | 2,3-Dimethoxybenzylamine | ESD-835001-25G |
Cas.: 4393-09-3 | Purity: 99% | 2,3-Dimethoxybenzylamine | ESD-835001-1G |
Cas.: 71-58-9 | Purity: 98% | Medroxyprogesterone Acetate | ESD-830020-100G |
Cas.: 75-87-6 | Purity: 99% | Chloral | ESD-875282-500G |
Cas.: 75-87-6 | Purity: 99% | Chloral | ESD-875282-100G |
Cas.: 3696-28-4 | Purity: ≥98% | 2,2′-Dithiobis(pyridine-N-oxide) | ESD-859212-100G |
Cas.: 1504-74-1 | Purity: 96% | o-Methoxycinnamaldehyde | ESD-812864-10G |
Cas.: 4887-82-5 | Purity: 97% | 5-Chlorobenzimidazole | ESD-858290-25G |
Cas.: 9005-65-6 | Purity: biotech grade | Tween 80 | ESD-6337-100ML |
Cas.: 2919-66-6 | Purity: 98% | Melengestrol Acetate | ESD-829963-500MG |
Cas.: 25023-22-7 | Purity: ≥97% | Methyl 2-(1-Imidazolyl)acetate | ESD-850984-250MG |
Cas.: 26570-48-9 | Purity: Average MW ~575, contains 400-600ppm MEHQstabilizer | Poly(ethylene glycol) diacrylate | ESD-816111-5ML |
Cas.: 63148-62-9 | Purity: Use For Oil Bath, 180°C | Dimethylsilicone oil | ESD-806808-100ML |
Cas.: 26570-48-9 | Purity: Average MW ~400 , contains <400ppm MEHQ stabilizer | Poly(ethylene glycol) diacrylate | ESD-816110-5ML |
Cas.: 9004-66-4 | Purity: 10%water solution | Iron–Dextran | ESD-875588-2.5KG |
Cas.: 33828-92-1 | Purity: 95% | 1-(6-hydroxy-2-naphthyl)-propan-1-one | ESD-909671-5G |
Cas.: 947-84-2 | Purity: 97% | 2-Biphenylcarboxylic acid | ESD-830818-25G |
Cas.: 947-84-2 | Purity: 97% | 2-Biphenylcarboxylic acid | ESD-830818-100G |
Cas.: 947-84-2 | Purity: 97% | 2-Biphenylcarboxylic acid | ESD-830818-500G |
Cas.: 58902-60-6 | Purity: 98% | Disialyloctasaccharide | ESD-869710-5MG |
Cas.: 72088-94-9 | Purity: ≥95% (HPLC) , 5- and 6-isomer mixture | 5(6)-Carboxyfluorescein, mixture of isomers | ESD-804900-250MG |
Cas.: 518-82-1 | Purity: ≥90% (HPLC) | Emodin | ESD-808871-25G |
Cas.: 186663-83-2 | Purity: 97% | 3-(Fmoc-amino)propyl bromide | ESD-846702-5G |
Cas.: 186663-83-2 | Purity: 97% | 3-(Fmoc-amino)propyl bromide | ESD-846702-10G |
Cas.: 1139-30-6 | Purity: 95% | (-)-Caryophyllene oxide | ESD-861097-1G |
Cas.: 1139-30-6 | Purity: 95% | (-)-Caryophyllene oxide | ESD-861097-5G |
Cas.: 643-12-9 | Purity: 98% | D-chiro Inositol | ESD-838621-1G |
Cas.: 643-12-9 | Purity: 98% | D-chiro Inositol | ESD-838621-5G |
Cas.: 643-12-9 | Purity: 98% | D-chiro Inositol | ESD-838621-25G |
Cas.: 81129-83-1 | Purity: 97% | Cilastatin Sodium Salt | ESD-869306-50MG |
Cas.: 620-17-7 | Purity: 95% | 3-Ethylphenol | ESD-838681-25G |
Cas.: 620-17-7 | Purity: 95% | 3-Ethylphenol | ESD-838681-100G |
Cas.: 15159-40-7 | Purity: 97% | 4-Morpholinecarbonyl chloride | ESD-831545-25G |
Cas.: 25617-98-5 | Purity: 99.9% metals basis | Indium(III) nitride | ESD-812066-250MG |
Cas.: 529-44-2 | Purity: 97% | Myricetin | ESD-813620-25G |
Cas.: 16851-82-4 | Purity: 97% | 1-(Phenylsulfonyl)pyrrole | ESD-831393-100G |
Cas.: 16851-82-4 | Purity: 97% | 1-(Phenylsulfonyl)pyrrole | ESD-831393-25G |
Cas.: 65391-42-6 | Purity: ≥98% (HPLC) | Bestatin hydrochloride | ESD-803267-100MG |
Cas.: 18640-74-9 | Purity: ≥98% | 2-Isobutylthiazole | ESD-859676-25G |
Cas.: 18640-74-9 | Purity: ≥98% | 2-Isobutylthiazole | ESD-859676-100G |
Cas.: 18640-74-9 | Purity: ≥98% | 2-Isobutylthiazole | ESD-859676-500G |
Cas.: 499-80-9 | Purity: ≥98% | 2,4-Pyridinedicarboxylic acid monohydrate | ESD-816100-500G |
Cas.: 629-82-3 | Purity: ≥97% | n-Octyl Ether | ESD-838448-500ML |
Cas.: 9029-44-1 | Purity: ≥1500U/mg, from Cucurbita species | Ascorbate oxidase | ESD-906570-5KU |
Cas.: 7682-20-4 | Purity: 99% | (|S|)-(+)-2-Aminobutanamide hydrochloride | ESD-801515-500G |
Cas.: 149330-25-6 | Purity: 95% | 2,2′-((2-Methyl-1,3-phenylene)bis(azanediyl))diethanol | ESD-843557-100G |
Cas.: 7758-02-3 | Purity: 99% | Potassium bromide | ESD-816701-10KG |
Cas.: 55672-92-9 | Purity: 85% | Coenzyme A sodium salt hydrate cofactor for acyl transfer | ESD-873373-5MG |
Cas.: 1907-65-9 | Purity: 97% | N-Butyl-p-toluenesulfonamide | ESD-869625-25G |
Cas.: 1318-02-1 | Purity: Particle size: 5mm | Permutit | ESD-828437-25KG |
Cas.: 1907-65-9 | Purity: 97% | N-Butyl-p-toluenesulfonamide | ESD-869625-100G |
Cas.: 75-26-3 | Purity: 99% | 2-Bromopropane | ESD-802611-10KG |
Cas.: 7758-89-6 | Purity: AR, 97% | Cuprous chloride | ESD-805350-10KG |
Cas.: 6044-30-0 | Purity: 95% | 2-Naphthyl bD-glucopyranoside | ESD-843849-5G |
Cas.: 571203-78-6 | Purity: 99% | Erastin | ESD-872564-10MG |
Cas.: 571203-78-6 | Purity: 99% | Erastin | ESD-872564-50MG |
Cas.: 571203-78-6 | Purity: 99% | Erastin | ESD-872564-100MG |
Cas.: 59227-89-3 | Purity: 97% | Laurocapram | ESD-800360-10L |
Cas.: 62006-39-7 | Purity: 98% | Senkyunolide A | ESD-873725-10MG |
Cas.: 22519-64-8 | Purity: ≥99% | Indium(III) chloride tetrahydrate | ESD-822400-500G |
Cas.: 446-36-6 | Purity: 98% | 5-Fluoro-2-nitrophenol | ESD-810251-1KG |
Cas.: 563-47-3 | Purity: 97% | 3-Chloro-2-methyl-1-propene | ESD-804791-20L |
Cas.: 10309-37-2 | Purity: Analysis control, ≥99% | Bakuchiol | ESD-803995-50MG |
Cas.: 43120-28-1 | Purity: ≥95% | Methyl 1H-indazole-3-carboxylate | ESD-824863-50G |
Cas.: NONE8098 | Purity: Mn: 36,000 | Thermoplastic polyester-ether elastomer (TPEE) | ESD-909673-100G |
Cas.: 10309-37-2 | Purity: ≥95% | Bakuchiol | ESD-909672-250MG |
Cas.: NONE8098 | Purity: Mn: 36,000 | Thermoplastic polyester-ether elastomer (TPEE) | ESD-909673-500G |
Cas.: NONE8098 | Purity: Mn: 36,000 | Thermoplastic polyester-ether elastomer (TPEE) | ESD-909673-2.5KG |
Cas.: 10309-37-2 | Purity: ≥95% | Bakuchiol | ESD-909672-1G |
Cas.: 108321-05-7 | Purity: 80% | 5-Phospho-D-ribose 1-diphosphate pentasodium salt | ESD-816333-50MG |
Cas.: 131-17-9 | Purity: 98% | Diallyl phthalate | ESD-806918-25ML |
Cas.: 111373-03-6 | Purity: 99% | 1-(2-Cyanophenyl)piperazine | ESD-805459-250MG |
Cas.: 58-36-6 | Purity: 98% | 10,10′-Oxybis(phenoxarsine) | ESD-868675-500G |
Cas.: 2235-00-9 | Purity: 99% | N-Vinylcaprolactam | ESD-838649-250G |
Cas.: 7126-38-7 | Purity: 97% | 1H-Pyrrole-3-carbonitrile | ESD-839866-1G |
Cas.: 1307301-38-7 | Purity: ≥98% | Sodium Picosulfate Monohydrate | ESD-867905-500MG |
Cas.: 14152-97-7 | Purity: 98% | 2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl isothiocyanate | ESD-819823-1G |
Cas.: 5978-70-1 | Purity: ≥97 % sum of enantiomers | (R)-Octan-2-ol | ESD-837861-5G |
Cas.: 58-36-6 | Purity: 98% | 10,10′-Oxybis(phenoxarsine) | ESD-868675-100G |
Cas.: 17526-94-2 | Purity: ≥98% | 3,3′-(4-METHYL-1,3-PHENYLENE) BIS (1,1-DIMETHYLUREA) | ESD-875701-500G |
Cas.: 60676-86-0 | Purity: 99.5%, 20±5nm | Silicon dioxide | ESD-861578-500G |
Cas.: 542-11-0 | Purity: ≥98% | Aniline Hydrobromide | ESD-866183-5G |
Cas.: 864070-44-0 | Purity: 98% | Empagliflozin | ESD-836892-5G |
Cas.: 864070-44-0 | Purity: 98% | Empagliflozin | ESD-836892-25G |
Cas.: 183321-74-6 | Purity: 98% | Erlotinib | ESD-828599-25G |
Cas.: 608-36-6 | Purity: 98% | meso-2,3-Dibromosuccinic acid | ESD-807062-10KG |
Cas.: 7779-90-0 | Purity: AR | Zinc phosphate | ESD-861544-2.5KG |
Cas.: 4383-05-5 | Purity: ≥98%(GC) | 2-Hydroxy-3-methoxybenzyl Alcohol | ESD-863124-1G |
Cas.: 4383-05-5 | Purity: ≥98%(GC) | 2-Hydroxy-3-methoxybenzyl Alcohol | ESD-863124-5G |
Cas.: NONE6806 | Purity: 2X, non-reducing | Tricine-SDS PAGE Loading Buffer | ESD-885370-10ML |
Cas.: NONE6806 | Purity: 2X, non-reducing | Tricine-SDS PAGE Loading Buffer | ESD-885370-100ML |
Cas.: 144494-65-5 | Purity: 95% | Tirofiban | ESD-855554-25MG |
Cas.: 68214-07-3 | Purity: >98.0%(T)(N) | Hexadecyltrimethylammonium bisulfate | ESD-811498-1G |
Cas.: 20905-98-0 | Purity: ≥97% | 3-(3-Thienyl)-1-propanol | ESD-852664-1G |
Cas.: 21059-46-1 | Purity: 99% | Calcium L-Aspartate | ESD-886242-2.5KG |
Cas.: NONE6321 | Purity: Degree of substitution 92% | ESD850125-100G | |
Cas.: NONE6321 | Purity: Degree of substitution 92% | ESD850125-500G | |
Cas.: 4691-65-0 | Purity: >98.0% | Inosine 5′-Monophosphate Disodium Salt Hydrate | ESD-832423-500G |
Cas.: 2319-29-1 | Purity: 98% | Decanamide | ESD-869862-5G |
Cas.: 3529-08-6 | Purity: 98% | 3-(Piperidin-1-yl)propan-1-amine | ESD-909674-1G |
Cas.: 3529-08-6 | Purity: 98% | 3-(Piperidin-1-yl)propan-1-amine | ESD-909674-5G |
Cas.: 18194-24-6 | Purity: >99% | 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) | ESD-832791-1G |
Cas.: 19423-86-0 | Purity: 99.99%, water: 0.5-0.8% | Thulium chloride hydrate | ESD-875954-1G |
Cas.: 1585-17-7 | Purity: 98% | 2,4-Bis(chloromethyl)-1,3,5-trimethylbenzene | ESD-871096-25G |
Cas.: 7719-09-7 | Purity: 99,5% | Thionyl chloride | ESD-819488-10L |
Cas.: 20601-38-1 | Purity: 98% | 4,4′-Bicyclohexanol | ESD-835223-100G |
Cas.: 20601-38-1 | Purity: 98% | 4,4′-Bicyclohexanol | ESD-835223-500G |
Cas.: 16851-82-4 | Purity: 97% | 1-(Phenylsulfonyl)pyrrole | ESD-831393-5G |
Cas.: 51-35-4 | Purity: 99% | L-Hydroxyproline | ESD-811196-5G |
Cas.: 161233-97-2 | Purity: 97% | 2-Cyanoisonicotinic acid | ESD-843622-5G |
Cas.: 1397-89-3 | Purity: 750μg/mg | Amphotericin B | ESD-800429-25G |
Cas.: 26009-03-0 | Purity: Mn~150,000 | Polyglycolic acid | ESD-909207-5G |
Cas.: 25513-46-6 | Purity: ≥95%, MW>700000 | γ-poly(L-glutamic acid) macromolecule | ESD-903672-250G |
Cas.: 32503-27-8 | Purity: Ion-pair Chromatography dedicated | Tetrabutylammonium hydrogen sulfate | ESD-819012-500G |
Cas.: 24817-51-4 | Purity: ≥98% | Phenethyl 2-methylbutanoate | ESD-859781-100G |
Cas.: 24817-51-4 | Purity: ≥98% | Phenethyl 2-methylbutanoate | ESD-859781-500G |
Cas.: 10288-28-5 | Purity: 98% | 2-(1-Cyano-1-methylethyl)azocarboxamide | ESD-829749-5G |
Cas.: 294-93-9 | Purity: 98% | 12-Crown-4 | ESD-804315-250MG |
Cas.: 67396-08-1 | Purity: ≥98.0% | D-Lysine Methyl Ester Dihydrochloride | ESD-864405-1G |
Cas.: 67396-08-1 | Purity: ≥98.0% | D-Lysine Methyl Ester Dihydrochloride | ESD-864405-25G |
Cas.: 9002-17-9 | Purity: 50u/mg | Xanthine Oxidase | ESD-902418-1KU |
Cas.: 66829-29-6 | Purity: 99% | Starch sodium octenylsuccinate | ESD-885075-2.5KG |
Cas.: 1460-34-0 | Purity: ≥95%(GC)(T) | 3-Methyl-2-oxovaleric Acid | ESD-863190-1G |
Cas.: 124-73-2 | Purity: 97% | 1,2-Dibromotetrafluoroethane | ESD-830340-500G |
Cas.: 1670-46-8 | Purity: 98% | 2-Acetylcyclopentanone | ESD-800103-1G |
Cas.: 932-72-9 | Purity: 95% | (Dichloroiodo)-Benzene | ESD-856661-250MG |
Cas.: 27599-63-9 | Purity: Fluorescence grade, >94%(HPLC) | 5(6)-Aminofluorescein | ESD-800610-5G |
Cas.: 1606-67-3 | Purity: >98.0%(HPLC)(T) | 1-Aminopyrene | ESD-836230-10G |
Cas.: 2001-45-8 | Purity: for the spectrophotometric det. of Bi, Co, ≥97% | Tetraphenylphosphonium chloride | ESD-909675-5G |
Cas.: 496-78-6 | Purity: 99% | 2,4,5-Trimethylpheno | ESD-849352-1G |
Cas.: 1004-75-7 | Purity: 97% | 2,5,6-Triamino-4-pyrimidinol | ESD-833458-1G |
Cas.: 1004-75-7 | Purity: 97% | 2,5,6-Triamino-4-pyrimidinol | ESD-833458-5G |
Cas.: 67-56-1 | Purity: ACS spectrophotometric grade, ≥99.9% | Methanol | ESD-909677-500ML |
Cas.: 42774-15-2 | Purity: ≥99% | N1,N3-Bis(2,2,6,6-tetramethylpiperidin-4-yl)isophthalamide | ESD-890603-25G |
Cas.: 42774-15-2 | Purity: ≥99% | N1,N3-Bis(2,2,6,6-tetramethylpiperidin-4-yl)isophthalamide | ESD-890603-100G |
Cas.: 805239-56-9 | Purity: 99% | PHTPP | ESD-872974-25MG |
Cas.: 805239-56-9 | Purity: 99% | PHTPP | ESD-872974-100MG |
Cas.: 58345-97-4 | Purity: 98% | 4′-phenyl-2,2′:6′,2”-terpyridine | ESD-864805-250MG |
Cas.: 40045-50-9 | Purity: 96% | 2-Amino-5-[(5-nitro-2-thiazolyl)thio]-1,3,4-thiadiazole | ESD-869157-50MG |
Cas.: 769-40-4 | Purity: 95% | 2,3,5,6-Tetrafluorobenzenethiol | ESD-838784-1G |
Cas.: 2105-94-4 | Purity: 98% | 4-Bromo-2-fluorophenol | ESD-822560-500G |
Cas.: 99-98-9 | Purity: for spectrophotometric det. of SO42-, S2-, ≥97% | N,N-Dimethyl-p-phenylenediamine | ESD-909678-25G |
Cas.: 6938-45-0 | Purity: ≥97% | Benzyl Hexanoate | ESD-860185-5G |
Cas.: 35112-27-7 | Purity: 98% | Ethyl 2,5-Dichlorobenzoate | ESD-835078-1G |
Cas.: NONE8099 | Purity: for spectrophotometric det. of enzyme activity | N,N-Dimethylcasein | ESD-909679-1G |
Cas.: 121-46-0 | Purity: 98% | Bicyclo[2.2.1]hepta-2,5-diene | ESD-823779-5ML |
Cas.: NONE8100 | Purity: 95% | tert-butyl (2,2-difluoro-1-(o-tolyl)cyclopropyl)carbamate | ESD-909680-1G |
Cas.: NONE8100 | Purity: 95% | tert-butyl (2,2-difluoro-1-(o-tolyl)cyclopropyl)carbamate | ESD-909680-100MG |
Cas.: NONE8100 | Purity: 95% | tert-butyl (2,2-difluoro-1-(o-tolyl)cyclopropyl)carbamate | ESD-909680-500MG |
Cas.: 446-72-0 | Purity: 97% | Genistein | ESD-810426-100G |
Cas.: 19752-57-9 | Purity: 98% | 1,3-Dibromo-5-iodobenzene | ESD-840999-25G |
Cas.: 1357471-44-3 | Purity: for spectrophotometric det. of nitrate and nitrite, ≥99% | N-(1-Naphthyl)ethylenediamine dihydrochloride monomethanolate | ESD-909681-5G |
Cas.: 3585-48-6 | Purity: 95% | 2-(4-isopropylphenyl)propanoic acid | ESD-909682-1G |
Cas.: 3585-48-6 | Purity: 95% | 2-(4-isopropylphenyl)propanoic acid | ESD-909682-5G |
Cas.: 3585-48-6 | Purity: 95% | 2-(4-isopropylphenyl)propanoic acid | ESD-909682-500MG |
Cas.: 39423-51-3 | Purity: average Mn 440 | Trimethylolpropane tris[poly(propylene glycol), amine terminated] ether | ESD-909683-25ML |
Cas.: 39423-51-3 | Purity: average Mn 440 | Trimethylolpropane tris[poly(propylene glycol), amine terminated] ether | ESD-909683-100ML |
Cas.: 21881-18-5 | Purity: 95% | Z-Phe-Ala-OH | ESD-844310-5G |
Cas.: 21881-18-5 | Purity: 95% | Z-Phe-Ala-OH | ESD-844310-25G |
Cas.: 106294-60-4 | Purity: 90% | (2,2′-Bipyridine)bis(2-phenylpyridinato)iridium(III) Hexafluorophosphate | ESD-868811-200MG |
Cas.: NONE8101 | Purity: 95% | ethyl 2,2-difluoro-1-(4-isopropylphenyl)cyclopropane-1-carboxylate | ESD-909684-500MG |
Cas.: NONE8101 | Purity: 95% | ethyl 2,2-difluoro-1-(4-isopropylphenyl)cyclopropane-1-carboxylate | ESD-909684-1G |
Cas.: NONE8101 | Purity: 95% | ethyl 2,2-difluoro-1-(4-isopropylphenyl)cyclopropane-1-carboxylate | ESD-909684-5G |
Cas.: 54708-14-4 | Purity: ≥98% | 2,6-Dimethylphenylacetonitrile | ESD-857985-5G |
Cas.: 2229454-39-9 | Purity: 95% | 2,2-difluoro-1-(4-isopropylphenyl)cyclopropane-1-carboxylic acid | ESD-909686-500MG |
Cas.: 2229454-39-9 | Purity: 95% | 2,2-difluoro-1-(4-isopropylphenyl)cyclopropane-1-carboxylic acid | ESD-909686-1G |
Cas.: 2229454-39-9 | Purity: 95% | 2,2-difluoro-1-(4-isopropylphenyl)cyclopropane-1-carboxylic acid | ESD-909686-5G |
Cas.: 73721-06-9 | Purity: 95% | 2-(m-tolyl)propanoic acid | ESD-909687-1G |
Cas.: 73721-06-9 | Purity: 95% | 2-(m-tolyl)propanoic acid | ESD-909687-500MG |
Cas.: 73721-06-9 | Purity: 95% | 2-(m-tolyl)propanoic acid | ESD-909687-5G |
Cas.: 56090-54-1 | triglycerol | ESD-909688-100G | |
Cas.: 56090-54-1 | triglycerol | ESD-909688-500G | |
Cas.: 12537-81-4 | Purity: 99%, ~300 Mesh | Titanium aluminum carbide lump | ESD-909685-1G |
Cas.: 12537-81-4 | Purity: 99%, ~300 Mesh | Titanium aluminum carbide lump | ESD-909685-5G |
Cas.: 56090-54-1 | triglycerol | ESD-909688-2.5KG | |
Cas.: 12537-81-4 | Purity: 99%, ~300 Mesh | Titanium aluminum carbide lump | ESD-909685-25G |
Cas.: 1710345-30-4 | Purity: 95% | 2,2-difluoro-1-(m-tolyl)cyclopropane-1-carboxylic acid | ESD-909689-1G |
Cas.: 1710345-30-4 | Purity: 95% | 2,2-difluoro-1-(m-tolyl)cyclopropane-1-carboxylic acid | ESD-909689-5G |
Cas.: 1710345-30-4 | Purity: 95% | 2,2-difluoro-1-(m-tolyl)cyclopropane-1-carboxylic acid | ESD-909689-500MG |
Cas.: 79637-05-1 | Purity: ≥98% | 1-Vinyl-3-benzyl imidazolium chlorine | ESD-909690-1G |
Cas.: 79637-05-1 | Purity: ≥98% | 1-Vinyl-3-benzyl imidazolium chlorine | ESD-909690-5G |
Cas.: NONE8102 | Purity: 95% | ethyl 2-(4-propylphenyl)propanoate | ESD-909691-1G |
Cas.: NONE8102 | Purity: 95% | ethyl 2-(4-propylphenyl)propanoate | ESD-909691-5G |
Cas.: NONE8102 | Purity: 95% | ethyl 2-(4-propylphenyl)propanoate | ESD-909691-500MG |
Cas.: 9041-07-0 | Purity: 98% | decaglycerol | ESD-909692-100G |
Cas.: 9041-07-0 | Purity: 98% | decaglycerol | ESD-909692-500G |
Cas.: 9041-07-0 | Purity: 98% | decaglycerol | ESD-909692-2.5KG |
Cas.: NONE8103 | Purity: 95% | ethyl 2,2-difluoro-1-(4-propylphenyl)cyclopropane-1-carboxylat | ESD-909693-500MG |
Cas.: NONE8103 | Purity: 95% | ethyl 2,2-difluoro-1-(4-propylphenyl)cyclopropane-1-carboxylat | ESD-909693-1G |
Cas.: NONE8103 | Purity: 95% | ethyl 2,2-difluoro-1-(4-propylphenyl)cyclopropane-1-carboxylat | ESD-909693-5G |
Cas.: 2991-42-6 | Purity: 98% | 4-(Trifluoromethyl)benzene-1-sulfonyl chloride | ESD-824425-100G |
Cas.: 250597-29-6 | Purity: 97% | 9,9-Dihexylfluorene-2,7-diboronic acid bis(1,3-propanediol) ester | ESD-909695-1G |
Cas.: NONE8105 | Purity: 95% | 2,2-difluoro-1-(4-propylphenyl)cyclopropane-1-carboxylic acid | ESD-909699-1G |
Cas.: NONE8105 | Purity: 95% | 2,2-difluoro-1-(4-propylphenyl)cyclopropane-1-carboxylic acid | ESD-909699-500MG |
Cas.: NONE8105 | Purity: 95% | 2,2-difluoro-1-(4-propylphenyl)cyclopropane-1-carboxylic acid | ESD-909699-5G |
Cas.: NONE8106 | Purity: 95% | methyl 2-(3,5-difluorophenyl)-2-methylpropanoate | ESD-909700-1G |
Cas.: NONE8106 | Purity: 95% | methyl 2-(3,5-difluorophenyl)-2-methylpropanoate | ESD-909700-5G |
Cas.: NONE8106 | Purity: 95% | methyl 2-(3,5-difluorophenyl)-2-methylpropanoate | ESD-909700-500MG |
Cas.: 4747-21-1 | Purity: 98% | N-Isopropyl-N-methylamine | ESD-831569-5ML |
Cas.: 25086-15-1 | Purity: Mn ~15, 000 by GPC; Mw ~34, 000 by GPC | Poly(methyl methacrylate-co-methacrylic acid) | ESD-909701-50G |
Cas.: 25086-15-1 | Purity: Mn ~15, 000 by GPC; Mw ~34, 000 by GPC | Poly(methyl methacrylate-co-methacrylic acid) | ESD-909701-250G |
Cas.: 1202864-39-8 | Purity: for spectrophotometric determination of metal ions | Xylenol Orange disodium salt | ESD-909705-5G |
Cas.: NONE8109 | Purity: 95% | methyl 2-(4-cyano-3-fluorophenyl)-2-methylpropanoate | ESD-909704-1G |
Cas.: NONE8109 | Purity: 95% | methyl 2-(4-cyano-3-fluorophenyl)-2-methylpropanoate | ESD-909704-5G |
Cas.: NONE8109 | Purity: 95% | methyl 2-(4-cyano-3-fluorophenyl)-2-methylpropanoate | ESD-909704-500MG |
Cas.: 4488-57-7 | Purity: 95% | 5,6-Dihydrodicyclopentadiene | ESD-868981-1G |
Cas.: 879904-44-6 | Purity: 95% | 2-(3,5-difluorophenyl)-2-methylpropanoic acid | ESD-909706-1G |
Cas.: 879904-44-6 | Purity: 95% | 2-(3,5-difluorophenyl)-2-methylpropanoic acid | ESD-909706-5G |
Cas.: 879904-44-6 | Purity: 95% | 2-(3,5-difluorophenyl)-2-methylpropanoic acid | ESD-909706-500MG |
Cas.: 75-87-6 | Purity: 99% | Chloral | ESD-875282-2.5KG |
Cas.: 303136-82-5 | Purity: for spectrophotometric det. of Cu, ≥99% | Neocuproine hydrochloride monohydrate | ESD-909707-1G |
Cas.: 2229533-86-0 | Purity: 95% | 2,2-difluoro-1-(4-(trifluoromethoxy)phenyl)cyclopropane-1-carboxylic acid | ESD-909708-1G |
Cas.: 2229533-86-0 | Purity: 95% | 2,2-difluoro-1-(4-(trifluoromethoxy)phenyl)cyclopropane-1-carboxylic acid | ESD-909708-5G |
Cas.: 2229533-86-0 | Purity: 95% | 2,2-difluoro-1-(4-(trifluoromethoxy)phenyl)cyclopropane-1-carboxylic acid | ESD-909708-500MG |
Cas.: NONE8110 | Purity: 95% | ethyl 1-(2,6-dimethoxyphenyl)-2,2-difluorocyclopropane-1-carboxylate | ESD-909710-500MG |
Cas.: NONE8110 | Purity: 95% | ethyl 1-(2,6-dimethoxyphenyl)-2,2-difluorocyclopropane-1-carboxylate | ESD-909710-1G |
Cas.: NONE8110 | Purity: 95% | ethyl 1-(2,6-dimethoxyphenyl)-2,2-difluorocyclopropane-1-carboxylate | ESD-909710-5G |
Cas.: 2229219-47-8 | Purity: 95% | 1-(2,6-dimethoxyphenyl)-2,2-difluorocyclopropane-1-carboxylic acid | ESD-909711-1G |
Cas.: 2229219-47-8 | Purity: 95% | 1-(2,6-dimethoxyphenyl)-2,2-difluorocyclopropane-1-carboxylic acid | ESD-909711-500MG |
Cas.: 2229219-47-8 | Purity: 95% | 1-(2,6-dimethoxyphenyl)-2,2-difluorocyclopropane-1-carboxylic acid | ESD-909711-5G |
Cas.: 39464-70-5 | Purity: Acid value 400~420 | Polyethyleneglycol phenyl ether phosphate | ESD-909712-100G |
Cas.: NONE8111 | Purity: 95% | (1-(2,6-dimethoxyphenyl)-2,2-difluorocyclopropyl)methanol | ESD-909713-1G |
Cas.: 39464-70-5 | Purity: Acid value 400~420 | Polyethyleneglycol phenyl ether phosphate | ESD-909712-500G |
Cas.: NONE8111 | Purity: 95% | (1-(2,6-dimethoxyphenyl)-2,2-difluorocyclopropyl)methanol | ESD-909713-5G |
Cas.: NONE8111 | Purity: 95% | (1-(2,6-dimethoxyphenyl)-2,2-difluorocyclopropyl)methanol | ESD-909713-500MG |
Cas.: 147741-30-8 | Purity: 98% | Tetrabutylammonium hydroxide 30-hydrate | ESD-807859-5G |
Cas.: 52746-49-3 | Purity: for the spectrophotometric det. of Fe, ≥98%(HPLC) | Bathophenanthrolinedisulfonic acid disodium salt trihydrate | ESD-909714-250MG |
Cas.: NONE8112 | Purity: 95% | ethyl 2-(4-butylphenyl)propanoate | ESD-909715-1G |
Cas.: NONE8112 | Purity: 95% | ethyl 2-(4-butylphenyl)propanoate | ESD-909715-500MG |
Cas.: NONE8112 | Purity: 95% | ethyl 2-(4-butylphenyl)propanoate | ESD-909715-5G |
Cas.: 1955514-17-6 | Purity: 95% | 2,2-difluoro-1-(m-tolyl)cyclopropane-1-carboxylic acid | ESD-909718-1G |
Cas.: 1955514-17-6 | Purity: 95% | 2,2-difluoro-1-(m-tolyl)cyclopropane-1-carboxylic acid | ESD-909718-500MG |
Cas.: 1955514-17-6 | Purity: 95% | 2,2-difluoro-1-(m-tolyl)cyclopropane-1-carboxylic acid | ESD-909718-100MG |
Cas.: 63148-62-0 | Purity: viscosity:800-5000 mPa.s | Amino-modified silicone oil | ESD-909719-100G |
Cas.: 63148-62-0 | Purity: viscosity:800-5000 mPa.s | Amino-modified silicone oil | ESD-909719-500G |
Cas.: 20325-40-0 | Purity: for enzymic, spectrophotometric determination | o-Dianisidine dihydrochloride | ESD-909720-5MG |
Cas.: 63148-62-0 | Purity: viscosity:800-5000 mPa.s | Amino-modified silicone oil | ESD-909719-2.5KG |
Cas.: 9003-53-6 | Purity: diameter 2.0- 2.9 μm , 5% w/v | Latex beads, polystyrene | ESD-815941-1ML |
Cas.: 2098065-08-6 | Purity: 95% | 2-(7,7-difluorobicyclo[4.1.0]heptan-1-yl)ethan-1-amine | ESD-909721-100MG |
Cas.: 2098065-08-6 | Purity: 95% | 2-(7,7-difluorobicyclo[4.1.0]heptan-1-yl)ethan-1-amine | ESD-909721-500MG |
Cas.: 2098065-08-6 | Purity: 95% | 2-(7,7-difluorobicyclo[4.1.0]heptan-1-yl)ethan-1-amine | ESD-909721-1G |
Cas.: 24937-79-9 | Purity: average Mw ~400, 000, powder | Poly(vinylidene fluoride) | ESD-875315-2.5KG |
Cas.: NONE8115 | Purity: 95% | 5-(tert-butyl) 6-methyl (6S)-1,1-difluoro-5-azaspiro[2.4]heptane-5,6-dicarboxylate | ESD-909722-1G |
Cas.: NONE8115 | Purity: 95% | 5-(tert-butyl) 6-methyl (6S)-1,1-difluoro-5-azaspiro[2.4]heptane-5,6-dicarboxylate | ESD-909722-100MG |
Cas.: NONE8115 | Purity: 95% | 5-(tert-butyl) 6-methyl (6S)-1,1-difluoro-5-azaspiro[2.4]heptane-5,6-dicarboxylate | ESD-909722-500MG |
Cas.: 698394-59-1 | Purity: 95% | methyl 2-(4-ethylphenyl)-2-methylpropanoate | ESD-909723-1G |
Cas.: 698394-59-1 | Purity: 95% | methyl 2-(4-ethylphenyl)-2-methylpropanoate | ESD-909723-5G |
Cas.: 698394-59-1 | Purity: 95% | methyl 2-(4-ethylphenyl)-2-methylpropanoate | ESD-909723-500MG |
Cas.: 157230-67-6 | Purity: 98% | 5-(Diethylphosphono)-5-methyl-1-pyrroline N-Oxide | ESD-869727-50MG |
Cas.: NONE8117 | Purity: 95% | methyl 2-(3-amino-4-methoxyphenyl)-2-methylpropanoate | ESD-909725-500MG |
Cas.: NONE8117 | Purity: 95% | methyl 2-(3-amino-4-methoxyphenyl)-2-methylpropanoate | ESD-909725-1G |
Cas.: NONE8117 | Purity: 95% | methyl 2-(3-amino-4-methoxyphenyl)-2-methylpropanoate | ESD-909725-5G |
Cas.: 5428-80-8 | Purity: 97% | NSC13316 | ESD-873829-5MG |
Cas.: 666-52-4 | Purity: (D, 99.9%) + 0.03 % (v/v) TMS | Acetone-d6 | ESD-800096-10G |
Cas.: 666-52-4 | Purity: (D, 99.9%) + 0.03 % (v/v) TMS | Acetone-d6 | ESD-800096-25G |
Cas.: 383671-84-9 | Purity: 95% | 2-(4-methoxy-3-nitrophenyl)-2-methylpropanoic acid | ESD-909726-1G |
Cas.: 383671-84-9 | Purity: 95% | 2-(4-methoxy-3-nitrophenyl)-2-methylpropanoic acid | ESD-909726-5G |
Cas.: 383671-84-9 | Purity: 95% | 2-(4-methoxy-3-nitrophenyl)-2-methylpropanoic acid | ESD-909726-500MG |
Cas.: 1247119-83-0 | Purity: 95% | 2-(4-ethylphenyl)-2-methylpropanoic acid | ESD-909728-1G |
Cas.: 1247119-83-0 | Purity: 95% | 2-(4-ethylphenyl)-2-methylpropanoic acid | ESD-909728-5G |
Cas.: 1247119-83-0 | Purity: 95% | 2-(4-ethylphenyl)-2-methylpropanoic acid | ESD-909728-500MG |
Cas.: NONE8118 | Purity: 95% | methyl 2-(3-amino-4-(trifluoromethoxy)phenyl)-2-methylpropanoate | ESD-909729-500MG |
Cas.: NONE8118 | Purity: 95% | methyl 2-(3-amino-4-(trifluoromethoxy)phenyl)-2-methylpropanoate | ESD-909729-1G |
Cas.: NONE8118 | Purity: 95% | methyl 2-(3-amino-4-(trifluoromethoxy)phenyl)-2-methylpropanoate | ESD-909729-5G |
Cas.: 18119-24-9 | Purity: 97% | 8-Chloroquinolin-6-ol | ESD-837828-5G |
Cas.: NONE8119 | Purity: 95% | 2-methyl-2-(3-nitro-4-(trifluoromethoxy)phenyl)propanoic acid | ESD-909730-1G |
Cas.: NONE8119 | Purity: 95% | 2-methyl-2-(3-nitro-4-(trifluoromethoxy)phenyl)propanoic acid | ESD-909730-5G |
Cas.: NONE8119 | Purity: 95% | 2-methyl-2-(3-nitro-4-(trifluoromethoxy)phenyl)propanoic acid | ESD-909730-500MG |
Cas.: 39464-70-5 | Purity: Acid value 400~420 | Polyethyleneglycol phenyl ether phosphate | ESD-909712-2.5KG |
Cas.: 1314745-86-2 | Purity: 95% | 2-(4-cyano-3-fluorophenyl)-2-methylpropanoic acid | ESD-909731-1G |
Cas.: 1314745-86-2 | Purity: 95% | 2-(4-cyano-3-fluorophenyl)-2-methylpropanoic acid | ESD-909731-5G |
Cas.: 1314745-86-2 | Purity: 95% | 2-(4-cyano-3-fluorophenyl)-2-methylpropanoic acid | ESD-909731-500MG |
Cas.: 5459-35-8 | Purity: 95% | ethyl 2-bromoacrylate | ESD-827980-5G |
Cas.: 25875-50-7 | Purity: VETRANAL, analytical standard | Robenidine HCl, Vetranal | ESD-838207-100ML |
Cas.: 5459-35-8 | Purity: 95% | ethyl 2-bromoacrylate | ESD-827980-10G |
Cas.: 3585-53-3 | Purity: 95% | 2-(4-phenoxyphenyl)propanoic acid | ESD-909732-1G |
Cas.: 3585-53-3 | Purity: 95% | 2-(4-phenoxyphenyl)propanoic acid | ESD-909732-5G |
Cas.: 3585-53-3 | Purity: 95% | 2-(4-phenoxyphenyl)propanoic acid | ESD-909732-500MG |
Cas.: 821-38-5 | Purity: 98% | Tetradecanedioic acid | ESD-819645-2.5KG |
Cas.: NONE8120 | Purity: 95% | ethyl 2-(4-phenoxyphenyl)propanoate | ESD-909733-500MG |
Cas.: 104872-42-6 | Purity: ≥96% | 1,2-di-O-octadecenyl-3-trimethylammonium propane (chloride salt) | ESD-890244-100MG |
Cas.: NONE8120 | Purity: 95% | ethyl 2-(4-phenoxyphenyl)propanoate | ESD-909733-1G |
Cas.: NONE8120 | Purity: 95% | ethyl 2-(4-phenoxyphenyl)propanoate | ESD-909733-5G |
Cas.: 104872-42-6 | Purity: ≥96% | 1,2-di-O-octadecenyl-3-trimethylammonium propane (chloride salt) | ESD-890244-5MG |
Cas.: NONE8121 | Purity: 95% | methyl 2-(4-methoxy-3-nitrophenyl)-2-methylpropanoate | ESD-909734-1G |
Cas.: NONE8121 | Purity: 95% | methyl 2-(4-methoxy-3-nitrophenyl)-2-methylpropanoate | ESD-909734-5G |
Cas.: NONE8121 | Purity: 95% | methyl 2-(4-methoxy-3-nitrophenyl)-2-methylpropanoate | ESD-909734-500MG |
Cas.: 250249-75-3 | Purity: 97% | Rutin trihydrate | ESD-817281-5G |
Cas.: 5454-83-1 | Purity: 98% | Methyl 5-bromovalerate | ESD-831172-25G |
Cas.: 110-80-5 | Purity: spectrophotometric grade, ≥99% | 2-Ethoxyethanol | ESD-909735-250ML |
Cas.: NONE8113 | Nucleating agent NA-21 | ESD-909716-50G | |
Cas.: NONE8113 | Nucleating agent NA-21 | ESD-909716-250G | |
Cas.: NONE8113 | Nucleating agent NA-21 | ESD-909716-1KG | |
Cas.: NONE8114 | HPN-20E | ESD-909717-50G | |
Cas.: NONE8114 | HPN-20E | ESD-909717-250G | |
Cas.: NONE8114 | HPN-20E | ESD-909717-1KG | |
Cas.: 13983-17-0 | Purity: 1,000 mesh | Calcium metasilicate | ESD-909736-25G |
Cas.: 13983-17-0 | Purity: 1,000 mesh | Calcium metasilicate | ESD-909736-100G |
Cas.: 1010689-64-1 | Purity: 95% | 2-(2,2-difluoro-1-phenylcyclopropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909737-500MG |
Cas.: 1010689-64-1 | Purity: 95% | 2-(2,2-difluoro-1-phenylcyclopropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909737-1G |
Cas.: 1010689-64-1 | Purity: 95% | 2-(2,2-difluoro-1-phenylcyclopropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909737-5G |
Cas.: 127-19-5 | Purity: spectrophotometric grade, ≥99% | NN-Dimethylacetamide | ESD-909738-250ML |
Cas.: NONE8122 | Purity: 95% | 1,1-difluorospiro[2.3]hexane-5-carbonitrile | ESD-909739-500MG |
Cas.: NONE8122 | Purity: 95% | 1,1-difluorospiro[2.3]hexane-5-carbonitrile | ESD-909739-1G |
Cas.: NONE8122 | Purity: 95% | 1,1-difluorospiro[2.3]hexane-5-carbonitrile | ESD-909739-5G |
Cas.: 25088-96-4 | Purity: 99% | Disodium stannous citrate | ESD-908977-2.5KG |
Cas.: NONE8123 | Purity: 95% | ethyl 2-(3-methoxyphenyl)acrylate | ESD-909740-500MG |
Cas.: NONE8123 | Purity: 95% | ethyl 2-(3-methoxyphenyl)acrylate | ESD-909740-1G |
Cas.: NONE8123 | Purity: 95% | ethyl 2-(3-methoxyphenyl)acrylate | ESD-909740-5G |
Cas.: NONE8124 | Purity: 95% | 2,2-difluoro-1-(4-phenoxyphenyl)cyclopropane-1-carboxylic acid | ESD-909741-500MG |
Cas.: NONE8124 | Purity: 95% | 2,2-difluoro-1-(4-phenoxyphenyl)cyclopropane-1-carboxylic acid | ESD-909741-1G |
Cas.: NONE8124 | Purity: 95% | 2,2-difluoro-1-(4-phenoxyphenyl)cyclopropane-1-carboxylic acid | ESD-909741-5G |
Cas.: 2228360-01-6 | Purity: 95% | 1-(4-(tert-butyl)phenyl)-2,2-difluorocyclopropane-1-carboxylic acid | ESD-909742-500MG |
Cas.: 2228360-01-6 | Purity: 95% | 1-(4-(tert-butyl)phenyl)-2,2-difluorocyclopropane-1-carboxylic acid | ESD-909742-1G |
Cas.: 2228360-01-6 | Purity: 95% | 1-(4-(tert-butyl)phenyl)-2,2-difluorocyclopropane-1-carboxylic acid | ESD-909742-5G |
Cas.: 40150-91-2 | Purity: 95% | 2-(4-(tert-butyl)phenyl)propanoic acid | ESD-909743-500MG |
Cas.: 40150-91-2 | Purity: 95% | 2-(4-(tert-butyl)phenyl)propanoic acid | ESD-909743-1G |
Cas.: 40150-91-2 | Purity: 95% | 2-(4-(tert-butyl)phenyl)propanoic acid | ESD-909743-5G |
Cas.: NONE8125 | Purity: 95% | ethyl 1-(4-(tert-butyl)phenyl)-2,2-difluorocyclopropane-1-carboxylate | ESD-909744-500MG |
Cas.: NONE8125 | Purity: 95% | ethyl 1-(4-(tert-butyl)phenyl)-2,2-difluorocyclopropane-1-carboxylate | ESD-909744-1G |
Cas.: NONE8125 | Purity: 95% | ethyl 1-(4-(tert-butyl)phenyl)-2,2-difluorocyclopropane-1-carboxylate | ESD-909744-5G |
Cas.: NONE8126 | Purity: 90% | ethyl 2-(4-(tert-butyl)phenyl)propanoate | ESD-909745-500MG |
Cas.: NONE8126 | Purity: 90% | ethyl 2-(4-(tert-butyl)phenyl)propanoate | ESD-909745-1G |
Cas.: NONE8126 | Purity: 90% | ethyl 2-(4-(tert-butyl)phenyl)propanoate | ESD-909745-5G |
Cas.: 163253-35-8 | Purity: 98% | Sitafloxacin Hydrate | ESD-873332-250MG |
Cas.: NONE8127 | Purity: 95% | ethyl 1-(4-butylphenyl)-2,2-difluorocyclopropane-1-carboxylate | ESD-909747-1G |
Cas.: NONE8127 | Purity: 95% | ethyl 1-(4-butylphenyl)-2,2-difluorocyclopropane-1-carboxylate | ESD-909747-5G |
Cas.: NONE8127 | Purity: 95% | ethyl 1-(4-butylphenyl)-2,2-difluorocyclopropane-1-carboxylate | ESD-909747-500MG |
Cas.: 643-01-6 | Purity: ≥97%(GC) | L-Mannitol | ESD-861784-500MG |
Cas.: 126050-54-2 | 2,2′-Methylenebis(4,6-di-tert-butylphenyl) 2-ethylhexyl phosphite | ESD-909748-100G | |
Cas.: 126050-54-2 | 2,2′-Methylenebis(4,6-di-tert-butylphenyl) 2-ethylhexyl phosphite | ESD-909748-500G | |
Cas.: 126050-54-2 | 2,2′-Methylenebis(4,6-di-tert-butylphenyl) 2-ethylhexyl phosphite | ESD-909748-2.5KG | |
Cas.: 13826-86-3 | Purity: 96% | Nitronium tetrafluoroborate | ESD-836144-1G |
Cas.: 2040-10-0 | Purity: 98% | 4′-tert-Butyl-2′,6′-dimethylacetophenone | ESD-909750-1G |
Cas.: 1927-06-6 | Purity: 98% | Choline Bromide | ESD-870595-100G |
Cas.: 75777-87-6 | Purity: 97% | Tris[4,4′-di-tert-butyl-(2,2′)-bipyridine]ruthenium(III) dihexafluorophosphate | ESD-902130-250MG |
Cas.: 75777-87-6 | Purity: 97% | Tris[4,4′-di-tert-butyl-(2,2′)-bipyridine]ruthenium(III) dihexafluorophosphate | ESD-902130-50MG |
Cas.: 90866-33-4 | Purity: 95% | |R|-4-Chloro-3-hydroxybutyric acid ethyl ester | ESD-804937-100G |
Cas.: 18127-87-2 | Purity: 98% | 4-(Diethylamino)benzophenone | ESD-909751-1G |
Cas.: 18127-87-2 | Purity: 98% | 4-(Diethylamino)benzophenone | ESD-909751-5G |
Cas.: 18127-87-2 | Purity: 98% | 4-(Diethylamino)benzophenone | ESD-909751-25G |
Cas.: 28084-48-2 | Purity: 97% | 4-Hydroxyphenyl 4-hydroxybenzoate | ESD-909752-1G |
Cas.: 28084-48-2 | Purity: 97% | 4-Hydroxyphenyl 4-hydroxybenzoate | ESD-909752-5G |
Cas.: 28084-48-2 | Purity: 97% | 4-Hydroxyphenyl 4-hydroxybenzoate | ESD-909752-250MG |
Cas.: 14273-90-6 | Purity: 98% | Methyl 6-bromohexanoate | ESD-831966-100G |
Cas.: 75081-21-9 | Purity: 97%, mixture of 2- and 4-isomers | Isopropyl-9H-thioxanthen-9-one | ESD-909753-1G |
Cas.: 75081-21-9 | Purity: 97%, mixture of 2- and 4-isomers | Isopropyl-9H-thioxanthen-9-one | ESD-909753-5G |
Cas.: 1120-24-7 | Purity: 95% | N,N-Dimethyldecylamine | ESD-837251-25ML |
Cas.: 470-69-9 | Purity: ≥98%(HPLC) | 1 – Kestose | ESD-861202-250MG |
Cas.: 470-69-9 | Purity: ≥98%(HPLC) | 1 – Kestose | ESD-861202-1G |
Cas.: 9001-75-6 | Purity: 1: 10000 | Pepsin | ESD-909754-5G |
Cas.: 9001-75-6 | Purity: 1: 10000 | Pepsin | ESD-909754-25G |
Cas.: 9001-75-6 | Purity: 1: 10000 | Pepsin | ESD-909754-100G |
Cas.: 9001-75-6 | Purity: 1: 10000 | Pepsin | ESD-909754-500G |
Cas.: 148044-07-9 | Purity: >98.0%(HPLC) | 1,3,5-Tri(9H-carbazol-9-yl)benzene | ESD-820243-250MG |
Cas.: 2350272-68-1 | Purity: >98.0%(T)(HPLC) | Bis[4-(tert-butyl)phenyl]iodonium Tetra(nonafluoro-tert-butoxy)aluminate | ESD-909755-50MG |
Cas.: 2350272-68-1 | Purity: >98.0%(T)(HPLC) | Bis[4-(tert-butyl)phenyl]iodonium Tetra(nonafluoro-tert-butoxy)aluminate | ESD-909755-250MG |
Cas.: 134708-14-8 | Purity: ≥99% trace metals basis | Tris(4-tert-butylphenyl)sulfonium triflate | ESD-909756-50MG |
Cas.: 134708-14-8 | Purity: ≥99% trace metals basis | Tris(4-tert-butylphenyl)sulfonium triflate | ESD-909756-250MG |
Cas.: 6074-84-6 | Purity: 99% | Tantalum(V) Ethoxide | ESD-838553-25G |
Cas.: 6265-73-2 | Purity: 95% | N-(2-Hydroxyethyl)nicotinamide | ESD-843421-5G |
Cas.: 134127-48-3 | Purity: >98.0%(HPLC) | IR-813 p-Toluenesulfonate | ESD-863887-5G |
Cas.: 134127-48-3 | Purity: >98.0%(HPLC) | IR-813 p-Toluenesulfonate | ESD-863887-25G |
Cas.: 241806-75-7 | Purity: ≥99% trace metals basis | Tris(4-tert-butylphenyl)sulfonium perfluoro-1-butanesulfonate | ESD-909757-50MG |
Cas.: 241806-75-7 | Purity: ≥99% trace metals basis | Tris(4-tert-butylphenyl)sulfonium perfluoro-1-butanesulfonate | ESD-909757-250MG |
Cas.: 66582-26-1 | Purity: 90% | 1,2-Bis(2-benzylaminoethoxy)ethane | ESD-868770-5G |
Cas.: 33329-35-0 | Purity: ≥98% | N,N-Bis[3-(Dimethylamino)Propyl]-N’,N’-Dimethylpropane-1,3-Diamine | ESD-859862-1G |
Cas.: 60827-45-4 | Purity: 97% | |S|-(+)-3-Chloro-1,2-propanediol | ESD-804748-500G |
Cas.: 13463-67-7 | Purity: EP grade, Average Particle size : 0.1-0.3μm | Titanium dioxide | ESD-818990-2.5KG |
Cas.: 109037-75-4 | Purity: 50 wt. % in propylene carbonate | Triarylsulfonium hexafluoroantimonate salts, mixed | ESD-909758-1ML |
Cas.: 109037-75-4 | Purity: 50 wt. % in propylene carbonate | Triarylsulfonium hexafluoroantimonate salts, mixed | ESD-909758-5ML |
Cas.: 473927-63-8 | Purity: 98% | ethyl 2-chloro-2-[(4-methoxyphenyl)hydrazinylidene]acetate | ESD-856898-50G |
Cas.: 107-21-1 | Purity: spectrophotometric grade, ≥99% | Ethylene glycol | ESD-909759-1L |
Cas.: 615-79-2 | Purity: 97% | Ethyl 2,4-dioxovalerate | ESD-823358-100G |
Cas.: 314041-08-2 | Purity: BR | Ellagic Acid hydrate | ESD-873739-25MG |
Cas.: 56289-64-6 | Purity: >97.0%(HPLC)(N) | IR 676 Iodide | ESD-863771-50MG |
Cas.: 314041-08-2 | Purity: BR | Ellagic Acid hydrate | ESD-873739-100MG |
Cas.: 6913-92-4 | Purity: 98% | 1-Benzyl-3-pyrroline | ESD-803720-25G |
Cas.: 18531-95-8 | Purity: 99% | (S)-(-)-2,2′-Diamino-1,1′-binaphthalene | ESD-830358-25G |
Cas.: 12537-81-4 | Purity: 99%, ~300 Mesh | Titanium aluminum carbide lump | ESD-909685-100G |
Cas.: 119001-43-3 | Purity: 97% | Tris(4-formylphenyl)amine | ESD-818585-1G |
Cas.: 527-31-1 | Purity: >95% | Triquinoyl Hydrate | ESD-837325-100G |
Cas.: 919783-22-5 | Purity: ≥98% | AZD-1656 | ESD-873863-5MG |
Cas.: 2737-20-4 | Purity: 98% | 4-Bromo-3-(hydroxymethyl)phenol | ESD-904743-250MG |
Cas.: NONE7019 | Purity: CH-95 | Mercury removal resin | ESD-886031-2.5KG |
Cas.: 21520-79-6 | Purity: 95% | N-hydroxyhydrazinecarboxamide | ESD-909760-5G |
Cas.: 21520-79-6 | Purity: 95% | N-hydroxyhydrazinecarboxamide | ESD-909760-25G |
Cas.: 21520-79-6 | Purity: 95% | N-hydroxyhydrazinecarboxamide | ESD-909760-100G |
Cas.: 38064-07-2 | Purity: 95% | phenyl hydroxycarbamate | ESD-909761-5G |
Cas.: 38064-07-2 | Purity: 95% | phenyl hydroxycarbamate | ESD-909761-25G |
Cas.: 38064-07-2 | Purity: 95% | phenyl hydroxycarbamate | ESD-909761-100G |
Cas.: 39208-15-6 | Purity: ≥98% | Copper(II) Disodium Ethylenediaminetetraacetate Tetrahydrate | ESD-859264-2.5KG |
Cas.: NONE8129 | Purity: 95% | 3-((2,6-dibromo-4-methylphenyl)diazenyl)-4,5-dihydroxynaphthalene-2,7-disulfonic acid | ESD-909762-5G |
Cas.: NONE8129 | Purity: 95% | 3-((2,6-dibromo-4-methylphenyl)diazenyl)-4,5-dihydroxynaphthalene-2,7-disulfonic acid | ESD-909762-25G |
Cas.: NONE8129 | Purity: 95% | 3-((2,6-dibromo-4-methylphenyl)diazenyl)-4,5-dihydroxynaphthalene-2,7-disulfonic acid | ESD-909762-50G |
Cas.: 16310-13-7 | Purity: ≥98% | Thiazolidine-2-carboxylic Acid | ESD-865974-5G |
Cas.: 16310-13-7 | Purity: ≥98% | Thiazolidine-2-carboxylic Acid | ESD-865974-25G |
Cas.: 68630-75-1 | Purity: >99% | Buserelin Acetate | ESD-860475-25MG |
Cas.: 6248-20-0 | Purity: 98% | 2,4-Dihydroxy-3-methylbenzaldehyde | ESD-842034-5G |
Cas.: 155830-69-6 | Purity: 95% | (R)-(-)-1-[(S)-2-Diphenylphosphino)ferrocenyl]ethyldi-tert-butylphosphine | ESD-835553-1G |
Cas.: NONE8130 | Purity: 95% | 4,5-dihydroxy-3-((4-methyl-2-sulfophenyl)diazenyl)naphthalene-2,7-disulfonic acid | ESD-909763-5G |
Cas.: NONE8130 | Purity: 95% | 4,5-dihydroxy-3-((4-methyl-2-sulfophenyl)diazenyl)naphthalene-2,7-disulfonic acid | ESD-909763-25G |
Cas.: NONE8130 | Purity: 95% | 4,5-dihydroxy-3-((4-methyl-2-sulfophenyl)diazenyl)naphthalene-2,7-disulfonic acid | ESD-909763-50G |
Cas.: 2043-57-4 | Purity: 97% | 1H,1H,2H,2H-Perfluorooctyl iodide | ESD-815884-100G |
Cas.: 145849-32-7 | Purity: >99% | 1,2-dipalmitoyl-sn-glycero-3-phospho-L-serine (sodium salt) | ESD-864078-100MG |
Cas.: 145849-32-7 | Purity: >99% | 1,2-dipalmitoyl-sn-glycero-3-phospho-L-serine (sodium salt) | ESD-864078-500MG |
Cas.: 76-43-7 | Purity: 98% | Fluoxymesterone | ESD-830084-5G |
Cas.: 683-98-7 | Purity: ≥97%(GC) | Methyl Bromodifluoroacetate | ESD-863455-25G |
Cas.: 4672-49-5 | Purity: 95% | ethylene dimethanesulfonate | ESD-888944-250MG |
Cas.: 187227-45-8 | Purity: ≥99% | Oseltamivir (acid) | ESD-881026-50MG |
Cas.: 9007-20-9 | CarbomerL30 | ESD-889422-100G | |
Cas.: 760952-88-3 | Purity: ≥97% | Tris(3-hydroxypropyltriazolylmethyl)amine | ESD-862631-250MG |
Cas.: 68424-95-3 | Purity: 80% | Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides | ESD-903644-500G |
Cas.: 25764-10-7 | Purity: 99.9% (REO) | Lanthanum(III) nitride | ESD-837107-25G |
Cas.: 136738-23-3 | Purity: 99% | 4-Acetylamino-6-methyl-3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine | ESD-909311-500G |
Cas.: 10226-29-6 | Purity: ≥95% | 6-Bromohexan-2-one | ESD-895596-1G |
Cas.: 66003-78-9 | Triphenylsulfonium triflate | ESD-909764-50MG | |
Cas.: 1860-26-0 | Purity: ≥97% | Tris(2-ethylhexyl)amine | ESD-837974-5G |
Cas.: 66003-78-9 | Triphenylsulfonium triflate | ESD-909764-250MG | |
Cas.: 1860-26-0 | Purity: ≥97% | Tris(2-ethylhexyl)amine | ESD-837974-25G |
Cas.: 111-76-2 | Purity: spectrophotometric grade, ≥99% | Ethylene glycol butyl ether | ESD-909765-500ML |
Cas.: 29584-64-3 | Purity: 98% | ethyl (E)-3-(3,5-dimethoxyphenyl)acrylate | ESD-909766-1G |
Cas.: 29584-64-3 | Purity: 98% | ethyl (E)-3-(3,5-dimethoxyphenyl)acrylate | ESD-909766-5G |
Cas.: 3452-97-9 | Purity: 85% | 3,5,5-Trimethyl-1-hexanol | ESD-830973-2.5L |
Cas.: 2227788-35-2 | Purity: 91% | ethyl trans-4-(3-ethoxy-4-methoxyphenyl)pyrrolidine-3-carboxylate hydrochloride | ESD-909767-250MG |
Cas.: 111-96-6 | Purity: spectrophotometric grade, ≥99% | 2-Methoxyethyl ether | ESD-909768-500ML |
Cas.: 2227788-35-2 | Purity: 91% | ethyl trans-4-(3-ethoxy-4-methoxyphenyl)pyrrolidine-3-carboxylate hydrochloride | ESD-909767-1G |
Cas.: 131717-99-2 | Purity: ≥99% trace metals basis | Bis(4-tert-butylphenyl)iodoniump-toluenesulfonate | ESD-909769-50MG |
Cas.: 131717-99-2 | Purity: ≥99% trace metals basis | Bis(4-tert-butylphenyl)iodoniump-toluenesulfonate | ESD-909769-250MG |
Cas.: 16925-25-0 | Purity: 98% | Sodium hexafluoroantimonate(V) | ESD-836250-2.5KG |
Cas.: NONE8131 | Purity: 98% | 1-(tert-butyl) 3-ethyl trans-4-(4-(tert-butyl)phenyl)pyrrolidine-1,3-dicarboxylate | ESD-909770-250MG |
Cas.: NONE8131 | Purity: 98% | 1-(tert-butyl) 3-ethyl trans-4-(4-(tert-butyl)phenyl)pyrrolidine-1,3-dicarboxylate | ESD-909770-1G |
Cas.: 109-66-0 | Purity: spectrophotometric grade, ≥99% | n-Pentane | ESD-909771-500ML |
Cas.: NONE8132 | Purity: 97% | tert-butyl trans-3-(hydroxymethyl)-4-(4-isopropylphenyl)pyrrolidine-1-carboxylate | ESD-909772-1G |
Cas.: NONE8132 | Purity: 97% | tert-butyl trans-3-(hydroxymethyl)-4-(4-isopropylphenyl)pyrrolidine-1-carboxylate | ESD-909772-250MG |
Cas.: 6293-66-9 | Purity: ≥99% trace metals basis | Diphenyliodoniump-toluenesulfonate | ESD-909773-50MG |
Cas.: 6293-66-9 | Purity: ≥99% trace metals basis | Diphenyliodoniump-toluenesulfonate | ESD-909773-250MG |
Cas.: NONE8133 | Purity: 98% | (trans-1-benzyl-4-(4-(tert-butyl)phenyl)pyrrolidin-3-yl)methanol | ESD-909774-250MG |
Cas.: NONE8133 | Purity: 98% | (trans-1-benzyl-4-(4-(tert-butyl)phenyl)pyrrolidin-3-yl)methanol | ESD-909774-1G |
Cas.: NONE8134 | Purity: 99% | ethyl 1-benzyl-3-(o-tolyl)pyrrolidine-3-carboxylate | ESD-909775-250MG |
Cas.: NONE8134 | Purity: 99% | ethyl 1-benzyl-3-(o-tolyl)pyrrolidine-3-carboxylate | ESD-909775-1G |
Cas.: 1263281-72-6 | Purity: 98% | trans-1-(tert-butoxycarbonyl)-4-(4-(tert-butyl)phenyl)pyrrolidine-3-carboxylic acid | ESD-909776-250MG |
Cas.: 1263281-72-6 | Purity: 98% | trans-1-(tert-butoxycarbonyl)-4-(4-(tert-butyl)phenyl)pyrrolidine-3-carboxylic acid | ESD-909776-1G |
Cas.: NONE8135 | Purity: 97% | tert-butyl trans-3-(4-(tert-butyl)phenyl)-4-(hydroxymethyl)pyrrolidine-1-carboxylate | ESD-909777-250MG |
Cas.: NONE8135 | Purity: 97% | tert-butyl trans-3-(4-(tert-butyl)phenyl)-4-(hydroxymethyl)pyrrolidine-1-carboxylate | ESD-909777-1G |
Cas.: 128408-02-6 | Purity: 99% | ethyl (E)-3-(4-isopropylphenyl)acrylate | ESD-909778-1G |
Cas.: 128408-02-6 | Purity: 99% | ethyl (E)-3-(4-isopropylphenyl)acrylate | ESD-909778-5G |
Cas.: NONE8136 | Purity: 98% | ethyl 3-(o-tolyl)pyrrolidine-3-carboxylate | ESD-909779-250MG |
Cas.: NONE8136 | Purity: 98% | ethyl 3-(o-tolyl)pyrrolidine-3-carboxylate | ESD-909779-500MG |
Cas.: 2227790-64-7 | Purity: 96% | ethyl trans-4-(4-fluorophenyl)pyrrolidine-3-carboxylate | ESD-909780-250MG |
Cas.: 2227790-64-7 | Purity: 96% | ethyl trans-4-(4-fluorophenyl)pyrrolidine-3-carboxylate | ESD-909780-1G |
Cas.: 289905-88-0 | Purity: 98% | TRAM-34 | ESD-849234-250MG |
Cas.: 289905-88-0 | Purity: 98% | TRAM-34 | ESD-849234-500MG |
Cas.: 108-87-2 | Purity: spectrophotometric grade, 99% | Methylcyclohexane | ESD-909781-500ML |
Cas.: 144317-44-2 | Purity: ≥99% | Triphenylsulfonium perfluoro-1-butanesufonate | ESD-909782-50MG |
Cas.: 144317-44-2 | Purity: ≥99% | Triphenylsulfonium perfluoro-1-butanesufonate | ESD-909782-250MG |
Cas.: 89151-44-0 | Purity: 98% | N-Boc-4-piperidineethanol | ESD-803685-100G |
Cas.: 169248-97-9 | Purity: 98% | trans-1-(tert-butoxycarbonyl)-4-(3-(trifluoromethyl)phenyl)pyrrolidine-3-carboxylic acid | ESD-843356-250MG |
Cas.: 169248-97-9 | Purity: 98% | trans-1-(tert-butoxycarbonyl)-4-(3-(trifluoromethyl)phenyl)pyrrolidine-3-carboxylic acid | ESD-843356-1G |
Cas.: 76045-71-1 | Purity: 98% | 3-Amino-5-hydroxybenzoic acid | ESD-843509-5G |
Cas.: 76045-71-1 | Purity: 98% | 3-Amino-5-hydroxybenzoic acid | ESD-843509-25G |
Cas.: NONE8137 | Purity: 98% | tert-butyl trans-3-(2,4-dimethoxyphenyl)-4-(hydroxymethyl)pyrrolidine-1-carboxylate | ESD-909783-250MG |
Cas.: NONE8137 | Purity: 98% | tert-butyl trans-3-(2,4-dimethoxyphenyl)-4-(hydroxymethyl)pyrrolidine-1-carboxylate | ESD-909783-1G |
Cas.: 116808-69-6 | 1-Naphthyl diphenylsulfonium triflate | ESD-909784-50MG | |
Cas.: 116808-69-6 | 1-Naphthyl diphenylsulfonium triflate | ESD-909784-250MG | |
Cas.: NONE8138 | Purity: 98% | (trans-1-benzyl-4-(4-isopropylphenyl)pyrrolidin-3-yl)methanol | ESD-909785-250MG |
Cas.: NONE8138 | Purity: 98% | (trans-1-benzyl-4-(4-isopropylphenyl)pyrrolidin-3-yl)methanol | ESD-909785-1G |
Cas.: 113048-68-3 | Purity: 98% | ethyl (E)-3-(3-(trifluoromethyl)phenyl)acrylate | ESD-909786-250MG |
Cas.: 113048-68-3 | Purity: 98% | ethyl (E)-3-(3-(trifluoromethyl)phenyl)acrylate | ESD-909786-1G |
Cas.: 240482-96-6 | (4-Phenoxyphenyl)diphenylsulfonium triflate | ESD-909787-50MG | |
Cas.: 240482-96-6 | (4-Phenoxyphenyl)diphenylsulfonium triflate | ESD-909787-250MG | |
Cas.: NONE8139 | Purity: 98% | ethyl 1-benzyl-3-(p-tolyl)pyrrolidine-3-carboxylate | ESD-909791-1G |
Cas.: NONE8139 | Purity: 98% | ethyl 1-benzyl-3-(p-tolyl)pyrrolidine-3-carboxylate | ESD-909791-250MG |
Cas.: 915390-53-3 | Purity: 98% | ethyl trans-1-benzyl-4-(3-(trifluoromethyl)phenyl)pyrrolidine-3-carboxylate | ESD-909794-250MG |
Cas.: 915390-53-3 | Purity: 98% | ethyl trans-1-benzyl-4-(3-(trifluoromethyl)phenyl)pyrrolidine-3-carboxylate | ESD-909794-1G |
Cas.: 111281-12-0 | (4-Phenylthiophenyl)diphenylsulfonium triflate | ESD-909796-50MG | |
Cas.: 111281-12-0 | (4-Phenylthiophenyl)diphenylsulfonium triflate | ESD-909796-250MG | |
Cas.: 108050-54-0 | Purity: 99% | Tilmicosin | ESD-871932-5G |
Cas.: 24393-50-8 | Purity: 98% | ethyl (E)-3-(4-fluorophenyl)acrylate | ESD-909797-1G |
Cas.: 24393-50-8 | Purity: 98% | ethyl (E)-3-(4-fluorophenyl)acrylate | ESD-909797-250MG |
Cas.: NONE8140 | Purity: 98% | 1-(tert-butyl) 3-ethyl 3-(p-tolyl)pyrrolidine-1,3-dicarboxylate | ESD-909798-1G |
Cas.: NONE8140 | Purity: 98% | 1-(tert-butyl) 3-ethyl 3-(p-tolyl)pyrrolidine-1,3-dicarboxylate | ESD-909798-250MG |
Cas.: 874990-58-6 | Purity: 99% | ethyl trans-1-benzyl-4-(4-fluorophenyl)pyrrolidine-3-carboxylate | ESD-909799-250MG |
Cas.: 874990-58-6 | Purity: 99% | ethyl trans-1-benzyl-4-(4-fluorophenyl)pyrrolidine-3-carboxylate | ESD-909799-1G |
Cas.: NONE8141 | Purity: 98% | 1-(tert-butyl) 3-ethyl trans-4-(3-(trifluoromethyl)phenyl)pyrrolidine-1,3-dicarboxylate | ESD-909800-1G |
Cas.: NONE8141 | Purity: 98% | 1-(tert-butyl) 3-ethyl trans-4-(3-(trifluoromethyl)phenyl)pyrrolidine-1,3-dicarboxylate | ESD-909800-250MG |
Cas.: 915390-54-4 | Purity: 97% | (trans-1-benzyl-4-(3-(trifluoromethyl)phenyl)pyrrolidin-3-yl)methanol | ESD-909801-1G |
Cas.: 915390-54-4 | Purity: 97% | (trans-1-benzyl-4-(3-(trifluoromethyl)phenyl)pyrrolidin-3-yl)methanol | ESD-909801-250MG |
Cas.: NONE8142 | Purity: 98% | 1-(tert-butoxycarbonyl)-3-(p-tolyl)pyrrolidine-3-carboxylic acid | ESD-909802-250MG |
Cas.: NONE8142 | Purity: 98% | 1-(tert-butoxycarbonyl)-3-(p-tolyl)pyrrolidine-3-carboxylic acid | ESD-909802-1G |
Cas.: 609359-56-0 | Purity: 98% | ethyl (E)-3-(2,6-difluorophenyl)acrylate | ESD-909803-250MG |
Cas.: 609359-56-0 | Purity: 98% | ethyl (E)-3-(2,6-difluorophenyl)acrylate | ESD-909803-1G |
Cas.: 9001-12-1 | Purity: ≥125 U/mg | Collagenase I | ESD-909788-25MG |
Cas.: 9001-12-1 | Purity: ≥125 U/mg | Collagenase I | ESD-909788-100MG |
Cas.: 9001-12-1 | Purity: ≥125 U/mg | Collagenase I | ESD-909788-500MG |
Cas.: 9001-12-1 | Purity: ≥125 U/mg | Collagenase II | ESD-909789-25MG |
Cas.: 9001-12-1 | Purity: ≥125 U/mg | Collagenase II | ESD-909789-100MG |
Cas.: 9001-12-1 | Purity: ≥125 U/mg | Collagenase II | ESD-909789-500MG |
Cas.: 9001-12-1 | Purity: ≥125 U/mg | Collagenase IV | ESD-909792-25MG |
Cas.: 9001-12-1 | Purity: ≥125 U/mg | Collagenase IV | ESD-909792-100MG |
Cas.: NONE8143 | Purity: 98% | ethyl 1-benzyl-3-(4-(trifluoromethoxy)phenyl)pyrrolidine-3-carboxylate | ESD-909804-1G |
Cas.: NONE8143 | Purity: 98% | ethyl 1-benzyl-3-(4-(trifluoromethoxy)phenyl)pyrrolidine-3-carboxylate | ESD-909804-250MG |
Cas.: 628-36-4 | Purity: 98% | 1,2-Diformylhydrazine | ESD-830929-500G |
Cas.: 199444-11-6 | Purity: >90.0%(N) | IR 775 Chloride | ESD-864734-1G |
Cas.: NONE8144 | Purity: 98% | 1-(tert-butyl) 3-ethyl trans-4-(4-fluorophenyl)pyrrolidine-1,3-dicarboxylate | ESD-909805-250MG |
Cas.: NONE8144 | Purity: 98% | 1-(tert-butyl) 3-ethyl trans-4-(4-fluorophenyl)pyrrolidine-1,3-dicarboxylate | ESD-909805-1G |
Cas.: NONE8145 | Purity: 98% | (trans-1-benzyl-4-(4-fluorophenyl)pyrrolidin-3-yl)methanol | ESD-909806-1G |
Cas.: NONE8145 | Purity: 98% | (trans-1-benzyl-4-(4-fluorophenyl)pyrrolidin-3-yl)methanol | ESD-909806-250MG |
Cas.: 621-54-5 | Purity: 98% | 3-(3-Hydroxyphenyl)propanoic acid | ESD-842192-25G |
Cas.: NONE8146 | Purity: 98% | tert-butyl trans-3-(hydroxymethyl)-4-(3-(trifluoromethyl)phenyl)pyrrolidine-1-carboxylate | ESD-909807-1G |
Cas.: NONE8146 | Purity: 98% | tert-butyl trans-3-(hydroxymethyl)-4-(3-(trifluoromethyl)phenyl)pyrrolidine-1-carboxylate | ESD-909807-250MG |
Cas.: 1218764-11-4 | Purity: 98% | trans-1-(tert-butoxycarbonyl)-4-(4-fluorophenyl)pyrrolidine-3-carboxylic acid | ESD-909808-1G |
Cas.: 1218764-11-4 | Purity: 98% | trans-1-(tert-butoxycarbonyl)-4-(4-fluorophenyl)pyrrolidine-3-carboxylic acid | ESD-909808-250MG |
Cas.: 633-99-8 | Purity: ≥98% | 1-Chloro-2-Naphthol | ESD-860131-1G |
Cas.: 633-99-8 | Purity: ≥98% | 1-Chloro-2-Naphthol | ESD-860131-25G |
Cas.: 633-99-8 | Purity: ≥98% | 1-Chloro-2-Naphthol | ESD-860131-100G |
Cas.: NONE8147 | Purity: 98% | (trans-1-benzyl-4-(p-tolyl)pyrrolidin-3-yl)methanol | ESD-909809-1G |
Cas.: NONE8147 | Purity: 98% | (trans-1-benzyl-4-(p-tolyl)pyrrolidin-3-yl)methanol | ESD-909809-250MG |
Cas.: 939823-88-8 | Purity: 98% | tert-butyl trans-3-(4-fluorophenyl)-4-(hydroxymethyl)pyrrolidine-1-carboxylate | ESD-909810-250MG |
Cas.: 939823-88-8 | Purity: 98% | tert-butyl trans-3-(4-fluorophenyl)-4-(hydroxymethyl)pyrrolidine-1-carboxylate | ESD-909810-1G |
Cas.: NONE8148 | Purity: 97% | 1-(tert-butyl) 3-ethyl (trans)-4-(p-tolyl)pyrrolidine-1,3-dicarboxylate | ESD-909811-250MG |
Cas.: NONE8148 | Purity: 97% | 1-(tert-butyl) 3-ethyl (trans)-4-(p-tolyl)pyrrolidine-1,3-dicarboxylate | ESD-909811-1G |
Cas.: 629-96-9 | Purity: 95% | 1-Eicosanol | ESD-838632-100G |
Cas.: 2173052-28-1 | Purity: 97% | tert-butyl trans-3-(hydroxymethyl)-4-(p-tolyl)pyrrolidine-1-carboxylate | ESD-909812-1G |
Cas.: 2173052-28-1 | Purity: 97% | tert-butyl trans-3-(hydroxymethyl)-4-(p-tolyl)pyrrolidine-1-carboxylate | ESD-909812-250MG |
Cas.: NONE8149 | Purity: 97% | ethyl 1-benzyl-3-(4-propylphenyl)pyrrolidine-3-carboxylate | ESD-909813-1G |
Cas.: NONE8149 | Purity: 97% | ethyl 1-benzyl-3-(4-propylphenyl)pyrrolidine-3-carboxylate | ESD-909813-250MG |
Cas.: NONE8150 | Purity: 95% | ethyl 1-benzyl-3-(4-(tert-butyl)phenyl)pyrrolidine-3-carboxylate | ESD-909814-1G |
Cas.: NONE8150 | Purity: 95% | ethyl 1-benzyl-3-(4-(tert-butyl)phenyl)pyrrolidine-3-carboxylate | ESD-909814-250MG |
Cas.: 2805-84-7 | Purity: 98% | 6-(Trifluoromethyl)-2,3,4,9-tetrahydro-1H-carbazole | ESD-893358-1G |
Cas.: 62174-97-4 | Purity: 98% | ethyl (E)-3-(m-tolyl)acrylate | ESD-909815-250MG |
Cas.: 62174-97-4 | Purity: 98% | ethyl (E)-3-(m-tolyl)acrylate | ESD-909815-1G |
Cas.: NONE8151 | Purity: 98% | 1-(tert-butyl) 3-ethyl 3-(4-propylphenyl)pyrrolidine-1,3-dicarboxylate | ESD-909816-250MG |
Cas.: NONE8151 | Purity: 98% | 1-(tert-butyl) 3-ethyl 3-(4-propylphenyl)pyrrolidine-1,3-dicarboxylate | ESD-909816-1G |
Cas.: 34801-95-1 | Purity: 97% | (1,5-Cycloctadiene)(hexafluoroacetylacetonato)iridium(I) | ESD-864037-1G |
Cas.: NONE8152 | Purity: 98% | 1-(tert-butyl) 3-ethyl 3-(o-tolyl)pyrrolidine-1,3-dicarboxylate | ESD-909817-1G |
Cas.: NONE8152 | Purity: 98% | 1-(tert-butyl) 3-ethyl 3-(o-tolyl)pyrrolidine-1,3-dicarboxylate | ESD-909817-250MG |
Cas.: 100-52-7 | Purity: >99.0% (GC) | Benzaldehyde | ESD-802741-10L |
Cas.: 75-07-0 | Purity: 40 wt. % in H2O, contains 0.01% ammonium acetate inhibitor | Acetaldehyde | ESD-823263-10L |
Cas.: 1073354-58-1 | Purity: 91% | (E)-2-(3,5-difluorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909818-500MG |
Cas.: 1073354-58-1 | Purity: 91% | (E)-2-(3,5-difluorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909818-1G |
Cas.: 149777-83-3 | Purity: 99% | (E)-2-(4-methoxystyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909819-1G |
Cas.: 149777-83-3 | Purity: 99% | (E)-2-(4-methoxystyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909819-250MG |
Cas.: 92220-65-0 | Purity: ≥95.0 % | Dichlorotetrakis(2-(2-pyridinyl)phenyl)diiridium(III) | ESD-863575-500MG |
Cas.: 1073354-88-7 | Purity: 98% | (E)-4,4,5,5-tetramethyl-2-(3-(trifluoromethyl)styryl)-1,3,2-dioxaborolane | ESD-909820-500MG |
Cas.: 1073354-88-7 | Purity: 98% | (E)-4,4,5,5-tetramethyl-2-(3-(trifluoromethyl)styryl)-1,3,2-dioxaborolane | ESD-909820-1G |
Cas.: NONE8153 | Purity: 99% | (E)-2-(4-isopropylstylyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909821-500MG |
Cas.: NONE8153 | Purity: 99% | (E)-2-(4-isopropylstylyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909821-1G |
Cas.: 108374-32-9 | Purity: 98% | Tetraammineplatinum chloride hydrate | ESD-832764-1G |
Cas.: 255056-46-3 | (4-Iodophenyl)diphenylsulfonium triflate | ESD-909822-250MG | |
Cas.: NONE8154 | Purity: 96% | (E)-4,4,5,5-tetramethyl-2-(4-(trifluoromethoxy)styryl)-1,3,2-dioxaborolane | ESD-909823-500MG |
Cas.: NONE8154 | Purity: 96% | (E)-4,4,5,5-tetramethyl-2-(4-(trifluoromethoxy)styryl)-1,3,2-dioxaborolane | ESD-909823-1G |
Cas.: 1390-65-4 | Purity: 97%, Use For Biological Staining | Carmine | ESD-805215-500G |
Cas.: 13078-80-3 | Purity: 98% | 2-Chlorophenethylamine | ESD-831090-500G |
Cas.: 13815-39-9 | Purity: 98% | Potassium tetranitroplatinate(II) | ESD-864488-5G |
Cas.: 1377151-58-0 | Purity: 94% | (E)-2-(3,4-difluorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909824-500MG |
Cas.: 1377151-58-0 | Purity: 94% | (E)-2-(3,4-difluorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909824-1G |
Cas.: 1892603-13-2 | Purity: 96% | (E)-2-(4-(tert-butyl)styryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909825-500MG |
Cas.: 1892603-13-2 | Purity: 96% | (E)-2-(4-(tert-butyl)styryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909825-1G |
Cas.: 149777-84-4 | Purity: 96% | (E)-4,4,5,5-tetramethyl-2-(4-methylstyryl)-1,3,2-dioxaborolane | ESD-909826-500MG |
Cas.: 149777-84-4 | Purity: 96% | (E)-4,4,5,5-tetramethyl-2-(4-methylstyryl)-1,3,2-dioxaborolane | ESD-909826-1G |
Cas.: 116808-67-4 | (4-Methoxyphenyl)diphenylsulfonium triflate | ESD-909827-1G | |
Cas.: 1892603-12-1 | Purity: 92% | (E)-2-(3,4-dimethylstylyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909828-250MG |
Cas.: 116808-67-4 | (4-Methoxyphenyl)diphenylsulfonium triflate | ESD-909827-250MG | |
Cas.: 1892603-12-1 | Purity: 92% | (E)-2-(3,4-dimethylstylyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909828-1G |
Cas.: 1377220-06-8 | Purity: 94% | (E)-2-(2,6-difluorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909829-500MG |
Cas.: 1377220-06-8 | Purity: 94% | (E)-2-(2,6-difluorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909829-1G |
Cas.: 2246919-02-6 | Purity: 94% | (E)-2-(5-fluoro-2-methylstyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909830-1G |
Cas.: 2246919-02-6 | Purity: 94% | (E)-2-(5-fluoro-2-methylstyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909830-500MG |
Cas.: 13755-38-9 | Purity: 99.98% metals basis | Sodium nitroferricyanide(III) dihydrate | ESD-818342-1KG |
Cas.: 633327-38-5 | Purity: 96% | (E)-2-(2-fluorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909831-500MG |
Cas.: 633327-38-5 | Purity: 96% | (E)-2-(2-fluorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909831-1G |
Cas.: 736987-80-7 | Purity: 95% | (E)-2-(2,5-difluorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909832-1G |
Cas.: 736987-80-7 | Purity: 95% | (E)-2-(2,5-difluorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909832-500MG |
Cas.: 154093-57-9 | (4-Fluorophenyl)diphenylsulfonium triflate | ESD-909833-50MG | |
Cas.: NONE8155 | Purity: 96% | (E)-2-(4-(difluoromethoxy)styryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909834-1G |
Cas.: 154093-57-9 | (4-Fluorophenyl)diphenylsulfonium triflate | ESD-909833-250MG | |
Cas.: NONE8155 | Purity: 96% | (E)-2-(4-(difluoromethoxy)styryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909834-500MG |
Cas.: 1585-40-6 | Purity: >99% | Pentacarboxybenzene; Benzenepentacarboxylic Acid | ESD-860530-500MG |
Cas.: 142994-05-6 | Purity: 97% | 2-Methylthio-4-trifluoromethylbenzoic acid | ESD-909835-250MG |
Cas.: 142994-05-6 | Purity: 97% | 2-Methylthio-4-trifluoromethylbenzoic acid | ESD-909835-1G |
Cas.: 142994-05-6 | Purity: 97% | 2-Methylthio-4-trifluoromethylbenzoic acid | ESD-909835-5G |
Cas.: 871125-68-7 | Purity: 92% | (E)-2-(3-methoxystyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-855428-500MG |
Cas.: 1618099-49-2 | Purity: 97% | (E)-2-(3,4-dimethoxystyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909836-500MG |
Cas.: 1618099-49-2 | Purity: 97% | (E)-2-(3,4-dimethoxystyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909836-1G |
Cas.: NONE8156 | Purity: 99% | tert-butyl (3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)cyclobutyl)carbamate | ESD-909837-500MG |
Cas.: NONE8156 | Purity: 99% | tert-butyl (3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)cyclobutyl)carbamate | ESD-909837-1G |
Cas.: 120-54-7 | Purity: ≥98% | Dipentamethylenethiuram Tetrasulfide | ESD-859221-500G |
Cas.: 2246885-43-6 | Purity: 98% | 2-((4,4-dimethylcyclohexylidene)methyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909838-500MG |
Cas.: 2246885-43-6 | Purity: 98% | 2-((4,4-dimethylcyclohexylidene)methyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909838-1G |
Cas.: 32862-97-8 | Purity: 98% | 3-Bromocinnamic acid, predominantly trans | ESD-802003-500G |
Cas.: 69617-84-1 | Purity: ≥95% | Rhododendrol | ESD-864182-1G |
Cas.: 69617-84-1 | Purity: ≥95% | Rhododendrol | ESD-864182-5G |
Cas.: NONE8157 | Purity: 98% | ethyl 3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)cyclopentane-1-carboxylate | ESD-909839-500MG |
Cas.: NONE8157 | Purity: 98% | ethyl 3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)cyclopentane-1-carboxylate | ESD-909839-1G |
Cas.: 1425970-61-1 | Purity: 99% | tert-butyl 4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)piperidine-1-carboxylate | ESD-909840-500MG |
Cas.: 1425970-61-1 | Purity: 99% | tert-butyl 4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)piperidine-1-carboxylate | ESD-909840-1G |
Cas.: 2304634-36-2 | Purity: 99% | 4,4,5,5-tetramethyl-2-((tetrahydro-4H-pyran-4-ylidene)methyl)-1,3,2-dioxaborolane | ESD-909841-500MG |
Cas.: 2304634-36-2 | Purity: 99% | 4,4,5,5-tetramethyl-2-((tetrahydro-4H-pyran-4-ylidene)methyl)-1,3,2-dioxaborolane | ESD-909841-1G |
Cas.: 2376764-47-3 | Purity: 99% | tert-butyl 3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)piperidine-1-carboxylate | ESD-909842-500MG |
Cas.: 2376764-47-3 | Purity: 99% | tert-butyl 3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)piperidine-1-carboxylate | ESD-909842-1G |
Cas.: 2365173-49-3 | Purity: 90% | tert-butyl 3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)pyrrolidine-1-carboxylate | ESD-909843-500MG |
Cas.: 2365173-49-3 | Purity: 90% | tert-butyl 3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)pyrrolidine-1-carboxylate | ESD-909843-1G |
Cas.: NONE8158 | Purity: 98% | tert-butyl (4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)cyclohexyl)carbamate | ESD-909844-500MG |
Cas.: NONE8158 | Purity: 98% | tert-butyl (4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)cyclohexyl)carbamate | ESD-909844-1G |
Cas.: 167693-19-8 | Purity: 98% | 2-(cyclopentylidenemethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909845-500MG |
Cas.: 167693-19-8 | Purity: 98% | 2-(cyclopentylidenemethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909845-1G |
Cas.: 61825-94-3 | Purity: 98% | Oxaliplatin | ESD-815348-25MG |
Cas.: 2246658-69-3 | Purity: 98% | 4,4,5,5-tetramethyl-2-(oxetan-3-ylidenemethyl)-1,3,2-dioxaborolane | ESD-909846-500MG |
Cas.: 2246658-69-3 | Purity: 98% | 4,4,5,5-tetramethyl-2-(oxetan-3-ylidenemethyl)-1,3,2-dioxaborolane | ESD-909846-1G |
Cas.: 147265-60-9 | 5(6)-CARBOXY-2′,7′-DICHLOROFLUORESCEIN DIACETATE N-SUCCINIMIDYL ESTER | ESD-909847-5MG | |
Cas.: 180801-55-2 | Boc-methoxyphenyldiphenylsulfonium triflate | ESD-909848-50MG | |
Cas.: 180801-55-2 | Boc-methoxyphenyldiphenylsulfonium triflate | ESD-909848-250MG | |
Cas.: 2365173-53-9 | Purity: 98% | tert-butyl 3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)-8-azabicyclo[3.2.1]octane-8-carboxylate | ESD-909849-500MG |
Cas.: 2365173-53-9 | Purity: 98% | tert-butyl 3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)-8-azabicyclo[3.2.1]octane-8-carboxylate | ESD-909849-1G |
Cas.: 2246816-47-5 | Purity: 98% | 2-(cyclobutylidenemethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909850-500MG |
Cas.: 2246816-47-5 | Purity: 98% | 2-(cyclobutylidenemethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-909850-1G |
Cas.: 2817-71-2 | Purity: 95% | 1-Ethyl-1H-pyrazole | ESD-838860-100G |
Cas.: 114772-36-0 | Purity: 90% | TERT-BUTYL 4′-METHYLBIPHENYL-2-CARBOXYLATE | ESD-909851-100MG |
Cas.: 114772-36-0 | Purity: 90% | TERT-BUTYL 4′-METHYLBIPHENYL-2-CARBOXYLATE | ESD-909851-500MG |
Cas.: 145612-66-4 | (4-tert-Butylphenyl)diphenylsulfonium triflate | ESD-909852-1G | |
Cas.: 145612-66-4 | (4-tert-Butylphenyl)diphenylsulfonium triflate | ESD-909852-250MG | |
Cas.: 420846-72-6 | Purity: 95% | 3-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoicacid | ESD-856408-1G |
Cas.: 13190-34-6 | Purity: ≥98% | Goitrin | ESD-873576-20MG |
Cas.: 39319-11-4 | Purity: 1% crossl. with DVB, 1.0-1.5 mmol/g, 100-200 mesh | Triphenylphosphine resin | ESD-832016-1G |
Cas.: 420846-72-6 | Purity: 95% | 3-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoicacid | ESD-856408-250MG |
Cas.: 6153-64-6 | Purity: 97% | Oxytetracycline dihydrate | ESD-815190-500G |
Cas.: 194999-85-4 | Bis(4-tert-butylphenyl)iodonium perfluoro-1-butanesulfonate | ESD-909853-50MG | |
Cas.: 194999-85-4 | Bis(4-tert-butylphenyl)iodonium perfluoro-1-butanesulfonate | ESD-909853-250MG | |
Cas.: 41716-18-1 | Purity: 98% | 1-Methyl-4-imidazolecarboxylic Acid | ESD-835010-5G |
Cas.: 41716-18-1 | Purity: 98% | 1-Methyl-4-imidazolecarboxylic Acid | ESD-835010-25G |
Cas.: 75-09-2 | Purity: Spectral grade, ≥99.9% | Dichloromethane | ESD-807832-4L |
Cas.: 31533-76-3 | Purity: 98% | Polyphenyl ether | ESD-909221-2.5KG |
Cas.: 88215-41-2 | Purity: 98% | Dichloro(2-pyridinecarboxylato)gold | ESD-807933-250MG |
Cas.: 177571-06-1 | PicoGreen | ESD-909854-1ML | |
Cas.: 177571-06-1 | PicoGreen | ESD-909854-10×100ΜL | |
Cas.: 61326-44-1 | Purity: 98% | 1,1,2,2-Tetrakis(4-bromophenyl)ethene | ESD-828254-5G |
Cas.: 75-18-3 | Purity: 99,7% | Methyl sulfide | ESD-909855-250ML |
Cas.: 75-18-3 | Purity: 99,7% | Methyl sulfide | ESD-909855-1L |
Cas.: 75-18-3 | Purity: 99,7% | Methyl sulfide | ESD-909855-5L |
Cas.: 60187-00-0 | Purity: 95% | 3,5-Dimethylpyrazin-2-ol | ESD-844488-1G |
Cas.: 26915-72-0 | Purity: Average MW ~475, contains 100 ppm MeHQ, 200 ppm BHT | Poly(ethylene glycol) methyl ether methacrylate | ESD-816114-10ML |
Cas.: 26915-72-0 | Purity: Average MW ~475, contains 100 ppm MeHQ, 200 ppm BHT | Poly(ethylene glycol) methyl ether methacrylate | ESD-816114-2ML |
Cas.: 2423-71-4 | Purity: 98% | 2,6-Dimethyl-4-nitrophenol | ESD-858387-25G |
Cas.: 155911-16-3 | 6-HEX | ESD-909856-5MG | |
Cas.: 155911-16-3 | 6-HEX | ESD-909856-1MG | |
Cas.: NONE8071 | Purity: Solid contains amount: 40% | Aqueous polyurethane emulsion | ESD-909857-100G |
Cas.: NONE8071 | Purity: Solid contains amount: 40% | Aqueous polyurethane emulsion | ESD-909857-500G |
Cas.: NONE8071 | Purity: Solid contains amount: 40% | Aqueous polyurethane emulsion | ESD-909857-2.5KG |
Cas.: 68131-04-4 | Purity: CP | Humic acid, sodium salt | ESD-810850-2.5KG |
Cas.: 26915-72-0 | Purity: Average MW ~950 | Poly(ethylene glycol) methyl ether methacrylate | ESD-816115-2.5L |
Cas.: 73536-69-3 | Purity: 98% | Dimethyl 7,7′-dimethoxy-[4,4′-bibenzo[d][1,3]dioxole]-5,5′-dicarboxylate | ESD-843899-100G |
Cas.: 3938-96-3 | Purity: ≥97% | Ethyl Methoxyacetate | ESD-835036-100ML |
Cas.: 589-66-2 | Purity: ≥98% | Isobutyl Trans-2-Butenoate | ESD-860083-100ML |
Cas.: 589-66-2 | Purity: ≥98% | Isobutyl Trans-2-Butenoate | ESD-860083-500ML |
Cas.: 125971-93-9 | Purity: 98% | tert-butyl (3R,5R)-6-cyano-3,5-dihydroxy-hexanoate | ESD-904760-25MG |
Cas.: 1006-01-5 | Purity: 97% | TRIMETHYLPHENYLPHOSPHONIUM IODIDE | ESD-833412-1G |
Cas.: 52090-56-9 | Purity: 95% | 6-Methoxy-2-methylpyridin-3-amine | ESD-836559-250MG |
Cas.: 52090-56-9 | Purity: 95% | 6-Methoxy-2-methylpyridin-3-amine | ESD-836559-1G |
Cas.: 52090-56-9 | Purity: 95% | 6-Methoxy-2-methylpyridin-3-amine | ESD-836559-5G |
Cas.: 52090-56-9 | Purity: 95% | 6-Methoxy-2-methylpyridin-3-amine | ESD-836559-10G |
Cas.: 52090-56-9 | Purity: 95% | 6-Methoxy-2-methylpyridin-3-amine | ESD-836559-25G |
Cas.: 1187525-03-6 | Purity: 99% | 4,4,5,5-tetramethyl-2-(2-phenylprop-1-en-1-yl)-1,3,2-dioxaborolane | ESD-909863-500MG |
Cas.: 1187525-03-6 | Purity: 99% | 4,4,5,5-tetramethyl-2-(2-phenylprop-1-en-1-yl)-1,3,2-dioxaborolane | ESD-909863-1G |
Cas.: NONE8094 | Purity: Branched type, Viscosity: 65 mPa s | Vinyl silicone oil | ESD-909859-100G |
Cas.: NONE8094 | Purity: Branched type, Viscosity: 65 mPa s | Vinyl silicone oil | ESD-909859-500G |
Cas.: NONE8094 | Purity: Branched type, Viscosity: 65 mPa s | Vinyl silicone oil | ESD-909859-2.5KG |
Cas.: NONE8094 | Purity: Branched type, Viscosity: 100 mPa s | Vinyl silicone oil | ESD-909860-100G |
Cas.: NONE8094 | Purity: Branched type, Viscosity: 100 mPa s | Vinyl silicone oil | ESD-909860-500G |
Cas.: NONE8094 | Purity: Branched type, Viscosity: 100 mPa s | Vinyl silicone oil | ESD-909860-2.5KG |
Cas.: NONE8094 | Purity: Straight, branched chain type, viscosity: 180 mPa s | Vinyl silicone oil | ESD-909861-100G |
Cas.: NONE8094 | Purity: Straight, branched chain type, viscosity: 180 mPa s | Vinyl silicone oil | ESD-909861-500G |
Cas.: NONE8094 | Purity: Straight, branched chain type, viscosity: 180 mPa s | Vinyl silicone oil | ESD-909861-2.5KG |
Cas.: NONE8094 | Purity: Straight, branched, viscosity: 1200 mPa s | Vinyl silicone oil | ESD-909862-100G |
Cas.: NONE8094 | Purity: Straight, branched, viscosity: 1200 mPa s | Vinyl silicone oil | ESD-909862-500G |
Cas.: NONE8094 | Purity: Straight, branched, viscosity: 1200 mPa s | Vinyl silicone oil | ESD-909862-2.5KG |
Cas.: 96998-61-7 | Purity: 99%biotech grade | DL-cysteine hydrochloride hydrate | ESD-6362-5G |
Cas.: 96998-61-7 | Purity: 99%biotech grade | DL-cysteine hydrochloride hydrate | ESD-6362-25G |
Cas.: 96998-61-7 | Purity: 99%biotech grade | DL-cysteine hydrochloride hydrate | ESD-6362-100G |
Cas.: 162167-97-7 | Purity: ≥95% | Tert-butyl 3-(aminomethyl)piperidine-1-carboxylate | ESD-827665-5G |
Cas.: 162167-97-7 | Purity: ≥95% | Tert-butyl 3-(aminomethyl)piperidine-1-carboxylate | ESD-827665-1G |
Cas.: 43112-38-5 | Purity: ≥98% | 3-Trimethylsilyl-2-oxazolidinone | ESD-867622-25G |
Cas.: 82855-40-1 | 6-carboxy-4′,5′-dichloro-2′,7′-dimethoxyfluorescein | ESD-909864-1MG | |
Cas.: 82855-40-1 | 6-carboxy-4′,5′-dichloro-2′,7′-dimethoxyfluorescein | ESD-909864-5MG | |
Cas.: 3564-09-8 | Purity: Strength: 100% | Ponceau 3R | ESD-832598-1G |
Cas.: 3564-09-8 | Purity: Strength: 100% | Ponceau 3R | ESD-832598-5G |
Cas.: 119313-12-1 | Purity: 97% | 2-Benzyl-2-(dimethylamino)-4′-morpholinobutyrophenone | ESD-835381-5G |
Cas.: 119313-12-1 | Purity: 97% | 2-Benzyl-2-(dimethylamino)-4′-morpholinobutyrophenone | ESD-835381-100G |
Cas.: 119313-12-1 | Purity: 97% | 2-Benzyl-2-(dimethylamino)-4′-morpholinobutyrophenone | ESD-835381-500G |
Cas.: 155911-14-1 | 6-TET | ESD-909865-1MG | |
Cas.: 155911-14-1 | 6-TET | ESD-909865-5MG | |
Cas.: 96702-03-3 | Purity: ≥97% | Ectoine | ESD-864812-25G |
Cas.: 15848-22-3 | Purity: ≥98% | 5-Bromopentyl Acetate | ESD-857824-25G |
Cas.: 15848-22-3 | Purity: ≥98% | 5-Bromopentyl Acetate | ESD-857824-100G |
Cas.: 24425-40-9 | Purity: ≥98.0% | 5-Aminoindan | ESD-863514-25G |
Cas.: 111-42-2 | Purity: ACS, ≥99.0% (GC) | Diethanolamine (DEA) | ESD-807526-10L |
Cas.: 16672-87-0 | Purity: >90.0%(HPLC) | Ethephon | ESD-809110-25G |
Cas.: 63-84-3 | Purity: 98% | 3,4-Dihydroxy-DL-phenylalanine | ESD-830064-1G |
Cas.: 88744-04-1 | Purity: 98% | 9-Fluorenylmethyl pentafluorophenyl carbonate | ESD-838125-1G |
Cas.: 670-95-1 | Purity: ≥98% | 4-Phenylimidazole | ESD-834809-25G |
Cas.: 13638-82-9 | Purity: >98%(HPLC) | 1,3,6,8-Tetraphenylpyrene | ESD-861644-1G |
Cas.: 42466-67-1 | Purity: 95% | (E)-Ethyl 2-cyano-3-ethoxyacrylate | ESD-844694-5G |
Cas.: 1889-59-4 | Purity: 98% | Ethyl vinyl sulfone | ESD-838135-25G |
Cas.: 1889-59-4 | Purity: 98% | Ethyl vinyl sulfone | ESD-838135-100G |
Cas.: 34551-41-2 | Purity: ≥95% | 5-bromo-1-chloroisoquinoline | ESD-825744-5G |
Cas.: 34551-41-2 | Purity: ≥95% | 5-bromo-1-chloroisoquinoline | ESD-825744-250MG |
Cas.: 34551-41-2 | Purity: ≥95% | 5-bromo-1-chloroisoquinoline | ESD-825744-10G |
Cas.: 9002-89-5 | Purity: Alcoholysis degree: 98.0-99.0%(mol/mol), Viscosity: 54.0-66.0 mPa.s | Poly(vinyl alcohol) 124 | ESD-909858-500G |
Cas.: 3016-97-5 | Purity: 99% | 1,4-Dibenzoylbenzene | ESD-835131-100G |
Cas.: 9002-89-5 | Purity: Alcoholysis degree: 98.0-99.0%(mol/mol), Viscosity: 54.0-66.0 mPa.s | Poly(vinyl alcohol) 124 | ESD-909858-2.5KG |
Cas.: 34552-14-2 | Purity: ≥95% | 2-bromo-5-methylpyridin-3-amine | ESD-827899-1G |
Cas.: 34552-14-2 | Purity: ≥95% | 2-bromo-5-methylpyridin-3-amine | ESD-827899-5G |
Cas.: 38613-77-3 | Purity: 98% | tetrakis(2,4-di-tert-butylphenyl)[1,1-biphenyl]-4,4′-diylbisphosphonite | ESD-830184-500G |
Cas.: 13246-52-1 | Purity: 97% | Ethyl 2,4-dioxohexanoate | ESD-839583-1G |
Cas.: 13246-52-1 | Purity: 97% | Ethyl 2,4-dioxohexanoate | ESD-839583-5G |
Cas.: 25081-39-4 | Purity: 97% | Methyl 3,5-dimethylbenzoate | ESD-839724-5G |
Cas.: 25081-39-4 | Purity: 97% | Methyl 3,5-dimethylbenzoate | ESD-839724-25G |
Cas.: 120-35-4 | Purity: 98% | 3-Amino-4-methoxybenzanilide | ESD-800206-500G |
Cas.: 25081-39-4 | Purity: 97% | Methyl 3,5-dimethylbenzoate | ESD-839724-100G |
Cas.: 75-12-7 | Purity: spectrophotometric grade, ≥99% | Formamide | ESD-909866-250ML |
Cas.: 6812-14-2 | Purity: ≥93% | 2,3-Anthracenedicarboxylic Anhydride | ESD-868414-25MG |
Cas.: 107-31-3 | Purity: spectrophotometric grade, 99% | Methyl formate | ESD-909871-250ML |
Cas.: 217500-96-4 | Purity: 98% | Tulathromycin A | ESD-873018-100MG |
Cas.: 217500-96-4 | Purity: 98% | Tulathromycin A | ESD-873018-500MG |
Cas.: 69102-90-5 | Purity: Type I, hydroxyl value (mmol/g): 0.47-0.53 | Hydroxyl-terminated polybutadiene (HTPB) | ESD-909867-100ML |
Cas.: 69102-90-5 | Purity: Type I, hydroxyl value (mmol/g): 0.47-0.53 | Hydroxyl-terminated polybutadiene (HTPB) | ESD-909867-250ML |
Cas.: 69102-90-5 | Purity: Type II, hydroxyl value (mmol/g): 0.54-0.64 | Hydroxyl-terminated polybutadiene (HTPB) | ESD-909868-100ML |
Cas.: 69102-90-5 | Purity: Type II, hydroxyl value (mmol/g): 0.54-0.64 | Hydroxyl-terminated polybutadiene (HTPB) | ESD-909868-250ML |
Cas.: 69102-90-5 | Purity: Type III, hydroxyl value (mmol/g): 0.65-0.70 | Hydroxyl-terminated polybutadiene (HTPB) | ESD-909869-100ML |
Cas.: 69102-90-5 | Purity: Type III, hydroxyl value (mmol/g): 0.65-0.70 | Hydroxyl-terminated polybutadiene (HTPB) | ESD-909869-250ML |
Cas.: 69102-90-5 | Purity: Type IV, hydroxyl value (mmol/g): 0.71-0.80 | Hydroxyl-terminated polybutadiene (HTPB) | ESD-909870-100ML |
Cas.: 69102-90-5 | Purity: Type IV, hydroxyl value (mmol/g): 0.71-0.80 | Hydroxyl-terminated polybutadiene (HTPB) | ESD-909870-250ML |
Cas.: 119515-38-7 | Purity: 98% | Icaridin | ESD-893366-100G |
Cas.: 12024-11-2 | Purity: 99,99% | gallium selenide | ESD-888845-5G |
Cas.: 8032-32-4 | Purity: spectrophotometric grade | Petroleum ether | ESD-909872-500ML |
Cas.: 41014-93-1 | Purity: 97% | (S)-2-Hydroxypentanoic acid | ESD-839822-500MG |
Cas.: 1791-26-0 | Purity: 95% | 4-ethenylbenzaldehyde | ESD-856202-1G |
Cas.: 9003-04-7 | Purity: average Mw 150000 | Sodium polyacrylate | ESD-909874-500G |
Cas.: 9003-04-7 | Purity: average Mw 150000 | Sodium polyacrylate | ESD-909874-2.5KG |
Cas.: 100-02-7 | Purity: spectrophotometric grade | p-Nitrophenol | ESD-909875-1G |
Cas.: NONE6321 | Purity: Degree of substitution 92% | ESD850125-2.5KG | |
Cas.: 12202-17-4 | Purity: 99% | Lead sulfate tribasic | ESD-909876-25G |
Cas.: 569-64-2 | Purity: 96% | Malachite green | ESD-822586-1G |
Cas.: 12202-17-4 | Purity: 99% | Lead sulfate tribasic | ESD-909876-100G |
Cas.: 569-64-2 | Purity: 96% | Malachite green | ESD-822586-5G |
Cas.: 12202-17-4 | Purity: 99% | Lead sulfate tribasic | ESD-909876-500G |
Cas.: 50-56-6 | Purity: ≥98% | Oxytocin | ESD-878761-25MG |
Cas.: 50-56-6 | Purity: ≥98% | Oxytocin | ESD-878761-100MG |
Cas.: 569-64-2 | Purity: 96% | Malachite green | ESD-822586-25G |
Cas.: 569-64-2 | Purity: 96% | Malachite green | ESD-822586-100G |
Cas.: 3133-16-2 | Purity: ≥99% | 4-Octyl Itaconate | ESD-879645-1G |
Cas.: 7575-62-4 | Purity: 98% | Disodium 4-dodecyl-2,4′-oxydibenzenesulfonate | ESD-909877-1G |
Cas.: 7575-62-4 | Purity: 98% | Disodium 4-dodecyl-2,4′-oxydibenzenesulfonate | ESD-909877-5G |
Cas.: 7575-62-4 | Purity: 98% | Disodium 4-dodecyl-2,4′-oxydibenzenesulfonate | ESD-909877-25G |
Cas.: 207386-83-2 | Purity: ≥98%(HPLC) | N-Hippuryl-His-Leu hydrate | ESD-874814-500MG |
Cas.: 3187-58-4 | Purity: 98% | Methyl orsellinate | ESD-879612-100MG |
Cas.: 3650-09-7 | Purity: 97% | Carnosic acid | ESD-888342-100MG |
Cas.: 6624-79-9 | Purity: 80% | dotriacontan-1-ol | ESD-856470-100G |
Cas.: 6624-79-9 | Purity: 80% | dotriacontan-1-ol | ESD-856470-25G |
Cas.: 15498-86-9 | Purity: 98% | Retinyl Retinoate | ESD-905899-5G |
Cas.: 380151-86-0 | Purity: ≥98% | 3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde | ESD-857667-25G |
Cas.: 6494-19-5 | Purity: 97% | 3-Methyl-6-nitroindazole | ESD-814342-100G |
Cas.: 46917-07-1 | Purity: 60% in water, 300-500ppm MEHQ | benzyldimethyl[2-[(2-methyl-1-oxoallyl)oxy]ethyl]ammonium chloride | ESD-904490-2.5KG |
Cas.: 117338-43-9 | Purity: ≥97% | 2,6-Difluorocinnamaldehyde | ESD-852099-250MG |
Cas.: 7790-69-4 | Purity: 99.999% metals basis | Lithium nitrate | ESD-837014-2G |
Cas.: 7790-69-4 | Purity: 99.999% metals basis | Lithium nitrate | ESD-837014-50G |
Cas.: 80382-23-6 | Purity: ≥99% | Loxoprofen sodium | ESD-859185-25G |
Cas.: 80382-23-6 | Purity: ≥99% | Loxoprofen sodium | ESD-859185-100G |
Cas.: 39079-62-4 | Purity: 98% | Chromone-3-carboxylic Acid | ESD-870805-1G |
Cas.: 1260897-38-8 | Purity: 95% | 6-Phenyl-1H-indazole | ESD-909878-1G |
Cas.: 1260897-38-8 | Purity: 95% | 6-Phenyl-1H-indazole | ESD-909878-250MG |
Cas.: 19752-84-2 | Purity: 97% | Tetrahydro-2H-pyran-3-ol | ESD-839083-5G |
Cas.: 7148-74-5 | Purity: 97% | 2-Bromopropionyl chloride | ESD-803423-1KG |
Cas.: 59001-10-4 | Purity: 95% | 5-(tert-Butyl)-1H-pyrrole-2-carbaldehyde | ESD-909879-250MG |
Cas.: 59001-10-4 | Purity: 95% | 5-(tert-Butyl)-1H-pyrrole-2-carbaldehyde | ESD-909879-100MG |
Cas.: 4883-60-7 | Purity: 98% | 2-Hydroxy-3,5,5-trimethyl-2-cyclohexen-1-one | ESD-834976-500G |
Cas.: 4883-60-7 | Purity: 98% | 2-Hydroxy-3,5,5-trimethyl-2-cyclohexen-1-one | ESD-834976-5G |
Cas.: 156327-07-0 | MW 1000 | Carbinol(Hydroxyl)Terminated Poly Dimethylsiloxanes | ESD-833858-500G |
Cas.: 79-83-4 | Purity: ≥97% | D-Pantothenic acid | ESD-909881-1G |
Cas.: 79-83-4 | Purity: ≥97% | D-Pantothenic acid | ESD-909881-5G |
Cas.: 507270-06-6 | Purity: 95% | 2-(2-Phenyl-2H-tetrazol-5-yl)pyridine | ESD-909882-250MG |
Cas.: 507270-06-6 | Purity: 95% | 2-(2-Phenyl-2H-tetrazol-5-yl)pyridine | ESD-909882-100MG |
Cas.: 573-03-5 | Purity: ≥98% | 4-Fluoro-1-Naphthoic Acid | ESD-858914-5G |
Cas.: 573-03-5 | Purity: ≥98% | 4-Fluoro-1-Naphthoic Acid | ESD-858914-25G |
Cas.: 10043-35-3 | Purity: 99%, 500 Mesh | Boric acid | ESD-887057-10KG |
Cas.: 15986-94-4 | Purity: 95% | 5-methyl-6-propyl-2,3-dihydro-pyrazine | ESD-909883-1G |
Cas.: 15986-94-4 | Purity: 95% | 5-methyl-6-propyl-2,3-dihydro-pyrazine | ESD-909883-250MG |
Cas.: 1343-98-2 | Purity: AR | Silicic acid | ESD-817679-2.5KG |
Cas.: 111-61-5 | Purity: 99% | Ethyl stearate | ESD-809075-500G |
Cas.: 10226-29-6 | Purity: ≥95% | 6-Bromohexan-2-one | ESD-895596-5G |
Cas.: 10226-29-6 | Purity: ≥95% | 6-Bromohexan-2-one | ESD-895596-25G |
Cas.: 87145-34-4 | Purity: 95% | 2-(bis(pyridine-2-yl-methyl)amino)ethane-1-thiol | ESD-909884-1G |
Cas.: 87145-34-4 | Purity: 95% | 2-(bis(pyridine-2-yl-methyl)amino)ethane-1-thiol | ESD-909884-250MG |
Cas.: 7758-80-7 | Purity: 99,9% | Monosodium phosphate | ESD-888174-500G |
Cas.: 6459-94-5 | Purity: AR | Acid Red 114 | ESD-871561-1G |
Cas.: 494-19-9 | Purity: 97% | Iminodibenzyl | ESD-812094-500G |
Cas.: 629-80-1 | Purity: 97% | Hexadecanal | ESD-849425-5G |
Cas.: 21239-29-2 | Purity: 97% | ETHYL 3,5-DIMETHYLBENZOATE | ESD-909885-5G |
Cas.: 21239-29-2 | Purity: 97% | ETHYL 3,5-DIMETHYLBENZOATE | ESD-909885-25G |
Cas.: 21239-29-2 | Purity: 97% | ETHYL 3,5-DIMETHYLBENZOATE | ESD-909885-100G |
Cas.: 10026-11-6 | Purity: 99.5%, hafnium chloride<50ppm | Zirconium(IV) chloride | ESD-888688-500G |
Cas.: 576-19-2 | Purity: ≥98% | Biocyte | ESD-878374-100MG |
Cas.: 4358-64-9 | Purity: 98% | 1,4-Anhydroerythritol | ESD-838699-1G |
Cas.: 3939-01-3 | Purity: 95% | Methyl 1-benzyl-4-oxopiperidine-3-carboxylate hydrochloride | ESD-842438-25G |
Cas.: 3939-01-3 | Purity: 95% | Methyl 1-benzyl-4-oxopiperidine-3-carboxylate hydrochloride | ESD-842438-100G |
Cas.: 108-49-6 | Purity: 98% | 2,6-DIMETHYLPIPERAZINE | ESD-833659-100G |
Cas.: 108-49-6 | Purity: 98% | 2,6-DIMETHYLPIPERAZINE | ESD-833659-500G |
Cas.: 15486-96-1 | Purity: 95% | 3-Bromopropionyl chloride | ESD-831546-25G |
Cas.: 750556-81-1 | Purity: 95% | 2-Bromo-1-(1-methyl-1H-imidazol-2-yl)ethanone | ESD-909886-250MG |
Cas.: 750556-81-1 | Purity: 95% | 2-Bromo-1-(1-methyl-1H-imidazol-2-yl)ethanone | ESD-909886-100MG |
Cas.: 5808-22-0 | Purity: ACS | Chromotropic acid disodium salt dihydrate | ESD-804182-5G |
Cas.: 5808-22-0 | Purity: ACS | Chromotropic acid disodium salt dihydrate | ESD-804182-100G |
Cas.: 25852-47-5 | Purity: average Mn 550, contains 270-330 ppm BHT as inhibitor, 80-120 ppm MEHQ as inhibitor | Poly(ethylene glycol) dimethacrylate | ESD-909887-250ML |
Cas.: 25852-47-5 | Purity: average Mn 550, contains 270-330 ppm BHT as inhibitor, 80-120 ppm MEHQ as inhibitor | Poly(ethylene glycol) dimethacrylate | ESD-909887-50ML |
Cas.: 141-22-0 | Purity: Analysis control, 99% | Ricinoleic acid | ESD-817285-500MG |
Cas.: 1242156-52-0 | Purity: 95% | 4-Cyclopropyl-2-fluoro-6-methylbenzamide | ESD-909888-250MG |
Cas.: 1242156-52-0 | Purity: 95% | 4-Cyclopropyl-2-fluoro-6-methylbenzamide | ESD-909888-100MG |
Cas.: 757-44-8 | Purity: ≥95% | Diethylphosphatoethyltriethoxysilane | ESD-906328-1G |
Cas.: 25852-47-5 | Purity: average Mn 6, 000, contains 1000 ppm 4-methoxyphenol as inhibitor | Poly(ethylene glycol) dimethacrylate | ESD-909890-1G |
Cas.: 503-87-7 | Purity: 98% | 2-Thiohydantoin | ESD-864219-25G |
Cas.: 25852-47-5 | Purity: average Mn 6, 000, contains 1000 ppm 4-methoxyphenol as inhibitor | Poly(ethylene glycol) dimethacrylate | ESD-909890-250MG |
Cas.: 503-87-7 | Purity: 98% | 2-Thiohydantoin | ESD-864219-1G |
Cas.: 25852-47-5 | Purity: average Mn 10, 000, contains MEHQ as inhibitor | Poly(ethylene glycol) dimethacrylate | ESD-909892-1G |
Cas.: 36625-64-6 | Purity: 95% | 2-(Hydroxymethyl)-3-nitropyridine | ESD-909891-250MG |
Cas.: 36625-64-6 | Purity: 95% | 2-(Hydroxymethyl)-3-nitropyridine | ESD-909891-100MG |
Cas.: 25852-47-5 | Purity: average Mn 20, 000, contains MEHQ as inhibitor | Poly(ethylene glycol) dimethacrylate | ESD-909893-1G |
Cas.: 25852-47-5 | Purity: average Mn 20, 000, contains MEHQ as inhibitor | Poly(ethylene glycol) dimethacrylate | ESD-909893-250MG |
Cas.: 6274-28-8 | Purity: 98% | 3-amino-4-methylbenzenesulfonamide | ESD-906692-250MG |
Cas.: 29198-43-4 | Purity: 95% | 2-Benzothiazolecarboxamide | ESD-909894-250MG |
Cas.: 29198-43-4 | Purity: 95% | 2-Benzothiazolecarboxamide | ESD-909894-100MG |
Cas.: 5294-61-1 | Purity: 98% | N-(2,6-Dimethylphenyl)-1-piperazineacetamide | ESD-834945-25G |
Cas.: 5294-61-1 | Purity: 98% | N-(2,6-Dimethylphenyl)-1-piperazineacetamide | ESD-834945-100G |
Cas.: 39828-37-0 | Purity: 95% | 2,4-Dihydroxy-5-methylbenzaldehyde | ESD-909895-1G |
Cas.: 39828-37-0 | Purity: 95% | 2,4-Dihydroxy-5-methylbenzaldehyde | ESD-909895-250MG |
Cas.: 1313021-93-0 | Purity: 95% | tert-Butyl (4-oxo-1,2,3,4-tetrahydronaphthalen-1-yl)carbamate | ESD-909897-250MG |
Cas.: 9017-74-8 | Purity: ≥5 units/μl | Recombinant bovine enterokinase | ESD-864205-1KU |
Cas.: 1313021-93-0 | Purity: 95% | tert-Butyl (4-oxo-1,2,3,4-tetrahydronaphthalen-1-yl)carbamate | ESD-909897-100MG |
Cas.: 70240-34-5 | Purity: ≥97% | N-(2-Aminoethyl)-3-Aminopropyl Methyl Diethoxysilane | ESD-909896-5G |
Cas.: 70240-34-5 | Purity: ≥97% | N-(2-Aminoethyl)-3-Aminopropyl Methyl Diethoxysilane | ESD-909896-25G |
Cas.: 70240-34-5 | Purity: ≥97% | N-(2-Aminoethyl)-3-Aminopropyl Methyl Diethoxysilane | ESD-909896-100G |
Cas.: 70240-34-5 | Purity: ≥97% | N-(2-Aminoethyl)-3-Aminopropyl Methyl Diethoxysilane | ESD-909896-500G |
Cas.: 625-69-4 | Purity: ≥98% | 2,4-Pentanediol | ESD-865932-5G |
Cas.: 67350-50-9 | Purity: ≥95% | 5-(Hydroxymethyl)-1H-pyrrole-2-carbaldehyde | ESD-900999-25MG |
Cas.: 377-38-8 | Purity: ≥98% | Tetrafluorosuccinic Acid | ESD-865451-25G |
Cas.: 9017-74-8 | Purity: ≥5 units/μl | Recombinant bovine enterokinase | ESD-864205-0.5KU |
Cas.: 9002-88-4 | Purity: Melt flow rate: 2g/10min | LLDPE | ESD-909898-100G |
Cas.: 9002-88-4 | Purity: Melt flow rate: 2g/10min | LLDPE | ESD-909898-500G |
Cas.: 9002-88-4 | Purity: Melt flow rate: 2g/10min | LLDPE | ESD-909898-2.5KG |
Cas.: 242478-37-1 | Purity: 98% | Solifenacin | ESD-857942-1G |
Cas.: 242478-37-1 | Purity: 98% | Solifenacin | ESD-857942-5G |
Cas.: 989-51-5 | Purity: 98% | EGCG | ESD-808892-5G |
Cas.: 77855-73-3 | Purity: 95% | Anilino-methyl-trimethoxysilane | ESD-909899-5G |
Cas.: 77855-73-3 | Purity: 95% | Anilino-methyl-trimethoxysilane | ESD-909899-25G |
Cas.: 227456-27-1 | Purity: 98% | 3-Mercapto-2-methylpenta-1-ol | ESD-886532-5G |
Cas.: 29651-54-5 | Purity: 97% | 4,4′-(Cyclododecane-1,1-diyl)diphenol | ESD-890846-25G |
Cas.: 116912-64-2 | Purity: 50% methanol solution | 3-Ureidopropyltriethoxysilane | ESD-909901-25G |
Cas.: 116912-64-2 | Purity: 50% methanol solution | 3-Ureidopropyltriethoxysilane | ESD-909901-100G |
Cas.: 116912-64-2 | Purity: 50% methanol solution | 3-Ureidopropyltriethoxysilane | ESD-909901-500G |
Cas.: 25852-47-5 | Purity: average Mn 200, contains MEHQ as inhibitor | Poly(ethylene glycol) dimethacrylate | ESD-909902-1KG |
Cas.: 25852-47-5 | Purity: average Mn 200, contains MEHQ as inhibitor | Poly(ethylene glycol) dimethacrylate | ESD-909902-250G |
Cas.: 25852-47-5 | Purity: average Mn 200, contains MEHQ as inhibitor | Poly(ethylene glycol) dimethacrylate | ESD-909902-50G |
Cas.: 25852-47-5 | Purity: average Mn 400, contains MEHQ as inhibitor | Poly(ethylene glycol) dimethacrylate | ESD-909903-1KG |
Cas.: 25852-47-5 | Purity: average Mn 400, contains MEHQ as inhibitor | Poly(ethylene glycol) dimethacrylate | ESD-909903-250G |
Cas.: 25852-47-5 | Purity: average Mn 400, contains MEHQ as inhibitor | Poly(ethylene glycol) dimethacrylate | ESD-909903-50G |
Cas.: 25852-47-5 | Purity: average Mn 600, contains MEHQ as inhibitor | Poly(ethylene glycol) dimethacrylate | ESD-909904-1KG |
Cas.: 25852-47-5 | Purity: average Mn 600, contains MEHQ as inhibitor | Poly(ethylene glycol) dimethacrylate | ESD-909904-250G |
Cas.: 25852-47-5 | Purity: average Mn 600, contains MEHQ as inhibitor | Poly(ethylene glycol) dimethacrylate | ESD-909904-50G |
Cas.: 9004-34-6 | Purity: For column chromatography | Cellulose microcrystalline | ESD-909900-50G |
Cas.: 9004-34-6 | Purity: For column chromatography | Cellulose microcrystalline | ESD-909900-250G |
Cas.: 68-11-1 | Purity: ~80% in H2O, for spectrophotometric det. of palladium, iron, uranium(VI), molybdates and nitrites | Thioglycolic acid solution | ESD-909576-50ML |
Cas.: 9013-34-7 | Purity: BR | DEAE-52 | ESD-902410-25G |
Cas.: 515111-36-1 | Purity: ≥95% | 2-(4-Iodophenyl)-3-(2,4-dinitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium Sodium Salt | ESD-909905-250MG |
Cas.: 515111-36-1 | Purity: ≥95% | 2-(4-Iodophenyl)-3-(2,4-dinitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium Sodium Salt | ESD-909905-50MG |
Cas.: 181040-42-6 | Purity: 95% | 6-(Bromomethyl)benzo[d]oxazole | ESD-909906-1G |
Cas.: 181040-42-6 | Purity: 95% | 6-(Bromomethyl)benzo[d]oxazole | ESD-909906-250MG |
Cas.: 7439-89-6 | Purity: 98%, 400 Mesh | Reduced iron powder | ESD-812028-2.5KG |
Cas.: 646054-51-5 | Purity: 95% | 1-Fluoro-4-(4-nitrophenyl)-2-(trifluoromethyl)benzene | ESD-909907-5G |
Cas.: 646054-51-5 | Purity: 95% | 1-Fluoro-4-(4-nitrophenyl)-2-(trifluoromethyl)benzene | ESD-909907-1G |
Cas.: 2442-10-6 | Purity: ≥97% | 1-Octen-3-yl Acetate | ESD-859392-500G |
Cas.: 2442-10-6 | Purity: ≥97% | 1-Octen-3-yl Acetate | ESD-859392-25G |
Cas.: 2973-17-3 | Purity: 95% | 1-Allyl-1H-pyrrole-2,5-dione | ESD-909908-1G |
Cas.: 2973-17-3 | Purity: 95% | 1-Allyl-1H-pyrrole-2,5-dione | ESD-909908-250MG |
Cas.: NONE6720 | Purity: Aliphatic, Amine value: 420~550mgKOH/g, Viscosity (25℃): 450~900mpa.s | Amine Curing agent | ESD-875177-5KG |
Cas.: 34688-71-6 | Purity: ≥98% | 2,4,6-Trimethylbenzyl Cyanide | ESD-867786-5G |
Cas.: 34688-71-6 | Purity: ≥98% | 2,4,6-Trimethylbenzyl Cyanide | ESD-867786-25G |
Cas.: 98-83-9 | Purity: Analytical Standards | α-Methylstyrene | ESD-813146-10ML |
Cas.: 1184174-04-6 | Purity: 95% | 3-(4-Bromophenyl)-1-methyl-1H-1,2,4-triazole | ESD-909909-1G |
Cas.: 1184174-04-6 | Purity: 95% | 3-(4-Bromophenyl)-1-methyl-1H-1,2,4-triazole | ESD-909909-250MG |
Cas.: 824983-91-7 | Purity: 95% | FEN1-IN-1 | ESD-909910-25MG |
Cas.: 824983-91-7 | Purity: 95% | FEN1-IN-1 | ESD-909910-10MG |
Cas.: 6873-09-2 | Purity: ≥98%(HPLC) | Epiberberine | ESD-861270-50MG |
Cas.: 38245-38-4 | Purity: 99,9% | Neodymium(III) carbonate hydrate | ESD-856181-100G |
Cas.: 38245-38-4 | Purity: 99,9% | Neodymium(III) carbonate hydrate | ESD-856181-5G |
Cas.: 106133-20-4 | Purity: ≥98% | Tamsulosin | ESD-890628-100MG |
Cas.: 51050-59-0 | Purity: 95% | 3,4-Dichloroisocoumarin | ESD-909911-5MG |
Cas.: 51050-59-0 | Purity: 95% | 3,4-Dichloroisocoumarin | ESD-909911-25MG |
Cas.: 51050-59-0 | Purity: 95% | 3,4-Dichloroisocoumarin | ESD-909911-50MG |
Cas.: 63-92-3 | Purity: ≥98% | Phenoxybenzamine HCl | ESD-864423-5G |
Cas.: 127-09-3 | Purity: 99,9% | Sodium acetate anhydrous | ESD-818281-10KG |
Cas.: 151721-79-8 | Purity: 96% | 1,3,5-Trichloro-2,4,6-triiodobenzene | ESD-869179-1G |
Cas.: 944059-24-9 | Purity: 97% | 7-Azaindole-5-boronic acid | ESD-832100-5G |
Cas.: 80445-78-9 | Purity: 98% | Na-Boc-D-2,4-diaminobutyric acid | ESD-834186-250MG |
Cas.: 104-73-4 | Purity: 97% | 1-Dodecylpyridin-1-ium bromide | ESD-896418-25G |
Cas.: 104-73-4 | Purity: 97% | 1-Dodecylpyridin-1-ium bromide | ESD-896418-100G |
Cas.: NONE7993 | Purity: AR, 99% | alumium polysulfate | ESD-909372-2.5KG |
Cas.: 1080-32-6 | Purity: 99% | Diethyl benzylphosphonate | ESD-808211-5G |
Cas.: 2570-26-5 | Purity: >95.0%(GC)(T) | 1-Aminopentadecane | ESD-861691-5G |
Cas.: 25393-98-0 | Purity: 97% | 1,4-Bis(1,2-dibromoethyl)benzene | ESD-869521-250MG |
Cas.: 77-63-4 | Purity: 98% | 2,4,6,8-Tetramethyl-2,4,6,8-tetraphenylcyclotetrasiloxane technical | ESD-830193-5G |
Cas.: 77-63-4 | Purity: 98% | 2,4,6,8-Tetramethyl-2,4,6,8-tetraphenylcyclotetrasiloxane technical | ESD-830193-25G |
Cas.: 77-63-4 | Purity: 98% | 2,4,6,8-Tetramethyl-2,4,6,8-tetraphenylcyclotetrasiloxane technical | ESD-830193-100G |
Cas.: 1069-08-5 | Purity: ≥98% | Dichloro(diethylamino)phosphine | ESD-865494-25G |
Cas.: 57314-13-3 | Purity: 95% | 2,4,5-Tribromothiazole | ESD-909915-1G |
Cas.: 57314-13-3 | Purity: 95% | 2,4,5-Tribromothiazole | ESD-909915-250MG |
Cas.: 1412103-08-2 | Purity: 95% | 9,10-bis((E)-2-(pyridin-2-yl)vinyl)anthracene | ESD-909917-1G |
Cas.: 1412103-08-2 | Purity: 95% | 9,10-bis((E)-2-(pyridin-2-yl)vinyl)anthracene | ESD-909917-250MG |
Cas.: 25608-12-2 | Mw~10 million | Potassium polyacrylate | ESD-909916-100G |
Cas.: 25608-12-2 | Mw~10 million | Potassium polyacrylate | ESD-909916-500G |
Cas.: 9002-83-9 | Polychlorotrifluoroethylene (PTFCE) | ESD-909914-5G | |
Cas.: 83395-38-4 | Purity: 97% | 2-propyn-1-yl 1H-imidazole-1-carboxylate | ESD-909918-5G |
Cas.: 83395-38-4 | Purity: 97% | 2-propyn-1-yl 1H-imidazole-1-carboxylate | ESD-909918-25G |
Cas.: 14752-66-0 | Purity: 98%, T | Sodium 4-Chlorobenzenesulfinate | ESD-849344-5G |
Cas.: 1314-23-4 | Purity: 99%, 200 Mesh | Zirconium(IV) dioxide | ESD-909919-5KG |
Cas.: 1314-23-4 | Purity: 99%, 200 Mesh | Zirconium(IV) dioxide | ESD-909919-1KG |
Cas.: 1314-23-4 | Purity: 99%, 200 Mesh | Zirconium(IV) dioxide | ESD-909919-500G |
Cas.: 1314-23-4 | Purity: 99%, 200 Mesh | Zirconium(IV) dioxide | ESD-909919-100G |
Cas.: 1075198-30-9 | Purity: 98% | COMU | ESD-906812-100G |
Cas.: 1429664-95-8 | Purity: 95% | 3,3′-[9,10-Anthracenediyldi-(1E)-2,1-ethenediyl]bis[pyridine] | ESD-909921-1G |
Cas.: 1429664-95-8 | Purity: 95% | 3,3′-[9,10-Anthracenediyldi-(1E)-2,1-ethenediyl]bis[pyridine] | ESD-909921-250MG |
Cas.: 9004-34-6 | Purity: 100-200 Mesh | Microcrystalline cellulose | ESD-909922-100G |
Cas.: 9004-34-6 | Purity: 100-200 Mesh | Microcrystalline cellulose | ESD-909922-500G |
Cas.: 66071-94-1 | Purity: suspension | Corn steep liquor | ESD-909923-500G |
Cas.: 66071-94-1 | Purity: suspension | Corn steep liquor | ESD-909923-2.5KG |
Cas.: 66071-94-1 | Purity: suspension | Corn steep liquor | ESD-909923-10KG |
Cas.: 134136-00-8 | Purity: 95% | Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[d]thiazole-6-carboxylate | ESD-909924-100MG |
Cas.: 134136-00-8 | Purity: 95% | Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[d]thiazole-6-carboxylate | ESD-909924-250MG |
Cas.: 51306-35-5 | Purity: 95% | 5-(4,6-Dichlorotriazinyl)aminofluorescein | ESD-855062-25MG |
Cas.: 80522-42-5 | Purity: 97% | Triisopropylsilyl trifluoromethanesulfonate | ESD-823259-100G |
Cas.: 32492-61-8 | Purity: Mn ~492 (n≈6) | Ethoxylated Bisphenol A | ESD-909925-250ML |
Cas.: 32492-61-8 | Purity: Mn ~492 (n≈6) | Ethoxylated Bisphenol A | ESD-909925-50ML |
Cas.: 13338-49-3 | Purity: 95% | 2-(Chloromethyl)-4,5-dihydro-1H-imidazole hydrochloride | ESD-844355-100G |
Cas.: 970-74-1 | Purity: ≥98%(HPLC) | (-)-EGC | ESD-808622-5G |
Cas.: 1303-86-2 | Purity: 98%, 200 Mesh | Boron oxide | ESD-804098-10KG |
Cas.: 4265-25-2 | Purity: 96% | 2-Methylbenzofuran | ESD-861491-5G |
Cas.: 148757-89-5 | Purity: 95% | 14-bromo-5-(14-bromo-1,1,1,2,2-pentafluorotetradecane-5-yl)sulfanyl-1,1,1,2,2-pentafluorotetradecane | ESD-909926-1G |
Cas.: 148757-89-5 | Purity: 95% | 14-bromo-5-(14-bromo-1,1,1,2,2-pentafluorotetradecane-5-yl)sulfanyl-1,1,1,2,2-pentafluorotetradecane | ESD-909926-250MG |
Cas.: 3240-94-6 | Purity: 98% | 4-(2-Chloroethyl)morpholine | ESD-902433-25G |
Cas.: 92339-11-2 | Purity: BR | Iodixanol | ESD-873705-25MG |
Cas.: 92339-11-2 | Purity: BR | Iodixanol | ESD-873705-100MG |
Cas.: 511545-94-1 | Purity: 95% | 9-(4,4,5,5,5-pentafluoropentylsulfanyl)nonan-1-ol | ESD-909927-1G |
Cas.: 511545-94-1 | Purity: 95% | 9-(4,4,5,5,5-pentafluoropentylsulfanyl)nonan-1-ol | ESD-909927-250MG |
Cas.: 1107606-68-7 | Purity: 98% | S-(4,4,5,5,5-Pentafluoropentyl)isothiourea Methanesulfonate | ESD-909928-1G |
Cas.: 1107606-68-7 | Purity: 98% | S-(4,4,5,5,5-Pentafluoropentyl)isothiourea Methanesulfonate | ESD-909928-5G |
Cas.: 1770840-43-1 | Purity: 95% | 4-amino-7-iodopyrrolo[2,1-f][1,2,4]triazine | ESD-909929-25G |
Cas.: 1770840-43-1 | Purity: 95% | 4-amino-7-iodopyrrolo[2,1-f][1,2,4]triazine | ESD-909929-5G |
Cas.: 57988-58-6 | Purity: 98% | 4-(4′-Bromophenyl)-4-hydroxypiperidine | ESD-871086-250MG |
Cas.: 25322-17-2 | Purity: 45-50%, Soluble in isobutanol | Dinonylnaphthalenesulfonic acid | ESD-887797-500ML |
Cas.: 25322-17-2 | Purity: 55%, Soluble in isobutanol | Dinonylnaphthalenesulfonic acid | ESD-855592-500ML |
Cas.: 74927-72-3 | Purity: ≥98% | (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylglycine | ESD-858046-25G |
Cas.: 30389-33-4 | Purity: 97% | 5-Hydroxy-3,4-dihydroquinolin-2(1H)-one | ESD-842704-5G |
Cas.: 605-94-7 | Purity: 97% | 2,3-Dimethoxy-5-methyl-|p|-benzoquinone | ESD-804770-100G |
Cas.: 41406-00-2 | Purity: 97% | 3-Isopropoxyaniline | ESD-838009-500G |
Cas.: 4871-97-0 | Purity: ≥97% | Curcumol | ESD-909930-25MG |
Cas.: 4871-97-0 | Purity: ≥97% | Curcumol | ESD-909930-100MG |
Cas.: 5535-49-9 | Purity: 98% | 2-Chloroethyl phenyl sulfide | ESD-804288-100G |
Cas.: 211915-06-9 | Purity: 97% | Dabigatran etexilate | ESD-830597-1G |
Cas.: 15159-40-7 | Purity: 97% | 4-Morpholinecarbonyl chloride | ESD-831545-100G |
Cas.: 4707-95-3 | Purity: ≥98% | tert-Butylphosphonic Dichloride | ESD-866026-5G |
Cas.: 7101-31-7 | Purity: >97% | Dimethyl Diselenide | ESD-837346-25G |
Cas.: 225927-21-9 | Purity: viscosity: 300-600 cSt | Polyphenylmethylsiloxane, vinyl terminated | ESD-909931-5G |
Cas.: 225927-21-9 | Purity: viscosity: 300-600 cSt | Polyphenylmethylsiloxane, vinyl terminated | ESD-909931-25G |
Cas.: 225927-21-9 | Purity: viscosity: 300-600 cSt | Polyphenylmethylsiloxane, vinyl terminated | ESD-909931-100G |
Cas.: 1122-12-9 | Purity: 97% | 3,4-Dibromofuran-2,5-dione | ESD-839862-25G |
Cas.: 110119-84-1 | Purity: ≥98% | Donepezil Hydrochloride | ESD-859457-25G |
Cas.: 16399-77-2 | Purity: 99% | FERROUS CHLORIDE DIHYDRATE | ESD-904758-25G |
Cas.: 16399-77-2 | Purity: 99% | FERROUS CHLORIDE DIHYDRATE | ESD-904758-100G |
Cas.: 10031-26-2 | Purity: 98% | Iron(III) bromide | ESD-822349-500G |
Cas.: 16399-77-2 | Purity: ≥95% | FERROUS CHLORIDE DIHYDRATE | ESD-909932-5G |
Cas.: 16399-77-2 | Purity: ≥95% | FERROUS CHLORIDE DIHYDRATE | ESD-909932-25G |
Cas.: 100-13-0 | Purity: 97%, contains stabilizerTBC | 4-Nitrostyrene | ESD-833430-5G |
Cas.: 16399-77-2 | Purity: ≥95% | FERROUS CHLORIDE DIHYDRATE | ESD-909932-100G |
Cas.: 16399-77-2 | Purity: ≥95% | FERROUS CHLORIDE DIHYDRATE | ESD-909932-500G |
Cas.: 1133123-02-0 | Purity: 95% | 4-Bromo-2-iodobenzoicAcid | ESD-829195-1G |
Cas.: 1133123-02-0 | Purity: 95% | 4-Bromo-2-iodobenzoicAcid | ESD-829195-5G |
Cas.: 2254-94-6 | Purity: 97% | 3-Methylbenzothiazole-2-thione | ESD-909933-1G |
Cas.: 2254-94-6 | Purity: 97% | 3-Methylbenzothiazole-2-thione | ESD-909933-5G |
Cas.: 7206-70-4 | Purity: 96% | 4-Amino-5-chloro-2-methoxybenzoic Acid | ESD-859301-1G |
Cas.: 50907-19-2 | Purity: 97% | 5-(2-Fluorophenyl)-1H-tetrazole | ESD-909934-250MG |
Cas.: 50907-19-2 | Purity: 97% | 5-(2-Fluorophenyl)-1H-tetrazole | ESD-909934-1G |
Cas.: 50907-19-2 | Purity: 97% | 5-(2-Fluorophenyl)-1H-tetrazole | ESD-909934-5G |
Cas.: 1240567-18-3 | Purity: 95% | 1-Cyclopropyl-1H-pyrazol-4-amine | ESD-909935-1G |
Cas.: 1240567-18-3 | Purity: 95% | 1-Cyclopropyl-1H-pyrazol-4-amine | ESD-909935-250MG |
Cas.: 34272-64-5 | Purity: 98% | 2-(4-Methyl-2-thioxo-2,3-dihydrothiazol-5-yl)acetic acid | ESD-829911-5G |
Cas.: 60169-72-4 | Purity: 95% | 1-Benzylpyrrolidine-2-carboxylic acid | ESD-909941-5G |
Cas.: 9004-61-9 | MW: 100,000-200,000 | Hyaluronic acid | ESD-909936-5G |
Cas.: 9004-61-9 | MW: 100,000-200,000 | Hyaluronic acid | ESD-909936-25G |
Cas.: 60169-72-4 | Purity: 95% | 1-Benzylpyrrolidine-2-carboxylic acid | ESD-909941-1G |
Cas.: 9004-61-9 | MW: 100,000-200,000 | Hyaluronic acid | ESD-909936-100G |
Cas.: 60169-72-4 | Purity: 95% | 1-Benzylpyrrolidine-2-carboxylic acid | ESD-909941-25G |
Cas.: 9004-61-9 | MW: 200,000-400,000 | Hyaluronic acid | ESD-909937-5G |
Cas.: 9004-61-9 | MW: 200,000-400,000 | Hyaluronic acid | ESD-909937-25G |
Cas.: 9004-61-9 | MW: 200,000-400,000 | Hyaluronic acid | ESD-909937-100G |
Cas.: 9004-61-9 | MW: 400,000-800,000 | Hyaluronic acid | ESD-909938-5G |
Cas.: 9004-61-9 | MW: 400,000-800,000 | Hyaluronic acid | ESD-909938-25G |
Cas.: 9004-61-9 | MW: 400,000-800,000 | Hyaluronic acid | ESD-909938-100G |
Cas.: 9004-61-9 | MW: 80-1.5 million | Hyaluronic acid | ESD-909939-5G |
Cas.: 592-55-2 | Purity: 98% | 2-Bromoethyl ethyl ether | ESD-824188-500G |
Cas.: 9004-61-9 | MW: 80-1.5 million | Hyaluronic acid | ESD-909939-25G |
Cas.: 9004-61-9 | MW: 80-1.5 million | Hyaluronic acid | ESD-909939-100G |
Cas.: 9004-61-9 | MW: 1.5-2.5 million | Hyaluronic acid | ESD-909940-5G |
Cas.: 9004-61-9 | MW: 1.5-2.5 million | Hyaluronic acid | ESD-909940-25G |
Cas.: 9004-61-9 | MW: 1.5-2.5 million | Hyaluronic acid | ESD-909940-100G |
Cas.: 307510-92-5 | Purity: 99% | CFTR inhibitor 172 | ESD-872554-25MG |
Cas.: 57297-29-7 | Purity: 97% | Cyclopropane-1-carboximidamide hydrochloride | ESD-831246-5G |
Cas.: 57297-29-7 | Purity: 97% | Cyclopropane-1-carboximidamide hydrochloride | ESD-831246-25G |
Cas.: 32492-61-8 | Purity: Mn ~492 (n≈6) | Ethoxylated Bisphenol A | ESD-909925-1L |
Cas.: 32492-61-8 | Purity: Mn ~492 (n≈6) | Ethoxylated Bisphenol A | ESD-909925-5L |
Cas.: 32492-61-8 | Purity: Mn ~404 | Ethoxylated Bisphenol A | ESD-909942-50G |
Cas.: 32492-61-8 | Purity: Mn ~404 | Ethoxylated Bisphenol A | ESD-909942-250G |
Cas.: 32492-61-8 | Purity: Mn ~404 | Ethoxylated Bisphenol A | ESD-909942-1KG |
Cas.: 32492-61-8 | Purity: Mn ~404 | Ethoxylated Bisphenol A | ESD-909942-5KG |
Cas.: 1576-43-8 | Purity: ≥97%(T) | 4-Hydroxybenzenesulfonamide | ESD-862838-1G |
Cas.: 32492-61-8 | Purity: Mn ~580 (n≈8) | Ethoxylated Bisphenol A | ESD-909943-50G |
Cas.: 32492-61-8 | Purity: Mn ~580 (n≈8) | Ethoxylated Bisphenol A | ESD-909943-250G |
Cas.: 32492-61-8 | Purity: Mn ~580 (n≈8) | Ethoxylated Bisphenol A | ESD-909943-1KG |
Cas.: 32492-61-8 | Purity: Mn ~580 (n≈8) | Ethoxylated Bisphenol A | ESD-909943-5KG |
Cas.: 32492-61-8 | Purity: Mn ~668 (n≈10) | Ethoxylated Bisphenol A | ESD-909944-50G |
Cas.: 32492-61-8 | Purity: Mn ~668 (n≈10) | Ethoxylated Bisphenol A | ESD-909944-250G |
Cas.: 32492-61-8 | Purity: Mn ~668 (n≈10) | Ethoxylated Bisphenol A | ESD-909944-1KG |
Cas.: 32492-61-8 | Purity: Mn ~668 (n≈10) | Ethoxylated Bisphenol A | ESD-909944-5KG |
Cas.: 1911578-98-7 | Purity: 95% | 2-Ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate | ESD-909945-25G |
Cas.: 1911578-98-7 | Purity: 95% | 2-Ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate | ESD-909945-100G |
Cas.: 1911578-98-7 | Purity: 95% | 2-Ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate | ESD-909945-5G |
Cas.: 110661-91-1 | Purity: 98% | tert-Butyl 4-bromobutanoate | ESD-839464-25G |
Cas.: 60-10-6 | Purity: ACS reagent, for spectrophotometric det. of Cd, Cu, Hg, Pb, Zn, ≥98%(TLC) | Dithizone | ESD-909520-1G |
Cas.: 103068-41-3 | Purity: 98% | 4-Fluororesorcinol | ESD-835411-250MG |
Cas.: 99-98-9 | Purity: for spectrophotometric det. of SO42-, S2-, ≥97% | N,N-Dimethyl-p-phenylenediamine | ESD-909678-5G |
Cas.: 99-98-9 | Purity: for spectrophotometric det. of SO42-, S2-, ≥97% | N,N-Dimethyl-p-phenylenediamine | ESD-909678-100G |
Cas.: 99-98-9 | Purity: for spectrophotometric det. of SO42-, S2-, ≥97% | N,N-Dimethyl-p-phenylenediamine | ESD-909678-500G |
Cas.: 9003-20-7 | Purity: approx. MW 170,000 | Poly(vinyl acetate) | ESD-823412-2.5KG |
Cas.: 13813-19-9 | Purity: D, 99% | Sulfuric acid-d2 solution | ESD-829583-0.55ML |
Cas.: 17697-12-0 | Purity: 98% | Benzeneseleninic acid anhydride | ESD-889360-1G |
Cas.: 17697-12-0 | Purity: 98% | Benzeneseleninic acid anhydride | ESD-889360-250MG |
Cas.: 10472-88-5 | Purity: 97% | 2-BROMO-4-FLUORO-6-NITROANILINE | ESD-834597-25G |
Cas.: 10472-88-5 | Purity: 97% | 2-BROMO-4-FLUORO-6-NITROANILINE | ESD-834597-5G |
Cas.: 10472-88-5 | Purity: 97% | 2-BROMO-4-FLUORO-6-NITROANILINE | ESD-834597-1G |
Cas.: 17766-26-6 | Purity: ≥98% | 1,3,5-Triazine-2,4,6-trithiol trisodium salt, approx. | ESD-837976-500G |
Cas.: 1134-49-2 | Purity: 97% | 3-PHENYL-1H-PYRAZOLE-5-CARBOXYLIC ACID | ESD-833698-5G |
Cas.: 1134-49-2 | Purity: 97% | 3-PHENYL-1H-PYRAZOLE-5-CARBOXYLIC ACID | ESD-833698-1G |
Cas.: 775304-57-9 | Purity: 98% | PTC124 | ESD-843715-5G |
Cas.: 76-54-0 | Purity: 98% | 2′,7′-Dichlorofluorescein | ESD-909946-25G |
Cas.: 76-54-0 | Purity: 98% | 2′,7′-Dichlorofluorescein | ESD-909946-5G |
Cas.: 76-54-0 | Purity: 98% | 2′,7′-Dichlorofluorescein | ESD-909946-1G |
Cas.: 84632-65-5 | Purity: ≥98% | Pigment Red 254 | ESD-860292-100G |
Cas.: 1257044-40-8 | Purity: ≥99% | ABT-199 (GDC-0199) | ESD-864241-100MG |
Cas.: 31694-55-0 | MW: 900 | Glycerol ethoxylate | ESD-909231-2.5KG |
Cas.: 5808-22-0 | Purity: ACS | Chromotropic acid disodium salt dihydrate | ESD-804182-500G |
Cas.: 25087-26-7 | Purity: AR | Poly(methacrylic acid) macromolecule | ESD-875950-500G |
Cas.: 1552-94-9 | Purity: 97% | 5-Phenyl-2,4-pentadienoic acid | ESD-858448-25G |
Cas.: 1552-94-9 | Purity: 97% | 5-Phenyl-2,4-pentadienoic acid | ESD-858448-1G |
Cas.: 99-20-7 | Purity: 99% | D-(+)-Trehalose Anhydrous | ESD-807343-2.5KG |
Cas.: 2257-85-4 | Purity: 95% | 4-Amino-2-methylisoindoline-1,3-dione | ESD-909947-1G |
Cas.: 5274-68-0 | Purity: 98% | Tetraethylene Glycol Monododecyl Ether | ESD-838440-25ML |
Cas.: 1204-60-0 | Purity: >96%(GC) | Biphenyl-3-carboxaldehyde | ESD-836049-5G |
Cas.: 1204-60-0 | Purity: >96%(GC) | Biphenyl-3-carboxaldehyde | ESD-836049-1G |
Cas.: 1204-60-0 | Purity: >96%(GC) | Biphenyl-3-carboxaldehyde | ESD-836049-250MG |
Cas.: 34946-82-2 | Purity: 98% | Copper(II) trifluoromethanesulfonate | ESD-804212-500G |
Cas.: 1484-26-0 | Purity: 98% | 3-BENZYLOXYANILINE | ESD-834600-100G |
Cas.: 1484-26-0 | Purity: 98% | 3-BENZYLOXYANILINE | ESD-834600-25G |
Cas.: 1484-26-0 | Purity: 98% | 3-BENZYLOXYANILINE | ESD-834600-5G |
Cas.: 1484-26-0 | Purity: 98% | 3-BENZYLOXYANILINE | ESD-834600-1G |
Cas.: 404001-62-3 | Purity: 99% | 1-Hexadecyl-3-methylimidazolium chloride monohydrate | ESD-889443-5G |
Cas.: 119478-56-7 | Purity: 98% | Meropenem trihydrate | ESD-843918-25G |
Cas.: 103177-37-3 | Purity: 99% | Pranlukast | ESD-834103-5G |
Cas.: 103177-37-3 | Purity: 99% | Pranlukast | ESD-834103-1G |
Cas.: 2682-20-4 | Purity: 30% solution in H2O | 2-Methyl-4-isothiazolin-3-one | ESD-890311-100G |
Cas.: 2682-20-4 | Purity: 30% solution in H2O | 2-Methyl-4-isothiazolin-3-one | ESD-890311-500G |
Cas.: 111-32-0 | Purity: 98% | 4-Methoxy-1-butanol | ESD-835987-1G |
Cas.: 87851-77-2 | Purity: ≥95% | O-(3-Chloroallyl)hydroxylamine | ESD-895766-25G |
Cas.: 526-18-1 | Purity: 98% | Osalmid | ESD-831489-5G |
Cas.: 526-18-1 | Purity: 98% | Osalmid | ESD-831489-1G |
Cas.: 12179-04-3 | Purity: 99.5%, 100 Mesh | Sodium tetraborate | ESD-887059-10KG |
Cas.: 5971-93-7 | Purity: 95% | Rubidium tetraphenylborate | ESD-909948-1G |
Cas.: 91-59-8 | Purity: AR, 98% | β-Naphthylamine | ESD-829877-100G |
Cas.: 3087-82-9 | Purity: 98% | Cesium tetraphenylborate | ESD-909949-1G |
Cas.: 3601-90-9 | Purity: 95% | 1-Chloro-3,5-di(4-chlorbenzoyl)-2-deoxy-D-ribose | ESD-829543-5G |
Cas.: 3601-90-9 | Purity: 95% | 1-Chloro-3,5-di(4-chlorbenzoyl)-2-deoxy-D-ribose | ESD-829543-25G |
Cas.: 41965-95-1 | Purity: 97% | 3-Chloro-4-methoxybenzylamine Hydrochloride | ESD-837991-5G |
Cas.: 41965-95-1 | Purity: 97% | 3-Chloro-4-methoxybenzylamine Hydrochloride | ESD-837991-25G |
Cas.: 41965-95-1 | Purity: 97% | 3-Chloro-4-methoxybenzylamine Hydrochloride | ESD-837991-100G |
Cas.: 1258327-07-9 | Purity: ≥98%, 99%ee | (11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1′, 7′-fg][1,3,2]dioxaphosphocin | ESD-854259-25MG |
Cas.: 7758-11-4 | Purity: 99.9% metals basis | Potassium phosphate dibasic anhydrous | ESD-875802-2.5KG |
Cas.: 1297613-76-3 | Purity: ≥98%, 99%ee | (11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1′, 7′-fg][1,3,2]dioxaphosphocin | ESD-854258-25MG |
Cas.: 26402-26-6 | Purity: ≥95% | Monocaprylin | ESD-909950-1G |
Cas.: 26402-26-6 | Purity: ≥95% | Monocaprylin | ESD-909950-5G |
Cas.: 26402-26-6 | Purity: ≥95% | Monocaprylin | ESD-909950-25G |
Cas.: 72829-09-5 | Purity: ≥95%, contains stabilizerMEHQ | 1,12-Dodecanediol Dimethacrylate | ESD-865682-100G |
Cas.: 122-99-6 | Purity: 99% | Ethylene glycol monophenyl ether | ESD-808972-10KG |
Cas.: 60303-68-6 | Purity: Sulfur contains amount: 30.1% | Poly-tert-butylphenol disulfide | ESD-909951-500G |
Cas.: 60303-68-6 | Purity: Sulfur contains amount: 30.1% | Poly-tert-butylphenol disulfide | ESD-909951-2.5KG |
Cas.: 60303-68-6 | Purity: Sulfur contains amount: 30.1% | Poly-tert-butylphenol disulfide | ESD-909951-10KG |
Cas.: 60303-68-6 | Purity: Sulfur contains amount: 30.1% | Poly-tert-butylphenol disulfide | ESD-909951-100G |
Cas.: 591-28-6 | Purity: 97% | 4-Thiouracil | ESD-820236-5G |
Cas.: 63-39-8 | Purity: ≥98% | Uridine triphosphate | ESD-878081-250MG |
Cas.: 51811-79-1 | Purity: Model:TXP-10, 99% | Nonylphenol POE Phosphate Ester | ESD-909952-100G |
Cas.: 51811-79-1 | Purity: Model:TXP-10, 99% | Nonylphenol POE Phosphate Ester | ESD-909952-500G |
Cas.: 768-91-2 | Purity: ≥98% | 1-Methyladamantane | ESD-860235-250MG |
Cas.: 93-48-1 | Purity: ≥98% | 2,5-Dimethylbenzylamine | ESD-860377-1G |
Cas.: 2595-05-3 | Purity: 98% | 1,2:5,6-Di-O-isopropylidene-α-D-allofuranose | ESD-808287-25G |
Cas.: 6639-87-8 | Purity: ≥95% | 6-nitroquinoxaline | ESD-824733-5G |
Cas.: 6639-87-8 | Purity: ≥95% | 6-nitroquinoxaline | ESD-824733-25G |
Cas.: 3964-52-1 | Purity: ≥90% | 3-Chloro-4-hydroxyaniline | ESD-823124-500G |
Cas.: 613-32-1 | Purity: 95% | 5,10-Dihydrophenazine | ESD-836637-50MG |
Cas.: 27306-78-1 | Purity: 99% | Polyalkyleneoxide modified heptamethyltrisiloxane | ESD-909953-100G |
Cas.: 27306-78-1 | Purity: 99% | Polyalkyleneoxide modified heptamethyltrisiloxane | ESD-909953-500G |
Cas.: 630-22-8 | Purity: 98% | 2,2-Dimethylpropanethioamide | ESD-831897-5G |
Cas.: 630-22-8 | Purity: 98% | 2,2-Dimethylpropanethioamide | ESD-831897-1G |
Cas.: 5333-84-6 | Purity: 98% | 3-Methyl-4-cyclohexene-1,2-dicarboxylic Anhydride | ESD-824293-5G |
Cas.: 5333-84-6 | Purity: 98% | 3-Methyl-4-cyclohexene-1,2-dicarboxylic Anhydride | ESD-824293-1G |
Cas.: 23786-14-3 | Purity: 97% | Methyl 4-methoxyphenylacetate | ESD-831972-500G |
Cas.: 23786-14-3 | Purity: 97% | Methyl 4-methoxyphenylacetate | ESD-831972-100G |
Cas.: 23786-14-3 | Purity: 97% | Methyl 4-methoxyphenylacetate | ESD-831972-25G |
Cas.: 23786-14-3 | Purity: 97% | Methyl 4-methoxyphenylacetate | ESD-831972-5G |
Cas.: 15374-45-5 | Purity: >94.0%(GC) | 1,2-Di(1-naphthyl)ethane | ESD-864695-250MG |
Cas.: 5883-17-0 | Purity: 97% | N-ethylprop-2-enamide | ESD-832028-1G |
Cas.: 5883-17-0 | Purity: 97% | N-ethylprop-2-enamide | ESD-832028-250MG |
Cas.: 1300-71-6 | Purity: 45-50% | Dimethylphenol | ESD-909954-100G |
Cas.: 1300-71-6 | Purity: 45-50% | Dimethylphenol | ESD-909954-25G |
Cas.: 317318-97-1 | Purity: 98% | Thiazole,5-(chloromethyl)-4-methyl-2-[4-(trifluoromethyl)phenyl]- | ESD-834567-1G |
Cas.: 1217-45-4 | Purity: ≥98% | 9,10-Dicyanoanthracene | ESD-866705-5G |
Cas.: 9011-13-6 | Purity: Mn ~28000 | Styrene maleic anhydride copolymer | ESD-909955-25G |
Cas.: 9011-13-6 | Purity: Mn ~28000 | Styrene maleic anhydride copolymer | ESD-909955-100G |
Cas.: 9011-13-6 | Purity: Mn ~28000 | Styrene maleic anhydride copolymer | ESD-909955-500G |
Cas.: 9011-13-6 | Purity: Mn ~28000 | Styrene maleic anhydride copolymer | ESD-909955-2.5KG |
Cas.: 127277-53-6 | Purity: ≥99% | Prohexadione calcium | ESD-909957-250MG |
Cas.: 127277-53-6 | Purity: ≥95% | Prohexadione calcium | ESD-888289-5G |
Cas.: 127277-53-6 | Purity: ≥99% | Prohexadione calcium | ESD-909957-5G |
Cas.: 127277-53-6 | Purity: ≥99% | Prohexadione calcium | ESD-909957-1G |
Cas.: 127277-53-6 | Purity: ≥99% | Prohexadione calcium | ESD-909957-50MG |
Cas.: 389806-32-0 | Purity: 95% | 2-Bromo-6-iodonaphthalene | ESD-909958-1G |
Cas.: 389806-32-0 | Purity: 95% | 2-Bromo-6-iodonaphthalene | ESD-909958-250MG |
Cas.: 9038-95-3 | Purity: average Mn ~1800 | Poly(ethylene glycol-ran-propylene glycol) monobutyl ether | ESD-909956-100ML |
Cas.: 9038-95-3 | Purity: average Mn ~1800 | Poly(ethylene glycol-ran-propylene glycol) monobutyl ether | ESD-909956-500ML |
Cas.: 5423-22-3 | Purity: 98% | Guanidinium dihydrogen phosphate | ESD-836581-100G |
Cas.: 5423-22-3 | Purity: 98% | Guanidinium dihydrogen phosphate | ESD-836581-500G |
Cas.: 6684-06-6 | Purity: 98% | 2-chloropyridine-3-sulphonylchloride | ESD-829371-1G |
Cas.: 2150-45-0 | Purity: 98% | Methyl 2,6-dihydroxybenzoate | ESD-834584-1G |
Cas.: 2150-45-0 | Purity: 98% | Methyl 2,6-dihydroxybenzoate | ESD-834584-5G |
Cas.: 2150-45-0 | Purity: 98% | Methyl 2,6-dihydroxybenzoate | ESD-834584-25G |
Cas.: 2150-45-0 | Purity: 98% | Methyl 2,6-dihydroxybenzoate | ESD-834584-100G |
Cas.: 76263-11-1 | Purity: 98% | Ethyl 2-amino-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxylate | ESD-909959-1G |
Cas.: 76263-11-1 | Purity: 98% | Ethyl 2-amino-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxylate | ESD-909959-5G |
Cas.: 76263-11-1 | Purity: 98% | Ethyl 2-amino-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxylate | ESD-909959-10G |
Cas.: 776-99-8 | Purity: 97% | (3,4-Dimethoxyphenyl)acetone | ESD-830769-500G |
Cas.: 776-99-8 | Purity: 97% | (3,4-Dimethoxyphenyl)acetone | ESD-830769-100G |
Cas.: 776-99-8 | Purity: 97% | (3,4-Dimethoxyphenyl)acetone | ESD-830769-25G |
Cas.: 776-99-8 | Purity: 97% | (3,4-Dimethoxyphenyl)acetone | ESD-830769-5G |
Cas.: 9001-48-3 | Purity: 189units/mg protein | Glutathionereductase | ESD-861439-500U |
Cas.: 494773-35-2 | Purity: 95% | tert-Butyl 4-(2-bromophenyl)piperazine-1-carboxylate | ESD-909961-1G |
Cas.: 494773-35-2 | Purity: 95% | tert-Butyl 4-(2-bromophenyl)piperazine-1-carboxylate | ESD-909961-5G |
Cas.: 1128-61-6 | Purity: ≥98% | 6-FLUORO-2-METHYLQUINOLINE | ESD-833687-25G |
Cas.: 1128-61-6 | Purity: ≥98% | 6-FLUORO-2-METHYLQUINOLINE | ESD-833687-5G |
Cas.: 1128-61-6 | Purity: ≥98% | 6-FLUORO-2-METHYLQUINOLINE | ESD-833687-1G |
Cas.: 911373-69-8 | Purity: 98% | (R)-1-(4-Methoxyphenyl)ethanamine hydrochloride | ESD-909963-1G |
Cas.: 911373-69-8 | Purity: 98% | (R)-1-(4-Methoxyphenyl)ethanamine hydrochloride | ESD-909963-5G |
Cas.: 181289-15-6 | Purity: 98% | 3-(2-Amino-2-oxoethyl)-5-methylhexanoic acid | ESD-850013-500G |
Cas.: 181289-15-6 | Purity: 98% | 3-(2-Amino-2-oxoethyl)-5-methylhexanoic acid | ESD-850013-100G |
Cas.: 181289-15-6 | Purity: 98% | 3-(2-Amino-2-oxoethyl)-5-methylhexanoic acid | ESD-850013-25G |
Cas.: 68951-96-2 | Purity: Viscosity: 3600~7000 mPa.s | Poly(dimethylsiloxane-co-diphenylsiloxane), divinyl terminated | ESD-909962-5G |
Cas.: 68951-96-2 | Purity: Viscosity: 3600~7000 mPa.s | Poly(dimethylsiloxane-co-diphenylsiloxane), divinyl terminated | ESD-909962-25G |
Cas.: 1887-02-1 | Purity: 97% | Tetrahydroxy-1,4-benzoquinone Disodium Salt | ESD-831394-25G |
Cas.: 1887-02-1 | Purity: 97% | Tetrahydroxy-1,4-benzoquinone Disodium Salt | ESD-831394-5G |
Cas.: 1887-02-1 | Purity: 97% | Tetrahydroxy-1,4-benzoquinone Disodium Salt | ESD-831394-1G |
Cas.: 30165-96-9 | Purity: 98% | 3-Chloro-4-morpholino-1,2,5-thiadiazole | ESD-834576-100G |
Cas.: 30165-96-9 | Purity: 98% | 3-Chloro-4-morpholino-1,2,5-thiadiazole | ESD-834576-25G |
Cas.: 30165-96-9 | Purity: 98% | 3-Chloro-4-morpholino-1,2,5-thiadiazole | ESD-834576-5G |
Cas.: 15690-25-2 | Purity: 98% | 2-Thiopheneacrylic Acid | ESD-858446-25G |
Cas.: 15690-25-2 | Purity: 98% | 2-Thiopheneacrylic Acid | ESD-858446-50G |
Cas.: 15690-25-2 | Purity: 98% | 2-Thiopheneacrylic Acid | ESD-858446-100G |
Cas.: 761440-65-7 | Purity: 95% | 1-(1-(3-Methoxy-4-nitrophenyl)piperidin-4-yl)-4-methylpiperazine | ESD-909965-1G |
Cas.: 761440-65-7 | Purity: 95% | 1-(1-(3-Methoxy-4-nitrophenyl)piperidin-4-yl)-4-methylpiperazine | ESD-909965-5G |
Cas.: 14059-33-7 | Purity: 99.9% trace metals basis | Bismuth vanadate | ESD-836152-100G |
Cas.: 1693-44-3 | Purity: >99.0% | 2,2,4,4,6,6-hexamethyl-8,8-diphenylcyclotetrasiloxane | ESD-909966-25G |
Cas.: 1693-44-3 | Purity: >99.0% | 2,2,4,4,6,6-hexamethyl-8,8-diphenylcyclotetrasiloxane | ESD-909966-100G |
Cas.: 1693-44-3 | Purity: >99.0% | 2,2,4,4,6,6-hexamethyl-8,8-diphenylcyclotetrasiloxane | ESD-909966-500G |
Cas.: 1693-44-3 | Purity: 99,85% | 2,2,4,4,6,6-hexamethyl-8,8-diphenylcyclotetrasiloxane | ESD-909967-25G |
Cas.: 1693-44-3 | Purity: 99,85% | 2,2,4,4,6,6-hexamethyl-8,8-diphenylcyclotetrasiloxane | ESD-909967-100G |
Cas.: 1693-44-3 | Purity: 99,85% | 2,2,4,4,6,6-hexamethyl-8,8-diphenylcyclotetrasiloxane | ESD-909967-500G |
Cas.: 1417456-04-2 | Purity: 95% | 2-Amino-6-fluoro-N-phenylbenzamide | ESD-909968-5G |
Cas.: 1417456-04-2 | Purity: 95% | 2-Amino-6-fluoro-N-phenylbenzamide | ESD-909968-1G |
Cas.: 848133-76-6 | Purity: 95% | N-(4-Chloro-3-cyano-7-ethoxy-6-quinolinyl)acetamide | ESD-909969-5G |
Cas.: 848133-76-6 | Purity: 95% | N-(4-Chloro-3-cyano-7-ethoxy-6-quinolinyl)acetamide | ESD-909969-25G |
Cas.: 362703-48-8 | Purity: 98% | Ethyl 1-Boc-piperidine-2-carboxylate | ESD-830214-100G |
Cas.: 362703-48-8 | Purity: 98% | Ethyl 1-Boc-piperidine-2-carboxylate | ESD-830214-25G |
Cas.: 362703-48-8 | Purity: 98% | Ethyl 1-Boc-piperidine-2-carboxylate | ESD-830214-5G |
Cas.: 15028-41-8 | Purity: 97% | Methyl alpha-aminoisobutyrate hydrochloride | ESD-831977-100G |
Cas.: 15028-41-8 | Purity: 97% | Methyl alpha-aminoisobutyrate hydrochloride | ESD-831977-25G |
Cas.: 15028-41-8 | Purity: 97% | Methyl alpha-aminoisobutyrate hydrochloride | ESD-831977-5G |
Cas.: 68951-93-9 | Purity: Viscosity: 5000~15000mPa.s | Poly(dimethylsiloxane-co-diphenylsiloxane), dihydroxy terminated | ESD-909970-5G |
Cas.: 68951-93-9 | Purity: Viscosity: 5000~15000mPa.s | Poly(dimethylsiloxane-co-diphenylsiloxane), dihydroxy terminated | ESD-909970-25G |
Cas.: 68951-93-9 | Purity: Viscosity: 5000~15000mPa.s | Poly(dimethylsiloxane-co-diphenylsiloxane), dihydroxy terminated | ESD-909970-100G |
Cas.: 68951-93-9 | Purity: Viscosity: 5000~15000mPa.s | Poly(dimethylsiloxane-co-diphenylsiloxane), dihydroxy terminated | ESD-909970-500G |
Cas.: 1374639-76-5 | Purity: 95% | 3-[2-Chloro-4-(cyclopentylamino)pyrimidin-5-yl]prop-2-yn-1-ol | ESD-909971-1G |
Cas.: 1374639-76-5 | Purity: 95% | 3-[2-Chloro-4-(cyclopentylamino)pyrimidin-5-yl]prop-2-yn-1-ol | ESD-909971-5G |
Cas.: 308831-94-9 | Purity: 95% | Ethyl 2-((2,6-difluorobenzyl)(ethoxycarbonyl)amino)-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate | ESD-909972-1G |
Cas.: 308831-94-9 | Purity: 95% | Ethyl 2-((2,6-difluorobenzyl)(ethoxycarbonyl)amino)-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate | ESD-909972-5G |
Cas.: 308831-94-9 | Purity: 95% | Ethyl 2-((2,6-difluorobenzyl)(ethoxycarbonyl)amino)-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate | ESD-909972-250MG |
Cas.: 15028-41-8 | Purity: ≥99% | Methyl 2-Aminoisobutyrate Hydrochloride | ESD-909973-100G |
Cas.: 15028-41-8 | Purity: ≥99% | Methyl 2-Aminoisobutyrate Hydrochloride | ESD-909973-25G |
Cas.: 15028-41-8 | Purity: ≥99% | Methyl 2-Aminoisobutyrate Hydrochloride | ESD-909973-5G |
Cas.: 17422-74-1 | Purity: 98% | 4H-1-Benzopyran-3-carboxaldehyde | ESD-824360-25G |
Cas.: 17422-74-1 | Purity: 98% | 4H-1-Benzopyran-3-carboxaldehyde | ESD-824360-1G |
Cas.: 3360-41-6 | Purity: 97% | 4-Phenyl-1-butanol | ESD-832024-500G |
Cas.: 3360-41-6 | Purity: 97% | 4-Phenyl-1-butanol | ESD-832024-100G |
Cas.: 3360-41-6 | Purity: 97% | 4-Phenyl-1-butanol | ESD-832024-25G |
Cas.: 3360-41-6 | Purity: 97% | 4-Phenyl-1-butanol | ESD-832024-5G |
Cas.: 558-86-1 | Purity: 95% | 1-Bromo-1,1,2,2,3,3,4,4-octafluorobutane | ESD-909974-1G |
Cas.: 558-86-1 | Purity: 95% | 1-Bromo-1,1,2,2,3,3,4,4-octafluorobutane | ESD-909974-5G |
Cas.: 142-31-4 | Purity: 99% | Sodium octyl sulfate | ESD-909975-1G |
Cas.: 142-31-4 | Purity: ≥95% | Sodium octyl sulfate | ESD-909976-1G |
Cas.: 142-31-4 | Purity: 99% | Sodium octyl sulfate | ESD-909975-5G |
Cas.: 142-31-4 | Purity: ≥95% | Sodium octyl sulfate | ESD-909976-5G |
Cas.: 61-68-7 | Purity: >98% | Mefenamic acid | ESD-830928-500G |
Cas.: 61-68-7 | Purity: >98% | Mefenamic acid | ESD-830928-100G |
Cas.: 61-68-7 | Purity: >98% | Mefenamic acid | ESD-830928-25G |
Cas.: 139-33-3 | Purity: 99% | EDTA disodium salt dihydrate | ESD-909977-500G |
Cas.: 139-33-3 | Purity: 99% | EDTA disodium salt dihydrate | ESD-909977-2.5KG |
Cas.: 66171-50-4 | Purity: >97%(HPLC) | Methyl 6-Hydroxynicotinate | ESD-829693-5G |
Cas.: 66171-50-4 | Purity: >97%(HPLC) | Methyl 6-Hydroxynicotinate | ESD-829693-1G |
Cas.: 26744-04-7 | Purity: ≥98% | Poly(β-hydroxybutyrate) | ESD-909978-100G |
Cas.: 26744-04-7 | Purity: ≥98% | Poly(β-hydroxybutyrate) | ESD-909978-500G |
Cas.: 26744-04-7 | Purity: ≥98% | Poly(β-hydroxybutyrate) | ESD-909978-2.5KG |
Cas.: 13138-53-9 | Purity: 97% | 4-Nitrophthalamide | ESD-836098-25G |
Cas.: 13138-53-9 | Purity: 97% | 4-Nitrophthalamide | ESD-836098-5G |
Cas.: 13138-53-9 | Purity: 97% | 4-Nitrophthalamide | ESD-836098-1G |
Cas.: 5685-05-2 | Purity: 95% | Thiazole-2(3H)-thione | ESD-909979-1G |
Cas.: 5685-05-2 | Purity: 95% | Thiazole-2(3H)-thione | ESD-909979-5G |
Cas.: 17796-82-6 | Purity: 98% | N-(Cyclohexylthio)phthalimide | ESD-836267-100G |
Cas.: 17796-82-6 | Purity: 98% | N-(Cyclohexylthio)phthalimide | ESD-836267-25G |
Cas.: 57149-07-2 | Purity: 98% | Naftopidil | ESD-836605-5G |
Cas.: 780-25-6 | Purity: ≥95% | N-Benzylidenebenzylamine | ESD-885940-1G |
Cas.: 6908-41-4 | Purity: 98% | Methyl 4-(hydroxymethyl)benzoate | ESD-830219-100G |
Cas.: 6908-41-4 | Purity: 98% | Methyl 4-(hydroxymethyl)benzoate | ESD-830219-25G |
Cas.: 6908-41-4 | Purity: 98% | Methyl 4-(hydroxymethyl)benzoate | ESD-830219-5G |
Cas.: 202463-68-1 | Purity: 98% | 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-morpholin-4-ylpyrazole-3-carboxamide | ESD-909981-5MG |
Cas.: 202463-68-1 | Purity: 98% | 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-morpholin-4-ylpyrazole-3-carboxamide | ESD-909981-10MG |
Cas.: 26161-33-1 | Purity: 99% | Polyquaternium-37 | ESD-909980-5G |
Cas.: 26161-33-1 | Purity: 99% | Polyquaternium-37 | ESD-909980-25G |
Cas.: 26161-33-1 | Purity: 99% | Polyquaternium-37 | ESD-909980-100G |
Cas.: 80181-31-3 | Purity: ≥98% | Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) | ESD-909982-100G |
Cas.: 80181-31-3 | Purity: ≥98% | Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) | ESD-909982-500G |
Cas.: 80181-31-3 | Purity: ≥98% | Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) | ESD-909982-2.5KG |
Cas.: 308068-56-6 | Purity: >95%, ID:5-15nm, OD:>50nm, Length:0.5-2μm, -OH:~0.7wt% | Short Hydroxy Purified Multi-Walled Carbon Nanotubes | ESD-835667-25G |
Cas.: 1779124-68-3 | Purity: 95% | tert-Butyl 4-(2-nitropyridin-3-yl)piperazine-1-carboxylate | ESD-909983-50MG |
Cas.: 1779124-68-3 | Purity: 95% | tert-Butyl 4-(2-nitropyridin-3-yl)piperazine-1-carboxylate | ESD-909983-100MG |
Cas.: 7223-38-3 | Purity: >97%(GC) | 1-Dimethylamino-2-propyne | ESD-836720-5ML |
Cas.: 2206-27-1 | Purity: D.99.9% +0.03%TMS | DMSO-d6 | ESD-806937-0.6ML |
Cas.: 9010-75-7 | Purity: AR, Fluorine contains amount25% | Ethene, 1-chloro-1,2,2-trifluoro-, polymer with 1,1-difluoroethene | ESD-909984-100G |
Cas.: 9010-75-7 | Purity: AR, Fluorine contains amount25% | Ethene, 1-chloro-1,2,2-trifluoro-, polymer with 1,1-difluoroethene | ESD-909984-500G |
Cas.: 5343-52-2 | Purity: 95% | 2-Ethyl-2-methylpentanoic acid | ESD-906839-250MG |
Cas.: 113451-59-5 | Purity: 98% | (1S,4S)-(-)-2-BOC-2,5-diazabicyclo[2.2.1]heptane | ESD-831556-5G |
Cas.: 113451-59-5 | Purity: 98% | (1S,4S)-(-)-2-BOC-2,5-diazabicyclo[2.2.1]heptane | ESD-831556-1G |
Cas.: 113451-59-5 | Purity: 98% | (1S,4S)-(-)-2-BOC-2,5-diazabicyclo[2.2.1]heptane | ESD-831556-250MG |
Cas.: 68131-04-4 | Purity: AR | Humic acid, sodium salt | ESD-810851-2.5KG |
Cas.: 25928-81-8 | Purity: 98% | Polybenzimidazole | ESD-909985-1G |
Cas.: 25928-81-8 | Purity: 98% | Polybenzimidazole | ESD-909985-5G |
Cas.: 19745-07-4 | Purity: 98% | 2,5-Dichloropyrazine | ESD-834586-1G |
Cas.: 25928-81-8 | Purity: 98% | Polybenzimidazole | ESD-909985-25G |
Cas.: 19745-07-4 | Purity: 98% | 2,5-Dichloropyrazine | ESD-834586-5G |
Cas.: 25928-81-8 | Purity: 98% | Polybenzimidazole | ESD-909985-250MG |
Cas.: 52434-90-9 | Purity: 97% | Tris(2,3-dibromopropyl) isocyanurate | ESD-824137-100G |
Cas.: 52434-90-9 | Purity: 97% | Tris(2,3-dibromopropyl) isocyanurate | ESD-824137-25G |
Cas.: 142-87-0 | Purity: 98% | Sodium decyl sulfate | ESD-909986-1G |
Cas.: 91653-50-8 | Purity: 98% | glucopyranosyl-(1-3)-deltonin | ESD-909987-5MG |
Cas.: 91653-50-8 | Purity: 98% | glucopyranosyl-(1-3)-deltonin | ESD-909987-20MG |
Cas.: NONE8160 | Purity: AR | Polysebacic polyanhydride | ESD-909988-1G |
Cas.: NONE8160 | Purity: AR | Polysebacic polyanhydride | ESD-909988-5G |
Cas.: NONE8160 | Purity: AR | Polysebacic polyanhydride | ESD-909988-25G |
Cas.: NONE8160 | Purity: AR | Polysebacic polyanhydride | ESD-909988-100G |
Cas.: 23666-13-9 | Purity: 98% | VICENIN | ESD-909990-5MG |
Cas.: 23666-13-9 | Purity: 98% | VICENIN | ESD-909990-25MG |
Cas.: 870704-14-6 | Purity: 95% | 2-Fluoro-5-methylBenzenesulfonylchloride | ESD-829362-5G |
Cas.: 870704-14-6 | Purity: 95% | 2-Fluoro-5-methylBenzenesulfonylchloride | ESD-829362-1G |
Cas.: 68783-41-5 | Purity: average Mn ~570 | Dimer acid, hydrogenated | ESD-909989-100G |
Cas.: 107264-09-5 | Purity: ≥95% | 1-Fluoropyridinium Tetrafluoroborate | ESD-834209-5G |
Cas.: 107264-09-5 | Purity: ≥95% | 1-Fluoropyridinium Tetrafluoroborate | ESD-834209-1G |
Cas.: 129946-88-9 | Purity: 97% | 5-(Trifluoromethyl)dibenzothiophenium trifluoromethanesulfonate | ESD-836092-5G |
Cas.: 754919-24-9 | Purity: Analytical Standards, HPLC≥98% | N-Methylnuciferine | ESD-909991-5MG |
Cas.: 129946-88-9 | Purity: 97% | 5-(Trifluoromethyl)dibenzothiophenium trifluoromethanesulfonate | ESD-836092-1G |
Cas.: 754919-24-9 | Purity: Analytical Standards, HPLC≥98% | N-Methylnuciferine | ESD-909991-25MG |
Cas.: 7226-77-9 | Purity: ≥98% | 2′-Deoxy-5-(hydroxymethyl)cytidine | ESD-868577-10MG |
Cas.: 14028-44-5 | Purity: 98% | Amoxapine | ESD-831451-1G |
Cas.: 14028-44-5 | Purity: 98% | Amoxapine | ESD-831451-250MG |
Cas.: 9004-34-6 | Purity: 100-200 Mesh | Microcrystalline cellulose | ESD-909922-2.5KG |
Cas.: 9005-71-4 | Tween 65 | ESD-909992-100ML | |
Cas.: 9005-71-4 | Tween 65 | ESD-909992-500ML | |
Cas.: 67674-67-3 | Purity: Viscosity: 20-50 mm2/S | Carbinol (hydroxyl) terminated polydimethylsiloxane | ESD-909993-25G |
Cas.: 67674-67-3 | Purity: Viscosity: 20-50 mm2/S | Carbinol (hydroxyl) terminated polydimethylsiloxane | ESD-909993-100G |
Cas.: 67674-67-3 | Purity: Viscosity: 20-50 mm2/S | Carbinol (hydroxyl) terminated polydimethylsiloxane | ESD-909993-500G |
Cas.: 67674-67-3 | Purity: Viscosity: 20-50 mm2/S | Carbinol (hydroxyl) terminated polydimethylsiloxane | ESD-909993-2.5KG |
Cas.: 10004-44-1 | Purity: 97% | Hymexazol | ESD-889427-5G |
Cas.: 25608-12-2 | Mw~10 million | Potassium polyacrylate | ESD-909916-2.5KG |
Cas.: 5918-93-4 | Purity: 98% | 1H-Imidazol-2(3H)-one | ESD-842386-5G |
Cas.: 14855-76-6 | Purity: 90% | Methyl Green | ESD-887411-100G |
Cas.: 7411-23-6 | Purity: 98% | 3,5-Dibromo-1H-1,2,4-triazole | ESD-842391-100G |
Cas.: 106-50-3 | Purity: 99% | |p|-Phenylenediamine | ESD-816018-25G |
Cas.: 484-14-0 | Purity: Analytical Standards, HPLC≥98% | osthenol | ESD-909994-5MG |
Cas.: 484-14-0 | Purity: Analytical Standards, HPLC≥98% | osthenol | ESD-909994-10MG |
Cas.: 115810-13-4 | Purity: Analytical Standards, HPLC≥98% | Tubeimoside III | ESD-909995-5MG |
Cas.: 115810-13-4 | Purity: Analytical Standards, HPLC≥98% | Tubeimoside III | ESD-909995-10MG |
Cas.: 710-11-2 | Purity: 98% | 2-Oxo-4-phenylbutyric Acid | ESD-834784-100G |
Cas.: 107-88-0 | Purity: 99,5% | (±)-1,3-Butanediol | ESD-890333-100ML |
Cas.: 107-88-0 | Purity: 99,5% | (±)-1,3-Butanediol | ESD-890333-25ML |
Cas.: 661463-17-8 | Purity: 95% | 4-Bromo-6-fluoroquinoline | ESD909996-1G |
Cas.: 661463-17-8 | Purity: 95% | 4-Bromo-6-fluoroquinoline | ESD909996-5G |
Cas.: 547-91-1 | Purity: for spectrophotometric det. of Fe(III), ≥98.5% | Ferron | ESD-909509-5G |
Cas.: 106-71-8 | Purity: 95%, contains stabilizerMEHQ | 2-Cyanoethyl Acrylate | ESD-871428-25G |
Cas.: 187227-45-8 | Purity: ≥99% | Oseltamivir (acid) | ESD-881026-250MG |
Cas.: NONE8000 | Purity: Diameter: 75 microns | Expandable Graphite | ESD-909385-500G |
Cas.: 60032-63-5 | Purity: 95% | 4-Hydroxy-3-iodobenzaldehyde | ESD-846741-1G |
Cas.: 60032-63-5 | Purity: 95% | 4-Hydroxy-3-iodobenzaldehyde | ESD-846741-5G |
Cas.: 19244-98-5 | Purity: ≥98%(T) | Guanidine Hydrobromide | ESD-862328-5G |
Cas.: 65140-91-2 | Purity: 95% | Calcium ethyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate | ESD-906776-2.5KG |
Cas.: 138-55-6 | Purity: Analysis control, ≥98%(HPLC) | Picrocrocin | ESD-909997-20MG |
Cas.: 452-82-4 | Purity: 97% | 4-Fluoro-3-iodotoluene | ESD-810212-25G |
Cas.: 176673-72-6 | Purity: 97% | 4-Chloro-3,5-Difluorobromobenzene | ESD-828964-1G |
Cas.: 176673-72-6 | Purity: 97% | 4-Chloro-3,5-Difluorobromobenzene | ESD-828964-5G |
Cas.: 176673-72-6 | Purity: 97% | 4-Chloro-3,5-Difluorobromobenzene | ESD-828964-25G |
Cas.: 207671-50-9 | Purity: 98% | Rutin hydrate | ESD-832949-500G |
Cas.: 13826-88-5 | Purity: AR | Zinc fluoborate hydrate | ESD-820670-2.5KG |
Cas.: 480449-70-5 | Purity: ≥98% | Edoxaban | ESD-863569-25MG |
Cas.: 480449-70-5 | Purity: ≥98% | Edoxaban | ESD-863569-100MG |
Cas.: 14589-44-7 | Purity: 99.9% (REO) | Thulium(III) 2,4-pentanedionate | ESD-856921-1G |
Cas.: 207671-50-9 | Purity: Analysis control, ≥98% | Rutin hydrate | ESD-909998-20MG |
Cas.: 452-82-4 | Purity: 97% | 4-Fluoro-3-iodotoluene | ESD-810212-100G |
Cas.: 1948-40-9 | Purity: ≥98% | 3,5-Diiodo-4-Hydroxybenzaldehyde | ESD-859697-5G |
Cas.: 1948-40-9 | Purity: ≥98% | 3,5-Diiodo-4-Hydroxybenzaldehyde | ESD-859697-25G |
Cas.: 36340-61-1 | Purity: 98% | 2-Amino-4-chloro-6-picoline | ESD-839760-1G |
Cas.: 256925-03-8 | Purity: ≥98% | AL 082D06 | ESD-879979-25MG |
Cas.: 256925-03-8 | Purity: ≥98% | AL 082D06 | ESD-879979-100MG |
Cas.: 144243-24-3 | Purity: 98% | 1-Boc-3-aminopiperidine | ESD-831452-1G |
Cas.: 144243-24-3 | Purity: 98% | 1-Boc-3-aminopiperidine | ESD-831452-5G |
Cas.: 14916-80-4 | Purity: >98%(GC) | 3-Octyn-1-ol | ESD-909999-5ML |
Cas.: 2065-67-0 | Purity: 98% | Tetraphenylphosphonium iodide | ESD-834508-25G |
Cas.: 2065-67-0 | Purity: 98% | Tetraphenylphosphonium iodide | ESD-834508-5G |
Cas.: 70458-95-6 | Purity: ≥99% | Pefloxacin mesylate | ESD-836711-5G |
Cas.: 70458-95-6 | Purity: ≥99% | Pefloxacin mesylate | ESD-836711-1G |
Cas.: 69102-90-5 | Purity: Type II, hydroxyl value (mmol/g): 0.54-0.64 | Hydroxyl-terminated polybutadiene (HTPB) | ESD-909868-1L |
Cas.: 69102-90-5 | Purity: Type I, hydroxyl value (mmol/g): 0.47-0.53 | Hydroxyl-terminated polybutadiene (HTPB) | ESD-909867-1L |
Cas.: 22921-58-0 | Purity: 97% | 2-Isopropoxybenzaldehyde | ESD-910000-250MG |
Cas.: 69102-90-5 | Purity: Type III, hydroxyl value (mmol/g): 0.65-0.70 | Hydroxyl-terminated polybutadiene (HTPB) | ESD-909869-1L |
Cas.: 22921-58-0 | Purity: 97% | 2-Isopropoxybenzaldehyde | ESD-910000-1G |
Cas.: 22921-58-0 | Purity: 97% | 2-Isopropoxybenzaldehyde | ESD-910000-5G |
Cas.: 69102-90-5 | Purity: Type IV, hydroxyl value (mmol/g): 0.71-0.80 | Hydroxyl-terminated polybutadiene (HTPB) | ESD-909870-1L |
Cas.: 3355-26-8 | Purity: >99% | 1,2-dibutyryl-sn-glycero-3-phosphocholine | ESD-863739-100MG |
Cas.: 228321-87-7 | Purity: 99% | Miconazole nitrate | ESD-909106-25G |
Cas.: 114590-20-4 | Purity: Analytical Standards, HPLC≥98% | Soyasaponin Ba | ESD-910001-10MG |
Cas.: 1218790-48-7 | Purity: 98% | 1,3-Dimethyl-5-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzylidene]-pyrimidine-2,4,6-trione | ESD-886774-5G |
Cas.: 4341-76-8 | Purity: 98% | Ethyl 2-butynoate | ESD-808864-100ML |
Cas.: 79397-50-5 | Purity: 98% | H-DL-Pro-OMe.HCl | ESD-844331-25G |
Cas.: 52012-29-0 | Purity: Analytical Standards, HPLC≥98% | Isoshaftoside | ESD-910002-20MG |
Cas.: 2467-03-0 | Purity: 98% | 2,4′-Dihydroxydiphenylmethane | ESD-870875-1G |
Cas.: 283159-90-0 | Purity: ≥98% | Valifenalate | ESD-879843-100MG |
Cas.: 6628-22-4 | Purity: 97% | 3,4-Dimethyl-5-pyrazolone | ESD-910003-250MG |
Cas.: 6628-22-4 | Purity: 97% | 3,4-Dimethyl-5-pyrazolone | ESD-910003-1G |
Cas.: 7630-74-2 | Purity: Analysis control, HPLC≥98% | dehydronuciferine | ESD-910004-25MG |
Cas.: 645-41-0 | Purity: ≥95% | Triisoamylamine | ESD-867572-5ML |
Cas.: 1589-60-2 | Purity: 98% | 1-Phenylcyclohexanol | ESD-855155-1G |
Cas.: NONE7981 | Purity: ≥98%, (Sum of α- and β-) | Disodium glycerophosphate hydrate | ESD-909356-25G |
Cas.: NONE017 | Purity: 1000μg/ml, solvent: carbon tetrachloride | ESD-820907-5ML | |
Cas.: 53369-71-4 | Purity: ≥98% | N,N,2,2-Tetramethyl-1,3-Propanediamine | ESD-857979-100ML |
Cas.: 2453-03-4 | Purity: ≥98% | 1,3-Dioxan-2-One | ESD-859393-25G |
Cas.: 72846-00-5 | Purity: ≥98% | 1-Phenylmethyl-5-phenyl-barbituric acid | ESD-834617-25G |
Cas.: 72846-00-5 | Purity: ≥98% | 1-Phenylmethyl-5-phenyl-barbituric acid | ESD-834617-5G |
Cas.: 1303-86-2 | Purity: 98%, 100 Mesh | Boron oxide | ESD-874782-10KG |
Cas.: 51052-78-9 | Purity: ≥95% | 4-Piperidineacetic Acid | ESD-850374-5G |
Cas.: 51052-78-9 | Purity: ≥95% | 4-Piperidineacetic Acid | ESD-850374-1G |
Cas.: 1591-30-6 | Purity: 98% | 4,4′-Biphenyldicarbonitrile | ESD-858444-5G |
Cas.: 610-35-5 | Purity: 98% | 4-Hydroxyphthalic acid | ESD-831298-5G |
Cas.: 610-35-5 | Purity: 98% | 4-Hydroxyphthalic acid | ESD-831298-25G |
Cas.: 6921-22-8 | Purity: 98% | 2,3-Difluoronitrobenzene | ESD-844469-25G |
Cas.: 6940-49-4 | Purity: ≥96% | 3-Bromophthalide | ESD-860187-100G |
Cas.: 55216-11-0 | Purity: 98% | Heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin | ESD-811488-250MG |
Cas.: 36675-34-0 | Purity: 99% | hexaglycerol | ESD-910005-100G |
Cas.: 36675-34-0 | Purity: 99% | hexaglycerol | ESD-910005-500G |
Cas.: 71301-98-9 | Purity: 97% | Ethyl (R)-(+)-2-(4-hydroxyphenoxy)propionate | ESD-905665-5G |
Cas.: 67-48-1 | Purity: Use For Cell and insect cell culture, >98% | Choline chloride | ESD-805029-1G |
Cas.: 67-48-1 | Purity: Use For Cell and insect cell culture, >98% | Choline chloride | ESD-805029-5G |
Cas.: 24206-39-1 | Purity: 98% | 1,2,3,4-Tetrahydroquinolin-4-ol | ESD-847317-250MG |
Cas.: 2223-93-0 | Purity: ≥98% | Cadmium stearate | ESD-836330-2.5KG |
Cas.: 192863-36-8 | Purity: ≥98% | Potassium (4-Methoxyphenyl)trifluoroborate | ESD-866376-25G |
Cas.: 2737-20-4 | Purity: 98% | 4-Bromo-3-(hydroxymethyl)phenol | ESD-904743-25G |
Cas.: 81525-13-5 | Purity: Analysis control, HPLC≥98% | Forsythoside B | ESD-823657-5MG |
Cas.: 81525-13-5 | Purity: Analysis control, HPLC≥98% | Forsythoside B | ESD-823657-10MG |
Cas.: 81525-13-5 | Purity: Analysis control, HPLC≥98% | Forsythoside B | ESD-823657-50MG |
Cas.: 51719-65-4 | Purity: ≥95% | 2-(3,5-dichlorophenyl)acetic acid | ESD-826114-25G |
Cas.: 25988-63-0 | MW: 150,000-300,000 | Poly-L-Lysine | ESD-875131-500MG |
Cas.: 69363-14-0 | Purity: Analysis control, HPLC≥98% | Schisanhenol | ESD-823499-5MG |
Cas.: 211915-06-9 | Purity: 97% | Dabigatran etexilate | ESD-830597-5G |
Cas.: 69363-14-0 | Purity: Analysis control, HPLC≥98% | Schisanhenol | ESD-823499-25MG |
Cas.: 50-69-1 | Purity: Use For Cell Culture, ≥99% (HPLC) | D-Ribose | ESD-817224-5G |
Cas.: 50-69-1 | Purity: Use For Plant Cell Culture, ≥99% (HPLC) | D-Ribose | ESD-817225-25G |
Cas.: 50-69-1 | Purity: Use For Plant Cell Culture, ≥99% (HPLC) | D-Ribose | ESD-817225-5G |
Cas.: 142451-48-7 | Purity: Analysis control, HPLC≥98% | Lobetyolinin | ESD-910007-5MG |
Cas.: 22777-05-5 | Purity: 96% | 5-Methyl-[1,4]diazepane | ESD-838986-250MG |
Cas.: 126-92-1 | Purity: 50% in H2O | Sodium 2-ethylhexyl sulfate | ESD-818450-5L |
Cas.: 117278-74-7 | Purity: Analysis control, HPLC≥98% | Tangshenoside I | ESD-910008-5MG |
Cas.: 537-47-3 | Purity: ≥98.0% | 4-Phenylsemicarbazide | ESD-864109-100G |
Cas.: 443922-06-3 | Purity: 98% | 2,4,6-Tris(4-formylphenyl)-1,3,5-triazine | ESD-887347-5G |
Cas.: 1015787-98-0 | Purity: ≥99% | Gefapixant | ESD-884944-50MG |
Cas.: 38691-95-1 | Purity: Analysis control, HPLC≥98% | Tetrahydricheilanthifolinium | ESD-910009-5MG |
Cas.: 4487-56-3 | Purity: 98% | 2,4-Dichloro-5-nitropyridine | ESD-844459-5G |
Cas.: 482-35-9 | Purity: ≥90% (HPLC) | Quercetin 3-β-D-glucoside | ESD-887807-250MG |
Cas.: 5452-35-7 | Purity: >97.0%(GC) | Cycloheptylamine | ESD-864528-500MG |
Cas.: 120013-45-8 | Purity: 97% | 1-Benzyl-4-((5,6-dimethoxy-1H-inden-2-yl)methyl)piperidine | ESD-910010-50MG |
Cas.: 28728-55-4 | Purity: 95% | Hexadimethrine bromide | ESD-872068-1G |
Cas.: 13775-53-6 | Purity: AR | Sodium fluoroaluminate | ESD-817994-10KG |
Cas.: 87-99-0 | Purity: ≥99.5% | Xylitol | ESD-910011-100G |
Cas.: 87-99-0 | Purity: ≥99.5% | Xylitol | ESD-910011-500G |
Cas.: 37905-08-1 | Purity: Analysis control, 98% | Jolkinolide B | ESD-910012-10MG |
Cas.: 87-99-0 | Purity: ≥99.5% | Xylitol | ESD-910011-2.5KG |
Cas.: 9003-53-6 | Purity: diameter 1.0 – 1.9μm, 2.5% w/v | Latex beads, amine-modified polystyrene | ESD-815953-1ML |
Cas.: 26915-72-0 | Purity: Average MW ~475, contains 100 ppm MeHQ, 200 ppm BHT | Poly(ethylene glycol) methyl ether methacrylate | ESD-816114-2.5L |
Cas.: 4519-28-2 | Purity: 98% | Tetramethylphosphonium bromide | ESD-820140-25G |
Cas.: 3568-90-9 | Purity: 98% | deoxylapachol | ESD-910013-10MG |
Cas.: 1852-04-6 | Purity: 97% | Undecanedioic acid | ESD-820329-2.5KG |
Cas.: 54383-28-7 | Purity: 98% | lirinidine | ESD-910014-10MG |
Cas.: 54260-72-9 | Purity: 98% | 2,3-methylenedioxy-10,11-dimethoxy-13-methylprotoberberine chloride | ESD-910015-10MG |
Cas.: 153-97-9 | Purity: 95% | 7-chlorotryptophan | ESD-910016-1G |
Cas.: 153-97-9 | Purity: 95% | 7-chlorotryptophan | ESD-910016-250MG |
Cas.: 105-06-6 | Purity: 95%, 3000ppm Quinol as stabilizer | p-Divinylbenzene | ESD-910017-1G |
Cas.: 105-06-6 | Purity: 95%, 3000ppm Quinol as stabilizer | p-Divinylbenzene | ESD-910017-5G |
Cas.: 138169-43-4 | Purity: ≥95% | MTS Reagent, cell proliferation assay reagent | ESD-910018-250MG |
Cas.: 491-11-2 | Purity: ≥98% | 3-Chloro-4-nitrophenol | ESD-857684-5G |
Cas.: 491-11-2 | Purity: ≥98% | 3-Chloro-4-nitrophenol | ESD-857684-25G |
Cas.: 280111-50-4 | Purity: 95% | Benzyl 4-(2-(tert-butoxycarbonyl)hydrazinyl)piperidine-1-carboxylate | ESD-910019-1G |
Cas.: 280111-50-4 | Purity: 95% | Benzyl 4-(2-(tert-butoxycarbonyl)hydrazinyl)piperidine-1-carboxylate | ESD-910019-5G |
Cas.: 1765-40-8 | Purity: Use For GC derivatization, 99% | 2,3,4,5,6-Pentafluorobenzyl bromide | ESD-890223-25G |
Cas.: 849217-48-7 | Purity: 95% | 1-((4-Fluorophenyl)carbamoyl)cyclopropanecarboxylic acid | ESD-910020-100G |
Cas.: 849217-48-7 | Purity: 95% | 1-((4-Fluorophenyl)carbamoyl)cyclopropanecarboxylic acid | ESD-910020-25G |
Cas.: 849217-48-7 | Purity: 95% | 1-((4-Fluorophenyl)carbamoyl)cyclopropanecarboxylic acid | ESD-910020-5G |
Cas.: 5324-13-0 | Purity: 98% | 2,6-Dibromo-4-chlorophenol | ESD-844434-25G |
Cas.: 7642-04-8 | Purity: ≥98% | Cis-2-Octene | ESD-859216-1ML |
Cas.: 2162-31-4 | Purity: ≥95% | 2-(TETRAHYDRO-2H-PYRAN-2-YLOXY)ETHANOL | ESD-889347-1G |
Cas.: 1484327-92-5 | Purity: 95% | tert-Butyl (2-(4-methylpiperazin-1-yl)ethyl)carbamate | ESD-910021-1G |
Cas.: 1484327-92-5 | Purity: 95% | tert-Butyl (2-(4-methylpiperazin-1-yl)ethyl)carbamate | ESD-910021-250MG |
Cas.: 174072-89-0 | Purity: 95% | Ethyl 2-amino-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate | ESD-910022-1G |
Cas.: 174072-89-0 | Purity: 95% | Ethyl 2-amino-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate | ESD-910022-5G |
Cas.: 308831-93-8 | Purity: 95% | ethyl 2-((ethoxycarbonyl)amino)-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate | ESD-910023-1G |
Cas.: 308831-93-8 | Purity: 95% | ethyl 2-((ethoxycarbonyl)amino)-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate | ESD-910023-5G |
Cas.: 1214345-17-1 | Purity: 95% | 6-Bromo-2-fluoronicotinic acid | ESD-910024-1G |
Cas.: 1214345-17-1 | Purity: 95% | 6-Bromo-2-fluoronicotinic acid | ESD-910024-5G |
Cas.: 77423-13-3 | Purity: 97% | 2,4-Dioxo-2,4-dihydro-1H-benzo[d][1,3]oxazine-6-carboxylic acid | ESD-910025-100MG |
Cas.: 77423-13-3 | Purity: 97% | 2,4-Dioxo-2,4-dihydro-1H-benzo[d][1,3]oxazine-6-carboxylic acid | ESD-910025-250MG |
Cas.: 77423-13-3 | Purity: 97% | 2,4-Dioxo-2,4-dihydro-1H-benzo[d][1,3]oxazine-6-carboxylic acid | ESD-910025-1G |
Cas.: 76-03-9 | Purity: 10%(W/V) | TCA Solution | ESD-885182-1L |
Cas.: 35139-28-7 | Purity: Fecontains amount: 21% | Polymer Ferric Sulphate | ESD-910006-500G |
Cas.: 35139-28-7 | Purity: Fecontains amount: 21% | Polymer Ferric Sulphate | ESD-910006-2.5KG |
Cas.: 1737-93-5 | Purity: 99% | 2,4,6-Trifluoro-3,5-dichloropyridine | ESD-828880-100G |
Cas.: 166412-78-8 | Purity: 98% | Bis(7-methyloctyl)cyclohexane-1,2-dicarboxylate | ESD-824363-500G |
Cas.: 898746-50-4 | Purity: 97% | 5-Iodo-1H-pyrrolo[2,3-b]pyridine | ESD-910026-250MG |
Cas.: 898746-50-4 | Purity: 97% | 5-Iodo-1H-pyrrolo[2,3-b]pyridine | ESD-910026-1G |
Cas.: 898746-50-4 | Purity: 97% | 5-Iodo-1H-pyrrolo[2,3-b]pyridine | ESD-910026-5G |
Cas.: 90317-77-4 | MW 1000 | Perfluoropolyether Alcohol | ESD-910027-100G |
Cas.: 90317-77-4 | MW 1000 | Perfluoropolyether Alcohol | ESD-910027-25G |
Cas.: 90317-77-4 | MW 5000 | Perfluoropolyether Alcohol | ESD-910028-25G |
Cas.: 90317-77-4 | MW 5000 | Perfluoropolyether Alcohol | ESD-910028-100G |
Cas.: 18719-24-9 | Purity: 97% | Oct-7-enoic acid | ESD-899734-250MG |
Cas.: 40134-18-7 | Purity: 99% | METHYL 2-CHLORONICOTINATE | ESD-910029-100G |
Cas.: 40134-18-7 | Purity: 99% | METHYL 2-CHLORONICOTINATE | ESD-910029-25G |
Cas.: 65208-35-7 | Mw~ 500 | HFPO Oligomer acid fluorides | ESD-910030-5G |
Cas.: 65208-35-7 | Mw~ 500 | HFPO Oligomer acid fluorides | ESD-910030-25G |
Cas.: 65208-35-7 | Mw~ 1000 | HFPO Oligomer acid fluorides | ESD-910031-5G |
Cas.: 65208-35-7 | Mw~ 1000 | HFPO Oligomer acid fluorides | ESD-910031-25G |
Cas.: 65208-35-7 | Mw~ 5000 | HFPO Oligomer acid fluorides | ESD-910032-5G |
Cas.: 65208-35-7 | Mw~ 5000 | HFPO Oligomer acid fluorides | ESD-910032-25G |
Cas.: 68141-45-7 | Purity: 97% | NADP monopotassium salt | ESD-899834-50MG |
Cas.: 39827-11-7 | Purity: >98.0%(T) | Benzo[b]thiophene-2-carbonyl Chloride | ESD-854805-250MG |
Cas.: 741683-19-2 | Purity: 95% | 3-Chloro-2-fluoroisonicotinic acid | ESD-910033-250MG |
Cas.: 104673-29-2 | Purity: Degree of substitution≥80% | Hydroxypropyl chitosan | ESD-910034-25G |
Cas.: 104673-29-2 | Purity: Degree of substitution≥80% | Hydroxypropyl chitosan | ESD-910034-100G |
Cas.: 104673-29-2 | Purity: Degree of substitution≥80% | Hydroxypropyl chitosan | ESD-910034-500G |
Cas.: 104673-29-2 | Purity: Degree of substitution≥80% | Hydroxypropyl chitosan | ESD-910034-2.5KG |
Cas.: 638-95-9 | Purity: 98% | α-amyrin | ESD-910035-5MG |
Cas.: 953039-15-1 | Purity: 97% | 2-Chloro-7-methoxyquinazoline | ESD-910036-1G |
Cas.: 953039-15-1 | Purity: 97% | 2-Chloro-7-methoxyquinazoline | ESD-910036-250MG |
Cas.: 73263-62-4 | Purity: 98% | 5-O-Caffeoylshikimic acid | ESD-910043-5MG |
Cas.: 915942-22-2 | Purity: 98% | Neratinib Maleate | ESD-910044-1G |
Cas.: 915942-22-2 | Purity: 98% | Neratinib Maleate | ESD-910044-5G |
Cas.: 65710-07-8 | Purity: >500U/mg | Apramycin sulfate salt | ESD-824553-100G |
Cas.: 16139-18-7 | Purity: 95% | Hydrazinecarboximidamide hydrochloride | ESD-905588-500G |
Cas.: 9004-61-9 | MW: 80-1.5 million | Hyaluronic acid | ESD-909939-500G |
Cas.: 7786-30-3 | Purity: 99.99% metals basis, powder | Magnesium chloride | ESD-813767-500G |
Cas.: 27374-25-0 | Purity: 97% | (1-ethoxycyclopropoxy)trimethylsilane | ESD-825775-100G |
Cas.: 1350518-27-2 | Purity: 95% | 2,3,6,7,10,11-hexaaminotriphenylene | ESD-886243-250MG |
Cas.: 9002-10-2 | Purity: ≥500 units/mg dry weight | TYROSINASE | ESD-828257-100KU |
Cas.: 88901-36-4 | Purity: 98% | Mogroside V | ESD-812926-50MG |
Cas.: 64248-59-5 | Purity: 97% | 2,3-Difluorobenzotrifluoride | ESD-808127-25G |
Cas.: 64248-59-5 | Purity: 97% | 2,3-Difluorobenzotrifluoride | ESD-808127-100G |
Cas.: 1737-93-5 | Purity: 99% | 2,4,6-Trifluoro-3,5-dichloropyridine | ESD-828880-500G |
Cas.: 5689-83-8 | Purity: ≥98% | 4-Methyl-1,3,2-dioxathiolane 2,2-Dioxide | ESD-867547-25G |
Cas.: 5689-83-8 | Purity: ≥98% | 4-Methyl-1,3,2-dioxathiolane 2,2-Dioxide | ESD-867547-100G |
Cas.: 9007-20-9 | Carbomer | ESD-889417-2.5KG | |
Cas.: 69812-29-9 | Purity: 95% | 2-Acetamido-4-methylthiazole-5-sulfonyl chloride | ESD-848897-1G |
Cas.: 395-33-5 | Purity: 98% | 4-Fluoromandelic Acid | ESD-851908-25G |
Cas.: 395-33-5 | Purity: 98% | 4-Fluoromandelic Acid | ESD-851908-100G |
Cas.: 395-33-5 | Purity: 98% | 4-Fluoromandelic Acid | ESD-851908-500G |
Cas.: 4792-29-4 | Purity: 98% | 5-Carboxyphthalide | ESD-910045-250MG |
Cas.: 4792-29-4 | Purity: 98% | 5-Carboxyphthalide | ESD-910045-1G |
Cas.: 4792-29-4 | Purity: 98% | 5-Carboxyphthalide | ESD-910045-5G |
Cas.: 9082-00-2 | Purity: Mn: ~1500 | Glycerol propoxylate-block-ethoxylate | ESD-910037-100G |
Cas.: 9082-00-2 | Purity: Mn: ~1500 | Glycerol propoxylate-block-ethoxylate | ESD-910037-500G |
Cas.: 9082-00-2 | Purity: Mn: ~3000 | Glycerol propoxylate-block-ethoxylate | ESD-910038-100G |
Cas.: 9082-00-2 | Purity: Mn: ~3000 | Glycerol propoxylate-block-ethoxylate | ESD-910038-500G |
Cas.: 9082-00-2 | Purity: Mn: ~4000 | Glycerol propoxylate-block-ethoxylate | ESD-910039-100G |
Cas.: 127-79-7 | Purity: 98% | Sulfamerazine | ESD-818186-5G |
Cas.: 9082-00-2 | Purity: Mn: ~4000 | Glycerol propoxylate-block-ethoxylate | ESD-910039-500G |
Cas.: 9082-00-2 | Purity: Mn: ~4800 | Glycerol propoxylate-block-ethoxylate | ESD-910040-100G |
Cas.: 9082-00-2 | Purity: Mn: ~4800 | Glycerol propoxylate-block-ethoxylate | ESD-910040-500G |
Cas.: 9082-00-2 | Purity: Mn: ~5300 | Glycerol propoxylate-block-ethoxylate | ESD-910041-100G |
Cas.: 6751-75-3 | Purity: 98% | 2-Bromoresorcinol | ESD-836685-1G |
Cas.: 9082-00-2 | Purity: Mn: ~5300 | Glycerol propoxylate-block-ethoxylate | ESD-910041-500G |
Cas.: 6751-75-3 | Purity: 98% | 2-Bromoresorcinol | ESD-836685-5G |
Cas.: 6751-75-3 | Purity: 98% | 2-Bromoresorcinol | ESD-836685-25G |
Cas.: 6751-75-3 | Purity: 98% | 2-Bromoresorcinol | ESD-836685-100G |
Cas.: 9004-66-4 | Purity: 20%water solution | Iron–Dextran | ESD-875589-2.5KG |
Cas.: 40133-06-0 | Purity: 97% | 5,6-dihydro-4H-cyclopenta[b]thiophene-2-carboxylic acid | ESD-910046-5G |
Cas.: 40133-06-0 | Purity: 97% | 5,6-dihydro-4H-cyclopenta[b]thiophene-2-carboxylic acid | ESD-910046-1G |
Cas.: 40133-06-0 | Purity: 97% | 5,6-dihydro-4H-cyclopenta[b]thiophene-2-carboxylic acid | ESD-910046-250MG |
Cas.: 9005-71-4 | Tween 65 | ESD-909992-2.5L | |
Cas.: 40133-06-0 | Purity: 97% | 5,6-dihydro-4H-cyclopenta[b]thiophene-2-carboxylic acid | ESD-910046-50MG |
Cas.: 9005-71-4 | Tween 65 | ESD-909992-10L | |
Cas.: 643-12-9 | Purity: 95% | D-chiro Inositol | ESD-910047-1G |
Cas.: 643-12-9 | Purity: 95% | D-chiro Inositol | ESD-910047-5G |
Cas.: 643-12-9 | Purity: 95% | D-chiro Inositol | ESD-910047-25G |
Cas.: 10555-76-7 | Purity: AR | Sodium metaborate tetrahydrate | ESD-818022-10KG |
Cas.: 105955-11-1 | Purity: ≥98%, BR | N-Oleoyl Dopamine (OLDA) | ESD-873353-5MG |
Cas.: 117946-91-5 | Purity: ≥98%(HPLC) | Luzindole | ESD-862592-5MG |
Cas.: 2166387-65-9 | Purity: ≥99% | BI-3802 | ESD-880409-50MG |
Cas.: 130-37-0 | Purity: 95% | Menadione sodium bisulfite | ESD-813308-5G |
Cas.: 15454-54-3 | Purity: 99% | 5-Aminotetrazole monohydrate | ESD-858449-2.5KG |
Cas.: 9012-76-4 | Purity: Deacetylation degree 50% | Chitosan | ESD-909960-100G |
Cas.: 9012-76-4 | Purity: Deacetylation degree 50% | Chitosan | ESD-909960-25G |
Cas.: 100587-94-8 | Purity: AR, 99% | Lanthanum(III) nitrate hydrate | ESD-822530-2.5KG |
Cas.: 100587-94-8 | Purity: AR, 99% | Lanthanum(III) nitrate hydrate | ESD-822530-10KG |
Cas.: 68441-17-8 | Purity: average Mv ~7100, 000, powder | Polyethylene oxide | ESD-888666-2.5KG |
Cas.: 599-04-2 | Purity: 99% | D-(-)-Pantolactone | ESD-817030-2.5KG |
Cas.: 80-26-2 | Purity: ≥97% | Terpinyl Acetate | ESD-858062-2.5KG |
Cas.: 8006-87-9 | Purity: 90% | Sandalwood oil | ESD-905723-500ML |
Cas.: 12027-67-7 | Purity: AR | Ammonium paramolybdate hydrate | ESD-854573-500G |
Cas.: 474510-57-1 | Purity: ≥95% | 1,1′-(Methylene-di-4,1-phenylene)bis[2-hydroxy-2-methyl-1-propanone] | ESD-902424-100G |
Cas.: 480-19-3 | Purity: 90% | Isorhamnetin | ESD-811871-50MG |
Cas.: 480-19-3 | Purity: 90% | Isorhamnetin | ESD-811871-250MG |
Cas.: 7664-38-2 | Purity: ≥85 wt. % in H2O, ≥99.99% metals basis | Phosphoric acid | ESD-816343-10L |
Cas.: 100299-08-9 | Purity: ≥99% | Pemirolast potassium | ESD-833015-250MG |
Cas.: 100299-08-9 | Purity: ≥99% | Pemirolast potassium | ESD-833015-1G |
Cas.: NONE8161 | Aluminum ferric chloride, basic | ESD-910048-100G | |
Cas.: NONE8161 | Aluminum ferric chloride, basic | ESD-910048-500G | |
Cas.: NONE8161 | Aluminum ferric chloride, basic | ESD-910048-2.5KG | |
Cas.: 544-16-1 | Purity: 90% | 1-Butyl nitrite | ESD-868665-1L |
Cas.: 502-69-2 | Purity: 97% | Phytone | ESD-878785-5MG |
Cas.: 13190-97-1 | Purity: 95% | Solanesol from tobacco | ESD-817760-1G |
Cas.: NONE6840 | Purity: 10%, Use For Pathology Experiments | Acetate Buffer | ESD-902455-250ML |
Cas.: 7756-94-7 | Purity: 90% | Triisobutylene | ESD-819438-25ML |
Cas.: 12013-10-4 | Purity: 99.5% (excluding Ni on metals basis), Ni <0.2% | Cobalt(IV) sulfide | ESD-849376-25G |
Cas.: 12013-10-4 | Purity: 99.5% (excluding Ni on metals basis), Ni <0.2% | Cobalt(IV) sulfide | ESD-849376-100G |
Cas.: 94-75-7 | Purity: 100ug/mL, U=2%Matrix: methanol | 2,4-D solution | ESD-806768-1.2ML |
Cas.: 16265-11-5 | Purity: ≥97% | 4-Bromo-2-methylimidazole | ESD-910049-1G |
Cas.: 16265-11-5 | Purity: ≥97% | 4-Bromo-2-methylimidazole | ESD-910049-5G |
Cas.: 2944-66-3 | Purity: 99% | Ferric oxalate | ESD-886093-2.5KG |
Cas.: 461-84-7 | Purity: ≥98.0% | 4-(Trifluoromethylthio)phenol | ESD-820266-500G |
Cas.: 2445-80-9 | Purity: 98% | 7,8-dimethoxychromen-2-one | ESD-910051-20MG |
Cas.: 39806-89-8 | Purity: 98% | 4-Ethynyl-1-methyl-1H-pyrazole | ESD-910052-1G |
Cas.: 39806-89-8 | Purity: 98% | 4-Ethynyl-1-methyl-1H-pyrazole | ESD-910052-250MG |
Cas.: 761440-64-6 | Purity: 97% | 1-(3-Methoxy-4-nitrophenyl)piperidin-4-one | ESD-910053-1G |
Cas.: 761440-64-6 | Purity: 97% | 1-(3-Methoxy-4-nitrophenyl)piperidin-4-one | ESD-910053-5G |
Cas.: 7647-15-6 | Purity: AR, 99% | Sodium bromide | ESD-818076-10KG |
Cas.: 615-20-3 | Purity: 95% | 2-Chlorobenzothiazole | ESD-831538-100G |
Cas.: 9031-11-2 | Purity: biotech grade | β-Galactosidase (Lactase) | ESD-6346-5KU |
Cas.: 861343-73-9 | Purity: 99% | 2-(Isopropylthio)aniline hydrochloride | ESD-910054-1G |
Cas.: 861343-73-9 | Purity: 99% | 2-(Isopropylthio)aniline hydrochloride | ESD-910054-250MG |
Cas.: 32492-74-3 | Purity: 96% | Myricanone | ESD-879590-1MG |
Cas.: 96556-05-7 | Purity: 98% | 1,4,7-Trimethyl-1,4,7-triazacyclononane | ESD-823756-5G |
Cas.: 1632485-14-3 | Purity: 98% | 2,5-Dichloro-N-(2-(isopropylthio)phenyl)pyrimidin-4-amine | ESD-910055-1G |
Cas.: 1632485-14-3 | Purity: 98% | 2,5-Dichloro-N-(2-(isopropylthio)phenyl)pyrimidin-4-amine | ESD-910055-250MG |
Cas.: 96556-05-7 | Purity: 98% | 1,4,7-Trimethyl-1,4,7-triazacyclononane | ESD-823756-1G |
Cas.: 2831-75-6 | Purity: 98% | Daurinoline | ESD-910056-5MG |
Cas.: 13755-38-9 | Purity: AR, 99.0% | Sodium nitroferricyanide(III) dihydrate | ESD-817932-2.5KG |
Cas.: 2947-61-7 | Purity: 98% | 4-Methylbenzyl cyanide | ESD-822877-500G |
Cas.: 33641-15-5 | Purity: 97% | 1-Methyl-1H-pyrazol-5-ol | ESD-910057-25G |
Cas.: 33641-15-5 | Purity: 97% | 1-Methyl-1H-pyrazol-5-ol | ESD-910057-5G |
Cas.: 33641-15-5 | Purity: 97% | 1-Methyl-1H-pyrazol-5-ol | ESD-910057-1G |
Cas.: 10147-37-2 | Purity: 97% | ISOPROPYLSULFONYL CHLORIDE | ESD-831431-100G |
Cas.: 308242-62-8 | Purity: 98% | Remimazolam | ESD-910058-5MG |
Cas.: 10147-37-2 | Purity: 97% | ISOPROPYLSULFONYL CHLORIDE | ESD-831431-25G |
Cas.: 10147-37-2 | Purity: 97% | ISOPROPYLSULFONYL CHLORIDE | ESD-831431-5G |
Cas.: 10147-37-2 | Purity: 97% | ISOPROPYLSULFONYL CHLORIDE | ESD-831431-1G |
Cas.: 1202-25-1 | Purity: 98% | Methyl 4-(Dimethylamino)Benzoate | ESD-849504-25G |
Cas.: 1852-17-1 | Purity: 98% | Propyleneurea | ESD-831201-100G |
Cas.: 1303-86-2 | Purity: 98%, 10-20 Mesh | Boron oxide | ESD-910050-10KG |
Cas.: 1303-86-2 | Purity: 98%, 10-20 Mesh | Boron oxide | ESD-910050-2.5KG |
Cas.: 1303-86-2 | Purity: 98%, 10-20 Mesh | Boron oxide | ESD-910050-500G |
Cas.: 10192-85-5 | Purity: 98% | PotassiumAcrylate | ESD-833966-25G |
Cas.: 10192-85-5 | Purity: 98% | PotassiumAcrylate | ESD-833966-100G |
Cas.: 7220-79-3 | Purity: Use For Biological Stain | Methylene blue | ESD-834457-2.5KG |
Cas.: 89140-85-2 | Purity: 97% | trans-5-Amino-6,7,8,9-tetrahydro-5H-benzo[7]annulen-6-ol | ESD-910059-1G |
Cas.: 1589503-98-9 | Purity: 95% | 6-methoxypyridazin-3-amine hydrochloride | ESD-910060-1G |
Cas.: 1589503-98-9 | Purity: 95% | 6-methoxypyridazin-3-amine hydrochloride | ESD-910060-5G |
Cas.: 16086-14-9 | Purity: 90% | Dichloroacetaldehyde Hydrate | ESD-868794-250MG |
Cas.: 881674-06-2 | Purity: 99% | Ethyl 5-(2-fluorophenyl)-1H-pyrrole-3-carboxylate | ESD-910061-1G |
Cas.: 881674-06-2 | Purity: 99% | Ethyl 5-(2-fluorophenyl)-1H-pyrrole-3-carboxylate | ESD-910061-5G |
Cas.: 9002-83-9 | Polychlorotrifluoroethylene (PTFCE) | ESD-909914-25G | |
Cas.: 9002-83-9 | Polychlorotrifluoroethylene (PTFCE) | ESD-909914-100G | |
Cas.: 135026-17-4 | Purity: 95% | Ethyl 2-amino-4-(trifluoromethyl)oxazole-5-carboxylate | ESD-910062-1G |
Cas.: 135026-17-4 | Purity: 95% | Ethyl 2-amino-4-(trifluoromethyl)oxazole-5-carboxylate | ESD-910062-5G |
Cas.: 135026-17-4 | Purity: 95% | Ethyl 2-amino-4-(trifluoromethyl)oxazole-5-carboxylate | ESD-910062-250MG |
Cas.: 37764-25-3 | Purity: 97% | Dichlormid | ESD-807169-100G |
Cas.: 221128-49-0 | Purity: 95% | 4-(Piperidin-1-yl)but-2-enoic acid hydrochloride | ESD-910063-1G |
Cas.: 221128-49-0 | Purity: 95% | 4-(Piperidin-1-yl)but-2-enoic acid hydrochloride | ESD-910063-5G |
Cas.: 150517-77-4 | Purity: ≥97% | 3-Fluoro-5-(Trifluoromethyl)Benzylamine | ESD-859604-5G |
Cas.: 1584-03-8 | Purity: 98% | Perfluoro-2-methyl-2-pentene | ESD-888088-100G |
Cas.: 868540-17-4 | Purity: 99% | Carfilzomib | ESD-858149-500MG |
Cas.: 598-19-6 | Purity: ≥97% | 2-Bromoallyl Alcohol | ESD-860089-5G |
Cas.: 598-19-6 | Purity: ≥97% | 2-Bromoallyl Alcohol | ESD-860089-25G |
Cas.: 347186-01-0 | Purity: 95% | tert-Butyl (3-aminocyclohexyl)carbamate | ESD-910064-1G |
Cas.: 133-04-0 | Purity: ≥98%(HPLC) | Asarinin | ESD-861226-5MG |
Cas.: 78-67-1 | Purity: 99%, recrystallization | 2,2′-Azobis(2-methylpropionitrile) | ESD-800355-2.5KG |
Cas.: 49669-26-3 | Purity: 97% | 2,2′-BIPYRIDINE-6,6′-DICARBALDEHYDE | ESD-888133-100MG |
Cas.: 583-06-2 | Purity: 97% | 3-BENZOYLACRYLIC ACID | ESD-859316-25G |
Cas.: 583-06-2 | Purity: 99% | 3-BENZOYLACRYLIC ACID | ESD-910065-5G |
Cas.: 583-06-2 | Purity: 99% | 3-BENZOYLACRYLIC ACID | ESD-910065-25G |
Cas.: 13304-62-6 | Purity: 99% | N-Benzylacrylamide | ESD-859539-25G |
Cas.: 13304-62-6 | Purity: 99% | N-Benzylacrylamide | ESD-859539-100G |
Cas.: 221682-41-3 | Purity: 95% | Jasmonic Acid (mixture of isomers) | ESD-910069-250MG |
Cas.: 221682-41-3 | Purity: 95% | Jasmonic Acid (mixture of isomers) | ESD-910069-1G |
Cas.: NONE8162 | Purity: SiO2/Al2O3 (mole ratio) ≈ 30 | SSZ-13 molecular sieve | ESD-910066-500G |
Cas.: NONE8162 | Purity: SiO2/Al2O3 (mole ratio) ≈ 30 | SSZ-13 molecular sieve | ESD-910066-100G |
Cas.: NONE8162 | Purity: SiO2/Al2O3 (mole ratio) ≈ 30 | SSZ-13 molecular sieve | ESD-910066-25G |
Cas.: NONE8162 | Purity: SiO2/Al2O3 (mole ratio) ≈ 20 | SSZ-13 molecular sieve | ESD-910067-500G |
Cas.: NONE8162 | Purity: SiO2/Al2O3 (mole ratio) ≈ 20 | SSZ-13 molecular sieve | ESD-910067-100G |
Cas.: NONE8162 | Purity: SiO2/Al2O3 (mole ratio) ≈ 20 | SSZ-13 molecular sieve | ESD-910067-25G |
Cas.: NONE8162 | Purity: SiO2/Al2O3 (mole ratio) ≈ 15 | SSZ-13 molecular sieve | ESD-910068-500G |
Cas.: NONE8162 | Purity: SiO2/Al2O3 (mole ratio) ≈ 15 | SSZ-13 molecular sieve | ESD-910068-100G |
Cas.: NONE8162 | Purity: SiO2/Al2O3 (mole ratio) ≈ 15 | SSZ-13 molecular sieve | ESD-910068-25G |
Cas.: 12232-99-4 | Purity: AR, 85.0% | Sodium bismuth dihydrate | ESD-818146-2.5KG |
Cas.: 3599-32-4 | Purity: 75% | Indocyanine Green | ESD-811817-5G |
Cas.: 3026-69-5 | Purity: >97.0%(T) | Dimethyldioctylammonium Bromide | ESD-864691-25G |
Cas.: 25014-41-9 | Purity: average Mw 250,000 | Polyacrylonitrile | ESD-823211-1KG |
Cas.: 10318-18-0 | Purity: 99%biotech grade | DL-Cysteine hydrochloride | ESD-6014-100G |
Cas.: 4733-39-5 | Purity: 98% | Bathocuproine | ESD-802393-25G |
Cas.: 2489-86-3 | Purity: 99% | 3-(1-Naphthyl)-1-propene | ESD-824306-5G |
Cas.: 2489-86-3 | Purity: 99% | 3-(1-Naphthyl)-1-propene | ESD-824306-25G |
Cas.: 31645-34-8 | Purity: 98% | 9-Anthracenylmethyl acrylate | ESD-879621-1G |
Cas.: 31645-34-8 | Purity: 98% | 9-Anthracenylmethyl acrylate | ESD-879621-5G |
Cas.: 31645-34-8 | Purity: 98% | 9-Anthracenylmethyl acrylate | ESD-879621-250MG |
Cas.: NONE8163 | Purity: SSA≥550 m2/g, pore volume≥0.27 cm3/g | SAPO-34 molecular sieve | ESD-910070-100G |
Cas.: NONE8163 | Purity: SSA≥550 m2/g, pore volume≥0.27 cm3/g | SAPO-34 molecular sieve | ESD-910070-25G |
Cas.: NONE6729 | pellets | Polyphenylsulfone | ESD-875331-500MG |
Cas.: NONE6729 | pellets | Polyphenylsulfone | ESD-875331-500G |
Cas.: 27314-97-2 | Purity: ≥98% | Tirapazamine | ESD-868503-1G |
Cas.: 109-86-4 | Purity: >99.5%(GC) | 2-Methoxyethanol | ESD-812955-2.5L |
Cas.: 129-00-0 | Purity: 97% | Pyrene | ESD-817273-2.5KG |
Cas.: 39515-51-0 | Purity: 98% | 3-Phenoxy-benzaldehyde | ESD-831335-25G |
Cas.: 39515-51-0 | Purity: 98% | 3-Phenoxy-benzaldehyde | ESD-831335-100G |
Cas.: 39515-51-0 | Purity: 98% | 3-Phenoxy-benzaldehyde | ESD-831335-500G |
Cas.: 52691-24-4 | Purity: 95% | Dichloro(1,2-diaminocyclohexane)platinum(II) | ESD-874895-100MG |
Cas.: 925705-73-3 | Purity: ≥97% | TG100713 | ESD-863671-5MG |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 90-110 | USY molecular sieve | ESD-910073-500G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 90-110 | USY molecular sieve | ESD-910073-100G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 90-110 | USY molecular sieve | ESD-910073-25G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 30-50 | USY molecular sieve | ESD-910072-500G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 30-50 | USY molecular sieve | ESD-910072-100G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 30-50 | USY molecular sieve | ESD-910072-25G |
Cas.: 566-48-3 | Purity: 99% | 4-Androsten-4-ol-3,17-dione | ESD-800766-25G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 13-17 | USY molecular sieve | ESD-910071-500G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 13-17 | USY molecular sieve | ESD-910071-100G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 13-17 | USY molecular sieve | ESD-910071-25G |
Cas.: 24871-34-9 | Purity: 99% | Oleth-10 | ESD-910074-100G |
Cas.: 24871-34-9 | Purity: 99% | Oleth-10 | ESD-910074-500G |
Cas.: 24871-34-9 | Purity: 99% | Oleth-10 | ESD-910074-2.5KG |
Cas.: 2040-10-0 | Purity: 98% | 4′-tert-Butyl-2′,6′-dimethylacetophenone | ESD-909750-250MG |
Cas.: 252364-22-0 | Purity: 98%, viscosity: 800~1200 mPa.s | Polyvinyl Acetal Resin | ESD-910075-100G |
Cas.: 252364-22-0 | Purity: 98%, viscosity: 800~1200 mPa.s | Polyvinyl Acetal Resin | ESD-910075-500G |
Cas.: 252364-22-0 | Purity: 98%, viscosity: 800~1200 mPa.s | Polyvinyl Acetal Resin | ESD-910075-2.5KG |
Cas.: 252364-22-0 | Purity: 98%, viscosity: 800~1200 mPa.s | Polyvinyl Acetal Resin | ESD-910075-10KG |
Cas.: 117358-52-8 | Purity: 99% | 1-Ethyl-3,5-difluorobenzene | ESD-858806-25G |
Cas.: 117358-52-8 | Purity: 99% | 1-Ethyl-3,5-difluorobenzene | ESD-858806-100G |
Cas.: 8047-15-2 | Purity: ≥60%, from green tea | Saponin | ESD-875796-2.5KG |
Cas.: 9002-85-1 | Polyvinylidene chloride (PVDC) | ESD-909295-25G | |
Cas.: 9002-85-1 | Polyvinylidene chloride (PVDC) | ESD-909295-100G | |
Cas.: 9002-85-1 | Polyvinylidene chloride (PVDC) | ESD-909295-500G | |
Cas.: 302962-49-8 | Purity: 98% | Dasatinib | ESD-828603-25G |
Cas.: 61791-63-7 | Purity: Total Amides: 375-450 mg/g | N-Coco-alkyltrimethylenediamines | ESD-889745-25G |
Cas.: 61791-63-7 | Purity: Total Amides: 375-450 mg/g | N-Coco-alkyltrimethylenediamines | ESD-889745-1KG |
Cas.: 103140-12-1 | Purity: 97% | 3,5-Dichlorophenoxyacetonitrile | ESD-910076-250MG |
Cas.: 1035270-39-3 | Purity: ≥99% | AZD4547 | ESD-833036-250MG |
Cas.: 12768-92-2 | Purity: 97% | Fluorescent Brightener 113 | ESD-909012-20G |
Cas.: 673-49-4 | Purity: ≥98% | N-Acetylhistamine | ESD-877878-10MG |
Cas.: 673-49-4 | Purity: ≥98% | N-Acetylhistamine | ESD-877878-250MG |
Cas.: 56-81-5 | Purity: ≥99.5%(GC) | Glycerol | ESD-810578-20L |
Cas.: 540-84-1 | Purity: Environmental grade | Isooctane | ESD-875694-4L |
Cas.: 110-82-7 | Purity: Environmental grade | Cyclohexane | ESD-875693-4L |
Cas.: 939055-18-2 | Purity: ≥99% | FIPI | ESD-876284-50MG |
Cas.: 75-09-2 | Purity: Environmental grade | Dichloromethane | ESD-875696-4L |
Cas.: 18600-42-5 | Purity: 97% | 4-Nitrobenzylamine Hydrochloride | ESD-838355-25G |
Cas.: 1314-13-2 | Purity: 99.9%, Total metallic impuriyies≤1000 PPM | Zinc oxide | ESD-823825-500G |
Cas.: 9004-32-4 | Purity: Viscosity: 3000-5000mpa.s , USP grade (original standard: 800-1200) | Carboxymethyl cellulose | ESD-804627-10KG |
Cas.: 1305-78-8 | Purity: AR, 98% | Calcium oxide | ESD-804125-5KG |
Cas.: 22884-31-7 | Purity: 97% | Pentamethylenebis(triphenylphosphonium bromide) | ESD-910077-5G |
Cas.: 22884-31-7 | Purity: 97% | Pentamethylenebis(triphenylphosphonium bromide) | ESD-910077-25G |
Cas.: 68468-30-4 | Purity: 97% | 2,3-Dimethoxypyrazine | ESD-910078-1G |
Cas.: 26226-72-2 | Purity: 97% | Ethyl 4-(2-chloroacetamido)benzoate | ESD-910079-1G |
Cas.: 26226-72-2 | Purity: 97% | Ethyl 4-(2-chloroacetamido)benzoate | ESD-910079-5G |
Cas.: 26226-72-2 | Purity: 97% | Ethyl 4-(2-chloroacetamido)benzoate | ESD-910079-25G |
Cas.: 1121-55-7 | Purity: 97%, contains TBCstabilizer | 3-vinylpyridine | ESD-825345-5G |
Cas.: 21635-88-1 | Purity: 98% | 3-Oxetanamine | ESD-844012-5G |
Cas.: 3955-57-5 | Purity: 97% | N,N’-Bis(salicylidene)-1,4-butanediamine | ESD-814546-5G |
Cas.: 3955-57-5 | Purity: 97% | N,N’-Bis(salicylidene)-1,4-butanediamine | ESD-814546-1G |
Cas.: NONE7003 | Purity: 0.5M, pH7.6 | Phosphate Buffer (PB Buffer) | ESD-885769-500ML |
Cas.: 12672-70-7 | Purity: 99,99% | Indium trichloride | ESD-910080-100G |
Cas.: 12672-70-7 | Purity: 99,99% | Indium trichloride | ESD-910080-25G |
Cas.: 14779-78-3 | Purity: 95% | Pentyl 4-(dimethylamino)benzoate | ESD-910081-1G |
Cas.: 73404-00-9 | Purity: 95% | 1-(4-(2-(Diethylamino)ethoxy)phenyl)-1,2-diphenylethanol | ESD-910082-1G |
Cas.: 73404-00-9 | Purity: 95% | 1-(4-(2-(Diethylamino)ethoxy)phenyl)-1,2-diphenylethanol | ESD-910082-5G |
Cas.: 60676-86-0 | Purity: Particle size :200nm, 2.5% w/v | Monodispersed silica micropheres | ESD-822745-25ML |
Cas.: 73404-00-9 | Purity: 95% | 1-(4-(2-(Diethylamino)ethoxy)phenyl)-1,2-diphenylethanol | ESD-910082-25G |
Cas.: 14644-61-2 | Purity: 98% | Zirconiumsulfate | ESD-888976-25G |
Cas.: 14644-61-2 | Purity: 98% | Zirconiumsulfate | ESD-888976-100G |
Cas.: 3815-31-4 | Purity: 95% | 4-(4-Bromophenyl)but-3-en-2-one | ESD-910083-1G |
Cas.: 869-10-3 | Purity: 98% | Diethyl 2,5-dibromohexanedioate | ESD-834478-5G |
Cas.: 869-10-3 | Purity: 98% | Diethyl 2,5-dibromohexanedioate | ESD-834478-25G |
Cas.: 869-10-3 | Purity: 98% | Diethyl 2,5-dibromohexanedioate | ESD-834478-100G |
Cas.: 21319-53-9 | Purity: 97% | 1-Benzylpiperidine-2-carboxylic acid | ESD-848902-5G |
Cas.: 40061-54-9 | Purity: 97% | Ethyl 2-(2-chlorophenyl)acetate | ESD-839992-25G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 20-30 | USY molecular sieve | ESD-910085-500G |
Cas.: 17078-27-2 | Purity: 99% | 4,4′-Bis(dimethylamino)benzil | ESD-858436-5G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 20-30 | USY molecular sieve | ESD-910085-100G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 20-30 | USY molecular sieve | ESD-910085-25G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 50-70 | USY molecular sieve | ESD-910086-500G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 50-70 | USY molecular sieve | ESD-910086-100G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 50-70 | USY molecular sieve | ESD-910086-25G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 70-90 | USY molecular sieve | ESD-910087-500G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 70-90 | USY molecular sieve | ESD-910087-100G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 70-90 | USY molecular sieve | ESD-910087-25G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 115-125 | USY molecular sieve | ESD-910088-500G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 115-125 | USY molecular sieve | ESD-910088-100G |
Cas.: NONE8164 | Purity: SiO2/Al2O3 (mole ratio) ≈ 115-125 | USY molecular sieve | ESD-910088-25G |
Cas.: 148-72-1 | Purity: 98% | Pilocarpine nitrate | ESD-882200-500MG |
Cas.: 58-39-9 | Purity: 99% | Perphenazine | ESD-831496-100G |
Cas.: 9000-90-2 | Purity: 50U/mg | α-Amylase | ESD-834633-5G |
Cas.: 40134-18-7 | Purity: 99% | METHYL 2-CHLORONICOTINATE | ESD-910029-500G |
Cas.: 30069-65-9 | Purity: 98% | 3-phenylnaphthalen-1-ol | ESD-909444-25G |
Cas.: 103-56-0 | Purity: 97% | Cinnamyl propionate | ESD-805687-500G |
Cas.: 112-62-9 | Purity: ≥99.8%(GC) | Methyl oleate | ESD-875677-25G |
Cas.: 6621-59-6 | Purity: 97% | 6-Bromohexanenitrile | ESD-910089-5G |
Cas.: 6621-59-6 | Purity: 97% | 6-Bromohexanenitrile | ESD-910089-1G |
Cas.: 23356-96-9 | Purity: 97% | L-Prolinol | ESD-815795-500G |
Cas.: 3454-28-2 | Purity: ≥98% | Furfuryl methacrylate | ESD-910090-5ML |
Cas.: 951-55-3 | Purity: ≥98%(T)(HPLC) | 5-Methyl-DL-tryptophan | ESD-861846-500MG |
Cas.: 3454-28-2 | Purity: ≥98% | Furfuryl methacrylate | ESD-910090-25ML |
Cas.: 80-73-9 | Purity: Use For GC-HS, ≥99.5%(GC) | 1,3-Dimethyl-2-imidazolidinone | ESD-821850-2.5L |
Cas.: 16323-43-6 | Purity: 98% | 1,4-Benzenediacrylic acid | ESD-854630-5G |
Cas.: 16323-43-6 | Purity: 98% | 1,4-Benzenediacrylic acid | ESD-854630-25G |
Cas.: 12036-21-4 | Purity: 99.99%, 1μm | VANADIUM(IV) OXIDE | ESD-910091-50G |
Cas.: 12036-21-4 | Purity: 99.99%, 1μm | VANADIUM(IV) OXIDE | ESD-910091-10G |
Cas.: 12036-21-4 | Purity: 99.99%, 1μm | VANADIUM(IV) OXIDE | ESD-910091-5G |
Cas.: 2210-93-7 | Purity: ≥98% | 1-Phenylpiperazine hydrochloride | ESD-863594-5G |
Cas.: 126956-48-7 | Purity: 99.9985% (metals basis) | Nickel(II) oxalate hydrate | ESD-849382-5G |
Cas.: 330680-46-1 | Purity: 96% | Trimethyl 2,2′:6′,2”-Terpyridine-4,4′,4”-tricarboxylate | ESD-823716-1G |
Cas.: 10476-85-4 | Purity: GR | Strontium chloride | ESD-823439-2.5KG |
Cas.: 933-88-0 | Purity: 98% | |o|-Toluoyl chloride | ESD-819211-10KG |
Cas.: 9000-11-7 | Purity: CM-52 | CM-Cellulose | ESD-889438-500G |
Cas.: 85333-43-3 | Purity: ≥95% | 8-chloro-2-methylimidazo[1,2-a]pyrazine | ESD-826511-250MG |
Cas.: 332-42-3 | Purity: 97% | 4-Fluorophenethyl bromide | ESD-810137-100G |
Cas.: 21921-76-6 | Purity: 98% | 4-Bromofuran-2-carbaldehyde | ESD-839467-5G |
Cas.: 931-19-1 | Purity: 98% | 2-Picoline-N-oxide | ESD-830880-100G |
Cas.: 931-19-1 | Purity: 98% | 2-Picoline-N-oxide | ESD-830880-5G |
Cas.: 8015-97-2 | natural | clove leaf oil | ESD-860266-500G |
Cas.: 8015-97-2 | natural | clove leaf oil | ESD-860266-2.5KG |
Cas.: 53902-12-8 | Purity: 98% | TRANILAST | ESD-838260-1G |
Cas.: 53902-12-8 | Purity: 98% | TRANILAST | ESD-838260-5G |
Cas.: 55876-91-0 | Purity: 98% | methyl 5-formylpicolinate | ESD-826131-1G |
Cas.: 55876-91-0 | Purity: 98% | methyl 5-formylpicolinate | ESD-826131-5G |
Cas.: 173089-82-2 | Purity: 97% | Methyl 6-Isoquinolinecarboxylate | ESD-851237-5G |
Cas.: 76836-02-7 | Purity: BC | PIPES disodium salt | ESD-816459-500G |
Cas.: 1029144-47-5 | Purity: 98% | methyl thieno[3,2-d]pyrimidine-4-carboxylate | ESD-910092-1G |
Cas.: 1029144-47-5 | Purity: 98% | methyl thieno[3,2-d]pyrimidine-4-carboxylate | ESD-910092-500MG |
Cas.: 108392-02-5 | Purity: >99% | 1,2-dioleoyl-sn-glycero-3-phosphate (sodium salt) | ESD-864428-100MG |
Cas.: 252025-50-6 | Purity: 98% | methyl 1-(2,4-dichlorobenzyl)-1H-indazole-3-carboxylate | ESD-910093-1G |
Cas.: 108392-02-5 | Purity: >99% | 1,2-dioleoyl-sn-glycero-3-phosphate (sodium salt) | ESD-864428-500MG |
Cas.: 252025-50-6 | Purity: 98% | methyl 1-(2,4-dichlorobenzyl)-1H-indazole-3-carboxylate | ESD-910093-5G |
Cas.: 79583-98-5 | Purity: 98% | 5-Azidovaleric Acid | ESD-869717-200MG |
Cas.: NONE8165 | Purity: 99% | methyl 2-(2,4-dichlorobenzyl)-2H-indazole-3-carboxylate | ESD-910094-1G |
Cas.: NONE8165 | Purity: 99% | methyl 2-(2,4-dichlorobenzyl)-2H-indazole-3-carboxylate | ESD-910094-5G |
Cas.: 2050-09-1 | Purity: ≥98% | Isopentyl Valerate | ESD-859389-5G |
Cas.: 9046-28-0 | Purity: BR | GLYCEROL-3-PHOSPHATE OXIDASE | ESD-832370-100U |
Cas.: 9046-28-0 | Purity: BR | GLYCEROL-3-PHOSPHATE OXIDASE | ESD-832370-2.5KU |
Cas.: 33402-75-4 | Purity: 98% | Methyl 4-methylnicotinate | ESD-839319-5G |
Cas.: 19282-44-1 | Purity: 97% | Ethyl 5,6-dihydro-4H-cyclopenta[b]thiophene-2-carboxylate | ESD-910095-250MG |
Cas.: 19282-44-1 | Purity: 97% | Ethyl 5,6-dihydro-4H-cyclopenta[b]thiophene-2-carboxylate | ESD-910095-1G |
Cas.: 19282-44-1 | Purity: 97% | Ethyl 5,6-dihydro-4H-cyclopenta[b]thiophene-2-carboxylate | ESD-910095-5G |
Cas.: 3222-50-2 | Purity: 98% | 4-methylnicotinic acid | ESD-827631-5G |
Cas.: 3222-50-2 | Purity: 98% | 4-methylnicotinic acid | ESD-827631-1G |
Cas.: 4664-27-1 | Purity: 98% | (4-methylpyridin-3-yl)methanol | ESD-910096-1G |
Cas.: 4664-27-1 | Purity: 98% | (4-methylpyridin-3-yl)methanol | ESD-910096-500MG |
Cas.: 84-79-7 | Purity: 98% | Lapachol | ESD-864030-1G |
Cas.: NONE8056 | Purity: industry grade | Dispersing agent 155 | ESD-909507-10KG |
Cas.: 521286-72-6 | Purity: 96% | methyl 4-(1-cyano-2-ethoxy-2-oxoethyl)-3-nitrobenzoate | ESD-910097-1G |
Cas.: 521286-72-6 | Purity: 96% | methyl 4-(1-cyano-2-ethoxy-2-oxoethyl)-3-nitrobenzoate | ESD-910097-5G |
Cas.: 1208-03-3 | Purity: 98% | 4-(bis(2-chloroethyl)amino)benzaldehyde | ESD-910098-1G |
Cas.: 1208-03-3 | Purity: 98% | 4-(bis(2-chloroethyl)amino)benzaldehyde | ESD-910098-5G |
Cas.: 2307-00-8 | Purity: ≥98% | 4-Amino-N-methylphthalimide | ESD-865209-25G |
Cas.: 97-65-4 | Purity: AR, >99.0%(T) | Itaconic acid | ESD-811766-20KG |
Cas.: 214398-99-9 | Purity: 97% | (S)-1-(2-Chloroacetyl)pyrrolidine-2-carboxaMide | ESD-910099-250MG |
Cas.: 214398-99-9 | Purity: 97% | (S)-1-(2-Chloroacetyl)pyrrolidine-2-carboxaMide | ESD-910099-1G |
Cas.: 688-71-1 | Purity: 99% | Tripropyl borate | ESD-818747-2.5L |
Cas.: 2736-37-0 | Purity: ≥98%(GC) | Isobutyryl Bromide | ESD-863142-1G |
Cas.: 767-60-2 | Purity: 97% | 3-Methyl-1H-indene | ESD-895800-5G |
Cas.: 2687-91-4 | Purity: 99% | 1-Ethyl-2-pyrrolidinone | ESD-808660-10KG |
Cas.: 9003-39-8 | Purity: Average MW 58000, K30 | Polyvinylpyrrolidone | ESD-823394-10KG |
Cas.: 9001-42-7 | Purity: 50U/mg | A-GLUCOSIDASE SACCHAROMYCES CEREVISIAE, RECOMBINANT | ESD-875219-500U |
Cas.: 12060-58-1 | Purity: 99.9% metals basis | Samarium oxide | ESD-817831-10KG |
Cas.: 1309-42-8 | Purity: AR, 95% | Magnesium hydroxide | ESD-813100-20KG |
Cas.: 89616-40-0 | Purity: epoxy value: 0.43 | Benzyl Glycidyl Ether | ESD-860345-25G |
Cas.: 89616-40-0 | Purity: epoxy value: 0.43 | Benzyl Glycidyl Ether | ESD-860345-100G |
Cas.: 594-27-4 | Purity: 96% | Tetramethyltin | ESD-858240-1G |
Cas.: 63449-39-8 | Purity: CP-52 | Chlorinated paraffin | ESD-875536-10L |
Cas.: 68030-18-2 | Purity: ≥99% | Berberine chloride hydrate | ESD-877835-1G |
Cas.: 116-38-1 | Purity: 98% | Edrophonium chloride | ESD-845143-1G |
Cas.: 116-38-1 | Purity: 98% | Edrophonium chloride | ESD-845143-5G |
Cas.: 107582-20-7 | Purity: 98% | Methyl 2,3-diaminobenzoate | ESD-845485-5G |
Cas.: 9001-05-2 | Purity: 3500 units/mg | Catalase | ESD-804188-25G |
Cas.: 2309-49-1 | Purity: 97% | 1,3,7,9-Tetramethyl-1H-purine-2,6,8(3H,7H,9H)-trione | ESD-894289-25G |
Cas.: 2309-49-1 | Purity: 97% | 1,3,7,9-Tetramethyl-1H-purine-2,6,8(3H,7H,9H)-trione | ESD-894289-100G |
Cas.: 1313900-20-7 | Purity: 98% | 2,7-Dibromo-9-(4-bromophenyl)-9H-carbazole | ESD-870093-1G |
Cas.: 574-09-4 | Purity: 97% | Benzoin ethyl ether | ESD-802222-2.5KG |
Cas.: 51-93-4 | Purity: 98% | Ethyltrimethylammonium Iodide | ESD-870321-1G |
Cas.: 6258-63-5 | Purity: >95% | 2-Thiophenemethanethiol | ESD-834848-25G |
Cas.: 769966-04-3 | Purity: 95% | 7-Fluoroindoline | ESD-910100-1G |
Cas.: 769966-04-3 | Purity: 95% | 7-Fluoroindoline | ESD-910100-250MG |
Cas.: 151224-99-6 | Purity: 95% | 5,6,7,8-Tetrahydroquinolin-3-amine | ESD-910102-100MG |
Cas.: 151224-99-6 | Purity: 95% | 5,6,7,8-Tetrahydroquinolin-3-amine | ESD-910102-250MG |
Cas.: 94022-97-6 | Purity: 95% | 1-[[2-(trifluoromethyl)phenyl]methyl]piperazine | ESD-910103-1G |
Cas.: 94022-97-6 | Purity: 95% | 1-[[2-(trifluoromethyl)phenyl]methyl]piperazine | ESD-910103-250MG |
Cas.: 619-81-8 | Purity: ≥90.0%(GC) | cis-1,4-Cyclohexanedicarboxylic Acid | ESD-863986-25G |
Cas.: 76474-56-1 | Purity: 98% | DihydrocurcuMin | ESD-910105-5MG |
Cas.: 1341-49-7 | Purity: AR, 98.5% | Ammonium bifluoride | ESD-801045-10KG |
Cas.: 1120-64-5 | Purity: 95% | 2-Methyl-2-oxazoline | ESD-835991-25G |
Cas.: 1120-64-5 | Purity: 95% | 2-Methyl-2-oxazoline | ESD-835991-5G |
Cas.: 4737-50-2 | Purity: 98% | n-Pentylboronic acid | ESD-839239-5G |
Cas.: 32289-58-0 | Purity: 98% | Poly (hexamethylene biguanide) hydrochloride | ESD-910104-500G |
Cas.: 4737-50-2 | Purity: 98% | n-Pentylboronic acid | ESD-839239-25G |
Cas.: 32289-58-0 | Purity: 98% | Poly (hexamethylene biguanide) hydrochloride | ESD-910104-100G |
Cas.: 32289-58-0 | Purity: 98% | Poly (hexamethylene biguanide) hydrochloride | ESD-910104-25G |
Cas.: 1150560-59-0 | Purity: 98% | 5-(2-fluoro-3-methoxy-phenyl)-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione | ESD-910106-1G |
Cas.: 1150560-59-0 | Purity: 98% | 5-(2-fluoro-3-methoxy-phenyl)-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione | ESD-910106-5G |
Cas.: 1214332-31-6 | Purity: 95% | 2-Bromo-6-fluoronicotinic acid | ESD-910107-250MG |
Cas.: 1214332-31-6 | Purity: 95% | 2-Bromo-6-fluoronicotinic acid | ESD-910107-100MG |
Cas.: 1214332-31-6 | Purity: 95% | 2-Bromo-6-fluoronicotinic acid | ESD-910107-1G |
Cas.: 1195-66-0 | Purity: 97% | 2-Methoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-829574-100G |
Cas.: 1195-66-0 | Purity: 97% | 2-Methoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-829574-25G |
Cas.: 1195-66-0 | Purity: 97% | 2-Methoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-829574-5G |
Cas.: 60164-51-4 | Mw~ 1500 | Perfluoropolyether oil | ESD-910108-25G |
Cas.: 60164-51-4 | Mw~ 1500 | Perfluoropolyether oil | ESD-910108-100G |
Cas.: 60164-51-4 | Mw~ 1500 | Perfluoropolyether oil | ESD-910108-500G |
Cas.: 60164-51-4 | Mw~ 3000 | Perfluoropolyether oil | ESD-910109-25G |
Cas.: 60164-51-4 | Mw~ 3000 | Perfluoropolyether oil | ESD-910109-100G |
Cas.: 60164-51-4 | Mw~ 3000 | Perfluoropolyether oil | ESD-910109-500G |
Cas.: 60164-51-4 | Mw~ 4500 | Perfluoropolyether oil | ESD-910110-25G |
Cas.: 1012341-54-6 | Purity: 98% | (2S,4R)-5-([1,1′-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid | ESD-910112-250MG |
Cas.: 60164-51-4 | Mw~ 4500 | Perfluoropolyether oil | ESD-910110-100G |
Cas.: 60164-51-4 | Mw~ 4500 | Perfluoropolyether oil | ESD-910110-500G |
Cas.: 1012341-54-6 | Purity: 98% | (2S,4R)-5-([1,1′-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid | ESD-910112-100MG |
Cas.: 60164-51-4 | Mw~ 6000 | Perfluoropolyether oil | ESD-910111-25G |
Cas.: 60164-51-4 | Mw~ 6000 | Perfluoropolyether oil | ESD-910111-100G |
Cas.: 60164-51-4 | Mw~ 6000 | Perfluoropolyether oil | ESD-910111-500G |
Cas.: 13273-53-5 | Purity: 98% | 1H-1,2,3-TRIAZOLE, 4-BROMO-1-METHYL- | ESD-834561-1G |
Cas.: 13273-53-5 | Purity: 98% | 1H-1,2,3-TRIAZOLE, 4-BROMO-1-METHYL- | ESD-834561-250MG |
Cas.: 3816-66-8 | Purity: 97% | 3-Hydroxy-4-methylbenzonitrile | ESD-829220-5G |
Cas.: 3816-66-8 | Purity: 97% | 3-Hydroxy-4-methylbenzonitrile | ESD-829220-1G |
Cas.: 34420-17-2 | Purity: 98% | Phenethylboronic acid | ESD-816891-5G |
Cas.: 58966-93-1 | Purity: 98% | 1,4,7-TRIAZACYCLONONANE TRIHYDROCHLORIDE | ESD-830777-1G |
Cas.: 58966-93-1 | Purity: 98% | 1,4,7-TRIAZACYCLONONANE TRIHYDROCHLORIDE | ESD-830777-5G |
Cas.: 34420-17-2 | Purity: 98% | Phenethylboronic acid | ESD-816891-25G |
Cas.: 61478-26-0 | Purity: 98% | BOC-HYP-OL | ESD-832001-5G |
Cas.: 61478-26-0 | Purity: 98% | BOC-HYP-OL | ESD-832001-1G |
Cas.: 479-92-5 | Purity: ≥98%(GC) | 4-Isopropylantipyrine | ESD-862583-5G |
Cas.: 34454-99-4 | Purity: 98% | N-(2-Hydroxyethyl)perfluorobutanesulfonamide | ESD-910113-1G |
Cas.: 34454-99-4 | Purity: 98% | N-(2-Hydroxyethyl)perfluorobutanesulfonamide | ESD-910113-5G |
Cas.: 34454-99-4 | Purity: 98% | N-(2-Hydroxyethyl)perfluorobutanesulfonamide | ESD-910113-25G |
Cas.: 1589503-95-6 | Purity: 98% | 2-((2,6-Difluorobenzyl)(ethoxycarbonyl)amino)-4-((dimethylamino)methyl)-5-(4-nitrophenyl)thiophene-3-carboxylic acid | ESD-910114-1G |
Cas.: 1589503-95-6 | Purity: 98% | 2-((2,6-Difluorobenzyl)(ethoxycarbonyl)amino)-4-((dimethylamino)methyl)-5-(4-nitrophenyl)thiophene-3-carboxylic acid | ESD-910114-5G |
Cas.: 625-08-1 | Purity: >96%(GC) | β-Hydroxyisovaleric Acid | ESD-910115-500G |
Cas.: 625-08-1 | Purity: >96%(GC) | β-Hydroxyisovaleric Acid | ESD-910115-100G |
Cas.: 625-08-1 | Purity: >96%(GC) | β-Hydroxyisovaleric Acid | ESD-910115-25G |
Cas.: 625-08-1 | Purity: >96%(GC) | β-Hydroxyisovaleric Acid | ESD-910115-5G |
Cas.: 1985607-70-2 | Purity: 99% | (R)-7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4] triazine-6,8-dione | ESD-910116-1G |
Cas.: 1985607-70-2 | Purity: 99% | (R)-7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4] triazine-6,8-dione | ESD-910116-250MG |
Cas.: 30334-69-1 | Purity: 98% | Perfluorobutylsulphonamide | ESD-910117-5G |
Cas.: 30334-69-1 | Purity: 98% | Perfluorobutylsulphonamide | ESD-910117-25G |
Cas.: 30334-69-1 | Purity: 98% | Perfluorobutylsulphonamide | ESD-910117-100G |
Cas.: 1344-28-1 | Purity: ≥92%, 80-150 Mesh, Acidic | Aluminum oxide | ESD-874961-10KG |
Cas.: 1660114-31-7 | Purity: 98% | NIK SMI1 | ESD-910118-5MG |
Cas.: 2349386-89-4 | Purity: 98% | EIDD-2801 | ESD-910119-5MG |
Cas.: 2349386-89-4 | Purity: 98% | EIDD-2801 | ESD-910119-10MG |
Cas.: 104219-63-8 | Purity: 20-60 mesh | Amberlite XAD16 | ESD-886003-2.5KG |
Cas.: 81971-39-3 | Purity: 97% | 5-bromo-1-methyl-1,2-dihydropyridin-2-one | ESD-832057-5G |
Cas.: 81971-39-3 | Purity: 97% | 5-bromo-1-methyl-1,2-dihydropyridin-2-one | ESD-832057-1G |
Cas.: 81971-39-3 | Purity: 97% | 5-bromo-1-methyl-1,2-dihydropyridin-2-one | ESD-832057-250MG |
Cas.: 81971-39-3 | Purity: 97% | 5-bromo-1-methyl-1,2-dihydropyridin-2-one | ESD-832057-25G |
Cas.: 7552-07-0 | Purity: 97% | 1,2,4-Thiadiazol-5-amine | ESD-830566-5G |
Cas.: 7552-07-0 | Purity: 97% | 1,2,4-Thiadiazol-5-amine | ESD-830566-1G |
Cas.: 7473-45-2 | Purity: 95% | Methyl β-D-Ribofuranoside | ESD-830474-1G |
Cas.: 81608-30-2 | Purity: ≥97% (HPLC) | Neuromedin C | ESD-815003-5MG |
Cas.: 81608-30-2 | Purity: ≥97% (HPLC) | Neuromedin C | ESD-815003-25MG |
Cas.: 883715-22-8 | Purity: 98% | (9Z,12Z)-N-(3-methoxybenzyl)octadeca-9,12-dienamide | ESD-910122-10MG |
Cas.: 115063-39-3 | Purity: 98% | Desmethylxanthohumol | ESD-910124-5MG |
Cas.: 31175-20-9 | Purity: 5 wt. % in mixture of lower aliphatic alcohols and water, contains 45% water | Nafion perfluorinated resin solution | ESD-871881-100ML |
Cas.: 91419-52-2 | Purity: 99% | N-Boc-piperidine-4-carbonitrile | ESD-823363-100G |
Cas.: 5531-98-6 | Purity: 98% | Atherosperminine | ESD-910125-5MG |
Cas.: 98-54-4 | Purity: 99,9% | p-tert-Butylphenol | ESD-910123-500G |
Cas.: 98-54-4 | Purity: 99,9% | p-tert-Butylphenol | ESD-910123-2.5KG |
Cas.: 98-54-4 | Purity: 99,9% | p-tert-Butylphenol | ESD-910123-10KG |
Cas.: 7287-82-3 | Purity: ≥97% | 1-(2-Methylphenyl)ethanol | ESD-852555-5G |
Cas.: 1217445-49-2 | Purity: 95% | (1R)-4-methoxy-2,3-dihydro-1H-inden-1-amine,hydrochloride | ESD-910126-1G |
Cas.: 6746-81-2 | Purity: 99% | 2-Oxiranemethanol, 2-(4-methylbenzenesulfonate) | ESD-904468-100G |
Cas.: 6017-21-6 | Purity: 96% | Benzeneazomalononitrile | ESD-831891-100G |
Cas.: 9025-70-1 | Purity: 98% | β-Glucanase | ESD-888658-2.5KG |
Cas.: 6017-21-6 | Purity: 96% | Benzeneazomalononitrile | ESD-831891-25G |
Cas.: 6017-21-6 | Purity: 96% | Benzeneazomalononitrile | ESD-831891-5G |
Cas.: 623143-38-4 | Purity: 95% | (R)-1-(2-Methoxyphenyl)propan-1-amine hydrochloride | ESD-910127-250MG |
Cas.: 623143-38-4 | Purity: 95% | (R)-1-(2-Methoxyphenyl)propan-1-amine hydrochloride | ESD-910127-100MG |
Cas.: 36675-34-0 | Purity: 99% | hexaglycerol | ESD-910005-2.5KG |
Cas.: 9004-61-9 | MW: 200,000-400,000 | Hyaluronic acid | ESD-909937-500G |
Cas.: 4803-57-0 | Purity: 95% | 5,6-dimethoxy-2-(pyridin-4-ylmethyl)-2,3-dihydroinden-1-one | ESD-910128-250MG |
Cas.: 4803-57-0 | Purity: 95% | 5,6-dimethoxy-2-(pyridin-4-ylmethyl)-2,3-dihydroinden-1-one | ESD-910128-50MG |
Cas.: 9004-61-9 | MW: 400,000-800,000 | Hyaluronic acid | ESD-909938-500G |
Cas.: 1807-14-3 | Purity: 95% | 11-Deoxy Prednisolone | ESD-910129-5MG |
Cas.: 74-96-4 | Purity: 99% | Bromoethane | ESD-802253-10KG |
Cas.: 98-54-4 | Purity: 99,9% | p-tert-Butylphenol | ESD-910123-100G |
Cas.: 150374-97-3 | Purity: 95% | benzyl 2-[(2-aminobenzoyl)amino]acetate | ESD-910130-1G |
Cas.: 150374-97-3 | Purity: 95% | benzyl 2-[(2-aminobenzoyl)amino]acetate | ESD-910130-5G |
Cas.: 37026-88-3 | Purity: ≥98% | Tributylmethylammonium Bromide | ESD-859906-5G |
Cas.: 37026-88-3 | Purity: ≥98% | Tributylmethylammonium Bromide | ESD-859906-100G |
Cas.: 2175-91-9 | Purity: 95% | 6,6-Dimethylfulvene | ESD-868884-1G |
Cas.: 2175-91-9 | Purity: 95% | 6,6-Dimethylfulvene | ESD-868884-5G |
Cas.: 5511-18-2 | Purity: 97% | 1-Adamantanecarboxamide | ESD-836590-25G |
Cas.: 5511-18-2 | Purity: 97% | 1-Adamantanecarboxamide | ESD-836590-5G |
Cas.: 5511-18-2 | Purity: 97% | 1-Adamantanecarboxamide | ESD-836590-1G |
Cas.: 4795-29-3 | Purity: 97% | Tetrahydrofurfurylamine | ESD-819547-5ML |
Cas.: 853-67-8 | Purity: ≥97% | Anthraquinone-2,7-disulfonic Acid Disodium Salt | ESD-862933-1G |
Cas.: 853-67-8 | Purity: ≥97% | Anthraquinone-2,7-disulfonic Acid Disodium Salt | ESD-862933-25G |
Cas.: 54788-38-4 | Purity: 98% | 3-Chloro-4-methylanisole | ESD-829231-25G |
Cas.: 132961-05-8 | Purity: 95% | 3-[2-[4-[(Z)-C-(2,4-difluorophenyl)-N-hydroxycarbonimidoyl]piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[ 1,2-a]pyrimidin-4-one | ESD-910131-5MG |
Cas.: 54788-38-4 | Purity: 98% | 3-Chloro-4-methylanisole | ESD-829231-5G |
Cas.: 54788-38-4 | Purity: 98% | 3-Chloro-4-methylanisole | ESD-829231-1G |
Cas.: 873-95-0 | Purity: >98.0%(GC) | 3-Amino-5,5-dimethyl-2-cyclohexen-1-one | ESD-864621-1G |
Cas.: 13692-14-3 | Purity: 98% | 2-Chloro-1-(2,4-dichlorophenyl)ethanol | ESD-910132-1G |
Cas.: 532-03-6 | Purity: 98% | Methocarbamol | ESD-831162-25G |
Cas.: 446065-12-9 | Purity: 98% | Potassium Hexyltrifluoroborate | ESD-886955-25G |
Cas.: 532-03-6 | Purity: 98% | Methocarbamol | ESD-831162-5G |
Cas.: 13692-14-3 | Purity: 98% | 2-Chloro-1-(2,4-dichlorophenyl)ethanol | ESD-910132-250MG |
Cas.: 37443-42-8 | Purity: 97% | Methyl 2-tetrahydrofuroate | ESD-831976-100G |
Cas.: 771581-15-8 | Purity: 95% | (3-Chloropyrazin-2-yl)methanamine | ESD-910133-1G |
Cas.: 37443-42-8 | Purity: 97% | Methyl 2-tetrahydrofuroate | ESD-831976-25G |
Cas.: 771581-15-8 | Purity: 95% | (3-Chloropyrazin-2-yl)methanamine | ESD-910133-5G |
Cas.: 37443-42-8 | Purity: 97% | Methyl 2-tetrahydrofuroate | ESD-831976-5G |
Cas.: 40133-07-1 | Purity: 98% | 4,5,6,7-Tetrahydrobenzo[b]thiophene-2-carboxylic acid | ESD-845938-5G |
Cas.: 35613-84-4 | Purity: 95% | Isobutyramidoxime | ESD-836473-5G |
Cas.: 35613-84-4 | Purity: 95% | Isobutyramidoxime | ESD-836473-1G |
Cas.: 97845-60-8 | Purity: 95% | 2-(2-(2-Amino-6-chloro-9H-purin-9-yl)ethyl)propane-1,3-diyl diacetate | ESD-910134-5G |
Cas.: 97845-60-8 | Purity: 95% | 2-(2-(2-Amino-6-chloro-9H-purin-9-yl)ethyl)propane-1,3-diyl diacetate | ESD-910134-25G |
Cas.: 276862-85-2 | Purity: 97% | 1H-Pyrrolo[3,2-b]pyridine-3-carboxaldehyde (9CI) | ESD-829696-1G |
Cas.: 276862-85-2 | Purity: 97% | 1H-Pyrrolo[3,2-b]pyridine-3-carboxaldehyde (9CI) | ESD-829696-250MG |
Cas.: 767282-94-0 | Purity: 95% | (3S)-3-amino-3-naphthalen-2-ylpropanoic acid | ESD-910135-1G |
Cas.: 1144107-80-1 | Purity: 95% | CY5.5-COOH | ESD-854974-25MG |
Cas.: 8001-25-0 | Purity: AR | olive oil | ESD-815211-10L |
Cas.: 111-87-5 | Purity: 99,5% | n-Octanol | ESD-815146-10L |
Cas.: 129497-78-5 | Purity: 97% | Verteporfin | ESD-873899-50MG |
Cas.: 13395-36-3 | Purity: ≥98%(GC) | 5,5-Dimethyl-2,4-dioxohexanoic Acid Ethyl Ester | ESD-862144-5G |
Cas.: 13395-36-3 | Purity: ≥98%(GC) | 5,5-Dimethyl-2,4-dioxohexanoic Acid Ethyl Ester | ESD-862144-25G |
Cas.: NONE8166 | 732 resin | ESD-910136-1KG | |
Cas.: 3061-90-3 | Purity: 98% | Ala-Phe | ESD-801597-1G |
Cas.: NONE8166 | 732 resin | ESD-910136-5KG | |
Cas.: 1207-72-3 | Purity: 98% | 10-Methyl-10H-phenothiazine | ESD-844316-5G |
Cas.: 1207-72-3 | Purity: 98% | 10-Methyl-10H-phenothiazine | ESD-844316-25G |
Cas.: 16518-62-0 | Purity: 97% | 3-Bromo-N,N-dimethylaniline | ESD-858441-25G |
Cas.: 1344-43-0 | Purity: 99% | Manganese monoxide | ESD-813169-10KG |
Cas.: 16518-62-0 | Purity: 97% | 3-Bromo-N,N-dimethylaniline | ESD-858441-1G |
Cas.: 25155-30-0 | Purity: AR, 90.0% | Sodium dodecylbenzenesulfonate | ESD-817806-25KG |
Cas.: 32811-40-8 | Purity: 98% | Coniferyl alcohol | ESD-879571-25MG |
Cas.: 68-94-0 | Purity: 99%biotech grade | Hypoxanthin (6-Hydroxypurine) | ESD-6264-100G |
Cas.: 27081-10-3 | Purity: ≥98% | Tropylium Tetrafluoroborate | ESD-866040-5G |
Cas.: 603-48-5 | Purity: 98% | Leucocrystal Violet | ESD-812457-500G |
Cas.: 37206-42-1 | Purity: ≥97.5% | Catocene | ESD-888879-250G |
Cas.: NONE6996 | Purity: 4X, pH8 | PBS-EDTA Solution | ESD-910139-100ML |
Cas.: NONE6996 | Purity: 4X, pH8 | PBS-EDTA Solution | ESD-910139-500ML |
Cas.: 361393-93-3 | Purity: ≥98% | 3-Chloro-4-(Trifluoromethyl)Benzyl Amine | ESD-859892-250MG |
Cas.: 74-79-3 | Purity: 99%biotech grade | L-Arginine | ESD-6287-20KG |
Cas.: 119301-59-6 | Purity: 98% | Phenol, 4,4′,4”,4”’-(1,2-ethenediylidene)tetrakis- | ESD-828247-5G |
Cas.: 119301-59-6 | Purity: 98% | Phenol, 4,4′,4”,4”’-(1,2-ethenediylidene)tetrakis- | ESD-828247-1G |
Cas.: 119301-59-6 | Purity: 98% | Phenol, 4,4′,4”,4”’-(1,2-ethenediylidene)tetrakis- | ESD-828247-250MG |
Cas.: 5108-96-3 | Purity: 99% | Ammonium pyrrolidinedithiocarbamate | ESD-800470-2.5KG |
Cas.: 554-13-2 | Purity: AR, 99.5% | Lithium carbonate | ESD-812283-10KG |
Cas.: 9003-01-4 | Purity: Average MW MW ~450,000 | Poly(acrylic acid) | ESD-815684-500G |
Cas.: 10019-24-6 | Purity: 98% | 1-methoxy-4-[1,2,2-tris(4-methoxyphenyl)ehenyl]benzene | ESD-828246-5G |
Cas.: 10019-24-6 | Purity: 98% | 1-methoxy-4-[1,2,2-tris(4-methoxyphenyl)ehenyl]benzene | ESD-828246-1G |
Cas.: 10019-24-6 | Purity: 98% | 1-methoxy-4-[1,2,2-tris(4-methoxyphenyl)ehenyl]benzene | ESD-828246-250MG |
Cas.: 68516-73-4 | Purity: 95% | pigment yellow 155 | ESD-910140-100G |
Cas.: 68516-73-4 | Purity: 95% | pigment yellow 155 | ESD-910140-500G |
Cas.: 68516-73-4 | Purity: 95% | pigment yellow 155 | ESD-910140-1KG |
Cas.: 6358-31-2 | Purity: 95% | pigment yellow 74 | ESD-910141-100G |
Cas.: 6358-31-2 | Purity: 95% | pigment yellow 74 | ESD-910141-500G |
Cas.: 6358-31-2 | Purity: 95% | pigment yellow 74 | ESD-910141-1KG |
Cas.: 50925-42-3 | Purity: 95% | Direct Yellow 86 | ESD-910143-1KG |
Cas.: 50925-42-3 | Purity: 95% | Direct Yellow 86 | ESD-910143-500G |
Cas.: 79794-75-5 | Purity: > 98 % HPLC, powder | LORATADINE | ESD-838245-1G |
Cas.: 50925-42-3 | Purity: 95% | Direct Yellow 86 | ESD-910143-100G |
Cas.: 79794-75-5 | Purity: > 98 % HPLC, powder | LORATADINE | ESD-838245-5G |
Cas.: 61968-26-1 | Purity: 95% | Direct Yellow 132 | ESD-910144-1KG |
Cas.: 61968-26-1 | Purity: 95% | Direct Yellow 132 | ESD-910144-500G |
Cas.: 61968-26-1 | Purity: 95% | Direct Yellow 132 | ESD-910144-100G |
Cas.: 6416-66-6 | Purity: 95% | Tracid Brilliant Red B | ESD-910145-1KG |
Cas.: 6416-66-6 | Purity: 95% | Tracid Brilliant Red B | ESD-910145-500G |
Cas.: 6416-66-6 | Purity: 95% | Tracid Brilliant Red B | ESD-910145-100G |
Cas.: 98114-32-0 | Purity: 95% | Reactive Red 180 | ESD-910146-50G |
Cas.: 98114-32-0 | Purity: 95% | Reactive Red 180 | ESD-910146-250G |
Cas.: 10349-57-2 | Purity: >98.0%(HPLC) | 6-Quinolinecarboxylic Acid | ESD-910148-25G |
Cas.: 85631-88-5 | Direct Black 168 | ESD-910147-100G | |
Cas.: 10349-57-2 | Purity: >98.0%(HPLC) | 6-Quinolinecarboxylic Acid | ESD-910148-5G |
Cas.: 10349-57-2 | Purity: >98.0%(HPLC) | 6-Quinolinecarboxylic Acid | ESD-910148-1G |
Cas.: 85631-88-5 | Direct Black 168 | ESD-910147-500G | |
Cas.: 85631-88-5 | Direct Black 168 | ESD-910147-1KG | |
Cas.: 64-19-7 | Purity: ULC-MS, 0.1% in Water | Acetic acid | ESD-875410-250ML |
Cas.: 26855-43-6 | Purity: 98% | Triglycerol monostearate | ESD-910149-25G |
Cas.: 26855-43-6 | Purity: 98% | Triglycerol monostearate | ESD-910149-100G |
Cas.: 26855-43-6 | Purity: 98% | Triglycerol monostearate | ESD-910149-500G |
Cas.: 26855-43-6 | Purity: 98% | Triglycerol monostearate | ESD-910149-2.5KG |
Cas.: 5216-36-4 | Purity: 98% | 4,4′-Dicyanostilbene | ESD-887289-50MG |
Cas.: 64724-29-4 | Purity: 95% | cis-Tributyl(2-ethoxyethenyl)stannane | ESD-909300-250MG |
Cas.: 20277-69-4 | Purity: 90% | Sodium methanesulphinate | ESD-830613-500G |
Cas.: 118864-75-8 | Purity: 98% | (S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline | ESD-830523-25G |
Cas.: 1444-94-6 | Purity: 98% | 1,2-Cyclohexanedicarboximide | ESD-824315-100G |
Cas.: 181765-86-6 | Purity: ≥98% | Methyl 5-bromo-2-iodobenzoate | ESD-856340-25G |
Cas.: 181765-86-6 | Purity: ≥98% | Methyl 5-bromo-2-iodobenzoate | ESD-856340-5G |
Cas.: 1679-47-6 | Purity: 98% | ALPHA-METHYL-GAMMA-BUTYROLACTONE | ESD-824259-1G |
Cas.: 181765-86-6 | Purity: ≥98% | Methyl 5-bromo-2-iodobenzoate | ESD-856340-1G |
Cas.: 29241-65-4 | Purity: 97% | 5-Bromo-2-chloronicotinic acid | ESD-803919-25G |
Cas.: 9002-89-5 | Purity: Alcoholysis degree: 96.0~98.0%(mol/mol) | Poly(vinyl alcohol) 1797 | ESD-815725-2.5KG |
Cas.: 29241-65-4 | Purity: 97% | 5-Bromo-2-chloronicotinic acid | ESD-803919-1G |
Cas.: 2644-93-1 | Purity: ≥98% | 1,3,5-Trimethyl-1H-pyrazole-4-carbaldehyde | ESD-839677-5G |
Cas.: 37909-95-8 | Purity: 97% | 4-Butylbiphenyl | ESD-803078-25G |
Cas.: 2987-17-9 | Purity: 98% | Cyclobutanecarboxaldehyde | ESD-857068-1G |
Cas.: 39806-90-1 | Purity: 97% | 4-Iodo-1-methyl-1H-pyrazole | ESD-812006-25G |
Cas.: 39806-90-1 | Purity: 97% | 4-Iodo-1-methyl-1H-pyrazole | ESD-812006-100G |
Cas.: 23256-50-0 | Purity: ≥98% | Guanabenz Acetate | ESD-859762-5G |
Cas.: 29671-92-9 | Purity: ≥98% | Chloroformamidine Hydrochloride | ESD-859831-5G |
Cas.: 29671-92-9 | Purity: ≥98% | Chloroformamidine Hydrochloride | ESD-859831-25G |
Cas.: 29671-92-9 | Purity: ≥98% | Chloroformamidine Hydrochloride | ESD-859831-100G |
Cas.: 2721-22-4 | Purity: 98% | Delta-Tetradecalactone | ESD-822575-100G |
Cas.: 308068-56-6 | Purity: >90%, ID:5-15nm, OD:>50nm, Length:10-20μm | Carbon nanotube, multi-walled | ESD-835681-250G |
Cas.: 35853-41-9 | Purity: 98% | 2,8-Bis(trifluoromethyl)-4-hydroxyquinoline | ESD-802525-25G |
Cas.: 604-69-3 | Purity: 98% | β-D-(+)-Glucose pentaacetate | ESD-810461-2.5KG |
Cas.: 86408-72-2 | Purity: 98% | Ecabet sodium | ESD-844234-5G |
Cas.: 3828-49-7 | Purity: 97% | 2,3-Difluorotoluene | ESD-808129-25G |
Cas.: 877397-65-4 | Purity: 97% | (S)-1-(2,6-Dichloro-3-fluorophenyl)ethanol | ESD-844319-25G |
Cas.: 877397-65-4 | Purity: 97% | (S)-1-(2,6-Dichloro-3-fluorophenyl)ethanol | ESD-844319-100G |
Cas.: 14036-55-6 | Purity: 97% | tert-Butyl 3-butenoate | ESD-818653-25G |
Cas.: 6154-04-7 | Purity: 98% | 5-Amino-2-methyl-2H-tetrazole | ESD-832303-1G |
Cas.: 6154-04-7 | Purity: 98% | 5-Amino-2-methyl-2H-tetrazole | ESD-832303-25G |
Cas.: 5104-49-4 | Purity: 98% | FLURBIPROFEN | ESD-838236-100G |
Cas.: 4799-68-2 | Purity: 97% | 3-Benzyloxy-1-propanol | ESD-831036-25G |
Cas.: 4799-68-2 | Purity: 97% | 3-Benzyloxy-1-propanol | ESD-831036-100G |
Cas.: 10429-82-0 | Purity: ≥95% | N-Benzyl-N,N-bis(2-chloroethyl)amine Hydrochloride | ESD-854658-25G |
Cas.: 10429-82-0 | Purity: ≥95% | N-Benzyl-N,N-bis(2-chloroethyl)amine Hydrochloride | ESD-854658-1G |
Cas.: 14036-55-6 | Purity: 97% | tert-Butyl 3-butenoate | ESD-818653-250MG |
Cas.: 56239-26-0 | Purity: 97% | cis-4-Aminocyclohexanol hydrochloride | ESD-836887-5G |
Cas.: 56239-26-0 | Purity: 97% | cis-4-Aminocyclohexanol hydrochloride | ESD-836887-25G |
Cas.: 849217-68-1 | Purity: 98% | cabozantinib | ESD-856619-250MG |
Cas.: 849217-68-1 | Purity: 98% | cabozantinib | ESD-856619-1G |
Cas.: 71653-64-0 | Purity: 97% | 2-(Difluoromethoxy)benzaldehyde | ESD-808541-25G |
Cas.: 111851-98-0 | Purity: ≥95% | 1-Ethyl-1H-imidazole-2-carbaldehyde | ESD-840002-5G |
Cas.: 7697-23-6 | Purity: 98% | 2-Fluoro-4-methylbenzoic acid | ESD-810065-25G |
Cas.: 2050-60-4 | Purity: 99% | Dibutyl oxalate | ESD-830987-2.5L |
Cas.: 1489-53-8 | Purity: 98% | 1,2,3-Trifluorobenzene | ESD-828683-5G |
Cas.: 1489-53-8 | Purity: 98% | 1,2,3-Trifluorobenzene | ESD-828683-25G |
Cas.: 1737-06-0 | Purity: ≥97% | 4-(Trifluoromethoxy)Acetanilide | ESD-859656-5G |
Cas.: 1829-32-9 | Purity: 98% | 3-Chlorosalicylic acid | ESD-806206-5G |
Cas.: 15826-37-6 | Purity: ≥99% | Cromolyn Disodium Salt Hydrate | ESD-832346-100G |
Cas.: 5459-58-5 | Purity: 98% | n-Butyl cyanoacetate | ESD-830316-25G |
Cas.: 5459-58-5 | Purity: 98% | n-Butyl cyanoacetate | ESD-830316-100G |
Cas.: 150529-73-0 | Purity: 97% | Methyl 2-(3-bromophenyl)acetate | ESD-830377-25G |
Cas.: 150529-73-0 | Purity: 97% | Methyl 2-(3-bromophenyl)acetate | ESD-830377-5G |
Cas.: 10045-25-7 | Purity: 98% | 1,4,7,10-Tetraazacyclododecane Tetrahydrochloride | ESD-823752-5G |
Cas.: 10045-25-7 | Purity: 98% | 1,4,7,10-Tetraazacyclododecane Tetrahydrochloride | ESD-823752-25G |
Cas.: NONE7003 | Purity: 0.2M, pH9.0 | Phosphate Buffer (PB Buffer) | ESD-885762-1L |
Cas.: 444796-09-2 | Purity: ≥98% | 2,7-Dibromo-9-phenylcarbazole | ESD-857515-5G |
Cas.: 6054-98-4 | Purity: ≥98% | Olsalazine Sodium | ESD-859096-5G |
Cas.: 17249-90-0 | Purity: 97% | 2,5-Dichloro-3-methylthiophene | ESD-839056-5G |
Cas.: 17249-90-0 | Purity: 97% | 2,5-Dichloro-3-methylthiophene | ESD-839056-25G |
Cas.: XBPY | Purity: 1M, pH7.4 | HEPES Buffer | ESD-885799-1L |
Cas.: 611-01-8 | Purity: 97% | 2,4-Dimethylbenzoic acid | ESD-806474-250G |
Cas.: 69951-02-6 | Purity: ≥98% | 2-Chloro-6-Methyl-4-Nitroaniline | ESD-858032-5G |
Cas.: 4214-74-8 | Purity: ≥97% | 2-Amino-3,5-dichloropyridine | ESD-853631-25G |
Cas.: 4214-74-8 | Purity: ≥97% | 2-Amino-3,5-dichloropyridine | ESD-853631-5G |
Cas.: 6299-25-8 | Purity: 98% | 4,6-Dichloro-2-(methylthio)pyrimidine | ESD-807379-100G |
Cas.: 51446-30-1 | Purity: 97% | 2-Fluoro-5-hydroxybenzoic acid | ESD-810262-5G |
Cas.: 68291-97-4 | Purity: ≥98% | Zonisamide | ESD-868328-1G |
Cas.: 68291-97-4 | Purity: ≥98% | Zonisamide | ESD-868328-5G |
Cas.: 7474-78-4 | Purity: ≥98% | 3,4-Diaminobenzenesulfonic acid | ESD-854723-100G |
Cas.: 84331-14-6 | Purity: ≥95% | 1-(6-Fluoropyridin-3-YL)Ethanone | ESD-858562-250MG |
Cas.: 147252-84-4 | Purity: 95% | tert-Butyl (1-hydroxypropan-2-yl)carbamate | ESD-840371-5G |
Cas.: 147252-84-4 | Purity: 95% | tert-Butyl (1-hydroxypropan-2-yl)carbamate | ESD-840371-25G |
Cas.: 7474-78-4 | Purity: ≥98% | 3,4-Diaminobenzenesulfonic acid | ESD-854723-5G |
Cas.: 237069-82-8 | Purity: ≥98% | 2′,4′-Bis(Trifluoromethyl)Acetophenone | ESD-859766-5G |
Cas.: 97145-88-5 | Purity: ≥98% | N-Methyl-3-Chloropropylamine Hydrochloride | ESD-860392-5G |
Cas.: 97145-88-5 | Purity: ≥98% | N-Methyl-3-Chloropropylamine Hydrochloride | ESD-860392-1G |
Cas.: 1630906-91-0 | Purity: 95% | 1,1-difluoro-5-azaspiro[2.3]hexane hydrochloride | ESD-909151-250MG |
Cas.: 27115-74-8 | Purity: ≥97% | 2-Amino-5-isopropyl-1,3,4-thiadiazole | ESD-853138-5G |
Cas.: 2557-13-3 | Purity: 99% | Methyl 3-(trifluoromethyl)benzoate | ESD-812998-100G |
Cas.: 103-39-9 | Purity: ≥98% | 2-[(1-Methyl-2-Phenoxyethyl)Amino]Ethanol | ESD-859435-100G |
Cas.: 103-39-9 | Purity: ≥98% | 2-[(1-Methyl-2-Phenoxyethyl)Amino]Ethanol | ESD-859435-1G |
Cas.: 103-39-9 | Purity: ≥98% | 2-[(1-Methyl-2-Phenoxyethyl)Amino]Ethanol | ESD-859435-5G |
Cas.: 326-66-9 | Purity: ≥98% | 4′-Bromo-2′-fluoroacetanilide | ESD-859856-25G |
Cas.: 326-66-9 | Purity: ≥98% | 4′-Bromo-2′-fluoroacetanilide | ESD-859856-100G |
Cas.: 183388-64-9 | Purity: 98% | (2S,3S,5S)-5-tert-Butyloxycarbonylamino-2-amino-3-hydroxy-1,6-diphenylhexane succinate | ESD-857233-2G |
Cas.: 183388-64-9 | Purity: 98% | (2S,3S,5S)-5-tert-Butyloxycarbonylamino-2-amino-3-hydroxy-1,6-diphenylhexane succinate | ESD-857233-50G |
Cas.: 18480-07-4 | Purity: 94% | Strontium hydroxide | ESD-822419-100G |
Cas.: 19598-90-4 | Purity: 99.9% metals basis | Gadolinium(III) nitrate hexahydrate | ESD-810673-2.5KG |
Cas.: 16778-70-4 | Purity: ≥97% | 1-Ethyl-1H-1,2,4-triazole | ESD-830537-1G |
Cas.: 16778-70-4 | Purity: ≥97% | 1-Ethyl-1H-1,2,4-triazole | ESD-830537-5G |
Cas.: 65376-05-8 | Purity: 97% | (1R,2R)-Cyclohexane-1,2-diyldimethanol | ESD-840237-5G |
Cas.: 34298-25-4 | Purity: ≥97% | (R)-beta-Methylphenylethanamine Hydrochloride | ESD-853376-25G |
Cas.: 67004-64-2 | Purity: 97% | 1-Methyl-2-pyrrolidine ethanol | ESD-812853-1G |
Cas.: 4412-96-8 | Purity: ≥98% | 3-Methyl-2-furancarboxylic Acid | ESD-866583-5G |
Cas.: 4412-96-8 | Purity: ≥98% | 3-Methyl-2-furancarboxylic Acid | ESD-866583-25G |
Cas.: 90536-66-6 | Purity: 97% | 4-(Methylsulfonyl)phenylacetic acid | ESD-813280-25G |
Cas.: 19821-80-8 | Purity: 98% | 1,3-Dibromo-2-iodobenzene | ESD-863528-5G |
Cas.: 86227-47-6 | Purity: ≥65.0%(GC), contains 2000ppm tocopherol stabilizer | Eicosapentaenoic Acid Ethyl Ester | ESD-863615-1G |
Cas.: 3964-04-3 | Purity: 95% | 4-Bromoquinoline | ESD-803986-5G |
Cas.: 73889-19-7 | Purity: ≥97% | 1-Benzyl-4-(Boc-amino)piperidine | ESD-853107-1G |
Cas.: 916320-82-6 | Purity: 97% | Di-p-chlorobenzyl Azodicarboxylate (DCAD) | ESD-853036-5G |
Cas.: 1159826-44-4 | Purity: ≥97% | 1-Cbz-2-(aminomethyl)piperidine Hydrochloride | ESD-853129-250MG |
Cas.: 1194-16-7 | Purity: 95% | Tetrahydro-2,2-dimethyl-4H-pyran-4-one | ESD-818644-5G |
Cas.: 38711-20-5 | Purity: ≥97% | (Dimethylamino)acetaldehyde Dimethyl Acetal | ESD-852121-5ML |
Cas.: 38711-20-5 | Purity: ≥97% | (Dimethylamino)acetaldehyde Dimethyl Acetal | ESD-852121-25ML |
Cas.: 467442-15-5 | Purity: 97% | 3,5-Difluoro-4-formylbenzonitrile | ESD-808315-250MG |
Cas.: 212385-73-4 | Purity: ≥98% | 9-(4′-Bromo-4-Biphenylyl)Carbazole | ESD-859734-5G |
Cas.: 5418-63-3 | Purity: 98% | 1,2,3,3-Tetramethyl-3H-indol-1-ium iodide | ESD-838703-100G |
Cas.: 17773-10-3 | Purity: 98% | Choline Iodide | ESD-870593-25G |
Cas.: 1904-24-1 | Purity: >97% | 5-ethyl-1H-pyrazol-3-amine | ESD-825269-5G |
Cas.: 144164-11-4 | Purity: 98% | Thiazol-5-ylmethyl ((2S,3S,5S)-5-amino-3-hydroxy-1,6-diphenylhexan-2-yl)carbamate | ESD-890205-250MG |
Cas.: 456-12-2 | Purity: 95% | N-(2-Hydroxy-2-(4-methoxyphenyl)ethyl)cinnamamide | ESD-843847-5G |
Cas.: 5042-30-8 | Purity: 65 wt. % in H2O | 2,2,2-Trifluoroethylhydrazine | ESD-838804-5G |
Cas.: 5042-30-8 | Purity: 65 wt. % in H2O | 2,2,2-Trifluoroethylhydrazine | ESD-838804-25G |
Cas.: 621-42-1 | Purity: 98% | 3′-Hydroxyacetanilide | ESD-858221-25G |
Cas.: 621-42-1 | Purity: 98% | 3′-Hydroxyacetanilide | ESD-858221-100G |
Cas.: 2160-62-5 | Purity: 97% | 5-Bromothiophene-2-carbonitrile | ESD-839473-5G |
Cas.: 320-32-1 | Purity: 97% | 4-Hydroxy-2-(trifluoromethyl)benzoic acid | ESD-811563-5G |
Cas.: 93957-55-2 | Purity: ≥98% | Fluvastatin Sodium | ESD-863487-250MG |
Cas.: 93957-55-2 | Purity: ≥98% | Fluvastatin Sodium | ESD-863487-1G |
Cas.: 374064-02-5 | Purity: 98% | 3-(2-Pyridinyl)-1H-pyrazole-5-carboxylic acid | ESD-817017-1G |
Cas.: 10417-94-4 | Purity: ≥95%(GC) | |cis|-5,8,11,14,17-Eicosapentaenoic acid | ESD-809323-5G |
Cas.: 4342-03-4 | Purity: 98% | DACARBAZINE | ESD-838233-1G |
Cas.: 4342-03-4 | Purity: 98% | DACARBAZINE | ESD-838233-5G |
Cas.: 96034-64-9 | Purity: 95% | (2S,4S)-4-Nitrobenzyl 2-(dimethylcarbamoyl)-4-mercaptopyrrolidine-1-carboxylate | ESD-843831-5G |
Cas.: 29166-72-1 | Purity: ≥97.0% (GC) | 2-|tert|-Butyl-1,1,3,3-tetramethylguanidine | ESD-822439-25ML |
Cas.: 29166-72-1 | Purity: ≥97.0% (GC) | 2-|tert|-Butyl-1,1,3,3-tetramethylguanidine | ESD-822439-1ML |
Cas.: 123334-03-2 | Purity: 99% | Melamine hydrogen flouride | ESD-910151-25G |
Cas.: 123334-03-2 | Purity: 99% | Melamine hydrogen flouride | ESD-910151-100G |
Cas.: 150812-13-8 | Purity: 95% | Retigabine | ESD-873323-250MG |
Cas.: 150812-13-8 | Purity: 95% | Retigabine | ESD-873323-1G |
Cas.: 530-91-6 | Purity: 98% | 1,2,3,4-Tetrahydronaphthalen-2-ol | ESD-870024-5G |
Cas.: 530-91-6 | Purity: 98% | 1,2,3,4-Tetrahydronaphthalen-2-ol | ESD-870024-1G |
Cas.: 9082-00-2 | Purity: Mn: ~4800 | Glycerol propoxylate-block-ethoxylate | ESD-910040-2.5KG |
Cas.: 64742-47-8 | Purity: low odor | Kerosene | ESD-836669-25L |
Cas.: 9082-00-2 | Purity: Mn: ~3000 | Glycerol propoxylate-block-ethoxylate | ESD-910038-2.5KG |
Cas.: 101410-18-8 | Purity: ≥98% | (S)-tert-Butyl 2-carbamothioylpyrrolidine-1-carboxylate | ESD-846224-1G |
Cas.: 101410-18-8 | Purity: ≥98% | (S)-tert-Butyl 2-carbamothioylpyrrolidine-1-carboxylate | ESD-846224-5G |
Cas.: 89891-65-6 | Purity: ≥95% | 7-Bromo-2-chloroquinoxaline | ESD-845859-5G |
Cas.: 13184-86-6 | Purity: ≥98% | 4-(Ethoxymethyl)-2-methoxyphenol | ESD-859239-1G |
Cas.: 13184-86-6 | Purity: ≥98% | 4-(Ethoxymethyl)-2-methoxyphenol | ESD-859239-25G |
Cas.: 171197-80-1 | Purity: 97% | 2-Fluoro-5-iodopyridine | ESD-810020-25G |
Cas.: 56724-09-5 | Purity: ≥98% | 5-methoxy-2-methylbenzaldehyde | ESD-826261-250MG |
Cas.: 18671-97-1 | Purity: 97% | 2,6-Dichloroquinoxaline | ESD-808460-25G |
Cas.: 18671-97-1 | Purity: 97% | 2,6-Dichloroquinoxaline | ESD-808460-1G |
Cas.: 621-36-3 | Purity: 99% | m-Tolylacetic acid | ESD-837929-5G |
Cas.: 64858-90-8 | Purity: 95% | ethyl 2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanoate | ESD-910152-25MG |
Cas.: 64858-90-8 | Purity: 95% | ethyl 2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanoate | ESD-910152-50MG |
Cas.: 64858-90-8 | Purity: 95% | ethyl 2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanoate | ESD-910152-100MG |
Cas.: 1032903-50-6 | Purity: 98% | 1-Chloro-5-isopropoxy-2-methyl-4-nitrobenzene | ESD-889015-1G |
Cas.: 1032903-50-6 | Purity: 98% | 1-Chloro-5-isopropoxy-2-methyl-4-nitrobenzene | ESD-889015-5G |
Cas.: 102940-86-3 | Purity: 97% | 2-Chloro-3-fluorobenzoic acid | ESD-805894-25G |
Cas.: 26039-74-7 | Purity: 95% | diethyl 2-(3-chloro-4-nitrophenyl)-2-methylmalonate | ESD-910153-25MG |
Cas.: 26039-74-7 | Purity: 95% | diethyl 2-(3-chloro-4-nitrophenyl)-2-methylmalonate | ESD-910153-50MG |
Cas.: 26039-74-7 | Purity: 95% | diethyl 2-(3-chloro-4-nitrophenyl)-2-methylmalonate | ESD-910153-100MG |
Cas.: 14615-72-6 | Purity: 98% | 3,5-Dibenzyloxybenzaldehyde | ESD-806692-25G |
Cas.: 35852-46-1 | Purity: 98% | |cis|-3-Hexenyl n-valerate | ESD-811408-1ML |
Cas.: 35852-46-1 | Purity: 98% | |cis|-3-Hexenyl n-valerate | ESD-811408-5ML |
Cas.: 35852-46-1 | Purity: 98% | |cis|-3-Hexenyl n-valerate | ESD-811408-100ML |
Cas.: 66202-86-6 | Purity: 95% | methyl 2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanoate | ESD-910154-25MG |
Cas.: 66202-86-6 | Purity: 95% | methyl 2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanoate | ESD-910154-50MG |
Cas.: 66202-86-6 | Purity: 95% | methyl 2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanoate | ESD-910154-100MG |
Cas.: NONE8167 | Purity: 95% | ethyl 2-(3-methoxyphenyl)propanoate | ESD-910155-500MG |
Cas.: NONE8167 | Purity: 95% | ethyl 2-(3-methoxyphenyl)propanoate | ESD-910155-1G |
Cas.: NONE8167 | Purity: 95% | ethyl 2-(3-methoxyphenyl)propanoate | ESD-910155-5G |
Cas.: 2160-93-2 | Purity: 97% | N-tert-Butyldiethanolamine | ESD-858400-25ML |
Cas.: 2160-93-2 | Purity: 97% | N-tert-Butyldiethanolamine | ESD-858400-100ML |
Cas.: NONE8168 | Purity: 95% | ethyl 2,2-difluoro-1-(3-methoxyphenyl)cyclopropane-1-carboxylate | ESD-910156-500MG |
Cas.: NONE8168 | Purity: 95% | ethyl 2,2-difluoro-1-(3-methoxyphenyl)cyclopropane-1-carboxylate | ESD-910156-1G |
Cas.: NONE8168 | Purity: 95% | ethyl 2,2-difluoro-1-(3-methoxyphenyl)cyclopropane-1-carboxylate | ESD-910156-5G |
Cas.: 83948-53-2 | Purity: 98% | 3-(Boc-Amino)propylbromide | ESD-844291-25G |
Cas.: 10212-04-1 | Purity: 98% | (3-Bromophenyl)diphenylphosphine Oxide | ESD-871258-1G |
Cas.: 29711-79-3 | Purity: 98% | 4-Dimethylamino-1-naphthyl Isothiocyanate | ESD-870865-1G |
Cas.: 14575-84-9 | Purity: 99% | D-(+)-α-Bromocamphor-8-sulfonic Acid Ammonium Salt | ESD-837882-5G |
Cas.: 14575-84-9 | Purity: 99% | D-(+)-α-Bromocamphor-8-sulfonic Acid Ammonium Salt | ESD-837882-25G |
Cas.: 833-50-1 | Purity: ≥98% | 2-Phenylbenzoxazole | ESD-867719-1G |
Cas.: 833-50-1 | Purity: ≥98% | 2-Phenylbenzoxazole | ESD-867719-5G |
Cas.: 89565-68-4 | Purity: 99% | Tropisetron | ESD-838261-1G |
Cas.: 89565-68-4 | Purity: 99% | Tropisetron | ESD-838261-5G |
Cas.: 89-54-3 | Purity: 98% | 5-Amino-2-chlorobenzoic acid | ESD-800352-5G |
Cas.: 703-61-7 | Purity: 98% | 2,4-dichloroquinoline | ESD-888371-1G |
Cas.: 31554-15-1 | Purity: 98% | 2,3-Bis(hydroxymethyl)naphthalene | ESD-869906-1G |
Cas.: 7149-49-7 | Purity: 99% | 2,3-Naphthalenedicarboxaldehyde | ESD-814655-500MG |
Cas.: 635-12-1 | Purity: >95.0%(HPLC) | 1,4-Anthraquinone | ESD-869548-5G |
Cas.: 4408-81-5 | Purity: 98% | 1,2-Diaminopropane-N,N,N’,N’-tetraacetic Acid | ESD-870318-1G |
Cas.: 3146-60-9 | Purity: 95% | 2-(3-methoxyphenyl)propanoic acid | ESD-910157-500MG |
Cas.: 3146-60-9 | Purity: 95% | 2-(3-methoxyphenyl)propanoic acid | ESD-910157-1G |
Cas.: 3146-60-9 | Purity: 95% | 2-(3-methoxyphenyl)propanoic acid | ESD-910157-5G |
Cas.: 42771-79-9 | Purity: 95% | 1-(2-fluoro-[1,1′-biphenyl]-4-yl)ethan-1-one | ESD-910158-25MG |
Cas.: 42771-79-9 | Purity: 95% | 1-(2-fluoro-[1,1′-biphenyl]-4-yl)ethan-1-one | ESD-910158-50MG |
Cas.: 42771-79-9 | Purity: 95% | 1-(2-fluoro-[1,1′-biphenyl]-4-yl)ethan-1-one | ESD-910158-100MG |
Cas.: 1005771-04-9 | Purity: >97.0%(GC) | 1,3-Dibromo-7-tert-butylpyrene | ESD-861631-500MG |
Cas.: 55258-76-9 | Purity: 90% | 4-ethyl-2-fluoro-1,1′-biphenyl | ESD-910159-25MG |
Cas.: 55258-76-9 | Purity: 90% | 4-ethyl-2-fluoro-1,1′-biphenyl | ESD-910159-50MG |
Cas.: 55258-76-9 | Purity: 90% | 4-ethyl-2-fluoro-1,1′-biphenyl | ESD-910159-100MG |
Cas.: 2168875-92-9 | Purity: 95% | 2,2-difluoro-1-(3-methoxyphenyl)cyclopropane-1-carboxylic acid | ESD-910160-500MG |
Cas.: 2168875-92-9 | Purity: 95% | 2,2-difluoro-1-(3-methoxyphenyl)cyclopropane-1-carboxylic acid | ESD-910160-1G |
Cas.: 34612-38-9 | Purity: ≥98% | Maltotetraose | ESD-814213-25MG |
Cas.: 2168875-92-9 | Purity: 95% | 2,2-difluoro-1-(3-methoxyphenyl)cyclopropane-1-carboxylic acid | ESD-910160-5G |
Cas.: 115843-99-7 | Purity: ≥98% | 4-Bromo-3-Chloro-2-Fluoroaniline | ESD-859469-5G |
Cas.: 115843-99-7 | Purity: ≥98% | 4-Bromo-3-Chloro-2-Fluoroaniline | ESD-859469-25G |
Cas.: 477860-13-2 | Purity: 95% | 2-fluoro-[1,1′-biphenyl]-4-ol | ESD-910161-25MG |
Cas.: 477860-13-2 | Purity: 95% | 2-fluoro-[1,1′-biphenyl]-4-ol | ESD-910161-50MG |
Cas.: 477860-13-2 | Purity: 95% | 2-fluoro-[1,1′-biphenyl]-4-ol | ESD-910161-100MG |
Cas.: 111-86-4 | Purity: 99% | n-Octylamine | ESD-815229-2.5L |
Cas.: 87657-78-1 | Purity: 95% | 2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanamide | ESD-910162-25MG |
Cas.: 87657-78-1 | Purity: 95% | 2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanamide | ESD-910162-50MG |
Cas.: 87657-78-1 | Purity: 95% | 2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanamide | ESD-910162-100MG |
Cas.: 116405-43-7 | Purity: 98% | Bis(triphenylphosphine)iminium trifluoroacetate | ESD-834511-5G |
Cas.: 119-84-6 | Purity: 99% | Dihydrocoumarin | ESD-807109-50G |
Cas.: 6341-72-6 | Purity: 95% | 2-([1,1′-biphenyl]-4-yl)propanoic acid | ESD-903032-5G |
Cas.: 74648-00-3 | Purity: 95% | 2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanenitrile | ESD-910163-25MG |
Cas.: 74648-00-3 | Purity: 95% | 2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanenitrile | ESD-910163-50MG |
Cas.: 74648-00-3 | Purity: 95% | 2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanenitrile | ESD-910163-100MG |
Cas.: 109-88-6 | Purity: 7-8 wt. % in methanol | Magnesium methoxide solution | ESD-822454-25ML |
Cas.: NONE8169 | Purity: 95% | methyl 2-(3-chloro-4-methylphenyl)-2-methylpropanoate | ESD-910164-1G |
Cas.: NONE8169 | Purity: 95% | methyl 2-(3-chloro-4-methylphenyl)-2-methylpropanoate | ESD-910164-5G |
Cas.: NONE8169 | Purity: 95% | methyl 2-(3-chloro-4-methylphenyl)-2-methylpropanoate | ESD-910164-500MG |
Cas.: 1569-16-0 | Purity: 98% | 2-Methyl-[1,8]naphthyridine | ESD-834201-5G |
Cas.: 1685278-08-3 | Purity: 95% | 1-acetoxyethyl 2-([1,1′-biphenyl]-4-yl)propanoate | ESD-910165-25MG |
Cas.: 1685278-08-3 | Purity: 95% | 1-acetoxyethyl 2-([1,1′-biphenyl]-4-yl)propanoate | ESD-910165-50MG |
Cas.: 1685278-08-3 | Purity: 95% | 1-acetoxyethyl 2-([1,1′-biphenyl]-4-yl)propanoate | ESD-910165-100MG |
Cas.: 1314700-83-8 | Purity: 95% | 2-(3-chloro-4-methylphenyl)-2-methylpropanoic acid | ESD-910166-500MG |
Cas.: 1314700-83-8 | Purity: 95% | 2-(3-chloro-4-methylphenyl)-2-methylpropanoic acid | ESD-910166-1G |
Cas.: 1314700-83-8 | Purity: 95% | 2-(3-chloro-4-methylphenyl)-2-methylpropanoic acid | ESD-910166-5G |
Cas.: 112-70-9 | Purity: 97% | 1-Tridecanol | ESD-818953-1G |
Cas.: 9012-76-4 | Purity: Deacetylation degree 50% | Chitosan | ESD-909960-500G |
Cas.: 9012-76-4 | Purity: Deacetylation degree 50% | Chitosan | ESD-909960-2.5KG |
Cas.: 875664-41-8 | Purity: ≥98% | 3-Bromo-4,5-Difluoroaniline | ESD-860319-250MG |
Cas.: 1198-27-2 | Purity: 97% | 1-Amino-2-naphthol hydrochloride | ESD-801141-250MG |
Cas.: 124728-93-4 | Purity: ≥98% | 2,3-Difluoro-1-Propoxybenzene | ESD-859513-5G |
Cas.: 12007-09-9 | Purity: 99% | Tungsten boride | ESD-819982-5G |
Cas.: 271-44-3 | Purity: 98% | Indazole | ESD-831469-25G |
Cas.: 2226-88-2 | Purity: AR, 99% | Ammonium succinate | ESD-836331-2.5KG |
Cas.: 16188-55-9 | Purity: 98% | 4-(Methylthio)phenylacetic acid | ESD-812836-25G |
Cas.: 15922-01-7 | Purity: ≥99% | 4-Nitrobenzoic Acid Potassium Salt | ESD-867365-25G |
Cas.: 24209-38-9 | Purity: 99% | 7-Amino-3-(1-methyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylicacid | ESD-857943-5G |
Cas.: 866319-00-8 | Purity: 98% | 5-Fluoro-1H-pyrrolo[2,3-b]pyridine | ESD-810230-250MG |
Cas.: 183278-30-0 | Purity: 95% | Sodium 4,4′-oxybis(butane-1-sulfonate) | ESD-900463-1G |
Cas.: 749927-69-3 | Purity: 98% | 4-Bromo-2-fluoro-N-methylbenzamide | ESD-856332-1G |
Cas.: 749927-69-3 | Purity: 98% | 4-Bromo-2-fluoro-N-methylbenzamide | ESD-856332-5G |
Cas.: 749927-69-3 | Purity: 98% | 4-Bromo-2-fluoro-N-methylbenzamide | ESD-856332-25G |
Cas.: 106877-29-6 | Purity: ≥98% | 5-Methyl-2-(Trifluoromethyl)Aniline | ESD-859448-250MG |
Cas.: 1861-32-1 | Purity: 96% | Chlorthal-dimethyl | ESD-805260-100G |
Cas.: 1470-99-1 | Purity: 98% | cis-Octahydroisoindole | ESD-828579-5G |
Cas.: 157634-02-1 | Purity: ≥95% | tert-Butyl 2-formylpiperidine-1-carboxylate | ESD-839873-5G |
Cas.: 6322-56-1 | Purity: ≥98.0%(GC) | 4′-Hydroxy-3′-nitroacetophenone | ESD-824389-500G |
Cas.: 6322-56-1 | Purity: ≥98.0%(GC) | 4′-Hydroxy-3′-nitroacetophenone | ESD-824389-100G |
Cas.: 6322-56-1 | Purity: ≥98.0%(GC) | 4′-Hydroxy-3′-nitroacetophenone | ESD-824389-25G |
Cas.: 6322-56-1 | Purity: ≥98.0%(GC) | 4′-Hydroxy-3′-nitroacetophenone | ESD-824389-5G |
Cas.: 6622-92-0 | Purity: 98% | 2,4-Dimethyl-6-hydroxypyrimidine | ESD-824391-100G |
Cas.: 6622-92-0 | Purity: 98% | 2,4-Dimethyl-6-hydroxypyrimidine | ESD-824391-25G |
Cas.: 6622-92-0 | Purity: 98% | 2,4-Dimethyl-6-hydroxypyrimidine | ESD-824391-5G |
Cas.: 19205-19-7 | Purity: >98.0%(HPLC) | |N|,|N|’-Dimethylquinacridone | ESD-808426-250MG |
Cas.: 38668-48-3 | Purity: ≥95% | Diisopropanol-p-toluidine | ESD-905716-2.5KG |
Cas.: 930-35-8 | Purity: 97% | 1,3-Dithiole-2-thione | ESD-856207-250MG |
Cas.: 15014-25-2 | Purity: 95% | Dibenzyl malonate | ESD-831906-100G |
Cas.: 15014-25-2 | Purity: 95% | Dibenzyl malonate | ESD-831906-25G |
Cas.: 15014-25-2 | Purity: 95% | Dibenzyl malonate | ESD-831906-5G |
Cas.: 15014-25-2 | Purity: 95% | Dibenzyl malonate | ESD-831906-1G |
Cas.: 19408-46-9 | Purity: ≥90% (HPLC) | Kasugamycin hydrochloride | ESD-812251-1G |
Cas.: 21397-07-9 | Purity: 98% | 2-Chloro-3-fluoronitrobenzene | ESD-828808-5G |
Cas.: 21397-07-9 | Purity: 98% | 2-Chloro-3-fluoronitrobenzene | ESD-828808-1G |
Cas.: 90776-59-3 | Purity: 97% | (4R,5R,6S)-4-Nitrobenzyl 3-((diphenoxyphosphoryl)oxy)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept- 2-ene-2-carboxylate | ESD-843984-5G |
Cas.: 641-49-6 | Purity: 98% | 3-Fluoro-2-nitroanisole | ESD-828781-25G |
Cas.: 641-49-6 | Purity: 98% | 3-Fluoro-2-nitroanisole | ESD-828781-5G |
Cas.: 641-49-6 | Purity: 98% | 3-Fluoro-2-nitroanisole | ESD-828781-1G |
Cas.: 8024-37-1 | Purity: ≥98% | Tumeric oleoresin | ESD-859167-5G |
Cas.: 8024-37-1 | Purity: ≥98% | Tumeric oleoresin | ESD-859167-25G |
Cas.: 236395-14-5 | Purity: 95% | Eslicarbazepine Acetate | ESD-855441-500MG |
Cas.: 1588-83-6 | Purity: 95% | 4-Amino-3-nitrobenzoic acid | ESD-910167-500G |
Cas.: 1588-83-6 | Purity: 95% | 4-Amino-3-nitrobenzoic acid | ESD-910167-100G |
Cas.: 1588-83-6 | Purity: 95% | 4-Amino-3-nitrobenzoic acid | ESD-910167-25G |
Cas.: 1588-83-6 | Purity: 95% | 4-Amino-3-nitrobenzoic acid | ESD-910167-5G |
Cas.: 2388-73-0 | Purity: 98% | 2-Methoxythioanisole | ESD-812827-1G |
Cas.: 25462-17-3 | Purity: 95% | 2-(hydroxymethyl)-2-methylpentyl isopropyl-carbamate | ESD-830211-100G |
Cas.: 17288-32-3 | Purity: 95% | 1H-Pyrrolo[3,2-b]pyridine-2-carboxylic acid ethyl ester | ESD-829667-5G |
Cas.: 17288-32-3 | Purity: 95% | 1H-Pyrrolo[3,2-b]pyridine-2-carboxylic acid ethyl ester | ESD-829667-1G |
Cas.: 17288-32-3 | Purity: 95% | 1H-Pyrrolo[3,2-b]pyridine-2-carboxylic acid ethyl ester | ESD-829667-250MG |
Cas.: 95798-23-5 | Purity: 97% | Benzyl 4-hydroxy-1-piperidinecarboxylate | ESD-803684-2G |
Cas.: 95798-23-5 | Purity: 97% | Benzyl 4-hydroxy-1-piperidinecarboxylate | ESD-803684-25G |
Cas.: 182121-12-6 | Purity: 98% | 9,9-bis(methoxymethyl)-9H-fluorene | ESD-829211-5G |
Cas.: 182121-12-6 | Purity: 98% | 9,9-bis(methoxymethyl)-9H-fluorene | ESD-829211-1G |
Cas.: 182121-12-6 | Purity: 98% | 9,9-bis(methoxymethyl)-9H-fluorene | ESD-829211-250MG |
Cas.: 182121-12-6 | Purity: 98% | 9,9-bis(methoxymethyl)-9H-fluorene | ESD-829211-25G |
Cas.: 93183-15-4 | Purity: 99% | DMT-dG(ib) Phosphoramidite | ESD-808079-5G |
Cas.: 93183-15-4 | Purity: 99% | DMT-dG(ib) Phosphoramidite | ESD-808079-25G |
Cas.: 17756-58-0 | Purity: 20% methanol solution, ~20% in methanol (T) | Tetraoctylammonium hydroxide | ESD-910168-25G |
Cas.: 17756-58-0 | Purity: 20% methanol solution, ~20% in methanol (T) | Tetraoctylammonium hydroxide | ESD-910168-100G |
Cas.: 17756-58-0 | Purity: 20% methanol solution, ~20% in methanol (T) | Tetraoctylammonium hydroxide | ESD-910168-500G |
Cas.: 583-61-9 | Purity: 98% | 2,3-Lutidine | ESD-812438-2.5L |
Cas.: 21791-94-6 | Purity: 98% | Sodium (+)-10-Camphorsulfonate | ESD-850004-100G |
Cas.: 21791-94-6 | Purity: 98% | Sodium (+)-10-Camphorsulfonate | ESD-850004-25G |
Cas.: 21791-94-6 | Purity: 98% | Sodium (+)-10-Camphorsulfonate | ESD-850004-5G |
Cas.: 68609-96-1 | Purity: industry grade | Octyl/decyl glycidyl ether | ESD-863881-1L |
Cas.: 1005771-04-9 | Purity: >97.0%(GC) | 1,3-Dibromo-7-tert-butylpyrene | ESD-861631-1G |
Cas.: 16370-63-1 | Purity: 97% | 2-Amino-4,6-dimethoxy-1,3,5-triazine | ESD-841895-5G |
Cas.: 16370-63-1 | Purity: 97% | 2-Amino-4,6-dimethoxy-1,3,5-triazine | ESD-841895-25G |
Cas.: 16251-45-9 | Purity: 98% | (4S,5R)-4-Methyl-5-phenyloxazolidin-2-one | ESD-842939-5G |
Cas.: 16251-45-9 | Purity: 98% | (4S,5R)-4-Methyl-5-phenyloxazolidin-2-one | ESD-842939-25G |
Cas.: 18880-05-2 | Purity: ≥98% | (3-Methoxybenzyl)triphenylphosphonium chloride | ESD-848914-5G |
Cas.: 614-76-6 | Purity: ≥98% | 2′-Bromoacetanilide | ESD-854731-5G |
Cas.: 133318-40-8 | Purity: 97% | Diethyl Ketomalonate Monohydrate | ESD-859541-25G |
Cas.: 72828-03-6 | Reactive Red 180 | ESD-910169-1KG | |
Cas.: 72828-03-6 | Reactive Red 180 | ESD-910169-250G | |
Cas.: 1349904-82-0 | Purity: 98% | taccalonolide AJ | ESD-910170-5MG |
Cas.: 30273-41-7 | Purity: ≥98% | 2,4-Dibromo-6-Methylaniline | ESD-859838-5G |
Cas.: 1188264-05-2 | Purity: 95% | 3-(1-Aminoethyl)benzonitrile hydrochloride | ESD-910171-1G |
Cas.: 1188264-05-2 | Purity: 95% | 3-(1-Aminoethyl)benzonitrile hydrochloride | ESD-910171-250MG |
Cas.: 1188264-05-2 | Purity: 95% | 3-(1-Aminoethyl)benzonitrile hydrochloride | ESD-910171-100MG |
Cas.: 33890-03-8 | Purity: ≥95% | 4-Aminobenzene-1,3-dicarboxylic acid | ESD-825769-5G |
Cas.: 33890-03-8 | Purity: ≥95% | 4-Aminobenzene-1,3-dicarboxylic acid | ESD-825769-250MG |
Cas.: 355423-48-2 | Purity: 95% | 5-Bromo-2,4-difluorophenol | ESD-910172-1G |
Cas.: 355423-48-2 | Purity: 95% | 5-Bromo-2,4-difluorophenol | ESD-910172-250MG |
Cas.: 95975-55-6 | Purity: BR | Guggulsterone E&Z | ESD-873825-5MG |
Cas.: 3207-12-3 | Purity: 98% | 2-Amino-2-methyl-1-propanol hydrochloride | ESD-801550-25G |
Cas.: 30273-41-7 | Purity: ≥98% | 2,4-Dibromo-6-Methylaniline | ESD-859838-25G |
Cas.: 92507-97-6 | Purity: 98% | 1-ETHYL-2,3-DIMETHYLIMIDAZOLIUM CHLORIDE | ESD-834558-500G |
Cas.: 92507-97-6 | Purity: 98% | 1-ETHYL-2,3-DIMETHYLIMIDAZOLIUM CHLORIDE | ESD-834558-100G |
Cas.: 92507-97-6 | Purity: 98% | 1-ETHYL-2,3-DIMETHYLIMIDAZOLIUM CHLORIDE | ESD-834558-25G |
Cas.: 92507-97-6 | Purity: 98% | 1-ETHYL-2,3-DIMETHYLIMIDAZOLIUM CHLORIDE | ESD-834558-5G |
Cas.: 6147-66-6 | Purity: 70% in water | Diallylamine Hydrochloride | ESD-860105-25G |
Cas.: 3483-11-2 | Purity: 95% | Lithium acetoacetate | ESD-812311-250MG |
Cas.: 113020-21-6 | Purity: 97% | 1,1-Cyclopropanedicarboxylic acid monomethyl ester | ESD-804921-25G |
Cas.: 143924-45-2 | Purity: 95% | 2-(Piperidin-4-yl)pyridine dihydrochloride | ESD-910173-1G |
Cas.: 143924-45-2 | Purity: 95% | 2-(Piperidin-4-yl)pyridine dihydrochloride | ESD-910173-250MG |
Cas.: 40483-47-4 | Purity: 98% | 5-Methyl-1,2,4-oxadiazol-3-amine | ESD-839512-500MG |
Cas.: 51227-28-2 | Purity: 95% | 4-Methyl-3-pyridinecarboxaldehyde | ESD-910174-1G |
Cas.: 51227-28-2 | Purity: 95% | 4-Methyl-3-pyridinecarboxaldehyde | ESD-910174-5G |
Cas.: 51227-28-2 | Purity: 95% | 4-Methyl-3-pyridinecarboxaldehyde | ESD-910174-250MG |
Cas.: 4943-85-5 | Purity: 97% | 2-Amino-benzoesaeure-o-toluidid; | ESD-834416-25G |
Cas.: 4943-85-5 | Purity: 97% | 2-Amino-benzoesaeure-o-toluidid; | ESD-834416-5G |
Cas.: 4943-85-5 | Purity: 97% | 2-Amino-benzoesaeure-o-toluidid; | ESD-834416-1G |
Cas.: 10563-23-2 | Purity: ≥97% | N-Ethyl-1,3-Propanediamine | ESD-859444-1G |
Cas.: 1060802-23-4 | Purity: 95% | 5-Bromo-2-chloroisonicotinaldehyde | ESD-910175-1G |
Cas.: 1060802-23-4 | Purity: 95% | 5-Bromo-2-chloroisonicotinaldehyde | ESD-910175-5G |
Cas.: 1060802-23-4 | Purity: 95% | 5-Bromo-2-chloroisonicotinaldehyde | ESD-910175-10G |
Cas.: 436799-34-7 | Purity: 95% | 3,5-Dibromo-2-iodopyridine | ESD-910176-1G |
Cas.: 1626387-80-1 | Purity: 99% | AZD3759 | ESD-873040-25MG |
Cas.: 1626387-80-1 | Purity: 99% | AZD3759 | ESD-873040-100MG |
Cas.: 1626387-80-1 | Purity: 99% | AZD3759 | ESD-873040-500MG |
Cas.: 2153472-91-2 | Purity: 95% | 2,2,2-trifluoro-1-(2-fluorophenyl)ethan-1-amine hydrochloride | ESD-910177-1G |
Cas.: 2153472-91-2 | Purity: 95% | 2,2,2-trifluoro-1-(2-fluorophenyl)ethan-1-amine hydrochloride | ESD-910177-250MG |
Cas.: 6668-56-0 | Purity: 95% | 4-Fluoro-3-nitrobenzenesulfonylChloride | ESD-829381-5G |
Cas.: 6668-56-0 | Purity: 95% | 4-Fluoro-3-nitrobenzenesulfonylChloride | ESD-829381-1G |
Cas.: 6668-56-0 | Purity: 95% | 4-Fluoro-3-nitrobenzenesulfonylChloride | ESD-829381-250MG |
Cas.: 23007-85-4 | Purity: ≥98% | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineHydrochloride | ESD-832930-1G |
Cas.: 475460-77-6 | Purity: >98.0%(HPLC) | 1,4-Di(1-pyrenyl)benzene | ESD-861632-250MG |
Cas.: 1136-89-6 | Purity: 99% | 1-Naphthyl phosphate | ESD-814862-250MG |
Cas.: 69360-26-5 | Purity: 97% | 2-Cyanobenzene-1-sulfonylchloride | ESD-829355-25G |
Cas.: 69360-26-5 | Purity: 97% | 2-Cyanobenzene-1-sulfonylchloride | ESD-829355-5G |
Cas.: 69360-26-5 | Purity: 97% | 2-Cyanobenzene-1-sulfonylchloride | ESD-829355-1G |
Cas.: 532-18-3 | Purity: 98% | 2,2′-Dinaphthylamine | ESD-806541-5G |
Cas.: 1014645-87-4 | Purity: 95% | methyl 4-(1-aminocyclopropyl)benzoate hydrochloride | ESD-828317-1G |
Cas.: 1014645-87-4 | Purity: 95% | methyl 4-(1-aminocyclopropyl)benzoate hydrochloride | ESD-828317-250MG |
Cas.: 1014645-87-4 | Purity: 95% | methyl 4-(1-aminocyclopropyl)benzoate hydrochloride | ESD-828317-50MG |
Cas.: 5586-73-2 | Purity: 97% | 3,3-Diphenylpropylamine | ESD-858252-25G |
Cas.: 5586-73-2 | Purity: 97% | 3,3-Diphenylpropylamine | ESD-858252-100G |
Cas.: 5411-14-3 | Purity: 97% | o-Phenylenedioxydiacetic acid | ESD-816255-1G |
Cas.: 20605-01-0 | Purity: 97% | Diethyl bis(hydroxymethyl)malonate | ESD-806595-5G |
Cas.: 120974-97-2 | Purity: 95% | (E)-Methyl 2-(methoxyimino)-2-(o-tolyl)acetate | ESD-850030-1G |
Cas.: 38763-29-0 | Purity: 98% | Worenine | ESD-910178-10MG |
Cas.: 38763-29-0 | Purity: 98% | Worenine | ESD-910178-50MG |
Cas.: 62009-47-6 | Purity: 98% | 2-Aminomalonamide | ESD-831855-250MG |
Cas.: 1263286-07-2 | Purity: 98% | 5-Acetyl-2-bromo-benzoic acid methyl ester | ESD-829410-5G |
Cas.: 1263286-07-2 | Purity: 98% | 5-Acetyl-2-bromo-benzoic acid methyl ester | ESD-829410-1G |
Cas.: 1263286-07-2 | Purity: 98% | 5-Acetyl-2-bromo-benzoic acid methyl ester | ESD-829410-250MG |
Cas.: 154127-42-1 | Purity: 97% | (S)-4-Hydroxy-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno-[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide | ESD-831892-5G |
Cas.: 154127-42-1 | Purity: 97% | (S)-4-Hydroxy-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno-[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide | ESD-831892-1G |
Cas.: 154127-42-1 | Purity: 97% | (S)-4-Hydroxy-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno-[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide | ESD-831892-250MG |
Cas.: 128231-55-0 | Purity: ≥95% | 1-(4-tert-butylphenyl)hydrazine hydrochloride | ESD-827983-1G |
Cas.: 545380-34-5 | Purity: 99% | QNZ (EVP4593) | ESD-873073-25MG |
Cas.: 493-01-6 | Purity: 98% | cis-Decahydronaphthalene | ESD-858289-500ML |
Cas.: 6197-39-3 | Purity: 98% | Norarecoline hydrochloride | ESD-910179-10MG |
Cas.: 158014-03-0 | Purity: 99% | 2-Cyano-2-(hydroxyimino)acetic Acid Ethyl Ester Potassium Salt | ESD-910180-25G |
Cas.: 158014-03-0 | Purity: 99% | 2-Cyano-2-(hydroxyimino)acetic Acid Ethyl Ester Potassium Salt | ESD-910180-5G |
Cas.: 13201-14-4 | Purity: 98% | Dihydrocucurbitacin B | ESD-910181-5MG |
Cas.: 158014-03-0 | Purity: 99% | 2-Cyano-2-(hydroxyimino)acetic Acid Ethyl Ester Potassium Salt | ESD-910180-1G |
Cas.: 13201-14-4 | Purity: 98% | Dihydrocucurbitacin B | ESD-910181-10MG |
Cas.: 56344-32-2 | Purity: >97.0%(GC)(T) | N-(3-Hydroxypropyl)ethylenediamine | ESD-855049-1G |
Cas.: 19716-60-0 | Purity: 98% | 8-oxo-epiberberine | ESD-910182-10MG |
Cas.: 5651-88-7 | Purity: 97% | Phenyl propargyl sulfide | ESD-815499-1ML |
Cas.: 13005-09-9 | Purity: 98% | Dehydrocorydaline nitrate | ESD-910183-10MG |
Cas.: 59146-56-4 | Purity: 96% | 2-(2-Bromoethoxy)tetrahydro-2H-pyran | ESD-802508-1G |
Cas.: 27178-16-1 | Purity: ≥95% | Diisodecyl Adipate | ESD-865743-2.5L |
Cas.: 1067-74-9 | Purity: 98% | Methyl diethylphosphonoacetate | ESD-830210-100G |
Cas.: 627-95-2 | Purity: 98%, low contains water | 5-Aminovaleric Acid Hydrochloride (Low water content) | ESD-871462-1G |
Cas.: 19716-61-1 | Purity: 98% | 8-Oxocoptisine | ESD-910185-10MG |
Cas.: 19716-61-1 | Purity: 98% | 8-Oxocoptisine | ESD-910185-5MG |
Cas.: 190656-01-0 | Purity: ≥98% | 9-Fluorenylmethyl N-Hydroxycarbamate | ESD-859689-5G |
Cas.: 3566-44-7 | Purity: ≥98%(T) | Variamine Blue B [Redox Indicator] | ESD-863252-1G |
Cas.: 3566-44-7 | Purity: ≥98%(T) | Variamine Blue B [Redox Indicator] | ESD-863252-5G |
Cas.: 9002-92-0 | Purity: 30%(Brij-35) in H2O | Brij | ESD-910186-1L |
Cas.: 9002-92-0 | Purity: 30%(Brij-35) in H2O | Brij | ESD-910186-500ML |
Cas.: 64275-73-6 | Purity: >90.0%(GC) | cis-5-Octen-1-ol | ESD-849429-5G |
Cas.: 64275-73-6 | Purity: >90.0%(GC) | cis-5-Octen-1-ol | ESD-849429-25G |
Cas.: 128595-07-3 | Purity: 98% | N-(Cyclopentyloxycarbonyloxy)succinimide | ESD-835365-5G |
Cas.: 6427-66-3 | Purity: 97% | p-Azidobenzoic Acid | ESD-828382-1G |
Cas.: 22055-22-7 | Purity: 98% | diphyllin | ESD-910187-10MG |
Cas.: 22055-22-7 | Purity: 98% | diphyllin | ESD-910187-5MG |
Cas.: 92-64-8 | Purity: ≥98% | N-Cyanoethyl-Hydroxyethyl Aniline | ESD-860370-100G |
Cas.: 92-64-8 | Purity: ≥98% | N-Cyanoethyl-Hydroxyethyl Aniline | ESD-860370-500G |
Cas.: 25190-06-1 | Purity: average Mn ~2,900 | Polytetramethylene Ether Glycol | ESD-903557-500ML |
Cas.: 24292-52-2 | Purity: 98% | Hesperidin methylchalcone | ESD-910188-1G |
Cas.: 24292-52-2 | Purity: 98% | Hesperidin methylchalcone | ESD-910188-5G |
Cas.: 642-05-7 | Purity: 98% | Alloimperatorin | ESD-910190-5MG |
Cas.: 123-01-3 | Purity: 99,5% | 1-Phenyldodecane | ESD-910189-5ML |
Cas.: 123-01-3 | Purity: 99,5% | 1-Phenyldodecane | ESD-910189-25ML |
Cas.: 2893-33-6 | Purity: 97% | 6-Isocyanopicolinonitrile | ESD-838071-25G |
Cas.: 603-47-4 | Purity: AR | Methyl vioet | ESD-910191-100G |
Cas.: 603-47-4 | Purity: AR | Methyl vioet | ESD-910191-500G |
Cas.: 2893-33-6 | Purity: 97% | 6-Isocyanopicolinonitrile | ESD-838071-100G |
Cas.: 691007-09-7 | Purity: 95% | 3-[2-[4-[(E)-C-(2,4-difluorophenyl)-N-hydroxycarbonimidoyl]piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[ 1,2-a]pyrimidin-4-one | ESD-910192-5MG |
Cas.: 691007-09-7 | Purity: 95% | 3-[2-[4-[(E)-C-(2,4-difluorophenyl)-N-hydroxycarbonimidoyl]piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[ 1,2-a]pyrimidin-4-one | ESD-910192-10MG |
Cas.: 3164-85-0 | Purity: 95% | Potassium 2-ethylhexanoate | ESD-830594-25G |
Cas.: 3164-85-0 | Purity: 95% | Potassium 2-ethylhexanoate | ESD-830594-100G |
Cas.: 68-34-8 | Purity: 98% | p-Toluenesulfonanilide | ESD-858191-25G |
Cas.: 1087223-70-8 | Purity: 98% | 1-Methoxy Amiodarone | ESD-910193-5MG |
Cas.: 21763-80-4 | Purity: 98% | 2-(3,4-Dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-4H-chromen-4-one | ESD-910194-5MG |
Cas.: 21763-80-4 | Purity: 98% | 2-(3,4-Dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-4H-chromen-4-one | ESD-910194-10MG |
Cas.: 23838-17-7 | Purity: 98% | 7-(((2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trien-1-yl)oxy)-2H-chromen-2-one | ESD-910195-5MG |
Cas.: 87233-62-3 | Purity: 98% | Emedastine Difumerate | ESD-850000-250MG |
Cas.: 29808-81-9 | Purity: 95% | 2-nitroacridine | ESD-908869-100MG |
Cas.: 95635-56-6 | Purity: > 99% HPLC, solid | RANOLAZINE DIHYDROCHLORIDE | ESD-838255-500MG |
Cas.: 155899-66-4 | Purity: 97% | (3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol | ESD-822276-25G |
Cas.: 155899-66-4 | Purity: 97% | (3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol | ESD-822276-5G |
Cas.: 155899-66-4 | Purity: 97% | (3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol | ESD-822276-1G |
Cas.: 85237-56-5 | Purity: ≥98% | 3-Amino-4-hydroxy-N-methylbenzenesulphonamide monohydrochloride | ESD-858081-5G |
Cas.: 1797-74-6 | Purity: ≥98% | Allyl Phenylacetate | ESD-867268-500ML |
Cas.: 1217542-13-6 | Purity: 95% | [[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propyl carbonate | ESD-910196-5MG |
Cas.: 176793-04-7 | Purity: 97% | 2-Bromo-1,3,4-trifluorobenzene | ESD-803827-500MG |
Cas.: 301669-82-9 | Purity: 95% | 2-[(6-methoxy-1H-benzimidazol-2-yl)sulfinylmethyl]-3,5-dimethyl-1H-pyridin-4-one | ESD-910197-5MG |
Cas.: 313995-40-3 | Purity: 95% | (2R)-2-aminobut-3-en-1-ol,hydrochloride | ESD-910198-1G |
Cas.: 321-07-3 | Purity: 95% | 1-Phenyl-3-(trifluoromethyl)-1H-pyrazol-5(4H)-one | ESD-910199-5G |
Cas.: 313995-40-3 | Purity: 95% | (2R)-2-aminobut-3-en-1-ol,hydrochloride | ESD-910198-250MG |
Cas.: 321-07-3 | Purity: 95% | 1-Phenyl-3-(trifluoromethyl)-1H-pyrazol-5(4H)-one | ESD-910199-1G |
Cas.: 313995-40-3 | Purity: 95% | (2R)-2-aminobut-3-en-1-ol,hydrochloride | ESD-910198-100MG |
Cas.: 1215213-92-5 | Purity: 95% | (S)-1-(4-(1-Aminoethyl)phenyl)ethanone hydrochloride | ESD-910200-1G |
Cas.: 1168139-52-3 | Purity: 95% | (R)-1-(3-Chlorophenyl)propan-1-amine | ESD-910201-1G |
Cas.: 82857-39-4 | Purity: 95% | (3S)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine,hydrochloride | ESD-910202-5MG |
Cas.: 4025-71-2 | Purity: 97% | 2-Phenylethanesulfonylchloride | ESD-829357-5G |
Cas.: 4025-71-2 | Purity: 97% | 2-Phenylethanesulfonylchloride | ESD-829357-1G |
Cas.: 4025-71-2 | Purity: 97% | 2-Phenylethanesulfonylchloride | ESD-829357-250MG |
Cas.: 6968-24-7 | Purity: 95% | 2,6-Dibromo-4-methylaniline | ESD-910203-5G |
Cas.: 61788-32-7 | Purity: 99% | Hydrogenated terphenyls | ESD-875092-5G |
Cas.: 4102-53-8 | Purity: 98% | 4-Iodo-2,6-dimethylaniline | ESD-824006-5G |
Cas.: 4102-53-8 | Purity: 98% | 4-Iodo-2,6-dimethylaniline | ESD-824006-1G |
Cas.: 4102-53-8 | Purity: 98% | 4-Iodo-2,6-dimethylaniline | ESD-824006-250MG |
Cas.: 5086-74-8 | Purity: 98% | Tetramisole hydrochloride | ESD-830839-100G |
Cas.: 5086-74-8 | Purity: 98% | Tetramisole hydrochloride | ESD-830839-25G |
Cas.: 890-98-2 | Purity: ≥98%(GC) | Benzyl DL-Mandelate | ESD-863282-1G |
Cas.: 5086-74-8 | Purity: 98% | Tetramisole hydrochloride | ESD-830839-5G |
Cas.: 6375-17-3 | Purity: 97% | 2′-Hydroxy-5′-methylacetanilide | ESD-858203-25G |
Cas.: 516-03-0 | Purity: 96% | Iron(II) oxalate hydrate | ESD-836554-100G |
Cas.: 17672-22-9 | Purity: ≥98% | 6-Amino-o-cresol | ESD-801629-250MG |
Cas.: 516-03-0 | Purity: Fe>30.5% | Ferrous oxalate | ESD-910204-500G |
Cas.: 516-03-0 | Purity: Fe>30.5% | Ferrous oxalate | ESD-910204-100G |
Cas.: 518070-29-6 | Purity: 95% | 2-Fluoro-4-methylBenzenesulfonylchloride | ESD-829361-5G |
Cas.: 518070-29-6 | Purity: 95% | 2-Fluoro-4-methylBenzenesulfonylchloride | ESD-829361-1G |
Cas.: 187101-94-6 | Purity: ≥98% | Nn-Butyl-N-Benzyl-m-Toluidine | ESD-859678-25G |
Cas.: 6331-71-1 | Purity: 97% | 4-Amino-N,N-dimethylbenzamide | ESD-836661-5G |
Cas.: 6331-71-1 | Purity: 97% | 4-Amino-N,N-dimethylbenzamide | ESD-836661-1G |
Cas.: 6331-71-1 | Purity: 97% | 4-Amino-N,N-dimethylbenzamide | ESD-836661-250MG |
Cas.: 6456-74-2 | Purity: 98% | tert-Butyl glycinate | ESD-831181-5G |
Cas.: 53123-88-9 | Purity: 98% | Rapamycin | ESD-817297-5G |
Cas.: 77513-40-7 | Purity: 98% | Benzyl 3-hydroxybenzoate | ESD-829391-250MG |
Cas.: 98-81-7 | Purity: 95% stabilized with TBC | Alpha-Bromostyrene | ESD-830496-1G |
Cas.: 20035-08-9 | Purity: 96% | Sodium ethanesulfinate | ESD-831693-100G |
Cas.: 20035-08-9 | Purity: 96% | Sodium ethanesulfinate | ESD-831693-25G |
Cas.: 20035-08-9 | Purity: 96% | Sodium ethanesulfinate | ESD-831693-5G |
Cas.: 20035-08-9 | Purity: 96% | Sodium ethanesulfinate | ESD-831693-1G |
Cas.: 92136-39-5 | Purity: 97% | N-Boc-propargylamine | ESD-836842-100G |
Cas.: 92136-39-5 | Purity: 97% | N-Boc-propargylamine | ESD-836842-25G |
Cas.: 92136-39-5 | Purity: 97% | N-Boc-propargylamine | ESD-836842-5G |
Cas.: 92136-39-5 | Purity: 97% | N-Boc-propargylamine | ESD-836842-1G |
Cas.: 41372-08-1 | Purity: ≥98% | Methyldopa hydrate | ESD-838210-5G |
Cas.: 3218-50-6 | Purity: 98% | 2,5-Dichlorophenylacetonitrile | ESD-829247-25G |
Cas.: 3218-50-6 | Purity: 98% | 2,5-Dichlorophenylacetonitrile | ESD-829247-5G |
Cas.: 3218-50-6 | Purity: 98% | 2,5-Dichlorophenylacetonitrile | ESD-829247-1G |
Cas.: 3218-50-6 | Purity: 98% | 2,5-Dichlorophenylacetonitrile | ESD-829247-250MG |
Cas.: 621-91-0 | Purity: ≥98% | 1,4-Dibenzyloxybenzene | ESD-860114-1G |
Cas.: 35354-86-0 | Purity: ≥98% | N-(Acetoacetyl)anthranilic acid | ESD-859882-100G |
Cas.: 1338545-01-9 | Purity: 98% | TOPK inhibitor-1 HCl | ESD-910205-10MG |
Cas.: 1338545-01-9 | Purity: 98% | TOPK inhibitor-1 HCl | ESD-910205-25MG |
Cas.: 1429179-07-6 | Purity: 98% | IDH-889 | ESD-910206-10MG |
Cas.: 1429179-07-6 | Purity: 98% | IDH-889 | ESD-910206-25MG |
Cas.: 732278-52-3 | Purity: 98% | AMPA/kainate antagonist-3 | ESD-910207-10MG |
Cas.: 732278-52-3 | Purity: 98% | AMPA/kainate antagonist-3 | ESD-910207-25MG |
Cas.: 133229-11-5 | Purity: 98% | 1-(4-Methanesulfonamidophenoxy)-3-(N-methyl-3,4-dichlorophenylethylamino)-2-propanol hydrochloride | ESD-910208-10MG |
Cas.: 133229-11-5 | Purity: 98% | 1-(4-Methanesulfonamidophenoxy)-3-(N-methyl-3,4-dichlorophenylethylamino)-2-propanol hydrochloride | ESD-910208-50MG |
Cas.: 35846-53-8 | Purity: 98% | Maytansine | ESD-910209-10MG |
Cas.: 35846-53-8 | Purity: 98% | Maytansine | ESD-910209-50MG |
Cas.: 503105-88-2 | Purity: 98% | BRITE338733 | ESD-910210-10MG |
Cas.: 503105-88-2 | Purity: 98% | BRITE338733 | ESD-910210-50MG |
Cas.: 1088991-73-4 | Purity: 98% | Filorexant | ESD-910211-5MG |
Cas.: 1088991-73-4 | Purity: 98% | Filorexant | ESD-910211-10MG |
Cas.: 1206801-37-7 | Purity: 99% | Merestinib dihydrochloride | ESD-910212-5MG |
Cas.: 1206801-37-7 | Purity: 99% | Merestinib dihydrochloride | ESD-910212-10MG |
Cas.: 1349719-98-7 | Purity: 98% | (S)-JQ-35 | ESD-910213-5MG |
Cas.: 1349719-98-7 | Purity: 98% | (S)-JQ-35 | ESD-910213-10MG |
Cas.: 1430806-04-4 | Purity: 98% | 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide | ESD-910214-5MG |
Cas.: 1430806-04-4 | Purity: 98% | 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide | ESD-910214-10MG |
Cas.: 1443235-95-7 | Purity: 98% | ethyl 4-(3-methacrylamidophenyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylate | ESD-910215-5MG |
Cas.: 1443235-95-7 | Purity: 98% | ethyl 4-(3-methacrylamidophenyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylate | ESD-910215-10MG |
Cas.: 1672668-24-4 | Purity: 98% | PT2977 | ESD-910216-5MG |
Cas.: 1700637-55-3 | Purity: 98% | CD38 inhibitor 78c | ESD-910217-5MG |
Cas.: 1700637-55-3 | Purity: 98% | CD38 inhibitor 78c | ESD-910217-10MG |
Cas.: 2243736-45-8 | Purity: 98% | FB23-2 (FTO Demethylase inhibitor FB23-2) | ESD-910218-5MG |
Cas.: 2243736-45-8 | Purity: 98% | FB23-2 (FTO Demethylase inhibitor FB23-2) | ESD-910218-10MG |
Cas.: 350997-39-6 | Purity: 98% | OGG1 inhibitor O8 | ESD-910219-5MG |
Cas.: 350997-39-6 | Purity: 98% | OGG1 inhibitor O8 | ESD-910219-10MG |
Cas.: 849675-87-2 | Purity: 98% | HM30181 mesylate (Encequidar mesylate) | ESD-910220-5MG |
Cas.: 849675-87-2 | Purity: 98% | HM30181 mesylate (Encequidar mesylate) | ESD-910220-10MG |
Cas.: 865231-46-5 | Purity: 98% | AMG-837 | ESD-910221-5MG |
Cas.: 865231-46-5 | Purity: 98% | AMG-837 | ESD-910221-10MG |
Cas.: 916141-36-1 | Purity: 98% | TCS 1102 | ESD-910222-5MG |
Cas.: 916141-36-1 | Purity: 98% | TCS 1102 | ESD-910222-10MG |
Cas.: 925434-55-5 | Purity: 98% | SRT1720 | ESD-910223-5MG |
Cas.: 925434-55-5 | Purity: 98% | SRT1720 | ESD-910223-10MG |
Cas.: 102067-84-5 | Purity: 98% | Sappanone A | ESD-910224-5MG |
Cas.: 102067-84-5 | Purity: 98% | Sappanone A | ESD-910224-10MG |
Cas.: 1026134-63-3 | Purity: 98% | Nelonicline | ESD-910225-5MG |
Cas.: 1026134-63-3 | Purity: 98% | Nelonicline | ESD-910225-10MG |
Cas.: 1061337-51-6 | Purity: 98% | Lefamulin (BC-3781) | ESD-910226-5MG |
Cas.: 1061337-51-6 | Purity: 98% | Lefamulin (BC-3781) | ESD-910226-10MG |
Cas.: 1125632-93-0 | Purity: 98% | Takeda-6d | ESD-910227-5MG |
Cas.: 1125632-93-0 | Purity: 98% | Takeda-6d | ESD-910227-10MG |
Cas.: 114014-15-2 | Purity: 98% | Cathepsin L inhibitor III | ESD-910228-5MG |
Cas.: 114014-15-2 | Purity: 98% | Cathepsin L inhibitor III | ESD-910228-10MG |
Cas.: 1166393-85-6 | Purity: 98% | PF4618433 | ESD-910229-5MG |
Cas.: 1166393-85-6 | Purity: 98% | PF4618433 | ESD-910229-10MG |
Cas.: 1180676-33-8 | Purity: 98% | PS-47 | ESD-910230-5MG |
Cas.: 1180676-33-8 | Purity: 98% | PS-47 | ESD-910230-10MG |
Cas.: 1204310-73-5 | Purity: 98% | WP1122 | ESD-910231-5MG |
Cas.: 1204310-73-5 | Purity: 98% | WP1122 | ESD-910231-10MG |
Cas.: 1207195-44-5 | Purity: 98% | SR-16507 | ESD-910232-5MG |
Cas.: 1207195-44-5 | Purity: 98% | SR-16507 | ESD-910232-10MG |
Cas.: 1231952-55-8 | Purity: 98% | SRT3025 | ESD-910233-5MG |
Cas.: 1231952-55-8 | Purity: 98% | SRT3025 | ESD-910233-10MG |
Cas.: 1241725-89-2 | Purity: 98% | Bisindolylmaleimide X(Ro 31-8425) | ESD-910234-5MG |
Cas.: 1241725-89-2 | Purity: 98% | Bisindolylmaleimide X(Ro 31-8425) | ESD-910234-10MG |
Cas.: 1308256-94-1 | Purity: 98% | LHW090-A7 | ESD-910235-5MG |
Cas.: 1308256-94-1 | Purity: 98% | LHW090-A7 | ESD-910235-10MG |
Cas.: 133876-92-3 | Purity: 99%, 20000 FU/g | Nattokinase | ESD-910236-10MG |
Cas.: 1346013-80-6 | Purity: 98% | UE2343 (Xanamm) | ESD-910237-5MG |
Cas.: 1346013-80-6 | Purity: 98% | UE2343 (Xanamm) | ESD-910237-10MG |
Cas.: 1394371-75-5 | Purity: 98% | nAChR agonist 1 | ESD-910238-5MG |
Cas.: 1394371-75-5 | Purity: 98% | nAChR agonist 1 | ESD-910238-10MG |
Cas.: 1399177-37-7 | Purity: 98% | TVB-2640 | ESD-910239-5MG |
Cas.: 1399177-37-7 | Purity: 98% | TVB-2640 | ESD-910239-10MG |
Cas.: 146714-97-8 | Purity: 98% | WAY 100635 Hydrochloride | ESD-910241-5MG |
Cas.: 146714-97-8 | Purity: 98% | WAY 100635 Hydrochloride | ESD-910241-10MG |
Cas.: 1550053-02-5 | Purity: 98% | BRD3308 | ESD-910243-5MG |
Cas.: 1550053-02-5 | Purity: 98% | BRD3308 | ESD-910243-10MG |
Cas.: 1610964-64-1 | Purity: 98% | PTC596 | ESD-910244-5MG |
Cas.: 1610964-64-1 | Purity: 98% | PTC596 | ESD-910244-10MG |
Cas.: 1643489-24-0 | Purity: 98% | Tavapadon | ESD-910245-5MG |
Cas.: 1643489-24-0 | Purity: 98% | Tavapadon | ESD-910245-10MG |
Cas.: 1646839-59-9 | Purity: 98% | ONO-7475 | ESD-910246-5MG |
Cas.: 1646839-59-9 | Purity: 98% | ONO-7475 | ESD-910246-10MG |
Cas.: 1800070-77-2 | Purity: 98% | Borusertib | ESD-910247-5MG |
Cas.: 1800070-77-2 | Purity: 98% | Borusertib | ESD-910247-10MG |
Cas.: 1898207-64-1 | Purity: 98% | DS-1001b | ESD-910248-5MG |
Cas.: 1898207-64-1 | Purity: 98% | DS-1001b | ESD-910248-10MG |
Cas.: 1903768-17-1 | Purity: 98% | Danicopan (ACH-4471) | ESD-910249-5MG |
Cas.: 1903768-17-1 | Purity: 98% | Danicopan (ACH-4471) | ESD-910249-10MG |
Cas.: 1951431-22-3 | Purity: 98% | BKI1369 | ESD-910250-5MG |
Cas.: 1951431-22-3 | Purity: 98% | BKI1369 | ESD-910250-10MG |
Cas.: 1966107-70-9 | Purity: 98% | MYC inhibitor DC-34 | ESD-910251-5MG |
Cas.: 1966107-70-9 | Purity: 98% | MYC inhibitor DC-34 | ESD-910251-10MG |
Cas.: 1975145-82-4 | Purity: 98% | BK-1361(cyclo(RLsKDK)) | ESD-910252-5MG |
Cas.: 1975145-82-4 | Purity: 98% | BK-1361(cyclo(RLsKDK)) | ESD-910252-10MG |
Cas.: 208264-84-0 | Purity: 98% | Caspase-1/4 Chromogenic Substrate | ESD-910253-5MG |
Cas.: 208264-84-0 | Purity: 98% | Caspase-1/4 Chromogenic Substrate | ESD-910253-10MG |
Cas.: 2089251-33-0 | Purity: 98% | Lipid 5 | ESD-910254-5MG |
Cas.: 2089251-33-0 | Purity: 98% | Lipid 5 | ESD-910254-10MG |
Cas.: 2131223-64-6 | Purity: 98% | YW1128 | ESD-910255-5MG |
Cas.: 2131223-64-6 | Purity: 98% | YW1128 | ESD-910255-10MG |
Cas.: 2131223-69-1 | Purity: 98% | YW1159 | ESD-910256-5MG |
Cas.: 2131223-69-1 | Purity: 98% | YW1159 | ESD-910256-10MG |
Cas.: 217099-14-4 | Purity: 98% | Cyclo(RGDyK) | ESD-910257-5MG |
Cas.: 217099-14-4 | Purity: 98% | Cyclo(RGDyK) | ESD-910257-10MG |
Cas.: 2230211-82-0 | Purity: 98% | ATX-081 | ESD-910258-5MG |
Cas.: 2230211-82-0 | Purity: 98% | ATX-081 | ESD-910258-10MG |
Cas.: 230299-95-3 | Purity: 98% | Apelin-36 | ESD-910259-5MG |
Cas.: 230299-95-3 | Purity: 98% | Apelin-36 | ESD-910259-10MG |
Cas.: 2408648-20-2 | Purity: 98% | BO-264 | ESD-910260-5MG |
Cas.: 2408648-20-2 | Purity: 98% | BO-264 | ESD-910260-10MG |
Cas.: 2414674-71-6 | Purity: 97% | SUVN-911(compound 9h) | ESD-910261-5MG |
Cas.: 2414674-71-6 | Purity: 97% | SUVN-911(compound 9h) | ESD-910261-10MG |
Cas.: 283167-06-6 | Purity: 98% | FK962 | ESD-910262-5MG |
Cas.: 283167-06-6 | Purity: 98% | FK962 | ESD-910262-10MG |
Cas.: 325457-89-4 | Purity: 98% | ICA-027243 | ESD-910263-5MG |
Cas.: 325457-89-4 | Purity: 98% | ICA-027243 | ESD-910263-10MG |
Cas.: 350992-10-8 | Purity: 98% | Bifeprunox | ESD-910264-5MG |
Cas.: 350992-10-8 | Purity: 98% | Bifeprunox | ESD-910264-10MG |
Cas.: 403848-57-7 | Purity: 98% | Caspase-9 Inhibitor III (Ac-LEHD-CMK) | ESD-910265-5MG |
Cas.: 403848-57-7 | Purity: 98% | Caspase-9 Inhibitor III (Ac-LEHD-CMK) | ESD-910265-10MG |
Cas.: 40592-88-9 | Purity: 98% | TLR4-IN-C34 | ESD-910266-5MG |
Cas.: 40592-88-9 | Purity: 98% | TLR4-IN-C34 | ESD-910266-10MG |
Cas.: 473382-50-2 | Purity: 98% | Akt-I-1,2 HCl | ESD-910267-5MG |
Cas.: 473382-50-2 | Purity: 98% | Akt-I-1,2 HCl | ESD-910267-10MG |
Cas.: 515141-51-2 | Purity: 98% | GW 803430 | ESD-910268-5MG |
Cas.: 515141-51-2 | Purity: 98% | GW 803430 | ESD-910268-10MG |
Cas.: 582316-00-5 | Purity: 98% | MX1013 | ESD-910269-5MG |
Cas.: 582316-00-5 | Purity: 98% | MX1013 | ESD-910269-10MG |
Cas.: 676266-31-2 | Purity: 98% | sudoterb | ESD-910270-5MG |
Cas.: 676266-31-2 | Purity: 98% | sudoterb | ESD-910270-10MG |
Cas.: 720000-48-6 | Purity: 95% | 2-(5-Chloro-1H-indol-2-yl)acetic acid | ESD-910271-5MG |
Cas.: 720000-48-6 | Purity: 95% | 2-(5-Chloro-1H-indol-2-yl)acetic acid | ESD-910271-10MG |
Cas.: 732973-87-4 | Purity: 98% | GOT1 inhibitor 2c | ESD-910272-5MG |
Cas.: 732973-87-4 | Purity: 98% | GOT1 inhibitor 2c | ESD-910272-10MG |
Cas.: 853299-52-2 | Purity: 98% | ATH686 | ESD-910273-5MG |
Cas.: 853299-52-2 | Purity: 98% | ATH686 | ESD-910273-10MG |
Cas.: 875863-22-2 | Purity: 98% | STING Agonist C11 | ESD-910274-5MG |
Cas.: 875863-22-2 | Purity: 98% | STING Agonist C11 | ESD-910274-10MG |
Cas.: 878489-28-2 | Purity: 98% | JNJ303 | ESD-910275-5MG |
Cas.: 878489-28-2 | Purity: 98% | JNJ303 | ESD-910275-10MG |
Cas.: 882256-55-5 | Purity: 98% | iGOT1-01 | ESD-910276-5MG |
Cas.: 882256-55-5 | Purity: 98% | iGOT1-01 | ESD-910276-10MG |
Cas.: 911115-16-7 | Purity: 98% | Decoglurant | ESD-910277-5MG |
Cas.: 911115-16-7 | Purity: 98% | Decoglurant | ESD-910277-10MG |
Cas.: 928659-17-0 | Purity: 98% | Triazavirin | ESD-910278-5MG |
Cas.: 928659-17-0 | Purity: 98% | Triazavirin | ESD-910278-10MG |
Cas.: 93718-83-3 | Purity: 98% | NSC95397 | ESD-910279-5MG |
Cas.: 93718-83-3 | Purity: 98% | NSC95397 | ESD-910279-10MG |
Cas.: 1021497-97-1 | Purity: 98% | KR-33493 | ESD-910280-10MG |
Cas.: 1103522-45-7 | Purity: 98% | Aprocitentan | ESD-910281-10MG |
Cas.: 1150701-66-8 | Purity: 98% | GSK1940029 | ESD-910282-10MG |
Cas.: 1161002-05-6 | Purity: 98% | G-15 | ESD-910283-10MG |
Cas.: 1173154-32-9 | Purity: 98% | ALB-127158A | ESD-910284-10MG |
Cas.: 1174130-61-0 | Purity: 98% | Aticaprant | ESD-910285-10MG |
Cas.: 1174161-86-4 | Purity: 98% | SCR-1481B1 | ESD-910286-10MG |
Cas.: 1186222-89-8 | Purity: 98% | 4SC-202 | ESD-910287-10MG |
Cas.: 1234015-52-1 | Purity: 98% | LY 2606368, LY-2606368 | ESD-910288-10MG |
Cas.: 1235449-52-1 | Purity: 98% | BEBT908 | ESD-910289-10MG |
Cas.: 1243259-19-9 | Purity: 98% | (2S,3S)-2-amino-3-methyl-N-(2-morpholinoethyl)pentanamide dihydrochloride | ESD-910290-10MG |
Cas.: 1260075-17-9 | Purity: 98% | IMP-1088,IMP1088,IMP1088 | ESD-910291-10MG |
Cas.: 1260533-36-5 | Purity: 96% | TAS116,TAS116 | ESD-910292-10MG |
Cas.: 1262041-49-5 | Purity: 98% | ASK IN 1 | ESD-910293-10MG |
Cas.: 1289023-67-1 | Purity: 98% | BMS-927711 | ESD-910294-10MG |
Cas.: 1292310-49-6 | Purity: 98% | IKK(epsilon)-IN-1, IKKE-IN-1 | ESD-910295-10MG |
Cas.: 1303420-67-8 | Purity: 98% | PLX 5622, PLX-5622 | ESD-910296-10MG |
Cas.: 1309357-15-0 | Purity: 98% | CX-4945 sodium salt | ESD-910297-10MG |
Cas.: 1313881-70-7 | Purity: 98% | ARQ-092 | ESD-910298-10MG |
Cas.: 131631-89-5 | Purity: 98% | N-[3-[4-[[4-(3,4-Dihydro-2-oxo-1(2H)quinolinyl)-1-piperidinyl]carbonyl]phenoxy]propyl]-acetamide | ESD-910299-10MG |
Cas.: 134665-72-8 | Purity: 98% | CNDAC HCl | ESD-910300-10MG |
Cas.: 1365267-27-1 | Purity: 98% | ensartinib | ESD-910301-10MG |
Cas.: 1377239-83-2 | Purity: 98% | MI136 | ESD-910302-10MG |
Cas.: 1397255-09-2 | Purity: 98% | AZD-3965 | ESD-910303-10MG |
Cas.: 1434635-54-7 | Purity: 98% | ND 630 | ESD-910304-10MG |
Cas.: 1443246-62-5 | Purity: 98% | 6022 | ESD-910305-10MG |
Cas.: 1446700-26-0 | Purity: 98% | Rociletinib hydrobromide | ESD-910306-10MG |
Cas.: 146669-29-6 | Purity: 98% | (RS)-MCPG | ESD-910307-10MG |
Cas.: 1474110-21-8 | Purity: 98% | GSK2981278 | ESD-910308-10MG |
Cas.: 1542135-76-1 | Purity: 98% | Lu 28-179 hydrochloride | ESD-910309-10MG |
Cas.: 1628925-77-8 | Purity: 98% | EPZ019997 | ESD-910310-10MG |
Cas.: 1630808-89-7 | Purity: 98% | FT113 | ESD-910311-10MG |
Cas.: 1637542-33-6 | Purity: 98% | az-505 | ESD-910312-10MG |
Cas.: 1642857-69-9 | Purity: 98% | TLR7-IN-1 | ESD-910313-10MG |
Cas.: 1644342-14-2 | Purity: 98% | ((1R,2S,4R)-4-((5-(1-(3-bromobenzyl)-1H-pyrazole-3-carbonyl)pyrimidin-4-yl)amino)-2-hydroxycyclopentyl)methyl sulfamate | ESD-910314-10MG |
Cas.: 1702816-75-8 | Purity: 98% | YY-20394 | ESD-910315-10MG |
Cas.: 1783816-74-9 | Purity: 98% | NVS-PAK1-1 | ESD-910316-10MG |
Cas.: 1784751-18-3 | Purity: 98% | 4-(2-(2,6-Difluorophenyl)-4-(fluorophenyl)-1H-imidazol-5-yl)pyridine | ESD-910317-10MG |
Cas.: 1784751-19-4 | Purity: 98% | TA-02 | ESD-910318-10MG |
Cas.: 1800046-95-0 | Purity: 98% | ENOblock | ESD-910319-10MG |
Cas.: 1818885-63-0 | Purity: 98% | Cereblon Ligand-Linker Conjugates 9 | ESD-910320-10MG |
Cas.: 185213-03-0 | Purity: 98% | Butabindide | ESD-910321-10MG |
Cas.: 1888305-96-1 | Purity: 98% | ERK5-IN-2 | ESD-910322-10MG |
Cas.: 192939-46-1 | Purity: 98% | Ximelagatran | ESD-910323-10MG |
Cas.: 196078-30-5 | Purity: 97% | Pramlintide Acetate | ESD-910324-10MG |
Cas.: 19608-29-8 | Purity: 99% | CB 03 01 | ESD-910325-10MG |
Cas.: 198283-73-7 | Purity: 98% | Tebanicline (ABT-594) | ESD-910326-10MG |
Cas.: 20012-10-6 | Purity: 98% | SKF 38393 | ESD-910327-10MG |
Cas.: 203115-63-3 | Purity: 98% | NSC617145(WRN inhibitor) | ESD-910328-10MG |
Cas.: 2055050-87-6 | Purity: 98% | LAU159 | ESD-910329-10MG |
Cas.: 2055536-64-4 | Purity: 98% | Cintirorgon | ESD-910330-10MG |
Cas.: 2059148-82-0 | Purity: 98% | IMP-1088 | ESD-910331-10MG |
Cas.: 2080306-21-2 | Purity: 98% | MRT-68921 hydrochloride | ESD-910332-10MG |
Cas.: 2088323-16-2 | Purity: 98% | TAS0728 | ESD-910333-10MG |
Cas.: 2091134-68-6 | Purity: 98% | AZD 4205 | ESD-910334-10MG |
Cas.: 2101317-21-7 | Purity: 98% | S-Gboxin | ESD-910335-10MG |
Cas.: 2101626-26-8 | Purity: 98% | GSK-2894631A | ESD-910336-10MG |
Cas.: 2102501-84-6 | Purity: 98% | PF-06835919 | ESD-910337-10MG |
Cas.: 2115701-93-2 | Purity: 98% | (+)-JQ1 PA | ESD-910338-10MG |
Cas.: 215303-72-3 | Purity: 98% | RWJ67657 | ESD-910339-10MG |
Cas.: 2170729-29-8 | Purity: 98% | AT-007 | ESD-910340-10MG |
Cas.: 2173134-00-2 | Purity: 98% | VUN34002(vanin-1 inhibitor) | ESD-910341-10MG |
Cas.: 218136-59-5 | Purity: 98% | SC-26196 | ESD-910342-10MG |
Cas.: 220810-26-4 | Purity: 98% | Histrelin (acetate) | ESD-910343-10MG |
Cas.: 2230820-11-6 | Purity: 98% | AZD-7648 | ESD-910344-10MG |
Cas.: 2239273-34-6 | Purity: 98% | AB928 | ESD-910345-10MG |
Cas.: 2305369-00-8 | Purity: 98% | Pomalidomide-C2-NH2 hydrochloride | ESD-910346-10MG |
Cas.: 2306388-57-6 | Purity: 98% | PROTAC ERRα ligand 2 | ESD-910347-10MG |
Cas.: 2351882-11-4 | Purity: 98% | Spastazoline | ESD-910348-10MG |
Cas.: 237430-03-4 | Purity: 98% | Alsterpaullone | ESD-910349-10MG |
Cas.: 246529-22-6 | Purity: 98% | Aramchol | ESD-910350-10MG |
Cas.: 248919-64-4 | Purity: 98% | AZD0865(Linaprazan) | ESD-910351-10MG |
Cas.: 2514-30-9 | Purity: 98% | PBIT | ESD-910352-10MG |
Cas.: 259674-19-6 | Purity: 98% | TRPM8 antagonist 14 | ESD-910353-10MG |
Cas.: 558447-26-0 | Purity: 98% | Mavorixafor (AMD-070) | ESD-910354-10MG |
Cas.: 606968-52-9 | Purity: 98% | FC131 | ESD-910355-10MG |
Cas.: 62288-83-9 | Purity: 98% | Desmopressin (Acetate) | ESD-910356-10MG |
Cas.: 675126-08-6 | Purity: 98% | Dasotraline Hydrochloride | ESD-910357-10MG |
Cas.: 701213-36-7 | Purity: 98% | Temsavir (BMS-626529) | ESD-910358-10MG |
Cas.: 75172-81-5 | Purity: 98% | Migalastat hydrochloride | ESD-910359-10MG |
Cas.: 864731-61-3 | Purity: 98% | Fluralaner | ESD-910360-10MG |
Cas.: 864821-90-9 | Purity: 98% | Eluxadoline | ESD-910361-10MG |
Cas.: 864864-17-5 | Purity: 98% | CFMTI | ESD-910362-10MG |
Cas.: 864953-29-7 | Purity: 98% | Fostemsavir (BMS-663068) | ESD-910363-10MG |
Cas.: 865305-30-2 | Purity: 98% | AF-353(Ro-4) | ESD-910364-10MG |
Cas.: 867017-68-3 | Purity: 98% | TC-S 7001 | ESD-910365-10MG |
Cas.: 86780-90-7 | Purity: 98% | Aranidipine (MPC1304) | ESD-910366-10MG |
Cas.: 868049-49-4 | Purity: 98% | Olodaterol | ESD-910367-10MG |
Cas.: 86867-01-8 | Purity: 98% | S-(5′-Adenosyl)-L-methionine chloride (SAM) | ESD-910368-10MG |
Cas.: 869296-13-9 | Purity: 98% | T-26c | ESD-910369-10MG |
Cas.: 870843-42-8 | Purity: 99% | E-2012 | ESD-910370-10MG |
Cas.: 871266-63-6 | Purity: 98% | PCI-27483 | ESD-910371-10MG |
Cas.: 877963-94-5 | Purity: 98% | LOC-14 | ESD-910372-10MG |
Cas.: 900510-03-4 | Purity: 98% | PF-3274167 (cligosiban) | ESD-910373-10MG |
Cas.: 900874-91-1 | Purity: 98% | T-00127-HEV1 | ESD-910374-10MG |
Cas.: 914638-30-5 | Purity: 98% | IDO-IN-1 | ESD-910375-10MG |
Cas.: 915303-09-2 | Purity: 98% | Indotecan (LMP400) | ESD-910376-10MG |
Cas.: 916489-36-6 | Purity: 98% | MS417 | ESD-910377-10MG |
Cas.: 917891-35-1 | Purity: 98% | LGD-3033 | ESD-910378-10MG |
Cas.: 918505-61-0 | Purity: 98% | BRAF inhibitor | ESD-910379-10MG |
Cas.: 920014-72-8 | Purity: 98% | Setmelanotide | ESD-910380-10MG |
Cas.: 923562-23-6 | Purity: 98% | STK321130 (FLT3-IN-2) | ESD-910381-10MG |
Cas.: 924296-39-9 | Purity: 98% | HBX41108 | ESD-910382-10MG |
Cas.: 934016-19-0 | Purity: 98% | Degarelix (acetate) | ESD-910383-10MG |
Cas.: 947620-48-6 | Purity: 98% | E6005 | ESD-910384-10MG |
Cas.: 950688-14-9 | Purity: 98% | Timapiprant sodium | ESD-910385-10MG |
Cas.: 96865-92-8 | Purity: 98% | Xanthine amine congener | ESD-910386-10MG |
Cas.: 1024828-77-0 | Purity: 98% | Difelikefalin (CR845) | ESD-910387-5MG |
Cas.: 147438-27-5 | Purity: 98% | Secorapamycin A (Seco Rapamycin) | ESD-910388-10MG |
Cas.: 1808714-73-9 | Purity: 98% | EN6 | ESD-910389-10MG |
Cas.: 2374313-54-7 | Purity: 98% | SIS-17 | ESD-910390-10MG |
Cas.: 925456-59-3 | Purity: 98% | Rp-8-bromo-Cyclic AMPS | ESD-910391-10MG |
Cas.: 1268244-88-7 | Purity: 98% | Px-104 | ESD-910392-10MG |
Cas.: 1638241-89-0 | Purity: 98% | ML RR-S2 CDA | ESD-910393-5MG |
Cas.: 1638750-96-5 | Purity: 98% | ML RR-S2 CDA ammonium salt | ESD-910394-5MG |
Cas.: 1673534-76-3 | Purity: 98% | CA-170 (AUPM-170)|PDL1 inhibitor | ESD-910395-10MG |
Cas.: 1799711-25-3 | Purity: 98% | E3 ligase Ligand-Linker Conjugates 16 | ESD-910396-500MG |
Cas.: 1802632-22-9 | Purity: 98% | CT1812 | ESD-910397-10MG |
Cas.: 1923851-49-3 | Purity: 98% | GSK9311 | ESD-910398-5MG |
Cas.: 1950635-16-1 | Purity: 98% | E3 ligase Ligand-Linker Conjugates 17 | ESD-910399-500MG |
Cas.: 2055397-18-5 | Purity: 98% | WM-8014 | ESD-910400-10MG |
Cas.: 2138299-29-1 | Purity: 98% | STING agonist-3 | ESD-910401-10MG |
Cas.: 2326521-71-3 | Purity: 99% | MRTX849 | ESD-910402-10MG |
Cas.: 2364489-81-4 | Purity: 98% | FMF-04-159-2 | ESD-910403-10MG |
Cas.: 83602-39-5 | Purity: 98% | Cyclosporin H | ESD-910404-10MG |
Cas.: 865311-47-3 | Purity: 98% | Quarfloxin (CX-3543) | ESD-910405-10MG |
Cas.: 871258-12-7 | Purity: 98% | DLinDMA | ESD-910406-10MG |
Cas.: 1609392-27-9 | Purity: 98% | Tyk2-IN-4(BMS986165) | ESD-910407-100MG |
Cas.: 82-89-3 | Purity: 98% | Prodigiosin | ESD-910408-1MG |
Cas.: 1005334-57-5 | Purity: 98% | CVT-10216 | ESD-910409-10MG |
Cas.: 1006388-38-0 | Purity: 98% | Cenupatide | ESD-910410-10MG |
Cas.: 100872-83-1 | Purity: 98% | ML-346 | ESD-910411-10MG |
Cas.: 1010396-29-8 | Purity: 98% | S23 | ESD-910412-10MG |
Cas.: 1015064-87-5 | Purity: 98% | ZL-004 | ESD-910414-10MG |
Cas.: 102562-74-3 | Purity: 98% | LM11A-31 | ESD-910415-10MG |
Cas.: 1026096-83-2 | Purity: 98% | NBI-59159 | ESD-910416-10MG |
Cas.: 1026582-88-6 | Purity: 98% | RO-3 | ESD-910417-10MG |
Cas.: 1031063-36-1 | Purity: 98% | DMU-2105 (CYP1B1 inhibitor 7k) | ESD-910418-10MG |
Cas.: 1032508-03-4 | Purity: 98% | PDM-11 | ESD-910419-10MG |
Cas.: 1034190-08-3 | Purity: 98% | ALZ-801 | ESD-910420-10MG |
Cas.: 103429-31-8 | Purity: 98% | CTOP | ESD-910421-10MG |
Cas.: 1051366-32-5 | Purity: 98% | Balixafortide (POL6326) | ESD-910422-5MG |
Cas.: 1051375-13-3 | Purity: 98% | Cabotegravir Sodium | ESD-910423-10MG |
Cas.: 106740-09-4 | Purity: 98% | GYY4137 morpholine salt | ESD-910424-10MG |
Cas.: 1079043-55-2 | Purity: 98% | AVP-786 | ESD-910425-10MG |
Cas.: 1093070-16-6 | Purity: 98% | GRL-0617 | ESD-910426-10MG |
Cas.: 1093861-60-9 | Purity: 98% | Afoxolaner | ESD-910427-10MG |
Cas.: 1095004-78-6 | Purity: 98% | AZD-7624 | ESD-910428-10MG |
Cas.: 109511-58-2 | Purity: 98% | U-0126 | ESD-910429-10MG |
Cas.: 1110873-99-8 | Purity: 98% | RU-301 | ESD-910430-10MG |
Cas.: 1119276-80-0 | Purity: 98% | Lifitegrast sodium | ESD-910431-10MG |
Cas.: 1136466-93-7 | Purity: 98% | IDE-2 | ESD-910432-10MG |
Cas.: 113711-77-6 | Purity: 98% | S-2765(FXa substrate) | ESD-910433-10MG |
Cas.: 114719-57-2 | Purity: 98% | Fascaplysin (chloride)|CDK4 inhibitor | ESD-910434-10MG |
Cas.: 115150-59-9 | Purity: 98% | Antagonist G | ESD-910435-10MG |
Cas.: 115388-96-0 | Purity: 98% | S-2238(Thrombin Substrate) | ESD-910436-10MG |
Cas.: 1154097-71-8 | Purity: 98% | IOX4 | ESD-910437-10MG |
Cas.: 1173022-21-3 | Purity: 98% | STO-609 (acetate) | ESD-910438-10MG |
Cas.: 1174161-69-3 | Purity: 98% | BMS-817378 free base | ESD-910439-10MG |
Cas.: 1179330-52-9 | Purity: 98% | SPR741 (NAB741) | ESD-910440-10MG |
Cas.: 1181083-81-7 | Purity: 98% | CLP-290 | ESD-910441-10MG |
Cas.: 118427-55-7 | Purity: 98% | MK-886 (sodium salt) | ESD-910442-10MG |
Cas.: 118511-97-0 | Purity: 98% | BISF-3 | ESD-910443-10MG |
Cas.: 1186195-62-9 | Purity: 98% | IKK-16 HCl | ESD-910444-10MG |
Cas.: 118967-28-9 | Purity: 98% | BI 409306 | ESD-910445-10MG |
Cas.: 1190217-35-6 | Purity: 98% | ASP 7663 | ESD-910446-10MG |
Cas.: 119110-38-2 | Purity: 98% | ETH 4030 (Magnesium ionophore III) | ESD-910447-10MG |
Cas.: 1191995-00-2 | Purity: 98% | Dorzagliatin | ESD-910448-10MG |
Cas.: 119630-77-2 | Purity: 98% | Arecaidine but-2-ynyl ester tosylate | ESD-910449-10MG |
Cas.: 1196504-54-7 | Purity: 98% | GDC-0575 | ESD-910450-10MG |
Cas.: 1197996-80-7 | Purity: 98% | CBL0137 | ESD-910451-10MG |
Cas.: 120116-88-3 | Purity: 98% | Cyazofamid | ESD-910452-10MG |
Cas.: 120138-50-3 | Purity: 98% | Quinupristin | ESD-910453-10MG |
Cas.: 1217195-61-3 | Purity: 98% | CP 31398 dihydrochloride | ESD-910454-10MG |
Cas.: 1227637-23-1 | Purity: 98% | Tegatrabetan | ESD-910455-10MG |
Cas.: 1231243-91-6 | Purity: 98% | SCD1 inhibitor | ESD-910456-10MG |
Cas.: 1233231-30-5 | Purity: 98% | DSP2230 | ESD-910457-10MG |
Cas.: 1242087-93-9 | Purity: 98% | Ravidasvir free base | ESD-910458-10MG |
Cas.: 1245792-67-9 | Purity: 98% | BCI-215 | ESD-910459-10MG |
Cas.: 124750-92-1 | Purity: 98% | Losartan Carboxylic Acid | ESD-910460-10MG |
Cas.: 124904-93-4 | Purity: 98% | Ganirelix | ESD-910461-10MG |
Cas.: 1254944-66-5 | Purity: 98% | SR 8278 | ESD-910462-10MG |
Cas.: 1256037-58-7 | Purity: 98% | CVM-1118 (CVM1118) | ESD-910463-10MG |
Cas.: 1262770-73-9 | Purity: 98% | KHS-101 | ESD-910464-10MG |
Cas.: 1265966-31-1 | Purity: 98% | S49076 (hydrochloride) | ESD-910465-10MG |
Cas.: 1270014-40-8 | Purity: 98% | SNS-062 | ESD-910466-10MG |
Cas.: 127500-84-9 | Purity: 98% | Ro 41-1049 hydrochloride | ESD-910467-10MG |
Cas.: 1275482-57-9 | Purity: 98% | AKR1C3 Inhibitor 5f | ESD-910468-10MG |
Cas.: 1290629-45-6 | Purity: 98% | CRT0066101 (hydrochloride) | ESD-910469-10MG |
Cas.: 129311-55-3 | Purity: 98% | Ganirelix (acetate) | ESD-910470-10MG |
Cas.: 1303533-81-4 | Purity: 98% | Ravidasvir hydrochloride (PPI-668) | ESD-910471-10MG |
Cas.: 1303993-72-7 | Purity: 98% | D-LAP5.Na | ESD-910472-10MG |
Cas.: 1312992-24-7 | Purity: 98% | DNQX disodium salt | ESD-910473-10MG |
Cas.: 1313498-08-6 | Purity: 96% | LSN2814617 | ESD-910474-10MG |
Cas.: 1315449-72-9 | Purity: 98% | Osilodrostat(LCI699) phosphate | ESD-910475-10MG |
Cas.: 1331782-27-4 | Purity: 98% | PF-04995274 | ESD-910476-10MG |
Cas.: 1332837-31-6 | Purity: 98% | Fosifloxuridine nafalbenamide (NUC-3373) | ESD-910477-10MG |
Cas.: 1334237-71-6 | Purity: 98% | Etelcalcetide Hydrochloride(AMG-416) | ESD-910478-10MG |
Cas.: 134029-62-2 | Purity: 98% | DMU-212 (resveratrol analog) | ESD-910479-10MG |
Cas.: 134052-73-6 | Purity: 98% | (S)-4CPG | ESD-910480-10MG |
Cas.: 1350547-65-7 | Purity: 98% | UNC569 | ESD-910481-10MG |
Cas.: 1352879-65-2 | Purity: 98% | PF-3450074 | ESD-910482-10MG |
Cas.: 1353644-70-8 | Purity: 98% | Theliatinib (HMPL-309) | ESD-910483-10MG |
Cas.: 135598-68-4 | Purity: 98% | CNDAC | ESD-910484-10MG |
Cas.: 135897-06-2 | Purity: 98% | SB218078 | ESD-910485-10MG |
Cas.: 1370290-34-8 | Purity: 98% | AZ-33 (AZ33) | ESD-910486-10MG |
Cas.: 1378524-41-4 | Purity: 98% | VUF11207 | ESD-910487-10MG |
Cas.: 1379545-95-5 | Purity: 98% | M2698 (MSC-2363318A) | ESD-910488-10MG |
Cas.: 1380087-86-4 | Purity: 98% | CPI-268456 | ESD-910489-10MG |
Cas.: 1380392-05-1 | Purity: 98% | JMS-17-2 | ESD-910490-10MG |
Cas.: 138117-50-7 | Purity: 98% | Leteprinim | ESD-910491-10MG |
Cas.: 138148-68-2 | Purity: 98% | DM1-SMe | ESD-910492-10MG |
Cas.: 1381769-23-8 | Purity: 98% | TC-2153 | ESD-910493-10MG |
Cas.: 1384984-18-2 | Purity: 98% | VXc-486 | ESD-910494-10MG |
Cas.: 1392429-79-6 | Purity: 98% | BI 882370 | ESD-910495-10MG |
Cas.: 1392487-51-2 | Purity: 98% | G-36 | ESD-910496-10MG |
Cas.: 1415251-36-3 | Purity: 98% | WJ460 | ESD-910497-10MG |
Cas.: 1416992-39-6 | Purity: 98% | GC-376 | ESD-910498-10MG |
Cas.: 1418217-95-4 | Purity: 98% | DBCO-Biotin | ESD-910499-10MG |
Cas.: 1425945-63-6 | Purity: 98% | EHT 5372 | ESD-910500-10MG |
Cas.: 1430723-35-5 | Purity: 98% | ODM-203 | ESD-910501-10MG |
Cas.: 1443211-72-0 | Purity: 98% | Eleclazine(GS-6615) | ESD-910502-10MG |
Cas.: 1443461-21-9 | Purity: 98% | HIV Inhibitor GSK2838232 | ESD-910503-10MG |
Cas.: 144576-10-3 | Purity: 98% | Gea3162 | ESD-910504-10MG |
Cas.: 1462949-64-9 | Purity: 98% | SAR348830 | ESD-910505-10MG |
Cas.: 149409-57-4 | Purity: 98% | NE-100 | ESD-910506-10MG |
Cas.: 150113-99-8 | Purity: 98% | Furin Inhibitor I | ESD-910507-10MG |
Cas.: 1505515-69-4 | Purity: 98% | DS-6051b | ESD-910508-10MG |
Cas.: 152362-51-1 | Purity: 98% | EMA400 | ESD-910509-10MG |
Cas.: 1527473-30-8 | Purity: 98% | PF-06454589 | ESD-910510-10MG |
Cas.: 154540-49-5 | Purity: 98% | Fluoroclebopride | ESD-910512-10MG |
Cas.: 1549811-53-1 | Purity: 98% | GSK-199 | ESD-910513-10MG |
Cas.: 1562406-27-2 | Purity: 98% | NUC-1031(SP) | ESD-910514-10MG |
Cas.: 1579965-12-0 | Purity: 98% | GSK2983559 | ESD-910515-10MG |
Cas.: 158081-99-3 | Purity: 98% | CP 105696 | ESD-910516-10MG |
Cas.: 1584121-99-2 | Purity: 98% | IT 901 | ESD-910517-10MG |
Cas.: 158841-76-0 | Purity: 98% | MMP-3 Inhibitor | ESD-910518-10MG |
Cas.: 1595129-71-7 | Purity: 98% | PWT143 (ME-401) | ESD-910519-10MG |
Cas.: 159776-70-2 | Purity: 98% | Melagatran | ESD-910520-10MG |
Cas.: 1610586-62-3 | Purity: 98% | MELK-T1 | ESD-910521-10MG |
Cas.: 1613410-75-5 | Purity: 98% | QC-3611 | ESD-910523-10MG |
Cas.: 1621673-53-7 | Purity: 98% | KY-226 | ESD-910524-10MG |
Cas.: 1622849-43-7 | Purity: 98% | GSK3145095 | ESD-910525-10MG |
Cas.: 1627607-88-8 | Purity: 97% | (S)-PFI-2HCl | ESD-910526-10MG |
Cas.: 162763-53-3 | Purity: 98% | ABT-719 HCl | ESD-910527-10MG |
Cas.: 162829-90-5 | Purity: 98% | ABT-719 | ESD-910528-10MG |
Cas.: 1631137-51-3 | Purity: 98% | VHL ligand 1 (TFA) | ESD-910529-10MG |
Cas.: 163655-37-6 | Purity: 98% | MAZ51 | ESD-910530-10MG |
Cas.: 163706-06-7 | Purity: 98% | Cangrelor free acid | ESD-910531-10MG |
Cas.: 164081-25-8 | Purity: 98% | PAR2 (1-6) (mouse, rat) | ESD-910532-10MG |
Cas.: 1642581-63-2 | Purity: 98% | Glumetinib | ESD-910533-10MG |
Cas.: 1690172-25-8 | Purity: 98% | I-191 | ESD-910534-10MG |
Cas.: 1781835-13-9 | Purity: 98% | RN-1 | ESD-910535-10MG |
Cas.: 178429-62-4 | Purity: 98% | Solriamfetol hydrochloride | ESD-910536-10MG |
Cas.: 1809885-32-2 | Purity: 95% | EC5026 | ESD-910537-10MG |
Cas.: 1821496-27-8 | Purity: 98% | BDA-366 | ESD-910538-10MG |
Cas.: 183658-72-2 | Purity: 98% | CYN 154806 | ESD-910539-10MG |
Cas.: 1846570-31-7 | Purity: 98% | CM-272 | ESD-910540-10MG |
Cas.: 1853279-29-4 | Purity: 98% | ZB716(Fulvestrant-3 Boronic Acid) | ESD-910541-10MG |
Cas.: 1869057-83-9 | Purity: 98% | Alflutinib | ESD-910542-10MG |
Cas.: 1883429-21-9 | Purity: 98% | BI-7273 | ESD-910543-10MG |
Cas.: 1883650-95-0 | Purity: 98% | CDDO-3P-Imidazolide | ESD-910544-10MG |
Cas.: 1883650-96-1 | Purity: 98% | CDDO-2P-Imidazolide | ESD-910545-10MG |
Cas.: 1883863-52-2 | Purity: 98% | dBET57 | ESD-910546-10MG |
Cas.: 1887014-12-1 | Purity: 98% | Olutasidenib (FT-2102) | ESD-910547-10MG |
Cas.: 189684-50-2 | Purity: 98% | Ac-DEVD-pNA (Caspase-3 Substrate) | ESD-910548-10MG |
Cas.: 1908414-82-3 | Purity: 98% | LMPTP inhibitor 23 | ESD-910549-10MG |
Cas.: 1923773-01-6 | Purity: 98% | MW-150 hydrochloride | ESD-910550-10MG |
Cas.: 1927857-61-1 | Purity: 98% | PQR530 | ESD-910551-10MG |
Cas.: 195615-83-9 | Purity: 98% | Anavex-2-73 free base (Blarcamesine) | ESD-910552-10MG |
Cas.: 1998725-11-3 | Purity: 98% | JHU-083 | ESD-910553-10MG |
Cas.: 2022182-58-5 | Purity: 98% | Thalidomide-O-amido-C3-NH2 | ESD-910554-10MG |
Cas.: 2043074-64-0 | Purity: 98% | ABX-1431 hydrochloride | ESD-910555-10MG |
Cas.: 2055538-47-9 | Purity: 98% | Cintirorgon Sodium | ESD-910556-10MG |
Cas.: 2055599-51-2 | Purity: 98% | NTP42 | ESD-910557-10MG |
Cas.: 2058116-52-0 | Purity: 98% | MDVN1003 | ESD-910558-10MG |
Cas.: 2064175-32-0 | Purity: 98% | dTAG-7 | ESD-910559-10MG |
Cas.: 2064175-41-1 | Purity: 98% | dTAG-13 | ESD-910560-10MG |
Cas.: 2073059-56-8 | Purity: 98% | SBI993 | ESD-910561-10MG |
Cas.: 2089227-65-4 | Purity: 98% | VBIT-12 | ESD-910562-10MG |
Cas.: 2089238-18-4 | Purity: 98% | GR3027 | ESD-910563-10MG |
Cas.: 2097132-94-8 | Purity: 98% | BLU-667 (Pralsetinib) | ESD-910564-10MG |
Cas.: 2097523-60-7 | Purity: 98% | CC-90011 besylate | ESD-910565-10MG |
Cas.: 2099142-76-2 | Purity: 98% | BAY-850 | ESD-910566-10MG |
Cas.: 2117405-13-5 | Purity: 98% | SEN-177 | ESD-910567-10MG |
Cas.: 2121-12-2 | Purity: 98% | Lycobetaine (Ungeremine) | ESD-910568-10MG |
Cas.: 2125956-82-1 | Purity: 98% | PXS-5153A | ESD-910569-10MG |
Cas.: 2126032-35-5 | Purity: 98% | Arbidol analog | ESD-910570-10MG |
Cas.: 2127390-15-0 | Purity: 98% | Shield-1 analog | ESD-910571-10MG |
Cas.: 2136247-12-4 | Purity: 98% | MD-224 | ESD-910572-5MG |
Cas.: 2141955-96-4 | Purity: 98% | BLU-782 | ESD-910573-10MG |
Cas.: 2152628-33-4 | Purity: 98% | Selpercatinib (LOXO-292) | ESD-910574-10MG |
Cas.: 2165322-94-9 | Purity: 98% | USP25 and 28 inhibitor AZ-1 | ESD-910575-10MG |
Cas.: 2171386-10-8 | Purity: 98% | RK-287107 | ESD-910576-10MG |
Cas.: 2172617-15-9 | Purity: 98% | YKL-06-061 | ESD-910577-10MG |
Cas.: 2225938-17-8 | Purity: 98% | MS1943 | ESD-910578-10MG |
Cas.: 2226735-55-1 | Purity: 98% | RIP1 inhibitor GSK547 | ESD-910579-10MG |
Cas.: 2230198-02-2 | Purity: 98% | PF-06882961 | ESD-910580-10MG |
Cas.: 2230613-03-1 | Purity: 98% | AP1867-2-carboxymethoxy(FKBP12 Ligand) | ESD-910581-10MG |
Cas.: 2237942-08-2 | Purity: 98% | MC180295 | ESD-910582-10MG |
Cas.: 2244904-70-7 | Purity: 98% | BAY-293 | ESD-910583-10MG |
Cas.: 2244989-34-0 | Purity: 98% | (S)-B-973B | ESD-910584-10MG |
Cas.: 2245255-65-4 | Purity: 98% | GSK2807 | ESD-910585-10MG |
Cas.: 2254001-81-3 | Purity: 98% | ZK824859 | ESD-910586-10MG |
Cas.: 2271358-64-4 | Purity: 98% | UAMC-3203 free base | ESD-910587-10MG |
Cas.: 2280037-51-4 | Purity: 98% | Bobcat339 | ESD-910588-10MG |
Cas.: 2289728-58-9 | Purity: BR | Enpp-1-IN-1 | ESD-910589-10MG |
Cas.: 2291164-02-6 | Purity: 98% | GS-4361 | ESD-910590-10MG |
Cas.: 229305-39-9 | Purity: 98% | Golotimod (SCV-07) | ESD-910591-10MG |
Cas.: 2304947-71-3 | Purity: 98% | TH5487 | ESD-910592-10MG |
Cas.: 2310392-52-8 | Purity: 98% | P2X2/3 receptor antagonist | ESD-910593-10MG |
Cas.: 2328073-61-4 | Purity: 98% | ZT-12-037-01 | ESD-910594-10MG |
Cas.: 2348493-39-8 | Purity: 98% | NUC-7738 | ESD-910595-10MG |
Cas.: 2349367-89-9 | Purity: 98% | NVS-ZP7-4 | ESD-910596-10MG |
Cas.: 2361493-16-3 | Purity: 98% | BSJ-03-123 | ESD-910597-10MG |
Cas.: 2361659-62-1 | Purity: 98% | GSK8612 | ESD-910598-10MG |
Cas.: 2375840-87-0 | Purity: 98% | NDI-091143 | ESD-910599-10MG |
Cas.: 239101-33-8 | Purity: 98% | Deferitrin | ESD-910600-10MG |
Cas.: 25526-93-6 | Purity: 98% | Alovudine | ESD-910601-10MG |
Cas.: 26097-80-3 | Purity: 98% | Cambendazol | ESD-910602-10MG |
Cas.: 294623-49-7 | Purity: 98% | L-006,235 | ESD-910603-10MG |
Cas.: 298-59-9 | Purity: 98% | Methylphenidate(Ritalin) | ESD-910604-10MG |
Cas.: 300561-58-4 | Purity: 98% | SKF 77434 | ESD-910605-10MG |
Cas.: 305335-31-3 | Purity: 98% | MLN-4760 | ESD-910606-5MG |
Cas.: 309739-67-1 | Purity: 98% | PP2 analog | ESD-910607-10MG |
Cas.: 313520-94-4 | Purity: 98% | TH263 | ESD-910608-10MG |
Cas.: 321695-57-2 | Purity: 98% | L002 (NSC764414) | ESD-910609-10MG |
Cas.: 325457-99-6 | Purity: 98% | ICA 110381 (Compound 16) | ESD-910610-10MG |
Cas.: 3258-02-4 | Purity: 98% | EIDD-1931 (NHC) | ESD-910611-10MG |
Cas.: 329198-87-0 | Purity: 98% | STING inhibitor C-178 | ESD-910612-10MG |
Cas.: 330789-03-2 | Purity: 98% | A-420983 | ESD-910613-10MG |
Cas.: 34023-62-6 | Purity: 98% | 1-BCP | ESD-910614-10MG |
Cas.: 357336-20-0 | Purity: 98% | Brivaracetam | ESD-910615-10MG |
Cas.: 35773-42-3 | Purity: 98% | EMI1 (EGFR MaMTH Inhibitor 1) | ESD-910616-10MG |
Cas.: 372196-67-3 | Purity: 98% | PIK-75 free base | ESD-910617-10MG |
Cas.: 402713-80-8 | Purity: 98% | SB-399885 HCl | ESD-910618-10MG |
Cas.: 4051-59-6 | Purity: 98% | MSX-130 | ESD-910619-10MG |
Cas.: 42228-92-2 | Purity: 98% | Acivicin | ESD-910620-10MG |
Cas.: 444805-28-1 | Purity: 98% | Brincidofovir (CMX-001) | ESD-910621-10MG |
Cas.: 448906-49-8 | Purity: 98% | ITE analog(ITK) | ESD-910622-10MG |
Cas.: 449811-92-1 | Purity: 98% | R1487 | ESD-910623-10MG |
Cas.: 4725-51-3 | Purity: 98% | Annaosanchun (YC-6) | ESD-910624-10MG |
Cas.: 476474-11-0 | Purity: 98% | TGF-B (beta) receptor inhibitor | ESD-910625-10MG |
Cas.: 479347-85-8 | Purity: 98% | CNQX disodium salt | ESD-910626-10MG |
Cas.: 487051-12-7 | Purity: 98% | SNAP-94847 hydrochloride | ESD-910627-10MG |
Cas.: 498555-58-1 | Purity: 98% | Z-IETD-pNA(GRANZYME B SUBSTRATE I) | ESD-910628-10MG |
Cas.: 51352-88-6 | Purity: 98% | PRL-8-53 | ESD-910629-10MG |
Cas.: 514200-66-9 | Purity: 98% | COG 133 | ESD-910630-10MG |
Cas.: 51987-99-6 | Purity: 98% | TGN-020 | ESD-910631-10MG |
Cas.: 522649-59-8 | Purity: 98% | Malic Enzyme inhibitor ME1 | ESD-910632-10MG |
Cas.: 544478-19-5 | Purity: 98% | MRS-1845 | ESD-910633-10MG |
Cas.: 554403-49-5 | Purity: 98% | WAY181187.HCl (WAY-181,187) | ESD-910634-10MG |
Cas.: 5704-60-9 | Purity: 98% | Nifenalol | ESD-910635-10MG |
Cas.: 574013-67-5 | Purity: 98% | Fexarine | ESD-910636-10MG |
Cas.: 574013-68-6 | Purity: 98% | Fexarene | ESD-910637-10MG |
Cas.: 579515-63-2 | Purity: 98% | GW806742X | ESD-910638-10MG |
Cas.: 58880-43-6 | Purity: 98% | Cridanimod sodium | ESD-910639-10MG |
Cas.: 592524-75-9 | Purity: 98% | Fexaramate | ESD-910640-10MG |
Cas.: 604769-01-9 | Purity: 97% | R306465 (JNJ-16241199) | ESD-910641-10MG |
Cas.: 611207-11-5 | Purity: 98% | LH-21 | ESD-910642-10MG |
Cas.: 61595-77-5 | Purity: 98% | ETH 157 (Sodium ionophore II) | ESD-910643-10MG |
Cas.: 616202-92-7 | Purity: 99% | Lorcaserin | ESD-910644-10MG |
Cas.: 620170-78-7 | Purity: 98% | 4-P-PDOT | ESD-910645-10MG |
Cas.: 6314-70-1 | Purity: 98% | NSC23005 free acid | ESD-910646-10MG |
Cas.: 6323-99-5 | Purity: 98% | DL-AP4 | ESD-910647-10MG |
Cas.: 634913-39-6 | Purity: 98% | AER-271 | ESD-910648-10MG |
Cas.: 656830-24-9 | Purity: 98% | Antrodin A | ESD-910649-10MG |
Cas.: 66258-96-6 | Purity: 98% | delta-Valerobetaine (hydrobromide) | ESD-910650-10MG |
Cas.: 681281-88-9 | Purity: 98% | Akt Inhibitor IV | ESD-910651-10MG |
Cas.: 68252-19-7 | Purity: 98% | (±)-Pirmenol | ESD-910652-10MG |
Cas.: 687561-60-0 | Purity: 98% | IWP-3 | ESD-910653-10MG |
Cas.: 6956-96-3 | Purity: 98% | DMNQ | ESD-910654-10MG |
Cas.: 70195-20-9 | Purity: BR | Papain Inhibitor | ESD-910655-10MG |
Cas.: 7150-23-4 | Purity: 98% | JBSNF-000088 | ESD-910656-10MG |
Cas.: 7318-55-0 | Purity: 98% | (+)-Narwedine | ESD-910657-10MG |
Cas.: 74267-27-9 | Purity: 98% | CALCIUM IONOPHORE II | ESD-910658-10MG |
Cas.: 74970-31-3 | Purity: 98% | Cephalosporin C Na salt | ESD-910659-10MG |
Cas.: 7599-79-3 | Purity: 98% | Enclomiphene citrate | ESD-910660-10MG |
Cas.: 793035-88-8 | Purity: 98% | AG-L-59687 | ESD-910661-10MG |
Cas.: 796874-99-2 | Purity: 98% | KYP-2047 | ESD-910662-10MG |
Cas.: 801227-82-7 | Purity: 98% | SirReal1 | ESD-910663-10MG |
Cas.: 80714-61-0 | Purity: 98% | Semax | ESD-910664-10MG |
Cas.: 81336-71-2 | Purity: 98% | Bis(tributylammonium) difluoromethylenediphosphonate | ESD-910665-10MG |
Cas.: 828934-43-6 | Purity: 98% | S-Etomxir | ESD-910666-10MG |
Cas.: 841259-17-4 | Purity: 98% | KW-2449 Hydrochloride | ESD-910667-10MG |
Cas.: 84408-37-7 | Purity: 98% | Desciclovir | ESD-910668-10MG |
Cas.: 845861-39-4 | Purity: 98% | CP 94253 hydrochloride | ESD-910669-10MG |
Cas.: 84-82-2 | Purity: 98% | Toxoflavin (PKF118-310) | ESD-910670-10MG |
Cas.: 848353-85-5 | Purity: 98% | Fluorofenidone | ESD-910671-10MG |
Cas.: 851107-28-3 | Purity: 98% | CMP8 | ESD-910672-10MG |
Cas.: 85797-13-3 | Purity: 98% | DL-AP7 | ESD-910673-10MG |
Cas.: 862772-11-0 | Purity: 98% | Cyclo(RGDfC) | ESD-910674-10MG |
Cas.: 864825-13-8 | Purity: 98% | Eluxadoline Dihydrochloride | ESD-910675-10MG |
Cas.: 865783-95-5 | Purity: 98% | ON-013100 | ESD-910676-10MG |
Cas.: 868265-28-5 | Purity: 98% | LY2365109 | ESD-910677-10MG |
Cas.: 869001-63-8 | Purity: 98% | NNZ-2591 TFA salt | ESD-910678-10MG |
Cas.: 869477-96-3 | Purity: 98% | Olodaterol(BI-1744) hydrochloride | ESD-910679-10MG |
Cas.: 874146-69-7 | Purity: 98% | PK11007 | ESD-910680-10MG |
Cas.: 874471-40-6 | Purity: 98% | NNZ-2591 | ESD-910681-10MG |
Cas.: 87726-17-8 | Purity: 98% | Panipenem | ESD-910682-10MG |
Cas.: 879127-16-9 | Purity: 98% | AKI-7169 (Aurora Kinase Inhibitor III) | ESD-910683-10MG |
Cas.: 880549-30-4 | Purity: 98% | AMD-070 hydrochloride (Mavorixafor) | ESD-910684-10MG |
Cas.: 881487-77-0 | Purity: 98% | KPT-6566 | ESD-910685-10MG |
Cas.: 898562-94-2 | Purity: 98% | PF-2545920(MP-10) | ESD-910686-10MG |
Cas.: 902688-24-8 | Purity: 98% | Qstatin | ESD-910687-10MG |
Cas.: 911208-73-6 | Purity: 98% | Tenofovir exalidex (CMX157) | ESD-910688-10MG |
Cas.: 913830-15-6 | Purity: 98% | NS 9283 | ESD-910689-10MG |
Cas.: 914805-33-7 | Purity: 99% | Shield-1 | ESD-910690-10MG |
Cas.: 936339-60-5 | Purity: 98% | E1210 (APX001A) | ESD-910691-5MG |
Cas.: 937-13-3 | Purity: 98% | Oritavancin Diphosphate (LY333328, Orbactiv) | ESD-910692-10MG |
Cas.: 942413-05-0 | Purity: 98% | VKGILS-NH2 | ESD-910693-10MG |
Cas.: 956014-19-0 | Purity: 98% | NS 11021 | ESD-910694-10MG |
Cas.: 96760-69-9 | Purity: BR | Adenosine Amine Congener | ESD-910695-10MG |
Cas.: 1000023-04-0 | Purity: 98% | Voruciclib | ESD-910696-10MG |
Cas.: 1209500-46-8 | Purity: 98% | GsMTx-4 | ESD-910697-1MG |
Cas.: 129425-81-6 | Purity: 97% | MSA-2 | ESD-910698-5MG |
Cas.: 1338540-81-0 | Purity: 98% | TOPK inhibitor-1 | ESD-910699-5MG |
Cas.: 1357362-02-7 | Purity: 98% | Vafidemstat (ORY-2001) | ESD-910700-5MG |
Cas.: 1422423-23-1 | Purity: 98% | EMICORON | ESD-910701-10MG |
Cas.: 1562024-11-6 | Purity: 90% | HS-27 | ESD-910703-10MG |
Cas.: 158930-17-7 | Purity: 98% | Frovatriptan | ESD-910704-10MG |
Cas.: 1803242-21-8 | Purity: 98% | DJ101 | ESD-910705-5MG |
Cas.: 1809427-18-6 | Purity: 98% | SMAP | ESD-910706-5MG |
Cas.: 1816989-16-8 | Purity: 98% | SY-1365 | ESD-910707-10MG |
Cas.: 2055362-74-6 | Purity: 98% | ADH-503 | ESD-910708-10MG |
Cas.: 2079892-79-6 | Purity: 98% | RORγt inhibitor 1 | ESD-910709-10MG |
Cas.: 2097826-24-7 | Purity: 98% | Yhhu-3792 | ESD-910710-5MG |
Cas.: 2375420-34-9 | Purity: 97% | SR-717 | ESD-910711-5MG |
Cas.: 328906-67-8 | Purity: 98% | AK778 | ESD-910712-5MG |
Cas.: 34695-81-3 | Purity: 95% | Sclerotioramine | ESD-910713-10MG |
Cas.: 468056-29-3 | Purity: 98% | KY-04031 | ESD-910714-10MG |
Cas.: 732277-05-3 | Purity: 98% | AMPA/kainate antagonist-1 | ESD-910715-10MG |
Cas.: 863975-32-0 | Purity: 98% | Bz-Nle-Lys-Arg-Arg-AMC | ESD-910716-10MG |
Cas.: 881188-51-8 | Purity: 98% | Foxy-5(Wnt5a peptide mimetic) | ESD-910717-5MG |
Cas.: 1020412-97-8 | Purity: 98% | Tie-2 inhibitor 7 | ESD-910719-1MG |
Cas.: 1143863-69-7 | Purity: 98% | KBU2046 | ESD-910720-10MG |
Cas.: 117279-73-9 | Purity: 98% | Israpafant | ESD-910721-5MG |
Cas.: 1187451-41-7 | Purity: 98% | Omidepag | ESD-910722-10MG |
Cas.: 1191996-10-7 | Purity: 98% | Sinogliatin (HMS5552, RO5305552) | ESD-910723-10MG |
Cas.: 1237541-73-9 | Purity: 98% | NAB-14 | ESD-910724-10MG |
Cas.: 1250963-36-0 | Purity: 98% | CLR1501 | ESD-910725-5MG |
Cas.: 1258417-54-7 | Purity: 98% | ACT-389949 | ESD-910726-10MG |
Cas.: 1296200-77-5 | Purity: 98% | Efpeglenatide | ESD-910727-10MG |
Cas.: 1299292-01-5 | Purity: 98% | CDM-NAG | ESD-910728-5MG |
Cas.: 137433-23-9 | Purity: 98%, ee | R-Hydroxychloroquine | ESD-910729-5MG |
Cas.: 137433-24-0 | Purity: 98%, ee | S-Hydroxychloroquine | ESD-910730-5MG |
Cas.: 138168-48-6 | Purity: 98% | Tyroserleutide (YSL) | ESD-910731-10MG |
Cas.: 1391426-22-4 | Purity: 98% | Lys05 | ESD-910732-100MG |
Cas.: 1429505-03-2 | Purity: 98% | Soticlestat | ESD-910733-10MG |
Cas.: 1441190-66-4 | Purity: 99,5% | 2’3′-cGAMP | ESD-910734-5MG |
Cas.: 1449746-00-2 | Purity: 98% | Mefuparib hydrochloride | ESD-910735-5MG |
Cas.: 1459687-89-8 | Purity: 98% | GJ103 | ESD-910736-100MG |
Cas.: 1500080-17-0 | Purity: 97% | UU-T02 | ESD-910737-5MG |
Cas.: 1513879-18-9 | Purity: 98% | KAI407 | ESD-910738-5MG |
Cas.: 1535187-91-7 | Purity: 98% | MC3343 | ESD-910739-10MG |
Cas.: 1628614-50-5 | Purity: 98% | XMD-17-51 | ESD-910740-10MG |
Cas.: 1698901-76-6 | Purity: 98% | GNE-8324 | ESD-910741-10MG |
Cas.: 1821484-84-7 | Purity: 98% | TrkA inhibitor compound 23 (TrkA-IN-23) | ESD-910742-10MG |
Cas.: 1916-59-2 | Purity: 98% | Questiomycin A | ESD-910743-10MG |
Cas.: 1957236-20-2 | Purity: 98% | E3 Ligand-Linker Conjugate 9 | ESD-910744-1G |
Cas.: 2012536-16-0 | Purity: 98% | NYX-2925 | ESD-910745-5MG |
Cas.: 2022961-17-5 | Purity: 99,5% | Raphin1 | ESD-910746-5MG |
Cas.: 205304-87-6 | Purity: 98% | Tubulysin B | ESD-910747-1MG |
Cas.: 205754-33-2 | Purity: 97% | 8-Hydroxy-efavirenz | ESD-910748-10MG |
Cas.: 2093400-18-9 | Purity: 98% | OTS186935 | ESD-910749-10MG |
Cas.: 2129998-32-7 | Purity: 98% | Deuterated AZ5104 | ESD-910750-10MG |
Cas.: 2138299-33-7 | Purity: 98% | STING agonist compound 3 | ESD-910751-5MG |
Cas.: 2138299-34-8 | Purity: 98% | STING agonist-1 (compound 3)trihydrochloride | ESD-910752-5MG |
Cas.: 2229036-62-6 | Purity: 98% | MS4078 | ESD-910753-10MG |
Cas.: 2241325-66-4 | Purity: 98% | GAK inhibitor 12r | ESD-910754-10MG |
Cas.: 2260886-64-2 | Purity: 98% | JND3229 | ESD-910755-5MG |
Cas.: 250694-07-6 | Purity: 98% | Teglicar | ESD-910756-5MG |
Cas.: 3316-02-7 | Purity: 98% | ζ-Stat (ZETA-STAT) | ESD-910757-5MG |
Cas.: 34973-27-8 | Purity: 95% | NHC(EIDD-1931) triphosphate | ESD-910758-5MG |
Cas.: 437742-34-2 | Purity: 98% | marizomib | ESD-910759-5MG |
Cas.: 50935-04-1 | Purity: 98% | Carubicin | ESD-910760-10MG |
Cas.: 55854-43-8 | Purity: 98% | ES9-17 | ESD-910761-10MG |
Cas.: 562-28-7 | Purity: 98% | Ent-kaurene | ESD-910762-1MG |
Cas.: 591239-68-8 | Purity: 98% | NEK6 inibitor 8 | ESD-910763-10MG |
Cas.: 6505-99-3 | Purity: 95% | JA2131 | ESD-910764-5MG |
Cas.: 681245-85-2 | Purity: 98% | A-800141 | ESD-910765-5MG |
Cas.: 71079-09-9 | Purity: 98% | FOY 251 (Camostat metabolite) | ESD-910766-10MG |
Cas.: 845647-80-5 | Purity: 98% | BF-227(E/Z) | ESD-910767-5MG |
Cas.: 849459-86-5 | Purity: 98% | AC-263093 | ESD-910768-10MG |
Cas.: 851717-83-4 | Purity: 98% | SW076956 | ESD-910769-10MG |
Cas.: 866399-87-3 | Purity: 98% | Obicetrapib | ESD-910770-5MG |
Cas.: 877822-41-8 | Purity: 98% | Eupalinolide B | ESD-910771-10MG |
Cas.: 885272-55-9 | Purity: 98% | TG693 | ESD-910772-5MG |
Cas.: 900308-51-2 | Purity: 98% | SEC inhibitor KL-2 | ESD-910773-10MG |
Cas.: 900308-84-1 | Purity: 98% | SEC inhibitor KL-1 | ESD-910774-10MG |
Cas.: 950261-75-3 | Purity: 98% | hClpP activator D9 | ESD-910775-10MG |
Cas.: 1001755-57-2 | Purity: 98% | 5-Formyl-2-pyrimidinecarbonitrile | ESD-910776-100MG |
Cas.: 1244967-98-3 | Purity: 95% | Pizuglanstat | ESD-910777-5MG |
Cas.: 2180127-82-4 | Purity: 96% | BMS-615 | ESD-910778-5MG |
Cas.: 239272-16-1 | Purity: 98% | AWZ1066S | ESD-910779-100MG |
Cas.: 2854-40-2 | Purity: 98% | Cyclo(L-Pro-L-Val) | ESD-910780-100MG |
Cas.: 554438-52-7 | Purity: 98% | LASV inhibitor 3.3 | ESD-910781-10MG |
Cas.: 874119-56-9 | Purity: 98% | GSK-25 | ESD-910782-10MG |
Cas.: 1000277-08-6 | Purity: 98% | MGB-BP-3 | ESD-910783-1MG |
Cas.: 100490-36-6 | Purity: BR | Tosufloxacin | ESD-910784-5MG |
Cas.: 1004990-28-6 | Purity: 98% | PF-AKT400 | ESD-910785-5MG |
Cas.: 1005168-10-4 | Purity: 98% | PAC-14028 | ESD-910786-5MG |
Cas.: 1005883-72-6 | Purity: 98% | Z433927330 | ESD-910787-5MG |
Cas.: 1007392-69-9 | Purity: 98% | ACT 178882 | ESD-910788-1MG |
Cas.: 100999-26-6 | Purity: 98% | CY 208-243 | ESD-910789-5MG |
Cas.: 101001-34-7 | Purity: 98% | Pamicogrel | ESD-910790-1MG |
Cas.: 101001-72-3 | Purity: 98% | Desethyl KBT-3022 | ESD-910791-1MG |
Cas.: 101193-62-8 | Purity: 98% | Quinotolast sodium (FR71021) | ESD-910792-1MG |
Cas.: 1013920-15-4 | Purity: 98% | Vorolanib | ESD-910793-5MG |
Cas.: 1013937-63-7 | Purity: 98% | VTP-27999 TFA | ESD-910794-10MG |
Cas.: 102418-74-6 | Purity: 98% | (+)-Biotin 4-Amidobenzoic Acid sodium salt | ESD-910795-5MG |
Cas.: 102507-71-1 | Purity: 98% | Tigemonam | ESD-910796-1MG |
Cas.: 1026987-94-9 | Purity: 98% | DUPA(OtBu)-OH | ESD-910797-5MG |
Cas.: 1029939-86-3 | Purity: 98% | Artefenomel | ESD-910798-5MG |
Cas.: 1033805-22-9 | Purity: ≥98% | Telotristat ethyl (LX1606) | ESD-910799-5MG |
Cas.: 1035688-66-4 | Purity: 98% | ASLAN003 | ESD-910800-5MG |
Cas.: 1038915-58-0 | Purity: 98% | Niraparib R-enantiomer | ESD-910801-5MG |
Cas.: 104180-23-6 | Purity: 98% | Angiotensinogen (1-14), human | ESD-910802-1MG |
Cas.: 1042-42-8 | Purity: 98% | Carcainium chloride | ESD-910803-5MG |
Cas.: 1048668-70-7 | Purity: 98% | AZD8329 | ESD-910804-5MG |
Cas.: 104870-56-6 | Purity: 98% | (+)-Isopulegol | ESD-910805-5MG |
Cas.: 104961-19-5 | Purity: 98% | CI-949 | ESD-910806-1MG |
Cas.: 1064662-40-3 | Purity: 98% | SNT-207707 | ESD-910807-5MG |
Cas.: 1079400-07-9 | Purity: 98% | PF 04531083 | ESD-910808-5MG |
Cas.: 1080645-95-9 | Purity: ≥98% | Tirbanibulin Mesylate | ESD-910809-5MG |
Cas.: 108068-98-0 | Purity: BR | KT5720 | ESD-910810-50ΜG |
Cas.: 1092977-61-1 | Purity: 98% | Evenamide | ESD-910811-5MG |
Cas.: 1093380-13-2 | Purity: ≥99% | Olanzapine-d8 | ESD-910812-500ΜG |
Cas.: 1104662-66-9 | Purity: 98% | SNT-207858 free base | ESD-910813-5MG |
Cas.: 110505-75-4 | Purity: 98% | N6-(4-Hydroxybenzyl)adenosine (Para-topolin riboside) | ESD-910814-10MG |
Cas.: 1112993-18-6 | Purity: 98% | Silvestrol aglycone enantiomer | ESD-910815-1MG |
Cas.: 1113-10-6 | Purity: 98% | Guancydine | ESD-910816-5MG |
Cas.: 1115270-63-7 | Purity: 98% | IAXO-102 | ESD-910817-5MG |
Cas.: 1117-61-9 | Purity: 98% | (+)-β-Citronellol | ESD-910818-50MG |
Cas.: 111786-07-3 | Purity: 98% | Prinoxodan | ESD-910819-1MG |
Cas.: 1119517-19-9 | Purity: 98% | GLP-1(7-36) Acetate | ESD-910820-1MG |
Cas.: 1127308-52-4 | Purity: 98% | ROCK inhibitor-2 | ESD-910821-5MG |
Cas.: 113932-41-5 | Purity: 98% | Tematropium | ESD-910822-1MG |
Cas.: 1142214-62-7 | Purity: 98% | AM-1638 | ESD-910823-5MG |
Cas.: 114606-56-3 | Purity: 98% | SDZ-MKS 492 | ESD-910824-5MG |
Cas.: 115092-85-8 | Purity: 98% | Carmoxirole hydrochloride (EMD 45609 hydrochloride) | ESD-910825-5MG |
Cas.: 1151813-61-4 | Purity: 98% | KSI-3716 | ESD-910826-5MG |
Cas.: 115344-47-3 | Purity: 98% | Siguazodan | ESD-910827-1MG |
Cas.: 115-51-5 | Purity: 98% | Ambutonium bromide (BL700) | ESD-910828-1MG |
Cas.: 115621-84-6 | Purity: 98% | PAF-AN-1 | ESD-910829-1MG |
Cas.: 115730-24-0 | Purity: 98% | ZT 52656A hydrochloride | ESD-910830-1MG |
Cas.: 116078-65-0 | Purity: 98% | Bidisomide (SC40230) | ESD-910831-1MG |
Cas.: 1161921-82-9 | Purity: 98% | BAY-85-8501 | ESD-910832-5MG |
Cas.: 116308-56-6 | Purity: 98% | AE0047 Hydrochloride | ESD-910833-1MG |
Cas.: 116853-25-9 | Purity: BR | Cefluprenam | ESD-910834-1MG |
Cas.: 117707-51-4 | Purity: 98% | ENS-163 phosphate | ESD-910835-1MG |
Cas.: 1177356-70-5 | Purity: 98% | (+)-Blebbistatin | ESD-910836-5MG |
Cas.: 118244-44-3 | Purity: 98% | PNF21 (Prednisolone Farnesylate) | ESD-910837-1MG |
Cas.: 118441-84-2 | Purity: 98% | Licoricesaponin G2 | ESD-910838-5MG |
Cas.: 1189561-66-7 | Purity: 98% | (S)-Gossypol acetic acid((S)-(+)-Gossypol acetic acid) | ESD-910839-10MG |
Cas.: 1193314-23-6 | Purity: 98% | Cipargamin | ESD-910840-5MG |
Cas.: 1195941-38-8 | Purity: 98% | SAR-100842 | ESD-910841-5MG |
Cas.: 1196070-26-4 | Purity: 98% | Fiboflapon sodium | ESD-910842-5MG |
Cas.: 1196800-39-1 | Purity: 98% | Omadacycline hydrochloride | ESD-910843-5MG |
Cas.: 119817-90-2 | Purity: 98% | Dexloxiglumide | ESD-910844-5MG |
Cas.: 1202758-21-1 | Purity: ≥98% | CNX-500 | ESD-910845-1MG |
Cas.: 1206524-86-8 | Purity: 98% | Grazoprevir potassium salt (MK-5172 potassium salt) | ESD-910846-5MG |
Cas.: 1207358-59-5 | Purity: 98% | mTOR inhibitor-3 | ESD-910847-5MG |
Cas.: 1207456-00-5 | Purity: 98% | (8R,9S)-Talazoparib | ESD-910848-5MG |
Cas.: 1208229-58-6 | Purity: 98% | Tepilamide fumarate | ESD-910849-5MG |
Cas.: 1208313-97-6 | Purity: 98% | BD-AcAc 2 (Ketone Ester) | ESD-910850-50MG |
Cas.: 121028-49-7 | Purity: 98% | Secretin (33-59), rat (Secretin (rat)) | ESD-910852-1MG |
Cas.: 1217757-71-5 | Purity: BR | (R)-(+)-5′-Hydroxyphenyl Carvedilol | ESD-910853-1MG |
Cas.: 1222810-74-3 | Purity: 98% | VU591 | ESD-910854-5MG |
Cas.: 122341-40-6 | Purity: 98% | Neuropeptide Y (13-36), amide, human (Neuropeptide Y (13-36), human) | ESD-910855-1MG |
Cas.: 1225383-33-4 | Purity: 98% | E3 ligase Ligand 8 | ESD-910856-50MG |
Cas.: 1227067-61-9 | Purity: 98% | AMG 579 | ESD-910857-5MG |
Cas.: 1227923-29-6 | Purity: 98% | MK-7622 | ESD-910858-5MG |
Cas.: 1228088-30-9 | Purity: 98% | Balovaptan (RG7314) | ESD-910859-5MG |
Cas.: 122852-43-1 | Purity: 98% | Alosetron ((Z)-2-butenedioate) (GR 68755 ((Z)-2-butenedioate)) | ESD-910860-10MG |
Cas.: 1232861-58-3 | Purity: 98% | Gemilukast (ONO-6950) | ESD-910861-5MG |
Cas.: 123388-25-0 | Purity: 98% | Semotiadil (recemate fumarate) | ESD-910862-1MG |
Cas.: 1239358-85-0 | Purity: ≥98% | Ilginatinib hydrochloride (NS-018 hydrochloride) | ESD-910863-5MG |
Cas.: 1239358-86-1 | Purity: ≥98% | Ilginatinib (NS-018) | ESD-910864-5MG |
Cas.: 1245477-09-1 | Purity: ≥99% | Oleoyl Ethanolamide-d2 (OEA-d2) | ESD-910865-500ΜG |
Cas.: 1247825-37-1 | Purity: 98% | USP7/USP47 inhibitor | ESD-910866-5MG |
Cas.: 1252637-35-6 | Purity: 98% | Petesicatib | ESD-910867-5MG |
Cas.: 1254472-97-3 | Purity: 98% | Setogepram sodium salt (PBI-4050 sodium salt) | ESD-910868-5MG |
Cas.: 125600-42-2 | Purity: 95% | 2-Ethynyl-4-nitroaniline | ESD-910869-100MG |
Cas.: 1256918-39-4 | Purity: 98% | XL041 (BMS-852927) | ESD-910870-1MG |
Cas.: 125720-21-0 | Purity: 98% | Fibronectin Adhesion-promoting Peptide (Heparin Binding Peptide) | ESD-910871-1MG |
Cas.: 126-29-4 | Purity: ≥90% (HPLC) | Violaxanthin | ESD-910872-1MG |
Cas.: 1263273-14-8 | Purity: 98% | (1R,2S)-VU0155041 | ESD-910873-5MG |
Cas.: 12676-15-2 | Purity: 98% | Angiotensin II (3-8), human | ESD-910874-5MG |
Cas.: 127917-66-2 | Purity: 98% | Ro 41-1049 hydrochloride | ESD-910875-5MG |
Cas.: 1281681-33-1 | Purity: 98% | VP3.15 dihydrobromide | ESD-910876-5MG |
Cas.: 129024-87-9 | Purity: 98% | NMI 8739 | ESD-910877-5MG |
Cas.: 129280-22-4 | Purity: 98% | Anti-hypertensive sulfonanilide 1 | ESD-910878-1MG |
Cas.: 129298-91-5 | Purity: 98% | TNP-470 (AGM-1470) | ESD-910879-5MG |
Cas.: 1300019-38-8 | Purity: 98% | I-BET762 carboxylic acid | ESD-910880-5MG |
Cas.: 1300031-70-2 | Purity: 98% | Bromodomain inhibitor-8 | ESD-910881-5MG |
Cas.: 130952-46-4 | Purity: 98% | Ozagrel sodium (OKY-046 sodium) | ESD-910882-10MG |
Cas.: 1309793-47-2 | Purity: 98% | (±)-CPSI-1306 | ESD-910883-5MG |
Cas.: 1311385-20-2 | Purity: 98% | LY2812223 | ESD-910884-1MG |
Cas.: 13153-27-0 | Purity: 98% | NBTGR | ESD-910885-1MG |
Cas.: 131543-25-4 | Purity: 98% | (-)-WIN 55,212-3 mesylate | ESD-910886-5MG |
Cas.: 1321546-70-6 | Purity: 98% | (S)-(-)-5-Fluorowillardiine hydrochloride ((5S)-Fluorowillardiine hydrochloride) | ESD-910887-10MG |
Cas.: 132195-65-4 | Purity: 98% | BMY-43748 | ESD-910888-1MG |
Cas.: 132414-02-9 | Purity: 98% | Alosetron (HCl(1:X)) | ESD-910889-10MG |
Cas.: 1330782-69-8 | Purity: 98% | (R)-Simurosertib ((R)-TAK-931 | ESD-910890-5MG |
Cas.: 1330782-76-7 | Purity: 98% | Simurosertib (TAK-931) | ESD-910891-5MG |
Cas.: 1333210-07-3 | Purity: 98% | SAR7334 | ESD-910892-5MG |
Cas.: 1334177-86-4 | Purity: 98% | Mal-amido-PEG8-C2-acid | ESD-910893-5MG |
Cas.: 1334532-24-9 | Purity: 98% | Octanoyl-L-carnitine-d3 chloride (L-Octanoylcarnitine-d3 chloride) | ESD-910894-1MG |
Cas.: 1345982-69-5 | Purity: 98% | linerixibat (GSK2330672) | ESD-910895-5MG |
Cas.: 13461-01-3 | Purity: BR | Acepromethazine | ESD-910896-5MG |
Cas.: 134624-73-0 | Purity: 98% | Stavudine sodium (d4T sodium) | ESD-910897-100MG |
Cas.: 134759-22-1 | Purity: 98% | Fluorescein Biotin | ESD-910898-1MG |
Cas.: 1349723-93-8 | Purity: 98% | Elacestrant dihydrochloride (RAD1901 dihydrochloride) | ESD-910899-5MG |
Cas.: 1350462-55-3 | Purity: 98% | Grazoprevir hydrate (MK-5172 hydrate) | ESD-910900-5MG |
Cas.: 1351169-29-3 | Purity: 98% | PROTAC ERα Degrader-2 | ESD-910901-5MG |
Cas.: 1352226-87-9 | Purity: 98% | (S)-Ceralasertib | ESD-910902-5MG |
Cas.: 1352610-25-3 | Purity: 98% | EW-7197 Hydrochloride | ESD-910903-5MG |
Cas.: 135383-60-7 | Purity: 98% | (S)-Dolaphenine hydrochloride | ESD-910904-100MG |
Cas.: 1354799-87-3 | Purity: ≥98% | Ilginatinib maleate (NS-018 maleate) | ESD-910905-5MG |
Cas.: 135729-75-8 | Purity: 98% | (R,R)-Palonosetron hydrochloride | ESD-910906-5MG |
Cas.: 1360053-81-1 | Purity: 98% | AVL-292 (benzenesulfonate) | ESD-910907-5MG |
Cas.: 136087-85-9 | Purity: 98% | Fidarestat (SNK 860) | ESD-910908-5MG |
Cas.: 136529-33-4 | Purity: 98% | Temiverine hydrochloride | ESD-910909-1MG |
Cas.: 1366000-58-9 | Purity: 98% | Atrial Natriuretic Peptide (ANP) (1-28), human, porcine (Acetate) | ESD-910910-1MG |
Cas.: 137361-05-8 | Purity: 98% | Nω-propyl-L-Arginine (N5- | ESD-910911-5MG |
Cas.: 1374639-79-8 | Purity: 98% | Ribociclib succinate hydrate (LEE011 succinate hydrate) | ESD-910912-5MG |
Cas.: 1375603-36-3 | Purity: 98% | Sevitronel racemate (VT-464 racemate) | ESD-910913-5MG |
Cas.: 1375603-38-5 | Purity: 98% | Sevitronel R enantiomer (VT-464 R enantiomer) | ESD-910914-5MG |
Cas.: 1380650-53-2 | Purity: 98% | BMS-986020 sodium | ESD-910915-5MG |
Cas.: 1383450-81-4 | Purity: 98% | JNJ-678 (JNJ-53718678) | ESD-910916-5MG |
Cas.: 138398-61-5 | Purity: 98% | Amylin (8-37), rat | ESD-910917-1MG |
Cas.: 1384082-96-5 | Purity: 98% | (1α,1’S,4β)-Lanabecestat | ESD-910918-5MG |
Cas.: 138449-07-7 | Purity: BR | FK 888 | ESD-910919-5MG |
Cas.: 1384860-29-0 | Purity: 98% | Conteltinib (CT-707) | ESD-910920-5MG |
Cas.: 1386455-76-0 | Purity: 98% | Complement factor D inhibitor 1 | ESD-910921-5MG |
Cas.: 13909-09-6 | Purity: 98% | Semustine | ESD-910922-5MG |
Cas.: 1391194-64-1 | Purity: 98% | (2S)-Octyl-α-hydroxyglutarate ((2S)-Octyl-2-HG) | ESD-910923-5MG |
Cas.: 1391194-67-4 | Purity: 98% | (2R)-Octyl-α-hydroxyglutarate ((2R)-Octyl-2-HG) | ESD-910924-5MG |
Cas.: 139340-56-0 | Purity: 98% | Darbufelone mesylate (CI-1004 mesylate) | ESD-910925-5MG |
Cas.: 1394121-05-1 | Purity: 98% | GNE 2861 | ESD-910926-5MG |
Cas.: 1396257-94-5 | Purity: 98% | Ipatasertib dihydrochloride | ESD-910927-5MG |
Cas.: 1398510-92-3 | Purity: 98% | MK-6913 (Tetrahydrofluoroene 52) | ESD-910928-1MG |
Cas.: 1401028-24-7 | Purity: ≥98% | Oliceridine (TRV130) | ESD-910929-5MG |
Cas.: 1401031-39-7 | Purity: ≥98% | Oliceridine hydrochloride (TRV130 hydrochloride) | ESD-910930-5MG |
Cas.: 1401728-56-0 | Purity: 98% | NE 52-QQ57 | ESD-910931-5MG |
Cas.: 140187-23-1 | Purity: 98% | (S)-(-)-5-Fluorowillardiine | ESD-910932-10MG |
Cas.: 1402821-24-2 | Purity: 98% | Ca2+ channel agonist 1 | ESD-910933-5MG |
Cas.: 1414842-70-8 | Purity: 98% | VU0364770 hydrochloride | ESD-910934-5MG |
Cas.: 1415390-47-4 | Purity: 98% | (R)-BPO-27 | ESD-910935-1MG |
Cas.: 141611-10-1 | Purity: 98% | D-myo-Inositol-1,4,5-triphosphate sodium salt | ESD-910936-1MG |
Cas.: 141611-11-2 | Purity: 98% | D-myo-Inositol-1,4,5-triphosphate potassium salt | ESD-910937-500ΜG |
Cas.: 1416133-88-4 | Purity: 98% | JW 618 | ESD-910938-10MG |
Cas.: 1416258-16-6 | Purity: 98% | (±)-BI-D | ESD-910939-5MG |
Cas.: 141750-63-2 | Purity: 98% | Pitavastatin lactone | ESD-910940-1MG |
Cas.: 141774-20-1 | Purity: 98% | NPC-15437 hydrochloride | ESD-910941-1MG |
Cas.: 1418131-46-0 | Purity: 98% | RSC-133 | ESD-910942-5MG |
Cas.: 142001-63-6 | Purity: 98% | Saredutant | ESD-910943-5MG |
Cas.: 1420071-13-1 | Purity: 98% | LAS191859 | ESD-910944-500ΜG |
Cas.: 1420791-14-5 | Purity: 98% | 15(S)-Fluprostenol isopropyl ester (15(S)-Flu-Ipr) | ESD-910945-1MG |
Cas.: 142128-57-2 | Purity: 98% | (-)-Ketoconazole | ESD-910946-10MG |
Cas.: 142128-59-4 | Purity: 98% | (+)-Ketoconazole | ESD-910947-10MG |
Cas.: 1421369-12-1 | Purity: 98% | 17-phenoxy trinor Prostaglandin F2α ethyl amide | ESD-910948-1MG |
Cas.: 142147-67-9 | Purity: 98% | Dihydro Montelukast | ESD-910949-500ΜG |
Cas.: 142227-51-8 | Purity: BR | 5′-Hydroxyphenyl Carvedilol | ESD-910950-5MG |
Cas.: 1422500-60-4 | Purity: 98% | Ziresovir | ESD-910951-5MG |
Cas.: 1422513-91-4 | Purity: 98% | Pentedrone metabolite hydrochloride ((±)-Ephedrine stereochemistry) | ESD-910952-500ΜG |
Cas.: 1423018-12-5 | Purity: 98% | LY2922470 | ESD-910953-5MG |
Cas.: 142439-95-0 | Purity: 98% | Sp-Cyclic AMPS sodium salt (Sp-cAMPS) | ESD-910954-1MG |
Cas.: 1424799-20-1 | Purity: 98% | (+)-SJ733 (SJ000557733) | ESD-910955-5MG |
Cas.: 142507-74-2 | Purity: 98% | D-myo-Inositol-1,3,4,6-tetraphosphate (ammonium salt) | ESD-910956-500ΜG |
Cas.: 142523-38-4 | Purity: 98% | L-690330 | ESD-910957-5MG |
Cas.: 1425381-60-7 | Purity: 98% | Gusacitinib | ESD-910958-5MG |
Cas.: 142561-96-4 | Purity: 98% | Zaragozic Acid A | ESD-910959-1MG |
Cas.: 142-58-5 | Purity: 98% | Myristoyl Ethanolamide | ESD-910960-5MG |
Cas.: 1426152-53-5 | Purity: 98% | UNC2327 | ESD-910961-5MG |
Cas.: 1426173-17-2 | Purity: 98% | Norhydrocodone-d3 hydrochloride | ESD-910962-500ΜG |
Cas.: 1426173-65-0 | Purity: 98% | Ampicillin-d5 | ESD-910963-500ΜG |
Cas.: 1426174-16-4 | Purity: 98% | Dextrorphan-d3 tartrate (d-3-hydroxy-N-Methylmorphinan tartrate-d3) | ESD-910964-1MG |
Cas.: 1426802-50-7 | Purity: 98% | GSK805 | ESD-910965-5MG |
Cas.: 1426916-00-8 | Purity: 98% | ML-299 (CID 56593087) | ESD-910966-500ΜG |
Cas.: 1427049-21-5 | Purity: 98% | Brexpiprazole-d8 | ESD-910967-500ΜG |
Cas.: 1427058-33-0 | Purity: 98% | E6130 | ESD-910968-5MG |
Cas.: 1427325-32-3 | Purity: 98% | JWH 018 2-hydroxyindole metabolite | ESD-910969-1MG |
Cas.: 1427325-40-3 | Purity: 98% | JWH 018 N-(1,2-dimethylpropyl) isomer | ESD-910970-1MG |
Cas.: 1427325-45-8 | Purity: 98% | JWH 018 N-(1-methylbutyl) isomer (JWH 073 1-methylbutyl homolog) | ESD-910971-1MG |
Cas.: 1427325-47-0 | Purity: 98% | JWH 018 N-(2,2-dimethylpropyl) isomer | ESD-910972-1MG |
Cas.: 1427325-49-2 | Purity: 98% | JWH 018 6-methoxyindole analog | ESD-910973-1MG |
Cas.: 1427325-54-9 | Purity: 98% | JWH 073 2-hydroxyindole metabolite | ESD-910974-1MG |
Cas.: 1427325-61-8 | Purity: 98% | JWH 073 2-methylnaphthyl analog | ESD-910975-1MG |
Cas.: 1427325-65-2 | Purity: 98% | JWH 081 5-methoxynaphthyl isomer | ESD-910976-1MG |
Cas.: 1427325-66-3 | Purity: 98% | JWH 081 N-(5-hydroxypentyl) metabolite | ESD-910977-1MG |
Cas.: 1427325-68-5 | Purity: 98% | JWH 122 6-methylnaphthyl isomer | ESD-910978-1MG |
Cas.: 1427325-69-6 | Purity: 98% | JWH 122 2-methylnaphthyl isomer | ESD-910979-1MG |
Cas.: 1427325-73-2 | Purity: 98% | JWH 200 4-hydroxyindole metabolite | ESD-910980-1MG |
Cas.: 1427325-76-5 | Purity: 98% | JWH 200 6-hydroxyindole metabolite | ESD-910981-1MG |
Cas.: 1427325-79-8 | Purity: 98% | JWH 210 2-ethylnaphthyl isomer | ESD-910982-1MG |
Cas.: 1427325-81-2 | Purity: 98% | JWH 210 5-hydroxyindole metabolite | ESD-910983-1MG |
Cas.: 1427325-83-4 | Purity: 98% | JWH 250 N-(5-hydroxypentyl) metabolite | ESD-910984-1MG |
Cas.: 1427325-88-9 | Purity: 98% | JWH 251 3-methylphenyl isomer (JWH 251 3-methyl isomer) | ESD-910985-5MG |
Cas.: 1427325-89-0 | Purity: 98% | JWH 398 5-chloronaphthyl isomer | ESD-910986-1MG |
Cas.: 1427325-91-4 | Purity: 98% | AM694 3-iodo isomer | ESD-910987-1MG |
Cas.: 1427325-92-5 | Purity: 98% | AM694 4-iodo isomer | ESD-910988-1MG |
Cas.: 1427325-95-8 | Purity: 98% | AM2201 N-(4-fluoropentyl)isomer | ESD-910989-500ΜG |
Cas.: 1427326-08-6 | Purity: 98% | RCS-8 3-methoxy isomer | ESD-910990-1MG |
Cas.: 1427326-10-0 | Purity: 98% | RCS-8 4-methoxy isomer | ESD-910991-1MG |
Cas.: 1427521-34-3 | Purity: 98% | AM2201 N-(4-hydroxypentyl) metabolite | ESD-910992-100ΜG |
Cas.: 1427521-35-4 | Purity: 98% | AM2201 6-hydroxyindole metabolite | ESD-910993-1MG |
Cas.: 1427521-36-5 | Purity: 98% | JWH 210 N-pentanoic acid metabolite (JWH 210 N-(5-carboxypentyl) metabolite) | ESD-910994-1MG |
Cas.: 1427521-37-6 | Purity: 98% | JWH 210 N-(4-hydroxypentyl) metabolite | ESD-910995-1MG |
Cas.: 1427521-38-7 | Purity: 98% | JWH 250 N-(4-hydroxypentyl) metabolite | ESD-910996-1MG |
Cas.: 1427521-39-8 | Purity: 98% | RCS-4 N-(5-carboxypentyl) metabolite | ESD-910997-1MG |
Cas.: 1427521-40-1 | Purity: 98% | JWH 210 N-(5-hydroxypentyl) metabolite | ESD-910998-1MG |
Cas.: 142760-33-6 | Purity: 98% | D-myo-Inositol-4-phosphate (ammonium salt) | ESD-910999-100ΜG |
Cas.: 1428126-74-2 | Purity: 98% | 2-Aminopurine hydrochloride (2-AP) | ESD-911000-50MG |
Cas.: 142828-42-0 | Purity: 98% | all-cis-4,7,10,13,16-Docosapentaenoic Acid ethyl ester | ESD-911001-5MG |
Cas.: 1428445-15-1 | Purity: 98% | ARN1203 | ESD-911002-1MG |
Cas.: 142852-50-4 | Purity: BR | Zanapezil | ESD-911003-5MG |
Cas.: 14292-27-4 | Purity: 98% | 3-hydroxy Octanoic Acid | ESD-911005-5MG |
Cas.: 1429402-13-0 | Purity: 98% | Isopentedrone hydrochloride | ESD-911006-1MG |
Cas.: 1430634-87-9 | Purity: 98% | SDB-006 N-phenyl analog | ESD-911007-1MG |
Cas.: 143086-29-7 | Purity: 98% | Cycloechinulin | ESD-911008-1MG |
Cas.: 1431303-72-8 | Purity: 98% | ORY-1001(trans) | ESD-911009-5MG |
Cas.: 1431362-79-6 | Purity: 98% | Ac-PAL-AMC | ESD-911010-1MG |
Cas.: 1431520-52-3 | Purity: 98% | UWA-101 hydrochloride | ESD-911011-1MG |
Cas.: 1431699-67-0 | Purity: 98% | (S)-Tedizolid | ESD-911012-5MG |
Cas.: 1432-04-8 | Purity: 98% | Cyclopropyl norfentanyl hydrochloride (Norcyclopropyl fentanyl) | ESD-911013-1MG |
Cas.: 14325-05-4 | Purity: 98% | Tin Protoporphyrin IX chloride | ESD-911014-5MG |
Cas.: 1432794-98-3 | Purity: 98% | 5-fluoro PB-22 3-carboxyindole metabolite | ESD-911015-1MG |
Cas.: 1432900-96-3 | Purity: 98% | AM694 N-pentanoic acid metabolite | ESD-911016-1MG |
Cas.: 143292-98-2 | Purity: 98% | 5(S)-HpEPE | ESD-911017-100ΜG |
Cas.: 143313-51-3 | Purity: 98% | Ac-YVAD-CHO (N-Ac-Tyr-Val-Ala-Asp-CHO) | ESD-911018-1MG |
Cas.: 143322-58-1 | Purity: 98% | Eletriptan (UK 116044) | ESD-911019-1MG |
Cas.: 1434048-34-6 | Purity: 98% | Fenebrutinib (GDC-0853) | ESD-911020-5MG |
Cas.: 143413-47-2 | Purity: 98% | Nona-arginine | ESD-911021-1MG |
Cas.: 1434-54-4 | Purity: 98% | Pregnenolone Carbonitrile | ESD-911022-50MG |
Cas.: 143492-38-0 | Purity: 98% | D-erythro-MAPP ((1S,2R-D-erythro-2-N-myristoylamino)-1-phenyl-1-propanol) | ESD-911023-1MG |
Cas.: 143537-62-6 | Purity: 98% | N-(β-ketocaproyl)-L-Homoserine lactone (3-O-C6-(L)-HSL) | ESD-911024-5MG |
Cas.: 1435727-11-9 | Purity: 98% | 6β-Naltrexol-d3 (6β-hydroxy Naltrexone-d3) | ESD-911025-500ΜG |
Cas.: 1435933-70-2 | Purity: 98% | 3-Methoxymethcathinone hydrochloride (3-MeOMC) | ESD-911026-5MG |
Cas.: 1435933-78-0 | Purity: 98% | Zopiclone-d4 ((±)-Zopiclone-d4) | ESD-911027-500ΜG |
Cas.: 1435933-83-7 | Purity: 98% | Meprobamate-d7 | ESD-911028-500ΜG |
Cas.: 1435934-29-4 | Purity: 98% | JWH 019 N-(6-hydroxyhexyl) metabolite | ESD-911029-1MG |
Cas.: 1435934-47-6 | Purity: 98% | JWH 019 N-(5-hydroxyhexyl) metabolite | ESD-911030-1MG |
Cas.: 1436383-95-7 | Purity: 98% | BF738735 | ESD-911031-5MG |
Cas.: 143673-93-2 | Purity: 98% | CAY10679 (N,N’-bis(glycyl-glycine)-hexane-1,6-Dicarboxyamide) | ESD-911032-10MG |
Cas.: 143703-25-7 | Purity: 98% | CE3F4 | ESD-911033-5MG |
Cas.: 143816-42-6 | Purity: 98% | Quininib | ESD-911034-1MG |
Cas.: 1438278-55-7 | Purity: 98% | 7′-methoxy NABUTIE (7′-MeO NABUTIE) | ESD-911035-1MG |
Cas.: 143943-72-0 | Purity: 98% | Ro 41-3290 | ESD-911036-1MG |
Cas.: 1439488-21-7 | Purity: 98% | CAY10680 | ESD-911037-5MG |
Cas.: 143-98-6 | Purity: 98% | Dextrorphan tartrate | ESD-911038-1MG |
Cas.: 1440898-82-7 | Purity: 98% | Deltarasin hydrochloride | ESD-911039-5MG |
Cas.: 144110-38-3 | Purity: 98% | Arphamenine B hemisulfate | ESD-911040-1MG |
Cas.: 1441421-73-3 | Purity: 98% | Leukotriene C4-d5 (LTC4-d5) | ESD-911041-100ΜG |
Cas.: 1443253-20-0 | Purity: 98% | CAY10677 (Icmt Inhibitor 15) | ESD-911042-1MG |
Cas.: 144337-18-8 | Purity: 98% | YM-26734 | ESD-911043-1MG |
Cas.: 1443-44-3 | Purity: 98% | Alpha-methyl Fentanyl hydrochloride (NSC 167733) | ESD-911044-1MG |
Cas.: 1443-49-8 | Purity: 98% | Furanylethyl fentanyl hydrochloride | ESD-911045-1MG |
Cas.: 1443-50-1 | Purity: 98% | N,N-Dimethylamido-despropionyl fentanyl | ESD-911046-1MG |
Cas.: 1443-51-2 | Purity: 98% | meta-methyl Acetyl fentanyl hydrochloride | ESD-911047-1MG |
Cas.: 1443-52-3 | Purity: 98% | Butyryl fentanyl hydrochloride | ESD-911048-1MG |
Cas.: 1443-53-4 | Purity: 98% | ortho-Methylfentanyl hydrochloride | ESD-911049-1MG |
Cas.: 1443763-60-7 | Purity: ≥98% | BAY 1161909 (Empesertib) | ESD-911051-5MG |
Cas.: 144397-99-9 | Purity: 98% | Obscurolide A1 | ESD-911052-1MG |
Cas.: 1445349-99-4 | Purity: 98% | 8,12-iso-iPF2α-VI | ESD-911053-10ΜG |
Cas.: 1445385-02-3 | Purity: 98% | Lumicitabine | ESD-911054-5MG |
Cas.: 1445700-01-5 | Purity: 98% | TFMB-(R)-2-HG | ESD-911056-5MG |
Cas.: 1446090-77-2 | Purity: 98% | Lifirafenib (BGB-283) | ESD-911057-5MG |
Cas.: 1446486-33-4 | Purity: 98% | 9-Propenyladenine (Tenofovir Impurity) | ESD-911058-5MG |
Cas.: 1448867-42-2 | Purity: 98% | NVP-HDM201 R Enantiomer (HDM201 R Enantiomer) | ESD-911059-5MG |
Cas.: 14528-64-4 | Purity: BR | 4-Nitrocatechol Sulfate Dipotassium Salt | ESD-911060-50MG |
Cas.: 145317-11-9 | Purity: 98% | Bisindolylmaleimide X hydrochloride | ESD-911061-5MG |
Cas.: 146255-66-5 | Purity: 98% | DHPG ((RS)-3,5-DHPG) | ESD-911062-5MG |
Cas.: 1464851-21-5 | Purity: 97% | (Z)-9-Propenyladenine ((Z)-Mutagenic Impurity of Tenofovir Disoproxil) | ESD-911063-5MG |
Cas.: 1467052-75-0 | Purity: 98% | Tazemetostat hydrobromide (EPZ-6438 hydrobromide) | ESD-911064-5MG |
Cas.: 1476074-39-1 | Purity: 98% | VX-984 (M9831) | ESD-911065-5MG |
Cas.: 149606-27-9 | Purity: 98% | Auristatin PE | ESD-911066-5MG |
Cas.: 150145-89-4 | Purity: 98% | (S)-MCPG | ESD-911067-5MG |
Cas.: 1532533-78-0 | Purity: ≥98% | Umbralisib hydrochloride | ESD-911068-5MG |
Cas.: 154-02-9 | Purity: 98% | 5-Hydroxytryptophol | ESD-911069-10MG |
Cas.: 154835-90-2 | Purity: 98% | Adrenomedullin (AM) (13-52), human (ADM (1-52)) | ESD-911070-1MG |
Cas.: 1549593-23-8 | Purity: 98% | Taltirelin acetate (TA-0910 acetate) | ESD-911071-5MG |
Cas.: 156251-01-3 | Purity: 98% | MART-1 (26-35) (human) | ESD-911072-1MG |
Cas.: 1572051-31-0 | Purity: 98% | O-7460 | ESD-911073-500ΜG |
Cas.: 15790-91-7 | Purity: 98% | (Z)-2-Decenoic acid (cis-2-Decenoic acid) | ESD-911074-5MG |
Cas.: 158205-05-1 | Purity: 98% | L-745337 (Thioflosulide) | ESD-911075-1MG |
Cas.: 1593673-23-4 | Purity: 98% | Etripamil | ESD-911076-5MG |
Cas.: 1599440-13-7 | Purity: 98% | Deruxtecan | ESD-911077-1MG |
Cas.: 1609563-71-4 | Purity: 98% | (1R,2R)-2-PCCA hydrochloride | ESD-911078-5MG |
Cas.: 1610022-76-8 | Purity: 98% | Nrf2 inhibitor 1 | ESD-911079-5MG |
Cas.: 1610358-53-6 | Purity: 98% | (±)-BAY-1251152 | ESD-911080-5MG |
Cas.: 1610358-56-9 | Purity: 98% | (+)-BAY-1251152 | ESD-911081-5MG |
Cas.: 1610358-59-2 | Purity: 98% | (-)-BAY-1251152 | ESD-911082-5MG |
Cas.: 1610537-15-9 | Purity: 98% | Sevitronel (VT-464) | ESD-911083-5MG |
Cas.: 1610610-48-4 | Purity: 98% | KDU731 | ESD-911084-5MG |
Cas.: 1610878-54-0 | Purity: 98% | Telomerase inhibitor 2 | ESD-911085-5MG |
Cas.: 1612782-86-1 | Purity: 98% | UNC2541 | ESD-911086-5MG |
Cas.: 1616113-45-1 | Purity: 98% | Antibiotic-202 | ESD-911087-5MG |
Cas.: 1616420-30-4 | Purity: 98% | CFI-400945 fumarate | ESD-911088-5MG |
Cas.: 162408-66-4 | Purity: 98% | GR 103691 | ESD-911089-5MG |
Cas.: 162652-95-1 | Purity: 98% | Vinflunine | ESD-911090-5MG |
Cas.: 1629063-78-0 | Purity: 98% | Ibiglustat L-Malic acid | ESD-911091-5MG |
Cas.: 163018-26-6 | Purity: 98% | 3-O-(2-Aminoethyl)-25-hydroxyvitamin D3 | ESD-911092-5MG |
Cas.: 1633350-06-7 | Purity: 98% | (±)-Zanubrutinib ((±)-BGB-3111) | ESD-911093-5MG |
Cas.: 163847-77-6 | Purity: 98% | TAPI-1 | ESD-911094-5MG |
Cas.: 1639220-15-7 | Purity: 98% | Sigma-1 receptor antagonist 2 | ESD-911095-1MG |
Cas.: 1639220-17-9 | Purity: 98% | Sigma-1 receptor antagonist 3 | ESD-911096-1MG |
Cas.: 1639220-19-1 | Purity: 98% | Sigma-1 receptor antagonist 1 | ESD-911097-1MG |
Cas.: 1642300-78-4 | Purity: 98% | Eltanexor Z-isomer (KPT-8602 Z-isomer) | ESD-911098-1MG |
Cas.: 165133-86-8 | Purity: BR | N-Desisopropyl Delavirdine | ESD-911099-1MG |
Cas.: 166090-74-0 | Purity: 98% | β-Amyloid (1-42), rat (Amyloid β-peptide (1-42) (rat)) | ESD-911100-1MG |
Cas.: 1672662-07-5 | Purity: 98% | (Rac)-PT2399 | ESD-911101-5MG |
Cas.: 1677668-27-7 | Purity: 98% | GNE-6468 | ESD-911102-5MG |
Cas.: 168079-32-1 | Purity: 98% | Lixivaptan | ESD-911103-5MG |
Cas.: 168161-71-5 | Purity: 98% | CCK-B Receptor Antagonist 1 | ESD-911104-5MG |
Cas.: 168266-90-8 | Purity: 98% | Vofopitant (GR 205171) | ESD-911105-5MG |
Cas.: 168770-31-8 | Purity: 98% | Oleanolic acid hemiphthalate disodium salt | ESD-911106-5MG |
Cas.: 1691249-44-1 | Purity: 98% | (R)-Zanubrutinib ((R)-BGB-3111) | ESD-911107-1MG |
Cas.: 169474-77-5 | Purity: 98% | FCE 28654 | ESD-911108-1MG |
Cas.: 169505-93-5 | Purity: 98% | RS 17053 hydrochloride (RS-17053) | ESD-911109-5MG |
Cas.: 1702967-37-0 | Purity: 98% | Vipivotide tetraxetan (PSMA-617) | ESD-911110-5MG |
Cas.: 1703768-74-4 | Purity: 98% | Vipivotide tetraxetan Linker | ESD-911111-50MG |
Cas.: 170571-01-4 | Purity: BR | Celecoxib Carboxylic Acid | ESD-911112-5MG |
Cas.: 170851-70-4 | Purity: 98% | ipamorelin | ESD-911113-10MG |
Cas.: 1710768-30-1 | Purity: 98% | Ibrutinib-MPEA | ESD-911114-5MG |
Cas.: 173352-39-1 | Purity: 98% | Fabomotizole hydrochloride (CM346 hydrochloride) | ESD-911115-5MG |
Cas.: 174473-88-2 | Purity: 98% | 2-γ-Linolenoyl-1,3-dilinoleoyl-sn-glycerol | ESD-911116-1MG |
Cas.: 176199-48-7 | Purity: ≥98% | Eglumegad | ESD-911117-5MG |
Cas.: 177277-99-5 | Purity: 98% | Implitapide Racemate | ESD-911118-1MG |
Cas.: 1780259-94-0 | Purity: 98% | ZK756326 Mesylate | ESD-911119-5MG |
Cas.: 1782070-22-7 | Purity: 98% | PAT-505 | ESD-911120-5MG |
Cas.: 1782573-67-4 | Purity: 98% | RU-SKI 43 hydrochloride (Hhat Inhibitor) | ESD-911121-5MG |
Cas.: 1784751-20-7 | Purity: 98% | CK1 inhibitor 1 | ESD-911122-5MG |
Cas.: 1786438-30-9 | Purity: BR | (R)-CR8 trihydrochloride | ESD-911123-5MG |
Cas.: 1787294-07-8 | Purity: 98% | Remibrutinib | ESD-911124-5MG |
Cas.: 179102-65-9 | Purity: 98% | YM158 (free base) (YM-57158) | ESD-911125-1MG |
Cas.: 1799506-06-1 | Purity: 98% | VH032-PEG5-C6-Cl (HaloPROTAC 2) | ESD-911126-5MG |
Cas.: 1799706-65-2 | Purity: 98% | MMAF sodium | ESD-911127-5MG |
Cas.: 18000-24-3 | Purity: 98% | 7-Chlorokynurenic acid | ESD-911128-10MG |
Cas.: 1800047-00-0 | Purity: 98% | Lanraplenib succinate (GS-9876 succinate) | ESD-911129-5MG |
Cas.: 1800405-30-4 | Purity: 98% | NQO1 activator 1 | ESD-911130-5MG |
Cas.: 180046-99-5 | Purity: BR | SDZ NKT 343 | ESD-911131-5MG |
Cas.: 1800505-64-9 | Purity: 98% | Pz-1 | ESD-911132-5MG |
Cas.: 180090-15-7 | Purity: 98% | CP-060 | ESD-911133-1MG |
Cas.: 180200-68-4 | Purity: 98% | JTE522 | ESD-911134-1MG |
Cas.: 180603-77-4 | Purity: BR | Candesartan Acyl-Glucuronide | ESD-911135-1MG |
Cas.: 1809336-93-3 | Purity: 98% | Valemetostat tosylate (DS-3201 tosylate) | ESD-911136-5MG |
Cas.: 181629-93-6 | Purity: 98% | SB228357 | ESD-911137-5MG |
Cas.: 18200-13-0 | Purity: 98% | BL-1249 | ESD-911138-5MG |
Cas.: 182564-41-6 | Purity: 98% | OAC3 | ESD-911139-5MG |
Cas.: 1835705-55-9 | Purity: 98% | (S,R,S)-AHPC-C6-PEG3-C4-Cl (VH032-C6-PEG3-C4-Cl) | ESD-911140-100MG |
Cas.: 1835705-57-1 | Purity: 98% | (S,R,S)-AHPC-PEG2-C4-Cl (VH032-PEG2-C4-Cl) | ESD-911141-100MG |
Cas.: 183598-56-3 | Purity: 98% | Leptin (22-56), human | ESD-911142-1MG |
Cas.: 18457-55-1 | Purity: 98% | (S)-()-Perillyl alcohol | ESD-911143-50MG |
Cas.: 1847485-91-9 | Purity: 98% | Ilorasertib hydrochloride (ABT-348 hydrochloride) | ESD-911144-5MG |
Cas.: 1848242-58-9 | Purity: 98% | PI3K/mTOR Inhibitor-2 | ESD-911145-5MG |
Cas.: 185517-21-9 | Purity: 98% | Arundic Acid (ONO-2506) | ESD-911146-5MG |
Cas.: 186390-35-2 | Purity: 98% | CP-319340(free base) | ESD-911147-1MG |
Cas.: 187870-95-7 | Purity: 98% | Rimeporide hydrochloride | ESD-911148-1MG |
Cas.: 188048-45-5 | Purity: 98% | (±)-WS75624B | ESD-911149-1MG |
Cas.: 1883545-52-5 | Purity: 98% | MM-102 TFA (HMTase Inhibitor IX TFA) | ESD-911150-5MG |
Cas.: 1883548-91-1 | Purity: 98% | ZLN024 hydrochloride | ESD-911151-5MG |
Cas.: 1887095-82-0 | Purity: 98% | RapaLink-1 | ESD-911152-1MG |
Cas.: 188844-34-0 | Purity: 98% | HX 531 | ESD-911153-1MG |
Cas.: 189013-61-4 | Purity: 98% | (5R)-BW-4030W92 | ESD-911154-1MG |
Cas.: 189059-71-0 | Purity: 98% | Lapaquistat (T-91485) | ESD-911155-1MG |
Cas.: 1893397-65-3 | Purity: 98% | TBK1/IKKε inhibitor 5 | ESD-911156-1MG |
Cas.: 1897428-40-8 | Purity: BR | (4S)-2,2,4-Trimethylpyrrolidine Hydrochloride | ESD-911157-10MG |
Cas.: 192203-60-4 | Purity: 98% | Carboxypeptidase G2 inhibitor (CPG2 Inhibitor) | ESD-911158-50MG |
Cas.: 192387-38-5 | Purity: 98% | Neuropeptide AF (93-110), Human (Neuropeptide AF (human)) | ESD-911159-1MG |
Cas.: 19473-49-5 | Purity: 98% | L-Glutamic acid monopotassium salt | ESD-911160-500MG |
Cas.: 1950635-14-9 | Purity: 98% | Thalidomide-O-amido-C6-NH2 (TFA) | ESD-911161-100MG |
Cas.: 1959551-26-8 | Purity: 98% | FT671 | ESD-911162-5MG |
Cas.: 199735-88-1 | Purity: 98% | CADD522 | ESD-911163-5MG |
Cas.: 199854-00-7 | Purity: 98% | O-Acetyl Salicylhydroxamic Acid | ESD-911164-1MG |
Cas.: 199934-16-2 | Purity: BR | UCL 1684 | ESD-911165-5MG |
Cas.: 20007-85-6 | Purity: 98% | (–)-Cyclopenol | ESD-911166-1MG |
Cas.: 2003234-64-6 | Purity: 98% | (S)-GNE-140 | ESD-911167-1MG |
Cas.: 20125-39-7 | Purity: 98% | N6-(2-Phenylethyl)adenosine | ESD-911168-10MG |
Cas.: 201410-66-4 | Purity: 98% | (+)-Talarozole | ESD-911169-5MG |
Cas.: 201410-67-5 | Purity: 98% | (-)-Talarozole | ESD-911170-1MG |
Cas.: 203564-54-9 | Purity: 98% | Tebanicline hydrochloride | ESD-911171-5MG |
Cas.: 203923-89-1 | Purity: 98% | Karenitecin | ESD-911172-5MG |
Cas.: 204205-90-3 | Purity: 98% | Indibulin (ZIO 301) | ESD-911173-5MG |
Cas.: 20424-00-4 | Purity: 98% | Deprodone propionate (RD20000) | ESD-911174-5MG |
Cas.: 2049872-86-6 | Purity: 98% | GSK962 | ESD-911175-5MG |
Cas.: 205640-90-0 | Purity: 98% | Orexin A (human, rat, mouse) | ESD-911176-1MG |
Cas.: 2065250-25-9 | Purity: 98% | DAAO inhibitor 1 | ESD-911177-5MG |
Cas.: 2070009-31-1 | Purity: 98% | (R,S)-Ivosidenib((R,S)-AG-120) | ESD-911178-5MG |
Cas.: 2070009-58-2 | Purity: 98% | GDC-0994 Hydrochloride (Ravoxertinib hydrochloride) | ESD-911179-5MG |
Cas.: 2070014-78-5 | Purity: 98% | PF-2545920 hydrochloridePF-2545920 hydrochloride (Mardepodect hydrochloride0 | ESD-911180-5MG |
Cas.: 2070015-10-8 | Purity: 98% | ML204 hydrochloride | ESD-911181-5MG |
Cas.: 2070015-13-1 | Purity: 98% | ML241 hydrochloride | ESD-911182-5MG |
Cas.: 2070018-31-2 | Purity: 98% | CARM1 inhibitor 1 hydrochloride | ESD-911183-5MG |
Cas.: 2070861-46-8 | Purity: 98% | GENZ-882706(Raceme) (GENZ-882706 racemate) | ESD-911184-5MG |
Cas.: 2071195-74-7 | Purity: 98% | Epertinib hydrochloride | ESD-911185-5MG |
Cas.: 207300-85-4 | Purity: 98% | 5′-GTP trisodium salt hydrate | ESD-911186-50MG |
Cas.: 2088852-47-3 | Purity: 98% | INCB053914 phosphate | ESD-911187-5MG |
Cas.: 2089293-61-6 | Purity: 98% | NAcM-OPT | ESD-911188-10MG |
Cas.: 20897-92-1 | Purity: 98% | 15-epi Prostaglandin A1 (15-epi PGA1) | ESD-911189-500ΜG |
Cas.: 2092923-21-0 | Purity: 98% | VU 6008667 | ESD-911190-5MG |
Cas.: 2093386-22-0 | Purity: 98% | PROTAC BET Degrader-1 | ESD-911191-5MG |
Cas.: 2095417-18-6 | Purity: 98% | 3′-Azido-3′-deoxy-5-fluorocytidine | ESD-911192-5MG |
Cas.: 2095417-28-8 | Purity: 98% | 3′-Azido-3′-deoxy-beta-L-uridine | ESD-911193-5MG |
Cas.: 2097068-39-6 | Purity: 98% | Octyl-α-hydroxyglutarate | ESD-911194-1MG |
Cas.: 2097818-14-7 | Purity: 98% | (R)-VU 6008667 | ESD-911195-5MG |
Cas.: 209789-08-2 | Purity: 98% | Gemcabene calcium (PD-72953 calcium) | ESD-911196-5MG |
Cas.: 2097938-59-3 | Purity: 98% | Lerociclib dihydrochloride (G1T38 dihydrochloride) | ESD-911197-5MG |
Cas.: 2098836-54-3 | Purity: 98% | VH032 thiol | ESD-911198-5MG |
Cas.: 2101314-20-7 | Purity: ≥98% | CX-5416 HCl | ESD-911199-5MG |
Cas.: 210755-45-6 | Purity: 98% | CP-471474 | ESD-911200-5MG |
Cas.: 211427-08-6 | Purity: 98% | Diquafosol tetrasodium (INS365) | ESD-911201-5MG |
Cas.: 2118356-96-8 | Purity: 98% | PROTAC CDK9 Degrader 1 | ESD-911202-5MG |
Cas.: 212329-37-8 | Purity: 98% | MRS1523 | ESD-911203-1MG |
Cas.: 2135304-43-5 | Purity: 98% | KHK inhibitor 2 | ESD-911204-5MG |
Cas.: 2135642-56-5 | Purity: 98% | TAM inhibitor 2 | ESD-911205-5MG |
Cas.: 2137030-98-7 | Purity: 98% | Ensartinib hydrochloride (X-396 hydrochloride) | ESD-911206-5MG |
Cas.: 213971-34-7 | Purity: 98% | FX-11 | ESD-911207-5MG |
Cas.: 2140-64-9 | Purity: 98% | 3-Methylcytidine | ESD-911208-10MG |
Cas.: 214149-42-5 | Purity: 98% | (±)-threo-3,4-Dichloromethylphenidate hydrochloride | ESD-911209-1MG |
Cas.: 21416-43-3 | Purity: 98% | (S)-Willardiine ((-)-Willardiine) | ESD-911210-10MG |
Cas.: 21416-53-5 | Purity: 98% | Picrotin | ESD-911211-5MG |
Cas.: 21416-88-6 | Purity: 98% | ICRF-193 | ESD-911212-1MG |
Cas.: 2144425-14-7 | Purity: 98% | IACS-8968 (IDO/TDO Inhibitor) | ESD-911213-5MG |
Cas.: 214902-82-6 | Purity: BR | Decladinose roxithromycin (Roxithromycin Impurity B) | ESD-911214-5MG |
Cas.: 2166487-21-2 | Purity: 98% | SIRT5 inhibitor 1 | ESD-911215-5MG |
Cas.: 2170696-76-9 | Purity: 98% | LysRs inhibitor 2 | ESD-911216-1MG |
Cas.: 2177266-81-6 | Purity: 98% | Ribocil-C R enantiomer | ESD-911217-5MG |
Cas.: 218791-21-0 | Purity: 98% | Imisopasem manganese (M40403) | ESD-911218-5MG |
Cas.: 2190-30-9 | Purity: 98% | Palmitodiolein | ESD-911219-10MG |
Cas.: 2206736-04-9 | Purity: 98% | MRTX-1257 | ESD-911220-5MG |
Cas.: 220953-69-5 | Purity: 98% | Antalarmin hydrochloride | ESD-911221-5MG |
Cas.: 2211903-84-1 | Purity: 98% | KX-01-191 | ESD-911222-5MG |
Cas.: 2215120-36-6 | Purity: 98% | Interferon receptor inducer-1 | ESD-911223-5MG |
Cas.: 2216712-66-0 | Purity: 98% | Elexacaftor (VX-445) | ESD-911224-1MG |
Cas.: 221877-56-1 | Purity: 98% | 42-(2-Tetrazolyl)rapamycin | ESD-911225-5MG |
Cas.: 2222941-37-7 | Purity: 98% | CBP inhibitor 1 | ESD-911226-5MG |
Cas.: 222318-55-0 | Purity: 98% | (4E)-SUN9221 | ESD-911227-1MG |
Cas.: 22242-96-2 | Purity: 98% | Jaspamycin (7-CN-7-C-Ino) | ESD-911228-5MG |
Cas.: 2230197-64-3 | Purity: 98% | GLP-1 receptor agonist 2 | ESD-911229-5MG |
Cas.: 2237268-08-3 | Purity: 98% | SBI-797812 | ESD-911231-5MG |
Cas.: 2239305-67-8 | Purity: 98% | IACS-8968 (R-enantiomer) (IDO/TDO Inhibitor (R-enantiomer)) | ESD-911232-5MG |
Cas.: 2239305-70-3 | Purity: 98% | IACS-8968 (S-enantiomer) (IDO/TDO Inhibitor (S-enantiomer)) | ESD-911233-5MG |
Cas.: 224169-27-1 | Purity: 98% | Memogain (GLN-1062) | ESD-911234-1MG |
Cas.: 2245697-83-8 | Purity: 98% | (S,R,S)-AHPC-C3-NH2 (VH032-C3-NH2) | ESD-911235-100MG |
Cas.: 2252395-44-9 | Purity: 98% | J22352 | ESD-911236-5MG |
Cas.: 225240-86-8 | Purity: 98% | CP-409092 hydrochloride | ESD-911237-5MG |
Cas.: 226081-74-9 | Purity: 98% | AR-08 | ESD-911238-1MG |
Cas.: 2265-22-7 | Purity: ≥95% | Dexamethasone 21-Mesylate | ESD-911239-5MG |
Cas.: 2267329-76-8 | Purity: BR | EGFR Inhibitor 2 | ESD-911240-5MG |
Cas.: 2271119-26-5 | Purity: 98% | CSF1R inhibitor 2 | ESD-911241-5MG |
Cas.: 227963-15-7 | Purity: 98% | MK-0429 (L-000845704) | ESD-911242-5MG |
Cas.: 2284621-75-4 | Purity: 98% | JAK/HDAC inhibitor 1 | ESD-911243-5MG |
Cas.: 2286411-30-9 | Purity: 98% | MBX-4132 | ESD-911244-5MG |
Cas.: 229002-10-2 | Purity: 98% | MAPK13 inhibitor 1 | ESD-911245-5MG |
Cas.: 2296729-00-3 | Purity: 98% | AMG-510 | ESD-911246-5MG |
Cas.: 2304-80-5 | Purity: 98% | C18 dihydro Ceramide (d18:0/18:0) | ESD-911247-5MG |
Cas.: 2307461-45-4 | Purity: 98% | FAK ligand-Linker Conjugate 1 | ESD-911248-1MG |
Cas.: 2308035-51-8 | Purity: 98% | Thalidomide-O-amido-C3-COOH | ESD-911249-100MG |
Cas.: 23089-26-1 | Purity: 98% | Levomenol ((–)-α-Bisabolol) | ESD-911250-10MG |
Cas.: 2309172-48-1 | Purity: 98% | LDN-192960 hydrochloride | ESD-911251-5MG |
Cas.: 230961-08-7 | Purity: 98% | UK 356618 | ESD-911252-5MG |
Cas.: 2310135-46-5 | Purity: 98% | LMPTP INHIBITOR 1 dihydrochloride | ESD-911253-5MG |
Cas.: 2319589-98-3 | Purity: 98% | WZ4141R | ESD-911254-5MG |
Cas.: 2319790-02-6 | Purity: 98% | SSD114 hydrochloride | ESD-911255-5MG |
Cas.: 2320274-78-8 | Purity: 98% | (RS)-Butyryltimolol | ESD-911256-5MG |
Cas.: 23210-56-2 | Purity: ≥98% | Ifenprodil hemitartrate | ESD-911257-5MG |
Cas.: 2361304-26-7 | Purity: 98% | STAT3 inhibitor 3 | ESD-911258-5MG |
Cas.: 2363169-01-9 | Purity: 98% | c-Kit inhibitor 3 | ESD-911259-5MG |
Cas.: 2375-03-3 | Purity: 98% | 6α-Methylprednisolone 21-hemisuccinate sodium salt | ESD-911260-10MG |
Cas.: 238074-03-8 | Purity: BR | Hyperforin Dicyclohexylammonium Salt | ESD-911261-1MG |
Cas.: 23827-91-0 | Purity: 98% | [Des-Arg9]-Bradykinin acetate | ESD-911262-5MG |
Cas.: 2435557-99-4 | Purity: 98% | (Rac)-NMDAR antagonist 1 | ESD-911263-5MG |
Cas.: 24435-25-4 | Purity: ≥95% | Oleoyl Ethanolamide Phosphate (OEA-P) | ESD-911264-1MG |
Cas.: 2449301-27-1 | Purity: 98% | GSK2643943A | ESD-911265-5MG |
Cas.: 24560-98-3 | Purity: 98% | cis-9,10-Epoxystearic acid | ESD-911266-5MG |
Cas.: 245747-71-1 | Purity: 98% | NFAT transcription factor regulator 1 | ESD-911267-5MG |
Cas.: 24730-10-7 | Purity: 98% | Dihydroergocristine mesylate | ESD-911268-5MG |
Cas.: 24775-71-1 | Purity: 98% | N-methyl Norfentanyl hydrochloride | ESD-911269-1MG |
Cas.: 251441-94-8 | Purity: 98% | 13-cis-N- | ESD-911270-5MG |
Cas.: 251994-14-6 | Purity: 98% | ICAM-1 inhibitor 1 | ESD-911271-1MG |
Cas.: 252003-65-9 | Purity: 98% | CP-547632 | ESD-911272-5MG |
Cas.: 252003-71-7 | Purity: 98% | CP-547632 hydrochloride | ESD-911273-5MG |
Cas.: 2531-04-6 | Purity: 98% | Piperylone (PR66) | ESD-911274-1MG |
Cas.: 2622-26-6 | Purity: 98% | Pericyazine (Propericiazine) | ESD-911275-5MG |
Cas.: 271576-80-8 | Purity: 98% | SD-06 (SD 0006) | ESD-911276-5MG |
Cas.: 272-57-1 | Purity: BR | 1H-Pyrazolo | ESD-911277-100MG |
Cas.: 2743-90-0 | Purity: 98% | (R,S)-Anatabine | ESD-911278-5MG |
Cas.: 27512-72-7 | Purity: BR | Ethychlozate | ESD-911279-50MG |
Cas.: 28052-84-8 | Purity: 98% | 5-Methoxy-DL-tryptophan | ESD-911280-10MG |
Cas.: 283159-94-4 | Purity: 98% | (S,S)-Valifenalate ((S,S)-IR5885) | ESD-911281-10MG |
Cas.: 287194-40-5 | Purity: 98% | (-)-DHMEQ (Dehydroxymethylepoxyquinomicin) | ESD-911282-5MG |
Cas.: 287194-41-6 | Purity: 98% | (+)-DHMEQ | ESD-911283-5MG |
Cas.: 287399-47-7 | Purity: 98% | AU-224 | ESD-911284-1MG |
Cas.: 28832-07-7 | Purity: BR | L-Dicentrine | ESD-911285-25MG |
Cas.: 29053-27-8 | Purity: 98% | Meseclazone | ESD-911286-1MG |
Cas.: 303156-68-5 | Purity: 98% | (–)-Rasfonin | ESD-911287-1MG |
Cas.: 3031-94-5 | Purity: BR | AICA-Riboside, 5′-Phosphate | ESD-911288-5MG |
Cas.: 3031-95-6 | Purity: 98% | SAICAR (Succino-AICAR) | ESD-911289-500ΜG |
Cas.: 309913-83-5 | Purity: 98% | Talmapimod (SCIO-469) | ESD-911291-5MG |
Cas.: 31002-79-6 | Purity: 98% | Triamcinolone Benetonide | ESD-911292-1MG |
Cas.: 313268-18-7 | Purity: 98% | P7C3-OMe | ESD-911293-5MG |
Cas.: 319460-94-1 | Purity: 98% | AG-13958 | ESD-911294-5MG |
Cas.: 319491-68-4 | Purity: BR | N-Des | ESD-911295-1MG |
Cas.: 320386-54-7 | Purity: 98% | SKF-34288 hydrochloride (3-Mercaptopicolinic acid) | ESD-911296-5MG |
Cas.: 32602-11-2 | Purity: 98% | 6-Quinoxalinecarboxylic acid, 2,3-bis(bromomethyl)- | ESD-911297-5MG |
Cas.: 327062-46-4 | Purity: 98% | NS19504 | ESD-911298-5MG |
Cas.: 3313-26-6 | Purity: 98% | (Z)-Thiothixene | ESD-911299-5MG |
Cas.: 332348-12-6 | Purity: 98% | Abatacept | ESD-911300-1MG |
Cas.: 342026-92-0 | Purity: BR | Sipoglitazar | ESD-911301-5MG |
Cas.: 343630-41-1 | Purity: 98% | NS3623 | ESD-911302-5MG |
Cas.: 3447-95-8 | Purity: 98% | Benzofurodil | ESD-911303-1MG |
Cas.: 34633-34-6 | Purity: 98% | Bifluranol (BX341) | ESD-911304-1MG |
Cas.: 347887-36-9 | Purity: 98% | Fedovapagon | ESD-911305-5MG |
Cas.: 35035-05-3 | Purity: 98% | SA504 | ESD-911306-1MG |
Cas.: 35607-20-6 | Purity: ≥95% | CP-20961 | ESD-911307-5MG |
Cas.: 35692-94-5 | Purity: BR | 4-Hydroxy-β-cyclocitral | ESD-911308-25MG |
Cas.: 35865-33-9 | Purity: 98% | Dianemycin (Nanchangmycin (free acid)) | ESD-911309-5MG |
Cas.: 35920-39-9 | Purity: 98% | 5′-N-Ethylcarboxamidoadenosine (NECA) | ESD-911310-5MG |
Cas.: 359625-79-9 | Purity: 98% | Roluperidone | ESD-911311-5MG |
Cas.: 35973-25-2 | Purity: 98% | DNA2 inhibitor C5 | ESD-911312-5MG |
Cas.: 369631-68-5 | Purity: 98% | Bragsin1 | ESD-911313-5MG |
Cas.: 37106-97-1 | Purity: 98% | Bentiromide | ESD-911314-10MG |
Cas.: 37286-92-3 | Purity: 98% | Calcium polystyrene sulfonate (Poly(styrenesulfonic acid) calcium salt) | ESD-911315-200MG |
Cas.: 37558-16-0 | Purity: 98% | Phorbol 12,13-dibutyrate | ESD-911316-1MG |
Cas.: 3778-76-5 | Purity: 98% | Todralazine hydrochloride (Ecarazine hydrochloride) | ESD-911317-10MG |
Cas.: 382180-17-8 | Purity: 98% | Pyroxamide | ESD-911318-5MG |
Cas.: 38363-41-6 | Purity: 98% | (+)-Penbutolol | ESD-911319-5MG |
Cas.: 38449-59-1 | Purity: 98% | m-Tyramine hydrobromide | ESD-911320-10MG |
Cas.: 3854-04-4 | Purity: 98% | Oxotremorine M iodide | ESD-911321-10MG |
Cas.: 38976-17-9 | Purity: 98% | α-Tocopherol phosphate | ESD-911322-10MG |
Cas.: 39800-16-3 | Purity: ≥95% | 4-hydroperoxy Cyclophosphamide (4-OOH-CY) | ESD-911323-5MG |
Cas.: 400760-25-0 | Purity: 98% | Oiligodendrocyte differentiation promoter 1 | ESD-911324-1MG |
Cas.: 40253-44-9 | Purity: 95% | Ethyl 4-methyl-1H-imidazole-2-carboxylate | ESD-911325-500MG |
Cas.: 402616-26-6 | Purity: 98% | FTY720 (S)-Phosphate | ESD-911326-1MG |
Cas.: 4037-01-8 | Purity: 98% | Adrenocorticotropic Hormone (ACTH) (4-10), human | ESD-911327-5MG |
Cas.: 40616-75-9 | Purity: 98% | DSP-4 hydrochloride (Neurotoxin DSP 4 hydrochloride) | ESD-911328-5MG |
Cas.: 406209-26-5 | Purity: 98% | ACHP Hydrochloride | ESD-911329-5MG |
Cas.: 41020-79-5 | Purity: 98% | SC26304 (Dicirenone) | ESD-911330-1MG |
Cas.: 41994-02-9 | Purity: 98% | Biotinyl tyramide | ESD-911331-10MG |
Cas.: 43119-28-4 | Purity: 98% | ()-G-Lactone | ESD-911332-50MG |
Cas.: 441785-25-7 | Purity: 98% | Besifovir (LB80331) | ESD-911333-5MG |
Cas.: 442633-00-3 | Purity: 98% | CK-666 | ESD-911334-5MG |
Cas.: 444606-18-2 | Purity: 98% | Dilmapimod | ESD-911335-1MG |
Cas.: 4450-98-0 | Purity: 98% | EBPC (NSC 229530) | ESD-911336-5MG |
Cas.: 447405-11-0 | Purity: 98% | FR252384 | ESD-911337-1MG |
Cas.: 4551-00-2 | Purity: 98% | SOS1 inhibitor 1 | ESD-911338-5MG |
Cas.: 4712-12-3 | Purity: 98% | 4′-Methylchrysoeriol | ESD-911340-5MG |
Cas.: 473-86-9 | Purity: BR | 3-Hydroxy-2-methylbutanoic Acid (2-Methyl-3-hydroxybutyric Acid) | ESD-911341-100MG |
Cas.: 477775-14-7 | Purity: 97% | AT2 receptor agonist C21 | ESD-911342-5MG |
Cas.: 481658-94-0 | Purity: 98% | CP742033 | ESD-911343-1MG |
Cas.: 496801-51-5 | Purity: 98% | OH-C-Chol | ESD-911344-500ΜG |
Cas.: 500794-88-7 | Purity: 98% | TR antagonist 1 | ESD-911345-5MG |
Cas.: 501364-82-5 | Purity: 98% | INO-1001 | ESD-911346-5MG |
Cas.: 50281-38-4 | Purity: BR | (3R)-3-Hydroxy-β-ionone | ESD-911347-5MG |
Cas.: 5072-26-4 | Purity: 98% | D,L-Butionine-(S,R)-sulfoximine | ESD-911348-50MG |
Cas.: 50767-79-8 | Purity: 98% | (9Z,11E)-Prodlure | ESD-911349-10MG |
Cas.: 50-90-8 | Purity: 98% | 5-Chloro-2′-deoxyuridine | ESD-911350-50MG |
Cas.: 51011-05-3 | Purity: 98% | 6”-O-Malonylgenistin | ESD-911351-5MG |
Cas.: 512177-83-2 | Purity: 98% | CCR2-RA- | ESD-911352-5MG |
Cas.: 51598-60-8 | Purity: 98% | Cimetropium Bromide | ESD-911353-1MG |
Cas.: 519178-28-0 | Purity: 98% | TNP | ESD-911354-5MG |
Cas.: 526191-19-5 | Purity: 98% | Valeryl fentanyl carboxy metabolite | ESD-911355-1MG |
Cas.: 52691-62-0 | Purity: 98% | Lyso-PAF C-16 | ESD-911356-1MG |
Cas.: 52977-29-4 | Purity: 98% | 1-Octadecyl Lysophosphatidic Acid (1-Octadecyl LPA) | ESD-911357-1MG |
Cas.: 530084-35-6 | Purity: 98% | TD-5471 hydrochloride | ESD-911358-1MG |
Cas.: 53027-55-7 | Purity: 98% | Adipokinetic Hormone (AKH) (24-32), locust | ESD-911359-1MG |
Cas.: 53501-41-0 | Purity: 98% | PIT-1 | ESD-911360-5MG |
Cas.: 53552-05-9 | Purity: 98% | ()-Bicuculline methochloride | ESD-911361-5MG |
Cas.: 53597-28-7 | Purity: 98% | Fludazonium chloride | ESD-911362-1MG |
Cas.: 53-83-8 | Purity: BR | 6-Thioinosine Phosphate | ESD-911364-5MG |
Cas.: 53866-33-4 | Purity: 98% | 17β-Estradiol-d2 | ESD-911365-1MG |
Cas.: 54197-31-8 | Purity: 98% | R(+)-IAA-94 (R(+)-Methylindazone) | ESD-911366-10MG |
Cas.: 54276-17-4 | Purity: 98% | Fluprostenol (16-m-trifluoromethylphenoxy tetranor Prostaglandin F2α) | ESD-911367-1MG |
Cas.: 54276-21-0 | Purity: 98% | (+)-Cloprostenol (D-Cloprostenol) | ESD-911368-5MG |
Cas.: 546-06-5 | Purity: 98% | Conessine | ESD-911369-10MG |
Cas.: 547-75-1 | Purity: 98% | Hyocholic Acid | ESD-911370-1MG |
Cas.: 54817-67-3 | Purity: 98% | 2-Thiothinone hydrochloride | ESD-911371-1MG |
Cas.: 54827-14-4 | Purity: BR | GM3-Ganglioside sodium | ESD-911372-1MG |
Cas.: 548461-82-1 | Purity: 98% | JWH 149 | ESD-911373-1MG |
Cas.: 549-02-0 | Purity: 98% | 10β,17β-dihydroxyestra-1,4-dien-3-one | ESD-911374-5MG |
Cas.: 550999-75-2 | Purity: 98% | Encenicline (EVP-6124) | ESD-911375-5MG |
Cas.: 55154-48-8 | Purity: 98% | N-phenylacetyl-L-Homoserine lactone | ESD-911376-1MG |
Cas.: 55206-22-9 | Purity: 98% | 5-hydroxy DMT hydrochloride | ESD-911377-1MG |
Cas.: 5527-71-9 | Purity: 98% | Methylclonazepam (Ro 05-4082) | ESD-911378-1MG |
Cas.: 55314-48-2 | Purity: 98% | Prostaglandin F2α 1,9-lactone (PGF2α 1,9-lactone) | ESD-911379-1MG |
Cas.: 55314-49-3 | Purity: 98% | Prostaglandin F2α 1,15-lactone (PGF2α 1,15-lactone) | ESD-911380-1MG |
Cas.: 55353-31-6 | Purity: 98% | Herbicidin A | ESD-911381-1MG |
Cas.: 553-63-9 | Purity: 98% | Dimethocaine hydrochloride | ESD-911382-1MG |
Cas.: 5537-17-7 | Purity: 98% | 4′-chloro-α-Pyrrolidinovalerophenone hydrochloride | ESD-911383-1MG |
Cas.: 55373-89-2 | Purity: 98% | Pentacosanoic Acid methyl ester (Methyl Pentacosanoate) | ESD-911384-50MG |
Cas.: 554-35-8 | Purity: 98% | Linamarin | ESD-911385-1MG |
Cas.: 554435-83-5 | Purity: 98% | Deferasirox (Fe3+ chelate) | ESD-911386-5MG |
Cas.: 55598-85-1 | Purity: BR | Vancomycin CDP-1 | ESD-911388-5MG |
Cas.: 55700-58-8 | Purity: 98% | (24S)-24,25-Dihydroxyvitamin D3 ((24S)-24,25-Dihydroxycholecalciferol) | ESD-911389-1MG |
Cas.: 55869-99-3 | Purity: 98% | Anisodamine (6-hydroxy Hyoscyamine) | ESD-911390-10MG |
Cas.: 56049-88-8 | Purity: 98% | MK196 | ESD-911391-1MG |
Cas.: 56281-37-9 | Purity: 98% | 2C-B hydrochloride (4-Bromo-2,5-dimethoxyphenethylamine) | ESD-911392-5MG |
Cas.: 56377-79-8 | Purity: 98% | Nosiheptide (Multhiomycin) | ESD-911393-5MG |
Cas.: 5652-28-8 | Purity: 98% | DL-AP3 | ESD-911394-10MG |
Cas.: 566169-97-9 | Purity: 98% | 4-(6-Bromo-2-benzothiazolyl)benzenamine | ESD-911395-10MG |
Cas.: 566169-98-0 | Purity: 98% | 4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine | ESD-911396-10MG |
Cas.: 56687-67-3 | Purity: 98% | DCPLA-ME | ESD-911397-5MG |
Cas.: 567-01-1 | Purity: 98% | Epiallopregnanolone | ESD-911398-1MG |
Cas.: 56715-13-0 | Purity: 98% | (R)-(+)-Atenolol | ESD-911399-1MG |
Cas.: 56875-67-3 | Purity: 98%, 25 mg/mL in ethanol | cis-7-Hexadecenoic Acid methyl ester | ESD-911400-5MG |
Cas.: 56939-52-7 | Purity: ≥98% | 2-O-Galloylmyricitrin | ESD-911401-5MG |
Cas.: 56990-57-9 | Purity: 98% | NSC-87877 | ESD-911402-5MG |
Cas.: 57055-82-0 | Purity: 98% | MoTP (4-(4-Morpholinylbutylthio)phenol) | ESD-911403-1MG |
Cas.: 5719-85-7 | Purity: 98% | 4-hydroxy Tolbutamide | ESD-911404-1MG |
Cas.: 57226-68-3 | Purity: 98% | Norfluoxetine hydrochloride (Desmethylfluoxetine) | ESD-911405-1MG |
Cas.: 57303-04-5 | Purity: 98% | Arachidonoyl Chloride (Arachidonic Acid Chloride) | ESD-911406-1MG |
Cas.: 5746-04-3 | Purity: 98% | Nε-(1-Carboxymethyl)-L-lysine | ESD-911407-5MG |
Cas.: 57470-78-7 | Purity: 98% | Celiprolol hydrochloride | ESD-911408-1MG |
Cas.: 57605-81-9 | Purity: 98% | β-Cembrenediol | ESD-911409-1MG |
Cas.: 5785-58-0 | Purity: 98% | Methylclostebol | ESD-911410-1MG |
Cas.: 58002-62-3 | Purity: 98% | ()-(α)-Kainic Acid hydrate | ESD-911411-5MG |
Cas.: 58158-77-3 | Purity: 98% | Amantanium bromide | ESD-911412-1MG |
Cas.: 58-19-5 | Purity: 98% | Drostanolone (Dromostanolone) | ESD-911413-1MG |
Cas.: 58286-56-9 | Purity: ≥95% | OM173-Αa | ESD-911414-1MG |
Cas.: 58293-56-4 | Purity: 98% | 9-(2,2-Dicyanovinyl)julolidine | ESD-911415-1MG |
Cas.: 58-38-8 | Purity: 98% | Prochlorperazine (D8 dimeleate) | ESD-911416-5MG |
Cas.: 58551-69-2 | Purity: 98% | Carboprost tromethamine | ESD-911417-5MG |
Cas.: 586368-06-1 | Purity: 98% | Olcegepant hydrochloride | ESD-911418-5MG |
Cas.: 586410-08-4 | Purity: 98% | CAY10616 | ESD-911419-1MG |
Cas.: 5875-41-2 | Purity: 98% | γ-L-Glutamyl-L-alanine | ESD-911420-100MG |
Cas.: 591-59-3 | Purity: 98% | DL-Glyceraldehyde-3-phosphate | ESD-911421-1MG |
Cas.: 5968-70-7 | Purity: 98% | β-acetyl-Boswellic Acid | ESD-911423-1MG |
Cas.: 5984-94-1 | Purity: BR | Isopilocarpine nitrate | ESD-911424-10MG |
Cas.: 59864-04-9 | Purity: 98% | Sulindac sulfone (Exisulind) | ESD-911425-1MG |
Cas.: 59877-57-5 | Purity: 98% | N-Propylamphetamine hydrochloride | ESD-911426-1MG |
Cas.: 60117-17-1 | Purity: 98% | [Met5]-Enkephalin, amide | ESD-911427-10MG |
Cas.: 60117-24-0 | Purity: 98% | [Leu5]-Enkephalin, amide | ESD-911428-10MG |
Cas.: 603139-12-4 | Purity: 98% | MK-0822 | ESD-911429-1MG |
Cas.: 603151-83-3 | Purity: 98% | NBI 35965 mesylate | ESD-911430-1MG |
Cas.: 603-41-8 | Purity: 98% | Desacetyl Bisacodyl | ESD-911431-5MG |
Cas.: 60374-41-6 | Purity: 98% | N-Oleoyl Valine | ESD-911432-1MG |
Cas.: 60398-91-6 | Purity: 98% | Bufuralol hydrochloride (Ro 3-4787) | ESD-911433-1MG |
Cas.: 604-34-2 | Purity: 98% | Cholesteryl Arachidonate | ESD-911434-1MG |
Cas.: 60482-95-3 | Purity: 98% | Neurotensin(8-13) | ESD-911435-1MG |
Cas.: 6063-36-1 | Purity: 98% | C24 dihydro Ceramide (d18:0/24:0) | ESD-911437-5MG |
Cas.: 606-59-7 | Purity: 98% | Cinnabarinic Acid | ESD-911438-10MG |
Cas.: 60676-84-8 | Purity: 98% | MMDA hydrochloride | ESD-911439-1MG |
Cas.: 608512-97-6 | Purity: 98% | PKR-IN-C16 | ESD-911440-1MG |
Cas.: 60-99-1 | Purity: 98% | Methotrimeprazine (Levomepromazine) | ESD-911441-10MG |
Cas.: 6099-95-2 | Purity: 98% | Piridocaine hydrochloride (Lucaine hydrochloride) | ESD-911442-1MG |
Cas.: 610300-00-0 | Purity: 98% | β-Amino Acid Imagabalin Hydrochloride (PD-0332334) | ESD-911443-1MG |
Cas.: 615538-51-7 | Purity: 98% | DC0-NH2 | ESD-911444-1MG |
Cas.: 61-56-3 | Purity: 98% | Sultiame | ESD-911445-1MG |
Cas.: 61622-34-2 | Purity: BR | Cefotiam | ESD-911446-10MG |
Cas.: 616884-63-0 | Purity: ≥98% | OMDM-2 ((R)-N-oleoyl Tyrosinol) | ESD-911447-5MG |
Cas.: 61849-14-7 | Purity: 98% | Epoprostenol sodium | ESD-911448-1MG |
Cas.: 63-12-7 | Purity: 98% | P2647 | ESD-911449-1MG |
Cas.: 63236-23-7 | Purity: 98% | Pareptide monohydrochloride | ESD-911450-1MG |
Cas.: 63442-81-9 | Purity: 98% | L,L-Dityrosine | ESD-911451-5MG |
Cas.: 63686-79-3 | Purity: 98% | Cicloprolol hydrochloride | ESD-911452-1MG |
Cas.: 63701-55-3 | Purity: 98% | (R)-Baclofen Hydrochloride (STX 209 hydrochloride) | ESD-911453-25MG |
Cas.: 6472-91-9 | Purity: BR | Chrysamine G | ESD-911454-5MG |
Cas.: 64790-15-4 | Purity: 98% | Glucagon (19-29) (human) | ESD-911455-5MG |
Cas.: 648922-41-2 | Purity: 98% | Tauroxicum | ESD-911456-1MG |
Cas.: 64952-97-2 | Purity: BR | Latamoxef | ESD-911457-10MG |
Cas.: 65358-18-1 | Purity: 98% | 2′-Deoxypseudoisocytidine | ESD-911459-5MG |
Cas.: 66225-78-3 | Purity: 98% | Gly-β-MCA | ESD-911460-5MG |
Cas.: 66318-17-0 | Purity: 98% | Furprofen | ESD-911461-5MG |
Cas.: 66635-92-5 | Purity: 98% | (S)-Ketorolac | ESD-911462-5MG |
Cas.: 66635-93-6 | Purity: 98% | (R)-Ketorolac | ESD-911463-5MG |
Cas.: 67700-30-5 | Purity: 98% | R803 | ESD-911464-1MG |
Cas.: 677772-84-8 | Purity: BR | MRK-560 (MRK560) | ESD-911465-5MG |
Cas.: 68252-28-8 | Purity: 98% | (R)-Oxiracetam ((R)-(+)-Oxiracetam) | ESD-911466-5MG |
Cas.: 69579-13-1 | Purity: 98% | GYKI-11679 | ESD-911467-1MG |
Cas.: 70132-51-3 | Purity: 98% | Pimonidazole hydrochloride | ESD-911468-5MG |
Cas.: 701977-08-4 | Purity: 98% | Taranabant ((1R,2R)stereoisomer) (MK0364 (1R,2R)stereoisomer) | ESD-911469-5MG |
Cas.: 70788-28-2 | Purity: 98% | Flurofamide | ESD-911470-5MG |
Cas.: 710655-15-5 | Purity: 98% | PF-592379 | ESD-911471-1MG |
Cas.: 71447-49-9 | Purity: 98% | Luteinizing Hormone Releasing Hormone (LH-RH), human | ESD-911472-5MG |
Cas.: 71897-07-9 | Purity: 98% | AG 1295 | ESD-911473-5MG |
Cas.: 72293-17-5 | Purity: 98% | BTM-1086 | ESD-911474-1MG |
Cas.: 72679-47-1 | Purity: 98% | Rentiapril racemate | ESD-911475-1MG |
Cas.: 72814-32-5 | Purity: 98% | BW 245C | ESD-911476-1MG |
Cas.: 745051-61-0 | Purity: 98% | PSN-GK1 | ESD-911477-1MG |
Cas.: 74681-77-9 | Purity: 98% | Ethoxyquin Dimer | ESD-911478-1MG |
Cas.: 75970-64-8 | Purity: BR | Norastemizole Hydrobromide | ESD-911479-5MG |
Cas.: 76001-09-7 | Purity: 98% | Antiulcer Agent 1 | ESD911480-1MG |
Cas.: 77465-10-2 | Purity: 98% | Adrenocorticotropic Hormone (ACTH) (1-39), rat | ESD-911481-1MG |
Cas.: 77603-42-0 | Purity: 98% | 8-Nitrotryptanthrin | ESD-911482-5MG |
Cas.: 78263-90-8 | Purity: 98% | 2-Methyl-5-HT | ESD-911483-5MG |
Cas.: 791587-67-2 | Purity: 98% | c-Fms inhibitor 2 | ESD-911484-5MG |
Cas.: 791835-21-7 | Purity: 98% | BI-6C9 | ESD-911485-5MG |
Cas.: 79352-78-6 | Purity: 98% | N-Desethyl amodiaquine | ESD-911486-1MG |
Cas.: 79586-22-4 | Purity: 98% | Ubiquitin (from bovine erythrocytes) | ESD-911487-5MG |
Cas.: 796073-68-2 | Purity: 98% | DM4-Sme | ESD-911488-5MG |
Cas.: 79644-90-9 | Purity: 98% | Vebufloxacin | ESD-911489-1MG |
Cas.: 79689-25-1 | Purity: 98% | Midaglizole hydrochloride) | ESD-911490-1MG |
Cas.: 79712-55-3 | Purity: 98% | (±)-Tazifylline | ESD-911491-1MG |
Cas.: 799279-80-4 | Purity: 98% | ABT 894 | ESD-911492-1MG |
Cas.: 80448-90-4 | Purity: 98% | Dynorphin A (Dynorphin A (1-17)) | ESD-911493-1MG |
Cas.: 80830-42-8 | Purity: 98% | Rentiapril | ESD-911494-5MG |
Cas.: 81189-92-6 | Purity: 98% | Acetyllovastatin | ESD-911495-5MG |
Cas.: 819850-14-1 | Purity: 98% | 2-methyl-3-Pyrimidin-2-yl-Propionic Acid | ESD-911496-10MG |
Cas.: 822-89-9 | Purity: 95% | 2-Pyridinol-1-oxide | ESD-911497-10MG |
Cas.: 824393-18-2 | Purity: 98% | Agomelatine (L(+)-Tartaric acid) (S-20098 L(+)-Tartaric acid) | ESD-911498-10MG |
Cas.: 83002-04-4 | Purity: 98% | (-)-CP 55,940 | ESD-911499-5MG |
Cas.: 832-92-8 | Purity: 98% | Mescaline hydrochloride | ESD-911500-5MG |
Cas.: 835621-11-9 | Purity: 98% | Regorafénib N-oxyde (M2) | ESD-911501-5MG |
Cas.: 83656-38-6 | Purity: 98% | Ipramidil | ESD-911502-1MG |
Cas.: 841-67-8 | Purity: 98% | (–)-Thalidomide | ESD-911503-5MG |
Cas.: 848035-21-2 | Purity: 98% | Compound 48/80 hydrochloride | ESD-911504-10MG |
Cas.: 848193-68-0 | Purity: 98% | Selisistat S-enantiomer (EX-527 S-enantiomer) | ESD-911505-5MG |
Cas.: 849479-74-9 | Purity: 98% | Vapreotide acetate | ESD-911506-1MG |
Cas.: 849675-66-7 | Purity: 98% | HM30181 (HM30181A) | ESD-911507-5MG |
Cas.: 850140-15-7 | Purity: 98% | 2C-T-7 hydrochloride (2,5-Dimethoxy-4-propylthiophenethylamine) | ESD-911508-5MG |
Cas.: 850734-85-9 | Purity: 98% | 7-Piperazin-1-yl-thieno | ESD-911509-10MG |
Cas.: 85118-44-1 | Purity: 98% | Minocromil (FPL59360) | ESD-911510-1MG |
Cas.: 851376-05-1 | Purity: 98% | JNJ-18038683 | ESD-911511-5MG |
Cas.: 85146-53-8 | Purity: 98% | Arachidonoyl amide | ESD-911512-5MG |
Cas.: 851599-82-1 | Purity: 98% | ELN 318463 racemate | ESD-911513-1MG |
Cas.: 851881-59-9 | Purity: 98% | (R)-ADX-47273 | ESD-911514-5MG |
Cas.: 85305-88-0 | Purity: 98% | Galactosylcerebrosides (bovine) | ESD-911515-10MG |
Cas.: 85532-75-8 | Purity: 98% | PK-11195 | ESD-911516-10MG |
Cas.: 85-66-5 | Purity: 98% | Pyocyanin | ESD-911517-5MG |
Cas.: 856699-18-8 | Purity: 98% | Biliverdin hydrochloride | ESD-911518-10MG |
Cas.: 85798-08-9 | Purity: 98% | Quinpirole Hydrochloride | ESD-911519-5MG |
Cas.: 85815-37-8 | Purity: 98% | Rilmazafone hydrochloride (450191S) | ESD-911520-1MG |
Cas.: 85966-90-1 | Purity: 98% | PAF C-18:1 | ESD-911521-5MG |
Cas.: 860005-21-6 | Purity: 98% | Latanoprostene bunod | ESD-911522-1MG |
Cas.: 86029-48-3 | Purity: 98% | 2,3-MDA hydrochloride (2,3-Methylenedioxyamphetamine) | ESD-911523-5MG |
Cas.: 86129-54-6 | Purity: 98% | SKF 86466 hydrochloride | ESD-911524-5MG |
Cas.: 862281-92-3 | Purity: 98% | PF-00446687 | ESD-911525-5MG |
Cas.: 862891-27-8 | Purity: 98% | CAY10583 | ESD-911526-5MG |
Cas.: 862913-13-1 | Purity: 98% | AMC Arachidonoyl Amide | ESD-911527-5MG |
Cas.: 863238-55-5 | Purity: 98% | Salicyl-AMS | ESD-911528-1MG |
Cas.: 863491-70-7 | Purity: 98% | PF-02575799 | ESD-911529-1MG |
Cas.: 86-35-1 | Purity: 98% | Ethotoin ((±)-Ethotoin) | ESD-911530-5MG |
Cas.: 86390-77-4 | Purity: 98% | 1-Oleoyl-2-acetyl-sn-glycerol (OAG) | ESD-911531-5MG |
Cas.: 86393-37-5 | Purity: 98% | Amifloxacin (Win49375) | ESD-911532-1MG |
Cas.: 864167-45-3 | Purity: 98% | Succinyl phosphonate trisodium salt | ESD-911533-5MG |
Cas.: 86-42-0 | Purity: 98% | Amodiaquine | ESD-911534-5MG |
Cas.: 864445-37-4 | Purity: 98% | JWH 167 | ESD-911535-5MG |
Cas.: 864445-39-6 | Purity: 98% | JWH 251 | ESD-911536-5MG |
Cas.: 864445-41-0 | Purity: 98% | JWH 251 4-methylphenyl isomer (JWH 251 4-methyl isomer) | ESD-911537-5MG |
Cas.: 864445-45-4 | Purity: 98% | JWH 302 | ESD-911538-5MG |
Cas.: 864445-47-6 | Purity: 98% | JWH 201 | ESD-911539-5MG |
Cas.: 864445-56-7 | Purity: 98% | JWH 203 3-chlorophenyl isomer | ESD-911540-5MG |
Cas.: 864445-60-3 | Purity: 98% | JWH 249 | ESD-911541-5MG |
Cas.: 86445-22-9 | Purity: 98% | Auxinole | ESD-911542-5MG |
Cas.: 864677-55-4 | Purity: 98% | IT1t | ESD-911543-5MG |
Cas.: 864863-72-9 | Purity: 98% | FPTQ | ESD-911544-1MG |
Cas.: 864864-86-8 | Purity: 98% | DFMTI (MK5435) | ESD-911545-1MG |
Cas.: 865231-45-4 | Purity: 98% | AMG 837 sodium salt | ESD-911546-5MG |
Cas.: 865285-29-6 | Purity: 98% | KKL-35 | ESD-911547-1MG |
Cas.: 865363-93-5 | Purity: 98% | Islatravir (MK-8591) | ESD-911548-5MG |
Cas.: 865466-24-6 | Purity: 98% | Narlaprevir (SCH 900518) | ESD-911549-10MG |
Cas.: 865838-26-2 | Purity: 98% | Fluorocyclopentenylcytosine | ESD-911550-5MG |
Cas.: 866927-10-8 | Purity: ≥98% | IC87201 | ESD-911551-5MG |
Cas.: 867331-64-4 | Purity: 98% | TG 100572 Hydrochloride | ESD-911552-1MG |
Cas.: 867331-82-6 | Purity: ≥98% | TG 100801 | ESD-911553-5MG |
Cas.: 867334-05-2 | Purity: 98% | TG 100572 | ESD-911554-5MG |
Cas.: 868592-56-7 | Purity: BR | NIAD-4 | ESD-911555-5MG |
Cas.: 868738-44-7 | Purity: 98% | 2C-T-4 hydrochloride (2,5-Dimethoxy-4-isopropylthiophenethylamine) | ESD-911556-5MG |
Cas.: 869185-85-3 | Purity: 98% | SB 203580 hydrochloride (RWJ 64809 hydrochloride) | ESD-911557-10MG |
Cas.: 869376-90-9 | Purity: 98% | CB-52 | ESD-911558-5MG |
Cas.: 869572-92-9 | Purity: 98% | Tecovirimat | ESD-911559-5MG |
Cas.: 869748-10-7 | Purity: 98% | A-770041 | ESD-911560-5MG |
Cas.: 869802-58-4 | Purity: 98% | A-841720 | ESD-911561-1MG |
Cas.: 869884-78-6 | Purity: ≥98% | Radezolid (RX-1741) | ESD-911562-5MG |
Cas.: 870061-27-1 | Purity: 98% | A 839977 | ESD-911563-10MG |
Cas.: 870142-71-5 | Purity: 98% | ACH-806 (GS9132) | ESD-911564-1MG |
Cas.: 87034-87-5 | Purity: 98% | Bamaluzole | ESD-911565-1MG |
Cas.: 870554-67-9 | Purity: 98% | GQ-16 | ESD-911566-5MG |
Cas.: 870823-12-4 | Purity: ≥98% | MK 0893 | ESD-911567-5MG |
Cas.: 870964-67-3 | Purity: 98% | Evocalcet (KHK7580) | ESD-911568-5MG |
Cas.: 87116-72-1 | Purity: 98% | Timobesone | ESD-911569-1MG |
Cas.: 871224-64-5 | Purity: 98% | Almorexant (ACT 078573) | ESD-911570-5MG |
Cas.: 871357-89-0 | Purity: 98% | Cenisertib (AS-703569) | ESD-911571-5MG |
Cas.: 871543-07-6 | Purity: ≥98% | H-1152 dihydrochloride | ESD-911572-5MG |
Cas.: 872363-17-2 | Purity: 98% | Dipraglurant (ADX48621) | ESD-911573-5MG |
Cas.: 87375-91-5 | Purity: 98% | Dehydronitrosonisoldipine | ESD-911574-1MG |
Cas.: 874745-43-4 | Purity: 98% | O-2545 hydrochloride | ESD-911575-1MG |
Cas.: 876150-14-0 | Purity: 98% | Octyl-α-ketoglutarate (α-KG octyl ester) | ESD-911576-1MG |
Cas.: 878006-06-5 | Purity: 98% | (E)- | ESD-911577-5MG |
Cas.: 878143-03-4 | Purity: 98% | Digeranyl bisphophonate (DGBP) | ESD-911578-1MG |
Cas.: 878557-19-8 | Purity: 98% | BODIPY-Cholesterol (BCh2) | ESD-911579-1MG |
Cas.: 87913-26-6 | Purity: 98% | Bromantane | ESD-911580-5MG |
Cas.: 879-36-7 | Purity: 98% | α-methyl Tryptamine hydrochloride | ESD-911581-5MG |
Cas.: 879665-92-6 | Purity: 98% | Methedrone hydrochloride | ESD-911582-5MG |
Cas.: 88247-69-2 | Purity: 98% | 25-hydroxy Cholesterol-d6 | ESD-911583-1MG |
Cas.: 883003-62-1 | Purity: 98% | FUBP1–IN-1 | ESD-911584-5MG |
Cas.: 883046-50-2 | Purity: 98% | S14161 | ESD-911585-1MG |
Cas.: 88475-69-8 | Purity: 98% | Beraprost sodium salt | ESD-911586-1MG |
Cas.: 885012-33-9 | Purity: 98% | trans-AUCB | ESD-911587-5MG |
Cas.: 887264-44-0 | Purity: 98% | JP83 | ESD-911588-5MG |
Cas.: 887375-15-7 | Purity: 98% | (S)-Mapracorat | ESD-911589-5MG |
Cas.: 88898-17-3 | Purity: 98% | Atrial Natriuretic Peptide (ANP) (1-28), rat (Atrial natriuretic factor(1-28)(rat)) | ESD-911591-1MG |
Cas.: 88979-61-7 | Purity: 98% | Bafilomycin C1 | ESD-911592-1MG |
Cas.: 890643-16-0 | Purity: ≥98% | DC-05 | ESD-911593-5MG |
Cas.: 89592-45-0 | Purity: BR | Ethyl 5-Isopropoxy-4-methyl–carboline-3-carboxylate | ESD-911594-5MG |
Cas.: 89705-21-5 | Purity: 98% | APNEA (N6- | ESD-911595-10MG |
Cas.: 89797-00-2 | Purity: BR | Iopentol | ESD-911596-5MG |
Cas.: 906669-07-6 | Purity: 98% | KPLH1130 | ESD-911597-5MG |
Cas.: 90880-35-6 | Purity: 98% | Neuropeptide Y (29-64), amide, human (Human neuropeptide Y (29-64)) | ESD-911598-1MG |
Cas.: 910484-32-1 | Purity: 98% | TTA-Q6 (isomer) | ESD-911599-5MG |
Cas.: 910-86-1 | Purity: 98% | Thiocarlide (Isoxyl) | ESD-911600-10MG |
Cas.: 912587-25-8 | Purity: 98% | Opigolix | ESD-911602-1MG |
Cas.: 912806-16-7 | Purity: 98% | BMS-582949 hydrochloride | ESD-911603-5MG |
Cas.: 913064-47-8 | Purity: 98% | ELN-441958 | ESD-911604-5MG |
Cas.: 91431-42-4 | Purity: 98% | RS4317 (Lonapalene) | ESD-911605-1MG |
Cas.: 915191-42-3 | Purity: 98% | MF498 | ESD-911606-5MG |
Cas.: 91531-30-5 | Purity: 98% | Antineoplaston A10 | ESD-911607-5MG |
Cas.: 915363-56-3 | Purity: 98% | Cot inhibitor-2 | ESD-911608-5MG |
Cas.: 915365-57-0 | Purity: 98% | Cot inhibitor 1 | ESD-911609-5MG |
Cas.: 915720-21-7 | Purity: 98% | AZ-23 | ESD-911610-5MG |
Cas.: 915967-82-7 | Purity: 98% | Piperaquine tetraphosphate tetrahydrate | ESD-911611-10MG |
Cas.: 916085-47-7 | Purity: 98% | Naveglitazar racemate | ESD-911612-1MG |
Cas.: 916151-99-0 | Purity: ≥98% | APTO-253 | ESD-911613-5MG |
Cas.: 91618-36-9 | Purity: 98% | R835 (S25930) | ESD-911614-1MG |
Cas.: 917111-49-0 | Purity: 98% | Lexibulin dihydrochloride (CYT-997 dihydrochloride) | ESD-911615-5MG |
Cas.: 917497-70-2 | Purity: 98% | SC144 Hydrochloride | ESD-911616-5MG |
Cas.: 917562-33-5 | Purity: 98% | JT010 | ESD-911617-5MG |
Cas.: 91757-46-9 | Purity: 98% | NSC 601980 analog | ESD-911618-5MG |
Cas.: 917910-45-3 | Purity: 98% | MK-6892 | ESD-911619-5MG |
Cas.: 918407-35-9 | Purity: 98% | Avoralstat (BCX4161) | ESD-911620-5MG |
Cas.: 91917-65-6 | Purity: 98% | Ro15-4513 | ESD-911621-1MG |
Cas.: 91940-87-3 | Purity: 98% | Zatebradine hydrochloride | ESD-911622-5MG |
Cas.: 92118-27-9 | Purity: ≥98% | Fotemustine (S10036) | ESD-911623-10MG |
Cas.: 92121-68-1 | Purity: 98% | Obafluorin | ESD-911624-1MG |
Cas.: 921625-62-9 | Purity: 98% | Cysteine Protease inhibitor | ESD-911625-5MG |
Cas.: 923262-96-8 | Purity: ≥98% | SAR407899 hydrochloride | ESD-911626-5MG |
Cas.: 923287-50-7 | Purity: 98% | Opicapone (BIA 9-1067) | ESD-911627-5MG |
Cas.: 923565-21-3 | Purity: 98% | Camicinal (GSK962040) | ESD-911628-5MG |
Cas.: 923565-22-4 | Purity: 98% | Camicinal hydrochloride (GSK962040 hydrochloride) | ESD-911629-5MG |
Cas.: 923590-37-8 | Purity: 98% | Vaniprevir (MK-7009) | ESD-911630-5MG |
Cas.: 924296-17-3 | Purity: 98% | DUBs inhibitor 3 | ESD-911631-5MG |
Cas.: 924296-18-4 | Purity: 98% | DUBs inhibitor 1 | ESD-911632-5MG |
Cas.: 924296-19-5 | Purity: 98% | DUBs inhibitor 2 | ESD-911633-5MG |
Cas.: 92478-27-8 | Purity: 98% | Morinidazole | ESD-911634-5MG |
Cas.: 925238-89-7 | Purity: 98% | JMV 2959 | ESD-911635-5MG |
Cas.: 925676-48-8 | Purity: 98% | LAS101057 | ESD-911636-1MG |
Cas.: 926927-42-6 | Purity: 98% | Toll-like receptor modulator | ESD-911637-5MG |
Cas.: 929904-85-8 | Purity: 98% | Guadecitabine sodium (SGI-110 sodium; S-110 sodium) | ESD-911638-5MG |
Cas.: 936350-00-4 | Purity: 98% | Fiboflapon | ESD-911639-5MG |
Cas.: 937807-66-4 | Purity: 98% | Neurodazine | ESD-911640-5MG |
Cas.: 941690-55-7 | Purity: 98% | MLE-4901 | ESD-911641-5MG |
Cas.: 942289-87-4 | Purity: 98% | PI-828 | ESD-911642-5MG |
Cas.: 943332-08-9 | Purity: 98% | Selumetinib sulfate (AZD6244 sulfate) | ESD-911643-50MG |
Cas.: 946524-36-3 | Purity: ≥99% | Oleoyl Ethanolamide-d4 (OEA-d4) | ESD-911644-500ΜG |
Cas.: 949021-68-5 | Purity: 98% | Sodium formononetin-3′-sulfonate (Sul-F) | ESD-911645-5MG |
Cas.: 949100-39-4 | Purity: 98% | Delcasertib | ESD-911646-5MG |
Cas.: 95523-13-0 | Purity: 98% | N-[(4-Aminophenyl)methyl]adenosine | ESD-911647-5MG |
Cas.: 956-90-1 | Purity: 98% | PCP hydrochloride | ESD-911648-1MG |
Cas.: 960404-86-8 | Purity: 98% | Dapagliflozin impurity | ESD-911649-5MG |
Cas.: 96960-92-8 | Purity: 98% | Hexadecyl Methyl Glycerol (1-O-hexadecyl-2-O-methyl-sn-Glycerol) | ESD-911651-10MG |
Cas.: 97627-24-2 | Purity: 98% | N-(2-Chloro-6-methylphenyl)-N’-4-pyridinylurea | ESD-911652-1MG |
Cas.: 97744-44-0 | Purity: 98% | Dibenzylfluorescein | ESD-911653-1MG |
Cas.: 97759-16-5 | Purity: 98% | S186 | ESD-911654-5MG |
Cas.: 97964-56-2 | Purity: BR | Lorglumide | ESD-911655-10MG |
Cas.: 98116-53-1 | Purity: BR | Sulukast | ESD-911656-1MG |
Cas.: 98206-09-8 | Purity: 98% | Eltoprazine Hydrochloride (DU 28853 hydrochloride) | ESD-911657-10MG |
Cas.: 98224-03-4 | Purity: 98% | Eltoprazine (DU 28853) | ESD-911658-10MG |
Cas.: 98770-65-1 | Purity: 98% | Eicosapentaenoyl Chloride | ESD-911659-5MG |
Cas.: 98791-67-4 | Purity: 98% | (R)-(+)-Bay-K-8644 | ESD-911660-5MG |
Cas.: 99011-78-6 | Purity: 98% | Imiquimod hydrochloride (R 837 hydrochloride) | ESD-911661-100MG |
Cas.: 99107-52-5 | Purity: 98% | U66858 (Bunaprolast) | ESD-911662-1MG |
Cas.: 99208-90-9 | Purity: 98% | Palmitic Acid Alkyne | ESD-911663-1MG |
Cas.: 99254-95-2 | Purity: 98% | McN5691 (RWJ26240) | ESD-911664-1MG |
Cas.: 99533-80-9 | Purity: 98% | K252a | ESD-911665-1MG |
Cas.: 99660-94-3 | Purity: 98% | Glycerol Trieicosapentaenoyl | ESD-911666-1MG |
Cas.: 182959-33-7 | Purity: 98% | 2-[(2E)-2-(1-azabicyclo[2.2.2]oct-3-ylidene)-2-fluoroethoxy]-9H-carbazole, monohydrochloride | ESD-911668-500ΜG |
Cas.: 1002100-44-8 | Purity: BR | Oleoyl Serotonin | ESD-911669-10MG |
Cas.: 100490-21-9 | Purity: 98% | A7132 | ESD-911670-5MG |
Cas.: 10129-56-3 | Purity: 98% | PETCM | ESD-911671-10MG |
Cas.: 101622-51-9 | Purity: ≥98% | Olomoucine | ESD-911672-10MG |
Cas.: 1017241-36-9 | Purity: ≥95% | Olanzapine Thiolactam Impurity | ESD-911673-1MG |
Cas.: 102212-99-7 | Purity: 98% | 5-BrdUTP sodium salt (5-Bromo-2′-deoxyuridine 5′-triphosphate sodium salt) | ESD-911674-1MG |
Cas.: 102685-83-6 | Purity: 98% | Saterinone hydrochloride (BDF 8634 hydrochloride) | ESD-911675-5MG |
Cas.: 1027847-67-1 | Purity: 98% | AMG-009 | ESD-911676-1MG |
Cas.: 103476-24-0 | Purity: 98% | D-myo-Inositol 1,4,5-trisphosphate hexapotassium salt | ESD-911677-1MG |
Cas.: 1044511-01-4 | Purity: BR | Benralizumab | ESD-911678-100MG |
Cas.: 105102-18-9 | Purity: 98% | Tibenelast sodium (LY 186655) | ESD-911679-5MG |
Cas.: 1063331-94-1 | Purity: 98% | NS13001 | ESD-911680-5MG |
Cas.: 1073529-41-5 | Purity: 98% | ABL127 | ESD-911681-5MG |
Cas.: 1081110-72-6 | Purity: 98% | Obestatin (human) | ESD-911682-500ΜG |
Cas.: 108700-03-4 | Purity: 98% | Teludipine hydrochloride | ESD-911683-1MG |
Cas.: 108964-32-5 | Purity: 98% | Fura-2 AM (Fura-2 Acetoxymethyl ester) | ESD-911684-1MG |
Cas.: 1096-38-4 | Purity: 98% | 16-Dehydroprogesterone | ESD-911685-500MG |
Cas.: 110267-81-7 | Purity: ≥98% | Amrubicin (AMR) | ESD-911686-5MG |
Cas.: 110311-30-3 | Purity: ≥98% | Amrubicin hydrochloride (AMR hydrochloride) | ESD-911687-5MG |
Cas.: 11052-72-5 | Purity: ≥95% | Oligomycin C | ESD-911688-1MG |
Cas.: 110588-57-3 | Purity: 98% | Saperconazole (R66905) | ESD-911689-1MG |
Cas.: 11079-53-1 | Purity: 98% | Hyperforin | ESD-911690-5MG |
Cas.: 1127298-67-2 | Purity: ≥99% | Olmesartan Medoxomil-d6 | ESD-911691-1MG |
Cas.: 112828-09-8 | Purity: 98% | (24R)-MC 976 | ESD-911692-1MG |
Cas.: 112849-14-6 | Purity: 98% | (24S)-MC 976 | ESD-911693-1MG |
Cas.: 112926-02-0 | Purity: 98% | Indo-1 AM (Indo-1 Acetoxymethyl ester) | ESD-911694-1MG |
Cas.: 113274-56-9 | Purity: 95% | Recombinant Hirudin | ESD-911695-100MG |
Cas.: 1134188-71-8 | Purity: ≥99% | Oxcarbazepine-d4 | ESD-911696-1MG |
Cas.: 115532-49-5 | Purity: 98% | TMRM | ESD-911697-5MG |
Cas.: 115534-33-3 | Purity: 98% | TMA-DPH | ESD-911698-1MG |
Cas.: 1160521-50-5 | Purity: 98% | ITI214 free base | ESD-911699-5MG |
Cas.: 116057-75-1 | Purity: 98% | Idoxifene | ESD-911700-1MG |
Cas.: 116759-35-4 | Purity: 98% | Nexopamil racemate | ESD-911701-5MG |
Cas.: 118021-35-5 | Purity: 98% | L-4-Oxalysine hydrochloride | ESD-911702-1MG |
Cas.: 119290-12-9 | Purity: 98% | O-11 (11-Oxatetradecanoic Acid) | ESD-911703-5MG |
Cas.: 119687-33-1 | Purity: 98% | Iganidipine | ESD-911704-5MG |
Cas.: 120092-65-1 | Purity: ≥99% | Oxybutynin-d10 hydrochloride | ESD-911705-1MG |
Cas.: 1201633-99-9 | Purity: BR | HIF-1alpha(556-574) (HIF-1alpha(556-574)) | ESD-911706-1MG |
Cas.: 120241-31-8 | Purity: 98% | Alvameline (Lu 25-109) | ESD-911707-1MG |
Cas.: 120406-37-3 | Purity: 98% | Jionoside B1 | ESD-911708-5MG |
Cas.: 121524-09-2 | Purity: 98% | Amibegron hydrochloride (SR 58611A) | ESD-911709-5MG |
Cas.: 1216792-30-1 | Purity: BR | ZK 93426 Hydrochloride | ESD-911710-5MG |
Cas.: 121695-87-2 | Purity: BR | Sarafotoxin S6c | ESD-911711-250ΜG |
Cas.: 1217667-10-1 | Purity: 98% | (–)-Ropivacaine-d7 hydrochloride | ESD-911712-1MG |
Cas.: 1234694-20-2 | Purity: 98% | (+)-trans-C75 | ESD-911713-1MG |
Cas.: 1234694-22-4 | Purity: 98% | ()-trans-C75 | ESD-911714-1MG |
Cas.: 1235560-31-2 | Purity: 98% | ABT-639 hydrochloride | ESD-911715-5MG |
Cas.: 123931-40-8 | Purity: 98% | (±)11(12)-EET | ESD-911716-500ΜG |
Cas.: 1253-28-7 | Purity: 98% | Gestonorone Capronate (Gestonorone caproate) | ESD-911717-5MG |
Cas.: 125-52-0 | Purity: 98% | Oxyphencyclimine hydrochloride | ESD-911718-100MG |
Cas.: 125-71-3 | Purity: BR | Dextromethorphan | ESD-911719-100MG |
Cas.: 125720-84-5 | Purity: 98% | (E)-Alprenoxime | ESD-911720-5MG |
Cas.: 1287777-24-5 | Purity: ≥95% | 1,1,2,2-tetrakis(4-(pyridin-3-yl)phenyl)ethene | ESD-911721-1G |
Cas.: 129-20-4 | Purity: ≥98% | Oxyphenbutazone | ESD-911722-1MG |
Cas.: 129299-81-6 | Purity: 98% | FK1052 hydrochloride | ESD-911723-5MG |
Cas.: 129831-99-8 | Purity: 98% | MC 976 | ESD-911724-1MG |
Cas.: 13187-06-9 | Purity: 98% | Pimethixene maleate | ESD-911725-10MG |
Cas.: 132449-89-9 | Purity: 98% | Lesopitron (dihydrochloride) (E4424) | ESD-911726-5MG |
Cas.: 1326-12-1 | Thioflavine S | ESD-911727-100MG | |
Cas.: 13312-52-2 | Purity: BR | (9Z)-β-Carotene | ESD-911728-1MG |
Cas.: 134-04-3 | Purity: BR | Pelargonidin chloride | ESD-911729-5MG |
Cas.: 1345275-22-0 | Purity: 98% | (±)10(11)-DiHDPA | ESD-911730-500ΜG |
Cas.: 1346233-68-8 | Purity: 98% | ML218 | ESD-911731-5MG |
Cas.: 135-09-1 | Purity: ≥98% | Hydroflumethiazide | ESD-911732-5MG |
Cas.: 1357349-91-7 | Purity: 98% | SPP-86 | ESD-911733-5MG |
Cas.: 136259-18-2 | Purity: 98% | DPP-IV inhibitor 2 | ESD-911734-50MG |
Cas.: 136461-80-8 | Purity: ≥95% | Osteocalcin (1-49) human TFA | ESD-911735-100ΜG |
Cas.: 1381782-08-6 | Purity: 98% | ()-Viriditoxin | ESD-911736-500ΜG |
Cas.: 1383577-62-5 | Purity: 98% | Alvimopan monohydrate | ESD-911737-1MG |
Cas.: 139889-62-6 | Purity: 98% | (+)-D-threo-PDMP hydrochloride | ESD-911738-5MG |
Cas.: 140112-65-8 | Purity: ≥98% | Oleic Acid-2,6-diisopropylanilide | ESD-911739-5MG |
Cas.: 140158-50-5 | Purity: 98% | ATPA | ESD-911740-5MG |
Cas.: 1404-59-7 | Purity: ≥95% | Oligomycin D | ESD-911741-500ΜG |
Cas.: 1415684-80-8 | Purity: 98% | PtdIns-(3,4,5)-P3-biotin sodium salt | ESD-911742-50ΜG |
Cas.: 1416872-50-8 | Purity: 98% | SF7-AM (Sulfidefluor-7 acetoxymethyl ester) | ESD-911743-1MG |
Cas.: 1418291-68-5 | Purity: 98% | Penicolinate A (Penicolinate B dimethyl ester) | ESD-911744-1MG |
Cas.: 142128-47-0 | Purity: 98% | R-Palmitoyl-(1-methyl) Ethanolamide (R-1 PMA) | ESD-911745-50MG |
Cas.: 1422355-59-6 | Purity: 98% | GSK2578999A | ESD-911746-5MG |
Cas.: 1422359-85-0 | Purity: 98% | Fumonisin B3 (FB3) | ESD-911747-1MG |
Cas.: 142375-60-8 | Purity: ≥99% | FR 139317 | ESD-911748-1MG |
Cas.: 142435-72-1 | Purity: 98% | A-83016F (Antibiotic A-83016F) | ESD-911749-500ΜG |
Cas.: 142439-96-1 | Purity: 98% | Sp-5,6-dichloro-cBIMPS sodium salt (Sp-5,6-DCI-cBIMPS) | ESD-911750-1MG |
Cas.: 1425945-60-3 | Purity: 98% | EHT 5372 | ESD-911751-5MG |
Cas.: 1426576-80-8 | Purity: 98% | ML-243 (CID-50910523) | ESD-911752-5MG |
Cas.: 1426916-02-0 | Purity: 98% | ML-298 | ESD-911753-1MG |
Cas.: 142720-24-9 | Purity: 98% | FGIN-1-27 | ESD-911754-10MG |
Cas.: 1427325-50-5 | Purity: 98% | JWH 018 N-(2-methylbutyl) isomer (JWH 073 2-methylbutyl homolog) | ESD-911755-10MG |
Cas.: 14277-97-5 | Purity: ≥90% (HPLC) | Domoic Acid | ESD-911756-1MG |
Cas.: 1428118-38-0 | Purity: 98% | (3S,5S)-Atorvastatin sodium salt | ESD-911757-10MG |
Cas.: 1431868-11-9 | Purity: 98% | L-Thyroxine-13C9,15N | ESD-911758-1MG |
Cas.: 1432062-16-2 | Purity: 98% | Meclizine-d8 hydrochloride | ESD-911759-1MG |
Cas.: 143209-04-5 | Purity: 98% | Dihydroaeruginoic Acid (CGP 52547) | ESD-911760-5MG |
Cas.: 1432478-91-5 | Purity: 98% | AM2233 azepane isomer | ESD-911761-1MG |
Cas.: 143442-54-0 | Purity: 98% | 9(S)-HODE cholesteryl ester | ESD-911762-50ΜG |
Cas.: 143545-90-8 | Purity: 98% | Cylindrospermopsin | ESD-911763-50ΜG |
Cas.: 1435782-38-9 | Purity: 98% | Tapentadol-d3 hydrochloride (CRM) | ESD-911764-1MG |
Cas.: 143615-69-4 | Purity: 98% | C2 L-threo Ceramide (d18:1/2:0) | ESD-911765-1MG |
Cas.: 143827-20-7 | Purity: 98% | Creatinine-d3 | ESD-911766-1MG |
Cas.: 144060-98-0 | Purity: 98% | 2-(4-Pyridyl)-4-methyl-thiazole-5-Carboxylic Acid | ESD-911767-1G |
Cas.: 144096-46-8 | Purity: 98% | Agistatin B | ESD-911768-1MG |
Cas.: 144236-99-7 | Purity: 98% | 13C C16 Sphingomyelin (d18:1/16:0) | ESD-911769-1MG |
Cas.: 1443-43-2 | Purity: 98% | β-methyl Fentanyl hydrochloride (CRM) | ESD-911770-100ΜG |
Cas.: 144409-98-3 | Purity: 98% | Amyloid β-peptide (1-40) (rat) (DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVV) | ESD-911771-1MG |
Cas.: 145037-81-6 | Purity: 98% | Rhod-2 AM | ESD-911772-1MG |
Cas.: 145075-81-6 | Purity: ≥95% | OSW-1 | ESD-911773-1MG |
Cas.: 145382-61-2 | Purity: 98% | Glyasperin F | ESD-911774-5MG |
Cas.: 145841-10-7 | Purity: 98% | Sch-42495 racemate | ESD-911775-5MG |
Cas.: 14660-91-4 | Purity: BR | Neoxanthin | ESD-911776-1MG |
Cas.: 1469284-79-4 | Purity: 98% | PF-06424439 methanesulfonate | ESD-911777-5MG |
Cas.: 147059-72-1 | Purity: BR | Trovafloxacin | ESD-911778-5MG |
Cas.: 148498-78-6 | Purity: 98% | Adrenomedullin (AM) (1-52), human (Human adrenomedullin-(1-52)-NH2) | ESD-911779-1MG |
Cas.: 14919-35-8 | Purity: 98% | Octanoyl-DL-carnitine chloride (DL-Octanoylcarnitine chloride) | ESD-911780-5MG |
Cas.: 149247-12-1 | Purity: 98% | QF0301B | ESD-911781-5MG |
Cas.: 1508256-20-9 | Purity: 98% | EGF816 (S-enantiomer) (Nazartinib S-enantiomer) | ESD-911782-5MG |
Cas.: 151213-16-0 | Purity: 98% | BAY-Y 3118 | ESD-911783-5MG |
Cas.: 151333-45-8 | Purity: ≥95% | Oleic Acid Alkyne | ESD-911784-1MG |
Cas.: 151606-29-0 | Purity: 98% | Zinquin | ESD-911785-1MG |
Cas.: 151888-20-9 | Purity: ≥97% | K2BSPP (Bis(p-sulfonatophenyl)phenylphosphine dihydrate dipotassium salt) | ESD-911786-500MG |
Cas.: 156779-05-4 | Purity: 98% | Octanoic Acid-d3 (Caprylic Acid-d3) | ESD-911787-5MG |
Cas.: 157283-66-4 | Purity: 98% | (+)-Cloprostenol isopropyl ester | ESD-911788-5MG |
Cas.: 15896-46-5 | Purity: 98% | cis-Zeatin riboside (cis-Zeatin-D-riboside) | ESD-911789-5MG |
Cas.: 1596-70-9 | Purity: 98% | ()-Propoxyphene hydrochloride | ESD-911790-1MG |
Cas.: 160756-38-7 | Purity: 98% | CNS-5161 hydrochloride (CNS 5161A) | ESD-911791-5MG |
Cas.: 161190-26-7 | Purity: 98% | SPD-473 citrate | ESD-911792-5MG |
Cas.: 161491-04-9 | Purity: 98% | ()-L-threo-PDMP hydrochloride | ESD-911793-5MG |
Cas.: 1616622-08-2 | Purity: 98% | (+)-Oxanthromicin | ESD-911794-100ΜG |
Cas.: 161848-60-8 | Purity: 98% | 5-BrUTP sodium salt (5-Bromouridine 5′-triphosphate sodium salt) | ESD-911795-5MG |
Cas.: 16220-07-8 | Purity: 98% | Allopurinol riboside | ESD-911796-5MG |
Cas.: 1638-41-1 | Purity: ≥98% | p38 MAPK Inhibitor IV | ESD-911797-5MG |
Cas.: 16585-08-3 | Purity: 98% | (–)-Himgaline | ESD-911798-1MG |
Cas.: 167626-17-7 | Purity: 98% | OPC-28326 | ESD-911799-5MG |
Cas.: 1681056-61-0 | Purity: ≥98% | OSMI-1 | ESD-911800-5MG |
Cas.: 170149-76-5 | Purity: 98% | ReN-1869 hydrochloride | ESD-911801-5MG |
Cas.: 170365-25-0 | Purity: 98% | KW-8232 free base | ESD-911802-1MG |
Cas.: 1703748-89-3 | Purity: BR | Fosnetupitant (Pronetupitant) | ESD-911803-1MG |
Cas.: 172733-08-3 | Purity: 98% | Varespladib methyl | ESD-911804-1MG |
Cas.: 172923-77-2 | Purity: 98% | (+)-Macrosphelide A | ESD-911805-1MG |
Cas.: 17422-12-7 | Purity: 97% | methyl 2-methyl-3-oxopentanoate (2-METHYL-3-OXO-PENTANOIC ACID METHYL ESTER) | ESD-911806-100MG |
Cas.: 1743-60-8 | Purity: 98% | β-Estradiol 17-acetate (1,3,5(10)-Estratriene-3,17β-diol 17-acetate) | ESD-911807-100MG |
Cas.: 17466-45-4 | Purity: 98% | Phalloidin | ESD-911808-1MG |
Cas.: 17670-19-8 | Purity: BR | 6-Thioguanosine Triphosphate Triethylamine Salt | ESD-911809-1MG |
Cas.: 177987-23-4 | Purity: ≥98% | Oleyl Trifluoromethyl Ketone | ESD-911810-10MG |
Cas.: 17817-20-8 | Purity: 98% | Fluorescein di(β-D-galactopyranoside) (FDG) | ESD-911811-1MG |
Cas.: 1781828-85-0 | Purity: BR | Ro 32-0432 hydrochloride | ESD-911812-1MG |
Cas.: 17878-69-2 | Purity: ≥95% | O-methyl Sterigmatocystin (OMST) | ESD-911813-1MG |
Cas.: 1797406-80-4 | Purity: 98% | (S,R,S)-AHPC-PEG3-N3 (VH032-PEG3-N3) | ESD-911814-100MG |
Cas.: 1797432-62-2 | Purity: 98% | Tyk2 inhibitor 5 | ESD-911815-5MG |
Cas.: 1806-98-0 | Purity: BR | 17β-Estradiol 17β-D-Glucuronide | ESD-911816-5MG |
Cas.: 1810710-59-8 | Purity: 98% | PCTR1 (Protein Conjugates in Tissue Regeneration 1) | ESD-911817-50ΜG |
Cas.: 1810710-63-4 | Purity: 98% | PCTR2 (Protein Conjugates in Tissue Regeneration 2) | ESD-911818-50ΜG |
Cas.: 1810710-69-0 | Purity: 98% | PCTR3 (Protein Conjugates in Tissue Regeneration 3) | ESD-911819-50ΜG |
Cas.: 181530-09-6 | Purity: 98% | Zinquin ethyl ester | ESD-911820-1MG |
Cas.: 181885-68-7 | Purity: 98% | LDS-751 | ESD-911821-5MG |
Cas.: 1821370-28-8 | Purity: 98% | MitoPQ (MitoParaquat) | ESD-911822-20MG |
Cas.: 1821908-49-9 | Purity: 98% | SGC2085 hydrochloride | ESD-911823-1MG |
Cas.: 182359-66-6 | Purity: 98% | N-pentadecanoyl-L-Homoserine lactone (C15-HSL) | ESD-911824-5MG |
Cas.: 1823776-22-2 | Purity: 98% | 5-EAPB hydrochloride (5-(2-Ethylaminopropyl)Benzofuran) | ESD-911825-1MG |
Cas.: 1823925-53-6 | Purity: 98% | 5-MAPB hydrochloride (5-(2-Methylaminopropyl)Benzofuran) | ESD-911826-1MG |
Cas.: 1824382-78-6 | Purity: 98% | 3-keto Sphinganine (d8:0) hydrochloride (3-keto-C8-Dihydrosphingosine) | ESD-911827-10MG |
Cas.: 1824544-52-6 | Purity: 98% | 3-keto Sphinganine (d6:0) hydrochloride (3-keto-C6-Dihydrosphingosine) | ESD-911828-10MG |
Cas.: 182485-36-5 | Purity: 98% | TPMPA | ESD-911829-5MG |
Cas.: 18268-14-9 | Purity: 98% | α-Isopropylaminopentiophenone hydrochloride (2-IPP) | ESD-911830-5MG |
Cas.: 18268-15-0 | Purity: 98% | α-Propylaminopentiophenone hydrochloride | ESD-911831-10MG |
Cas.: 18268-16-1 | Purity: 98% | α-Ethylaminopentiophenone hydrochloride | ESD-911832-10MG |
Cas.: 18268-19-4 | Purity: 98% | 4-Methyl-α-ethylaminobutiophenone hydrochloride | ESD-911833-5MG |
Cas.: 182683-50-7 | Purity: 98% | PKCε Inhibitor Peptide | ESD-911834-5MG |
Cas.: 18281-07-7 | Purity: 98% | Ethyl Tricosanoate | ESD-911835-50MG |
Cas.: 182897-30-9 | Purity: 98% | Iberiotoxin trifluoroacetate salt | ESD-911836-100ΜG |
Cas.: 182926-45-0 | Purity: 98% | Setosusin | ESD-911837-500ΜG |
Cas.: 1830320-32-5 | Purity: 98% | RB394 | ESD-911838-5MG |
Cas.: 1831135-30-8 | Purity: 98% | JJH260 | ESD-911839-1MG |
Cas.: 1831135-56-8 | Purity: 98% | ABC34 | ESD-911840-1MG |
Cas.: 183202-73-5 | Purity: 98% | Kendomycin (TAN 2162) | ESD-911841-500ΜG |
Cas.: 183321-86-0 | Purity: 98% | Desmethyl Erlotinib | ESD-911843-5MG |
Cas.: 183323-26-4 | Purity: 98% | Arachidonoyl Ethanolamide Phosphate | ESD-911844-1MG |
Cas.: 183387-50-0 | Purity: 98% | HE-3235 | ESD-911845-5MG |
Cas.: 183509-22-0 | Purity: 98% | 16(R)-HETE | ESD-911846-50ΜG |
Cas.: 183509-23-1 | Purity: 98% | 16(S)-HETE | ESD-911847-50ΜG |
Cas.: 183509-24-2 | Purity: 98% | 17(R)-HETE | ESD-911848-50ΜG |
Cas.: 183509-25-3 | Purity: 98% | 17(S)-HETE | ESD-911849-50ΜG |
Cas.: 1835705-52-6 | Purity: 98% | Boc-C5-O-C5-O-C6-Cl (PROTAC Linker 2) | ESD-911850-100MG |
Cas.: 18361-45-0 | Purity: 98% | Leucomycin A5 | ESD-911851-5MG |
Cas.: 183718-70-9 | Purity: 98% | Arachidonoyl Serinol | ESD-911852-10MG |
Cas.: 183718-75-4 | Purity: 98% | N-(3-hydroxyphenyl)-Arachidonoyl amide (3-HPAA) | ESD-911853-5MG |
Cas.: 183718-77-6 | Purity: 98% | AM404 | ESD-911854-5MG |
Cas.: 1839524-44-5 | Purity: 98% | Endosidin 2 (ES2) | ESD-911855-20MG |
Cas.: 1841421-67-7 | Purity: 98% | CAY10703 | ESD-911856-5MG |
Cas.: 18427-44-6 | Purity: 98% | cis-Parinaric Acid (α-Parinaric Acid) | ESD-911857-500ΜG |
Cas.: 1843184-37-1 | Purity: 98% | JWH 203 N-(5-hydroxypentyl) metabolite | ESD-911858-1MG |
Cas.: 1843184-38-2 | Purity: 98% | JWH 203 N-(4-hydroxypentyl) metabolite | ESD-911859-1MG |
Cas.: 1843184-41-7 | Purity: 98% | AKB48 N-(4-hydroxypentyl) metabolite (APINACA N-(4-hydroxypentyl) metabolite) | ESD-911860-1MG |
Cas.: 1843184-42-8 | Purity: 98% | 5-fluoro AKB48 N-(4-hydroxypentyl) metabolite | ESD-911861-500ΜG |
Cas.: 18439-24-2 | Purity: 98% | Coenzyme A lithium salt | ESD-911862-20MG |
Cas.: 184644-83-5 | Purity: 98% | MTSES (Sodium (2-Sulfonatoethyl)methanethiosulfonate) | ESD-911863-10MG |
Cas.: 184708-66-5 | Purity: 98% | Palmitoleic Acid-d14 | ESD-911864-500ΜG |
Cas.: 184901-82-4 | Purity: 98% | AAF-CMK trifluoroacetate salt | ESD-911865-10MG |
Cas.: 1850293-95-6 | Purity: 98% | Se-Aspirin (Selenium-acetylsalicylic Acid) | ESD-911866-5MG |
Cas.: 185039-91-2 | Purity: 98% | PD 166326 | ESD-911867-1MG |
Cas.: 1850409-16-3 | Purity: 98% | THJ2201 N-(5-hydroxypentyl) metabolite (CRM) | ESD-911868-1MG |
Cas.: 1850409-18-5 | Purity: 98% | THJ2201 N-pentanoic acid metabolite (CRM) (THJ 018 N-pentanoic acid metabolite) | ESD-911869-1MG |
Cas.: 1852-38-6 | Purity: 98% | Pregnenolone sulfate sodium salt | ESD-911870-50MG |
Cas.: 185246-32-6 | Purity: 98% | Rp-8-bromo-PET-Cyclic GMPS sodium salt (Rp-8-bromo-PET-cGMPS) | ESD-911871-1MG |
Cas.: 185351-19-3 | Purity: 98% | NQTrp (1,4-Naphthoquinon-2-yl-L-tryptophan) | ESD-911872-5MG |
Cas.: 1854126-45-6 | Purity: 98% | Hydroxychloroquine-d4 sulfate (HCQ-d4) | ESD-911873-500ΜG |
Cas.: 1854-25-7 | Purity: 98% | 2-keto-D-Glucose (D-Glucosone) | ESD-911874-100MG |
Cas.: 1859218-30-6 | Purity: 98% | 5-Fluoropentylindole | ESD-911875-5MG |
Cas.: 1859-42-3 | Purity: 98% | Heat Shock Protein Inhibitor II | ESD-911876-5MG |
Cas.: 186097-54-1 | Purity: 98% | Cilobradine Hydrochloride (DK-AH 269) | ESD-911877-5MG |
Cas.: 186204-31-9 | Purity: 98% | Lurasidone metabolite 14283 | ESD-911878-1MG |
Cas.: 186299-34-3 | Purity: 98% | EUK 118 | ESD-911879-5MG |
Cas.: 186299-35-4 | Purity: 98% | EUK 124 | ESD-911880-10MG |
Cas.: 1863065-82-0 | Purity: 98% | 5-fluoro ADBICA (5F-ADBICA) | ESD-911881-10MG |
Cas.: 1863065-90-0 | Purity: 98% | 5-fluoro ADB-PINACA | ESD-911882-1MG |
Cas.: 186545-76-6 | Purity: 98% | N-Benzylacetamidine hydrobromide | ESD-911883-10MG |
Cas.: 1869912-39-9 | Purity: 98% | AZD 5153 | ESD-911885-5MG |
Cas.: 1869951-99-4 | Purity: 98% | JWH 018 2′-naphthyl-N-(1,1-dimethylpropyl) isomer | ESD-911886-5MG |
Cas.: 1869954-38-0 | Purity: 98% | JWH 018 2′-naphthyl-N-(2,2-dimethylpropyl) isomer | ESD-911887-5MG |
Cas.: 1869959-37-4 | Purity: 98% | JWH 018 2′-naphthyl-N-(1-ethylpropyl) isomer | ESD-911888-5MG |
Cas.: 1869980-05-1 | Purity: 98% | JWH 073 6-methoxyindole analog | ESD-911889-1MG |
Cas.: 1870811-01-0 | Purity: 98% | SLC5111312 hydrochloride | ESD-911890-1MG |
Cas.: 187099-99-6 | Purity: 98% | Sulforhodamine 101 DHPE | ESD-911891-1MG |
Cas.: 187224-29-9 | Purity: 98% | N-Arachidonoyl-L-Serine (ARA-S) | ESD-911892-1MG |
Cas.: 1872296-37-1 | Purity: 98% | CALX8 | ESD-911893-50MG |
Cas.: 187389-53-3 | Purity: 98% | Boc-D-FMK | ESD-911894-1MG |
Cas.: 1874-54-0 | Purity: 98% | Psicofuranine | ESD-911895-1MG |
Cas.: 1877243-60-1 | Purity: 98% | AB-FUBINACA metabolite 3 (MMB-FUBINACA metabolite 1) | ESD-911896-1MG |
Cas.: 1878151-58-6 | Purity: 98% | Kumbicin C | ESD-911897-1MG |
Cas.: 187865-22-1 | Purity: 98% | Derquantel | ESD-911898-5MG |
Cas.: 187888-13-7 | Purity: 98% | Parvodicin Complex | ESD-911899-5MG |
Cas.: 1879029-93-2 | Purity: 98% | AB-PINACA pentanoic acid metabolite | ESD-911900-1MG |
Cas.: 18791-21-4 | Purity: 98% | Pyridomycin | ESD-911901-500ΜG |
Cas.: 187947-37-1 | Purity: 98% | Arachidonoyl Serotonin (AA-5HT) | ESD-911902-10MG |
Cas.: 187960-08-3 | Purity: 98% | Genistein-d4 | ESD-911903-500ΜG |
Cas.: 1881277-32-2 | Purity: 98% | Resolvin D1-d5 | ESD-911904-50ΜG |
Cas.: 1881277-33-3 | Purity: 98% | Resolvin D2-d5 | ESD-911905-100ΜG |
Cas.: 1883-13-2 | Purity: 98% | 3-hydroxy Lauric Acid | ESD-911906-20MG |
Cas.: 1883284-94-3 | Purity: 98% | FDU-PB-22 | ESD-911907-1MG |
Cas.: 1883548-87-5 | Purity: 98% | ML-179 (CID-45100448) | ESD-911908-5MG |
Cas.: 18838-38-5 | Purity: 98% | Creatine Phosphate potassium salt (Phosphocreatine) | ESD-911909-5MG |
Cas.: 188398-87-0 | Purity: 98% | (S)-Desoxy-D2PM hydrochloride ((S)-2-Diphenylmethylpyrrolidine) | ESD-911910-5MG |
Cas.: 1884269-07-1 | Purity: 98% | AHU377-d4 (Sacubitril-d4) | ESD-911911-1MG |
Cas.: 1890250-13-1 | Purity: 98% | AMB (AMP) | ESD-911912-5MG |
Cas.: 1890250-14-2 | Purity: 98% | 5-fluoro AMB metabolite 2 | ESD-911913-1MG |
Cas.: 1890250-21-1 | Purity: 98% | 5-fluoro AMB metabolite 3 | ESD-911914-1MG |
Cas.: 189061-11-8 | Purity: 98% | NGB 2904 hydrochloride | ESD-911915-5MG |
Cas.: 189261-10-7 | Purity: 98% | Natalizumab | ESD-911916-10MG |
Cas.: 189280-13-5 | Purity: 98% | WQ 2743 | ESD-911917-5MG |
Cas.: 1895916-79-6 | Purity: 98% | 9-SAHSA | ESD-911918-5MG |
Cas.: 189696-20-6 | Purity: 98% | Mca-DEVDAPK(Dnp)-OH (Caspase-3 Fluorogenic Substrate III) | ESD-911919-500ΜG |
Cas.: 1897379-33-7 | Purity: 98% | SLM6031434 | ESD-911920-5MG |
Cas.: 189894-78-8 | Purity: 98% | C6 L-erythro Ceramide (d18:1/6:0) | ESD-911921-1MG |
Cas.: 189894-79-9 | Purity: 98% | C6 D-threo Ceramide (d18:1/6:0) | ESD-911922-1MG |
Cas.: 189894-80-2 | Purity: 98% | C6 L-threo Ceramide (d18:1/6:0) | ESD-911923-1MG |
Cas.: 189939-61-5 | Purity: 98% | Palmitoyl N-Isopropylamide (PIA) | ESD-911924-10MG |
Cas.: 19022-51-6 | Purity: ≥98% | Ophiobolin C | ESD-911925-1MG |
Cas.: 190249-36-6 | Purity: 98% | C16((±)-2′-hydroxy)dihydro Ceramide (d18:0/16:0) | ESD-911926-5MG |
Cas.: 190274-53-4 | Purity: 98% | Calpain Inhibitor VI (SJA 6017) | ESD-911927-1MG |
Cas.: 19054-27-4 | Purity: 98% | Curvulin | ESD-911928-1MG |
Cas.: 190788-61-5 | Purity: 98% | Coumarin Boronic Acid pinacolate ester | ESD-911929-10MG |
Cas.: 191102-79-1 | Purity: 98% | GGTI 2133 | ESD-911930-1MG |
Cas.: 191173-82-7 | Purity: 98% | OH-Chol | ESD-911931-5MG |
Cas.: 19117-92-1 | Purity: 98% | 2-chloro Palmitic Acid | ESD-911932-5MG |
Cas.: 191471-52-0 | Purity: 98% | LY379268 | ESD-911933-5MG |
Cas.: 1914971-16-6 | Purity: 98% | PHGDH-inactive (3-Phosphoglycerate Dehydrogenase-inactive) | ESD-911934-10MG |
Cas.: 191545-08-1 | Purity: 98% | 12(Z),15(Z)-Heneicosadienoic Acid | ESD-911935-5MG |
Cas.: 191919-01-4 | Purity: 98% | 8-iso-15-keto Prostaglandin F2α | ESD-911936-500ΜG |
Cas.: 191919-02-5 | Purity: 98% | 8-iso-13,14-dihydro-15-keto Prostaglandin F2α (8-iso-13,14-dihydro-15-keto PGF2α) | ESD-911937-100ΜG |
Cas.: 1919-91-1 | Purity: 98% | Naphthol AS-BI-Phosphate | ESD-911938-100MG |
Cas.: 192140-58-2 | Purity: 98% | Fura-FF potassium salt | ESD-911939-500ΜG |
Cas.: 1922099-21-5 | Purity: 98% | CCG-232601 | ESD-911940-1MG |
Cas.: 19227-13-5 | Purity: 98% | 4-Methylbenzamide oxime (p-Toylamide oxime) | ESD-911941-500MG |
Cas.: 19231-60-8 | Purity: 98% | CAY10578 | ESD-911942-5MG |
Cas.: 192329-42-3 | Purity: 98% | Prinomastat | ESD-911943-5MG |
Cas.: 19245-55-7 | Purity: 98% | Arachidonic Acid methyl ester-d8 (Methyl Arachidonate-d8) | ESD-911944-1MG |
Cas.: 192461-96-4 | Purity: 98% | (±)8(9)-DiHET ((±)8,9-DiHETrE) | ESD-911945-100ΜG |
Cas.: 192564-13-9 | Purity: 98% | Leteprinim potassium salt (AIT 082) | ESD-911946-5MG |
Cas.: 1926163-82-7 | Purity: 98% | Mca-PLAC(p-OMeBz)-WAR(Dpa)-NH2 | ESD-911947-1MG |
Cas.: 192705-80-9 | Purity: 98% | PD 161570 | ESD-911948-5MG |
Cas.: 192883-12-8 | Purity: 98% | N-3-hydroxydecanoyl-L-Homoserine lactone (OH-C10-HSL) | ESD-911949-1MG |
Cas.: 192883-14-0 | Purity: 98% | N-3-hydroxyoctanoyl-L-Homoserine lactone | ESD-911950-5MG |
Cas.: 19313-28-1 | Purity: 98% | 13,14-dihydro Prostaglandin E1 | ESD-911951-1MG |
Cas.: 1931-78-8 | Purity: 98% | 2-O-Hexadecyl Glycerol | ESD-911952-5MG |
Cas.: 1933-15-9 | Purity: 98% | 4-methoxy PCE hydrochloride | ESD-911953-1MG |
Cas.: 1934302-23-4 | Purity: 98% | MI-nc hydrochloride | ESD-911954-5MG |
Cas.: 1934-55-0 | Purity: 98% | PCPr hydrochloride | ESD-911955-5MG |
Cas.: 1934-63-0 | Purity: 98% | PCMPA hydrochloride | ESD-911956-5MG |
Cas.: 19351-63-4 | Purity: 90% | Secologanin (NSC 640525) | ESD-911957-5MG |
Cas.: 193551-00-7 | Purity: 98% | CAY10398 | ESD-911958-5MG |
Cas.: 1936529-84-8 | Purity: 98% | (±)-JWH 018 N-(2-hydroxypentyl) metabolite | ESD-911959-1MG |
Cas.: 193807-60-2 | Purity: 98% | MMP-2/MMP-9 Inhibitor II | ESD-911960-1MG |
Cas.: 193825-78-4 | Purity: 98% | Commendamide (N-acyl-3-hydroxypalmitoyl-Glycine) | ESD-911961-1MG |
Cas.: 19395-87-0 | Purity: 98% | SC-19220 | ESD-911962-5MG |
Cas.: 194085-75-1 | Purity: 98% | Carisbamate | ESD-911963-1MG |
Cas.: 194098-25-4 | Purity: 98% | CP-409092 | ESD-911964-5MG |
Cas.: 1942919-63-2 | Purity: 98% | CAY10719 | ESD-911965-5MG |
Cas.: 19437-20-8 | Purity: 98% | α-Phthalimidopropiophenone | ESD-911966-1MG |
Cas.: 194608-29-2 | Purity: 98% | Petromurin C | ESD-911967-50ΜG |
Cas.: 194874-06-1 | Purity: 98% | Apoptolidin (Apoptolidin A) | ESD-911968-100ΜG |
Cas.: 194918-76-8 | Purity: 98% | ACPT-I | ESD-911969-5MG |
Cas.: 194930-00-2 | Purity: 98% | Rivastigmine-d6 tartrate | ESD-911970-1MG |
Cas.: 195061-94-0 | Purity: 98% | 5(S)-HETrE | ESD-911971-50ΜG |
Cas.: 195209-04-2 | Purity: 98% | ACPT-II | ESD-911972-5MG |
Cas.: 195211-53-1 | Purity: 98% | DBO-83 | ESD-911973-5MG |
Cas.: 1952-15-4 | Purity: 98% | 4-DAMP (4-Diphenylacetoxy-N-methyl-piperidine methiodide) | ESD-911974-10MG |
Cas.: 1952336-77-4 | Purity: 98% | RCS-4 M10 metabolite (RCS-4 N-(5-hydroxypentyl)phenol metabolite) | ESD-911975-1MG |
Cas.: 1952336-78-5 | Purity: 98% | RCS-4 M11 metabolite (RCS-4 N-(4-oxo-pentyl)phenol metabolite) | ESD-911976-1MG |
Cas.: 19545-95-0 | Purity: 98% | (4-Chloro-3,5-dimethylphenoxy)acetic Acid | ESD-911977-50MG |
Cas.: 195503-20-9 | Purity: 98% | 17-trifluoromethylphenyl trinor Prostaglandin F2α methyl ester | ESD-911978-5MG |
Cas.: 19553-76-5 | Purity: 98% | Ganglioside GD1b Mixture sodium salt | ESD-911979-1MG |
Cas.: 1962928-26-2 | Purity: 98% | BGC 20-1531 hydrochloride (PGN 1531) | ESD-911980-5MG |
Cas.: 196493-76-2 | Purity: 98% | 2,3-dinor Thromboxane B1 (2,3-dinor TXB1) | ESD-911981-100ΜG |
Cas.: 196497-48-0 | Purity: 98% | 1-Deoxysphinganine (m18:0) | ESD-911982-1MG |
Cas.: 1969261-68-4 | Purity: 98% | 5-fluoro-3,5-ADB-PFUPPYCA | ESD-911983-1MG |
Cas.: 1969264-37-6 | Purity: 98% | AB-BICA | ESD-911984-1MG |
Cas.: 196928-50-4 | Purity: 98% | XAP044 | ESD-911985-5MG |
Cas.: 1971007-87-0 | Purity: 98% | MMB2201 | ESD-911986-5MG |
Cas.: 1971007-90-5 | Purity: 98% | MMB-FUBICA (AMB-FUBICA) | ESD-911987-1MG |
Cas.: 1971007-91-6 | Purity: 98% | MDMB-FUBICA | ESD-911988-1MG |
Cas.: 1971007-96-1 | Purity: 98% | MA-CHMINACA | ESD-911989-5MG |
Cas.: 1971007-97-2 | Purity: 98% | MMB018 | ESD-911990-1MG |
Cas.: 197247-23-7 | Purity: 98% | dinor-12-oxo Phytodienoic Acid | ESD-911991-100ΜG |
Cas.: 19728-88-2 | Purity: 98% | Methiothepin maleate | ESD-911992-20MG |
Cas.: 19735-74-1 | Purity: 98% | 2-amino-4-(1-adamantyl) Thiazole | ESD-911993-100MG |
Cas.: 1977535-33-3 | Purity: 98% | 13C6-3-Nitrophenylhydrazine hydrochloride (13C6-3-NPH) | ESD-911994-5MG |
Cas.: 19794-97-9 | Purity: 98% | Sphinganine-1-phosphate (d18:0) | ESD-911995-1MG |
Cas.: 1984789-90-3 | Purity: 98% | FUBIMINA | ESD-911996-1MG |
Cas.: 1987882-62-1 | Purity: 98% | epi-Doramectin | ESD-911997-1MG |
Cas.: 1987882-63-2 | Purity: 98% | Δ2-Doramectin | ESD-911998-1MG |
Cas.: 1987883-26-0 | Purity: 98% | doramectin aglycone | ESD-911999-1MG |
Cas.: 1992047-61-6 | Purity: 98% | NVS-CECR2-1 (NVS-1) | ESD-912000-1MG |
Cas.: 199656-46-7 | Purity: 98% | CP-392, 110 maleate | ESD-912001-5MG |
Cas.: 199672-06-5 | Purity: 98% | 4-fluoro BZP hydrochloride | ESD-912002-20MG |
Cas.: 1997286-65-3 | Purity: 98% | 12-PAHSA | ESD-912003-5MG |
Cas.: 1997338-61-0 | Purity: 98% | Canagliflozin-d4 | ESD-912004-1MG |
Cas.: 199798-84-0 | Purity: 98% | BXL-628 | ESD-912005-1MG |
Cas.: 1998158-84-1 | Purity: 98% | Cloniprazepam | ESD-912006-5MG |
Cas.: 199850-67-4 | Purity: 98% | PD 166793 | ESD-912007-5MG |
Cas.: 199875-69-9 | Purity: 98%, 50mg/mL in ethanol | N-Arachidonoyl Dopamine (NADA) | ESD-912008-10MG |
Cas.: 199875-71-3 | Purity: 98% | Eicosapentaenoyl Serotonin | ESD-912009-5MG |
Cas.: 199999-60-5 | Purity: 98% | TNF-α Antagonist (WP9QY) | ESD-912010-1MG |
Cas.: 20004-62-0 | Purity: 98% | Resistomycin | ESD-912011-1MG |
Cas.: 20007-87-8 | Purity: 98% | Cyclopenin | ESD-912012-5MG |
Cas.: 2001571-40-8 | Purity: 98% | eCF309 | ESD-912013-1MG |
Cas.: 200189-97-5 | Purity: 98% | CGP 3466 maleate (CGP 3466B) | ESD-912014-5MG |
Cas.: 200630-46-2 | Purity: 98% | 3-O-methyl-L-DOPA hydrate | ESD-912015-10MG |
Cas.: 200716-66-1 | Purity: 98% | 1,3-PBIT dihydrobromide | ESD-912016-20MG |
Cas.: 200933-14-8 | Purity: 98% | m-3M3FBS | ESD-912017-10MG |
Cas.: 201036-16-0 | Purity: 98% | 1,2-Diphytanoyl-sn-glycero-3-PE | ESD-912018-20MG |
Cas.: 20108-30-9 | Purity: ≥90% | Fusicoccin (NSC 113500) | ESD-912019-1MG |
Cas.: 20110-56-9 | Purity: 98% | 3-Iodoamphetamine hydrochloride | ESD-912020-1MG |
Cas.: 2011762-82-4 | Purity: 98% | C18 Ceramide-d3 (d18:1/18:0-d3) | ESD-912021-1MG |
Cas.: 2012-14-8 | Purity: 98% | 9,12-Octadecadiynoic Acid (Ro 3-1314) | ESD-912022-5MG |
Cas.: 201216-37-7 | Purity: 98% | Lyso-PAF C-16-d4 (Lyso-Platelet-activating Factor C-16-d4) | ESD-912023-1MG |
Cas.: 20137-14-8 | Purity: 98% | Makisterone A | ESD-912024-1MG |
Cas.: 201608-18-6 | Purity: 98% | Prostaglandin A2-d4 | ESD-912025-100ΜG |
Cas.: 201730-11-2 | Purity: 98% | DCPG ((S)-3,4-DCPG) | ESD-912026-5MG |
Cas.: 201731-19-3 | Purity: 98% | 3-hexanoyl-NBD Cholesterol (3-C6-NBD Cholesterol) | ESD-912027-1MG |
Cas.: 201738-24-1 | Purity: 98% | Glycerophospho-N-Oleoyl Ethanolamine | ESD-912028-1MG |
Cas.: 201738-25-2 | Purity: 98% | Glycerophospho-N-Arachidonoyl Ethanolamine | ESD-912029-1MG |
Cas.: 201848-10-4 | Purity: 98% | 13,14-dihydro-15(R)-Prostaglandin E1 (13,14-dihydro-15(R)-PGE1) | ESD-912030-5MG |
Cas.: 2021255-73-0 | Purity: 98% | Phenylephrine Glucuronide | ESD-912031-1MG |
Cas.: 202284-85-3 | Purity: 98% | N-butyryl-L-Homocysteine thiolactone | ESD-912032-10MG |
Cas.: 202284-87-5 | Purity: 98% | N-tetradecanoyl-L-Homoserine lactone | ESD-912033-10MG |
Cas.: 20235-78-3 | Purity: 98% | 2-Thiouridine | ESD-912034-20MG |
Cas.: 20261-85-2 | Purity: 98% | Dinactin | ESD-912035-1MG |
Cas.: 202850-01-9 | Purity: 98% | C12 NBD Ceramide (d18:1/12:0) | ESD-912036-1MG |
Cas.: 20290-75-9 | Purity: 1mg/ml in Ethanol | Stearidonic Acid (Moroctic Acid) | ESD-912037-5MG |
Cas.: 20374-46-3 | Purity: 98% | 4-chloro-α-Cyanocinnamic Acid (Cl-CCA) | ESD-912038-5MG |
Cas.: 203911-27-7 | Purity: 98% | Fasudil dihydrochloride (HA-1077 dihydrochloride) | ESD-912039-100MG |
Cas.: 203915-59-7 | Purity: 98% | MMP Inhibitor II | ESD-912040-5MG |
Cas.: 204066-82-0 | Purity: 98% | PD 168368 | ESD-912041-5MG |
Cas.: 20410-95-1 | Purity: 98% | 6α-Naloxol (CRM) | ESD-912042-1MG |
Cas.: 20410-98-4 | Purity: 98% | 6α-Naltrexol (6α-hydroxy Naltrexone) | ESD-912043-1MG |
Cas.: 204140-01-2 | Purity: 98% | MMP-9/MMP-13 Inhibitor I | ESD-912044-1MG |
Cas.: 204395-52-8 | Purity: 98% | Clozapine-d4 | ESD-912045-50ΜG |
Cas.: 204398-90-3 | Purity: 98% | Drimentine A | ESD-912046-1MG |
Cas.: 204398-91-4 | Purity: 98% | Drimentine B | ESD-912047-1MG |
Cas.: 204398-92-5 | Purity: 98% | Drimentine C | ESD-912048-1MG |
Cas.: 2044701-99-5 | Purity: 98% | HDAC3 Inhibitor (Histone Deacetylase 3) | ESD-912049-5MG |
Cas.: 2044714-53-4 | Purity: 98% | 5-methyl-2-HOBA hydrochloride | ESD-912050-10MG |
Cas.: 204975-45-1 | Purity: 98% | (+)-Goniothalesdiol | ESD-912051-1MG |
Cas.: 205309-81-5 | Purity: 98% | DL-TBOA | ESD-912052-5MG |
Cas.: 205391-01-1 | Purity: ≥95% | DAF-2 (4,5-Diaminofluorescein) | ESD-912053-1MG |
Cas.: 205432-12-8 | Purity: 98% | JS-K | ESD-912054-5MG |
Cas.: 2055172-43-3 | Purity: 98% | ML-226 | ESD-912055-1MG |
Cas.: 2055172-60-4 | Purity: 98% | (R)-KT109 | ESD-912056-1MG |
Cas.: 2055172-61-5 | Purity: 98% | (S)-KT109 | ESD-912057-1MG |
Cas.: 2055494-09-0 | Purity: 98% | 3′-Ethoxy-5,6-dihydro Spinosyn J 17-pseudoaglycone | ESD-912058-1MG |
Cas.: 20590-32-3 | Purity: 98% | 5(Z),8(Z),11(Z)-Eicosatrienoic Acid (Mead Acid) | ESD-912059-1MG |
Cas.: 20592-20-5 | Purity: 98% | 13,14-dihydro Prostaglandin F1α | ESD-912060-5MG |
Cas.: 205989-12-4 | Purity: 98% | Luotonin A | ESD-912061-5MG |
Cas.: 20601-85-8 | Purity: 98% | Tetrahydromagnolol (Magnolignan) | ESD-912062-20MG |
Cas.: 206052-01-9 | Purity: 98% | PPOH | ESD-912063-5MG |
Cas.: 206052-02-0 | Purity: 98% | MS-PPOH | ESD-912064-5MG |
Cas.: 206052-03-1 | Purity: 98% | DDMS (Dibromo-dodecenyl-methylsulfimide) | ESD-912065-5MG |
Cas.: 206443-06-3 | Purity: 98% | 4-Methylumbelliferyl β-D-Galactopyranoside-6-sulfate sodium salt | ESD-912066-5MG |
Cas.: 206549-55-5 | Purity: 98% | MMP-9 Inhibitor I (Matrix Metalloproteinase-9 Inhibitor I) | ESD-912067-500ΜG |
Cas.: 20675-51-8 | Purity: 98% | (±)-Cannabichromene (CRM) | ESD-912068-10MG |
Cas.: 20675-85-8 | Purity: 98% | 13,14-dihydro-15-keto-tetranor Prostaglandin E2 | ESD-912069-50ΜG |
Cas.: 2068-83-9 | Purity: 98% | (S)-3-Hydroxyisobutyric acid | ESD-912070-5MG |
Cas.: 2068-89-5 | Purity: 98% | L-myo-Inositol-1,4,5-triphosphate sodium salt | ESD-912071-100ΜG |
Cas.: 206978-14-5 | Purity: 98% | 6′,7′-Epoxybergamottin (Epoxybergamottin) | ESD-912072-10MG |
Cas.: 2070009-25-3 | Purity: 98% | PSI-7977-13C-d3 (Sofosbuvir-13C-d3) | ESD-912073-1MG |
Cas.: 2070009-41-3 | Purity: 98% | Rosuvastatin-d6 sodium salt | ESD-912074-500ΜG |
Cas.: 207131-40-6 | Purity: 98% | 1,2-Diphytanoyl-sn-glycero-3-PC | ESD-912075-10MG |
Cas.: 207300-70-7 | Purity: 98% | Sodium D-glucuronate monohydrate | ESD-912076-100MG |
Cas.: 20735-15-3 | Purity: 98% | 2-Amino-1-phenylbutane hydrochloride | ESD-912077-5MG |
Cas.: 207572-68-7 | Purity: 98% | Rilmenidine (hemifumarate) | ESD-912078-5MG |
Cas.: 2079895-62-6 | Purity: 98% | TP-472 | ESD-912079-5MG |
Cas.: 2080306-20-1 | Purity: 98% | TP-064 | ESD-912080-10MG |
Cas.: 208107-14-6 | Purity: 98% | Temozolomide-d3 | ESD-912081-1MG |
Cas.: 208114-93-6 | Purity: 98% | AL 8810 isopropyl ester | ESD-912082-5MG |
Cas.: 20829-55-4 | Purity: 98% | Cyclo(L-Trp-L-Trp) (Cyclic dioxopiperazine-L-tryptophan-L-tryptophan) | ESD-912083-20MG |
Cas.: 208445-06-1 | Purity: 98% | Rp-8-bromo-Cyclic GMPS sodium salt (Rp-8-bromo-cGMPS) | ESD-912084-1MG |
Cas.: 208445-07-2 | Purity: 98% | Rp-8-pCPT-Cyclic GMPS sodium salt (Rp-8-pCPT-cGMPS) | ESD-912085-1MG |
Cas.: 208584-51-4 | Purity: 98% | D-myo-Inositol-1,2-diphosphate sodium salt | ESD-912086-500ΜG |
Cas.: 208584-52-5 | Purity: 98% | D-myo-Inositol-1,3-diphosphate sodium salt | ESD-912087-500ΜG |
Cas.: 208645-74-3 | Purity: 98% | Gly-Gly-AMC | ESD-912088-5MG |
Cas.: 208663-26-7 | Purity: 98% | MMP-3 Inhibitor VIII | ESD-912089-1MG |
Cas.: 20897-91-0 | Purity: 98% | 15(R)-Prostaglandin E1 | ESD-912090-5MG |
Cas.: 208993-54-8 | Purity: 98% | fiduxosin | ESD-912091-1MG |
Cas.: 2091-39-6 | Purity: 98% | Eicosadienoic acid | ESD-912092-25MG |
Cas.: 209268-36-0 | Purity: 98% | S-5751 | ESD-912093-1MG |
Cas.: 209342-41-6 | Purity: 98% | Finafloxacin hydrochloride | ESD-912094-500ΜG |
Cas.: 209414-05-1 | Purity: 98% | JWH 071 | ESD-912095-5MG |
Cas.: 209414-06-2 | Purity: 98% | JWH 072 | ESD-912096-10MG |
Cas.: 209414-09-5 | Purity: 98% | JWH 020 | ESD-912097-10MG |
Cas.: 209414-16-4 | Purity: 98% | JWH 022 (AM2201 N-(4-pentenyl) analog) | ESD-912098-5MG |
Cas.: 2095107-57-4 | Purity: 98% | CAY10723 | ESD-912099-1MG |
Cas.: 209538-87-4 | Purity: 98% | ethyl 2-(3-hydroxyphenyl)-4-methylthiazole-5-Carboxylate | ESD-912100-50MG |
Cas.: 2095432-59-8 | Purity: 98% | MS049 hydrochloride | ESD-912101-5MG |
Cas.: 209589-59-3 | Purity: 98% | S-methyl-L-Thiocitrulline hydrochloride | ESD-912102-20MG |
Cas.: 2097130-84-0 | Purity: 98% | 9(R)-PAHSA | ESD-912103-500ΜG |
Cas.: 2097130-87-3 | Purity: 98% | 9(S)-PAHSA | ESD-912104-500ΜG |
Cas.: 2097136-42-8 | Purity: 98% | (S)-3′-hydroxy Blebbistatin | ESD-912105-5MG |
Cas.: 2097141-18-7 | Purity: 98% | (S)-3′-amino Blebbistatin | ESD-912106-1MG |
Cas.: 2097561-20-9 | Purity: 98% | C2 Ceramide (d14:1/2:0) | ESD-912107-5MG |
Cas.: 2097938-44-6 | Purity: 98% | Pomalidomide-PEG4-C-COOH | ESD-912108-100MG |
Cas.: 209860-88-8 | Purity: 98% | Tafluprost free acid (AFP-172) | ESD-912109-1MG |
Cas.: 209860-89-9 | Purity: 98% | Tafluprost ethyl ester (AFP 175) | ESD-912110-1MG |
Cas.: 21003-46-3 | Purity: 98% | 8-iso Prostaglandin E1 | ESD-912111-1MG |
Cas.: 21005-63-0 | Purity: 98% | 6-IT | ESD-912112-5MG |
Cas.: 2101505-58-0 | Purity: 98% | Cefazolin-13C2,15N | ESD-912113-1MG |
Cas.: 210179-44-5 | Purity: 98% | JWH 080 | ESD-912114-10MG |
Cas.: 21028-20-6 | Purity: 98% | 3-Methylcytidine methosulfate | ESD-912115-5MG |
Cas.: 210297-47-5 | Purity: 98% | HA-100 hydrochloride | ESD-912116-10MG |
Cas.: 210344-94-8 | Purity: 98% | Ac-VDVAD-AFC | ESD-912117-5MG |
Cas.: 210344-99-3 | Purity: 98% | Ac-WEHD-AFC | ESD-912118-5MG |
Cas.: 210345-02-1 | Purity: 98% | Ac-LETD-AFC | ESD-912119-5MG |
Cas.: 210345-03-2 | Purity: 98% | Ac-LEHD-AFC | ESD-912120-5MG |
Cas.: 210488-61-2 | Purity: 98% | D-myo-Inositol-1,3,4,5-tetraphosphate sodium salt | ESD-912121-500ΜG |
Cas.: 210580-75-9 | Purity: 98% | AL 34662 (AL 34497) | ESD-912122-10MG |
Cas.: 21061-10-9 | Purity: 98% | Dihomo-γ-Linolenic Acid methyl ester | ESD-912123-20MG |
Cas.: 210686-41-2 | Purity: 98% | Hydroxyebastine | ESD-912124-500ΜG |
Cas.: 2108100-73-6 | Purity: 98% | WOBE437 | ESD-912125-1MG |
Cas.: 210821-63-9 | Purity: ≥98% | ORG 12962 hydrochloride | ESD-912126-5MG |
Cas.: 2108603-03-6 | Purity: 98% | CAY10406 | ESD-912127-5MG |
Cas.: 2108631-19-0 | Purity: 98% | MS023 hydrochloride | ESD-912128-10MG |
Cas.: 2108665-15-0 | Purity: 98% | GSK-J2 sodium salt | ESD-912129-5MG |
Cas.: 210976-81-1 | Purity: 98% | Prostaglandin E1 Ethanolamide | ESD-912130-5MG |
Cas.: 210978-26-0 | Purity: 98% | 15(R)-15-methyl Prostaglandin D2 (15(R)-15-methyl PGD2) | ESD-912131-1MG |
Cas.: 210979-33-2 | Purity: 98% | 17-trans Prostaglandin E3 (17-trans PGE3) | ESD-912132-50ΜG |
Cas.: 211100-24-2 | Purity: 98% | 17-trans Prostaglandin F3α (17-trans PGF3α) | ESD-912133-100MG |
Cas.: 211105-29-2 | Purity: 98% | Prostaglandin D2-d4 (PGD2-d4) | ESD-912134-50ΜG |
Cas.: 211105-33-8 | Purity: 98% | Prostaglandin E1-d4 | ESD-912135-100ΜG |
Cas.: 211105-40-7 | Purity: 98% | 8-iso Prostaglandin F2α-d4 | ESD-912136-50ΜG |
Cas.: 211106-54-6 | Purity: 98% | PAF C-16-d4 (Platelet-activating Factor C-16-d4) | ESD-912137-500ΜG |
Cas.: 211186-29-7 | Purity: 98% | 8-iso Prostaglandin A1 | ESD-912138-1MG |
Cas.: 211237-33-1 | Purity: 98% | Biotin-XX hydrazide | ESD-912139-5MG |
Cas.: 211364-78-2 | Purity: ≥98% | R18 (PHCVPRDLSWLDLEANMCLP) | ESD-912140-5MG |
Cas.: 21150-22-1 | Purity: 98% | β-Amanitin | ESD-912141-1MG |
Cas.: 21178-57-4 | Purity: 98% | 10,11-dehydro Curvularin (α,β-dehydro Curvularin) | ESD-912142-1MG |
Cas.: 211817-55-9 | Purity: 98% | 4(Z),7(Z),10(Z),13(Z),16(Z)-N-(2-hydroxyethyl)-Docosapentaenamide | ESD-912143-5MG |
Cas.: 211990-57-7 | Purity: 98% | Ac-IETD-AFC (N-Acetyl-Ile-Glu-Thr-Asp-7-amino-4-Trifluoromethylcoumarin) | ESD-912144-5MG |
Cas.: 21200-24-8 | Purity: 98% | Indolmycin | ESD-912145-1MG |
Cas.: 212118-77-9 | Purity: 98% | FlAsH-EDT2 | ESD-912146-5MG |
Cas.: 2121543-66-4 | Purity: 98% | Calxchol | ESD-912147-10MG |
Cas.: 212310-16-2 | Purity: 98% | CAY10408 | ESD-912148-1MG |
Cas.: 212332-35-9 | Purity: 98% | TC 2559 fumarate | ESD-912149-5MG |
Cas.: 2123484-71-7 | Purity: 98% | (±)10(11)-EDP Ethanolamide | ESD-912150-100ΜG |
Cas.: 2123485-34-5 | Purity: 98% | 19,20-EDP epoxide | ESD-912151-100ΜG |
Cas.: 21259-20-1 | Purity: 98% | T-2 Toxin | ESD-912152-5MG |
Cas.: 2126178-55-8 | Purity: 98% | Regorafenib-13C-d3 | ESD-912153-500ΜG |
Cas.: 212631-61-3 | Purity: 98% | PD 198306 | ESD-912154-1MG |
Cas.: 212631-67-9 | Purity: 98% | PD 184161 | ESD-912155-10MG |
Cas.: 212707-51-2 | Purity: 98% | Palmitoyl Serotonin | ESD-912156-5MG |
Cas.: 2127095-72-9 | Purity: 98% | Δ2-trans Eicosenoic Acid | ESD-912157-10MG |
Cas.: 213126-92-2 | Purity: 98% | (±)5(6)-DiHET lactone ((±)5,6-DiHETrE lactone) | ESD-912158-50ΜG |
Cas.: 213137-53-2 | Purity: 98% | Iromycin A (NK 26588) | ESD-912159-1MG |
Cas.: 213182-22-0 | Purity: 98% | AM3102 (KDS-5104) | ESD-912160-10MG |
Cas.: 2140262-53-7 | Purity: 98% | Galantamine-d3 (hydrobromide) | ESD-912161-1MG |
Cas.: 214149-46-9 | Purity: 98% | (±)-threo-Ethylphenidate hydrochloride (Ritalinic Acid ethyl ester) | ESD-912162-5MG |
Cas.: 21463-31-0 | Purity: 98% | AMT hydrochloride | ESD-912163-10MG |
Cas.: 214748-65-9 | Purity: 98% | 8-iso-15(R)-Prostaglandin F2α (8-iso-15-epi PGF2α) | ESD-912164-500ΜG |
Cas.: 214748-66-0 | Purity: 98% | ent-8-iso-15(S)-Prostaglandin F2α | ESD-912165-50ΜG |
Cas.: 2147701-33-3 | Purity: 98% | I-CBP112 hydrochloride | ESD-912166-5MG |
Cas.: 215030-90-3 | Purity: 98% | BMS 493 (BMS 204493) | ESD-912167-5MG |
Cas.: 215168-33-5 | Purity: 98% | (R)-Butaprost free acid | ESD-912168-1MG |
Cas.: 215510-22-8 | Purity: 98% | Prolactin-Releasing Peptide (1-31) (human) | ESD-912169-500ΜG |
Cas.: 215528-91-9 | Purity: 98% | C18 ((±)-2′-hydroxy) dihydro Ceramide (d18:0/18:0) | ESD-912170-5MG |
Cas.: 21562-57-2 | Purity: 98% | Prostaglandin E1 Alcohol | ESD-912171-5MG |
Cas.: 21562-58-3 | Purity: 98% | 15-keto Prostaglandin F1α (15-keto PGF1α) | ESD-912172-5MG |
Cas.: 21593-23-7 | Purity: 98% | Cefapirin | ESD-912173-5MG |
Cas.: 2160555-51-9 | Purity: 98% | 5-bromo APINACA | ESD-912174-1MG |
Cas.: 2160555-53-1 | Purity: 98% | 4-cyano CUMYL-BUT7AICA | ESD-912175-1MG |
Cas.: 2160555-55-3 | Purity: 98% | CUMYL-PeGACLONE (SGT-151) | ESD-912176-1MG |
Cas.: 216158-34-8 | Purity: ≥98% | ONO-8711 | ESD-912177-5MG |
Cas.: 216163-53-0 | Purity: 98% | PD 174265 | ESD-912178-1MG |
Cas.: 2161-86-6 | Purity: 98% | 2,4-Diacetylphloroglucinol | ESD-912179-5MG |
Cas.: 216227-54-2 | Purity: ≥98% | ONT-093 (OC 144093) | ESD-912180-5MG |
Cas.: 216453-54-2 | Purity: 98% | BTC potassium salt | ESD-912181-1MG |
Cas.: 21658-70-8 | Purity: 98% | BODIPY 505/515 | ESD-912182-100MG |
Cas.: 216590-44-2 | Purity: 98% | Actinotetraose Hexatiglate (Tigloside) | ESD-912183-1MG |
Cas.: 216596-71-3 | Purity: 98% | N-undecanoyl-L-Homoserine lactone (C11-HSL) | ESD-912184-10MG |
Cas.: 216699-07-9 | Purity: 98% | Abacavir sulfate | ESD-912185-5MG |
Cas.: 216758-20-2 | Purity: 98% | AMP-Deoxynojirimycin | ESD-912186-1MG |
Cas.: 217082-58-1 | Purity: 98% | Apelin-13 | ESD-912187-1MG |
Cas.: 217190-09-5 | Purity: 98% | 3-BODIPY-propanoylaminocaproic Acid N-hydroxysuccinimide ester | ESD-912188-500ΜG |
Cas.: 21754-25-6 | Purity: 98% | Cyclo(L-Tyr-L-Val) (Cyclo(Tyr-Val)) | ESD-912189-5MG |
Cas.: 2183239-01-0 | Purity: 98% | Varenicline-d4 | ESD-912190-1MG |
Cas.: 218461-97-3 | Purity: 98% | (±)14(15)-EET-SI | ESD-912191-50ΜG |
Cas.: 2185-93-5 | Purity: 98% | 4-methoxy PCP hydrochloride | ESD-912192-5MG |
Cas.: 21870-97-3 | Purity: 98% | 10(E),12(Z)-Conjugated Linoleic Acid methyl ester | ESD-912193-20MG |
Cas.: 21884-45-7 | Purity: 98% | ()-Rugulosin | ESD-912194-1MG |
Cas.: 21888-98-2 | Purity: 98% | Dexetimide ((+)-Benzetimide) | ESD-912195-10MG |
Cas.: 21888-99-3 | Purity: 98% | Levetimide | ESD-912196-10MG |
Cas.: 21894-58-6 | Purity: 98% | 4-Iodoamphetamine hydrochloride | ESD-912197-1MG |
Cas.: 2190487-94-4 | Purity: 98% | 1-Deoxysphingosine (m18:1(14Z)) | ESD-912198-500ΜG |
Cas.: 219137-85-6 | Purity: 98% | Ac-YVAD-AFC | ESD-912199-5MG |
Cas.: 219137-97-0 | Purity: 98% | Ac-VEID-AMC | ESD-912200-1MG |
Cas.: 219138-21-3 | Purity: 98% | Ac-IETD-pNA | ESD-912201-1MG |
Cas.: 219138-24-6 | Purity: ≥98% | p38 MAPK Inhibitor | ESD-912202-1MG |
Cas.: 219915-69-2 | Purity: 98% | (±)-threo-Methylnaphthidate hydrochloride (HDMP-28) | ESD-912203-1MG |
Cas.: 219986-78-4 | Purity: 98% | Bromo-DragonFLY hydrochloride | ESD-912204-1MG |
Cas.: 22002-85-3 | Purity: 98% | 1-Palmitoyl Lysophosphatidic Acid (1-Palmitoyl LPA free acid) | ESD-912205-1MG |
Cas.: 220088-42-6 | Purity: 98% | Binucleine 2 | ESD-912206-5MG |
Cas.: 22029-09-0 | Purity: 98% | Aspochracin | ESD-912207-500ΜG |
Cas.: 220519-06-2 | Purity: 98% | A-437203 | ESD-912208-1MG |
Cas.: 220556-69-4 | Purity: 98% | Arachidonoyl 2′-Chloroethylamide | ESD-912209-5MG |
Cas.: 220556-74-1 | Purity: 98% | (R)-(+)-Linoleyl-1′-Hydroxy-2′-Propylamide | ESD-912210-1MG |
Cas.: 220792-57-4 | Purity: 98% | Aminopurvalanol A (NG 97) | ESD-912211-5MG |
Cas.: 22080-10-0 | Purity: 98% | 2-Iodoamphetamine hydrochloride | ESD-912212-1MG |
Cas.: 220805-22-1 | Purity: 98% | NG,NG-dimethyl-L-Arginine hydrochloride (ADMA) | ESD-912213-5MG |
Cas.: 2208-41-5 | Purity: 98% | 6-hydroxymelatonin | ESD-912215-1MG |
Cas.: 221246-34-0 | Purity: 98% | 17-trifluoromethylphenyl trinor Prostaglandin F2α | ESD-912216-1MG |
Cas.: 22148-75-0 | Purity: 98% | N-Formylamphetamine (NSC 511083) | ESD-912217-1MG |
Cas.: 221664-05-7 | Purity: 98% | 2,3-dinor-8-iso Prostaglandin F2α | ESD-912218-50ΜG |
Cas.: 221905-35-7 | Purity: 98% | Rp-8-CPT-Cyclic AMP sodium salt (Rp-8-CPT-cAMP) | ESD-912219-500ΜG |
Cas.: 222035-13-4 | Purity: 98% | Cdk2 Inhibitor II | ESD-912220-5MG |
Cas.: 22204-89-3 | Purity: 98% | 4-hydroxy DET | ESD-912221-10MG |
Cas.: 2222132-40-1 | Purity: 98% | Cyclic di-GMP sodium salt | ESD-912222-500ΜG |
Cas.: 22235-81-0 | Purity: 98% | N-Isopropylnoratropine (NINA) | ESD-912223-5MG |
Cas.: 222412-82-0 | Purity: 98% | Atorvastatin-d5 calcium salt | ESD-912224-500ΜG |
Cas.: 222638-65-5 | Purity: 98% | ABH (Amino-2-Borono-6-Hexanoic Acid) | ESD-912225-5MG |
Cas.: 222723-55-9 | Purity: 98% | 2-Arachidonyl Glycerol ether | ESD-912226-5MG |
Cas.: 22298-29-9 | Purity: 98% | Betamethasone 17-benzoate | ESD-912227-5MG |
Cas.: 22316-55-8 | Purity: 98% | N-Desmethylclobazam (nor-Clobazam) | ESD-912228-100ΜG |
Cas.: 22348-64-7 | Purity: 98% | 22(S)-hydroxy Cholesterol (22β-hydroxy Cholesterol) | ESD-912229-5MG |
Cas.: 223507-96-8 | Purity: 98% | SOTS-1 | ESD-912230-5MG |
Cas.: 22352-82-5 | Purity: 98% | Acetyl norfentanyl hydrochloride | ESD-912231-1MG |
Cas.: 2235-97-4 | Purity: 98% | 5-(N,N-dimethyl)-Amiloride hydrochloride | ESD-912232-1MG |
Cas.: 223749-46-0 | Purity: BR | HMR 1556 | ESD-912233-5MG |
Cas.: 223769-64-0 | Purity: 98% | Hydroxystilbamidine bis(methanesulfonate) | ESD-912234-1MG |
Cas.: 22388-89-2 | Purity: 98% | Luteoreticulin (Griseulin) | ESD-912235-500ΜG |
Cas.: 22419-74-5 | Purity: 98% | Incensole | ESD-912236-1MG |
Cas.: 22431-46-5 | Purity: 98% | Clindamycin Sulfoxide | ESD-912237-500ΜG |
Cas.: 224445-12-9 | Purity: 98% | bis(7)-Tacrine (1,7-N-heptylene-bis-9,9′-amino-1,2,3,4-tetrahydro-acridine) | ESD-912238-10MG |
Cas.: 2245711-27-5 | Purity: 98% | Stearoyl-L-carnitine-d3 chloride (L-Stearoylcarnitine-d3) | ESD-912239-1MG |
Cas.: 22467-07-8 | Purity: 98% | Gymnemagenin | ESD-912240-1MG |
Cas.: 22467-31-8 | Purity: 98% | Rubratoxin A | ESD-912241-250ΜG |
Cas.: 225233-99-8 | Purity: 98% | SNVP (S-Nitroso-N-valeryl-DL-penicillamine) | ESD-912242-10MG |
Cas.: 22644-96-8 | Purity: 98% | (E)-2-Hexadecenal (trans-2-Hexadecenal) | ESD-912243-1MG |
Cas.: 226878-01-9 | Purity: 98% | NPS 2390 | ESD-912244-5MG |
Cas.: 226883-79-0 | Purity: 98% | FUB-PB-22 3-carboxyindole metabolite | ESD-912245-5MG |
Cas.: 226907-52-4 | Purity: 98% | Toll-Like Receptor 7 Ligand II | ESD-912246-1MG |
Cas.: 226956-06-5 | Purity: 98% | Unguisin A | ESD-912247-500ΜG |
Cas.: 226956-07-6 | Purity: 98% | Unguisin B | ESD-912248-500ΜG |
Cas.: 22733-60-4 | Purity: 98% | Siccanin | ESD-912249-500ΜG |
Cas.: 227449-73-2 | Purity: 98% | Syk Inhibitor II hydrochloride (Spleen Tyrosine Kinase Inhibitor II) | ESD-912250-1MG |
Cas.: 2280796-90-7 | Purity: 98% | Real Thiol | ESD-912251-1MG |
Cas.: 2280796-94-1 | Purity: 98% | RT-AM | ESD-912252-1MG |
Cas.: 22816-60-0 | Purity: 98% | MreB Perturbing Compound A22 | ESD-912253-10MG |
Cas.: 228264-19-5 | Purity: 98% | MRS2179 ammonium salt | ESD-912254-5MG |
Cas.: 22852-13-7 | Purity: 98% | N-Acetylpuromycin | ESD-912255-1MG |
Cas.: 22862-63-1 | Purity: 98% | Neoantimycin | ESD-912256-500ΜG |
Cas.: 229021-64-1 | Purity: 98% | Arachidonoyl Cyclopropylamide (ACPA) | ESD-912257-5MG |
Cas.: 22913-17-3 | Purity: 98% | CAY10568 (Santinamide) | ESD-912258-20MG |
Cas.: 22930-82-1 | Purity: 98% | 3,4-Dimethoxymethcathinone hydrochloride | ESD-912259-5MG |
Cas.: 229644-17-1 | Purity: 98% | 4-Methylumbelliferyl 6-thio-Palmitate-β-D-Glucopyranoside (Mu-6S-Palm-β-Glc) | ESD-912260-500ΜG |
Cas.: 22972-55-0 | Purity: 98% | Abnormal Cannabidiol (Abn-CBD) | ESD-912261-5MG |
Cas.: 22973-19-9 | Purity: 98% | 15-keto Prostaglandin E1 (15-keto PGE1) | ESD-912262-1MG |
Cas.: 23015-45-4 | Purity: 98% | 13,14-dihydro-15-keto-tetranor Prostaglandin F1β | ESD-912263-50ΜG |
Cas.: 23017-93-8 | Purity: 98% | (±)13-HpODE | ESD-912264-100ΜG |
Cas.: 23017-97-2 | Purity: 98% | Δ4-Dafachronic Acid (3-keto-4-Cholestenoic Acid) | ESD-912265-1MG |
Cas.: 2303-35-7 | Purity: 98% | (+)-Muscarine chloride | ESD-912266-5MG |
Cas.: 2304-81-6 | Purity: 98% | C18 Ceramide (d18:1/18:0) | ESD-912267-5MG |
Cas.: 23109-94-6 | Purity: 98% | tetranor-PGFM (tetranor-Prostaglandin F Metabolite) | ESD-912268-50ΜG |
Cas.: 23113-43-1 | Purity: 98% | Guanabenz hydrochloride (Wytensin) | ESD-912269-10MG |
Cas.: 23127-41-5 | Purity: 98% | N-Acetyl-S-allyl-L-cysteine | ESD-912270-5MG |
Cas.: 23152-29-6 | Purity: 98% | Virginiamycin S1 | ESD-912271-5MG |
Cas.: 2315-61-9 | Purity: 98% | 4-tert-Octylphenol diethoxylate (OP2EO) | ESD-912272-500ΜG |
Cas.: 231957-54-3 | Purity: 98% | MIV-150 (PC-815) | ESD-912273-1MG |
Cas.: 23205-42-7 | Purity: 98% | 3-Deazauridine (NSC 126849) | ESD-912274-5MG |
Cas.: 2321343-06-8 | Purity: 98% | RT-NH2 (Real Thiol-NH2) | ESD-912275-1MG |
Cas.: 23257-56-9 | Purity: 98% | Levophacetoperane hydrochloride | ESD-912276-1MG |
Cas.: 23292-08-2 | Purity: 98% | 4-CAB hydrochloride | ESD-912277-5MG |
Cas.: 23313-80-6 | Purity: 98% | Epitetracycline hydrochloride | ESD-912278-5MG |
Cas.: 23314-57-0 | Purity: 98% | Glycerol Triarachidonoyl | ESD-912279-5MG |
Cas.: 234075-45-7 | Purity: 98% | Phen Green SK diacetate (PGSK diacetate) | ESD-912280-1MG |
Cas.: 2341740-84-7 | Purity: 98% | BI-3663 | ESD-912281-5MG |
Cas.: 23452-98-4 | Purity: 98% | 1a,1b-dihomo Prostaglandin E1 (1a,1b-dihomo PGE1) | ESD-912282-1MG |
Cas.: 23470-00-0 | Purity: 98% | 2-Palmitoyl Glycerol | ESD-912283-5MG |
Cas.: 234772-64-6 | Purity: 98% | CGP 77675 | ESD-912284-10MG |
Cas.: 235106-62-4 | Purity: 98% | VP-14637 | ESD-912285-5MG |
Cas.: 23537-16-8 | Purity: 98% | (+)-Rugulosin | ESD-912286-1MG |
Cas.: 23554-81-6 | Purity: 98% | Lagochiline | ESD-912287-10MG |
Cas.: 23583-48-4 | Purity: 98% | 8-bromo-Cyclic AMP | ESD-912288-5MG |
Cas.: 23609-41-8 | Purity: 98% | para-Methoxyfentanyl hydrochloride | ESD-912289-100ΜG |
Cas.: 236403-25-1 | Purity: 98% | MMP-8 Inhibitor I (Matrix Metalloproteinase-8 Inhibitor I) | ESD-912290-1MG |
Cas.: 2380-27-0 | Purity: 98% | 12-oxo Stearic Acid methyl ester | ESD-912291-20MG |
Cas.: 23820-80-6 | Purity: 98% | Viridiol (NSC 658706) | ESD-912292-1MG |
Cas.: 2393-58-0 | Purity: 98% | α-Muricholic Acid | ESD-912293-1MG |
Cas.: 2393-59-1 | Purity: 98% | β-Muricholic Acid | ESD-912294-1MG |
Cas.: 2398-34-7 | Purity: 98% | 3-hydroxy Palmitic Acid | ESD-912296-50MG |
Cas.: 23986-74-5 | Purity: 98% | Germacrene D ((-)-Germacrene D) | ESD-912297-1MG |
Cas.: 24003-58-5 | Purity: 98% | QX-314 Bromide | ESD-912298-10MG |
Cas.: 24003-67-6 | Purity: 98% | Hexanoyl Glycine (NSC 224460) | ESD-912299-5MG |
Cas.: 24006-62-0 | Purity: 98% | Sphinganine (d20:0) | ESD-912300-1MG |
Cas.: 24027-80-3 | Purity: 98%, 10 mM in H2O | ddATP (2′,3′-Dideoxyadenosine 5′-triphosphate) | ESD-912301-100ΜL |
Cas.: 240405-20-3 | Purity: 98% | 2,3-dinor-11β-Prostaglandin F2α | ESD-912302-100ΜG |
Cas.: 24150-24-1 | Purity: 98% | tetramethyl Nordihydroguaiaretic Acid | ESD-912303-50MG |
Cas.: 2416-19-5 | Purity: 98% | cis-7-Hexadecenoic Acid | ESD-912304-10MG |
Cas.: 241800-97-5 | Purity: 98% | Zoniporide hydrochloride (CP 597,396) | ESD-912305-5MG |
Cas.: 24198-95-6 | Purity: 98% | Juvenile Hormone III (trans-trans-10,11-Epoxyfarnesenic Acid methyl ester) | ESD-912306-5MG |
Cas.: 24198-97-8 | Purity: 98% | (±)-Taxifolin ((±)-Dihydroquercetin) | ESD-912307-20MG |
Cas.: 2420-35-1 | Purity: 98% | 2-hydroxy Stearic Acid methyl ester | ESD-912308-10MG |
Cas.: 2420-36-2 | Purity: 98% | 3-hydroxy Stearic Acid methyl ester | ESD-912309-5MG |
Cas.: 24257-10-1 | Purity: 98% | Heneicosapentaenoic Acid (HPA) | ESD-912310-5MG |
Cas.: 2426-76-8 | Purity: 98% | 6-methoxy DiPT hydrochloride | ESD-912311-5MG |
Cas.: 2433-95-6 | Purity: 98% | 2-hydroxy Lignoceric Acid methyl ester (methyl 2-hydroxy Tetracosanoate) | ESD-912312-5MG |
Cas.: 24379-94-0 | Purity: 98% | 13,14-dihydro-15-keto-tetranor Prostaglandin F1α | ESD-912313-50ΜG |
Cas.: 2438-40-6 | Purity: 98% | 1,2,3-Triheptadecanoyl Glycerol | ESD-912314-10MG |
Cas.: 24385-10-2 | Purity: 98% | Doxorubicinone | ESD-912315-5MG |
Cas.: 24404-83-9 | Purity: 98% | Glycolithocholic Acid sodium salt | ESD-912316-5MG |
Cas.: 244101-03-9 | Purity: 98% | L-826,266 | ESD-912317-5MG |
Cas.: 2441-41-0 | Purity: 98% | N-Palmitoyl Glycine | ESD-912318-50MG |
Cas.: 2441-64-7 | Purity: 98% | Linoleoyl Phenylalanine (N-Linoleoyl Phenylalanine) | ESD-912319-5MG |
Cas.: 244192-94-7 | Purity: 98% | L-748,337 | ESD-912320-5MG |
Cas.: 244215-65-4 | Purity: 98% | C18 3′-sulfo Galactosylceramide (d18:1/18:0) | ESD-912321-1MG |
Cas.: 2442-61-7 | Purity: 98% | 1,2-Dioleoyl-rac-glycerol | ESD-912322-10MG |
Cas.: 244616-85-1 | Purity: 98% | Luotonin F | ESD-912323-1MG |
Cas.: 24465-45-0 | Purity: 98% | Normeperidine hydrochloride (Norpethidine) | ESD-912324-1MG |
Cas.: 24529-88-2 | Purity: 98% | 1,2-Dioleoyl-sn-glycerol | ESD-912325-10MG |
Cas.: 24529-89-3 | Purity: 98% | 1,2-Dilinoleoyl-sn-glycerol (1,2-Dioleoyl-sn-glycerol) | ESD-912326-5MG |
Cas.: 245329-02-6 | Purity: 98% | FSLLRY-amide | ESD-912327-1MG |
Cas.: 24558-60-9 | Purity: 98% | Sphingosine (d14:1) (D-erythro-Sphingosine C14) | ESD-912328-1MG |
Cas.: 24570-01-2 | Purity: 98% | 11β-Prostaglandin E1 | ESD-912329-1MG |
Cas.: 245744-13-2 | Purity: 98% | RWJ 52353 hydrochloride | ESD-912330-1MG |
Cas.: 24622-60-4 | Purity: 98% | 3,4-Methylenedioxy-α-Pyrrolidinobutiophenone hydrochloride (3,4-MDPBP) | ESD-912331-5MG |
Cas.: 24622-61-5 | Purity: 98% | 3,4-Methylenedioxy-α-Pyrrolidinohexanophenone hydrochloride | ESD-912332-1MG |
Cas.: 24622-62-6 | Purity: 98% | 3,4-Methylenedioxy Pyrovalerone hydrochloride (3,4-MDPV) | ESD-912333-5MG |
Cas.: 246246-19-5 | Purity: 98% | AL 8810 | ESD-912334-1MG |
Cas.: 24646-39-7 | Purity: 98% | 3,4-Methylenedioxy PV8 hydrochloride | ESD-912335-1MG |
Cas.: 24646-40-0 | Purity: 98% | 3,4-Methylenedioxy PV9 hydrochloride | ESD-912336-1MG |
Cas.: 24696-26-2 | Purity: 98% | C16 Ceramide (d18:1/16:0) | ESD-912337-5MG |
Cas.: 24698-57-5 | Purity: 98% | 3,4-Methylenedioxy-α-Pyrrolidinopropiophenone hydrochloride | ESD-912338-5MG |
Cas.: 24769-56-0 | Purity: 98% | tetranor-PGEM (tetranor-Prostaglandin E Metabolite) | ESD-912339-50ΜG |
Cas.: 247923-29-1 | Purity: 98% | GW 9578 | ESD-912340-5MG |
Cas.: 24796-94-9 | Purity: 98% | Oxazine 1 perchlorate | ESD-912341-5MG |
Cas.: 2485-71-4 | Purity: 98% | 13-methyl Myristic Acid | ESD-912342-10MG |
Cas.: 251572-86-8 | Purity: ≥95% | P32/98 hemifumarate | ESD-912343-1MG |
Cas.: 25390-17-4 | Purity: 98% | (RS)-Carbocisteine (S-(Carboxymethyl)-DL-cysteine) | ESD-912344-100MG |
Cas.: 25576-40-3 | Purity: 98% | Butyrylcarnitine | ESD-912345-5MG |
Cas.: 2601-90-3 | Purity: 98% | N-Oleoyl glycine | ESD-912346-10MG |
Cas.: 26339-90-2 | Purity: 98% | Escin IB | ESD-912347-5MG |
Cas.: 263399-35-5 | Purity: 98% | (±)12(13)-DiHOME | ESD-912348-500ΜG |
Cas.: 27570-38-3 | Purity: BR | Withanone | ESD-912349-5MG |
Cas.: 27652-34-2 | Purity: BR | 6-Thioinosine 5′-Triphosphate | ESD-912350-1MG |
Cas.: 28656-91-9 | Purity: 98% | Aeroplysinin 1 ((+)-Aeroplysinin-1) | ESD-912351-100ΜG |
Cas.: 29066-42-0 | Purity: ≥95% | Hymeglusin | ESD-912352-1MG |
Cas.: 30286-75-0 | Purity: 98% | Oxitropium (Bromide) | ESD-912353-5MG |
Cas.: 3063-05-6 | Purity: 98% | Leucyl-phenylalanine | ESD-912354-50MG |
Cas.: 31314-39-3 | Purity: 98% | Prodipine hydrochloride | ESD-912355-1MG |
Cas.: 313981-55-4 | Purity: 98% | o-3M3FBS | ESD-912356-5MG |
Cas.: 315-72-0 | Purity: ≥98% | Opipramol | ESD-912357-10MG |
Cas.: 317321-41-8 | Purity: 98% | O-1602 | ESD-912358-5MG |
Cas.: 317366-82-8 | Purity: 98% | Amyloid β Peptide (42-1)(human) (AIVVGGVMLGIIAGKNSGVDEAFFVLKQHHVEYGSDHRFEAD) | ESD-912359-1MG |
Cas.: 321351-00-2 | Purity: ≥98% | p38 MAPK Inhibitor VIII | ESD-912360-10MG |
Cas.: 331744-72-0 | Purity: 98% | Peliglitazar racemate (BMS 426707-01 racemate) | ESD-912361-5MG |
Cas.: 334827-98-4 | Purity: ≥98% | Gisadenafil besylate (UK 369003-26) | ESD-912362-1MG |
Cas.: 339177-26-3 | Purity: 98% | Panitumumab (ABX-EGF) | ESD-912363-10MG |
Cas.: 34020-33-2 | Purity: BR | 6-S-Methyl-6-thio-5′-guanylic Acid | ESD-912364-1MG |
Cas.: 34450-15-2 | Purity: 98% | N8-Acetylspermidine dihydrochloride | ESD-912365-5MG |
Cas.: 35482-50-9 | Purity: 98% | O-1821 | ESD-912366-5MG |
Cas.: 356568-70-2 | Purity: 98% | Barbadin | ESD-912367-5MG |
Cas.: 35775-49-6 | Purity: 98% | Chrysin-7-O-glucuronide | ESD-912368-5MG |
Cas.: 35906-36-6 | Purity: BR | Onjisaponin B | ESD-912369-5MG |
Cas.: 3616-04-4 | Purity: 98% | Phosphorylcholine (Phosphocholine) | ESD-912370-500MG |
Cas.: 36902-82-6 | Purity: 98% | Pargolol hydrochloride (Ko 1400 hydrochloride) | ESD-912371-5MG |
Cas.: 37300-21-3 | Purity: 98% | Pentosan Polysulfate | ESD-912372-100MG |
Cas.: 38677-66-6 | Purity: ≥95% | Oleoylcarnitine | ESD-912373-10MG |
Cas.: 3943-91-7 | Purity: 98% | ethyl 2,5-Dihydroxybenzoate | ESD-912374-100MG |
Cas.: 39552-01-7 | Purity: 98% | (±)-Befunolol | ESD-912375-1MG |
Cas.: 39685-31-9 | Purity: 98% | SKF81367 (Cefuracetime) | ESD-912376-5MG |
Cas.: 40507-78-6 | Purity: 98% | Indanazoline | ESD-912377-1MG |
Cas.: 406-90-6 | Purity: 98% | Fluroxene (2,2,2-Trifluoroethyl vinyl ether) | ESD-912378-100MG |
Cas.: 4079-26-9 | Purity: 98% | PD146176 (NSC168807) | ESD-912379-5MG |
Cas.: 408502-06-7 | Purity: 98% | KDR-in-4 | ESD-912380-5MG |
Cas.: 41680-09-5 | Purity: BR | (±)-Liquiritigenin | ESD-912381-10MG |
Cas.: 416876-71-6 | Purity: ≥98% | ortho-fluoro 4-ANBP | ESD-912382-5MG |
Cas.: 41830-80-2 | Purity: 98% | Cresyl Violet perchlorate (Oxazine 9 perchlorate) | ESD-912383-50MG |
Cas.: 427-63-4 | Purity: 98% | (+)-Geodin | ESD-912384-5MG |
Cas.: 439146-24-4 | Purity: 98% | O-Arachidonoyl Glycidol | ESD-912385-5MG |
Cas.: 443129-35-9 | Purity: 98% | O-Arachidonoyl Ethanolamine hydrochloride | ESD-912386-5MG |
Cas.: 4499-40-5 | Purity: ≥98% | Oxtriphylline (Choline theophyllinate) | ESD-912387-50MG |
Cas.: 4611-05-6 | Purity: ≥95% | Ophiobolin A | ESD-912388-1MG |
Cas.: 462-88-4 | Purity: 98% | Ureidopropionic acid | ESD-912389-100MG |
Cas.: 463-00-3 | Purity: 98% | 4-Guanidinobutanoic acid | ESD-912390-100MG |
Cas.: 472-70-8 | Purity: BR | β-Cryptoxanthin (Caricaxanthin) | ESD-912391-1MG |
Cas.: 475-54-7 | Purity: ≥70% | Oosporein (NSC 88466) | ESD-912392-1MG |
Cas.: 47739-98-0 | Purity: 98% | Clocapramine | ESD-912393-1MG |
Cas.: 4865-85-4 | Purity: 98% | Ochratoxin C (Ochratoxin A ethyl ester) | ESD-912394-1MG |
Cas.: 491-72-5 | Purity: ≥90% (mixture of isomers) | Olivetolic Acid | ESD-912395-10MG |
Cas.: 49642-07-1 | Purity: 98% | Statine | ESD-912396-10MG |
Cas.: 50-10-2 | Purity: ≥98% | Oxyphenonium bromide | ESD-912397-50MG |
Cas.: 502-55-6 | Purity: 98% | Dixanthogen | ESD-912398-50MG |
Cas.: 504435-15-8 | Purity: 98% | (±)11(12)-EpETE | ESD-912399-100ΜG |
Cas.: 5088-75-5 | Purity: 98% | Neoliquiritin | ESD-912400-5MG |
Cas.: 51321-79-0 | Purity: BR | N-phosphonacetyl-L-aspartate | ESD-912401-100MG |
Cas.: 51529-02-3 | Purity: BR | trans-(E)-Flupentixol Dihydrochloride | ESD-912402-5MG |
Cas.: 51555-87-4 | Purity: 98% | Thiodigalactoside | ESD-912403-50MG |
Cas.: 516-55-2 | Purity: 98% | Alloepipregnanolone | ESD-912404-50MG |
Cas.: 51726-83-1 | Purity: 98% | NSC 210902 | ESD-912405-5MG |
Cas.: 519170-13-9 | Purity: ≥95% | OU749 | ESD-912406-5MG |
Cas.: 52078-42-9 | Purity: 98% | 7(Z)-Tricosene | ESD-912407-5MG |
Cas.: 52087-58-8 | Purity: 98% | 19(R)-hydroxy Prostaglandin A2 (19(R)-hydroxy PGA2) | ESD-912408-100ΜG |
Cas.: 521-48-2 | Purity: 98% | Isoxanthohumol | ESD-912409-1MG |
Cas.: 52169-36-5 | Purity: 98% | Glyburide potassium salt (Glibenclamide) | ESD-912410-100MG |
Cas.: 52179-44-9 | Purity: 98% | Graphislactone A | ESD-912411-1MG |
Cas.: 52187-80-1 | Purity: 98% | Luteolin-3′,7-di-O-glucoside | ESD-912412-5MG |
Cas.: 522-53-2 | Purity: 98% | Lobaric Acid | ESD-912414-500ΜG |
Cas.: 5233-42-1 | Purity: 98% | 5-chloro Hydrochlorothiazide | ESD-912415-5MG |
Cas.: 52344-27-1 | Purity: 98% | 16-phenyl tetranor Prostaglandin E1 (16-phenyl tetranor PGE1) | ESD-912416-1MG |
Cas.: 524713-56-2 | Purity: 98% | Dextromethorphan-d3 (CRM) | ESD-912417-1MG |
Cas.: 52510-53-9 | Purity: 98% | tetranor-PGAM (tetranor-Prostaglandin A Metabolite) | ESD-912418-50ΜG |
Cas.: 52514-04-2 | Purity: 98% | N-Oleoyl Taurine | ESD-912419-1MG |
Cas.: 52589-22-7 | Purity: 98% | Prostaglandin H1 (PGH1) | ESD-912420-50ΜG |
Cas.: 52603-03-9 | Purity: 98% | 1-Hexadecyl Lysophosphatidic Acid | ESD-912421-5MG |
Cas.: 5262-39-5 | Purity: 98% | N-Oxalylglycine (NOG) | ESD-912422-10MG |
Cas.: 52694-54-9 | Purity: 98% | (S)-(+)-MT-45 hydrochloride | ESD-912423-5MG |
Cas.: 52807-12-2 | Purity: 98% | 4′-hydroxy Flurbiprofen (FPH) | ESD-912424-1MG |
Cas.: 52809-07-1 | Purity: 98% | L-Quisqualic Acid | ESD-912425-5MG |
Cas.: 528583-89-3 | Purity: 98% | 17(R)-Resolvin D4 | ESD-912426-50ΜG |
Cas.: 528583-91-7 | Purity: 98% | 17(R)-Resolvin D1 | ESD-912427-50ΜG |
Cas.: 528851-31-2 | Purity: 98% | Desethylene Ciprofloxacin hydrochloride | ESD-912428-5MG |
Cas.: 52946-22-2 | Purity: 98% | D,L-1′-Acetoxychavicol Acetate | ESD-912429-5MG |
Cas.: 529-69-1 | Purity: 98% | Isoxanthopterin | ESD-912430-5MG |
Cas.: 52994-23-7 | Purity: 98% | Butyryl fentanyl carboxy metabolite | ESD-912431-1MG |
Cas.: 53101-49-8 | Purity: 98% | (R)-Trolox | ESD-912432-50MG |
Cas.: 53110-06-8 | Purity: 98% | ent-Corey PG-Lactone Diol | ESD-912433-1MG |
Cas.: 531-46-4 | Purity: 98% | ML-090 | ESD-912434-10MG |
Cas.: 53154-12-4 | Purity: 98% | 6β-Naloxol (CRM) | ESD-912435-5MG |
Cas.: 53213-82-4 | Purity: 98% | 3,3′-Dihexyloxacarbocyanine iodide (DiOC6(3) iodide) | ESD-912436-50MG |
Cas.: 53268-33-0 | Purity: 98% | 2-amino Pyridyl-5-thioamide | ESD-912437-100MG |
Cas.: 533-10-8 | Purity: 98% | Homarylamine hydrochloride | ESD-912438-1MG |
Cas.: 53319-30-5 | Purity: 98% | 8-iso-16-cyclohexyl-tetranor Prostaglandin E2 (8-iso-16-cyclohexyl-tetranor PGE2) | ESD-912439-1MG |
Cas.: 533884-09-2 | Purity: 98% | Erteberel (LY500307) | ESD-912440-1MG |
Cas.: 534-64-5 | Purity: 98% | Pyrithiamine hydrobromide | ESD-912441-1MG |
Cas.: 53464-72-5 | Purity: 98% | TMB 8 hydrochloride | ESD-912442-10MG |
Cas.: 53467-23-5 | Purity: 98% | (3S)-hydroxy Quinidine | ESD-912443-1MG |
Cas.: 53495-21-9 | Purity: 98% | (3β,20E)-24-Norcola-5,20(22)-diene-3,23-diol | ESD-912444-1MG |
Cas.: 5352-63-6 | Purity: 98% | Digoxigenin Monodigitoxoside | ESD-912445-1MG |
Cas.: 536-08-3 | Purity: 95% | Digallic acid | ESD-912446-1MG |
Cas.: 536-13-0 | Purity: 98% | Galactosylcerebrosides (non-hydroxy) | ESD-912447-5MG |
Cas.: 53632-92-1 | Purity: 98% | Thiopropamine hydrochloride | ESD-912448-5MG |
Cas.: 53643-13-3 | Purity: 98% | 4-Methylumbelliferyl-β-DN,N’,N”-Triacetylchitotrioside (MUF-triNAG) | ESD-912449-5MG |
Cas.: 53658-98-3 | Purity: 98% | 11-deoxy-16,16-dimethyl Prostaglandin E2 (11-deoxy-16,16-dimethyl PGE2) | ESD-912450-10MG |
Cas.: 536697-79-7 | Purity: 98% | O-1918 | ESD-912451-5MG |
Cas.: 536745-81-0 | Purity: 98% | C17 Globotriaosylceramide (d18:1/17:0) | ESD-912452-500ΜG |
Cas.: 536745-84-3 | Purity: 98% | C23 Globotriaosylceramide (d18:1/23:0) | ESD-912453-500ΜG |
Cas.: 537-09-7 | Purity: 98% | Evernic Acid (NSC 81164) | ESD-912454-10MG |
Cas.: 537-12-2 | Purity: 98% | Diperodon hydrochloride | ESD-912455-100MG |
Cas.: 53755-02-5 | Purity: 98% | trans-Clovamide | ESD-912456-5MG |
Cas.: 53760-20-6 | Purity: 98% | Cytochalasin J | ESD-912457-5MG |
Cas.: 53764-90-2 | Purity: 98% | Prostaglandin F2α isopropyl ester | ESD-912458-1MG |
Cas.: 537695-15-1 | Purity: 98% | 15-deoxy-Δ12,14-Prostaglandin J2 Glutathione (15-deoxy-Δ12,14-PGJ2 Glutathione) | ESD-912459-50ΜG |
Cas.: 53832-58-9 | Purity: 98% | Pentadecanoyl Ethanolamide | ESD-912460-10MG |
Cas.: 53832-59-0 | Purity: 98% | Heptadecanoyl Ethanolamide | ESD-912461-50MG |
Cas.: 53866-32-3 | Purity: 98% | Estriol-d2 | ESD-912462-500ΜG |
Cas.: 5393-81-7 | Purity: 98% | 2-hydroxy Decanoic Acid | ESD-912463-100MG |
Cas.: 540-12-5 | Purity: 98% | Ricinelaidic Acid | ESD-912464-100MG |
Cas.: 54130-36-8 | Purity: 98% | Prostaglandin F2α ethyl amide | ESD-912466-5MG |
Cas.: 54135-60-3 | Purity: 98% | M50054 | ESD-912467-1MG |
Cas.: 5415-44-1 | Purity: 98% | 1,3,7-Trimethyluric Acid | ESD-912468-10MG |
Cas.: 54164-50-0 | Purity: 98% | C24:1 Ceramide (d18:1/24:1(15Z)) | ESD-912469-5MG |
Cas.: 54232-59-6 | Purity: 98% | 9-OxoODE (9-KODE) | ESD-912470-50ΜG |
Cas.: 542-42-7 | Purity: 98% | Palmitate (calcium salt) (Calcium palmitate) | ESD-912472-100MG |
Cas.: 54276-22-1 | Purity: 98% | (+)-15-epi Cloprostenol | ESD-912473-5MG |
Cas.: 54276-24-3 | Purity: 98% | 15(S)-Fluprostenol | ESD-912474-5MG |
Cas.: 54280-71-6 | Purity: 98% | Nemadipine A | ESD-912475-5MG |
Cas.: 5429-85-6 | Purity: ≥95% | Oleyl Anilide (Oleic Acid Anilide) | ESD-912476-5MG |
Cas.: 54-30-8 | Purity: 98% | Camylofine | ESD-912477-1G |
Cas.: 543-18-0 | Purity: 98% | Guanidinoethyl sulfonate | ESD-912478-100MG |
Cas.: 543-21-5 | Purity: 98% | Cellocidin | ESD-912479-5MG |
Cas.: 54336-69-5 | Purity: 98% | C18 Sphingomyelin (d18:1/18:0) | ESD-912480-5MG |
Cas.: 54377-02-5 | Purity: 98% | Octanoyl-L-carnitine chloride (L-Octanoylcarnitine chloride) | ESD-912481-5MG |
Cas.: 54382-74-0 | Purity: 98% | 16-phenoxy tetranor Prostaglandin E2 (16-phenoxy tetranor PGE2) | ESD-912482-5MG |
Cas.: 54397-84-1 | Purity: 98% | 12(S)-HHTrE (12(S)-HHT) | ESD-912483-50ΜG |
Cas.: 54432-43-8 | Purity: 98% | 3-methoxy Prostaglandin F1α (3-methoxy PGF1α) | ESD-912484-5MG |
Cas.: 544-57-0 | Purity: 98% | 2-hydroxy Lignoceric Acid (Cerebronic Acid) | ESD-912485-5MG |
Cas.: 544686-21-7 | Purity: 98% | Celecoxib-d7 | ESD-912487-1MG |
Cas.: 544-70-7 | Purity: 98% | 9(Z),11(Z)-Conjugated Linoleic Acid | ESD-912488-5MG |
Cas.: 544707-20-2 | Purity: 98% | JNJ-10181457 hydrochloride | ESD-912489-1MG |
Cas.: 544-71-8 | Purity: 98% | 9(E),11(E)-Conjugated Linoleic Acid | ESD-912490-10MG |
Cas.: 54472-66-1 | Purity: 98% | Somatostatin-14 (acetate) | ESD-912491-5MG |
Cas.: 544-73-0 | Purity: 98% | 9(E),11(E),13(E)-Octadecatrienoic Acid | ESD-912493-5MG |
Cas.: 54483-31-7 | Purity: 98% | ent-Prostaglandin F2α | ESD-912494-100ΜG |
Cas.: 5450-40-8 | Purity: 98% | N-(2-hydroxyethyl)-Naphthalimide | ESD-912495-100MG |
Cas.: 545-84-6 | Purity: 98% | ()-Voacangarine | ESD-912496-1MG |
Cas.: 546102-60-7 | Purity: 98% | Cdk4 Inhibitor (Cyclin-dependent kinase 4 Inhibitor) | ESD-912497-1MG |
Cas.: 54642-23-8 | Purity: 98% | SP 600125, negative control (JNK Inhibitor II, negative control) | ESD-912498-1MG |
Cas.: 54651-05-7 | Purity: 98% | Echinocandin B | ESD-912499-1MG |
Cas.: 546-80-5 | Purity: 96% | α-Thujone | ESD-912500-100MG |
Cas.: 54687-43-3 | Purity: 98% | 2,5-DMMA (2,5-Dimethoxymethamphetamine) | ESD-912501-5MG |
Cas.: 54739-30-9 | Purity: 98% | 13-OxoODE (13-KODE) | ESD-912502-50ΜG |
Cas.: 54802-19-6 | Purity: 98% | 5,6,7,8-tetrahydro-2-Quinolone (NSC 99006) | ESD-912503-100MG |
Cas.: 54-80-8 | Purity: 98% | Pronethalo (()-Pronethalo) | ESD-912504-10MG |
Cas.: 54845-95-3 | Purity: 98% | 15(S)-HETE MaxSpec Standard | ESD-912505-100ΜG |
Cas.: 54848-30-5 | Purity: 98% | Protogracillin | ESD-912506-5MG |
Cas.: 5487-50-3 | Purity: 98% | 13-methyl Pentadecanoic Acid methyl ester (Methyl 13-methyl Pentadecanoate Acid) | ESD-912507-5MG |
Cas.: 548756-68-9 | Purity: 98% | PD 334581 | ESD-912508-1MG |
Cas.: 54886-50-9 | Purity: 98% | 11(S)-HETE | ESD-912509-50ΜG |
Cas.: 549-23-5 | Purity: 98% | Sclerotiorin | ESD-912510-500ΜG |
Cas.: 54934-75-7 | Purity: 98% | 6β-Oxymorphol (14-Hydroxydihydroisomorphine) | ESD-912511-1MG |
Cas.: 54982-43-3 | Purity: 98% | 3-Fluoroethamphetamine hydrochloride | ESD-912512-1MG |
Cas.: 55028-70-1 | Purity: 98% | 15(R)-15-methyl Prostaglandin E2 | ESD-912513-1MG |
Cas.: 5502-91-0 | Purity: 98% | (±)9-HpODE | ESD-912514-100ΜG |
Cas.: 5502-94-3 | Purity: 98% | 12-methyl Myristic Acid ((±)-12-methyl Tetradecanoic Acid) | ESD-912515-1MG |
Cas.: 55124-97-5 | Purity: 98% | 17-methyl Stearic Acid methyl ester (Methyl 17-methyl Octadecanoate Acid) | ESD-912516-1MG |
Cas.: 55224-94-7 | Purity: 98% | AP-18 | ESD-912517-5MG |
Cas.: 552830-51-0 | Purity: 98% | Resolvin E1 (RvE1) | ESD-912518-50ΜG |
Cas.: 5537-19-9 | Purity: 98% | 4-methoxy-α-Pyrrolidinopentiophenone hydrochloride | ESD-912519-5MG |
Cas.: 5543-57-7 | Purity: 98% | (-)-Warfarin | ESD-912520-5MG |
Cas.: 5543-58-8 | Purity: 98% | (+)-Warfarin | ESD-912521-5MG |
Cas.: 5556-74-1 | Purity: 98% | 2,3,5-Trimethoxyamphetamine hydrochloride | ESD-912522-1MG |
Cas.: 55623-37-5 | Purity: ≥70% | Oxaline | ESD-912523-1MG |
Cas.: 55659-75-1 | Purity: 98% | Deltonin | ESD-912524-5MG |
Cas.: 55682-83-2 | Purity: 98% | 3-hydroxy Myristic Acid methyl ester | ESD-912525-10MG |
Cas.: 55720-48-4 | Purity: 98% | 6α-hydroxy Methandienone (6α-hydroxy Methandrostenolone) | ESD-912526-5MG |
Cas.: 55729-17-4 | Purity: 98% | Flambalactone | ESD-912527-1MG |
Cas.: 557794-38-4 | Purity: 98% | Dapsone-d8 | ESD-912528-5MG |
Cas.: 55824-09-4 | Purity: 98% | (±)-Cannabichromeorcin (CRM) (CBCO) | ESD-912529-1MG |
Cas.: 55824-11-8 | Purity: 98% | Cannabigerovarin (CBGV) | ESD-912530-1MG |
Cas.: 55879-47-5 | Purity: 98% | 6β-hydroxy Dexamethasone | ESD-912531-1MG |
Cas.: 5591-45-7 | Purity: 98% | Thiothixene | ESD-912532-1MG |
Cas.: 55968-21-3 | Purity: 98% | Dihomo-γ-Linolenic Acid ethyl ester (Ethyl DGLA) | ESD-912533-50MG |
Cas.: 5598-37-8 | Purity: 98% | (±)11-HEDE | ESD-912534-100ΜG |
Cas.: 56009-40-6 | Purity: 98% | 2-hydroxy Myristic Acid methyl ester | ESD-912535-50MG |
Cas.: 5601-74-1 | Purity: ≥95% | Ophiobolin B | ESD-912536-1MG |
Cas.: 561-63-7 | Purity: 98% | 19-hydroxy Cholesterol | ESD-912537-5MG |
Cas.: 56165-93-6 | Purity: 98% | Alamethicin F50 (18-L-Glutamine Alamethicin I) | ESD-912538-1MG |
Cas.: 56219-06-8 | Purity: 98% | Myristoleic Acid methyl ester | ESD-912539-50MG |
Cas.: 56279-49-3 | Purity: 98% | 2-chloro Stearic Acid (α-Chlorostearic acid) | ESD-912541-5MG |
Cas.: 56341-08-3 | Purity: 98% | Mabuterol | ESD-912543-5MG |
Cas.: 56421-62-6 | Purity: 98% | ethyl 4-methyl-2-(2-thienyl)-thiazole-5 Carboxylate | ESD-912544-100MG |
Cas.: 564-35-2 | Purity: 98% | 11-keto Testosterone (CRM) | ESD-912545-1MG |
Cas.: 565-20-8 | Purity: 98% | N-acetyl Dapsone (NSC 27184) | ESD-912547-5MG |
Cas.: 565453-41-0 | Purity: 98% | Vildagliptin carboxylic acid metabolite trifluoroacetate salt(TFA) | ESD-912548-1MG |
Cas.: 566-27-8 | Purity: 98% | 7β-hydroxy Cholesterol | ESD-912549-1MG |
Cas.: 56651-43-5 | Purity: 98% | 3-trifluoromethyl-N-Methylamphetamine hydrochloride | ESD-912550-5MG |
Cas.: 566-76-7 | Purity: 98% | 16α-hydroxy Estrone (16α-OHE1) | ESD-912551-5MG |
Cas.: 56687-85-5 | Purity: 98% | (+)-Cloprostenol methyl ester | ESD-912552-1MG |
Cas.: 566914-00-9 | Purity: 98% | IL-1R Antagonist | ESD-912553-5MG |
Cas.: 56845-83-1 | Purity: 98% | 25(S)-27-hydroxy Cholesterol ((25S)-26-hydroxy cholesterol) | ESD-912554-5MG |
Cas.: 56-88-2 | Purity: 98% | L-Cystathionine | ESD-912555-5MG |
Cas.: 5688-80-2 | Purity: 98% | 3,4,5-Trimethoxyamphetamine hydrochloride | ESD-912556-10MG |
Cas.: 569371-10-4 | Purity: 98% | UBP 301 | ESD-912557-5MG |
Cas.: 56985-32-1 | Purity: 98% | U-44069 | ESD-912558-1MG |
Cas.: 56985-40-1 | Purity: 98% | U-46619 | ESD-912559-1MG |
Cas.: 57010-32-9 | Purity: 98% | Tiapamil hydrochloride (Ro 11-1781) | ESD-912560-5MG |
Cas.: 57072-35-2 | Purity: 98% | 4-Nitrophenyl Phenylphosphonate | ESD-912561-100MG |
Cas.: 5707-55-1 | Purity: 98% | DOPAL | ESD-912562-10MG |
Cas.: 57086-93-8 | Purity: 98% | α-Linolenoyl Ethanolamide (N-Linolenoyl Ethanolamine) | ESD-912563-10MG |
Cas.: 57092-52-1 | Purity: 98% | Z-Phe-Phe-Phe-OH | ESD-912564-100MG |
Cas.: 5714-00-1 | Purity: 98% | Acetophenazine dimaleate | ESD-912565-100MG |
Cas.: 572-03-2 | Purity: 98% | Pomiferin | ESD-912566-5MG |
Cas.: 573951-20-9 | Purity: 98% | 15-deoxy-Δ12,14-Prostaglandin A1 (15-deoxy-Δ12,14-PGA1) | ESD-912567-1MG |
Cas.: 57460-41-0 | Purity: 98% | (±)-Talinolol | ESD-912568-5MG |
Cas.: 574-64-1 | Purity: 98% | Trypan red (CI 22850) | ESD-912569-5MG |
Cas.: 574738-16-2 | Purity: 98% | C2 Adamantanyl Galactosylceramide (d18:1/2:0) | ESD-912570-5MG |
Cas.: 57649-10-2 | Purity: 98% | Kanosamine hydrochloride | ESD-912571-1MG |
Cas.: 57664-96-7 | Purity: 98% | Noroxycodone | ESD-912572-1MG |
Cas.: 57704-16-2 | Purity: 98% | 1′-hydroxy Bufuralol (Ro 03-7410) | ESD-912573-1MG |
Cas.: 57710-57-3 | Purity: 98% | Heptelidic Acid | ESD-912574-1MG |
Cas.: 57749-43-6 | Purity: 98% | Equisetin | ESD-912575-1MG |
Cas.: 577-64-0 | Purity: 98% | Asterric Acid | ESD-912576-1MG |
Cas.: 577779-57-8 | Purity: 98% | 4,5,6,7-Tetrabromobenzimidazole | ESD-912577-10MG |
Cas.: 57790-52-0 | Purity: 98% | Prostaglandin E2 p-acetamidophenyl ester (PGE2 p-acetamidophenyl ester) | ESD-912578-1MG |
Cas.: 57790-53-1 | Purity: 98% | Prostaglandin E2 p-benzamidophenyl ester (PGE2 p-benzamidophenyl ester) | ESD-912579-1MG |
Cas.: 578008-43-2 | Purity: 98% | Resolvin D5 | ESD-912580-50ΜG |
Cas.: 57818-36-7 | Purity: 98% | Furan Fatty Acid F6 | ESD-912581-1MG |
Cas.: 57818-37-8 | Purity: 98% | Furan Fatty Acid F5 (12,15-Epoxy-13-methyleicosa-12,14-dienoic Acid) | ESD-912582-1MG |
Cas.: 57818-44-7 | Purity: 98% | α-Hydroxylinoleic acid | ESD-912583-5MG |
Cas.: 57930-92-4 | Purity: 98% | 20-hydroxy Prostaglandin F2α (20-hydroxy PGF2α) | ESD-912584-100ΜG |
Cas.: 57930-95-7 | Purity: 98% | 20-hydroxy Prostaglandin E2 (20-hydroxy PGE2) | ESD-912585-100ΜG |
Cas.: 57944-39-5 | Purity: 98% | 1a,1b-dihomo Prostaglandin F2α (1a,1b-dihomo PGF2α) | ESD-912586-1MG |
Cas.: 57968-81-7 | Purity: 98% | (+)-5-trans Cloprostenol | ESD-912587-5MG |
Cas.: 57968-83-9 | Purity: 98% | 5-trans Fluprostenol (5,6-trans Fluprostenol) | ESD-912588-1MG |
Cas.: 58053-83-1 | Purity: 98% | 17β-hydroxy Wortmannin | ESD-912589-1MG |
Cas.: 58068-85-2 | Purity: 98% | DMABA NHS ester | ESD-912590-100MG |
Cas.: 581098-48-8 | Purity: 98% | (S)-p38 MAPK Inhibitor III | ESD-912591-500ΜG |
Cas.: 582314-48-5 | Purity: 98% | CAY10443 ((S)-Indan-1-yl 3,4-dichlorobenzylcarbamate) | ESD-912592-5MG |
Cas.: 582-46-7 | Purity: 98% | Terrein (NSC 291308) | ESD-912593-1MG |
Cas.: 58331-17-2 | Purity: 98% | Narasin sodium salt | ESD-912594-5MG |
Cas.: 5839-61-2 | Purity: 98% | Deoxyviolacein | ESD-912595-1MG |
Cas.: 58399-46-5 | Purity: 98% | N-(3-ethylindole) Norfentanyl | ESD-912596-1MG |
Cas.: 58400-88-7 | Purity: 98% | 4-Bromoamphetamine hydrochloride | ESD-912597-5MG |
Cas.: 58493-49-5 | Purity: ≥98% | Olvanil (NE 19550) | ESD-912598-10MG |
Cas.: 58688-54-3 | Purity: 98% | 5,6-dehydro Arachidonic Acid (5,6-dehydro AA) | ESD-912599-50ΜG |
Cas.: 58717-36-5 | Purity: 98% | 11β-Misoprostol | ESD-912600-1MG |
Cas.: 58735-64-1 | Purity: 98% | Roquefortine C (NSC 292134) | ESD-912601-1MG |
Cas.: 58798-97-3 | Purity: 98% | Berninamycin A | ESD-912602-1MG |
Cas.: 58801-34-6 | Purity: 98% | Calcium Ionophore I | ESD-912603-5MG |
Cas.: 58917-25-2 | Purity: 98% | (R)-γ-Valerolactone | ESD-912604-100MG |
Cas.: 58940-28-6 | Purity: 98% | ()-6α-hydroxy Cannabidiol | ESD-912605-5MG |
Cas.: 58944-73-3 | Purity: 98% | Sinefungin | ESD-912606-1MG |
Cas.: 58976-50-4 | Purity: 98% | 17-phenyl trinor Prostaglandin F2α-d4 | ESD-912607-50ΜG |
Cas.: 59108-90-6 | Purity: 98% | Indole-3-thio Carboxamide | ESD-912608-100MG |
Cas.: 59165-34-3 | Purity: 98% | Actagadin | ESD-912609-1MG |
Cas.: 5918-29-6 | Purity: 98% | 14-methyl Palmitic Acid | ESD-912610-1MG |
Cas.: 59247-13-1 | Purity: 98% | Ganglioside GT1b Mixture sodium salt (Ganglioside G1 Mixture) | ESD-912611-1MG |
Cas.: 592-95-0 | Purity: 98% | L-Sulforaphene | ESD-912612-5MG |
Cas.: 593-40-8 | Purity: 98% | trans-Petroselinic Acid | ESD-912613-5MG |
Cas.: 5939-37-7 | Purity: 98% | 7-hydroxy Methotrexate | ESD-912615-1MG |
Cas.: 59468-90-5 | Purity: ≥95% | 1′-hydroxy Midazolam (Ro 21-6347) | ESD-912616-1MG |
Cas.: 59474-01-0 | Purity: 98% | NSC 146109 hydrochloride (XI-011) | ESD-912617-5MG |
Cas.: 59491-62-2 | Purity: 98% | 1-Oleoyl-2-palmitoyl-sn-glycero-3-PC | ESD-912618-5MG |
Cas.: 59556-17-1 | Purity: 98% | Gabaculine hydrochloride | ESD-912619-1MG |
Cas.: 596108-59-7 | Purity: 98% | Aminopeptidase N Inhibitor (AP-N Inhibitor) | ESD-912620-1MG |
Cas.: 5963-14-4 | Purity: 98% | 8-methyl Nonanoic Acid (Isocapric Acid) | ESD-912621-50MG |
Cas.: 59-63-2 | Purity: 98% | Isocarboxazid | ESD-912622-5MG |
Cas.: 5966-29-0 | Purity: 98% | C16 dihydro Ceramide (d18:0/16:0) | ESD-912623-1MG |
Cas.: 59678-46-5 | Purity: 98% | Enterocin (Vulgamycin) | ESD-912624-1MG |
Cas.: 5969-39-1 | Purity: 98% | N-methyl-2-Phenylpropan-1-amine hydrochloride | ESD-912625-1MG |
Cas.: 596-94-1 | Purity: ≥95% | Oxy-16 | ESD-912626-1MG |
Cas.: 5975-78-0 | Purity: 98% | Zearalanone | ESD-912627-1MG |
Cas.: 59769-89-0 | Purity: 98% | 16,16-dimethyl Prostaglandin F2β | ESD-912628-1MG |
Cas.: 5984-59-8 | Purity: 98% | 2-Amino-6-methylheptane hydrochloride | ESD-912629-1G |
Cas.: 59865-16-6 | Purity: 98% | Isocyclosporin A | ESD-912630-1MG |
Cas.: 59894-05-2 | Purity: 98% | 15(R)-Prostaglandin D2 (15(R)-PGD2) | ESD-912631-1MG |
Cas.: 59894-07-4 | Purity: 98% | 13,14-dihydro-15-keto Prostaglandin D2 | ESD-912632-100ΜG |
Cas.: 599150-20-6 | Purity: 98% | HPI-1 | ESD-912633-5MG |
Cas.: 599151-35-6 | Purity: 98% | FQI 1 | ESD-912634-5MG |
Cas.: 59926-78-2 | Purity: 98% | Malformin C (Malformin B1b) | ESD-912635-1MG |
Cas.: 60124-17-6 | Purity: 98% | 12-Deoxywithastramonolide | ESD-912636-1MG |
Cas.: 6014-30-8 | Purity: 98% | Methyldopate (α-Methyldopa ethyl ester) | ESD-912637-1MG |
Cas.: 60189-34-6 | Purity: 98% | Cosyntropin (acetate) | ESD-912638-1MG |
Cas.: 60203-57-8 | Purity: 98% | Prostaglandin J2 (PGJ2) | ESD-912639-1MG |
Cas.: 602-06-2 | Purity: 98% | Skyrin | ESD-912640-1MG |
Cas.: 60218-41-9 | Purity: 98% | (E,Z)-2-propyl-2-Pentenoic Acid | ESD-912641-1MG |
Cas.: 60232-85-1 | Purity: 98% | 1-(1-Phenylcyclohexyl)-4-hydroxypiperidine | ESD-912642-1MG |
Cas.: 6026-65-9 | Purity: 98% | Anhydroophiobolin A | ESD-912643-1MG |
Cas.: 60320-05-0 | Purity: 98% | Cholic Acid 7-sulfate | ESD-912644-1MG |
Cas.: 60325-46-4 | Purity: 98% | Sulprostone | ESD-912645-1MG |
Cas.: 6036-75-5 | Purity: 98% | L-erythro Sphingosine (d18:1) | ESD-912646-1MG |
Cas.: 6036-76-6 | Purity: 98% | L-erythro Sphinganine (d18:0) | ESD-912647-1MG |
Cas.: 6036-86-8 | Purity: 98% | D-threo Sphinganine (d18:0) | ESD-912648-1MG |
Cas.: 6042-32-6 | Purity: 98% | Taurolithocholic Acid sodium salt (NSC 681057) | ESD-912649-5MG |
Cas.: 60477-38-5 | Purity: 98% | p-nitro-Cyclic Pifithrin-α | ESD-912650-5MG |
Cas.: 6049-57-6 | Purity: 98% | Ethylmalonyl Coenzyme A (Ethylmalonyl-CoA) | ESD-912651-1MG |
Cas.: 60514-49-0 | Purity: 98% | 1,2-Didecanoyl-sn-glycerol | ESD-912652-50MG |
Cas.: 60562-16-5 | Purity: 98% | 1,2-Dimyristoyl-sn-glycerol (1,2-DMG) | ESD-912653-100MG |
Cas.: 606139-26-8 | Purity: 98% | Epicoccamide | ESD-912654-1MG |
Cas.: 607351-44-0 | Purity: 98% | Latanoprost ethyl amide (Lat-NEt) | ESD-912655-1MG |
Cas.: 60756-74-3 | Purity: 98% | 1,2,3-Tri-γ-Linolenoyl Glycerol | ESD-912656-5MG |
Cas.: 60761-51-5 | Purity: 98% | (3R)-hydroxy Quinidine (3-epi-hydroxy Quinidine) | ESD-912657-1MG |
Cas.: 614-05-1 | Purity: ≥95% | Oxythiamine chloride hydrochloride | ESD-912658-500MG |
Cas.: 61443-78-5 | Purity: BR | 8-Hydroxy Amoxapine (8-Hydroxyamoxapin) | ESD-912659-10MG |
Cas.: 6152-57-4 | Purity: BR | O-Methylviridicatin (AIDS-089094) | ESD-912660-1MG |
Cas.: 616884-62-9 | Purity: ≥98% | OMDM-1 ((S)-N-oleoyl Tyrosinol) | ESD-912661-10MG |
Cas.: 6205-08-9 | Purity: 98% | N-Acetylornithine | ESD-912662-50MG |
Cas.: 62229-50-9 | Purity: BR | Epidermal Growth Factor (from mouse) | ESD-912663-100ΜG |
Cas.: 62253-63-8 | Purity: 95% | rhEGF | ESD-912664-1MG |
Cas.: 62561-03-9 | Purity: 98% | (+)-Cloprostenol sodium salt | ESD-912665-5MG |
Cas.: 62572-94-5 | Purity: 98% | O-Desmethyl Metoprolol | ESD-912666-1MG |
Cas.: 6336-34-1 | Purity: ≥95% | OUL35 | ESD-912667-10MG |
Cas.: 63368-54-7 | Purity: 98% | 5-IAF (5-Iodoacetamidofluorescein) | ESD-912668-5MG |
Cas.: 640-03-9 | Purity: 95% | Antheraxanthin | ESD-912669-1MG |
Cas.: 64118-36-1 | Purity: 98% | Octanoic Acid-d2 (Caprylic Acid-d2) | ESD-912670-5MG |
Cas.: 6452-73-9 | Purity: ≥98% | Oxprenolol hydrochloride | ESD-912671-1MG |
Cas.: 64664-99-9 | Purity: 98% | CUG (3-Carboxyumbelliferyl-β-D-galactopyranoside) | ESD-912672-5MG |
Cas.: 654059-21-9 | Purity: 98% | HSL inhibitor 2 | ESD-912673-5MG |
Cas.: 674-38-4 | Purity: 98% | Bethanechol (Carbamyl-β-methylcholine) | ESD-912674-1G |
Cas.: 69567-10-8 | Purity: 98% | N-Methylmoranoline | ESD-912675-1MG |
Cas.: 7021-52-5 | Purity: BR | 6-Methylthiopurine Ribonucleotide | ESD-912676-5MG |
Cas.: 71116-82-0 | Purity: 98% | Tiaprost (Iliren) | ESD-912677-1MG |
Cas.: 7182-77-6 | Purity: 97% | Sodium glucuronate | ESD-912678-100MG |
Cas.: 7240-37-1 | Purity: 98% | 7-Aminoactinomycin D (7-AAD) | ESD-912680-1MG |
Cas.: 72803-02-2 | Purity: 98% | Darodipine | ESD-912681-1MG |
Cas.: 72809-08-6 | Purity: ≥98% | Oleoyl Serinol | ESD-912682-10MG |
Cas.: 72877-50-0 | Purity: 98% | (-)-Neplanocin A | ESD-912683-1MG |
Cas.: 73033-09-7 | Purity: 98% | 10Z-Nonadecenoic acid | ESD-912684-10MG |
Cas.: 73340-41-7 | Purity: BR | Methylnissolin (Astrapterocarpan) | ESD-912685-10MG |
Cas.: 73804-65-6 | Purity: 98% | (±)11-HETE | ESD-912686-100ΜG |
Cas.: 73913-63-0 | Purity: ≥95% | O-Phospho-D-Serine | ESD-912688-100MG |
Cas.: 7400-11-5 | Purity: 98% | (+)-Lupanine perchlorate | ESD-912689-5MG |
Cas.: 745055-91-8 | Purity: 98% | UBP 302 | ESD-912690-5MG |
Cas.: 75166-67-5 | Purity: 98% | Nosantine racemate (NPT-15392 racemate) | ESD-912691-5MG |
Cas.: 76421-73-3 | Purity: 98% | Monochlorobimane (Chlorobimane) | ESD-912692-5MG |
Cas.: 76666-32-5 | Purity: 98% | 3′-Methoxyflavonol | ESD-912693-50MG |
Cas.: 7681-14-3 | Purity: 98% | Prednisolone Tebutate | ESD-912694-5MG |
Cas.: 779333-58-3 | Purity: ≥95% | Oleoyl 3-carbacyclic Phosphatidic Acid | ESD-912695-1MG |
Cas.: 78994-23-7 | Purity: BR | L-Centchroman | ESD-912696-2MG |
Cas.: 799764-07-1 | Purity: 98% | PKCζ Pseudosubstrate Inhibitor (Protein Kinase Cζ Pseudosubstrate Inhibitor) | ESD-912697-1MG |
Cas.: 80115-95-3 | Purity: 98% | N-acetyl Leukotriene E4 (N-acetyl LTE4) | ESD-912698-50ΜG |
Cas.: 8011-61-8 | Purity: 98% | Tyrocidine Complex | ESD-912699-5MG |
Cas.: 80210-62-4 | Purity: 98% | Cefpodoxime (R 3763) | ESD-912701-10MG |
Cas.: 802-31-3 | Purity: 98% | Prostaglandin E3 (PGE3) | ESD-912702-50ΜG |
Cas.: 80234-65-7 | Purity: 98% | 8(S), 15(S)-DiHETE | ESD-912703-50ΜG |
Cas.: 80368-68-9 | Purity: 98% | (+)-Epoxysuberosin | ESD-912704-1MG |
Cas.: 80434-82-8 | Purity: 98% | 20-carboxy Leukotriene B4 (20-carboxy LTB4) | ESD-912705-50ΜG |
Cas.: 80445-66-5 | Purity: 98% | Leukotriene B5 (LTB5) | ESD-912706-50ΜG |
Cas.: 80469-10-9 | Purity: 98% | Polymyxin B1 Isoleucine | ESD-912707-1MG |
Cas.: 80489-90-3 | Purity: 98% | Amorfrutin A (Amorfrutin 1) | ESD-912708-500ΜG |
Cas.: 80529-93-7 | Purity: 98% | Gadopentetic acid | ESD-912709-100MG |
Cas.: 80532-66-7 | Purity: 98% | BMK methyl glycidate | ESD-912710-5MG |
Cas.: 80651-65-6 | Purity: 98% | 17β-Hydroxy-androstano | ESD-912711-5MG |
Cas.: 8068-28-8 | Purity: 98% | Colistin Methanesulfonate sodium salt | ESD-912712-50MG |
Cas.: 80731-10-8 | Purity: 98% | D-()-3-Phosphoglyceric Acid sodium salt | ESD-912713-5MG |
Cas.: 807370-75-8 | Purity: 98% | N-Lignoceroyl Taurine | ESD-912714-5MG |
Cas.: 80749-33-3 | Purity: 98% | 1′-Naphthoyl-2-methylindole | ESD-912715-5MG |
Cas.: 80938-69-8 | Purity: 98% | DL-threo-PDMP hydrochloride | ESD-912716-5MG |
Cas.: 810668-37-2 | Purity: 98% | Resolvin D2 | ESD-912717-50ΜG |
Cas.: 810668-53-2 | Purity: 98% | Resolvin D2 methyl ester | ESD-912718-50ΜG |
Cas.: 81187-21-5 | Purity: 98% | (±)12-HEPE | ESD-912719-50ΜG |
Cas.: 81202-36-0 | Purity: ≥98% | Choerospondin | ESD-912720-10MG |
Cas.: 81213-52-7 | Purity: 98% | MTSSL | ESD-912721-5MG |
Cas.: 81371-59-7 | Purity: 98% | 19(R)-hydroxy Prostaglandin F1α (19(R)-hydroxy PGF1α) | ESD-912722-100ΜG |
Cas.: 81416-72-0 | Purity: 98% | 15-OxoETE (15-KETE) | ESD-912723-50ΜG |
Cas.: 81444-57-7 | Purity: 98% | 5,6-epoxy-13-cis Retinoic Acid (5,6-epoxy-13-cis RA) | ESD-912724-1MG |
Cas.: 81496-19-7 | Purity: 98% | AH 23848 (calcium salt) | ESD-912725-1MG |
Cas.: 81540-86-5 | Purity: 98% | Dihomo-γ-Linolenic Acid-d6 (DGLA-d6) | ESD-912726-1MG |
Cas.: 81552-33-2 | Purity: 98% | Concanamycin B | ESD-912727-250ΜG |
Cas.: 81552-34-3 | Purity: 98% | Concanamycin C (4′-O-de(aminocarbonyl)-Concanamycin A) | ESD-912728-500ΜG |
Cas.: 815576-68-2 | Purity: 98% | (+)-Quinolactacin A1 | ESD-912729-1MG |
Cas.: 81593-54-6 | Purity: 98% | MEAI hydrochloride | ESD-912731-1MG |
Cas.: 81703-55-1 | Purity: 98% | Ciprostene (calcium salt) | ESD-912732-1MG |
Cas.: 81720-10-7 | Purity: 98% | Dinophysistoxin-1 | ESD-912733-100ΜG |
Cas.: 81797-27-5 | Purity: 98% | Aszonalenin (NSC 374337) | ESD-912734-1MG |
Cas.: 81872-10-8 | Purity: 98% | Zofenopril | ESD-912735-5MG |
Cas.: 81907-82-6 | Purity: 98% | 5-hydroxy Propranolol | ESD-912736-1MG |
Cas.: 81921-35-9 | Purity: 98% | N6-Methyladenosine 5′-monophosphate sodium salt (N6-Methyl-AMP) | ESD-912737-5MG |
Cas.: 81926-94-5 | Purity: 98% | Docosahexaenoic Acid ethyl ester | ESD-912738-100MG |
Cas.: 819850-13-0 | Purity: 98% | (1H-Indol-4-yl)-Carbamic Acid tert-butyl ester | ESD-912739-100MG |
Cas.: 819850-16-3 | Purity: 98% | 2-Pyrimidin-2-yl-Propionic Acid | ESD-912740-10MG |
Cas.: 819850-18-5 | Purity: 98% | Pyrimidine-4-Carboxylic Acid sodium salt | ESD-912741-10MG |
Cas.: 82005-12-7 | Purity: 98% | 10Z-Hymenialdisine | ESD-912742-500ΜG |
Cas.: 82005-44-5 | Purity: ≥98% | Oleic Acid-13C | ESD-912743-5MG |
Cas.: 820240-77-5 | Purity: 98% | AUY954 | ESD-912744-1MG |
Cas.: 82189-03-5 | Purity: 98% | Ansatrienin A (Mycotrienin I) | ESD-912745-1MG |
Cas.: 82189-04-6 | Purity: 98% | Ansatrienin B | ESD-912746-1MG |
Cas.: 82198-76-3 | Purity: BR | Vancomycin Aglycon | ESD-912747-1MG |
Cas.: 82200-87-1 | Purity: 98% | 5(S), 15(S)-DiHETE | ESD-912748-50ΜG |
Cas.: 822-10-6 | Purity: 98% | 9(Z),11(Z)-Conjugated Linoleic Acid methyl ester (9Z,11Z-CLA) | ESD-912749-10MG |
Cas.: 822-18-4 | Purity: 98% | α-Linolenic Acid sodium salt (ALA) | ESD-912750-50MG |
Cas.: 82337-46-0 | Purity: 98% | 12(R)-HETE | ESD-912751-50ΜG |
Cas.: 82413-23-8 | Purity: 98% | 4′-hydroxy Tamoxifen | ESD-912752-1MG |
Cas.: 82414-64-0 | Purity: 98% | 6-keto Prostaglandin F1α-d4 (6-keto PGF1α-d4) | ESD-912753-50ΜG |
Cas.: 824405-61-0 | Purity: 98% | Abz-Ala-Pro-Glu-Glu-Ile-Met-Arg-Arg-Gln-EDDnp | ESD-912754-1MG |
Cas.: 824958-12-5 | Purity: 98% | LP44 hydrochloride | ESD-912755-10MG |
Cas.: 824959-83-3 | Purity: 98% | JWH 213 | ESD-912757-5MG |
Cas.: 824960-02-3 | Purity: 98% | JWH 182 | ESD-912759-5MG |
Cas.: 824960-56-7 | Purity: 98% | JWH 122 7-methylnaphthyl isomer | ESD-912760-5MG |
Cas.: 824960-64-7 | Purity: 98% | JWH 210 7-ethylnaphthyl isomer (JWH 234) | ESD-912761-5MG |
Cas.: 824960-76-1 | Purity: 98% | JWH 081 2-methoxynaphthyl isomer (JWH 267) | ESD-912762-5MG |
Cas.: 824961-41-3 | Purity: 98% | JWH 081 6-methoxynaphthyl isomer (JWH 166) | ESD-912763-5MG |
Cas.: 824961-61-7 | Purity: 98% | JWH 081 7-methoxynaphthyl isomer (JWH 164) | ESD-912764-5MG |
Cas.: 826-10-8 | Purity: 98% | ()-Methamphetamine hydrochloride | ESD-912765-1MG |
Cas.: 82657-23-6 | Purity: 98% | U-47700 | ESD-912766-5MG |
Cas.: 827030-33-1 | Purity: 98% | MPI-0441138 (EP128265) | ESD-912767-5MG |
Cas.: 82765-47-7 | Purity: 98% | 1-Palmitoyl-2-lauroyl-sn-glycero-3-PC | ESD-912768-50MG |
Cas.: 82801-73-8 | Purity: 98% | PKG Inhibitor | ESD-912769-5MG |
Cas.: 82857-38-3 | Purity: 98% | Bopindolol (malonate) | ESD-912770-50MG |
Cas.: 82889-99-4 | Purity: 98% | 5-cis Iloprost (5-cis Ciloprost) | ESD-912771-5MG |
Cas.: 82909-47-5 | Purity: 98% | Myristic Acid Alkyne | ESD-912772-500ΜG |
Cas.: 82948-87-6 | Purity: 98% | 5(S),6(S)-DiHETE | ESD-912773-50ΜG |
Cas.: 82948-88-7 | Purity: 98% | 5(S),6(R)-DiHETE | ESD-912774-100ΜG |
Cas.: 829-74-3 | Purity: 98% | Levonordefrin | ESD-912775-100MG |
Cas.: 83003-12-7 | Purity: 98% | (±)-CP 55,940 | ESD-912776-10MG |
Cas.: 83015-26-3 | Purity: 98% | Atomoxetine | ESD-912777-10MG |
Cas.: 83024-92-4 | Purity: 98% | Leukotriene B4 dimethyl amide (LTB4 dimethyl amide) | ESD-912778-50ΜG |
Cas.: 83056-50-2 | Purity: 98% | Diazepam-d8 | ESD-912779-5MG |
Cas.: 83104-85-2 | Purity: 98% | Quin-2AM (Quin-2 acetoxymethyl ester) | ESD-912780-1MG |
Cas.: 831217-01-7 | Purity: 98% | Acetildenafil (Hongdenafil) | ESD-912781-5MG |
Cas.: 83167-59-3 | Purity: 98% | 1-O-Octadecyl-2-O-methyl-sn-glycerol | ESD-912782-50MG |
Cas.: 83199-47-7 | Purity: 98% | Cholesterol-d7 | ESD-912783-5MG |
Cas.: 83200-10-6 | Purity: 98% | Anipamil | ESD-912784-1MG |
Cas.: 83209-65-8 | Purity: 98% | HC Toxin (Toxin I (Helminthosporium carbonum)) | ESD-912785-500ΜG |
Cas.: 832-68-8 | Purity: 98% | 6-Aminophenanthridine (6AP) | ESD-912786-5MG |
Cas.: 835876-32-9 | Purity: 98% | Platensimycin (PTM) | ESD-912787-250ΜG |
Cas.: 83603-31-0 | Purity: 98% | 15(R)-HETE | ESD-912788-50ΜG |
Cas.: 83619-73-2 | Purity: 98% | 3,6-diacetoxy Phthalonitrile | ESD-912789-5MG |
Cas.: 83701-16-0 | Purity: 98% | Lithocholic Acid-d4 (Lithocholate-d4) | ESD-912790-1MG |
Cas.: 83709-73-3 | Purity: 98% | 12-epi Leukotriene B4 (12-epi LTB4) | ESD-912791-50ΜG |
Cas.: 83729-01-5 | Purity: 98% | Salvinorin A (Divinorin A) | ESD-912792-5MG |
Cas.: 83792-61-4 | Purity: 98% | Vinclozolin M2 (M2) | ESD-912793-5MG |
Cas.: 83851-38-1 | Purity: 98% | Leukotriene A3 methyl ester (LTA3 methyl ester) | ESD-912794-50ΜG |
Cas.: 83851-42-7 | Purity: 98% | Leukotriene F4 (LTF4) | ESD-912795-50ΜG |
Cas.: 83952-40-3 | Purity: 98% | (±)5-HEPE | ESD-912796-100ΜG |
Cas.: 83968-06-3 | Purity: 98% | 3-hydroxy Nonanoic Acid methyl ester (Methyl 3-hydroxynonanoate) | ESD-912797-5MG |
Cas.: 839699-72-8 | Purity: 98% | CAY10591 | ESD-912798-5MG |
Cas.: 83982-06-3 | Purity: 98% | N-Palmitoyl Taurine | ESD-912799-5MG |
Cas.: 84324-56-1 | Purity: 90% | Cefpimizole Disodium Salt | ESD-912800-5MG |
Cas.: 84477-71-4 | Purity: 98% | 2-BZP | ESD-912801-1MG |
Cas.: 845673-68-9 | Purity: 98% | (±)4(5)-DiHDPA lactone | ESD-912802-50ΜG |
Cas.: 845673-74-7 | Purity: 98% | 4-oxo Docosahexaenoic Acid (4-oxo DHA) | ESD-912803-100ΜG |
Cas.: 845673-97-4 | Purity: 98% | (±)5(6)-DiHETE | ESD-912804-50ΜG |
Cas.: 845959-55-9 | Purity: 98% | Mitoquinol | ESD-912805-5MG |
Cas.: 84599-16-6 | Purity: 98% | delta-CEHC | ESD-912806-5MG |
Cas.: 84601-19-4 | Purity: ≥98% | Oleyloxyethyl Phosphorylcholine | ESD-912807-10MG |
Cas.: 846-50-4 | Purity: 98% | Temazepam | ESD-912809-1MG |
Cas.: 847163-28-4 | Purity: 98% | ML351 (CID 664510) | ESD-912810-5MG |
Cas.: 84743-29-3 | Purity: 98% | 10(Z)-Pentadecenoic Acid ( cis-10-Pentadecenoic acid) | ESD-912811-5MG |
Cas.: 847674-32-2 | Purity: 98% | 6α-chloroTestosterone | ESD-912812-1MG |
Cas.: 847727-81-5 | Purity: 98% | AAT-008 | ESD-912813-5MG |
Cas.: 847949-49-9 | Purity: 98% | O-Desmethyl Gefitinib | ESD-912814-1MG |
Cas.: 84807-87-4 | Purity: 98% | 15(S)-HETE-d8 | ESD-912815-50ΜG |
Cas.: 84807-90-9 | Purity: 98% | 12(S)-HETE-d8 | ESD-912816-50ΜG |
Cas.: 848133-17-5 | Purity: 98% | HKI 357 | ESD-912817-10MG |
Cas.: 848667-56-1 | Purity: 98% | (±)2-(14,15-Epoxyeicosatrienoyl) Glycerol ((±)2-14,15-EG) | ESD-912818-50ΜG |
Cas.: 848688-62-0 | Purity: 98% | CAY10721 | ESD-912819-5MG |
Cas.: 849067-18-1 | Purity: 98% | N-acetyl-2-carboxy Benzenesulfonamide | ESD-912820-10MG |
Cas.: 84952-63-6 | Purity: 98% | 2-Methylamino-1-phenylbutane hydrochloride (α-ethyl-N-methyl-Benzeneethanamine) | ESD-912821-10MG |
Cas.: 849642-09-7 | Purity: 98% | 2-NMC | ESD-912822-5MG |
Cas.: 849727-81-7 | Purity: 98% | AMPK activator (D942) | ESD-912823-5MG |
Cas.: 850032-66-5 | Purity: 98% | 5-methoxy EiPT | ESD-912824-5MG |
Cas.: 85026-51-3 | Purity: 98% | 15(R)-Iloprost | ESD-912825-1MG |
Cas.: 850351-99-4 | Purity: 98% | 3,4-dimethoxy-α-Pyrrolidinopentiophenone hydrochloride | ESD-912826-10MG |
Cas.: 850352-11-3 | Purity: 98% | Naphyrone hydrochloride | ESD-912827-5MG |
Cas.: 850352-31-7 | Purity: 98% | 4-fluoro-α-Pyrrolidinopentiophenone hydrochloride | ESD-912828-10MG |
Cas.: 850734-84-8 | Purity: 98% | 8-Isoquinoline methanamine hydrochloride | ESD-912829-50MG |
Cas.: 85075-82-7 | Purity: 10mg/ml in MAC | Oleoyl Ethyl Amide | ESD-912830-10MG |
Cas.: 850807-63-5 | Purity: 98% | RSM-932A | ESD-912831-5MG |
Cas.: 851204-35-8 | Purity: 98% | EP1-antanoist-1 | ESD-912832-5MG |
Cas.: 851378-93-3 | Purity: 98% | (±)8(9)-EpETE | ESD-912833-100ΜG |
Cas.: 851536-75-9 | Purity: 98% | Umirolimus | ESD-912834-1MG |
Cas.: 851636-83-4 | Purity: 98% | Cysmethynil (Icmt Inhibitor) | ESD-912835-10MG |
Cas.: 851667-96-4 | Purity: 98% | Farnesyl Alcohol Azide (Click Tag Farnesyl Alcohol Azide) | ESD-912836-500ΜG |
Cas.: 851761-42-7 | Purity: 98% | Prostaglandin D2 serinol amide (PGD2-SA) | ESD-912837-5MG |
Cas.: 852045-46-6 | Purity: 98% | FLT3 Inhibitor III (Fms-like Tyrosine Kinase Inhibitor III) | ESD-912838-5MG |
Cas.: 852100-88-0 | Purity: 98% | C12 3′-sulfo Galactosylceramide (d18:1/12:0) | ESD-912839-1MG |
Cas.: 852146-73-7 | Purity: 98% | KR-32568 | ESD-912840-5MG |
Cas.: 852230-33-2 | Purity: 98% | ML-031 (CID-2113511) | ESD-912841-5MG |
Cas.: 85235-11-6 | Purity: 98% | 15-deoxy-Δ12,14-Prostaglandin D2 (15-deoxy-Δ12,14-PGD2) | ESD-912842-1MG |
Cas.: 85280-90-6 | Purity: 98% | 15(S)-15-methyl Prostaglandin D2 (15(S)-15-methyl PGD2) | ESD-912843-1MG |
Cas.: 85280-91-7 | Purity: 98% | 17-phenyl trinor Prostaglandin D2 (17-phenyl trinor PGD2) | ESD-912844-5MG |
Cas.: 85305-87-9 | Purity: 98% | Glucocerebrosides (Gaucher’s spleen) | ESD-912845-5MG |
Cas.: 853400-67-6 | Purity: 98% | Fluo-3 potassium salt | ESD-912846-1MG |
Cas.: 85405-03-4 | Purity: 98% | Butanoyl PAF | ESD-912847-5MG |
Cas.: 854127-90-5 | Purity: 98% | LY303511 hydrochloride | ESD-912848-1MG |
Cas.: 85547-22-4 | Purity: 98% | Aaptamine | ESD-912849-1MG |
Cas.: 856609-26-2 | Purity: 98% | 2-chloro-N,N-Dimethylcathinone hydrochloride (2-chloro-N,N-DMC) | ESD-912851-5MG |
Cas.: 85666-17-7 | Purity: 98% | Furegrelate sodium salt (U-63557A) | ESD-912852-5MG |
Cas.: 856925-75-2 | Purity: 98% | (S)-nitro-Blebbistatin (S-()-7-Desmethyl-8-nitro Blebbistatin) | ESD-912853-5MG |
Cas.: 857361-90-1 | Purity: 98% | Methiopropamine 3′-thiophene isomer hydrochloride (3-MPA) | ESD-912854-5MG |
Cas.: 85753-43-1 | Purity: 98% | K252c | ESD-912855-5MG |
Cas.: 858127-11-4 | Purity: 98% | Resveratrol-3-O-Sulfate sodium salt | ESD-912856-1MG |
Cas.: 858134-23-3 | Purity: 98% | Vialinin A (Terrestrin A) | ESD-912857-5MG |
Cas.: 858215-05-1 | Purity: 98% | MDA 2-amido analog | ESD-912858-5MG |
Cas.: 858345-57-0 | Purity: 98% | Salvinorin A Carbamate | ESD-912859-1MG |
Cas.: 858515-71-6 | Purity: 98% | BB-22 3-carboxyindole metabolite | ESD-912860-1MG |
Cas.: 858515-82-9 | Purity: 98% | methyl-1-(cyclohexylmethyl)-1H-indole-3-Carboxylate | ESD-912861-5MG |
Cas.: 85-87-0 | Purity: 98% | Pyridoxylamine | ESD-912862-100MG |
Cas.: 85956-22-5 | Purity: 98% | Pravastatin lactone | ESD-912863-10MG |
Cas.: 861006-36-2 | Purity: 98% | 2-Bromoamphetamine hydrochloride | ESD-912864-5MG |
Cas.: 861891-50-1 | Purity: 98% | IM-54 | ESD-912865-5MG |
Cas.: 862073-77-6 | Purity: 98% | Herkinorin | ESD-912866-1MG |
Cas.: 862073-79-8 | Purity: 98% | Salvinorin B Mesylate (Mesyl Sal B) | ESD-912867-1MG |
Cas.: 86282-92-0 | Purity: 98% | 15(S)-HEPE | ESD-912868-50ΜG |
Cas.: 86288-11-1 | Purity: 98% | Arachidonoyl PAF C-16 (1-O-hexadecyl-2-Arachidonoyl-sn-glycero-3-Phosphocholine) | ESD-912869-5MG |
Cas.: 862891-04-1 | Purity: 98% | HMB-Val-Ser-Leu-VE | ESD-912870-5MG |
Cas.: 862901-87-9 | Purity: 98% | LT175 | ESD-912871-10MG |
Cas.: 863202-33-9 | Purity: 98% | CAY10498 (2-phenyl-amino-N6-endo-norbornyladenine) | ESD-912872-1MG |
Cas.: 863223-43-2 | Purity: 98% | Epoxy Fluor 7 | ESD-912873-5MG |
Cas.: 863513-93-3 | Purity: 98% | Cebranopadol | ESD-912874-5MG |
Cas.: 863918-78-9 | Purity: 98% | Methoxy-X04 | ESD-912875-10MG |
Cas.: 864289-85-0 | Purity: 98% | CCR4 Antagonist | ESD-912876-5MG |
Cas.: 864422-91-3 | Purity: 98% | Despropionyl ortho-Fluorofentanyl | ESD-912877-1MG |
Cas.: 864445-43-2 | Purity: 98% | JWH 250 | ESD-912878-1MG |
Cas.: 864445-58-9 | Purity: 98% | JWH 203 4-chlorophenyl isomer | ESD-912879-10MG |
Cas.: 86484-91-5 | Purity: 98% | Dopexamine hydrochloride (FPL60278AR) | ESD-912880-1MG |
Cas.: 865368-30-5 | Purity: 98% | Hirsutide | ESD-912881-1MG |
Cas.: 86541-78-8 | Purity: 98% | Benazeprilat (CGS 14831) | ESD-912882-5MG |
Cas.: 86555-28-4 | Purity: 98% | Sphingosine (d15:1) (D-erythro-Sphingosine C-15) | ESD-912883-5MG |
Cas.: 866022-28-8 | Purity: 98% | Bischloroanthrabenzoxocinone | ESD-912884-500ΜG |
Cas.: 867021-83-8 | Purity: 98% | Colivelin | ESD-912885-1MG |
Cas.: 867350-87-6 | Purity: 98% | (±)8,9-DiHETE | ESD-912886-50ΜG |
Cas.: 867350-92-3 | Purity: 98% | (±)11(12)-DiHETE | ESD-912887-100ΜG |
Cas.: 86879-39-2 | Purity: 98% | CMPF | ESD-912888-5MG |
Cas.: 86880-51-5 | Purity: 98% | ICI141292 | ESD-912889-1MG |
Cas.: 869376-63-6 | Purity: 98% | CB-25 | ESD-912890-5MG |
Cas.: 869490-23-3 | Purity: 98% | Gosogliptin | ESD-912891-1MG |
Cas.: 869577-51-5 | Purity: 98% | MMP-2 Inhibitor II (Matrix Metalloproteinase-2 Inhibitor II) | ESD-912892-5MG |
Cas.: 869898-86-2 | Purity: 98% | Platencin | ESD-912893-100ΜG |
Cas.: 869998-49-2 | Purity: 99% | SPD304 | ESD-912894-1MG |
Cas.: 870076-72-5 | Purity: 98% | Albuterol methyl ether (Salbutamol methyl ether) | ESD-912895-1MG |
Cas.: 87018-59-5 | Purity: 98% | (±)11-HDHA | ESD-912896-100ΜG |
Cas.: 87042-40-8 | Purity: 98% | (±)14-HDHA | ESD-912897-100ΜG |
Cas.: 870677-05-7 | Purity: 98% | DMAPT | ESD-912898-5MG |
Cas.: 871307-18-5 | Purity: 98% | Tpl2 Kinase Inhibitor | ESD-912899-1MG |
Cas.: 871540-97-5 | Purity: 98% | C30 Ceramide (d18:1/30:0) | ESD-912900-1MG |
Cas.: 87173-80-6 | Purity: 98% | (±)5(6)-EET ((±)5,6-EpETrE) | ESD-912901-100ΜG |
Cas.: 87173-97-5 | Purity: 98% | U-62066 mesylate | ESD-912902-5MG |
Cas.: 871826-47-0 | Purity: 98% | 10(S), 17(S)-DiHDHA | ESD-912903-50ΜG |
Cas.: 871982-52-4 | Purity: 98% | Roquefortine E | ESD-912904-1MG |
Cas.: 87206-01-7 | Purity: 98% | N-hexadecanoyl-L-Homoserine lactone | ESD-912905-10MG |
Cas.: 872201-12-2 | Purity: 98% | K 114 | ESD-912906-5MG |
Cas.: 87269-97-4 | Purity: 98% | Ramiprilat (Ramiprilat) | ESD-912907-10MG |
Cas.: 87272-20-6 | Purity: 98% | MEDICA 16 | ESD-912908-10MG |
Cas.: 872726-44-8 | Purity: 98% | GW 610 (NSC 721648) | ESD-912909-5MG |
Cas.: 872993-05-0 | Purity: 98% | Resolvin D1 | ESD-912910-50ΜG |
Cas.: 873079-69-7 | Purity: 98% | AX 048 | ESD-912911-1MG |
Cas.: 873108-81-7 | Purity: 98% | 4(Z),7(Z),10(Z),13(Z)-Hexadecatetraenoic Acid methyl ester | ESD-912912-100ΜG |
Cas.: 87377-08-0 | Purity: 98% | Indomethacin-d4 | ESD-912913-1MG |
Cas.: 87414-49-1 | Purity: 98% | Butyrolactone I | ESD-912914-1MG |
Cas.: 875014-22-5 | Purity: 98% | CAY10570 | ESD-912915-5MG |
Cas.: 875685-44-2 | Purity: 98% | 9-Nitrooleate | ESD-912916-1MG |
Cas.: 875685-46-4 | Purity: 98% | 10-Nitrooleate | ESD-912917-1MG |
Cas.: 876-26-6 | Purity: 98% | 4-hydroxy Amphetamine hydrochloride | ESD-912918-10MG |
Cas.: 876305-42-9 | Purity: 98% | N-Arachidonyl Maleimide (NAM) | ESD-912919-10MG |
Cas.: 877061-66-0 | Purity: 98% | SCH 725674 | ESD-912920-1MG |
Cas.: 877459-63-7 | Purity: 98% | Leukotriene B4 Ethanolamide (LTB4-EA) | ESD-912921-50ΜG |
Cas.: 877617-46-4 | Purity: 98% | F-Amidine trifluoroacetate salt | ESD-912922-1MG |
Cas.: 877618-79-6 | Purity: 98% | IWP-2-V2 (Inhibitor of Wnt Production-2-V2) | ESD-912923-5MG |
Cas.: 878533-35-8 | Purity: 98% | CAY10508 | ESD-912924-10MG |
Cas.: 87860-39-7 | Purity: 98% | Fostriecin sodium salt | ESD-912925-100ΜG |
Cas.: 87862-25-7 | Purity: 98% | m-Iodobenzylguanidine hemisulfate (MIBG) | ESD-912926-5MG |
Cas.: 878627-21-5 | Purity: 98% | N-tridecanoyl-L-Homoserine lactone (C13-HSL) | ESD-912927-10MG |
Cas.: 87864-20-8 | Purity: 98% | PPHP | ESD-912928-1MG |
Cas.: 87893-54-7 | Purity: 98% | Δ12-Prostaglandin J2 (Δ12-PGJ2) | ESD-912929-1MG |
Cas.: 87893-55-8 | Purity: 98% | 15-deoxy-Δ12,14-Prostaglandin J2 MaxSpec Standard (15-deoxy-Δ12,14-PGJ2) | ESD-912930-1MG |
Cas.: 879-08-3 | Purity: 98% | 9-Ethylguanine | ESD-912931-100MG |
Cas.: 879660-23-8 | Purity: 98% | 2-Chloroethcathinone hydrochloride (2-CEC) | ESD-912932-5MG |
Cas.: 879669-95-1 | Purity: 98% | Pentedrone hydrochloride (α-methylamino-Valerophenone) | ESD-912933-1MG |
Cas.: 87984-82-5 | Purity: 98% | 13(S)-HOTrE | ESD-912934-500ΜG |
Cas.: 879894-27-6 | Purity: 98% | 7-Aminoflunitrazepam-d7 (CRM) | ESD-912935-1MG |
Cas.: 880487-62-7 | Purity: 98% | Phthalazinone pyrazole | ESD-912936-5MG |
Cas.: 88082-60-4 | Purity: 98% | Cinnamtannin B-1 (LDN-0022358) | ESD-912937-5MG |
Cas.: 88099-35-8 | Purity: 98% | Leukotriene B3 (LTB3) | ESD-912938-50ΜG |
Cas.: 88107-10-2 | Purity: 98% | LY171883 | ESD-912939-10MG |
Cas.: 88149-94-4 | Purity: 98% | DuP-697 | ESD-912940-10MG |
Cas.: 881914-35-8 | Purity: 98% | azido-FTY720 | ESD-912941-1MG |
Cas.: 88235-25-0 | Purity: 98% | C-6 NBD | ESD-912942-50MG |
Cas.: 883296-70-6 | Purity: ≥98% | oxy-Arachidonoyl Ethanolamide | ESD-912943-1MG |
Cas.: 88360-87-6 | Purity: 98% | Amauromine | ESD-912944-1MG |
Cas.: 88378-59-0 | Purity: 98% | Actinopyrone A | ESD-912945-500ΜG |
Cas.: 883973-99-7 | Purity: 98% | Fructose-1,6-bisphosphatase-1 Inhibitor | ESD-912946-5MG |
Cas.: 883976-12-3 | Purity: 98% | M8-B hydrochloride | ESD-912947-5MG |
Cas.: 88418-69-3 | Purity: 98% | 4-isocyanato TEMPO | ESD-912948-5MG |
Cas.: 884324-34-9 | Purity: 98% | 1-Palmitoyl-3-oleoyl-sn-glycero-2-PE | ESD-912949-5MG |
Cas.: 88441-15-0 | Purity: 98% | 2C-C hydrochloride (2,5-Dimethoxy-4-chlorophenethylamine) | ESD-912950-5MG |
Cas.: 884483-38-9 | Purity: 98% | 17β-Hydroxy-androstano | ESD-912951-5MG |
Cas.: 884539-95-1 | Purity: 98% | PX-13-17OH | ESD-912952-5MG |
Cas.: 88641-20-7 | Purity: 98% | (±)-cis-3-methyl Butyryl fentanyl hydrochloride | ESD-912953-5MG |
Cas.: 886465-70-9 | Purity: 98% | Ridaifen-B | ESD-912954-5MG |
Cas.: 88699-91-6 | Purity: BR | Fluvoxamine Acid | ESD-912955-5MG |
Cas.: 887264-45-1 | Purity: 98% | JP104 (Click Tag JP104) | ESD-912956-5MG |
Cas.: 887405-21-2 | Purity: 98% | Nervonoyl Ethanolamide | ESD-912957-5MG |
Cas.: 887752-13-8 | Purity: 98% | 7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid | ESD-912958-50ΜG |
Cas.: 887927-59-5 | Purity: 98% | (+)-2,5-epi Goniothalesdiol | ESD-912959-1MG |
Cas.: 888032-58-4 | Purity: 98% | WQ3810 | ESD-912960-5MG |
Cas.: 888320-29-4 | Purity: 98% | CAY10502 | ESD-912961-5MG |
Cas.: 88851-62-1 | Purity: 98% | Piriprost potassium salt (U-60257B) | ESD-912962-5MG |
Cas.: 88852-33-9 | Purity: 98% | (±)15-HEPE | ESD-912963-50ΜG |
Cas.: 88903-69-9 | Purity: 98% | Xestospongin C | ESD-912964-50ΜG |
Cas.: 88909-96-0 | Purity: 98% | Virstatin | ESD-912965-10MG |
Cas.: 889101-41-1 | Purity: 98% | (-)-Altenuene | ESD-912966-1MG |
Cas.: 889573-69-7 | Purity: 98% | 8(S)-HETrE | ESD-912967-50ΜG |
Cas.: 889860-85-9 | Purity: 98% | GAT229 | ESD-912968-5MG |
Cas.: 890041-50-6 | Purity: 98% | C16 (2′(S)-hydroxy) Ceramide (d18:1/16:0) (16:0 (2S-OH)-Ceramide) | ESD-912969-5MG |
Cas.: 89019-63-6 | Purity: 98%, 25mg/ml in Ethanol | 1,2-bis(heptanoylthio) Glycerophosphocholine | ESD-912970-10MG |
Cas.: 890854-82-7 | Purity: 98% | CAY10503 | ESD-912971-5MG |
Cas.: 890888-12-7 | Purity: 98% | S3QEL-2 | ESD-912972-10MG |
Cas.: 890955-25-6 | Purity: 98% | 9(S)-HODE-d4 MaxSpecStandard | ESD-912973-50ΜG |
Cas.: 89159-60-4 | Purity: 98% | ML-354 (VU0099704) | ESD-912974-10MG |
Cas.: 891859-12-4 | Purity: 98% | Ceralifimod (ONO-4641) | ESD-912975-10MG |
Cas.: 89197-69-3 | Purity: 98% | Dibutyl-3-Hydroxybutyl Phosphate (TBP-OH) | ESD-912976-1MG |
Cas.: 89213-87-6 | Purity: 98% | Atrial Natriuretic Peptide (1-28) (human) trifluoroacetate salt | ESD-912977-1MG |
Cas.: 892489-52-0 | Purity: 98% | AZD3988 | ESD-912978-5MG |
Cas.: 89304-26-7 | Purity: ≥95% | Oxalomalic Acid sodium salt | ESD-912979-5MG |
Cas.: 89339-17-3 | Purity: 98% | 2′-hydroxy Cocaine | ESD-912980-1MG |
Cas.: 893449-38-2 | Purity: 98% | PRL-3 Inhibitor | ESD-912981-50MG |
Cas.: 895127-64-7 | Purity: 98% | (±)13(14)-EpDPA | ESD-912982-100ΜG |
Cas.: 895127-65-8 | Purity: 98% | (±)10(11)-EpDPA | ESD-912983-500ΜG |
Cas.: 895127-66-9 | Purity: 98% | (±)7(8)-EpDPA | ESD-912984-100ΜG |
Cas.: 895155-25-6 | Purity: 98% | AB-005 | ESD-912985-5MG |
Cas.: 895155-78-9 | Purity: 98% | XLR12 | ESD-912988-5MG |
Cas.: 895155-95-0 | Purity: 98% | UR-144 N-(5-hydroxypentyl) metabolite (XLR11 N-(5-hydroxypentyl) metabolite) | ESD-912989-5MG |
Cas.: 89596-43-0 | Purity: 98% | Leukotriene B4-3-aminopropylamide (LTB4-3-aminopropylamide) | ESD-912990-50ΜG |
Cas.: 89663-86-5 | Purity: 98% | 5S,6R-LipoxinA4 | ESD-912991-50ΜG |
Cas.: 896795-60-1 | Purity: 98% | CM037 | ESD-912992-10MG |
Cas.: 897613-29-5 | Purity: 98% | S1QEL | ESD-912993-5MG |
Cas.: 89771-78-8 | Purity: 98% | C16 3′-sulfo Galactosylceramide (d18:1/16:0) | ESD-912994-1MG |
Cas.: 89-79-2 | Purity: 98% | ()-Isopulegol (l-Isopulegol) | ESD-912995-100MG |
Cas.: 89805-39-0 | Purity: 98% | YS-035 hydrochloride | ESD-912996-10MG |
Cas.: 898235-65-9 | Purity: 98% | PF-622 | ESD-912997-10MG |
Cas.: 89847-02-9 | Purity: 98% | Prostaglandin F2β (tromethamine salt) | ESD-912998-1MG |
Cas.: 89886-42-0 | Purity: 98% | 9(S)-HOTrE | ESD-912999-500ΜG |
Cas.: 89911-64-8 | Purity: 98% | CCK (26-31) (non-sulfated) (N-Acetyl Cholecystokinin (26-31), (non-sulfated)) | ESD-913000-1MG |
Cas.: 89911-65-9 | Purity: 98% | CCK (26-31) (sulfated) (N-Acetyl Cholecystokinin (26-31), (sulfated)) | ESD-913001-1MG |
Cas.: 89911-69-3 | Purity: 98% | CCK (26-30) (sulfated) (N-Acetyl Cholecystokinin (26-30)) | ESD-913002-1MG |
Cas.: 89913-60-0 | Purity: 98% | α-acetyl Boswellic Acid | ESD-913003-5MG |
Cas.: 89946-08-7 | Purity: 98% | 3-hydroxy Docosanoic Acid | ESD-913004-1MG |
Cas.: 89947-79-5 | Purity: 98% | PGPC | ESD-913005-1MG |
Cas.: 899827-36-2 | Purity: 98% | PtdIns-(1,2-dioctanoyl) sodium salt | ESD-913006-500ΜG |
Cas.: 9008-30-4 | Purity: 98% | Lysophosphatidylcholines (egg) (Lyso-Lecithins (egg)) | ESD-913007-10MG |
Cas.: 90105-02-5 | Purity: 98% | 5(Z),8(Z),14(Z)-Eicosatrienoic Acid | ESD-913008-500ΜG |
Cas.: 90132-32-4 | Purity: 98% | Metaescaline hydrochloride (3,4-Dimethoxy-5-ethoxyphenethylamine) | ESD-913009-5MG |
Cas.: 90217-02-0 | Purity: 98% | 5-Cyano-2,3-di-(p-tolyl)tetrazolium chloride | ESD-913010-10MG |
Cas.: 902464-46-4 | Purity: 98% | UBP 310 | ESD-913011-5MG |
Cas.: 902502-82-3 | Purity: 98% | ML-262 | ESD-913012-5MG |
Cas.: 902523-58-4 | Purity: 98% | ML-261 (CID-9550710) | ESD-913013-5MG |
Cas.: 902589-96-2 | Purity: 98% | YMU1 | ESD-913014-5MG |
Cas.: 902779-59-3 | Purity: 98% | Akt Inhibitor XI (FPA-124) | ESD-913015-10MG |
Cas.: 903499-49-0 | Purity: 98% | PRLX-93936 | ESD-913016-5MG |
Cas.: 903549-49-5 | Purity: 98% | 5-trans Latanoprost free acid (5,6-trans Latanoprost free acid) | ESD-913017-5MG |
Cas.: 90365-57-4 | Purity: ≥98% | (-)-Indolactam V (Indolactam V) | ESD-913018-5MG |
Cas.: 9037-90-5 | Purity: 98% | Irisin (human recombinant) | ESD-913019-100ΜG |
Cas.: 90384-82-0 | Purity: 98% | FeTPPS | ESD-913020-50MG |
Cas.: 903892-99-9 | Purity: 98% | Lachnone A | ESD-913021-500ΜG |
Cas.: 90536-15-5 | Purity: 98% | PD 145305 | ESD-913022-5MG |
Cas.: 906366-79-8 | Purity: 98% | Iotilone | ESD-913023-5MG |
Cas.: 9072-41-7 | Purity: 98% | Motilin (porcine) | ESD-913024-1MG |
Cas.: 90729-42-3 | Purity: 98% | Carebastine | ESD-913025-10MG |
Cas.: 90780-46-4 | Purity: 98% | 22-HDHA | ESD-913026-50ΜG |
Cas.: 90780-50-0 | Purity: 98% | (±)10-HDHA | ESD-913027-100ΜG |
Cas.: 90780-51-1 | Purity: 98% | (±)16-HDHA | ESD-913028-100ΜG |
Cas.: 90780-52-2 | Purity: 98% | (±)17-HDHA MaxSpec Standard | ESD-913029-100ΜG |
Cas.: 90780-53-3 | Purity: 98% | (±)13-HDHA | ESD-913030-100ΜG |
Cas.: 90780-54-4 | Purity: 98% | (±)8-HDHA | ESD-913031-100ΜG |
Cas.: 90780-55-5 | Purity: 98% | (±)7-HDHA | ESD-913032-100ΜG |
Cas.: 90831-71-3 | Purity: 98% | Ristocetin A sulfate (Ristomycin III) | ESD-913033-10MG |
Cas.: 908568-01-4 | Purity: 98% | Inflachromene (ICM) | ESD-913034-10MG |
Cas.: 90869-66-2 | Purity: 98% | 2-Chloromethcathinone hydrochloride (2-CMC) | ESD-913035-5MG |
Cas.: 90906-40-4 | Purity: 98% | (±)4-HDHA | ESD-913036-50ΜG |
Cas.: 90906-41-5 | Purity: 98% | (±)20-HDHA | ESD-913037-1MG |
Cas.: 909725-62-8 | Purity: 98% | W146 trifluoroacetate salt | ESD-913038-1MG |
Cas.: 909725-64-0 | Purity: 98% | W140 trifluoroacetate salt | ESD-913039-1MG |
Cas.: 91021-63-5 | Purity: 98% | Pyrrolidino PAF C-16 | ESD-913040-5MG |
Cas.: 91021-66-8 | Purity: 98% | Leucanidin | ESD-913041-500ΜG |
Cas.: 910228-13-6 | Purity: 98% | Palmitoleoyl 3-carbacyclic Phosphatidic Acid | ESD-913042-1MG |
Cas.: 91032-36-9 | Purity: 98% | Teicoplanin A2-3 | ESD-913043-1MG |
Cas.: 91032-37-0 | Purity: 98% | Teicoplanin A2-4 | ESD-913044-1MG |
Cas.: 91032-38-1 | Purity: 98% | Teicoplanin A2-5 | ESD-913045-1MG |
Cas.: 910376-39-5 | Purity: 98% | PF-03550096 | ESD-913046-1MG |
Cas.: 911378-38-6 | Purity: 98% | RBI 257 (maleate) | ESD-913047-5MG |
Cas.: 91164-58-8 | Purity: 98% | 3-methoxy PCP hydrochloride | ESD-913048-10MG |
Cas.: 912656-34-9 | Purity: 98% | XEN907 | ESD-913049-5MG |
Cas.: 912758-00-0 | Purity: 98% | ATB-337 | ESD-913050-5MG |
Cas.: 912798-42-6 | Purity: 98% | ML115 | ESD-913051-1MG |
Cas.: 91295-74-8 | Purity: 98% | ATM4 4-acetoxy analog | ESD-913052-1MG |
Cas.: 91297-89-1 | Purity: 98% | 3-hydroxy Lignoceric Acid | ESD-913053-500ΜG |
Cas.: 91300-60-6 | Purity: 98% | LY83583 | ESD-913054-5MG |
Cas.: 913258-34-1 | Purity: 98% | 5-trans Latanoprost (5,6-trans Latanoprost) | ESD-913055-5MG |
Cas.: 913844-45-8 | Purity: 98% | (S)-Glycyl-H-1152 hydrochloride (Rho Kinase Inhibitor IV) | ESD-913056-1MG |
Cas.: 914458-19-8 | Purity: 98% | JWH 145 | ESD-913057-5MG |
Cas.: 914458-20-1 | Purity: 98% | JWH 147 | ESD-913058-10MG |
Cas.: 914458-21-2 | Purity: 98% | JWH 146 | ESD-913059-5MG |
Cas.: 914458-26-7 | Purity: 98% | JWH 307 | ESD-913061-10MG |
Cas.: 914458-27-8 | Purity: 98% | JWH 369 | ESD-913062-10MG |
Cas.: 914458-31-4 | Purity: 98% | JWH 368 | ESD-913063-10MG |
Cas.: 914458-42-7 | Purity: 98% | JWH 309 | ESD-913064-10MG |
Cas.: 914613-35-7 | Purity: 98% | 1H-1-ethyl Candesartan Cilexetil | ESD-913065-5MG |
Cas.: 914804-63-0 | Purity: 98% | 8-iso-15-keto Prostaglandin E2 | ESD-913066-1MG |
Cas.: 915087-27-3 | Purity: 98% | RD162 | ESD-913067-5MG |
Cas.: 91575-58-5 | Purity: 98% | Methylcarbamyl PAF C-16 | ESD-913068-5MG |
Cas.: 916046-55-4 | Purity: 98% | CAY10597 | ESD-913069-5MG |
Cas.: 916047-16-0 | Purity: 98% | CAY10595 | ESD-913070-5MG |
Cas.: 916048-02-7 | Purity: 98% | CAY10648 | ESD-913071-5MG |
Cas.: 916440-85-2 | Purity: 98% | 7BIO (7-Bromoindirubin-3′-oxime) | ESD-913072-10MG |
Cas.: 916482-17-2 | Purity: 98% | YS-121 | ESD-913073-10MG |
Cas.: 91683-38-4 | Purity: 98% | Gemfibrozil 1-O-β-Glucuronide | ESD-913074-1MG |
Cas.: 916888-47-6 | Purity: 98% | Resolvin D3 (RvD3) | ESD-913075-50ΜG |
Cas.: 916985-21-2 | Purity: 98% | CAY10575 | ESD-913076-1MG |
Cas.: 91700-91-3 | Purity: 98% | TAN 420C | ESD-913077-500ΜG |
Cas.: 91700-92-4 | Purity: 98% | Herbimycin C (Antibiotic TAN 420D) | ESD-913078-500ΜG |
Cas.: 91833-49-7 | Purity: 98% | Rocastine | ESD-913079-5MG |
Cas.: 918659-56-0 | Purity: 98% | (–)-Chaetominine | ESD-913080-500ΜG |
Cas.: 919973-69-6 | Purity: 98% | 1-demethyl Phenazolam | ESD-913081-5MG |
Cas.: 92008-51-0 | Purity: 98% | 5(S)-HEPE MaxSpec Standard | ESD-913082-50ΜG |
Cas.: 92040-10-3 | Purity: 98% | α-Pyrrolidinopropiophenone hydrochloride (α-PPP) | ESD-913083-10MG |
Cas.: 922150-11-6 | Purity: 98% | SCH 529074 | ESD-913084-10MG |
Cas.: 922727-14-8 | Purity: 98% | α-GalCer analog 8 (α-Galactosylceramide analog 8) | ESD-913085-500ΜG |
Cas.: 923013-67-6 | Purity: 98% | 2C-E hydrochloride (2,5-Dimethoxy-4-ethylphenethylamine) | ESD-913086-1MG |
Cas.: 923032-38-6 | Purity: 98% | Refametinib R enantiomer | ESD-913087-1MG |
Cas.: 92340-57-3 | Purity: 98% | 5-hydroxy Omeprazole | ESD-913088-1MG |
Cas.: 92439-20-8 | Purity: 98% | 6,2′-Dihydroxyflavone | ESD-913089-50MG |
Cas.: 924894-97-3 | Purity: 98% | 2-Arachidonoyl Glycerol-d8 (2-AG-d8) | ESD-913090-100ΜG |
Cas.: 924894-98-4 | Purity: 98% | Arachidonoyl Ethanolamide-d8 | ESD-913091-1MG |
Cas.: 925239-03-8 | Purity: 98% | JMV3002 | ESD-913092-1MG |
Cas.: 925448-37-9 | Purity: 98% | N-3-oxo-hexadecanoyl-L-Homoserine lactone | ESD-913093-10MG |
Cas.: 92545-30-7 | Purity: 98% | Salvinorin B (Divinorin B) | ESD-913094-5MG |
Cas.: 92564-08-4 | Purity: 98% | HA-1004 hydrochloride | ESD-913095-5MG |
Cas.: 925891-74-3 | Purity: 98% | N-Octadecyl-N’-propyl-sulfamide | ESD-913096-10MG |
Cas.: 926023-82-7 | Purity: 98% | AMTB | ESD-913097-5MG |
Cas.: 92665-29-7 | Purity: 98% | Cefprozil (BMY-28100) | ESD-913098-50MG |
Cas.: 926657-43-4 | Purity: 98% | (-)-AS 115 | ESD-913099-1MG |
Cas.: 92693-02-2 | Purity: 98% | 15(S)-HETrE | ESD-913100-100ΜG |
Cas.: 92693-03-3 | Purity: 98% | 17(S)-HDHA | ESD-913101-100ΜG |
Cas.: 92693-04-4 | Purity: 98% | 15(S)-HEDE | ESD-913102-100ΜG |
Cas.: 927019-63-4 | Purity: 98% | Lysine-specific Demethylase Inhibitor (1C) | ESD-913103-5MG |
Cas.: 92728-82-0 | Purity: 98% | α-Piperidinobutiophenone hydrochloride (α-PipBP) | ESD-913104-10MG |
Cas.: 927635-64-1 | Purity: 98% | HA-14-1 | ESD-913105-10MG |
Cas.: 927691-21-2 | Purity: 98% | PQ-10 | ESD-913106-10MG |
Cas.: 928320-12-1 | Purity: 98% | AS-1892802 | ESD-913107-5MG |
Cas.: 928853-86-5 | Purity: 98% | 15-Lipoxygenase Inhibitor 1 (15-LO Inhibitor 1) | ESD-913108-5MG |
Cas.: 929042-39-7 | Purity: 98% | [3,2-c]Pyrazole-androst-4-en-17β-ol | ESD-913109-5MG |
Cas.: 929106-58-1 | Purity: 98% | Carvedilol-d5 | ESD-913110-1MG |
Cas.: 929221-88-5 | Purity: 98% | Rimonabant-d10 | ESD-913111-1MG |
Cas.: 92924-45-3 | Purity: 98% | SNOB 1 Reagent (S-Nitrosylated Binding 1 Reagent) | ESD-913112-5MG |
Cas.: 92933-48-7 | Purity: 98% | LUF6283 | ESD-913113-10MG |
Cas.: 929-79-3 | Purity: 98% | Δ2-trans-Hexadecenoic Acid | ESD-913114-10MG |
Cas.: 930772-88-6 | Purity: 98% | SAHA-Bpyne | ESD-913115-1MG |
Cas.: 93100-99-3 | Purity: 98% | W-15 | ESD-913116-5MG |
Cas.: 93101-02-1 | Purity: ≥98% | W-18 | ESD-913117-5MG |
Cas.: 93138-53-5 | Purity: 98% | 1-Benzyl-2-methylpiperazine hydrochloride | ESD-913118-1MG |
Cas.: 931695-79-3 | Purity: 98% | ML-191 | ESD-913119-10MG |
Cas.: 93261-39-3 | Purity: 98% | 1-Naphthyl 3,5-dinitrobenzoate | ESD-913120-5MG |
Cas.: 932730-52-4 | Purity: 98% | CDDO-TFEA | ESD-913121-5MG |
Cas.: 933030-60-5 | Purity: 98% | (E)-C-HDMAPP (ammonium salt) ((E)-5-hydroxy-4-methylpent-3-enyl pyrophosphate) | ESD-913122-500ΜG |
Cas.: 93307-24-5 | Purity: 98% | 4′-chloro-α-Pyrrolidinopropiophenone hydrochloride | ESD-913123-10MG |
Cas.: 933786-58-4 | Purity: 98% | CAY10561 (Pyrazolylpyrrole ERK Inhibitor) | ESD-913124-5MG |
Cas.: 934182-09-9 | Purity: 98% | CYPMPO (RR 071) | ESD-913125-5MG |
Cas.: 934293-92-2 | Purity: 98% | Omeprazole-d3 | ESD-913126-5MG |
Cas.: 934294-22-1 | Purity: 98% | Lansoprazole-d4 | ESD-913127-1MG |
Cas.: 934464-77-4 | Purity: 98% | Kibdelone A | ESD-913128-1MG |
Cas.: 934464-78-5 | Purity: 98% | Kibdelone B | ESD-913129-1MG |
Cas.: 934464-79-6 | Purity: 98% | Kibdelone C ((+)-Kibdelone C) | ESD-913130-1MG |
Cas.: 93464-24-5 | Purity: 98% | Prostaglandin A1 ethyl ester (PGA1 ethyl ester) | ESD-913131-5MG |
Cas.: 934660-94-3 | Purity: 98% | Cobimetinib R-enantiomer | ESD-913132-5MG |
Cas.: 93515-00-5 | Purity: 98% | 2-Iodomelatonin | ESD-913133-10MG |
Cas.: 93616-27-4 | Purity: 98% | Teicoplanin A3-1 (Antibiotic L 17054) | ESD-913134-1MG |
Cas.: 936327-10-5 | Purity: 98% | AA-dUTP sodium salt | ESD-913136-1MG |
Cas.: 936500-94-6 | Purity: 98% | Elinogrel | ESD-913137-5MG |
Cas.: 936643-76-4 | Purity: 98% | 3-Pyrimidin-2-yl-2-pyrimidin-2-ylmethyl-Propionic Acid | ESD-913138-50MG |
Cas.: 936643-77-5 | Purity: 98% | 6-piperazin-1-yl-Isoquinoline hydrochloride | ESD-913139-50MG |
Cas.: 936643-79-7 | Purity: 98% | 8-piperazin-1-yl-Isoquinoline hydrochloride | ESD-913140-100MG |
Cas.: 936889-68-8 | Purity: ≥98% | OXA-01 | ESD-913141-5MG |
Cas.: 93752-78-4 | Purity: 98% | Lateropyrone (Avenacein Y) | ESD-913142-5MG |
Cas.: 93772-82-8 | Purity: 98% | Δ2-cis Eicosenoic Acid | ESD-913143-10MG |
Cas.: 937738-63-1 | Purity: 98% | Resolvin D1 methyl ester | ESD-913144-50ΜG |
Cas.: 937738-64-2 | Purity: 98% | 17(R)-Resolvin D1 methyl ester | ESD-913145-50ΜG |
Cas.: 938069-71-7 | Purity: 98% | CAY10526 | ESD-913146-5MG |
Cas.: 93839-89-5 | Purity: 98% | Adenosine 5′-(γ-thio)-triphosphate (lithium salt) (ATPγS) | ESD-913147-10MG |
Cas.: 93882-12-3 | Purity: 98% | 8-CPT-Cyclic AMP sodium salt | ESD-913148-50MG |
Cas.: 93908-02-2 | Purity: 98% | Rebeccamycin | ESD-913149-1MG |
Cas.: 93987-29-2 | Purity: 98% | BI-6015 | ESD-913150-10MG |
Cas.: 939960-34-6 | Purity: ≥98% | Orfamide A | ESD-913151-1MG |
Cas.: 939960-35-7 | Purity: ≥98% | Orfamide B | ESD-913152-1MG |
Cas.: 940002-59-5 | Purity: 98% | (–)-Sitagliptin Carbamoyl Glucuronide | ESD-913153-1MG |
Cas.: 94035-98-0 | Purity: 98% | 21-hydroxy Heneicosanoic Acid methyl ester | ESD-913154-10MG |
Cas.: 94036-00-7 | Purity: 98% | 17-hydroxy Heptadecanoic Acid methyl ester | ESD-913155-10MG |
Cas.: 94079-80-8 | Purity: 98% | Cicaprost (ZK 96480) | ESD-913156-1MG |
Cas.: 940867-25-4 | Purity: 98% | Docetaxel-d9 (Taxotel-d9) | ESD-913157-1MG |
Cas.: 940961-04-6 | Purity: 98% | NBD-Fructose | ESD-913158-1MG |
Cas.: 94109-05-4 | Purity: 98% | Docosanoyl Ethanolamide | ESD-913159-10MG |
Cas.: 94133-42-3 | Purity: 98% | (+)-Chloropseudoephedrine hydrochloride | ESD-913160-1MG |
Cas.: 942047-63-4 | Purity: 98% | Meloxicam-d3 | ESD-913161-1MG |
Cas.: 942069-11-6 | Purity: 98% | 20-HETE Ethanolamide | ESD-913162-50ΜG |
Cas.: 942285-55-4 | Purity: ≥98% | P11 | ESD-913163-5MG |
Cas.: 94292-80-5 | Purity: 98% | 6(S)-Lipoxin A4 | ESD-913164-50ΜG |
Cas.: 943022-11-5 | Purity: 98% | thio-Miltefosine | ESD-913165-5MG |
Cas.: 94359-12-3 | Purity: 98% | C22 Sphingomyelin (d18:1/22:0) | ESD-913166-500U |
Cas.: 94367-20-1 | Purity: 98% | Suc-Leu-Tyr-AMC (Suc-LY-AMC) | ESD-913167-50MG |
Cas.: 944130-99-8 | Purity: 98% | Rhodamine B isothiocyanate (mixed isomers) | ESD-913168-50MG |
Cas.: 944154-76-1 | Purity: 98% | MJ15 | ESD-913169-10MG |
Cas.: 94421-67-7 | Purity: 98% | Palmitoleoyl Ethanolamide (POEA) | ESD-913170-5MG |
Cas.: 94421-69-9 | Purity: 98% | Arachidoyl Ethanolamide (N-Arachidoylethanolamine) | ESD-913171-10MG |
Cas.: 94470-67-4 | Purity: 98% | (±)-Cromakalim (BRL 34915) | ESD-913172-10MG |
Cas.: 944997-60-8 | Purity: 98% | C3a Receptor Agonist | ESD-913173-1MG |
Cas.: 945-43-7 | Purity: 98% | 6,7-dimethyl-5,6,7,8-Tetrahydropterin hydrochloride | ESD-913174-10MG |
Cas.: 945716-28-9 | Purity: 98% | CAY10535 | ESD-913175-5MG |
Cas.: 94608-23-8 | Purity: 98% | cis-trismethoxy Resveratrol (cis-Trimethoxy Stilbene) | ESD-913177-50MG |
Cas.: 946152-80-3 | Purity: 98% | (1R,3R)-3-Hydroxycyclopentane carboxylic acid benzyl ester | ESD-913178-10MG |
Cas.: 946524-34-1 | Purity: 98% | Palmitoyl Ethanolamide-d4 | ESD-913179-1MG |
Cas.: 946524-41-0 | Purity: 98% | Eicosapentaenoyl Ethanolamide-d4 (EPEA-d4) | ESD-913180-1MG |
Cas.: 946524-43-2 | Purity: 98% | Docosahexaenoyl Ethanolamide-d4 | ESD-913181-5MG |
Cas.: 946572-73-2 | Purity: 98% | Capsiconiate (Coniferyl (E)-8-methyl-6-nonenoate) | ESD-913182-5MG |
Cas.: 947018-15-7 | Purity: 98% | Glucocorticoid Resistance Inhibitor | ESD-913183-1MG |
Cas.: 94709-12-3 | Purity: 98% | 3,4′,5-Trismethoxybenzophenone | ESD-913184-10MG |
Cas.: 94731-13-2 | Purity: 98% | (±)-4-hydroxy Propranolol β-D-Glucuronide | ESD-913185-1MG |
Cas.: 947381-58-0 | Purity: 98% | 1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE | ESD-913186-100ΜG |
Cas.: 947669-86-5 | Purity: 98% | WWL113 | ESD-913187-10MG |
Cas.: 947687-13-0 | Purity: 98% | Ramucirumab | ESD-913188-5MG |
Cas.: 94784-92-6 | Purity: 98% | 4-MTA hydrochloride | ESD-913189-1MG |
Cas.: 94825-74-8 | Purity: 98% | 3-O-methyl-N-acetyl-D-Glucosamine (3-O-methyl-GlcNAc) | ESD-913190-10MG |
Cas.: 94850-28-9 | Purity: 98% | 5,7-dichloro Tryptamine hydrochloride | ESD-913191-5MG |
Cas.: 94885-02-6 | Purity: 98% | C6 NBD Ceramide (d18:1/6:0) | ESD-913192-1MG |
Cas.: 94885-04-8 | Purity: 98% | C6 NBD Sphingomyelin (d18:1/6:0) | ESD-913193-1MG |
Cas.: 949004-12-0 | Purity: 98% | (25S)-Δ7-Dafachronic Acid (UPF-1404) | ESD-913194-100ΜG |
Cas.: 94944-70-4 | Purity: 98% | 2-Acetyl-5-tetrahydroxybutyl Imidazole | ESD-913195-5MG |
Cas.: 949564-89-0 | Purity: 98% | 15-keto-17-phenyl trinor Prostaglandin F2α (15-keto-17-phenyl trinor PGF2α) | ESD-913196-5MG |
Cas.: 95037-06-2 | Purity: 98% | C18 L-threo Ceramide (d18:1/18:0) | ESD-913197-1MG |
Cas.: 950-99-2 | Purity: 98% | 2,2,5,7,8-Pentamethyl-6-Chromanol | ESD-913198-100MG |
Cas.: 951209-67-9 | Purity: 98% | Prostaglandin E2 serinol amide (PGE2-SA) | ESD-913199-5MG |
Cas.: 951319-59-8 | Purity: 98% | 16-phenoxy Prostaglandin F2α ethyl amide (16-phenoxy PGF2α ethyl amide) | ESD-913200-5MG |
Cas.: 95153-31-4 | Purity: 98% | Perindoprilat (S-9780) | ESD-913201-5MG |
Cas.: 95398-45-1 | Purity: 98% | A-54556A | ESD-913202-1MG |
Cas.: 95497-55-5 | Purity: 98% | 9(Z),11(E),13(Z)-Octadecatrienoic Acid methyl ester | ESD-913203-5MG |
Cas.: 955382-52-2 | Purity: 98% | Avenanthramide-C methyl ester | ESD-913204-1MG |
Cas.: 956025-83-5 | Purity: 98% | 3MB-PP1 | ESD-913205-5MG |
Cas.: 956154-63-5 | Purity: 98% | TCS HDAC6 20b | ESD-913206-1MG |
Cas.: 95649-37-9 | Purity: 98% | Indole-3-amidoxime | ESD-913207-100MG |
Cas.: 957136-80-0 | Purity: 98% | 4-(2,2,3-Trimethylcyclopentyl)butanoic Acid (GIV3727) | ESD-913208-5MG |
Cas.: 958001-92-8 | Purity: 98% | Ac-DNLD-AMC | ESD-913209-1MG |
Cas.: 958025-66-6 | Purity: 98% | MPC-3100 | ESD-913210-5MG |
Cas.: 958293-77-1 | Purity: 98% | (±)-Naproxen-d3 (DL-Naproxen-d3) | ESD-913211-1MG |
Cas.: 95847-70-4 | Purity: 98% | Ipsapirone (TVXQ 7821) | ESD-913212-10MG |
Cas.: 95864-17-8 | Purity: 98% | 10-Pyrene-PC (1-Palmitoyl-2-pyrenedecanoyl Phosphatidylcholine) | ESD-913213-5MG |
Cas.: 959151-50-9 | Purity: 98% | PF-750 | ESD-913214-5MG |
Cas.: 95927-67-6 | Purity: 98% | Swinholide A | ESD-913215-50ΜG |
Cas.: 95933-74-7 | Purity: 98% | Trimidox (VF 233) | ESD-913216-10MG |
Cas.: 95933-75-8 | Purity: 98% | Trimidox hydrochloride (CF 233 hydrochloride) | ESD-913217-5MG |
Cas.: 959417-21-1 | Purity: 98% | 4-hydroxy Alternariol | ESD-913218-1MG |
Cas.: 959605-90-4 | Purity: 98% | Zolpidem-d6 (SL 80-0750-d6) | ESD-913219-1MG |
Cas.: 959761-62-7 | Purity: 98% | N-Arachidonoyl-3-hydroxy-γ-Aminobutyric Acid (NAG-3H-ABA) | ESD-913220-5MG |
Cas.: 960129-66-2 | Purity: 98% | Extracellular Death Factor (EDF) | ESD-913221-5MG |
Cas.: 960151-65-9 | Purity: 98% | Tedatioxetine hydrobromide | ESD-913222-5MG |
Cas.: 960226-55-5 | Purity: 98% | Tadalafil-d3 | ESD-913223-1MG |
Cas.: 96027-74-6 | Purity: 98% | N-Desethylamiodarone hydrochloride | ESD-913224-5MG |
Cas.: 960593-70-8 | Purity: 98% | Docosapentaenoyl Chloride | ESD-913225-1MG |
Cas.: 96096-52-5 | Purity: 98% | MiPT (N-Methyl-N-Isopropyltryptamine) | ESD-913226-1MG |
Cas.: 96180-79-9 | Purity: 98% | Microcystin-LA | ESD-913227-100ΜG |
Cas.: 96440-68-5 | Purity: 98% | 15(R)-15-methyl Prostaglandin A2 (15(R)-15-methyl PGA2) | ESD-913228-5MG |
Cas.: 96750-66-2 | Purity: 98% | Chlorisondamine (iodide) | ESD-913229-5MG |
Cas.: 96801-55-7 | Purity: 98% | 2-thio-PAF | ESD-913230-5MG |
Cas.: 97040-38-5 | Purity: 98% | EOS (d18:1/30:0/18:2) | ESD-913231-1MG |
Cas.: 97151-02-5 | Purity: 98% | α-hydroxy Tamoxifen | ESD-913232-5MG |
Cas.: 97281-40-8 | Purity: 98% | Lysophosphatidylethanolamines (egg) | ESD-913233-5MG |
Cas.: 97281-51-1 | Purity: 98% | Phosphatidylethanolamines (soy) (PE (soy)) | ESD-913234-5MG |
Cas.: 97512-83-9 | Purity: 98% | S-Phenylsulfonylcysteine (SPSC) | ESD-913235-5MG |
Cas.: 97589-07-6 | Purity: 98% | Lipoxin B4 methyl ester (LXB4 methyl ester) | ESD-913236-50MG |
Cas.: 97643-35-1 | Purity: 98% | Lipoxin A4 methyl ester | ESD-913237-50MG |
Cas.: 97730-95-5 | Purity: 98% | (±)-SDZ-201 106 (DPI 201-106) | ESD-913238-10MG |
Cas.: 97743-99-2 | Purity: 98% | Desmethylcitalopram hydrochloride | ESD-913239-5MG |
Cas.: 97781-16-3 | Purity: 98% | Aspirin-d4 (Acetylsalicylic Acid-d4) | ESD-913240-5MG |
Cas.: 98049-69-5 | Purity: 98% | Lipoxin B4 (LXB4) | ESD-913241-50ΜG |
Cas.: 98326-32-0 | Purity: 98% | Senazodan | ESD-913242-5MG |
Cas.: 98374-54-0 | Purity: 98% | Siltenzepine | ESD-913243-5MG |
Cas.: 98462-03-4 | Purity: 98% | 8(S)-HETE | ESD-913244-50ΜG |
Cas.: 985-12-6 | Purity: 98% | Drotaverine hydrochloride | ESD-913245-50MG |
Cas.: 98524-19-7 | Purity: 98% | (±)9-HODE | ESD-913246-100ΜG |
Cas.: 98672-91-4 | Purity: 98% | SQ 29,548 | ESD-913247-5MG |
Cas.: 98813-13-9 | Purity: 98% | Bafilomycin D | ESD-913248-1MG |
Cas.: 98891-36-2 | Purity: 98% | L-Homopropargyl Glycine | ESD-913249-50MG |
Cas.: 99217-77-3 | Purity: 98% | (±)8-HEPE | ESD-913250-100ΜG |
Cas.: 99217-78-4 | Purity: 98% | (±)11-HEPE | ESD-913251-100ΜG |
Cas.: 992-65-4 | Purity: 98% | Erythromycin A N-oxide | ESD-913252-5MG |
Cas.: 99495-90-6 | Purity: 98% | R-(–)-Flecainide | ESD-913254-1MG |
Cas.: 99514-99-5 | Purity: 98% | 5-bromo-3-phenyl Salicylic Acid | ESD-913255-5MG |
Cas.: 99534-03-9 | Purity: 98% | PKA Inhibitor (5-24) (PKI (5-24) | ESD-913256-5MG |
Cas.: 99566-27-5 | Purity: 98% | Neuropeptide FF trifluoroacetate salt (NPFF) | ESD-913257-1MG |
Cas.: 99570-78-2 | Purity: 98% | K252b | ESD-913258-1MG |
Cas.: 99754-06-0 | Purity: ≥98% | ONO-RS-082 | ESD-913259-10MG |
Cas.: 99918-45-3 | Purity: 98% | Despropionyl meta-Methylfentanyl | ESD-913260-5MG |
Cas.: 99996-65-3 | Purity: 98% | [3,2-c]Pyrazole-5α-androstan-17β-ol | ESD-913261-5MG |
Cas.: 7553-56-2 | Purity: c(I2)=0.1000 mol/L in H2O | Iodine solution | ESD-812023-500ML |
Cas.: 120422-91-5 | Purity: 95% | 3-Methyl-1H-pyrazolo[4,3-c]pyridine | ESD-913262-1G |
Cas.: 16308-92-2 | Purity: 97% | 2,4-Dimethylbenzyl Alcohol | ESD-838161-1ML |
Cas.: 120422-91-5 | Purity: 95% | 3-Methyl-1H-pyrazolo[4,3-c]pyridine | ESD-913262-250MG |
Cas.: 321318-11-0 | Purity: 95% | 1-(3,5-Difluorophenyl)ethanamine hydrochloride | ESD-913263-1G |
Cas.: 321318-11-0 | Purity: 95% | 1-(3,5-Difluorophenyl)ethanamine hydrochloride | ESD-913263-250MG |
Cas.: 321318-11-0 | Purity: 95% | 1-(3,5-Difluorophenyl)ethanamine hydrochloride | ESD-913263-100MG |
Cas.: 1114559-14-6 | Purity: 95% | (R)-1-(4-chloro-3-fluorophenyl)ethan-1-amine | ESD-913264-1G |
Cas.: 1114559-14-6 | Purity: 95% | (R)-1-(4-chloro-3-fluorophenyl)ethan-1-amine | ESD-913264-250MG |
Cas.: 2025376-01-4 | Purity: 95% | (S)-2-Aminopentan-1-ol hydrochloride | ESD-913265-1G |
Cas.: 2025376-01-4 | Purity: 95% | (S)-2-Aminopentan-1-ol hydrochloride | ESD-913265-250MG |
Cas.: 34756-16-6 | Purity: ≥98% | 5-Methylfuran-2-propionaldehyde | ESD-913266-5G |
Cas.: 34756-16-6 | Purity: ≥98% | 5-Methylfuran-2-propionaldehyde | ESD-913266-25G |
Cas.: 34756-16-6 | Purity: ≥98% | 5-Methylfuran-2-propionaldehyde | ESD-913266-100G |
Cas.: 588702-80-1 | Purity: ≥97% | 2,3-Dihydro-5-benzofurancarboxylic acid methyl ester | ESD-828635-5G |
Cas.: 588702-80-1 | Purity: ≥97% | 2,3-Dihydro-5-benzofurancarboxylic acid methyl ester | ESD-828635-1G |
Cas.: 63160-13-4 | Purity: 98% | Davis oxaziridine | ESD-829671-25G |
Cas.: 63160-13-4 | Purity: 98% | Davis oxaziridine | ESD-829671-5G |
Cas.: 63160-13-4 | Purity: 98% | Davis oxaziridine | ESD-829671-1G |
Cas.: 63160-13-4 | Purity: 98% | Davis oxaziridine | ESD-829671-250MG |
Cas.: 3891-33-6 | Purity: 98% | 1,4-Bis(vinyloxy)-butane | ESD-913267-25ML |
Cas.: 3891-33-6 | Purity: 98% | 1,4-Bis(vinyloxy)-butane | ESD-913267-100ML |
Cas.: 3891-33-6 | Purity: 98% | 1,4-Bis(vinyloxy)-butane | ESD-913267-500ML |
Cas.: 935-04-6 | Purity: ≥97% | Benzyl vinyl ether | ESD-913268-1G |
Cas.: 935-04-6 | Purity: ≥97% | Benzyl vinyl ether | ESD-913268-5G |
Cas.: 935-04-6 | Purity: ≥97% | Benzyl vinyl ether | ESD-913268-25G |
Cas.: 944129-07-1 | Purity: 98% | 4-Chloro-2-fluoro-3-methoxyphenylboronic acid | ESD-913269-250MG |
Cas.: 944129-07-1 | Purity: 98% | 4-Chloro-2-fluoro-3-methoxyphenylboronic acid | ESD-913269-1G |
Cas.: 944129-07-1 | Purity: 98% | 4-Chloro-2-fluoro-3-methoxyphenylboronic acid | ESD-913269-5G |
Cas.: 506-37-6 | Purity: 90% | Nervonic acid | ESD-913270-5G |
Cas.: 506-37-6 | Purity: 90% | Nervonic acid | ESD-913270-250MG |
Cas.: 506-37-6 | Purity: 98% | Nervonic acid | ESD-913271-5G |
Cas.: 506-37-6 | Purity: 98% | Nervonic acid | ESD-913271-1G |
Cas.: 506-37-6 | Purity: 98% | Nervonic acid | ESD-913271-250MG |
Cas.: 506-37-6 | Purity: 90% | Nervonic acid | ESD-913270-1G |
Cas.: 5413-05-8 | Purity: 98% | Ethyl 2-phenylacetoacetate | ESD-913272-1G |
Cas.: 5413-05-8 | Purity: 98% | Ethyl 2-phenylacetoacetate | ESD-913272-5G |
Cas.: 5413-05-8 | Purity: 98% | Ethyl 2-phenylacetoacetate | ESD-913272-25G |
Cas.: 5413-05-8 | Purity: 98% | Ethyl 2-phenylacetoacetate | ESD-913272-100G |
Cas.: NONE8170 | Hematoxylin staining solution | ESD-913273-100ML | |
Cas.: 2305-25-1 | Purity: 99% | Ethyl 3-hydroxyhexanoate | ESD-809202-5G |
Cas.: 2305-25-1 | Purity: 99% | Ethyl 3-hydroxyhexanoate | ESD-809202-25G |
Cas.: 2305-25-1 | Purity: 99% | Ethyl 3-hydroxyhexanoate | ESD-809202-100G |
Cas.: 873-41-6 | Purity: 97% | 3,5,6-Trichloro-[1,2,4]triazine | ESD-830575-250MG |
Cas.: 25119-68-0 | Purity: 98% | Poly(methyl vinyl ether-alt-maleicacidmonobutylester) | ESD-913274-25G |
Cas.: 25119-68-0 | Purity: 98% | Poly(methyl vinyl ether-alt-maleicacidmonobutylester) | ESD-913274-100G |
Cas.: 25119-68-0 | Purity: 98% | Poly(methyl vinyl ether-alt-maleicacidmonobutylester) | ESD-913274-500G |
Cas.: 148757-88-4 | Purity: 99% | 4,4,5,5,5-Pentafluoro-1-pentanethiol | ESD-913276-1G |
Cas.: 148757-88-4 | Purity: 99% | 4,4,5,5,5-Pentafluoro-1-pentanethiol | ESD-913276-5G |
Cas.: 63512-50-5 | Purity: 95% | L-α-Hydroxyglutaric acid disodium salt | ESD-913277-5G |
Cas.: 148757-88-4 | Purity: 99% | 4,4,5,5,5-Pentafluoro-1-pentanethiol | ESD-913276-25G |
Cas.: 63512-50-5 | Purity: 95% | L-α-Hydroxyglutaric acid disodium salt | ESD-913277-1G |
Cas.: 9005-37-2 | Purity: 98% | Propyleneglycol Alginate | ESD-913278-25G |
Cas.: 9005-37-2 | Purity: 98% | Propyleneglycol Alginate | ESD-913278-100G |
Cas.: 128-63-2 | Purity: 97% | 1,3,6,8-Tetrabromopyrene | ESD-856436-25G |
Cas.: 25119-68-0 | Purity: Solid contains amount 48-52% | Poly(methyl vinyl ether-alt-maleicacidmonobutylester) | ESD-913275-25G |
Cas.: 25119-68-0 | Purity: Solid contains amount 48-52% | Poly(methyl vinyl ether-alt-maleicacidmonobutylester) | ESD-913275-100G |
Cas.: 25119-68-0 | Purity: Solid contains amount 48-52% | Poly(methyl vinyl ether-alt-maleicacidmonobutylester) | ESD-913275-500G |
Cas.: 2547-61-7 | Purity: >95.0%(T) | Trichloromethanesulfonyl Chloride | ESD-863780-250MG |
Cas.: 646-24-2 | Purity: 97% | 1,9-Diaminononane | ESD-913279-1G |
Cas.: 646-24-2 | Purity: 97% | 1,9-Diaminononane | ESD-913279-250MG |
Cas.: 110615-47-9 | Purity: 40% in water | Lauryl glucoside | ESD-913280-500ML |
Cas.: 25087-06-3 | Purity: Solid contains amount 48-52% | Poly(methyl vinyl ether-alt-maleic acid monoethyl ester) | ESD-913281-25G |
Cas.: 25087-06-3 | Purity: Solid contains amount 48-52% | Poly(methyl vinyl ether-alt-maleic acid monoethyl ester) | ESD-913281-100G |
Cas.: 25087-06-3 | Purity: Solid contains amount 48-52% | Poly(methyl vinyl ether-alt-maleic acid monoethyl ester) | ESD-913281-500G |
Cas.: 3162-58-1 | Sulfur trioxide trimethylamine complex | ESD-913282-100G | |
Cas.: 3162-58-1 | Sulfur trioxide trimethylamine complex | ESD-913282-25G | |
Cas.: 3162-58-1 | Sulfur trioxide trimethylamine complex | ESD-913282-5G | |
Cas.: 118-42-3 | Purity: 98% | 2-((4-((7-Chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethanol | ESD-913283-5G |
Cas.: 118-42-3 | Purity: 98% | 2-((4-((7-Chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethanol | ESD-913283-1G |
Cas.: 118-42-3 | Purity: 98% | 2-((4-((7-Chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethanol | ESD-913283-250MG |
Cas.: 14610-37-8 | Purity: 95% | N-Methyl-tert-butylamine | ESD-913285-25G |
Cas.: 14610-37-8 | Purity: 95% | N-Methyl-tert-butylamine | ESD-913285-5G |
Cas.: 14610-37-8 | Purity: 95% | N-Methyl-tert-butylamine | ESD-913285-1G |
Cas.: 475-31-0 | Purity: 97% | N-Choloylglycine | ESD-848870-25G |
Cas.: 615-76-9 | Purity: 98% | 6-Methyl-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2H)-one | ESD-913286-5G |
Cas.: 615-76-9 | Purity: 98% | 6-Methyl-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2H)-one | ESD-913286-1G |
Cas.: 55750-61-3 | Purity: 98% | N-Succinimidyl Maleimidoacetate | ESD-855540-250MG |
Cas.: 55750-61-3 | Purity: 98% | N-Succinimidyl Maleimidoacetate | ESD-855540-1G |
Cas.: 80-44-4 | Purity: ≥98.0% | Butyl Benzenesulfonate | ESD-864615-100ML |
Cas.: 610-16-2 | Purity: 97% | 2-(Dimethylamino)benzoic acid | ESD-840652-5G |
Cas.: 120-80-9 | Purity: AR, 99.5% | Catechol | ESD-805198-10KG |
Cas.: 61788-47-4 | Purity: ≥99% | Cocinic acid | ESD-905879-10KG |
Cas.: 91-20-3 | Purity: AR | Naphthalene | ESD-814788-20KG |
Cas.: 108-91-8 | Purity: >99.0%(GC) | Cyclohexylamine | ESD-804633-25L |
Cas.: 54247-05-1 | Purity: 98 atom % D | 1,3-Dinitrobenzene-d4 | ESD-874758-500MG |
Cas.: 70504-28-8 | Purity: ≥98% | decyl 2-(trimethylammonio)ethyl phosphate | ESD-887317-250MG |
Cas.: 63148-67-4 | Mw~1000 | Polysulfide rubber | ESD-913288-25G |
Cas.: 63148-67-4 | Mw~1000 | Polysulfide rubber | ESD-913288-100G |
Cas.: 63148-67-4 | Mw~1000 | Polysulfide rubber | ESD-913288-500G |
Cas.: 63148-67-4 | Mw~1000 | Polysulfide rubber | ESD-913288-2.5KG |
Cas.: 71027-02-6 | Purity: 97% | 4,4,4-Trifluorocrotonic acid | ESD-913289-250MG |
Cas.: 64165-64-6 | Purity: 98% | DL-Propargylglycine | ESD-856237-1G |
Cas.: 71027-02-6 | Purity: 97% | 4,4,4-Trifluorocrotonic acid | ESD-913289-1G |
Cas.: 71027-02-6 | Purity: 97% | 4,4,4-Trifluorocrotonic acid | ESD-913289-5G |
Cas.: 71027-02-6 | Purity: 97% | 4,4,4-Trifluorocrotonic acid | ESD-913289-25G |
Cas.: 64165-64-6 | Purity: 98% | DL-Propargylglycine | ESD-856237-250MG |
Cas.: 62978-73-8 | Purity: 97% | 5-Acetyl-8-hydroxy-1H-quinolin-2-one | ESD-913290-250MG |
Cas.: 62978-73-8 | Purity: 97% | 5-Acetyl-8-hydroxy-1H-quinolin-2-one | ESD-913290-1G |
Cas.: 62978-73-8 | Purity: 97% | 5-Acetyl-8-hydroxy-1H-quinolin-2-one | ESD-913290-5G |
Cas.: 6860-47-5 | Purity: ≥98%(HPLC) | Xylobiose | ESD-861207-250MG |
Cas.: 659-72-3 | Purity: 95% | Ethyl 4,4-difluoropentanoate | ESD-913291-250MG |
Cas.: 10192-85-5 | Purity: 95% | PotassiumAcrylate | ESD-886124-100G |
Cas.: 10192-85-5 | Purity: 95% | PotassiumAcrylate | ESD-886124-500G |
Cas.: 10192-85-5 | Purity: 95% | PotassiumAcrylate | ESD-886124-2.5KG |
Cas.: 100331-89-3 | Purity: 98% | 8-Benzyloxy-5-(2-bromoacetyl)-2-hydroxyquinoline | ESD-913292-1G |
Cas.: 100331-89-3 | Purity: 98% | 8-Benzyloxy-5-(2-bromoacetyl)-2-hydroxyquinoline | ESD-913292-5G |
Cas.: 100331-89-3 | Purity: 98% | 8-Benzyloxy-5-(2-bromoacetyl)-2-hydroxyquinoline | ESD-913292-25G |
Cas.: 76738-62-0 | Purity: 95% | Paclobutrazol | ESD-909631-500G |
Cas.: 14075-53-7 | Purity: AR, 99.0% | Potassium fluoroborate | ESD-816426-10KG |
Cas.: 122-48-5 | Purity: 97%, spice grade | Vanillylacetone | ESD-820488-5G |
Cas.: 21535-97-7 | Purity: ≥98%(GC) | 3-Methylbenzofuran | ESD-862474-5G |
Cas.: 1350518-27-2 | Purity: 95% | 2,3,6,7,10,11-hexaaminotriphenylene | ESD-886243-50MG |
Cas.: 159635-39-9 | Purity: 95% | Spiro[Chromene-2,4′-pipidin]-4(3H)-one hydrochloride | ESD-881885-5G |
Cas.: 95-01-2 | Purity: 98% | 2,4-Dihydroxybenzaldehyde | ESD-807024-2.5KG |
Cas.: 5867-45-8 | Purity: 98% | 3-Acetamidopyridine | ESD-870705-5G |
Cas.: 207671-51-0 | Purity: 99,9% | Scandium(III) Acetate Hydrate | ESD-850365-25G |
Cas.: 45534-08-5 | Purity: 97% | 3-(Methylthio)-1H-1,2,4-triazol-5-amine | ESD-838759-5G |
Cas.: 929-62-4 | Purity: ≥99% | 1-(vinyloxy)octane | ESD-913287-100G |
Cas.: 929-62-4 | Purity: ≥99% | 1-(vinyloxy)octane | ESD-913287-500G |
Cas.: 2366-56-5 | Purity: 98% | Methyl 2-Fluoropropanoate | ESD-913294-5G |
Cas.: 2366-56-5 | Purity: 98% | Methyl 2-Fluoropropanoate | ESD-913294-1G |
Cas.: 623-53-0 | Purity: 98% | Ethyl methyl carbonate (EMC) | ESD-808984-10L |
Cas.: 327-92-4 | Purity: 97% | 1,5-Difluoro-2,4-dinitrobenzene | ESD-806532-100G |
Cas.: 25037-45-0 | Purity: average Mw ~26, 000 by GPC | Poly(Bisphenol A carbonate) | ESD-888353-2.5KG |
Cas.: 119736-16-2 | Purity: ≥95% | 3-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid | ESD-890995-100G |
Cas.: 15791-87-4 | Purity: 98% | 4,6-Diaminoresorcinol | ESD-906146-5G |
Cas.: 87392-05-0 | Purity: 98% | (R)-(+)-Tetrahydro-2-furoic acid | ESD-828538-500G |
Cas.: 34193-38-9 | Purity: 99 atom % D | 1-Butanol-d10 | ESD-874539-250MG |
Cas.: 382150-50-7 | Purity: 98%, LC&T | 1-Hexyl-3-methylimidazolium Bis(trifluoromethanesulfonyl)imide | ESD-849549-25G |
Cas.: 502-47-6 | Purity: 95% | Citronellic Acid | ESD-869004-25ML |
Cas.: 1792-40-1 | Purity: 98% | 2-Methyl-5-nitro-1H-benzo[d]imidazole | ESD-843464-5G |
Cas.: 30636-90-9 | Purity: >98% | Protopanaxdiol | ESD-816273-500MG |
Cas.: 9068-59-1 | Purity: BR, 50u/mg | Dispase | ESD-832688-1KG |
Cas.: 9068-59-1 | Purity: BR, 50u/mg | Dispase | ESD-832688-5KG |
Cas.: 142-87-0 | Purity: Ion pair Chromatography grade, ≥99% | Sodium decyl sulfate | ESD-818433-1G |
Cas.: 2365173-46-0 | Purity: 95% | ethyl 4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)cyclohexane-1-carboxylate | ESD-913295-1G |
Cas.: 2365173-46-0 | Purity: 95% | ethyl 4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)cyclohexane-1-carboxylate | ESD-913295-5G |
Cas.: 7697-46-3 | Purity: ≥98% | 2-Benzoylpyrrole | ESD-865522-25G |
Cas.: 41292-66-4 | Purity: ≥95% | 2-Methyl-1H-benzo[d]imidazol-5-ol | ESD-891448-1G |
Cas.: 2246878-23-7 | Purity: 98% | 2-((1,4-dioxaspiro[4.5]decan-8-ylidene)methyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913296-1G |
Cas.: 2246878-23-7 | Purity: 98% | 2-((1,4-dioxaspiro[4.5]decan-8-ylidene)methyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913296-5G |
Cas.: 766-92-7 | Purity: 98% | Benzyl Methyl Sulfide | ESD-858173-100G |
Cas.: 58656-99-8 | Purity: 98% | TERT-BUTYL 3-NITROBENZOATE | ESD-913297-5G |
Cas.: 58656-99-8 | Purity: 98% | TERT-BUTYL 3-NITROBENZOATE | ESD-913297-1G |
Cas.: 6770-38-3 | Purity: ≥98% | 1,4-Bis(Methoxymethyl)Benzene | ESD-858577-100G |
Cas.: 6770-38-3 | Purity: ≥98% | 1,4-Bis(Methoxymethyl)Benzene | ESD-858577-500G |
Cas.: 349-49-5 | Purity: ≥95% | 4-(trifluoromethyl)thiazol-2-amine | ESD-827734-5G |
Cas.: NONE8171 | Purity: 95% | tert-butyl bicyclo[6.1.0]nonan-9-ylcarbamate | ESD-913298-1G |
Cas.: NONE8171 | Purity: 95% | tert-butyl bicyclo[6.1.0]nonan-9-ylcarbamate | ESD-913298-250MG |
Cas.: 1955-67-5 | Purity: 97% | L-Glutamic acid γ-monohydroxamate | ESD-885851-50MG |
Cas.: 1083162-61-1 | Purity: 99% | FIN56 | ESD-872873-25MG |
Cas.: 72258-14-1 | Purity: 98% | 3-(ethoxycarbonyl)tricyclo[3.2.1.0<<2,4>>]octane | ESD-913299-1G |
Cas.: 72258-14-1 | Purity: 98% | 3-(ethoxycarbonyl)tricyclo[3.2.1.0<<2,4>>]octane | ESD-913299-5G |
Cas.: 72258-14-1 | Purity: 98% | 3-(ethoxycarbonyl)tricyclo[3.2.1.0<<2,4>>]octane | ESD-913299-250MG |
Cas.: 1571-85-3 | Purity: ≥95% | 6-Nitro-2-phenyl-1H-benzo[d]imidazole | ESD-897681-5G |
Cas.: 57683-71-3 | Purity: 98% | Methyl 2-(Aminosulfonyl)benzoate | ESD-812805-2.5KG |
Cas.: 1212345-30-6 | Purity: 98% | tricyclo[3.2.1.0<<2,4>>]octane-3-carboxylic acid | ESD-913300-1G |
Cas.: 1212345-30-6 | Purity: 98% | tricyclo[3.2.1.0<<2,4>>]octane-3-carboxylic acid | ESD-913300-5G |
Cas.: 1212345-30-6 | Purity: 98% | tricyclo[3.2.1.0<<2,4>>]octane-3-carboxylic acid | ESD-913300-250MG |
Cas.: 96-27-5 | Purity: 97%, Use For Cell Culture | 1-Thioglycerol | ESD-819382-2.5KG |
Cas.: 6009-70-7 | Purity: AR, 99.8% | Ammonium oxalate monohydrate | ESD-800946-10KG |
Cas.: 50925-42-3 | Purity: 95% | Direct Yellow 86 | ESD-910143-5KG |
Cas.: 7727-43-7 | Purity: 2μm, medical grade | Barium sulfate | ESD-875381-2.5KG |
Cas.: NONE8172 | Purity: 95% | tert-butyl tricyclo[3.2.1.0<<2,4>>]octan-3-ylcarbamate | ESD-913301-1G |
Cas.: NONE8172 | Purity: 95% | tert-butyl tricyclo[3.2.1.0<<2,4>>]octan-3-ylcarbamate | ESD-913301-250MG |
Cas.: 51550-25-5 | Purity: AR | Beryllon II | ESD-802321-1G |
Cas.: NONE8173 | Purity: 98% | tert-butyl (3-oxabicyclo[4.1.0]heptan-7-yl)carbamate | ESD-913302-1G |
Cas.: NONE8173 | Purity: 98% | tert-butyl (3-oxabicyclo[4.1.0]heptan-7-yl)carbamate | ESD-913302-250MG |
Cas.: 12068-69-8 | Purity: 99.99% metals basis | Bismuth selenide | ESD-803367-250G |
Cas.: 89555-39-5 | Purity: 99% | methyl 1-bromonaphthalene-2-carboxylate | ESD-856526-1G |
Cas.: 308068-56-6 | Purity: >95%, ID:2-5nm, OD:<8nm, Length:0.5-2μm, -OH:~5.6wt% | Short Hydroxy Purified Multi-Walled Carbon Nanotubes | ESD-835664-5G |
Cas.: 89555-39-5 | Purity: 99% | methyl 1-bromonaphthalene-2-carboxylate | ESD-856526-5G |
Cas.: NONE8174 | Purity: 98% | 4,4,5,5-tetramethyl-2-((2-methylcyclohexylidene)methyl)-1,3,2-dioxaborolane | ESD-913303-1G |
Cas.: NONE8174 | Purity: 98% | 4,4,5,5-tetramethyl-2-((2-methylcyclohexylidene)methyl)-1,3,2-dioxaborolane | ESD-913303-5G |
Cas.: 89555-39-5 | Purity: 99% | methyl 1-bromonaphthalene-2-carboxylate | ESD-856526-25G |
Cas.: NONE8175 | Purity: 90% | ethyl 3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)cyclobutane-1-carboxylate | ESD-913304-1G |
Cas.: NONE8175 | Purity: 90% | ethyl 3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)cyclobutane-1-carboxylate | ESD-913304-5G |
Cas.: 57381-43-8 | Purity: 98% | 2,5-Dibromobenzoic Acid Methyl Ester | ESD-823551-10G |
Cas.: 83947-50-6 | Purity: 94% | 2-(2,2-diphenylvinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913305-1G |
Cas.: 95975-55-6 | Purity: BR | Guggulsterone E&Z | ESD-873825-25MG |
Cas.: 83947-50-6 | Purity: 94% | 2-(2,2-diphenylvinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913305-5G |
Cas.: 22717-57-3 | Purity: 95% | Methyl 5-methylsalicylate | ESD-824150-1G |
Cas.: 22717-57-3 | Purity: 95% | Methyl 5-methylsalicylate | ESD-824150-25G |
Cas.: 929-77-1 | Purity: 99% | Methyl behenate | ESD-813994-5G |
Cas.: 92339-11-2 | Purity: BR | Iodixanol | ESD-873705-1G |
Cas.: 2243-58-5 | Purity: 95% | Naphthalen-2-ylhydrazine hydrochloride | ESD-842349-500G |
Cas.: 2246650-11-1 | Purity: 98% | 2-((4,4-difluorocyclohexylidene)methyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913306-1G |
Cas.: 2246650-11-1 | Purity: 98% | 2-((4,4-difluorocyclohexylidene)methyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913306-5G |
Cas.: 13463-67-7 | Purity: 99.99% metals basis | Titanium oxide, rutile | ESD-818991-2.5KG |
Cas.: 9048-46-8 | Purity: 10% solution | Bovine Serum Albumin Solution | ESD-885115-50ML |
Cas.: 145826-81-9 | Purity: ≥97% | Tetraethylammonium Fluoride Tetrahydrofluoride | ESD-867766-5G |
Cas.: NONE8176 | Purity: 96% | 1-(tert-butyl) 2-methyl (S)-4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)pyrrolidine-1,2-dicarboxylate | ESD-913307-1G |
Cas.: NONE8176 | Purity: 96% | 1-(tert-butyl) 2-methyl (S)-4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)pyrrolidine-1,2-dicarboxylate | ESD-913307-5G |
Cas.: 53795-92-9 | Purity: 98 atom % D | DL-Alanine,2,3,3,3-d4 | ESD-874275-250MG |
Cas.: 157945-82-9 | Purity: 98% | (E)-2-(2-cyclopentylvinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913308-1G |
Cas.: 157945-82-9 | Purity: 98% | (E)-2-(2-cyclopentylvinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913308-5G |
Cas.: 2246919-45-7 | Purity: 99% | 2-(2-cyclopropylprop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913309-1G |
Cas.: 2246919-45-7 | Purity: 99% | 2-(2-cyclopropylprop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913309-5G |
Cas.: NONE8177 | Purity: 91% | 4,4,5,5-tetramethyl-2-((3-methylcyclopent-2-en-1-ylidene)methyl)-1,3,2-dioxaborolane | ESD-913310-1G |
Cas.: NONE8177 | Purity: 91% | 4,4,5,5-tetramethyl-2-((3-methylcyclopent-2-en-1-ylidene)methyl)-1,3,2-dioxaborolane | ESD-913310-5G |
Cas.: 6136-93-2 | Purity: 98% | 2,2-Diethoxy Acetonitrile | ESD-833870-500G |
Cas.: 6136-93-2 | Purity: 98% | 2,2-Diethoxy Acetonitrile | ESD-833870-100G |
Cas.: 6136-93-2 | Purity: 98% | 2,2-Diethoxy Acetonitrile | ESD-833870-25G |
Cas.: 1216805-11-6 | Purity: 98% | 2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindoline-5-carboxylic acid | ESD-913311-1G |
Cas.: 1216805-11-6 | Purity: 98% | 2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindoline-5-carboxylic acid | ESD-913311-5G |
Cas.: 6136-93-2 | Purity: 98% | 2,2-Diethoxy Acetonitrile | ESD-833870-5G |
Cas.: 1216805-11-6 | Purity: 98% | 2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindoline-5-carboxylic acid | ESD-913311-10G |
Cas.: 17104-75-5 | Purity: 98% | trimethyl 4,4′,4”-nitrilotribenzoate | ESD-913313-1G |
Cas.: 17104-75-5 | Purity: 98% | trimethyl 4,4′,4”-nitrilotribenzoate | ESD-913313-5G |
Cas.: 2920-38-9 | Purity: 97% | 4-Phenylbenzonitrile | ESD-815518-500G |
Cas.: 57103-02-3 | Purity: 98% | 3,6-diiodo-9H-carbazole | ESD-832151-500G |
Cas.: 874990-36-0 | Purity: 98% | ethyl (trans)-1-benzyl-4-(m-tolyl)pyrrolidine-3-carboxylate | ESD-913315-1G |
Cas.: 62020-09-1 | Purity: >98.0%(GC) | Methyl methanesulfonylacetate | ESD-814403-100G |
Cas.: 874990-36-0 | Purity: 98% | ethyl (trans)-1-benzyl-4-(m-tolyl)pyrrolidine-3-carboxylate | ESD-913315-250MG |
Cas.: 874990-36-0 | Purity: 98% | ethyl (trans)-1-benzyl-4-(m-tolyl)pyrrolidine-3-carboxylate | ESD-913315-100MG |
Cas.: 290331-71-4 | Purity: 95% | 1-Boc-5-methoxyindole-2-boronic acid | ESD-913314-1G |
Cas.: 290331-71-4 | Purity: 95% | 1-Boc-5-methoxyindole-2-boronic acid | ESD-913314-250MG |
Cas.: 98114-32-0 | Purity: 95% | Reactive Red 180 | ESD-910146-1KG |
Cas.: 4455-15-6 | Purity: ≥98% | Ethyl 2-(methylsulfonyl)acetate | ESD-827537-100G |
Cas.: 4455-15-6 | Purity: ≥98% | Ethyl 2-(methylsulfonyl)acetate | ESD-827537-5G |
Cas.: NONE8179 | Purity: 99% | 2-(2-(3-methoxyphenyl)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913316-1G |
Cas.: NONE8179 | Purity: 99% | 2-(2-(3-methoxyphenyl)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913316-5G |
Cas.: 159119-10-5 | Purity: 99% | 2-Fluoro-4-(trans-4-propylcyclohexyl)phenylboronic acid | ESD-913312-250MG |
Cas.: 9002-12-4 | Purity: from arthrobacter protophormiae, ≥20 u/mg | URICASE | ESD-833294-250MG |
Cas.: 159119-10-5 | Purity: 99% | 2-Fluoro-4-(trans-4-propylcyclohexyl)phenylboronic acid | ESD-913312-1G |
Cas.: 159119-10-5 | Purity: 99% | 2-Fluoro-4-(trans-4-propylcyclohexyl)phenylboronic acid | ESD-913312-5G |
Cas.: 944896-42-8 | Purity: 95% | 6-Bromoimidazo[1,2-a]pyridine-3-carboxylic Acid | ESD-852013-25G |
Cas.: 944896-42-8 | Purity: 95% | 6-Bromoimidazo[1,2-a]pyridine-3-carboxylic Acid | ESD-852013-5G |
Cas.: 1398771-21-5 | Purity: 99% | 4,4,5,5-tetramethyl-2-(2-(p-tolyl)prop-1-en-1-yl)-1,3,2-dioxaborolane | ESD-913317-1G |
Cas.: 1398771-21-5 | Purity: 99% | 4,4,5,5-tetramethyl-2-(2-(p-tolyl)prop-1-en-1-yl)-1,3,2-dioxaborolane | ESD-913317-5G |
Cas.: 30379-55-6 | Purity: >95.0%(GC) | Benzyloxyacetic acid | ESD-804058-250G |
Cas.: 30379-55-6 | Purity: >95.0%(GC) | Benzyloxyacetic acid | ESD-804058-50G |
Cas.: 163006-96-0 | Purity: 99% | (4-(trans-3-Fluoro-4-pentylcyclohexyl)phenyl)boronic acid | ESD-913318-250MG |
Cas.: 30379-55-6 | Purity: >95.0%(GC) | Benzyloxyacetic acid | ESD-804058-10G |
Cas.: 163006-96-0 | Purity: 99% | (4-(trans-3-Fluoro-4-pentylcyclohexyl)phenyl)boronic acid | ESD-913318-1G |
Cas.: 163006-96-0 | Purity: 99% | (4-(trans-3-Fluoro-4-pentylcyclohexyl)phenyl)boronic acid | ESD-913318-5G |
Cas.: 1187525-05-8 | Purity: 99% | 2-(2-(4-chloro)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913319-1G |
Cas.: 1187525-05-8 | Purity: 99% | 2-(2-(4-chloro)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913319-5G |
Cas.: 21293-29-8 | Purity: ≥90% (HPLC) | (+)-Abscisic acid | ESD-800057-25G |
Cas.: 1398771-27-1 | Purity: 99% | 2-(2-(4-Bromo)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913320-1G |
Cas.: 1398771-27-1 | Purity: 99% | 2-(2-(4-Bromo)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913320-5G |
Cas.: NONE8180 | Purity: 98% | 2-(2-(3-Bromo)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913321-1G |
Cas.: NONE8180 | Purity: 98% | 2-(2-(3-Bromo)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913321-5G |
Cas.: NONE8181 | Purity: 98% | 2-(2-(3-chlorophenyl)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913322-1G |
Cas.: NONE8181 | Purity: 98% | 2-(2-(3-chlorophenyl)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913322-5G |
Cas.: 1398771-23-7 | Purity: 98% | 4,4,5,5-tetramethyl-2-(2-(m-tolyl)prop-1-en-1-yl)-1,3,2-dioxaborolane | ESD-913323-1G |
Cas.: 1398771-23-7 | Purity: 98% | 4,4,5,5-tetramethyl-2-(2-(m-tolyl)prop-1-en-1-yl)-1,3,2-dioxaborolane | ESD-913323-5G |
Cas.: 1398771-24-8 | Purity: 98% | 2-(2-(4-methoxyphenyl)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913324-1G |
Cas.: 1398771-24-8 | Purity: 98% | 2-(2-(4-methoxyphenyl)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913324-5G |
Cas.: 16627-68-2 | Purity: ≥98% | 1,1,2,2-Tetrafluoroethyl-2,2,3,3-Tetrafluoropropylether | ESD-854672-500G |
Cas.: 1398771-25-9 | Purity: 97% | 2-(2-(2-methoxyphenyl)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913325-1G |
Cas.: 1398771-25-9 | Purity: 97% | 2-(2-(2-methoxyphenyl)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913325-5G |
Cas.: 1398771-28-2 | Purity: 98% | 2-(2-(3-fluorophenyl)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913326-1G |
Cas.: 1398771-28-2 | Purity: 98% | 2-(2-(3-fluorophenyl)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913326-5G |
Cas.: 2246920-03-4 | Purity: 99% | 2-(2-(2-chlorophenyl)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913327-1G |
Cas.: 1277-43-6 | Purity: 95% | Bis(cyclopentadienyl)cobalt(II) | ESD-836087-5G |
Cas.: 2246920-03-4 | Purity: 99% | 2-(2-(2-chlorophenyl)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-913327-5G |
Cas.: 1144037-43-3 | Purity: 98% | tert-butyl 4-(2-(4-chlorophenoxy)acetyl)piperazine-1-carboxylate | ESD-913328-500MG |
Cas.: 1144037-43-3 | Purity: 98% | tert-butyl 4-(2-(4-chlorophenoxy)acetyl)piperazine-1-carboxylate | ESD-913328-1G |
Cas.: 1144037-43-3 | Purity: 98% | tert-butyl 4-(2-(4-chlorophenoxy)acetyl)piperazine-1-carboxylate | ESD-913328-5G |
Cas.: 1144037-44-4 | Purity: 98% | 2-(4-chlorophenoxy)-1-(piperazin-1-yl)ethan-1-one hydrochloride | ESD-913329-1G |
Cas.: 1144037-44-4 | Purity: 98% | 2-(4-chlorophenoxy)-1-(piperazin-1-yl)ethan-1-one hydrochloride | ESD-913329-5G |
Cas.: 129181-43-7 | Purity: 98% | tert-butyldimethyl(4-(prop-1-en-2-yl)phenoxy)silane | ESD-913330-1G |
Cas.: 129181-43-7 | Purity: 98% | tert-butyldimethyl(4-(prop-1-en-2-yl)phenoxy)silane | ESD-913330-5G |
Cas.: 1590372-40-9 | Purity: 98% | tert-butyl 3-(2-ethoxy-2-oxoethylidene)piperidine-1-carboxylate | ESD-913331-1G |
Cas.: 1590372-40-9 | Purity: 98% | tert-butyl 3-(2-ethoxy-2-oxoethylidene)piperidine-1-carboxylate | ESD-913331-5G |
Cas.: 883554-93-6 | Purity: 98% | 5-BROMO-2-NITRO-BENZOIC ACID METHYL ESTER | ESD-913332-1G |
Cas.: 883554-93-6 | Purity: 98% | 5-BROMO-2-NITRO-BENZOIC ACID METHYL ESTER | ESD-913332-5G |
Cas.: 883554-93-6 | Purity: 98% | 5-BROMO-2-NITRO-BENZOIC ACID METHYL ESTER | ESD-913332-10G |
Cas.: 9003-05-8 | Purity: Nonionic, MW: 12 million | Polyacrylamide | ESD-821242-10KG |
Cas.: 349-97-3 | Purity: 98% | 4-(TRIFLUOROMETHYL)ACETANILIDE | ESD-913333-5G |
Cas.: 349-97-3 | Purity: 98% | 4-(TRIFLUOROMETHYL)ACETANILIDE | ESD-913333-25G |
Cas.: 349-97-3 | Purity: 98% | 4-(TRIFLUOROMETHYL)ACETANILIDE | ESD-913333-1G |
Cas.: 105-05-5 | Purity: 99% | 1,4-Diethylbenzene (PDEB) | ESD-807119-2.5L |
Cas.: 1309-48-4 | Purity: Special for FRP | Magnesium oxide | ESD-875111-2.5KG |
Cas.: 106-49-0 | Purity: AR, 99.0% | |p|-Toluidine | ESD-819304-10KG |
Cas.: NONE6812 | Purity: 1.0M, pH8.5 | Tris-HCl Buffer | ESD-885403-1L |
Cas.: 100523-84-0 | Purity: 97% | 5-bromothiophene-3-carboxylic acid | ESD-803943-25G |
Cas.: 59729-32-7 | Purity: 98% | Citalopram hydrobromide | ESD-806098-25G |
Cas.: NONE8182 | Purity: 98% | bicyclo[6.1.0]nonan-9-amine hydrochloride | ESD-913334-100MG |
Cas.: NONE8182 | Purity: 98% | bicyclo[6.1.0]nonan-9-amine hydrochloride | ESD-913334-250MG |
Cas.: 2171802-75-6 | Purity: 95% | 3-oxabicyclo[4.1.0]heptan-7-amine hydrochloride | ESD-913335-100MG |
Cas.: 2171802-75-6 | Purity: 95% | 3-oxabicyclo[4.1.0]heptan-7-amine hydrochloride | ESD-913335-250MG |
Cas.: 113882-48-7 | Purity: 98% | benzyl pent-4-enoate | ESD-913336-1G |
Cas.: 113882-48-7 | Purity: 98% | benzyl pent-4-enoate | ESD-913336-5G |
Cas.: 86170-45-8 | Purity: 96% | benzyl but-3-enoate | ESD-913337-1G |
Cas.: 86170-45-8 | Purity: 96% | benzyl but-3-enoate | ESD-913337-5G |
Cas.: 1380291-49-5 | Purity: 97% | benzyl 3-(3-oxocyclobutyl)propanoate | ESD-913338-1G |
Cas.: 1380291-49-5 | Purity: 97% | benzyl 3-(3-oxocyclobutyl)propanoate | ESD-913338-500MG |
Cas.: 1380291-34-8 | Purity: 97% | 3-(3-oxocyclobutyl)propanoic acid | ESD-913339-250MG |
Cas.: 1380291-34-8 | Purity: 97% | 3-(3-oxocyclobutyl)propanoic acid | ESD-913339-1G |
Cas.: 2916-09-8 | Purity: 98% | 2-Ethyl-benzo[d][1,3]oxazin-4-one | ESD-913340-1G |
Cas.: 2916-09-8 | Purity: 98% | 2-Ethyl-benzo[d][1,3]oxazin-4-one | ESD-913340-5G |
Cas.: 2916-09-8 | Purity: 98% | 2-Ethyl-benzo[d][1,3]oxazin-4-one | ESD-913340-10G |
Cas.: 7789-38-0 | Purity: GR, 99.5% | Sodium bromate | ESD-817796-10KG |
Cas.: 10361-92-9 | Purity: powder, 99.99% metals basis | Yttrium chloride(III) | ESD-820646-1KG |
Cas.: 3460-44-4 | Purity: ≥98% | α-Methylbenzyl butyrate | ESD-859876-5G |
Cas.: 626-06-2 | Purity: ≥97% | 2,6-Dihydroxypyridine | ESD-850867-250MG |
Cas.: 52225-20-4 | Purity: ≥98% | DL-α-Tocopherol acetate | ESD-878657-500MG |
Cas.: 58880-19-6 | Purity: ≥98% | Trichostatin A | ESD-838462-25MG |
Cas.: 78560-47-1 | Purity: 95% | 1H,1H,2H,2H-Perfluorohexyltrichlorosilane | ESD-913342-100G |
Cas.: 78560-47-1 | Purity: 95% | 1H,1H,2H,2H-Perfluorohexyltrichlorosilane | ESD-913342-25G |
Cas.: 145-50-6 | α-Naphtholbenzein | ESD-854503-100G | |
Cas.: 78560-47-1 | Purity: 95% | 1H,1H,2H,2H-Perfluorohexyltrichlorosilane | ESD-913342-5G |
Cas.: 3012-65-5 | Purity: 98% | Ammonium citrate dibasic | ESD-800250-10KG |
Cas.: 58-05-9 | Purity: 98% | Folinic acid | ESD-885044-25MG |
Cas.: 597-52-4 | Purity: 97% | Triethylsilanol | ESD-819176-100ML |
Cas.: 21211-65-4 | Purity: ≥97.0%(GC) | 2,2′-Dipyrrolylmethane | ESD-832961-250MG |
Cas.: 95-48-7 | Purity: AR, 98% | |o|-Cresol | ESD-804949-2.5KG |
Cas.: 84775-42-8 | Purity: 95% | Anise oil | ESD-905730-2.5KG |
Cas.: 13893-53-3 | Purity: 90% | 2-Amino-2,3-dimethylbutanenitrile | ESD-838977-500G |
Cas.: 683-08-9 | Purity: 97% | Diethyl methylphosphonate | ESD-836696-100G |
Cas.: 1592-20-7 | Purity: 98%, stabilized with TBC | 4-Vinylbenzyl chloride | ESD-875829-500G |
Cas.: 860193-10-8 | Purity: 95% | 3-(2-ethoxyphenyl)-2-ethylquinazolin-4(3H)-one | ESD-913343-500MG |
Cas.: 860193-10-8 | Purity: 95% | 3-(2-ethoxyphenyl)-2-ethylquinazolin-4(3H)-one | ESD-913343-1G |
Cas.: 860193-10-8 | Purity: 95% | 3-(2-ethoxyphenyl)-2-ethylquinazolin-4(3H)-one | ESD-913343-5G |
Cas.: NONE8183 | Purity: 95% | 2-(2-(4-(2-(4-chlorophenoxy)acetyl)piperazin-1-yl)ethyl)-3-(2-ethoxyphenyl)quinazolin-4(3H)-one | ESD-913344-5MG |
Cas.: NONE8183 | Purity: 95% | 2-(2-(4-(2-(4-chlorophenoxy)acetyl)piperazin-1-yl)ethyl)-3-(2-ethoxyphenyl)quinazolin-4(3H)-one | ESD-913344-10MG |
Cas.: NONE8183 | Purity: 95% | 2-(2-(4-(2-(4-chlorophenoxy)acetyl)piperazin-1-yl)ethyl)-3-(2-ethoxyphenyl)quinazolin-4(3H)-one | ESD-913344-50MG |
Cas.: NONE8183 | Purity: 95% | 2-(2-(4-(2-(4-chlorophenoxy)acetyl)piperazin-1-yl)ethyl)-3-(2-ethoxyphenyl)quinazolin-4(3H)-one | ESD-913344-100MG |
Cas.: 1261438-69-0 | Purity: 99% | (4-bromo-2-iodophenyl)methanol | ESD-913345-500MG |
Cas.: 1261438-69-0 | Purity: 99% | (4-bromo-2-iodophenyl)methanol | ESD-913345-1G |
Cas.: 1261438-69-0 | Purity: 99% | (4-bromo-2-iodophenyl)methanol | ESD-913345-5G |
Cas.: 1225023-88-0 | Purity: 99% | di-tert-butyl 3,3′-(anthracene-9,10-diyl)-diacrylate | ESD-913346-1G |
Cas.: 1225023-88-0 | Purity: 99% | di-tert-butyl 3,3′-(anthracene-9,10-diyl)-diacrylate | ESD-913346-500MG |
Cas.: 1225023-88-0 | Purity: 99% | di-tert-butyl 3,3′-(anthracene-9,10-diyl)-diacrylate | ESD-913346-5G |
Cas.: 34124-14-6 | Purity: 98% | 2,2′-Ethylenedianiline | ESD-870290-25G |
Cas.: 4338-47-0 | Purity: ≥99% | Kinetin riboside | ESD-879045-500MG |
Cas.: 112926-00-8 | Purity: AR | Silica gel | ESD-818053-10KG |
Cas.: 6104-58-1 | Purity: AR | Brilliant Blue G | ESD-802205-1KG |
Cas.: 7727-21-1 | Purity: ≥99.0% Total nitrogen contains amount≤0.0005%, suitable for Use For HJ636-2012 | Potassium persulfate | ESD-913348-500G |
Cas.: 278779-30-9 | Purity: 99% | GW4064 | ESD-872313-5MG |
Cas.: 10035-04-8 | Purity: AR | Calcium chloride dihydrate | ESD-804987-10KG |
Cas.: 90076-65-6 | Purity: 99% | Bistrifluoromethanesulfonimidate | ESD-802084-2.5KG |
Cas.: 73590-58-6 | Purity: 98% | Omeprazole | ESD-815323-500G |
Cas.: 1400-61-9 | Purity: USP, ≥4, 400 units/mg | Nystatin | ESD-814559-100G |
Cas.: 7727-21-1 | Purity: Environmental grade, 99.5% | Potassium persulfate | ESD-913349-500G |
Cas.: 7727-21-1 | Purity: Environmental grade, 99.5% | Potassium persulfate | ESD-913349-250G |
Cas.: 7727-21-1 | Purity: ≥99.0% Total nitrogen contains amount≤0.0005%, suitable for Use For HJ636-2012 | Potassium persulfate | ESD-913348-250G |
Cas.: 370860-74-5 | Purity: ≥97%(GC) | 4-(cis-4-Hydroxycyclohexyl)phenol | ESD-862679-1G |
Cas.: 370860-74-5 | Purity: ≥97%(GC) | 4-(cis-4-Hydroxycyclohexyl)phenol | ESD-862679-250MG |
Cas.: 761-01-3 | Purity: 95% | Sulfur Trioxide – Triethylamine Complex | ESD-831121-100G |
Cas.: 761-01-3 | Purity: 95% | Sulfur Trioxide – Triethylamine Complex | ESD-831121-500G |
Cas.: 28077-64-7 | Purity: 99 atom % D | Acetophenone-2,3,4,5,6-d5 | ESD-874212-250MG |
Cas.: 12262-58-7 | Purity: 70% in Water | Cyclohexanone peroxide | ESD-913350-2.5KG |
Cas.: 12262-58-7 | Purity: 70% in Water | Cyclohexanone peroxide | ESD-913350-500G |
Cas.: 12262-58-7 | Purity: 70% in Water | Cyclohexanone peroxide | ESD-913350-100G |
Cas.: 12262-58-7 | Purity: ≥95% | Cyclohexanone peroxide | ESD-913351-2.5KG |
Cas.: 127-18-4 | Purity: Infrared oil measuring instrument dedicated, ≥99.8% | Tetrachloroethylene | ESD-913352-500ML |
Cas.: 12262-58-7 | Purity: ≥95% | Cyclohexanone peroxide | ESD-913351-500G |
Cas.: 127-18-4 | Purity: Infrared oil measuring instrument dedicated, ≥99.8% | Tetrachloroethylene | ESD-913352-100ML |
Cas.: 127-18-4 | Purity: Infrared oil measuring instrument dedicated, ≥99.8% | Tetrachloroethylene | ESD-913352-1L |
Cas.: 12262-58-7 | Purity: ≥95% | Cyclohexanone peroxide | ESD-913351-100G |
Cas.: 12039-88-2 | Purity: -325 Mesh, 99.5% | Tungsten silicide | ESD-819989-250G |
Cas.: 56706-10-6 | Purity: S: 13.5-15.5% | Bis(Triethoxysilylpropyl)Disulfide | ESD-833978-50ML |
Cas.: 54547-34-1 | Purity: 98% | Trimethylolpropane tribenzoate | ESD-913353-500G |
Cas.: 54547-34-1 | Purity: 98% | Trimethylolpropane tribenzoate | ESD-913353-100G |
Cas.: 54547-34-1 | Purity: 98% | Trimethylolpropane tribenzoate | ESD-913353-25G |
Cas.: 13492-01-8 | Purity: ≥99% | Tranylcypromine hemisulfate | ESD-883088-250MG |
Cas.: 13492-01-8 | Purity: ≥99% | Tranylcypromine hemisulfate | ESD-883088-1G |
Cas.: NONE8185 | Purity: Use For HJ636-2012 | Alkaline potassium persulfate solution | ESD-913355-500ML |
Cas.: NONE8185 | Purity: Use For HJ636-2012 | Alkaline potassium persulfate solution | ESD-913355-100ML |
Cas.: 1310-73-2 | Purity: ρ (NaOH)=200g/L, suitable for Use For HJ636-2012 | Sodium hydroxide solution | ESD-913356-1L |
Cas.: 1310-73-2 | Purity: ρ (NaOH)=20g/L, suitable for Use For HJ636-2012 | Sodium hydroxide solution | ESD-913357-1L |
Cas.: 25189-55-3 | Purity: Mn ~300,000 | Poly(N-isopropylacrylamide) | ESD-875493-5G |
Cas.: 9000-59-3 | Purity: Acid value 40-70mg KOH/g | Shellac | ESD-834644-500G |
Cas.: 16674-78-5 | Purity: 99.997% metals basis | Magnesium acetate tetrahydrate | ESD-837015-25G |
Cas.: 16674-78-5 | Purity: 99.997% metals basis | Magnesium acetate tetrahydrate | ESD-837015-100G |
Cas.: 16674-78-5 | Purity: 99.997% metals basis | Magnesium acetate tetrahydrate | ESD-837015-500G |
Cas.: 6574-98-7 | Purity: 98% | 2,4-Dichlorobenzonitrile | ESD-806347-500G |
Cas.: 9002-85-1 | Polyvinylidene chloride (PVDC) | ESD-909295-2.5KG | |
Cas.: 870281-83-7 | Purity: 97% | 2-Fluoro-6-nitro-N-phenylbenzamide | ESD-896265-25G |
Cas.: NONE7920 | Proclin 300 | ESD-903551-10L | |
Cas.: 395-05-1 | Purity: ≥95% | 2-(3-Fluorophenyl)-2-hydroxyacetic acid | ESD-893690-5G |
Cas.: 614-33-5 | Purity: 98% | Glycerol tribenzoate | ESD-913358-25G |
Cas.: 614-33-5 | Purity: 98% | Glycerol tribenzoate | ESD-913358-100G |
Cas.: 614-33-5 | Purity: 98% | Glycerol tribenzoate | ESD-913358-500G |
Cas.: 614-33-5 | Purity: 98% | Glycerol tribenzoate | ESD-913358-2.5KG |
Cas.: 115144-35-9 | Purity: ≥98.0% (HPLC) | D-Luciferin potassium salt | ESD-812648-500MG |
Cas.: 637-84-3 | Purity: ≥97%(HPLC)(T) | H-Gly-Gly-Gly-Gly-OH | ESD-863017-50MG |
Cas.: 637-84-3 | Purity: ≥97%(HPLC)(T) | H-Gly-Gly-Gly-Gly-OH | ESD-863017-250MG |
Cas.: NONE8071 | Purity: Solid contains amount: 60% | Waterborne polyurethane | ESD-909580-100G |
Cas.: 929-77-1 | Purity: 99% | Methyl behenate | ESD-813994-25G |
Cas.: 59134-90-6 | Purity: 95% | N-(2-Bromothiazol-4-yl)-2,2,2-trifluoroacetamide | ESD-913359-250MG |
Cas.: 59134-90-6 | Purity: 95% | N-(2-Bromothiazol-4-yl)-2,2,2-trifluoroacetamide | ESD-913359-1G |
Cas.: 70681-41-3 | Purity: 98% | Dimethyl D-malate | ESD-806624-100G |
Cas.: 70681-41-3 | Purity: 98% | Dimethyl D-malate | ESD-806624-500G |
Cas.: 5875-06-9 | Purity: BR | Proparacaine Hydrochloride | ESD-860743-500MG |
Cas.: 5875-06-9 | Purity: BR | Proparacaine Hydrochloride | ESD-860743-1G |
Cas.: 90823-38-4 | Purity: 98% | Denatonium Saccharide | ESD-913360-5G |
Cas.: 90823-38-4 | Purity: 98% | Denatonium Saccharide | ESD-913360-25G |
Cas.: 90823-38-4 | Purity: 98% | Denatonium Saccharide | ESD-913360-100G |
Cas.: 90823-38-4 | Purity: 98% | Denatonium Saccharide | ESD-913360-500G |
Cas.: 4499-86-9 | Purity: 25% in water | Tetrapropylammonium hydroxide solution | ESD-832219-2.5KG |
Cas.: 2107-76-8 | Purity: 98% | 5,7-Dihydroxy-4-methylcoumarin | ESD-870982-25G |
Cas.: 2998-23-4 | Purity: ≥98.0%(GC), Inhibited with 100 ppm MEHQ | Pentyl acrylate | ESD-885083-500MG |
Cas.: 36801-01-1 | Purity: 95% | 4-CYANOTHIOPHENOL | ESD-913362-5G |
Cas.: 36801-01-1 | Purity: 95% | 4-CYANOTHIOPHENOL | ESD-913362-1G |
Cas.: 36801-01-1 | Purity: 95% | 4-CYANOTHIOPHENOL | ESD-913362-250MG |
Cas.: 12036-39-4 | Purity: -325 Mesh powder, 99.0% metals basis | Strontium zirconate | ESD-818394-50G |
Cas.: 2987-16-8 | Purity: 95% | 3,3-Dimethylbutyraldehyde | ESD-835497-100ML |
Cas.: 1121-92-2 | Purity: ≥97% | Heptamethyleneimine | ESD-838418-1G |
Cas.: 1912-33-0 | Purity: 98% | Methyl Indole-3-acetate | ESD-824031-25G |
Cas.: 1912-33-0 | Purity: 98% | Methyl Indole-3-acetate | ESD-824031-100G |
Cas.: 10366-05-9 | Purity: 97%(mix) | 12,43-Dichloro-1,4(1,4)-dibenzenacyclohexaphane | ESD-892071-25G |
Cas.: 110677-45-7 | Purity: ≥96% | 4-(9H-Carbazol-9-yl)benzaldehyde | ESD-866866-5G |
Cas.: 1898-66-4 | Purity: 96% | 2,2-Diphenyl-1-picrylhydrazyl | ESD-807298-25G |
Cas.: 142-87-0 | Purity: 98% | Sodium decyl sulfate | ESD-909986-5G |
Cas.: 6279-86-3 | Purity: 97% | Triethyl methanetricarboxylate | ESD-836650-100G |
Cas.: 26074-52-2 | Purity: 95% | 2-Bromobutyryl Bromide | ESD-858374-100G |
Cas.: 26074-52-2 | Purity: 95% | 2-Bromobutyryl Bromide | ESD-858374-500G |
Cas.: 371-26-6 | Purity: 98% | Ethyl 4,4,4-Trifluorobutyrate | ESD-835057-5G |
Cas.: 28380-24-7 | Purity: 97% | Nigericin | ESD-849348-25MG |
Cas.: 6976-91-6 | Purity: ≥98% | N,N-Dimethylmethacrylamide | ESD-859068-5ML |
Cas.: 69-74-9 | Purity: ≥98%, HPLC | Cytosine β-D-arabinofuranoside hydrochloride | ESD-822670-100G |
Cas.: 4163-59-1 | Purity: 98% | alpha-D-Galactopyranosepentaacetate | ESD-913366-500G |
Cas.: 4163-59-1 | Purity: 98% | alpha-D-Galactopyranosepentaacetate | ESD-913366-100G |
Cas.: 4163-59-1 | Purity: 98% | alpha-D-Galactopyranosepentaacetate | ESD-913366-25G |
Cas.: 4163-59-1 | Purity: 98% | alpha-D-Galactopyranosepentaacetate | ESD-913366-5G |
Cas.: 582323-16-8 | Purity: ≥98% | ICA-069673 | ESD-878340-50MG |
Cas.: 582323-16-8 | Purity: ≥98% | ICA-069673 | ESD-878340-100MG |
Cas.: 19481-79-9 | Purity: >96.0%(GC) | 2-Iodo-2-methylpropionitrile | ESD-861739-250MG |
Cas.: 35139-28-7 | Purity: Fecontains amount: 21% | Polymer Ferric Sulphate | ESD-910006-10KG |
Cas.: 80-41-1 | Purity: 97% | 2-Chloroethyl p-toluenesulfonate | ESD-838184-5ML |
Cas.: 80-41-1 | Purity: 97% | 2-Chloroethyl p-toluenesulfonate | ESD-838184-1ML |
Cas.: 68285-24-5 | Purity: 95% | (S)-1-(2-Methoxyphenyl)ethanamine | ESD-913369-1G |
Cas.: 68285-24-5 | Purity: 95% | (S)-1-(2-Methoxyphenyl)ethanamine | ESD-913369-250MG |
Cas.: 68285-24-5 | Purity: 95% | (S)-1-(2-Methoxyphenyl)ethanamine | ESD-913369-100MG |
Cas.: 875468-59-0 | Purity: 99% | 1-Ethoxy-2,3-difluoro-4-[(trans-4-propylcyclohexyl)methoxy]benzene | ESD-913370-5G |
Cas.: 875468-59-0 | Purity: 99% | 1-Ethoxy-2,3-difluoro-4-[(trans-4-propylcyclohexyl)methoxy]benzene | ESD-913370-25G |
Cas.: 875468-59-0 | Purity: 99% | 1-Ethoxy-2,3-difluoro-4-[(trans-4-propylcyclohexyl)methoxy]benzene | ESD-913370-100G |
Cas.: 6575-08-2 | Purity: 98% | 2-Bromo-6-chlorobenzonitrile | ESD-844353-1G |
Cas.: 6575-08-2 | Purity: 98% | 2-Bromo-6-chlorobenzonitrile | ESD-844353-5G |
Cas.: 6575-08-2 | Purity: 98% | 2-Bromo-6-chlorobenzonitrile | ESD-844353-25G |
Cas.: 1310923-37-5 | Purity: 95% | (S)-1-(4-Chlorophenyl)propan-1-amine hydrochloride | ESD-913371-1G |
Cas.: 1310923-37-5 | Purity: 95% | (S)-1-(4-Chlorophenyl)propan-1-amine hydrochloride | ESD-913371-250MG |
Cas.: 13323-67-6 | Purity: 98% | (E)-1-(2,4-dihydroxyphenyl)-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-one | ESD-913372-5MG |
Cas.: 115250-39-0 | Purity: 98% | Tetrabenzyl-voglibose | ESD-913373-1G |
Cas.: 115250-39-0 | Purity: 98% | Tetrabenzyl-voglibose | ESD-913373-250MG |
Cas.: 71751-41-2 | Purity: 97% | Abamectin | ESD-913374-1G |
Cas.: 115250-39-0 | Purity: 98% | Tetrabenzyl-voglibose | ESD-913373-100MG |
Cas.: 71751-41-2 | Purity: 97% | Abamectin | ESD-913374-5G |
Cas.: 71751-41-2 | Purity: 97% | Abamectin | ESD-913374-25G |
Cas.: 1126-20-1 | Purity: 98% | 2-(Allyloxy)phenol | ESD-855104-1G |
Cas.: 2234-13-1 | Purity: 98% | Octachloronaphthalene | ESD-822686-25G |
Cas.: 76-62-0 | Purity: 98% | 3,3-Bis(3,5-dibromo-4-hydroxyphenyl)isobenzofuran-1(3H)-one | ESD-913375-100G |
Cas.: 76-62-0 | Purity: 98% | 3,3-Bis(3,5-dibromo-4-hydroxyphenyl)isobenzofuran-1(3H)-one | ESD-913375-50G |
Cas.: 84632-65-5 | Purity: ≥98% | Pigment Red 254 | ESD-860292-500G |
Cas.: 49694-21-5 | Purity: Analysis control, >95% | Xylohexaose | ESD-889710-10MG |
Cas.: 214045-85-9 | Purity: 98% | 6-Fluoroisoquinolin-1(2H)-one | ESD-913376-1G |
Cas.: 214045-85-9 | Purity: 98% | 6-Fluoroisoquinolin-1(2H)-one | ESD-913376-250MG |
Cas.: 21324-39-0 | Purity: 98% | Sodium hexafluorophosphate | ESD-831065-500G |
Cas.: 127852-30-6 | Purity: 95% | (R)-1-(3-(Trifluoromethyl)phenyl)ethanamine | ESD-913378-1G |
Cas.: 127852-30-6 | Purity: 95% | (R)-1-(3-(Trifluoromethyl)phenyl)ethanamine | ESD-913378-5G |
Cas.: 127852-30-6 | Purity: 95% | (R)-1-(3-(Trifluoromethyl)phenyl)ethanamine | ESD-913378-250MG |
Cas.: 67784-82-1 | Purity: 99% | Polyglyceryl fatty ester | ESD-913379-100G |
Cas.: 67784-82-1 | Purity: 99% | Polyglyceryl fatty ester | ESD-913379-500G |
Cas.: 3984-22-3 | Purity: 98% | 2-Vinyl-1,3-dioxolane | ESD-913380-1ML |
Cas.: 1205-58-9 | Purity: 98% | 4-(Acetamidomethyl)benzoic acid | ESD-913381-10G |
Cas.: 1205-58-9 | Purity: 98% | 4-(Acetamidomethyl)benzoic acid | ESD-913381-5G |
Cas.: 1205-58-9 | Purity: 98% | 4-(Acetamidomethyl)benzoic acid | ESD-913381-1G |
Cas.: 123560-52-1 | Purity: 98% | 1-Ethoxy-2,3-difluoro-4-[[(trans,trans)-4′-propyl[1,1′-bicyclohexyl]-4-yl]methoxy]benzene | ESD-913382-250MG |
Cas.: 123560-52-1 | Purity: 98% | 1-Ethoxy-2,3-difluoro-4-[[(trans,trans)-4′-propyl[1,1′-bicyclohexyl]-4-yl]methoxy]benzene | ESD-913382-1G |
Cas.: 3063-94-3 | Purity: 99% | 1,1,1,3,3,3-Hexafluoroisopropyl methacrylate | ESD-838107-25G |
Cas.: 3063-94-3 | Purity: 99% | 1,1,1,3,3,3-Hexafluoroisopropyl methacrylate | ESD-838107-100G |
Cas.: 13195-76-1 | Purity: 99% | tris(2-methylpropyl) borate | ESD-913383-1KG |
Cas.: 3063-94-3 | Purity: 99% | 1,1,1,3,3,3-Hexafluoroisopropyl methacrylate | ESD-838107-1G |
Cas.: 13195-76-1 | Purity: 99% | tris(2-methylpropyl) borate | ESD-913383-250G |
Cas.: 773100-76-8 | Purity: 98% | 5-(bromomethyl)-2-fluorobenzoic acid | ESD-913384-1G |
Cas.: 773100-76-8 | Purity: 98% | 5-(bromomethyl)-2-fluorobenzoic acid | ESD-913384-250MG |
Cas.: 773100-76-8 | Purity: 98% | 5-(bromomethyl)-2-fluorobenzoic acid | ESD-913384-5G |
Cas.: 18200-72-1 | Purity: 98% | Sodium 1-carboxylatoethyl stearate | ESD-913341-500G |
Cas.: 18200-72-1 | Purity: 98% | Sodium 1-carboxylatoethyl stearate | ESD-913341-2.5KG |
Cas.: 1832583-40-0 | Purity: 97% | 3-Chloro-5-nitro-2-(2H-1,2,3-triazol-2-yl)pyridine | ESD-913385-1G |
Cas.: 1832583-40-0 | Purity: 97% | 3-Chloro-5-nitro-2-(2H-1,2,3-triazol-2-yl)pyridine | ESD-913385-250MG |
Cas.: 149587-72-4 | Purity: 97% | methyl 3-[(2-methylpropan-2-yl)oxycarbonylamino]thiophene-2-carboxylate | ESD-913386-1G |
Cas.: 149587-72-4 | Purity: 97% | methyl 3-[(2-methylpropan-2-yl)oxycarbonylamino]thiophene-2-carboxylate | ESD-913386-5G |
Cas.: 81-37-8 | Purity: ≥95% | FLUOROL YELLOW 088 | ESD-885969-250MG |
Cas.: 689251-97-6 | Purity: 95% | (E)-3-(1-Methyl-1H-pyrazol-4-yl)acrylic acid | ESD-913387-1G |
Cas.: 689251-97-6 | Purity: 95% | (E)-3-(1-Methyl-1H-pyrazol-4-yl)acrylic acid | ESD-913387-250MG |
Cas.: 7698-05-7 | Purity: (D, 99%) DCl 36.5% in D2O | Deuterium chloride | ESD-835611-0.6ML |
Cas.: 337456-92-5 | Purity: 99% | 3,5-Difluoro-4-[difluoro(3,4,5-trifluorophenoxy)methyl]-4′-propyl-1,1′-biphenyl | ESD-913388-250MG |
Cas.: 1027617-86-2 | Purity: 95% | 5-Cyclopropyl-3-(trifluoromethyl)-1H-pyrazole | ESD-913389-100MG |
Cas.: 1027617-86-2 | Purity: 95% | 5-Cyclopropyl-3-(trifluoromethyl)-1H-pyrazole | ESD-913389-50MG |
Cas.: 63302-64-7 | Purity: 98% | 3-Cyclohexene-1-carboxylic acid 2-ethylhexyl ester | ESD-913390-5G |
Cas.: 63302-64-7 | Purity: 98% | 3-Cyclohexene-1-carboxylic acid 2-ethylhexyl ester | ESD-913390-25G |
Cas.: 63302-64-7 | Purity: 98% | 3-Cyclohexene-1-carboxylic acid 2-ethylhexyl ester | ESD-913390-100G |
Cas.: 63302-64-7 | Purity: 98% | 3-Cyclohexene-1-carboxylic acid 2-ethylhexyl ester | ESD-913390-500G |
Cas.: 67784-82-1 | Purity: 99% | Polyglyceryl fatty ester | ESD-913379-2.5KG |
Cas.: 1214328-96-7 | Purity: 95% | Methyl 3-bromo-6-chloropicolinate | ESD-913392-100MG |
Cas.: 1214328-96-7 | Purity: 95% | Methyl 3-bromo-6-chloropicolinate | ESD-913392-250MG |
Cas.: 1214328-96-7 | Purity: 95% | Methyl 3-bromo-6-chloropicolinate | ESD-913392-1G |
Cas.: 1029769-35-4 | Purity: 95% | N-(3-(4H-1,2,4-Triazol-4-yl)phenyl)acetamide | ESD-913393-250MG |
Cas.: 393-53-3 | Purity: 97% | 3-Fluoropyridine-4-carboxylic acid | ESD-810187-100G |
Cas.: 1029769-35-4 | Purity: 95% | N-(3-(4H-1,2,4-Triazol-4-yl)phenyl)acetamide | ESD-913393-100MG |
Cas.: 376347-09-0 | Purity: 95% | N-(3-(Hydroxymethyl)phenyl)methanesulfonamide | ESD-913394-250MG |
Cas.: 376347-09-0 | Purity: 95% | N-(3-(Hydroxymethyl)phenyl)methanesulfonamide | ESD-913394-1G |
Cas.: 376347-09-0 | Purity: 95% | N-(3-(Hydroxymethyl)phenyl)methanesulfonamide | ESD-913394-100MG |
Cas.: 55366-56-8 | Purity: 98% | Hibifolin | ESD-913396-10MG |
Cas.: 596-51-0 | Purity: 99% | Glycopyrrolate | ESD-913397-10MG |
Cas.: 596-51-0 | Purity: 99% | Glycopyrrolate | ESD-913397-50MG |
Cas.: 596-51-0 | Purity: 99% | Glycopyrrolate | ESD-913397-100MG |
Cas.: 41743-74-2 | Purity: 98% | Toralactone | ESD-913398-10MG |
Cas.: 1167424-32-9 | Purity: 98% | 9”’-Methylsalvianolate B | ESD-913399-10MG |
Cas.: 50656-65-0 | Purity: 98% | Rotundifuran | ESD-913400-10MG |
Cas.: 2968-33-4 | Purity: 97% | 3,3,3-Trifluoropropan-1-amine hydrochloride | ESD-913401-250MG |
Cas.: 2968-33-4 | Purity: 97% | 3,3,3-Trifluoropropan-1-amine hydrochloride | ESD-913401-100MG |
Cas.: 1722-26-5 | Purity: 97% | Borane triethylamine complex | ESD-913402-5G |
Cas.: 1722-26-5 | Purity: 97% | Borane triethylamine complex | ESD-913402-25G |
Cas.: 1722-26-5 | Purity: 97% | Borane triethylamine complex | ESD-913402-100G |
Cas.: 630-60-4 | Purity: 99% | NSC 25485 | ESD-872552-100MG |
Cas.: 178420-75-2 | Purity: 95% | N-[3-[4-amino-7-[(2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidin-5-yl] prop-2-ynyl]-2,2,2-trifluoroacetamide | ESD-913403-1G |
Cas.: 178420-75-2 | Purity: 95% | N-[3-[4-amino-7-[(2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidin-5-yl] prop-2-ynyl]-2,2,2-trifluoroacetamide | ESD-913403-5G |
Cas.: 178420-75-2 | Purity: 95% | N-[3-[4-amino-7-[(2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidin-5-yl] prop-2-ynyl]-2,2,2-trifluoroacetamide | ESD-913403-250MG |
Cas.: 977051-29-8 | Purity: 99% | Diacetyl tartaric acid ester of mono(di)glycerides | ESD-913405-2.5KG |
Cas.: 977051-29-8 | Purity: 99% | Diacetyl tartaric acid ester of mono(di)glycerides | ESD-913405-500G |
Cas.: 977051-29-8 | Purity: 99% | Diacetyl tartaric acid ester of mono(di)glycerides | ESD-913405-100G |
Cas.: 174462-91-0 | Purity: 95% | N{2}-Isobutyryl-7-iodo-7-deaza-2′-deoxyguanosine | ESD-913406-1G |
Cas.: 174462-91-0 | Purity: 95% | N{2}-Isobutyryl-7-iodo-7-deaza-2′-deoxyguanosine | ESD-913406-5G |
Cas.: 174462-91-0 | Purity: 95% | N{2}-Isobutyryl-7-iodo-7-deaza-2′-deoxyguanosine | ESD-913406-250MG |
Cas.: 172163-62-1 | Purity: 95% | 7-Deaza-7-Iodo-2′-DeoxyGuanosine | ESD-849935-1G |
Cas.: 528-21-2 | Purity: 98% | 2,3,4-Trihydroxyacetophenone | ESD-838428-5G |
Cas.: 172163-62-1 | Purity: 95% | 7-Deaza-7-Iodo-2′-DeoxyGuanosine | ESD-849935-250MG |
Cas.: 143601-09-6 | Purity: 98% | curculigoside B | ESD-913407-5MG |
Cas.: 33527-91-2 | Purity: 98% | Tris[2-(dimethylamino)ethyl]amine | ESD-823759-5G |
Cas.: 15174-47-7 | Purity: 97% | Alpha-Methyl-Trans-Cinnamaldehyde | ESD-859359-2.5KG |
Cas.: 30197-14-9 | Purity: 98% | Desoxyrhaponticin | ESD-913408-10MG |
Cas.: 29550-13-8 | Purity: 98% | 7-O-Methylbaicalein | ESD-913410-10MG |
Cas.: 108228-37-1 | Purity: 98% | 1,1′-Bis[3-(trimethylammonio)propyl]-4,4′-bipyridinium Tetrachloride Dihydrate | ESD-871266-250MG |
Cas.: 7758-01-2 | Purity: 99,8% | Potassium bromate | ESD-816477-100G |
Cas.: 58274-56-9 | Purity: 98% | Kakkalide | ESD-913412-10MG |
Cas.: 10125-13-0 | Purity: AR | Copric chloride dihydrate | ESD-805299-100G |
Cas.: 10125-13-0 | Purity: AR | Copric chloride dihydrate | ESD-805299-10KG |
Cas.: 2345-17-7 | Purity: 98% | Irisolidone | ESD-913413-5MG |
Cas.: 2345-17-7 | Purity: 98% | Irisolidone | ESD-913413-10MG |
Cas.: 39012-01-6 | Purity: 98% | Iristectorigenin A | ESD-913414-5MG |
Cas.: 39012-01-6 | Purity: 98% | Iristectorigenin A | ESD-913414-10MG |
Cas.: 308068-56-6 | Purity: >95%, ID:2-5nm, OD:<8nm, Length:0.5-2μm, -OH:~5.6wt% | Short Hydroxy Purified Multi-Walled Carbon Nanotubes | ESD-835664-25G |
Cas.: 30557-81-4 | Purity: 98% | Bisabolangelone | ESD-913415-10MG |
Cas.: 72674-05-6 | Sodium α-olefinsulfonate | ESD-913416-500G | |
Cas.: 72674-05-6 | Sodium α-olefinsulfonate | ESD-913416-100G | |
Cas.: 1208091-47-7 | Purity: 95% | 4-Cyclopropyl-3-methylaniline | ESD-913417-100MG |
Cas.: 1208091-47-7 | Purity: 95% | 4-Cyclopropyl-3-methylaniline | ESD-913417-50MG |
Cas.: 1956379-02-4 | Purity: 95% | 5,7-Dibromo-1H-pyrazolo[4,3-b]pyridine | ESD-913419-100MG |
Cas.: 1956379-02-4 | Purity: 95% | 5,7-Dibromo-1H-pyrazolo[4,3-b]pyridine | ESD-913419-50MG |
Cas.: 106644-33-1 | Purity: 98% | otophylloside A | ESD-913420-5MG |
Cas.: 106644-33-1 | Purity: 98% | otophylloside A | ESD-913420-10MG |
Cas.: 4947-75-5 | Purity: 98% | Smilagenin acetate | ESD-913421-10MG |
Cas.: 85566-12-7 | Purity: 99% | Alcohols,C8-10 | ESD-913422-500G |
Cas.: 4947-75-5 | Purity: 98% | Smilagenin acetate | ESD-913421-5MG |
Cas.: 85566-12-7 | Purity: 99% | Alcohols,C8-10 | ESD-913422-100G |
Cas.: 85566-12-7 | Purity: 99% | Alcohols,C8-10 | ESD-913422-25G |
Cas.: 143502-51-6 | Purity: 98% | yibeissine | ESD-913423-5MG |
Cas.: 143502-51-6 | Purity: 98% | yibeissine | ESD-913423-10MG |
Cas.: 268733-18-2 | Purity: 98% | 4-BROMO-3,5-BIS(TRIFLUOROMETHYL)ANILINE | ESD-913425-250MG |
Cas.: 268733-18-2 | Purity: 98% | 4-BROMO-3,5-BIS(TRIFLUOROMETHYL)ANILINE | ESD-913425-1G |
Cas.: 268733-18-2 | Purity: 98% | 4-BROMO-3,5-BIS(TRIFLUOROMETHYL)ANILINE | ESD-913425-5G |
Cas.: 268733-18-2 | Purity: 98% | 4-BROMO-3,5-BIS(TRIFLUOROMETHYL)ANILINE | ESD-913425-10G |
Cas.: 268733-18-2 | Purity: 98% | 4-BROMO-3,5-BIS(TRIFLUOROMETHYL)ANILINE | ESD-913425-25G |
Cas.: 140-38-5 | Purity: 98% | 4-Chlorophenylurea | ESD-859321-1G |
Cas.: 140-38-5 | Purity: 98% | 4-Chlorophenylurea | ESD-859321-25G |
Cas.: 464-72-2 | Purity: 95% | 1,1,2,2-Tetraphenyl-1,2-ethanediol | ESD-909450-500G |
Cas.: 10416-59-8 | Purity: 95% | |N|,|O|-Bis(trimethylsilyl)acetamide (TMS-BA) | ESD-819353-2.5L |
Cas.: 543-80-6 | Purity: AR, 99% | Barium acetate | ESD-802118-10KG |
Cas.: 80206-82-2 | Purity: 99% | Alcohols, C12-14 | ESD-913430-500G |
Cas.: 80206-82-2 | Purity: 99% | Alcohols, C12-14 | ESD-913430-2.5KG |
Cas.: 90-12-0 | Purity: 98% | 1-Methylnaphthalene | ESD-813139-10KG |
Cas.: 8005-44-5 | Purity: 99% | Cetostearyl alcohol | ESD-913431-100G |
Cas.: 8005-44-5 | Purity: 99% | Cetostearyl alcohol | ESD-913431-500G |
Cas.: 8005-44-5 | Purity: 99% | Cetostearyl alcohol | ESD-913431-2.5KG |
Cas.: 16215-21-7 | Purity: 98% | Butyl 3-mercaptopropionate | ESD-828644-100ML |
Cas.: 72824-04-5 | Purity: ≥95% | 2-allyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-824883-100G |
Cas.: 1211593-45-1 | Purity: 95% | N-(5-Bromothiazol-4-yl)-2,2,2-trifluoroacetamide | ESD-913432-250MG |
Cas.: 1211593-45-1 | Purity: 95% | N-(5-Bromothiazol-4-yl)-2,2,2-trifluoroacetamide | ESD-913432-1G |
Cas.: 1211593-45-1 | Purity: 95% | N-(5-Bromothiazol-4-yl)-2,2,2-trifluoroacetamide | ESD-913432-50MG |
Cas.: 9041-08-1 | Purity: ≥150 units/mg | Heparin sodium salt | ESD-913433-5G |
Cas.: 9041-08-1 | Purity: ≥150 units/mg | Heparin sodium salt | ESD-913433-1G |
Cas.: 7440-64-4 | Purity: Sublimation, 99.9% (REO) | Ytterbium pieces | ESD-837143-1G |
Cas.: 57-62-5 | Purity: ≥98% | Chlorotetracycline | ESD-822259-50MG |
Cas.: 57-62-5 | Purity: ≥98% | Chlorotetracycline | ESD-822259-250MG |
Cas.: 884494-74-0 | Purity: 98% | 2-Chloro-5-fluoroisonicotinic acid | ESD-842747-5G |
Cas.: 884494-74-0 | Purity: 98% | 2-Chloro-5-fluoroisonicotinic acid | ESD-842747-10G |
Cas.: 884494-74-0 | Purity: 98% | 2-Chloro-5-fluoroisonicotinic acid | ESD-842747-25G |
Cas.: 884494-74-0 | Purity: 98% | 2-Chloro-5-fluoroisonicotinic acid | ESD-842747-100MG |
Cas.: 110238-91-0 | Purity: 98% | Methyl tetrahydro-2H-pyran-4-carboxylate | ESD-814080-1ML |
Cas.: 34620-77-4 | Purity: 95% | Maltohexaose | ESD-814212-50MG |
Cas.: 59134-92-8 | Purity: 95% | 2,2,2-Trifluoro-N-4-thiazolyl-acetamide | ESD-913434-50MG |
Cas.: 59134-92-8 | Purity: 95% | 2,2,2-Trifluoro-N-4-thiazolyl-acetamide | ESD-913434-250MG |
Cas.: 59134-92-8 | Purity: 95% | 2,2,2-Trifluoro-N-4-thiazolyl-acetamide | ESD-913434-1G |
Cas.: 99662-34-7 | Purity: 99,9% | 4-(1H-Pyrazol-1-yl)benzaldehyde | ESD-913438-1G |
Cas.: 99662-34-7 | Purity: 99,9% | 4-(1H-Pyrazol-1-yl)benzaldehyde | ESD-913438-5G |
Cas.: 99662-34-7 | Purity: 99,9% | 4-(1H-Pyrazol-1-yl)benzaldehyde | ESD-913438-10G |
Cas.: 99662-34-7 | Purity: 99,9% | 4-(1H-Pyrazol-1-yl)benzaldehyde | ESD-913438-25G |
Cas.: 34620-76-3 | Purity: 95% | Maltopentaose | ESD-814211-10MG |
Cas.: 123-96-6 | Purity: AR, 98% | 2-Octanol | ESD-815247-10L |
Cas.: NONE6654 | Purity: >96% | 3X FLAG peptide, Met-Asp-Tyr-Lys-Asp-His-Asp-Gly-Asp-Tyr-Lys-Asp-His-Asp-Ile-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys, MDYKDHDGDYKDHDIDYKDDDDK | ESD-860820-25MG |
Cas.: 2156-56-1 | Purity: 98% | Sodium dichloroacetate | ESD-831190-100G |
Cas.: 6156-84-9 | Purity: 95% | Maltooctaose | ESD-913440-500MG |
Cas.: 6156-84-9 | Purity: 95% | Maltooctaose | ESD-913440-100MG |
Cas.: 82257-09-8 | Purity: 98% | 3-Bromo-4-methoxypyridine | ESD-839316-1G |
Cas.: 82257-09-8 | Purity: 98% | 3-Bromo-4-methoxypyridine | ESD-839316-10G |
Cas.: 82257-09-8 | Purity: 98% | 3-Bromo-4-methoxypyridine | ESD-839316-25G |
Cas.: 82257-09-8 | Purity: 98% | 3-Bromo-4-methoxypyridine | ESD-839316-100G |
Cas.: 81045-39-8 | Purity: 98% | 5,8-Dibromoisoquinoline | ESD-842371-5G |
Cas.: 81045-39-8 | Purity: 98% | 5,8-Dibromoisoquinoline | ESD-842371-10G |
Cas.: 9003-53-6 | Purity: 25mg/5mL in PBS, non-magnetic, 1um | Streptavidin modified polystyrene microspheres | ESD-913443-5ML |
Cas.: 57381-59-6 | Purity: ≥97% | Methyl 5-Bromo-2-Fluorobenzoate | ESD-859007-5G |
Cas.: 57381-59-6 | Purity: ≥97% | Methyl 5-Bromo-2-Fluorobenzoate | ESD-859007-25G |
Cas.: 95-12-5 | Purity: 99% | 5-Norbornen-2-methanol (mixture of isomers) | ESD-824326-500G |
Cas.: 944401-77-8 | Purity: 98% | 2-AMINO-4-FLUOROPYRIDINE | ESD-830513-5G |
Cas.: 944401-77-8 | Purity: 98% | 2-AMINO-4-FLUOROPYRIDINE | ESD-830513-10G |
Cas.: 944401-77-8 | Purity: 98% | 2-AMINO-4-FLUOROPYRIDINE | ESD-830513-25G |
Cas.: 944401-77-8 | Purity: 98% | 2-AMINO-4-FLUOROPYRIDINE | ESD-830513-1G |
Cas.: 622-45-7 | Purity: 99% | Cyclohexyl Acetate | ESD-871356-500ML |
Cas.: 71-44-3 | Purity: 97% | Spermine | ESD-874788-25G |
Cas.: 96690-41-4 | Purity: 90% | Protein hydrolyzates, silk | ESD-885106-500G |
Cas.: 91-77-0 | Purity: ≥98% | 2,4-Diamino-6-diallylamino-1,3,5-triazine | ESD-865906-5G |
Cas.: 1191-43-1 | Purity: 97% | 1,6-Hexanedithiol | ESD-811008-500ML |
Cas.: 4645-15-2 | Purity: 95% | 1,1′-oxybis(cyclohexane) | ESD-913451-100G |
Cas.: 4645-15-2 | Purity: 95% | 1,1′-oxybis(cyclohexane) | ESD-913451-25G |
Cas.: 4645-15-2 | Purity: 95% | 1,1′-oxybis(cyclohexane) | ESD-913451-5G |
Cas.: 727382-14-1 | Purity: 94% | (3S)-4-Chloro-3-[(triMethylsilyl)oxy]butanenitrile | ESD-913452-5G |
Cas.: 727382-14-1 | Purity: 94% | (3S)-4-Chloro-3-[(triMethylsilyl)oxy]butanenitrile | ESD-913452-25G |
Cas.: 727382-14-1 | Purity: 94% | (3S)-4-Chloro-3-[(triMethylsilyl)oxy]butanenitrile | ESD-913452-100G |
Cas.: 180410-47-3 | Purity: ≥95% | 2,3-Difluoro-N-hydroxy-6-(trifluoromethyl)-benzimidamide | ESD-913454-1G |
Cas.: 727382-14-1 | Purity: 94% | (3S)-4-Chloro-3-[(triMethylsilyl)oxy]butanenitrile | ESD-913452-500G |
Cas.: 178306-52-0 | Purity: 98% | Benzenepropanoic acid,a-hydroxy-b-methoxy-b-phenyl-,(aS)- | ESD-822271-1G |
Cas.: 178306-52-0 | Purity: 98% | Benzenepropanoic acid,a-hydroxy-b-methoxy-b-phenyl-,(aS)- | ESD-822271-5G |
Cas.: 178306-52-0 | Purity: 98% | Benzenepropanoic acid,a-hydroxy-b-methoxy-b-phenyl-,(aS)- | ESD-822271-10G |
Cas.: 1888-71-7 | Purity: 95% | HEXACHLOROPROPENE | ESD-913456-50G |
Cas.: 1888-71-7 | Purity: 95% | HEXACHLOROPROPENE | ESD-913456-250G |
Cas.: 14376-79-5 | Purity: 98% | 3,3,5,5-Tetramethylcyclohexanone | ESD-821323-1G |
Cas.: 634-62-8 | Purity: ≥98%(T) | Hydrazine L-(+)-Tartrate | ESD-862744-1G |
Cas.: 542-46-1 | Purity: 95% | 9-Cycloheptadecen-1-one | ESD-906685-100G |
Cas.: 363-72-4 | Purity: 98% | Pentafluorobenzene | ESD-831062-500G |
Cas.: 383150-41-2 | Purity: 99% | JTE 013 | ESD-872597-25MG |
Cas.: 766-92-7 | Purity: 98% | Benzyl Methyl Sulfide | ESD-858173-500G |
Cas.: 6792-31-0 | Purity: 97% | Hexafluoropropene trimer | ESD-896041-500G |
Cas.: 27025-41-8 | Purity: 99%biotech grade | Glutathione oxysomed | ESD-6120-100G |
Cas.: 628692-22-8 | Purity: ≥98% | 2-Chloro-3-Fluoro-4-(Trifluoromethyl)Pyridine | ESD-858012-250MG |
Cas.: 155090-83-8 | Purity: 1.3%-1.5% in isopropanol | Poly(3,4-ethylenedioxythiophene)-poly(styrenesulfonate) | ESD-913458-100ML |
Cas.: 155090-83-8 | Purity: 1.3%-1.5% in isopropanol | Poly(3,4-ethylenedioxythiophene)-poly(styrenesulfonate) | ESD-913458-25ML |
Cas.: 6789-88-4 | Purity: 98% | Hexyl Benzoate | ESD-859347-100G |
Cas.: 6789-88-4 | Purity: 98% | Hexyl Benzoate | ESD-859347-500G |
Cas.: 2440-22-4 | Purity: ≥98% | 2-(2-Hydroxy-5-methylphenyl)benzotriazole | ESD-857463-500G |
Cas.: 2440-22-4 | Purity: ≥98% | 2-(2-Hydroxy-5-methylphenyl)benzotriazole | ESD-857463-2.5KG |
Cas.: 19501-58-7 | Purity: 98% | 4-Methoxyphenylhydrazine hydrochloride | ESD-813567-500G |
Cas.: 52-01-7 | Purity: ≥97% | Spironolactone | ESD-837932-100G |
Cas.: 409071-16-5 | Purity: ≥99% | Lithium difluoro(oxalato)borate | ESD-875430-500G |
Cas.: 124729-98-2 | Purity: ≥99.0% | 4,4′,4”-Tris(N-3-methylphenyl-N-phenylamino)triphenylamine | ESD-820248-250MG |
Cas.: 645-43-2 | Purity: 98% | Guanethidine Monosulfate | ESD-856824-1G |
Cas.: 29427-58-5 | Purity: 97% | Methyl carbamimidate sulfate | ESD-848925-500G |
Cas.: 26473-47-2 | Purity: ≥98%(GC)(T) | 3-Mercaptoisobutyric Acid | ESD-863350-1G |
Cas.: 22233-52-9 | Purity: 95% | 3-CHLORO-2-NITROBENZALDEHYDE | ESD-908594-5G |
Cas.: 33311-29-4 | Purity: 98% | 4-(2-Methoxyethoxy)aniline | ESD-847281-5G |
Cas.: 33311-29-4 | Purity: 98% | 4-(2-Methoxyethoxy)aniline | ESD-847281-25G |
Cas.: 4897-84-1 | Purity: 98% | Methyl 4-bromobutyrate | ESD-824193-5G |
Cas.: 2938-98-9 | Purity: ≥95% | 2-methylbutane-1,4-diol | ESD-913465-250MG |
Cas.: 25148-68-9 | Purity: 99% | N-Methyl-1,2-benzenediamine dihydrochloride | ESD-813210-25G |
Cas.: 10405-02-4 | Purity: 98% | Trospium chloride | ESD-833039-500MG |
Cas.: 10405-02-4 | Purity: 98% | Trospium chloride | ESD-833039-1G |
Cas.: 10405-02-4 | Purity: 98% | Trospium chloride | ESD-833039-5G |
Cas.: 22236-11-9 | Purity: 98% | N-[4-(Difluoromethoxy)phenyl]acetamide | ESD-823914-1G |
Cas.: 22236-11-9 | Purity: 98% | N-[4-(Difluoromethoxy)phenyl]acetamide | ESD-823914-250MG |
Cas.: 9002-92-0 | Purity: ≥90%, n=9 | Brij | ESD-913467-5KG |
Cas.: 9002-92-0 | Purity: ≥90%, n=9 | Brij | ESD-913467-1KG |
Cas.: 9002-92-0 | Purity: ≥90%, n=9 | Brij | ESD-913467-250G |
Cas.: 9002-92-0 | Purity: ≥90%, n=9 | Brij | ESD-913467-100G |
Cas.: 5989-54-8 | Purity: 95% | (-)-Limonene | ESD-831202-2.5L |
Cas.: 1257642-74-2 | Bathocuproinedisulfonic acid disodiuM salt hydrate | ESD-913470-1G | |
Cas.: 10236-47-2 | Purity: ≥99% | Naringin | ESD-872021-100G |
Cas.: 5041-09-8 | Purity: ≥99%(T) | Isobutylamine Hydrochloride | ESD-862576-100G |
Cas.: 2996-92-1 | Purity: ≥98%, GC | Trimethoxyphenylsilane | ESD-819938-10L |
Cas.: 60-33-3 | Purity: ≥95%(GC) | Linoleic acid | ESD-812258-2.5KG |
Cas.: 609-22-3 | Purity: 98% | 2,4-Dibromo-6-methylphenol | ESD-913479-1G |
Cas.: 609-22-3 | Purity: 98% | 2,4-Dibromo-6-methylphenol | ESD-913479-5G |
Cas.: 609-22-3 | Purity: 98% | 2,4-Dibromo-6-methylphenol | ESD-913479-10G |
Cas.: 609-22-3 | Purity: 98% | 2,4-Dibromo-6-methylphenol | ESD-913479-25G |
Cas.: 26570-48-9 | Purity: Average MW ~200 , contains 80-120 ppm MEHQ stabilizer | Poly(ethylene glycol) diacrylate | ESD-835539-2.5L |
Cas.: 61788-44-1 | Purity: 95% | Styrenated phenol | ESD-906671-500G |
Cas.: 590-63-6 | Purity: ≥99% | Bethanechol Chloride | ESD-837926-25G |
Cas.: 590-63-6 | Purity: ≥99% | Bethanechol Chloride | ESD-837926-100G |
Cas.: 8005-02-5 | Purity: ≥98% | Solvent Black 7 | ESD-875102-100G |
Cas.: 8005-02-5 | Purity: ≥98% | Solvent Black 7 | ESD-875102-500G |
Cas.: 8005-02-5 | Purity: ≥98% | Solvent Black 7 | ESD-875102-2.5KG |
Cas.: 52208-56-7 | Purity: 95% | 3-Chloro-2,6-difluoropyridine | ESD-913482-1G |
Cas.: 52208-56-7 | Purity: 95% | 3-Chloro-2,6-difluoropyridine | ESD-913482-5G |
Cas.: 52208-56-7 | Purity: 95% | 3-Chloro-2,6-difluoropyridine | ESD-913482-10G |
Cas.: 52208-56-7 | Purity: 95% | 3-Chloro-2,6-difluoropyridine | ESD-913482-25G |
Cas.: 18595-13-6 | Purity: ≥98% | Methyl 2-amino-6-methylbenzoate | ESD-857538-5G |
Cas.: 2452-01-9 | Zinc Laurate | ESD-859284-25G | |
Cas.: 2452-01-9 | Zinc Laurate | ESD-859284-100G | |
Cas.: 2452-01-9 | Zinc Laurate | ESD-859284-500G | |
Cas.: 62655-20-3 | Purity: 96% | 1,3-DIBROMO-5-ISOPROPYLBENZENE | ESD-913484-1G |
Cas.: 62655-20-3 | Purity: 96% | 1,3-DIBROMO-5-ISOPROPYLBENZENE | ESD-913484-5G |
Cas.: 62655-20-3 | Purity: 96% | 1,3-DIBROMO-5-ISOPROPYLBENZENE | ESD-913484-25G |
Cas.: 6064-83-1 | Purity: ≥97% | 2-(Phosphonooxy)benzoic Acid | ESD-867907-1G |
Cas.: 40928-13-0 | Purity: 97% | 4-Chloroisatoic anhydride | ESD-805788-25G |
Cas.: 40928-13-0 | Purity: 97% | 4-Chloroisatoic anhydride | ESD-805788-100G |
Cas.: 97281-48-6 | Purity: >99% | L-α-phosphatidylcholine, hydrogenated (Soy) | ESD-863826-100MG |
Cas.: 97281-48-6 | Purity: >99% | L-α-phosphatidylcholine, hydrogenated (Soy) | ESD-863826-500MG |
Cas.: 1015082-83-3 | Purity: 97% | BenzeneMethanol, 4-(1,2,2-triphenylethenyl)- | ESD-913486-5G |
Cas.: 1015082-83-3 | Purity: 97% | BenzeneMethanol, 4-(1,2,2-triphenylethenyl)- | ESD-913486-1G |
Cas.: 252947-01-6 | Purity: ≥95% | 4,4,5,5,5-Pentafluoropentyl Methanesulfonate | ESD-913488-1G |
Cas.: 252947-01-6 | Purity: ≥95% | 4,4,5,5,5-Pentafluoropentyl Methanesulfonate | ESD-913488-250MG |
Cas.: 446292-04-2 | Purity: 98% | 4-(4-Nitrophenyl)morpholin-3-one | ESD-843754-100G |
Cas.: 252947-01-6 | Purity: ≥95% | 4,4,5,5,5-Pentafluoropentyl Methanesulfonate | ESD-913488-5G |
Cas.: 61788-46-3 | Purity: 98% | Coco alkyl amines | ESD-889743-1KG |
Cas.: 13656-36-5 | Purity: 97% | 3,5-Dichloro-2,4,6-trifluorobenzoic acid | ESD-913492-25G |
Cas.: 950194-37-3 | Purity: 98% | (-)-Benzotetramisole | ESD-803607-250MG |
Cas.: 950194-37-3 | Purity: 98% | (-)-Benzotetramisole | ESD-803607-5G |
Cas.: 8008-31-9 | Purity: Limonene>90% | Mandarin green oil | ESD-913497-100G |
Cas.: 8008-31-9 | Purity: Limonene>90% | Mandarin green oil | ESD-913497-500G |
Cas.: 8008-31-9 | Purity: Limonene>90% | Mandarin green oil | ESD-913497-2.5KG |
Cas.: 39713-40-1 | Purity: 98% | 7,8-Dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione | ESD-913439-100MG |
Cas.: 39713-40-1 | Purity: 98% | 7,8-Dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione | ESD-913439-250MG |
Cas.: 39713-40-1 | Purity: 98% | 7,8-Dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione | ESD-913439-1G |
Cas.: 54285-91-5 | Purity: >99.5% | Hexaneammonium iodide | ESD-904393-1G |
Cas.: 54285-91-5 | Purity: >99.5% | Hexaneammonium iodide | ESD-904393-5G |
Cas.: 40106-98-7 | Purity: 97% | 4-Chloro-5-nitroquinoline | ESD-893164-1G |
Cas.: 40106-98-7 | Purity: 97% | 4-Chloro-5-nitroquinoline | ESD-893164-5G |
Cas.: 29914-81-6 | Purity: 95% | 1,3-Bis(1H-benzo[d]imidazol-2-yl)benzene | ESD-843923-5G |
Cas.: 17372-87-1 | Purity: AR, 80% | Eosin Y water solution | ESD-809097-1KG |
Cas.: 3248-91-7 | New Fuchsin | ESD-867291-25G | |
Cas.: 95058-81-4 | Purity: 98% | Gemcitabine | ESD-824362-25G |
Cas.: 3248-91-7 | New Fuchsin | ESD-867291-100G | |
Cas.: 111-58-0 | Purity: ≥90% | N-Oleoylethanolamine | ESD-859460-25G |
Cas.: 1965308-99-9 | Purity: 95% | 5-Aminopyrazine-2-carbaldehyde hydrochloride | ESD-913508-100MG |
Cas.: 1965308-99-9 | Purity: 95% | 5-Aminopyrazine-2-carbaldehyde hydrochloride | ESD-913508-25MG |
Cas.: 12228-87-4 | Purity: 98.9-101.2% B2O3 basis | Ammonium biborate tetrahydrate | ESD-886272-100G |
Cas.: 12228-87-4 | Purity: 98.9-101.2% B2O3 basis | Ammonium biborate tetrahydrate | ESD-886272-25G |
Cas.: 67416-61-9 | Purity: >98% | AKBA | ESD-860606-1MG |
Cas.: 80443-63-6 | Purity: ≥96% | 2-tert-Butyl-2-[2-(4-chlorophenyl)ethyl]oxirane | ESD-864870-25G |
Cas.: 80443-63-6 | Purity: ≥96% | 2-tert-Butyl-2-[2-(4-chlorophenyl)ethyl]oxirane | ESD-864870-100G |
Cas.: 97653-93-5 | Purity: 98% | Lucidone B | ESD-913511-2MG |
Cas.: 8008-63-7 | Purity: ≥42% | GALL | ESD-913513-100G |
Cas.: 8008-63-7 | Purity: ≥42% | GALL | ESD-913513-500G |
Cas.: 8008-63-7 | Purity: ≥45% | GALL | ESD-913514-100G |
Cas.: 8008-63-7 | Purity: ≥45% | GALL | ESD-913514-500G |
Cas.: 89913-60-0 | Purity: 98% | α-acetyl Boswellic Acid | ESD-913003-1MG |
Cas.: 158923-07-0 | Purity: 97% | (S)-(+)-1-[(R)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldicyclohexylphosphine | ESD-835568-25MG |
Cas.: 223595-28-6 | Purity: 97% | 2,4-Dibromo-3-(difluoromethoxy)benzoic acid | ESD-913517-1G |
Cas.: 223595-28-6 | Purity: 97% | 2,4-Dibromo-3-(difluoromethoxy)benzoic acid | ESD-913517-5G |
Cas.: 70588-06-6 | Purity: 98% | Chrysoobtusin | ESD-913518-10MG |
Cas.: 6319-06-8 | Purity: 98% | noreximide | ESD-913519-1G |
Cas.: 6319-06-8 | Purity: 98% | noreximide | ESD-913519-5G |
Cas.: 13477-97-9 | Purity: ≥98% | Nickel hypophosphite hexahydrate | ESD-875850-2.5KG |
Cas.: 944252-63-5 | Purity: 97% | Murepavadin | ESD-902162-1MG |
Cas.: 70588-05-5 | Purity: 98% | Obtusin | ESD-913523-20MG |
Cas.: 70588-05-5 | Purity: 98% | Obtusin | ESD-913523-10MG |
Cas.: 31284-89-6 | Purity: 98% | 2-Hydroxy-2-(4-methylphenyl)acetic acid | ESD-913525-1G |
Cas.: 31284-89-6 | Purity: 98% | 2-Hydroxy-2-(4-methylphenyl)acetic acid | ESD-913525-5G |